[
  {
    "id": "12925480",
    "question": "Does desflurane afford greater protection than halothane against focal cerebral ischaemia in the rat?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether desflurane provides better protection than halothane against focal cerebral ischemia in rats. To answer this, I would need to know about comparative studies between these two anesthetic agents specifically in rat models of focal cerebral ischemia. Without specific research data, I cannot definitively answer whether desflurane affords greater protection than halothane in this specific context. The question is asking for a factual comparison between two specific anesthetic agents in a specific experimental model, which requires knowledge of relevant scientific literature.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15044662",
    "question": "Do high local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if high local concentrations and effects on differentiation implicate interleukin-6 (IL-6) as a paracrine regulator. Let me analyze this:\n\nParacrine regulation refers to a form of cell signaling where a cell produces a signal that affects nearby cells. For a molecule to be considered a paracrine regulator, it typically:\n1. Acts locally (high local concentrations)\n2. Affects nearby cells (not distant cells)\n3. Influences cellular processes like differentiation\n\nThe question mentions that IL-6 has:\n- High local concentrations (suggesting localized action)\n- Effects on differentiation (a cellular process that can be regulated by paracrine factors)\n\nThese characteristics are consistent with paracrine regulation. IL-6 is indeed known in immunology and cell biology as a cytokine that can function in a paracrine manner, affecting nearby cells and influencing processes including differentiation.\n\nBased on these factors, the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24028087",
    "question": "Is experience-dependent persistent expression of zif268 during rest preserved in the aged dentate gyrus?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about whether a specific biological phenomenon, namely the 'experience-dependent persistent expression of zif268 during rest', is preserved in the aged dentate gyrus. The dentate gyrus is a region of the hippocampus in the brain, and zif268 (also known as Egr1) is an immediate early gene that is often used as a marker for neural activity. The question is specifically asking if the expression of this gene, which occurs in response to experience and persists during rest, continues to function the same way in aged (older) dentate gyrus compared to younger dentate gyrus. Without specific research data on this topic, I cannot definitively answer whether this particular expression pattern is preserved with aging.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16458482",
    "question": "Does dietary glutamine supplementation reduce cellular adhesion molecule expression and tissue myeloperoxidase activity in mice with gut-derived sepsis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if dietary glutamine supplementation reduces cellular adhesion molecule expression and tissue myeloperoxidase activity in mice with gut-derived sepsis. To answer this, I need to consider what is known about glutamine supplementation effects in sepsis models, particularly gut-derived sepsis in mice. Glutamine is an amino acid that has been studied for its potential immunomodulatory and anti-inflammatory properties. In some studies, glutamine supplementation has been shown to have beneficial effects on intestinal barrier function and immune response during sepsis. Cellular adhesion molecules are important in the inflammatory response, and myeloperoxidase activity is a marker of neutrophil infiltration and inflammation. Research has suggested that glutamine can modulate these inflammatory markers in various disease models. Based on existing literature, glutamine supplementation has been shown to reduce both cellular adhesion molecule expression and tissue myeloperoxidase activity in experimental models of gut-derived sepsis in mice.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20614481",
    "question": "Is cD74 a survival receptor on colon epithelial cells?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to determine if cD74 is a survival receptor on colon epithelial cells. CD74 (also known as invariant chain or Ii) is primarily known as a chaperone protein involved in MHC class II antigen presentation. It's expressed on antigen-presenting cells like B cells, dendritic cells, and macrophages. While CD74 can function as a receptor for macrophage migration inhibitory factor (MIF) and has been implicated in survival signaling in some cell types, I need to specifically determine if it serves as a survival receptor on colon epithelial cells. Based on my knowledge, while CD74 is expressed in some epithelial tissues and has been studied in colorectal cancer, there isn't definitive evidence establishing it as a survival receptor specifically on normal colon epithelial cells. The research on CD74 in colon epithelium has focused more on its role in inflammation and cancer rather than as a definitive survival receptor in normal colon epithelial cells.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15736403",
    "question": "Do antibiotics directly induce apoptosis in B cell lymphoma cells derived from BALB/c mice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific mechanism: whether antibiotics directly induce apoptosis (programmed cell death) in a specific type of cancer cells (B cell lymphoma cells) that come from a specific strain of mice (BALB/c mice). To answer this accurately, I need to consider what is known about antibiotics' mechanisms of action. Antibiotics are generally designed to target bacterial cells by interfering with bacterial-specific processes like cell wall synthesis, protein synthesis, or DNA replication. They are not typically designed to directly induce apoptosis in mammalian cells, including cancer cells. While some antibiotics may have off-target effects on mammalian cells, a direct apoptotic effect specifically on B cell lymphoma cells from BALB/c mice would be a very specific claim requiring specific evidence. Without evidence of such a direct mechanism, the answer would be no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22717544",
    "question": "Is regression of ECG-LVH associated with lower risk of new-onset heart failure and mortality in patients with isolated systolic hypertension ; The LIFE study?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether regression of ECG-LVH (electrocardiographic left ventricular hypertrophy) is associated with lower risk of new-onset heart failure and mortality in patients with isolated systolic hypertension, specifically in the context of the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.\\n\\nTo answer this question accurately, I would need to know the specific findings of the LIFE study regarding ECG-LVH regression and its relationship to heart failure and mortality outcomes in the subgroup of patients with isolated systolic hypertension. Without having the specific data from this study, I cannot provide a definitive answer.\\n\\nHowever, the LIFE study is a well-known clinical trial that did demonstrate that regression of ECG-LVH was generally associated with reduced cardiovascular morbidity and mortality. Whether this specific association held true in the subgroup of patients with isolated systolic hypertension would require specific data from that study.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21864484",
    "question": "Is treatment with beta-hydroxybutyrate and melatonin associated with improved survival in a porcine model of hemorrhagic shock?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if treatment with beta-hydroxybutyrate and melatonin is associated with improved survival in a porcine model of hemorrhagic shock. To answer this, I need to consider whether there is evidence that this specific combination therapy improves survival outcomes in pig models of hemorrhagic shock. Without specific research studies cited in the question, I need to determine if this is a generally accepted finding in the medical literature. Based on my knowledge, there have been studies showing that both beta-hydroxybutyrate and melatonin individually have protective effects in hemorrhagic shock models, and some research has investigated their combined use with positive results for survival outcomes in experimental animal models including porcine models.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "9752025",
    "question": "Is [ Management of psoriasis in family practice now in closer agreement with the guidelines of the Netherlands Society of Family Physicians ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether the management of psoriasis in family practice is now in closer agreement with the guidelines of the Netherlands Society of Family Physicians. To answer this question, I would need specific information about: 1) what the current management practices for psoriasis in family practice are, 2) what the guidelines of the Netherlands Society of Family Physicians recommend, and 3) whether there has been a change over time bringing practice closer to these guidelines. The question contains an assertion but doesn't provide evidence or context to evaluate whether this statement is true. Without specific data or references about current practice patterns and how they've changed relative to the guidelines, I cannot determine if the assertion is accurate.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16755236",
    "question": "Is primary osteoarthritis in the ankle joint associated with finger metacarpophalangeal osteoarthritis and the H63D mutation in the HFE gene : evidence for a hemochromatosis-like polyarticular osteoarthritis phenotype?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific association between primary osteoarthritis in the ankle joint, finger metacarpophalangeal osteoarthritis, and the H63D mutation in the HFE gene. The question specifically asks if there is evidence for a 'hemochromatosis-like polyarticular osteoarthritis phenotype' that connects these conditions.\\n\\nTo answer this accurately, I would need to know if research has established this specific association. The question itself seems to be phrased like a research question or title, suggesting this might be a hypothesis rather than an established fact. Without specific scientific evidence confirming this association, I cannot answer 'yes'.\\n\\nSince I don't have access to the latest medical research that might confirm this specific association between ankle osteoarthritis, finger metacarpophalangeal osteoarthritis, and the H63D mutation in the HFE gene as a hemochromatosis-like phenotype, I should answer 'no'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23534852",
    "question": "Is natural experimentation a challenging method for identifying headache triggers?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Natural experimentation refers to observing naturally occurring variations or events to draw causal inferences, rather than setting up controlled experiments. When it comes to identifying headache triggers, natural experimentation would involve patients observing their daily lives and noting when headaches occur, then trying to identify patterns or correlations with potential triggers.\\n\\nThis method is indeed challenging for several reasons:\\n1. Multiple variables: In daily life, people are exposed to numerous potential triggers simultaneously (stress, food, weather, sleep patterns, etc.), making it difficult to isolate which factor caused a headache.\\n2. Delayed effects: Some triggers may cause headaches hours or even days later, making connections difficult to establish.\\n3. Subjective reporting: Reliance on patient self-reporting introduces recall bias and other inaccuracies.\\n4. Individual variation: Triggers vary significantly between individuals.\\n5. Lack of control: Unlike controlled clinical trials, natural settings don't allow for systematic manipulation of variables.\\n\\nThese challenges make natural experimentation a difficult method for precisely identifying headache triggers, though it remains commonly used in clinical practice.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15660244",
    "question": "Do breath-to-breath analysis of abdominal and rib cage motion in surfactant-depleted piglets during high-frequency oscillatory ventilation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether breath-to-breath analysis of abdominal and rib cage motion is performed in surfactant-depleted piglets during high-frequency oscillatory ventilation. This appears to be a specific scientific research question about a particular methodology used in a study involving piglets. The question is phrased as a yes/no question, but it's not clear if it's asking whether such analysis is possible, commonly done, or if it's asking about a specific study. Without more context or specific reference to a study, I cannot definitively say whether this specific analysis is performed. However, high-frequency oscillatory ventilation (HFOV) and monitoring of chest/abdominal motion in animal models are established research techniques in respiratory physiology. The question seems to be asking if a specific type of analysis is done in a specific experimental setup, but doesn't provide enough context for me to give a definitive answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20820986",
    "question": "Does high preoperative neutrophil-lymphocyte ratio predict poor survival in patients with gastric cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if a high preoperative neutrophil-lymphocyte ratio (NLR) predicts poor survival in gastric cancer patients. Based on medical literature, elevated NLR has been associated with poor prognosis in various cancers including gastric cancer. Multiple studies and meta-analyses have shown that high preoperative NLR is an independent predictor of poor overall survival in gastric cancer patients. This is likely because elevated NLR reflects both neutrophilia (associated with systemic inflammation) and lymphopenia (indicating impaired host immunity), which can contribute to cancer progression and reduced survival. So the evidence supports that high preoperative NLR does predict poor survival in gastric cancer patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19397826",
    "question": "Are m-protein and other intrinsic virulence factors of Streptococcus pyogenes encoded on an ancient pathogenicity island?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze what is known about the virulence factors of Streptococcus pyogenes (Group A Streptococcus). M-protein is a major virulence factor of S. pyogenes that allows the bacterium to resist phagocytosis. It is encoded by the emm gene, which is part of the core genome of S. pyogenes, not on a pathogenicity island. Pathogenicity islands are distinct genetic elements that are acquired through horizontal gene transfer and contain virulence-associated genes. While S. pyogenes does have some virulence factors encoded on mobile genetic elements like prophages, the major intrinsic virulence factors including M-protein are part of the core genome. There is no evidence in the scientific literature that M-protein and other intrinsic virulence factors of S. pyogenes are encoded on an ancient pathogenicity island.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23778480",
    "question": "Does genotoxicity and acute and subchronic toxicity studies of a standardized methanolic extract of Ficus deltoidea leave?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether genotoxicity and acute and subchronic toxicity studies of a standardized methanolic extract of Ficus deltoidea leaves exist. This is asking about the existence of specific scientific studies. Without specific information about whether such studies have been conducted and published, I cannot definitively answer this question. The question itself is also incomplete grammatically - it should probably be 'Does genotoxicity and acute and subchronic toxicity studies of a standardized methanolic extract of Ficus deltoidea leaves exist?' Since I don't have specific information about the existence of these studies, I cannot answer yes or no with certainty.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27017164",
    "question": "Does preoperative cognitive function predict survival in patients with resectable pancreatic ductal adenocarcinoma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if preoperative cognitive function is a predictor of survival in patients with resectable pancreatic ductal adenocarcinoma. To answer this, I would need to know if there are established research findings showing a correlation between cognitive function before surgery and survival outcomes specifically in pancreatic ductal adenocarcinoma patients who undergo resection. Without specific research evidence mentioned in the question, I cannot definitively say whether preoperative cognitive function is a proven predictor of survival in this specific patient population. There are many established prognostic factors for pancreatic cancer (like tumor stage, margin status, lymph node involvement), but cognitive function is not typically among the most commonly cited predictors. However, general health status and functional status can impact surgical outcomes in many cancers, so it's plausible but not definitively established based on the information provided.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20035513",
    "question": "Do three-dimensional surface maps link local atrophy and fast ripples in human epileptic hippocampus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific relationship between three-dimensional surface maps, local atrophy, and fast ripples in the human epileptic hippocampus. To answer this accurately, I need to consider whether there is established scientific evidence showing that 3D surface mapping techniques have demonstrated a correlation or connection between areas of hippocampal atrophy and the occurrence of fast ripples (high-frequency oscillations that are biomarkers of epileptogenicity) in epilepsy patients. Based on neuroscience literature, there are indeed studies that have used 3D surface mapping to correlate structural abnormalities (atrophy) with electrophysiological phenomena like fast ripples in epileptic hippocampi. For example, research has shown that fast ripples tend to occur in regions showing hippocampal atrophy, and 3D surface mapping has been used to visualize and quantify this relationship.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25530715",
    "question": "Are the differential susceptibilities of MCF-7 and MDA-MB-231 cells to the cytotoxic effects of curcumin associated with the PI3K/Akt-SKP2-Cip/Kips pathway?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether the different susceptibilities of two breast cancer cell lines (MCF-7 and MDA-MB-231) to curcumin's cytotoxic effects are related to the PI3K/Akt-SKP2-Cip/Kips pathway. To answer this, I would need to know if research has established this specific pathway as the mechanism for the differential response. Without specific research information provided in the question, I cannot determine if this particular pathway is definitively associated with the differential cytotoxic effects of curcumin in these cell lines. The question is asking for a factual connection between a specific molecular pathway and observed differential effects, which requires evidence from research studies.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23106493",
    "question": "Do children monosensitized to pine nuts have similar patterns of sensitization?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if children who are monosensitized to pine nuts (meaning they are allergic only to pine nuts and not to other nuts or allergens) have similar patterns of sensitization. To answer this, I would need to know if there's a consistent immunological response pattern among children who are specifically allergic only to pine nuts. Based on allergy literature, allergen sensitization patterns can vary between individuals, even when they're allergic to the same food. Without specific research showing that children monosensitized to pine nuts display uniform sensitization patterns (like similar IgE binding profiles or similar clinical manifestations), I cannot confidently say they all follow the same pattern.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27399532",
    "question": "Does 334 A Functional Screen identify miRNAs that Induce Radioresistance in Glioblastomas?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question. The question is asking whether '334 A Functional Screen identifies miRNAs that Induce Radioresistance in Glioblastomas'. This appears to be asking about a specific research study or paper titled or numbered '334 A Functional Screen' and whether this study identifies miRNAs (microRNAs) that cause radioresistance in glioblastomas (a type of brain tumor). Without having access to this specific paper or study, I cannot definitively say whether this study does identify such miRNAs. The question is very specific about a particular research work that I don't have information about.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22661631",
    "question": "Do screening tests for Chlamydia trachomatis or Neisseria gonorrhoeae using the cobas 4800 PCR system require a second test to confirm : an audit of patients issued with equivocal results at a sexual health clinic in the Northwest of England , U.K?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether screening tests for Chlamydia trachomatis or Neisseria gonorrhoeae using the cobas 4800 PCR system require a second confirmatory test when equivocal results are issued. This appears to be referencing a specific audit conducted at a sexual health clinic in Northwest England. Based on the phrasing, it seems to be asking about the findings or conclusions of this audit regarding confirmation testing protocols for equivocal results. Without having access to the specific audit mentioned, I cannot determine whether the audit found that confirmatory tests were required or not for equivocal results.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "8956814",
    "question": "Does aging exaggerate the blood glucose response to total parenteral nutrition?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether aging exaggerates the blood glucose response to total parenteral nutrition (TPN). To answer this, I need to consider whether there's evidence that older individuals have a more pronounced increase in blood glucose levels when receiving TPN compared to younger individuals. \\n\\nAging is associated with decreased insulin sensitivity and impaired glucose tolerance. Total parenteral nutrition typically contains glucose and can cause hyperglycemia, especially in susceptible individuals. Research has shown that elderly patients often have reduced glucose tolerance and insulin resistance compared to younger patients. Studies have demonstrated that older patients receiving TPN are more likely to develop hyperglycemia and require insulin therapy to maintain normal glucose levels. This suggests that aging does indeed exaggerate the blood glucose response to TPN.\\n\\nBased on the physiological changes that occur with aging and the available clinical evidence, I can conclude that yes, aging does exaggerate the blood glucose response to total parenteral nutrition.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25703413",
    "question": "Does surgeon-performed ultrasound-guided FNAC with on-site cytopathology improve adequacy and accuracy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if surgeon-performed ultrasound-guided fine-needle aspiration cytology (FNAC) with on-site cytopathology improves adequacy and accuracy. To answer this, I need to consider whether there is evidence that having surgeons perform ultrasound-guided FNAC with immediate cytopathology assessment improves sample adequacy rates and diagnostic accuracy compared to standard approaches. Based on medical literature, surgeon-performed ultrasound-guided FNAC with on-site cytopathology evaluation has been shown to improve specimen adequacy rates and diagnostic accuracy in various settings, particularly for thyroid nodules and lymph nodes. The immediate feedback from on-site cytopathology allows for repeat sampling if needed, reducing inadequate samples and improving overall diagnostic yield.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26184548",
    "question": "Does vasopeptidase Inhibition correct the Structure and Function of the Small Arteries in Experimental Renal Insufficiency?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if vasopeptidase inhibition corrects the structure and function of small arteries in experimental renal insufficiency. To answer this, I would need to know specific research findings on this topic. Vasopeptidase inhibitors are agents that simultaneously inhibit angiotensin-converting enzyme and neutral endopeptidase. They have been studied for potential benefits in various cardiovascular and renal conditions. However, without specific research data on their effects on small artery structure and function in renal insufficiency models, I cannot definitively answer yes or no. Since this appears to be a specific scientific question that would require evidence from research studies, and I don't have access to that specific information, I cannot provide a definitive answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26160678",
    "question": "Are schistosoma haematobium egg-induced bladder urothelial abnormalities dependent on p53 modulated by host sex?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between schistosoma haematobium egg-induced bladder urothelial abnormalities, p53 modulation, and host sex. To answer this, I need to determine if research has established that these bladder abnormalities caused by schistosoma haematobium eggs are dependent on p53 that is specifically modulated by the sex of the host.\\n\\nSchistosoma haematobium is a parasitic flatworm that causes urogenital schistosomiasis. The eggs can cause inflammation and abnormalities in the bladder urothelium. P53 is a tumor suppressor protein that plays a role in cell cycle regulation and preventing cancer.\\n\\nWhile there is research showing that schistosoma infection can affect p53 pathways and that there may be sex differences in schistosomiasis infection outcomes, I don't have definitive evidence that the bladder urothelial abnormalities caused by S. haematobium eggs are specifically dependent on p53 that is modulated by host sex. This would require specific studies demonstrating this three-way interaction.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23915716",
    "question": "Does selective ablation of mast cells or basophils reduce peanut-induced anaphylaxis in mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether selectively removing (ablating) mast cells or basophils reduces anaphylaxis (a severe allergic reaction) caused by peanuts in mice. To answer this, I need to consider what scientific research has shown about the role of these specific immune cells in peanut-induced anaphylaxis in mouse models.\\n\\nMast cells and basophils are both important effector cells in allergic reactions, containing granules with inflammatory mediators like histamine. They express high-affinity IgE receptors and are involved in the pathophysiology of anaphylaxis.\\n\\nResearch has indeed shown that selective ablation of mast cells significantly reduces peanut-induced anaphylaxis in mouse models. Studies using mast cell-deficient mice or mice with selective mast cell ablation have demonstrated reduced severity of anaphylactic reactions to peanut allergens.\\n\\nSimilarly, studies targeting basophils have shown that these cells also contribute to peanut-induced anaphylaxis in mice, and their selective depletion can reduce the severity of reactions.\\n\\nTherefore, scientific evidence supports that selective ablation of either mast cells or basophils does reduce peanut-induced anaphylaxis in mice.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19156895",
    "question": "Do postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the associations between postmenopausal hormone use and breast cancer differ based on the specific hormone regimen used and the histologic subtype of breast cancer. Based on medical research, there is evidence that different hormone therapy regimens (e.g., estrogen-only vs. combined estrogen-progestin) have different risk profiles for breast cancer. Additionally, studies have shown that hormone therapy may be associated with different risks for different histologic subtypes of breast cancer (such as ductal vs. lobular carcinomas). The Women's Health Initiative and other large studies have demonstrated these differential associations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "14506159",
    "question": "Are laminin-5 chains expressed differentially in metastatic and nonmetastatic hepatocellular carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if laminin-5 chains are expressed differently in metastatic versus nonmetastatic hepatocellular carcinoma (HCC). To answer this, I need to consider what is known about laminin-5 expression patterns in these two states of HCC. Laminin-5 (also known as laminin-332) is composed of α3, β3, and γ2 chains and is involved in cell adhesion and migration. Research has shown that laminin-5, particularly the γ2 chain, is often overexpressed in invasive cancers. In hepatocellular carcinoma specifically, studies have demonstrated that there are indeed differential expression patterns of laminin-5 chains between metastatic and nonmetastatic cases, with higher expression typically associated with the metastatic phenotype. This differential expression has been documented in multiple studies examining the relationship between laminin-5 and HCC progression.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25849951",
    "question": "Does atorvastatin reduce long pentraxin 3 expression in vascular cells by inhibiting protein geranylgeranylation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether atorvastatin reduces long pentraxin 3 expression in vascular cells specifically through the mechanism of inhibiting protein geranylgeranylation. To answer this, I need to consider what is known about atorvastatin's mechanism of action and its effects on pentraxin 3.\\n\\nAtorvastatin is a statin drug that primarily works by inhibiting HMG-CoA reductase, which blocks cholesterol synthesis. This inhibition also reduces the production of isoprenoid intermediates like geranylgeranyl pyrophosphate, which are needed for protein geranylgeranylation. \\n\\nResearch has shown that statins, including atorvastatin, can reduce the expression of inflammatory markers in vascular cells. Long pentraxin 3 (PTX3) is an inflammatory marker produced by vascular cells.\\n\\nThere are studies indicating that atorvastatin can reduce PTX3 expression, and that this effect is mediated through inhibition of protein geranylgeranylation. When geranylgeranyl transferase is inhibited, certain signaling pathways that upregulate PTX3 are blocked.\\n\\nBased on the scientific literature, atorvastatin does reduce long pentraxin 3 expression in vascular cells, and this effect is at least partly mediated through inhibition of protein geranylgeranylation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15167829",
    "question": "Is vaginal pH similar to follicle-stimulating hormone for menopause diagnosis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To answer this question, I need to compare vaginal pH and follicle-stimulating hormone (FSH) as diagnostic tools for menopause.\\n\\nVaginal pH: During menopause, declining estrogen levels cause the vaginal environment to become less acidic, resulting in a higher pH (typically >4.5). This is a physical change that occurs as part of menopause.\\n\\nFollicle-stimulating hormone (FSH): During menopause, FSH levels rise significantly as the body attempts to stimulate the declining ovarian function. Elevated FSH (typically >30 mIU/mL) is a hormonal marker used clinically to help confirm menopause.\\n\\nWhile both parameters change during menopause, they are fundamentally different measurements:\\n- Vaginal pH is a physical/chemical measurement of the vaginal environment\\n- FSH is a hormone measurement in the blood\\n\\nThey measure different physiological aspects of menopause and are not similar in terms of what they measure, how they're measured, or their specific diagnostic value. They are complementary but distinct diagnostic tools.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17617446",
    "question": "Does beclin 1-mediated macroautophagy involve regulation of caspase-9 expression in cervical cancer HeLa cells?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if beclin 1-mediated macroautophagy involves regulation of caspase-9 expression in cervical cancer HeLa cells. To answer this, I need to consider whether there is established evidence in scientific literature showing that beclin 1, which is a key regulator of macroautophagy, specifically regulates the expression of caspase-9 (an apoptotic protein) in HeLa cells. This is a very specific molecular relationship being asked about in a specific cell line. Without specific research evidence demonstrating this particular regulatory relationship in HeLa cells, I cannot confirm this as true. While both beclin 1 and caspase-9 are important in cellular processes and there may be broader connections between autophagy and apoptosis pathways, the specific regulatory relationship asked about requires direct experimental evidence in HeLa cells.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25153661",
    "question": "Does a genetic variant at KIF1B predict clinical outcome of HBV-related hepatocellular carcinoma in Chinese?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether a genetic variant at KIF1B predicts clinical outcome of HBV-related hepatocellular carcinoma (liver cancer) in Chinese patients. To answer this, I would need specific scientific evidence about this genetic variant and its relationship to outcomes in this specific population. Without having access to specific research studies on this topic, I cannot make a definitive statement. This is a very specific medical genetics question that would require evidence from published research.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21882048",
    "question": "Is iD4 frequently downregulated and partially hypermethylated in prostate cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if iD4 is frequently downregulated and partially hypermethylated in prostate cancer. To answer this, I need to consider what is known about iD4 in relation to prostate cancer. ID4 (inhibitor of DNA binding 4) is a helix-loop-helix protein that has been studied in various cancers. In prostate cancer specifically, multiple studies have shown that ID4 is indeed frequently downregulated compared to normal prostate tissue. This downregulation has been associated with promoter hypermethylation in prostate cancer cells. The hypermethylation of the ID4 promoter is a common epigenetic mechanism that leads to its silencing in prostate cancer. So based on the scientific literature, ID4 is frequently downregulated and this is often associated with promoter hypermethylation in prostate cancer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19672574",
    "question": "Does constitutive expression of suppressor of cytokine signalling-3 in skeletal muscle lead to reduced mobility and overweight in mice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the effects of constitutive expression (continuous expression) of a protein called suppressor of cytokine signalling-3 (SOCS-3) in skeletal muscle of mice. Specifically, it asks whether this leads to two outcomes: 1) reduced mobility and 2) overweight in mice.\\n\\nTo answer this accurately, I would need to know the research findings on this specific genetic modification. SOCS-3 is known to be involved in negative regulation of cytokine signaling, which could potentially affect metabolism and muscle function. However, without specific research data on this particular genetic modification in mice, I cannot definitively say whether constitutive expression of SOCS-3 in skeletal muscle causes reduced mobility and overweight.\\n\\nSince I don't have access to this specific research information, I cannot provide a confident yes or no answer based on scientific evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "14744973",
    "question": "Does vascular oxidant stress enhance progression and angiogenesis of experimental atheroma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. To answer this, I need to consider what is known about oxidant stress and its effects on atherosclerosis.\\n\\nAtheroma refers to the fatty plaque that builds up in arteries in atherosclerosis. Oxidant stress involves the production of reactive oxygen species that can damage cells and tissues. \\n\\nBased on scientific literature, oxidant stress is indeed known to contribute to the progression of atherosclerosis. Oxidative modification of low-density lipoproteins (LDL) is a key step in atherogenesis. Oxidized LDL promotes inflammation, foam cell formation, and endothelial dysfunction - all key processes in atherosclerosis progression.\\n\\nRegarding angiogenesis (the formation of new blood vessels), oxidant stress has been shown to stimulate angiogenic factors like VEGF (Vascular Endothelial Growth Factor). In the context of atheroma, intraplaque angiogenesis is associated with plaque growth and instability.\\n\\nMultiple experimental studies have demonstrated that increased vascular oxidant stress accelerates atheroma formation and progression, and promotes neovascularization within plaques.\\n\\nSo yes, vascular oxidant stress does enhance both the progression and angiogenesis of experimental atheroma.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15891315",
    "question": "Is clinical implementation of the ARDS network protocol associated with reduced hospital mortality compared with historical controls?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the clinical implementation of the ARDS (Acute Respiratory Distress Syndrome) network protocol is associated with reduced hospital mortality compared with historical controls. To answer this, I would need to know if studies have shown that implementing the ARDS network protocol in clinical practice has led to lower mortality rates compared to before its implementation. The ARDS network protocol includes lung-protective ventilation strategies with lower tidal volumes and other management guidelines. Multiple studies have indeed shown that implementation of the ARDS network protocol is associated with reduced hospital mortality compared with historical controls. For example, the original ARDS Network trial published in 2000 showed a significant reduction in mortality (31.0% vs. 39.8%) with the lung-protective ventilation strategy, and subsequent implementation studies have confirmed these benefits in real-world clinical settings.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24401008",
    "question": "Is glycemic variability higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether glycemic variability (the swings in blood glucose levels) is higher in type 1 diabetes patients who have microvascular complications (like retinopathy, nephropathy, or neuropathy), regardless of their overall glycemic control (typically measured by HbA1c). \\n\\nTo answer this accurately, I need to consider the research evidence. Studies have indeed shown that glycemic variability is independently associated with microvascular complications in type 1 diabetes, even when accounting for overall glycemic control. Research has demonstrated that patients with type 1 diabetes who have developed microvascular complications tend to exhibit greater glycemic variability compared to those without complications, even when matched for similar HbA1c levels.\\n\\nThis suggests that the fluctuations in glucose levels themselves may contribute to vascular damage beyond what is captured by average glucose measurements.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18489026",
    "question": "Is the development of atopic dermatitis independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether atopic dermatitis develops independently of IgE up-regulation in the K14-IL-4 SKH1 transgenic mouse model. To answer this, I need to consider what is known about this specific mouse model.\\n\\nThe K14-IL-4 SKH1 transgenic mouse model is engineered to overexpress interleukin-4 (IL-4) in keratinocytes under the control of the K14 promoter. IL-4 is a key Th2 cytokine involved in allergic responses and is known to promote IgE production.\\n\\nIn this model, the development of atopic dermatitis-like skin inflammation is typically associated with increased IgE levels, as IL-4 directly promotes isotype switching to IgE in B cells. The model is actually used to study the relationship between IL-4 overexpression, IgE production, and atopic dermatitis pathogenesis.\\n\\nTherefore, in this specific transgenic mouse model, atopic dermatitis development is NOT independent of IgE up-regulation - they are mechanistically linked through the IL-4 pathway.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19378439",
    "question": "Is a combined abnormality in heart rate variation and QT corrected interval a strong predictor of cardiovascular death in type 1 diabetes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about whether a combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death specifically in type 1 diabetes patients. To answer this accurately, I would need to know if research has established this specific combination as a strong predictor in this specific population. Based on medical literature, abnormalities in heart rate variability and prolonged QT intervals have both been associated with increased cardiovascular risk in diabetes patients. Some studies have shown that these markers, especially when combined, can predict cardiovascular mortality in diabetic populations. However, most of the stronger evidence relates to type 2 diabetes or diabetes in general. For type 1 diabetes specifically, while these markers are relevant, I'm not certain the evidence conclusively establishes their combined presence as a 'strong' predictor of cardiovascular death. Without citing specific studies that demonstrate this relationship in type 1 diabetes patients, I should be cautious about affirming this as a strong predictor.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22327983",
    "question": "Does radiation exposure have increased in trauma patients over time?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether radiation exposure has increased in trauma patients over time. To answer this accurately, I need to consider the medical literature and trends in diagnostic imaging for trauma patients.\\n\\nOver the past several decades, there has been a significant increase in the use of CT scans and other radiological imaging in trauma care. Studies have documented that trauma patients now routinely undergo multiple CT scans during their hospital stays, leading to higher cumulative radiation doses compared to previous eras when these technologies were less available or less frequently used.\\n\\nResearch has shown concerns about increased radiation exposure in trauma patients due to:\\n1. Greater availability and faster CT scanners\\n2. Expanded protocols for trauma evaluation\\n3. Defensive medicine practices\\n4. Repeat imaging during transfers or prolonged hospital stays\\n\\nMultiple studies in the medical literature have documented this trend of increasing radiation exposure in trauma patients over time, with some studies showing substantial increases in the average radiation dose per trauma patient compared to previous decades.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24323901",
    "question": "Do colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific mechanism by which colon cancer cells might evade death from 5FU chemotherapy. Specifically, it's asking if these cells escape by entering stemness (stem cell-like state) and quiescence (dormant state) through a mechanism involving the c-Yes/YAP signaling axis. This appears to be referring to a specific research finding or hypothesis in cancer biology. To answer accurately, I would need to know if this specific mechanism has been established in scientific literature. Based on my knowledge, there is research showing that YAP (Yes-associated protein) signaling can be involved in cancer stem cell properties and drug resistance in various cancers including colorectal cancer, and c-Yes is a Src-family kinase that can activate YAP. Some studies have indeed suggested that activation of the YAP pathway can promote chemoresistance to 5-fluorouracil (5FU) in colon cancer by inducing stemness properties. However, I should be careful not to overgeneralize if this specific mechanism with all the elements mentioned (5FU resistance, stemness, quiescence, and specifically the c-Yes/YAP axis together) has been conclusively demonstrated.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23578734",
    "question": "Does smoking overrule many other risk factors for small for gestational age birth in less educated mothers?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if smoking overrules many other risk factors for small for gestational age (SGA) birth specifically in less educated mothers. To answer this, I would need evidence from medical research that specifically compares the impact of smoking versus other risk factors (like maternal nutrition, hypertension, etc.) on SGA births, with a specific focus on how these factors interact in populations with lower education levels. Without specific research showing that smoking has such a dominant effect that it negates or significantly diminishes the importance of other risk factors in this specific population, I cannot confidently say 'yes'. While smoking is certainly a known risk factor for SGA, claiming it 'overrules' many other factors specifically in less educated mothers requires specific evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19769973",
    "question": "Does hepatitis C virus core protein subvert the antiviral activities of human Kupffer cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if hepatitis C virus (HCV) core protein subverts the antiviral activities of human Kupffer cells. Kupffer cells are specialized macrophages located in the liver that play a role in the immune response against pathogens. To answer this question, I need to consider whether there is evidence that the HCV core protein specifically interferes with or undermines the antiviral functions of Kupffer cells.\\n\\nResearch has shown that HCV has various mechanisms to evade host immune responses. The HCV core protein in particular has been demonstrated to interfere with several immune pathways. Studies have indicated that HCV core protein can modulate the function of various immune cells, including dendritic cells and T cells.\\n\\nRegarding Kupffer cells specifically, research has shown that HCV core protein can indeed impair their function. It has been found to suppress cytokine production, interfere with antigen presentation, and inhibit the activation of Kupffer cells. These effects contribute to the virus's ability to establish persistent infection in the liver.\\n\\nBased on the scientific literature, HCV core protein does subvert the antiviral activities of human Kupffer cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27308072",
    "question": "Does effectiveness of Using Dual-source CT and the Upshot it create on Both Heart Rate and Image Quality?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether dual-source CT has an effect on both heart rate and image quality. Dual-source CT is a type of computed tomography that uses two X-ray tubes and two detectors, which can improve temporal resolution and is particularly useful for cardiac imaging. Research has shown that dual-source CT can provide good image quality even at higher heart rates, where traditional single-source CT might produce motion artifacts. So dual-source CT does have effects on both image quality (typically improving it) and can work effectively across different heart rates (making it less dependent on heart rate control). However, the question is phrased in a somewhat confusing way, asking about 'effectiveness' and 'upshot it create on' which makes it unclear if it's asking if dual-source CT affects these parameters or if it's effective at improving them. Based on the technical understanding, I would say yes, dual-source CT does have effects on both heart rate tolerance and image quality in cardiac imaging.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24680982",
    "question": "Is plasma proprotein convertase subtilisin-kexin type 9 predominantly related to intermediate density lipoproteins?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Plasma proprotein convertase subtilisin-kexin type 9 (PCSK9) is an enzyme that plays a key role in regulating LDL (low-density lipoprotein) receptor levels on cell surfaces, particularly in the liver. PCSK9 binds to LDL receptors and promotes their degradation, which leads to reduced clearance of LDL cholesterol from the bloodstream. PCSK9 is primarily associated with LDL metabolism rather than intermediate density lipoproteins (IDL). While IDL is part of the lipoprotein cascade (VLDL → IDL → LDL), PCSK9's main documented relationship is with LDL receptors and LDL cholesterol regulation. PCSK9 inhibitors are used therapeutically to lower LDL cholesterol levels by preventing PCSK9-mediated degradation of LDL receptors.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17275554",
    "question": "Is total thyroidectomy the preferred treatment for patients with Graves ' disease and a thyroid nodule?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether total thyroidectomy is the preferred treatment for patients with Graves' disease who also have a thyroid nodule. To answer this accurately, I need to consider the standard clinical guidelines and treatment approaches for this specific combination of conditions.\\n\\nGraves' disease is an autoimmune disorder causing hyperthyroidism, and treatment options typically include:\\n1. Antithyroid medications\\n2. Radioactive iodine therapy\\n3. Surgery (thyroidectomy)\\n\\nWhen a patient with Graves' disease also has a thyroid nodule, the treatment approach may be influenced by several factors:\\n- The nature of the nodule (benign vs. suspicious/malignant)\\n- Size of the nodule\\n- Patient's age and overall health\\n- Patient's preference\\n- Severity of hyperthyroidism\\n- Response to medical therapy\\n\\nWhile total thyroidectomy is certainly one treatment option in this scenario, especially if the nodule is suspicious for malignancy or causing compressive symptoms, it is not universally considered the \\\"preferred\\\" first-line treatment for all patients with this combination. Many cases are still managed with medical therapy first, with surgery reserved for specific indications.\\n\\nThe presence of a nodule does increase the consideration for surgical management compared to Graves' disease alone, but calling it the \\\"preferred\\\" treatment would be an overstatement of current clinical practice guidelines.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18676770",
    "question": "Does the targeted immunocytokine L19-IL2 efficiently inhibit the growth of orthotopic pancreatic cancer?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the targeted immunocytokine L19-IL2 efficiently inhibits the growth of orthotopic pancreatic cancer. To answer this, I need to consider what is known about L19-IL2 and its effects specifically on orthotopic pancreatic cancer models. L19-IL2 is an immunocytokine consisting of the L19 antibody (which targets the ED-B domain of fibronectin, a marker of tumor neovasculature) fused to interleukin-2 (IL2, an immune stimulatory cytokine). While L19-IL2 has shown efficacy in some cancer models, I need to determine if there is specific evidence for its efficacy in orthotopic pancreatic cancer. Based on the limited information provided in the question, and without specific studies to reference showing L19-IL2's efficacy in orthotopic pancreatic cancer models, I cannot definitively state that it efficiently inhibits growth in this specific cancer type and model.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24136647",
    "question": "Is pretreatment ADC histogram analysis a predictive imaging biomarker for bevacizumab treatment but not chemotherapy in recurrent glioblastoma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if pretreatment ADC (Apparent Diffusion Coefficient) histogram analysis is a predictive imaging biomarker specifically for bevacizumab treatment but not for chemotherapy in recurrent glioblastoma. To answer this, I would need to know if research has established that ADC histogram analysis before treatment can predict response to bevacizumab (an angiogenesis inhibitor) but does not predict response to standard chemotherapy agents in patients with recurrent glioblastoma. Without specific research citations or evidence provided in the question, I cannot make a definitive determination about this specific biomarker's differential predictive value between these two treatment approaches for recurrent glioblastoma.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26358193",
    "question": "Does altered metabolism of LDL in the arterial wall precede atherosclerosis regression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if altered metabolism of LDL (low-density lipoprotein) in the arterial wall precedes atherosclerosis regression. To answer this, I need to consider the relationship between LDL metabolism and atherosclerosis regression.\\n\\nAtherosclerosis is characterized by the accumulation of lipids, particularly LDL, in the arterial wall. Regression of atherosclerosis refers to the reversal or reduction of atherosclerotic plaques.\\n\\nResearch indicates that for atherosclerosis regression to occur, there typically needs to be a reduction in LDL levels and changes in LDL metabolism. These changes include decreased LDL infiltration into the arterial wall, increased efflux of cholesterol from foam cells, and reduced inflammation.\\n\\nSo, yes, altered metabolism of LDL (specifically, improved or normalized metabolism) in the arterial wall does generally precede atherosclerosis regression. Changes in how LDL is processed in the arterial wall are a necessary step before regression can occur.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21492171",
    "question": "Does astragaloside IV inhibit adenovirus replication and apoptosis in A549 cells in vitro?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if astragaloside IV inhibits adenovirus replication and apoptosis in A549 cells in vitro. To answer this, I need to consider whether there is scientific evidence showing that astragaloside IV (a compound found in Astragalus membranaceus) has been demonstrated to inhibit both adenovirus replication and apoptosis specifically in A549 cells (a human lung cancer cell line) in laboratory settings. While astragaloside IV has been studied for various antiviral and anti-inflammatory properties, I don't have specific evidence that it inhibits adenovirus replication and apoptosis in A549 cells. Without clear scientific evidence supporting this specific claim, I should answer 'no'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25222806",
    "question": "Does rhBSSL improve growth and LCPUFA absorption in preterm infants fed formula or pasteurized breast milk?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if rhBSSL (recombinant human bile salt-stimulated lipase) improves growth and LCPUFA (long-chain polyunsaturated fatty acids) absorption in preterm infants who are fed formula or pasteurized breast milk. To answer this, I need to consider if there's evidence that rhBSSL has these specific effects in this specific population. Based on my knowledge, rhBSSL has been studied as an enzyme supplement for preterm infants because pasteurization of breast milk inactivates the naturally occurring BSSL, and formula lacks it entirely. Some studies have investigated whether supplementing with rhBSSL improves fat absorption and growth in preterm infants. However, I don't have specific conclusive evidence that it definitively improves both growth and LCPUFA absorption in preterm infants.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22529161",
    "question": "Is urinalysis more specific and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question about the diagnostic characteristics of urinalysis and urinary neutrophil gelatinase-associated lipocalin (NGAL) for acute kidney injury (AKI).\\n\\nUrinalysis is a traditional test that looks for various elements in urine including protein, blood, and casts. It has been used to detect kidney damage but is generally considered to have limited sensitivity for early AKI detection.\\n\\nUrinary NGAL, on the other hand, is a biomarker that rises rapidly in response to kidney injury. Research has consistently shown that NGAL is a highly sensitive early biomarker for AKI, often rising 24-48 hours before serum creatinine changes are detected.\\n\\nRegarding specificity, urinalysis findings like granular casts can be specific for kidney injury when present, but they're not always present in early AKI. NGAL, while very sensitive, can be elevated in other conditions like infections or inflammation, making it somewhat less specific.\\n\\nSo the statement is correct: urinalysis tends to be more specific (fewer false positives) while NGAL is more sensitive (better at detecting early cases) for AKI detection.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23374269",
    "question": "Does epicutaneous sensitization result in IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether epicutaneous sensitization (sensitization through the skin) leads to IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis. To answer this, I need to consider what's known about the relationship between skin exposure to allergens and subsequent food allergic reactions.\\n\\nResearch has shown that epicutaneous exposure to food allergens can indeed lead to sensitization, where the immune system produces IgE antibodies against these allergens. These IgE antibodies can bind to mast cells in various tissues, including the intestine. When the allergen is later consumed, it can cross-link these IgE antibodies on mast cells, causing them to degranulate and release inflammatory mediators.\\n\\nStudies, particularly in mouse models, have demonstrated that epicutaneous sensitization to food allergens can lead to:\\n1. Production of food-specific IgE antibodies\\n2. Expansion of mast cells in the intestinal tissue\\n3. Systemic anaphylactic reactions upon subsequent oral exposure to the food allergen\\n\\nThis pathway is considered one of the mechanisms behind the \\\"dual-allergen exposure hypothesis\\\" which explains how skin exposure to food allergens (especially through damaged skin as in eczema) can lead to food allergies rather than oral tolerance.\\n\\nSo based on current scientific understanding, epicutaneous sensitization can indeed result in IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22280157",
    "question": "Does d-Serine regulate proliferation and neuronal differentiation of neural stem cells from postnatal mouse forebrain?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether d-Serine regulates proliferation and neuronal differentiation of neural stem cells from postnatal mouse forebrain. To answer this, I need to consider whether there is scientific evidence supporting this regulatory role of d-Serine in these specific neural stem cells. Based on scientific literature, d-Serine is known to be an endogenous co-agonist of NMDA receptors in the brain and has been implicated in various neurological processes. There is evidence that d-Serine can regulate neural stem cell proliferation and differentiation, particularly through NMDA receptor activation. Studies have specifically shown that d-Serine can influence the proliferation and neuronal differentiation of neural stem cells derived from the postnatal mouse forebrain. Therefore, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24398409",
    "question": "Is menopause associated with self-reported poor sleep quality in women without vasomotor symptoms?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the association between menopause and self-reported poor sleep quality specifically in women who do NOT have vasomotor symptoms (like hot flashes and night sweats). I need to consider whether menopause itself, independent of these common symptoms, is linked to poor sleep quality.\\n\\nResearch has shown that while vasomotor symptoms are a major contributor to sleep disturbances during menopause, there are other menopause-related factors that can affect sleep quality. These include hormonal changes (declining estrogen and progesterone), mood disorders (increased rates of depression and anxiety), age-related changes in sleep architecture, and other physical symptoms.\\n\\nStudies have found that even when controlling for vasomotor symptoms, postmenopausal women tend to report poorer sleep quality compared to premenopausal women. The hormonal changes alone can affect sleep regulation, and other aspects of menopause like psychological factors and aging also contribute.\\n\\nSo yes, menopause is associated with self-reported poor sleep quality in women even when vasomotor symptoms are not present.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21030271",
    "question": "Does mesenchymal stem cell conditioned media attenuate in vitro and ex vivo myocardial reperfusion injury?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if mesenchymal stem cell conditioned media (MSC-CM) attenuates myocardial reperfusion injury in both in vitro and ex vivo settings. To answer this, I need to consider what is known about MSC-CM effects on reperfusion injury in heart tissue.\\n\\nMesenchymal stem cell conditioned media contains paracrine factors secreted by MSCs that have been shown to have cardioprotective effects. Research has demonstrated that MSC-CM can reduce oxidative stress, inflammation, and apoptosis in cardiac cells subjected to ischemia-reperfusion injury. Studies have shown protective effects in both in vitro models (using cultured cardiomyocytes) and ex vivo models (using isolated perfused hearts in Langendorff systems).\\n\\nThe paracrine factors in MSC-CM, including growth factors, cytokines, and exosomes, have been shown to activate cardioprotective signaling pathways that reduce the damage caused by reperfusion injury.\\n\\nBased on the scientific literature, MSC-CM has demonstrated protective effects against myocardial reperfusion injury in both in vitro and ex vivo experimental settings.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20462770",
    "question": "Is donor myocardial apollon mRNA associated with cardiac allograft rejection?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the association between donor myocardial apollon mRNA and cardiac allograft rejection. To answer this, I would need to know if there is scientific evidence showing a relationship between apollon mRNA levels in donor heart tissue and the likelihood or severity of rejection after heart transplantation. Apollon (also known as BIRC6 or BRUCE) is an inhibitor of apoptosis protein. Without specific research studies on this relationship, I cannot provide a definitive answer. I am not aware of established evidence showing that donor myocardial apollon mRNA is a biomarker or factor associated with cardiac allograft rejection. However, this is a specialized medical question that would require recent research literature to answer accurately.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27334429",
    "question": "Do pain Drawings Improve Subgrouping of Low Back Pain Patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether pain drawings improve the subgrouping of low back pain patients. To answer this, I would need to know if there is evidence that using pain drawings (visual representations where patients mark the location and type of their pain) helps to better categorize or classify patients with low back pain into meaningful subgroups that could guide treatment or prognosis. Without specific research evidence provided in the question, I cannot make a definitive statement. However, based on general knowledge of pain assessment tools, pain drawings are sometimes used as part of comprehensive assessment protocols for low back pain patients, but their standalone value for subgrouping is debated in the literature. Some studies suggest they may have value when combined with other assessment tools, while others question their reliability and validity for this specific purpose.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15485682",
    "question": "Do cholesterol- and caveolin-rich membrane domains are essential for phospholipase A2-dependent EDHF formation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether cholesterol- and caveolin-rich membrane domains are essential for phospholipase A2-dependent EDHF (Endothelium-Derived Hyperpolarizing Factor) formation. This is a specific biochemical question about cellular signaling mechanisms.\\n\\nTo answer this accurately, I would need to know whether research has established that these membrane domains (likely referring to lipid rafts or caveolae) are indeed required for the phospholipase A2 pathway that leads to EDHF formation. \\n\\nBased on scientific literature, cholesterol-rich membrane domains (lipid rafts) and caveolae (which contain caveolin) are often important for organizing signaling complexes in cell membranes. There is evidence suggesting that these domains can be important for various phospholipase A2-dependent processes and for EDHF signaling pathways. Several studies have shown that disruption of these domains can impair EDHF responses.\\n\\nSo the scientific consensus appears to be that yes, these membrane domains are essential for proper phospholipase A2-dependent EDHF formation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21573242",
    "question": "Is fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes facilitated by parasite-induced new permeability pathways?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if fosmidomycin uptake into erythrocytes (red blood cells) infected with Plasmodium and Babesia parasites is facilitated by new permeability pathways that are induced by the parasites.\\n\\nFosmidomycin is an antibiotic that inhibits the non-mevalonate pathway of isoprenoid biosynthesis, which is present in many bacteria and some protozoan parasites including Plasmodium (malaria parasite).\\n\\nWhen Plasmodium parasites infect red blood cells, they do induce new permeability pathways (NPPs) that allow the uptake of various nutrients and other compounds that normally cannot cross the erythrocyte membrane. These NPPs are essential for parasite survival.\\n\\nResearch has shown that fosmidomycin uptake into Plasmodium-infected erythrocytes is indeed facilitated by these parasite-induced new permeability pathways. This is why fosmidomycin is effective against blood-stage malaria parasites despite being a charged molecule that would not normally cross cell membranes easily.\\n\\nSimilar mechanisms have been described for Babesia, another intraerythrocytic parasite that also modifies its host cell's permeability.\\n\\nBased on the scientific literature, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16015129",
    "question": "Is single-fiber MHC polymorphic expression unaffected by sprint cycle training?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether single-fiber MHC (myosin heavy chain) polymorphic expression remains unchanged (unaffected) by sprint cycle training. To answer this, I need to consider whether sprint cycle training alters the MHC polymorphic expression in individual muscle fibers. Based on exercise physiology research, sprint cycle training typically induces changes in muscle fiber type composition and MHC isoform expression. Sprint training can cause transitions between MHC isoforms and alter the polymorphic expression patterns within single muscle fibers as an adaptation to the high-intensity exercise stimulus. Therefore, single-fiber MHC polymorphic expression is generally affected (changed) by sprint cycle training, not unaffected.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27770258",
    "question": "Does kidney transplantation fail to provide adequate growth in children with chronic kidney disease born small for gestational age?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if kidney transplantation fails to provide adequate growth in children with chronic kidney disease (CKD) who were born small for gestational age (SGA). To answer this, I need to consider what the research shows about growth outcomes after kidney transplantation specifically in SGA children with CKD.\\n\\nFrom medical literature, children with CKD often have growth impairment, and kidney transplantation generally improves growth potential compared to dialysis. However, the specific question is about children who were already born small for gestational age (SGA).\\n\\nResearch indicates that while kidney transplantation improves growth in most children with CKD, those born SGA may have more persistent growth challenges even after transplantation. Studies have shown that SGA status is an independent risk factor for suboptimal catch-up growth post-transplant. These children often don't achieve the same height potential as children with CKD who were born appropriate for gestational age.\\n\\nSo while kidney transplantation provides some growth improvement in SGA children with CKD, it often fails to provide complete catch-up growth to normal height ranges in this specific population.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23726237",
    "question": "Is microglial activation induced by traumatic brain injury suppressed by postinjury treatment with hyperbaric oxygen therapy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether microglial activation (an inflammatory response in the brain) that occurs after traumatic brain injury (TBI) is suppressed when hyperbaric oxygen therapy (HBOT) is administered after the injury. To answer this, I need to consider whether there is evidence that HBOT reduces or inhibits microglial activation in post-TBI scenarios.\\n\\nBased on research literature, hyperbaric oxygen therapy has been shown to have anti-inflammatory effects in brain injury models. Studies have demonstrated that HBOT can indeed suppress microglial activation following traumatic brain injury. HBOT appears to modulate the inflammatory response by reducing microglial activation and the release of pro-inflammatory cytokines. This effect is part of HBOT's neuroprotective mechanisms in TBI treatment.\\n\\nFor example, research has shown that HBOT reduces markers of microglial activation such as Iba-1 and CD68 in animal models of TBI, and this correlates with improved neurological outcomes. The therapy appears to shift microglia from a pro-inflammatory (M1) to an anti-inflammatory (M2) phenotype.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18826564",
    "question": "Is wnt signalling in human breast cancer : expression of the putative Wnt inhibitor Dickkopf-3 ( DKK3 ) frequently suppressed by promoter hypermethylation in mammary tumours?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether the expression of Dickkopf-3 (DKK3), which is described as a putative Wnt inhibitor, is frequently suppressed by promoter hypermethylation in mammary tumors. Let me analyze this statement.\\n\\nThe question contains a specific claim about DKK3 expression being suppressed by promoter hypermethylation in breast cancer. This appears to be a scientific claim about epigenetic regulation of a specific gene (DKK3) in breast cancer. \\n\\nBased on scientific literature, DKK3 is indeed considered a tumor suppressor gene that can inhibit Wnt signaling, and studies have shown that its expression is frequently downregulated in various cancers including breast cancer. Furthermore, promoter hypermethylation is a common mechanism for silencing tumor suppressor genes in cancer. Several studies have specifically demonstrated that DKK3 is frequently silenced by promoter hypermethylation in breast cancer/mammary tumors.\\n\\nTherefore, the statement appears to be scientifically accurate.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27553912",
    "question": "Does faster rate of blood volume change in pediatric hemodialysis patients impair cardiac index?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a faster rate of blood volume change in pediatric hemodialysis patients impairs cardiac index. To answer this, I need to consider what research shows about the relationship between blood volume change rates and cardiac function specifically in pediatric hemodialysis patients. \\n\\nIn hemodialysis, rapid fluid removal can lead to intravascular volume depletion, which might affect cardiac output. The cardiac index is a measurement of cardiac output adjusted for body surface area. \\n\\nBased on my knowledge, rapid fluid shifts during hemodialysis can lead to hemodynamic instability, but whether this specifically impairs cardiac index in pediatric patients would depend on research findings. Without specific studies showing this relationship in pediatric patients, I cannot definitively say yes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24444035",
    "question": "Does gOLPH3 predict survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question. I need to determine if gOLPH3 is a predictor for survival in colorectal cancer patients who are treated with 5-fluorouracil-based adjuvant chemotherapy.\\n\\nI don't have specific information about a biomarker or protein called 'gOLPH3' in relation to colorectal cancer prognosis or treatment response. In the medical literature, there are various biomarkers studied for colorectal cancer (like KRAS, BRAF, MSI status), but 'gOLPH3' is not a well-established or commonly referenced biomarker that I'm aware of. There may be a protein called GOLPH3 (Golgi phosphoprotein 3) that has been studied in cancer research, but I don't have specific information about its role in predicting survival specifically for colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy.\\n\\nWithout specific evidence that gOLPH3 has this predictive capability, I should answer 'no'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23623396",
    "question": "Is prealbumin associated with visceral fat mass in patients receiving hemodialysis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if prealbumin is associated with visceral fat mass in hemodialysis patients. Prealbumin (transthyretin) is a protein used as a nutritional marker in clinical settings. Visceral fat refers to fat that surrounds internal organs in the abdominal cavity. Hemodialysis is a treatment for kidney failure where a machine filters blood outside the body. To answer this question accurately, I need to consider if research has established a relationship between prealbumin levels and visceral fat mass specifically in the hemodialysis patient population. Based on medical literature, there is evidence suggesting that prealbumin levels do correlate with nutritional status and body composition in hemodialysis patients, including associations with visceral fat mass. Several studies have shown that higher prealbumin levels are associated with greater visceral fat mass in this patient population.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17547692",
    "question": "Does genetic polymorphism of CYP2D6 influence susceptibility to papillary thyroid cancer?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if genetic polymorphism of CYP2D6 influences susceptibility to papillary thyroid cancer. CYP2D6 is a cytochrome P450 enzyme involved in drug metabolism. To answer this question accurately, I need to consider whether there is established scientific evidence linking CYP2D6 genetic variations to papillary thyroid cancer risk. While CYP2D6 polymorphisms are well-studied in relation to drug metabolism and some cancer types, the specific link to papillary thyroid cancer is not well-established in the scientific literature. There are studies examining various genetic factors in thyroid cancer, but CYP2D6 is not among the consistently reported risk factors for papillary thyroid cancer specifically. Without strong evidence supporting this specific association, the answer would be no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19172105",
    "question": "Is low transscrotal orchidopexy a safe and effective approach for undescended testes distal to the external inguinal ring?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the safety and effectiveness of low transscrotal orchidopexy for treating undescended testes that are located distal to the external inguinal ring. \\n\\nLow transscrotal orchidopexy is a surgical technique used to fix undescended testes. When the testes are distal to the external inguinal ring (meaning they have already passed through the inguinal canal and are located near the scrotum), this approach is generally considered appropriate.\\n\\nBased on medical literature, the transscrotal approach for palpable testes located distal to the external ring is considered safe and effective, with comparable outcomes to traditional inguinal approaches but with shorter operative times, less pain, and better cosmetic results. Multiple studies have demonstrated good success rates with this technique for appropriately selected cases.\\n\\nTherefore, the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17682093",
    "question": "Do endothelial nitric oxide synthase ( eNOS ) knockout mice have defective mitochondrial beta-oxidation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific metabolic defect in a specific genetically modified mouse model. Specifically, it's asking whether mice that lack the gene for endothelial nitric oxide synthase (eNOS knockout mice) have problems with mitochondrial beta-oxidation (a process by which fatty acids are broken down for energy in mitochondria).\n\nTo answer this accurately, I need to recall if there's established evidence in the scientific literature linking eNOS deficiency to impaired mitochondrial beta-oxidation.\n\neNOS produces nitric oxide (NO) in endothelial cells, which has various functions including vasodilation. While eNOS knockout mice have been studied extensively for vascular and cardiovascular phenotypes, I need to consider if there's evidence specifically about mitochondrial fatty acid oxidation.\n\nFrom what I recall, eNOS knockout mice do show some metabolic abnormalities, including insulin resistance and altered glucose metabolism. However, I don't recall specific evidence demonstrating defective mitochondrial beta-oxidation in these mice. While NO can affect mitochondrial function, a direct link between eNOS knockout and impaired beta-oxidation is not something I can confidently confirm based on established research.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17680316",
    "question": "Is cytoplasmic CD24 expression a novel prognostic factor in diffuse-type gastric adenocarcinoma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma. To answer this, I need to determine if research has established CD24 expression in the cytoplasm as a new/novel indicator for prognosis specifically in diffuse-type gastric adenocarcinoma. Without specific research papers or evidence provided in the question, I cannot definitively confirm this scientific claim. While CD24 is a cell surface protein that has been studied as a prognostic marker in various cancers, I cannot verify that cytoplasmic (as opposed to membranous) CD24 expression has been specifically established as a novel prognostic factor in the diffuse subtype of gastric adenocarcinoma without referencing specific research.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "8986693",
    "question": "Is day 3 serum inhibin-B predictive of assisted reproductive technologies outcome?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if day 3 serum inhibin-B levels can predict the outcome of assisted reproductive technologies (ART). To answer this, I need to consider whether there is scientific evidence supporting inhibin-B as a predictive biomarker for ART success.\\n\\nInhibin-B is a hormone produced by granulosa cells in the ovaries and is considered a marker of ovarian reserve and follicular development. Some studies have investigated whether baseline (day 3) inhibin-B levels correlate with ART outcomes such as ovarian response, embryo quality, and pregnancy rates.\\n\\nBased on the scientific literature, there is evidence suggesting that day 3 inhibin-B levels can be associated with ovarian response to stimulation. However, regarding its ability to predict actual ART outcomes (like live birth rates), the evidence is more mixed and inconsistent. Multiple studies have shown that while inhibin-B may have some correlation with ovarian response, it does not consistently predict pregnancy or live birth outcomes in ART.\\n\\nOther markers like AMH (anti-Müllerian hormone) have generally shown better predictive value for ART outcomes in more recent research.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20028558",
    "question": "Does canine tumor cross-species genomics uncover targets linked to osteosarcoma progression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression. To answer this, I need to consider whether there is evidence that studying genomics of canine tumors across species has revealed targets associated with the progression of osteosarcoma. \\n\\nOsteosarcoma is a type of bone cancer that affects both humans and dogs. Cross-species genomics involves comparing genetic data between different species (in this case, likely dogs and humans) to identify common patterns or targets.\\n\\nBased on scientific literature, there have been studies showing that canine osteosarcoma serves as a good model for human osteosarcoma due to similarities in genetics, biology, and clinical behavior. Researchers have indeed used comparative genomics between canine and human osteosarcoma to identify conserved aberrations and potential therapeutic targets linked to disease progression.\\n\\nSeveral studies have demonstrated that cross-species genomic approaches with canine tumors have successfully identified genetic drivers and potential therapeutic targets relevant to osteosarcoma progression in both dogs and humans.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22094963",
    "question": "Are immature muscle precursors a source of interferon-β in myositis : role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether immature muscle precursors are a source of interferon-β in myositis, and specifically about the role of Toll-like receptor 3 activation and its contribution to HLA class I up-regulation. This appears to be a specific scientific question about cellular mechanisms in myositis (muscle inflammation). Without specific scientific knowledge about this particular research question, I cannot definitively answer yes or no. The question seems to be referencing a specific research finding or paper title rather than asking for a general fact I can verify.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22361399",
    "question": "Does allopurinol acutely increase adenosine triphospate energy delivery in failing human hearts?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether allopurinol acutely increases adenosine triphosphate (ATP) energy delivery in failing human hearts. Let me analyze this based on pharmacological knowledge.\\n\\nAllopurinol is a xanthine oxidase inhibitor primarily used to treat gout and kidney stones. It works by reducing uric acid production. In the context of heart failure, some research has investigated allopurinol's potential benefits due to its ability to reduce oxidative stress by inhibiting xanthine oxidase.\\n\\nHowever, regarding the specific claim about acutely increasing ATP energy delivery in failing human hearts, the evidence is limited. While allopurinol may improve endothelial function and potentially myocardial efficiency in heart failure through reduction of oxidative stress, this is different from directly increasing ATP energy delivery in an acute manner.\\n\\nThe primary mechanism of allopurinol is not directly related to ATP production or energy metabolism pathways. It doesn't function as a metabolic enhancer that would acutely increase ATP delivery to cardiac tissue.\\n\\nBased on established pharmacological mechanisms, allopurinol does not acutely increase ATP energy delivery in failing human hearts.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11375376",
    "question": "Does aldose reductase inhibition ameliorate pupillary light reflex and F-wave latency in patients with mild diabetic neuropathy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether aldose reductase inhibition improves pupillary light reflex and F-wave latency in patients with mild diabetic neuropathy. To answer this, I would need specific research evidence about the effects of aldose reductase inhibitors on these particular neurological parameters in diabetic neuropathy patients. Without having access to specific studies that directly address this relationship, I cannot provide a definitive answer. Some aldose reductase inhibitors have been studied for diabetic neuropathy, but whether they specifically improve pupillary light reflex and F-wave latency in mild cases would require evidence from clinical trials that measured these specific outcomes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23427863",
    "question": "Do zinc oxide nanoparticles show antidiabetic activity in streptozotocin-induced Type 1 and 2 diabetic rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question asks if zinc oxide nanoparticles demonstrate antidiabetic activity in streptozotocin-induced Type 1 and 2 diabetic rats. To answer this, I need to consider the scientific literature on this specific topic. There have been several studies examining the effects of zinc oxide nanoparticles on diabetes models. Research has shown that zinc oxide nanoparticles can improve glucose metabolism, reduce oxidative stress, and enhance insulin sensitivity in diabetic animal models. Specifically for streptozotocin-induced diabetic rats (which is a common experimental model for both Type 1 and Type 2 diabetes), studies have demonstrated that zinc oxide nanoparticles can reduce blood glucose levels, improve lipid profiles, and protect pancreatic β-cells. Therefore, based on the existing scientific evidence, zinc oxide nanoparticles do show antidiabetic activity in streptozotocin-induced diabetic rat models.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12019031",
    "question": "Is expression of monolysocardiolipin acyltransferase activity regulated in concert with the level of cardiolipin and cardiolipin biosynthesis in the mammalian heart?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the expression of monolysocardiolipin acyltransferase activity is regulated in concert with the level of cardiolipin and cardiolipin biosynthesis in the mammalian heart. To answer this, I need to determine if there is a coordinated regulation between these elements.\\n\\nMonolysocardiolipin acyltransferase (MLCL AT) is an enzyme involved in the remodeling of cardiolipin, particularly in the reacylation of monolysocardiolipin to form mature cardiolipin. \\n\\nBased on research in the field, there is evidence that MLCL AT activity is indeed regulated in coordination with cardiolipin levels and biosynthesis in mammalian hearts. Studies have shown that when cardiolipin levels are altered (such as in certain cardiac diseases or during development), there are corresponding changes in MLCL AT activity to maintain cardiolipin homeostasis. The biosynthetic pathway and remodeling processes appear to be coordinately regulated to ensure appropriate cardiolipin composition and levels in heart tissue.\\n\\nTherefore, the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27158200",
    "question": "Does growth hormone abolish the negative effects of everolimus on intestinal wound healing?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if growth hormone can counteract or abolish the negative effects that everolimus has on intestinal wound healing. To answer this, I would need to know if there is scientific evidence showing that growth hormone specifically reverses or prevents the detrimental effects of everolimus on intestinal healing processes. Everolimus is an mTOR inhibitor used as an immunosuppressant and in cancer treatment, and it can impair wound healing. Growth hormone is known to promote tissue repair in some contexts. However, without specific research showing that growth hormone specifically counteracts everolimus's effects on intestinal wound healing, I cannot confidently say 'yes'. Based on general knowledge of pharmacology and wound healing, I don't have evidence to support this specific interaction.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26194352",
    "question": "Is emerging evidence that the ban on asbestos use reducing the occurrence of pleural mesothelioma in Sweden?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if there is emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden. To answer this, I would need specific information about: 1) When Sweden banned asbestos, 2) Recent epidemiological data on pleural mesothelioma rates in Sweden, and 3) Studies that establish a causal link between the ban and any observed reduction. Without this specific information provided in the question, I cannot make a determination about whether such evidence exists. The question is asking about the existence of specific scientific evidence regarding a public health outcome in a specific country.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16188742",
    "question": "Does ultraviolet B radiation improve serum levels of vitamin D in patients with cystic fibrosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether ultraviolet B (UVB) radiation improves serum levels of vitamin D in patients with cystic fibrosis. To answer this, I need to consider what is known about the relationship between UVB radiation and vitamin D production, and specifically whether this relationship holds true in patients with cystic fibrosis.\\n\\nUVB radiation from sunlight is known to be the primary natural source of vitamin D for humans, as it triggers vitamin D synthesis in the skin. In the general population, UVB exposure does increase vitamin D levels.\\n\\nPatients with cystic fibrosis often have vitamin D deficiency due to several factors including malabsorption of fat-soluble vitamins (including vitamin D), reduced sun exposure, and potentially reduced cutaneous synthesis. \\n\\nResearch has shown that controlled UVB exposure can indeed increase serum vitamin D levels in patients with cystic fibrosis, similar to the general population, though the efficiency may vary. Several studies have demonstrated that UVB phototherapy can be an effective method to improve vitamin D status in cystic fibrosis patients.\\n\\nBased on the scientific evidence, UVB radiation does improve serum levels of vitamin D in patients with cystic fibrosis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20006546",
    "question": "Are breaks during 5Hz rTMS essential for facilitatory after effects?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether breaks during 5Hz rTMS (repetitive Transcranial Magnetic Stimulation) are essential for facilitatory after effects. I need to consider what research shows about 5Hz rTMS protocols and whether the inclusion of breaks is necessary for producing facilitatory effects after the stimulation ends.\\n\\nIn rTMS research, 5Hz stimulation is generally considered a facilitatory protocol that can increase cortical excitability. The question is specifically about whether breaks during the stimulation are essential for these facilitatory effects.\\n\\nFrom the literature, continuous 5Hz rTMS without breaks can produce facilitatory after-effects. While some protocols do incorporate breaks (sometimes called 'intertrain intervals'), these breaks are not universally considered essential for facilitatory outcomes. In fact, many studies have demonstrated facilitatory after-effects using continuous 5Hz stimulation without breaks.\\n\\nThe necessity of breaks is more commonly associated with higher frequency protocols (like 10-20Hz) where safety concerns about heat and seizure risk make breaks important. For 5Hz, continuous stimulation without breaks can still produce the facilitatory effects.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17110875",
    "question": "Are negative mesenteric effects of lung recruitment maneuvers in oleic acid lung injury transient and short lasting?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the negative mesenteric effects (effects on the mesentery, which is the tissue that connects the intestines to the abdominal wall) of lung recruitment maneuvers in oleic acid lung injury are transient and short lasting. To answer this, I would need to know about research on this specific topic. Lung recruitment maneuvers are techniques used to re-open collapsed alveoli in the lungs, often used in acute respiratory distress syndrome (ARDS) or similar conditions. Oleic acid lung injury is an experimental model of acute lung injury. The question is asking if any negative effects these maneuvers have on mesenteric circulation or function are temporary rather than persistent. Without specific knowledge of research on this topic, I cannot confidently answer yes or no.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22932818",
    "question": "Is right ventricular ejection fraction measured by multigated planar equilibrium radionuclide ventriculography an independent prognostic factor in patients with ischemic heart disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if right ventricular ejection fraction (RVEF) measured by multigated planar equilibrium radionuclide ventriculography is an independent prognostic factor in patients with ischemic heart disease. To answer this, I would need to know if studies have shown that this specific measurement independently predicts outcomes in ischemic heart disease patients, even after controlling for other factors. Without specific research evidence provided in the question, I cannot definitively state whether this particular measurement has been established as an independent prognostic factor. The question requires knowledge of specific cardiology research findings.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17609305",
    "question": "Does thyroid echogenicity predict outcome of radioiodine therapy in patients with Graves ' disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if thyroid echogenicity (the way thyroid tissue appears on ultrasound) can predict the outcome of radioiodine therapy in patients with Graves' disease. To answer this, I would need to know if there are established correlations between ultrasound findings (specifically echogenicity patterns) and treatment success rates with radioiodine in Graves' disease patients. Without specific research studies or medical literature cited in the question, I cannot make a definitive statement about whether such a predictive relationship exists. Some studies may have investigated this relationship, but I don't have enough information to confirm if thyroid echogenicity is an established predictor of radioiodine therapy outcomes in Graves' disease.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "7963509",
    "question": "Does atrial natriuretic factor increase in response to an acute glucose load?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Atrial natriuretic factor (ANF), also known as atrial natriuretic peptide (ANP), is a hormone secreted by cardiac atrial cells in response to high blood pressure or increased atrial stretching. It functions to reduce blood pressure by promoting sodium and water excretion and vasodilation.\\n\\nThe question asks whether ANF increases in response to an acute glucose load. Based on physiological mechanisms, ANF secretion is primarily triggered by cardiac wall stretch due to increased blood volume or pressure, not directly by glucose. While insulin (which increases after glucose intake) can affect sodium retention and potentially blood volume, there isn't a well-established direct mechanism for acute glucose loading to significantly increase ANF secretion.\\n\\nReviewing the scientific literature, there isn't strong evidence supporting a significant direct increase in ANF in response to acute glucose loading. Some studies have examined relationships between glucose metabolism and natriuretic peptides, but the relationship is complex and often involves chronic rather than acute changes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27030384",
    "question": "Does miR-21 contribute to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischemic preconditioning?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific molecular mechanism: whether miR-21 (a microRNA) contributes to renal protection by targeting prolyl hydroxylase domain protein 2 (PHD2) specifically in the context of delayed ischemic preconditioning. To answer this, I would need to know if research has established this specific relationship. Without specific research knowledge about miR-21 targeting PHD2 in delayed ischemic preconditioning for renal protection, I cannot confidently answer yes. This appears to be a very specific scientific question that would require evidence from research studies.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11583906",
    "question": "Does moderate hypothermia during cardiopulmonary bypass reduce myocardial cell damage and myocardial cell death related to cardiac surgery?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the effects of moderate hypothermia during cardiopulmonary bypass on myocardial (heart muscle) cell damage and death during cardiac surgery. To answer this, I need to consider the established medical evidence.\\n\\nModerate hypothermia (typically 28-32°C) during cardiopulmonary bypass is a standard technique used in cardiac surgery. The scientific literature generally supports that controlled hypothermia provides myocardial protection by:\\n\\n1. Reducing myocardial oxygen demand and metabolism\\n2. Decreasing inflammatory responses\\n3. Reducing reperfusion injury\\n4. Providing protection against ischemic damage\\n\\nMultiple clinical studies and meta-analyses have demonstrated that moderate hypothermia during cardiopulmonary bypass is associated with reduced biomarkers of myocardial injury (like troponin and CK-MB) compared to normothermic conditions.\\n\\nThe evidence indicates that moderate hypothermia does have protective effects on myocardial cells during cardiac surgery.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16458700",
    "question": "Does nimesulide oral administration increase the intraocular pressure-lowering effect of latanoprost in patients with primary open-angle glaucoma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether nimesulide oral administration increases the intraocular pressure-lowering effect of latanoprost in patients with primary open-angle glaucoma. To answer this, I would need specific clinical evidence about the interaction between nimesulide (an NSAID) and latanoprost (a prostaglandin analog used for glaucoma). Without specific studies showing this interaction, I cannot confirm that nimesulide enhances latanoprost's pressure-lowering effects. While some NSAIDs might theoretically interact with prostaglandin pathways, I don't have evidence of a clinically significant beneficial interaction specifically between nimesulide and latanoprost for glaucoma treatment.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25222127",
    "question": "Do the coupling between gaze behavior and opponent kinematics during anticipation of badminton shots?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether there is a coupling (i.e., a relationship or connection) between gaze behavior (where a player looks) and opponent kinematics (the movement patterns of the opponent) when a badminton player is trying to anticipate shots. Research in sports science has indeed shown that skilled players use visual cues from their opponent's body movements (kinematics) to anticipate the direction and type of shots in racket sports like badminton. Expert players typically demonstrate more efficient gaze patterns, focusing on relevant kinematic cues from their opponents to predict the upcoming shot. So there is evidence supporting a coupling between where players look and their opponent's movements during anticipation in badminton.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26000324",
    "question": "Do sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Metachromatic leukodystrophy (MLD) is a lysosomal storage disorder characterized by the accumulation of sulfatides (a type of sulfated glycolipid) due to a deficiency in the enzyme arylsulfatase A. This accumulation leads to demyelination and progressive neurological deterioration. The question asks whether sulfatide levels correlate with the severity of neuropathy in MLD.\\n\\nBased on the scientific literature, there is evidence that sulfatide accumulation is directly related to the pathophysiology of MLD, and higher levels of sulfatide accumulation in tissues and body fluids have been associated with more severe clinical manifestations of the disease, including neuropathy. The degree of sulfatide storage in the nervous system correlates with the extent of demyelination and subsequent neurological dysfunction. Studies have shown that patients with more severe forms of MLD typically have higher sulfatide levels in various tissues and body fluids compared to those with milder forms.\\n\\nTherefore, sulfatide levels do generally correlate with the severity of neuropathy in metachromatic leukodystrophy.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26277513",
    "question": "Does [ Minocycline reduce hyperpolarization-activated current in rat substantia gelatinosa neurons ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether Minocycline reduces hyperpolarization-activated current in rat substantia gelatinosa neurons. To answer this, I would need specific scientific evidence about Minocycline's effects on hyperpolarization-activated currents (Ih) in these specific neurons. Without access to scientific literature or specific studies on this topic, I cannot definitively answer whether this pharmacological effect has been demonstrated. The question is asking about a very specific electrophysiological effect of a drug in a particular type of neuron, which requires evidence from neuropharmacology research.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24989160",
    "question": "Is red cell distribution width increased in chronic thromboembolic pulmonary hypertension?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether red cell distribution width (RDW) is increased in chronic thromboembolic pulmonary hypertension (CTEPH). To answer this, I need to recall what is known about hematological parameters in CTEPH.\\n\\nCTEPH is a form of pulmonary hypertension caused by blood clots that don't dissolve and lead to scarring and obstruction of pulmonary vessels. Several studies have investigated the relationship between RDW and various forms of pulmonary hypertension, including CTEPH.\\n\\nResearch has shown that RDW is indeed elevated in patients with CTEPH compared to healthy controls. Multiple studies have demonstrated that RDW values are significantly higher in CTEPH patients. This elevation is thought to be related to inflammation, oxidative stress, and hypoxemia that occur in CTEPH. Some research has even suggested that RDW could be used as a biomarker for disease severity and prognosis in CTEPH.\\n\\nBased on the available medical literature, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19780877",
    "question": "Does n-Acetylcysteine improve disturbed ileal contractility following partial hepatectomy in rats?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if n-Acetylcysteine improves disturbed ileal contractility following partial hepatectomy in rats. To answer this, I would need specific research evidence about this particular effect. This is a very specific scientific question about the effect of a particular compound (n-Acetylcysteine) on a specific physiological process (ileal contractility) in a specific context (following partial hepatectomy) in a specific animal model (rats). Without having access to specific research studies on this exact topic, I cannot provide a definitive answer. I don't have information about this specific effect in my knowledge base.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25757217",
    "question": "Does recipient-matching of Passenger Leukocytes prolong Survival of Donor Lung Allografts in Miniature Swine?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether recipient-matching of passenger leukocytes prolongs survival of donor lung allografts in miniature swine. To answer this, I would need to know about specific research studies that have examined this relationship in miniature swine models. Passenger leukocytes are donor-derived white blood cells that are transferred with the transplanted organ. Recipient-matching would involve ensuring these leukocytes are compatible with the recipient's immune system. Without specific information about studies showing that this matching prolongs survival in the miniature swine model specifically, I cannot confidently answer yes. I don't have evidence in my knowledge base confirming this specific relationship in miniature swine lung transplant models.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17119051",
    "question": "Is coexpression of fragile histidine triad and c-kit relevant for prediction of survival in patients with small cell lung cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the coexpression of fragile histidine triad (FHIT) and c-kit is relevant for predicting survival in small cell lung cancer (SCLC) patients. To answer this, I would need to know if there are scientific studies showing a correlation between these biomarkers and patient outcomes in SCLC. Without specific research data provided in the question, I cannot make a definitive determination. However, both FHIT (a tumor suppressor gene) and c-kit (a receptor tyrosine kinase) have been individually studied in various cancers including lung cancer. The question specifically asks about their coexpression and its relevance to survival prediction in SCLC patients, which would require evidence from clinical studies showing statistical significance in survival analysis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12631131",
    "question": "Is c-reactive protein associated with renal function abnormalities in a non-diabetic population?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if c-reactive protein (CRP) is associated with renal function abnormalities in people without diabetes. CRP is an inflammatory marker produced by the liver in response to inflammation. Renal function abnormalities refer to problems with kidney function. \\n\\nBased on medical literature, there is evidence that elevated CRP levels are associated with kidney dysfunction even in non-diabetic populations. Multiple studies have shown that higher CRP levels correlate with reduced estimated glomerular filtration rate (eGFR) and other markers of kidney damage in the general population, including those without diabetes. Inflammation appears to play a role in kidney disease progression regardless of diabetic status.\\n\\nSo yes, c-reactive protein is associated with renal function abnormalities in non-diabetic populations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24885194",
    "question": "Does ubiquitin ligase Cbl-b repress IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific molecular mechanism in gastric cancer cells. Let me analyze what it's asking:\\n\\n1. Does ubiquitin ligase Cbl-b repress IGF-I-induced epithelial mesenchymal transition (EMT)\\n2. If so, is this repression mediated via ZEB2 and microRNA-200c regulation\\n3. This is specifically in the context of gastric cancer cells\\n\\nThis is a very specific scientific question about molecular pathways in cancer biology. Without specific scientific literature or studies on this exact pathway, I cannot definitively answer whether Cbl-b represses IGF-I-induced EMT via the specific mechanism of ZEB2 and microRNA-200c regulation in gastric cancer cells. This would require knowledge of specific research findings in this area of cancer biology.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17639086",
    "question": "Is non-steroidal anti-inflammatory drug-induced small intestinal damage Toll-like receptor 4 dependent?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether non-steroidal anti-inflammatory drug (NSAID)-induced damage to the small intestine depends on Toll-like receptor 4 (TLR4). To answer this, I need to consider the current scientific understanding of the mechanisms behind NSAID-induced intestinal damage.\\n\\nResearch has shown that TLR4 plays a significant role in NSAID-induced small intestinal damage. Studies have demonstrated that TLR4-deficient mice show reduced intestinal damage after NSAID administration compared to wild-type mice. The mechanism involves TLR4 recognition of bacterial components (like LPS) that translocate across the intestinal barrier after initial NSAID-induced damage, leading to inflammatory responses that exacerbate the injury.\\n\\nMultiple studies have confirmed this TLR4 dependency, showing that TLR4 antagonists or genetic knockout of TLR4 significantly reduces NSAID enteropathy. This indicates that while the initial damage may be caused by direct NSAID effects on the intestinal epithelium, the amplification and progression of damage is TLR4-dependent.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22330321",
    "question": "Does genetic variation in MMP20 contribute to higher caries experience?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if genetic variation in MMP20 contributes to higher caries experience. MMP20 (Matrix Metalloproteinase-20) is an enzyme involved in tooth enamel formation. Several studies have investigated the association between MMP20 gene variants and dental caries (tooth decay). Research has shown that certain polymorphisms in the MMP20 gene are associated with increased susceptibility to dental caries. For example, studies have found that specific MMP20 variants can affect enamel formation and quality, potentially making teeth more susceptible to decay. There is scientific evidence supporting that genetic variation in MMP20 can contribute to higher caries experience.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20813683",
    "question": "Does [ Norcantharidin inhibit DNA replication initiation protein Cdc6 in cancer cells ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if Norcantharidin inhibits DNA replication initiation protein Cdc6 in cancer cells. To answer this, I need to know if there is scientific evidence showing that Norcantharidin specifically targets and inhibits the Cdc6 protein in cancer cells. Cdc6 is a protein involved in the initiation of DNA replication, and it's often overexpressed in cancer cells. Norcantharidin is a demethylated analog of cantharidin that has shown anti-cancer properties. However, without specific knowledge of studies demonstrating that Norcantharidin directly inhibits Cdc6 protein, I cannot confirm this relationship. I don't have definitive information showing that Norcantharidin specifically targets Cdc6 in its mechanism of action against cancer cells.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21046298",
    "question": "Are perivascular and diffuse lymphocytic inflammation specific for failed metal-on-metal hip implants?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if perivascular and diffuse lymphocytic inflammation are specific for failed metal-on-metal hip implants. To answer this, I need to consider whether these inflammatory patterns occur exclusively in metal-on-metal hip implant failures or if they can also be found in other types of implant failures or conditions.\\n\\nBased on medical literature, while perivascular and diffuse lymphocytic inflammation are commonly associated with adverse reactions to metal debris from metal-on-metal hip implants (sometimes called ALVAL - aseptic lymphocyte-dominated vasculitis-associated lesion), these inflammatory patterns can also be observed in other conditions:\\n\\n1. Similar lymphocytic inflammation can occur in metal-on-polyethylene implants\\n2. Ceramic implant failures can also show lymphocytic inflammation\\n3. Hypersensitivity reactions to various implant materials can present with similar histological features\\n4. Some infections can also cause lymphocytic infiltration patterns\\n\\nTherefore, while these inflammatory patterns are characteristic of metal-on-metal implant failures, they are not exclusively specific to them.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "17484880",
    "question": "Do t84-intestinal epithelial exosomes bear MHC class II/peptide complexes potentiating antigen presentation by dendritic cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if t84-intestinal epithelial exosomes bear MHC class II/peptide complexes that potentiate antigen presentation by dendritic cells. This is a specific scientific question about the properties of exosomes derived from t84 intestinal epithelial cells.\\n\\nTo answer this accurately, I would need to know if these specific exosomes (from t84 intestinal epithelial cells) contain MHC class II molecules with peptides that can enhance antigen presentation when they interact with dendritic cells.\\n\\nBased on general knowledge of exosomes, some epithelial cell-derived exosomes can contain MHC molecules and participate in immune responses. However, without specific information about t84-intestinal epithelial exosomes in particular, I cannot provide a definitive answer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22011763",
    "question": "Does donor graft steatosis influence immunity to hepatitis C virus and allograft outcome after liver transplantation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether donor graft steatosis (fatty liver in the donor organ) affects immunity to hepatitis C virus (HCV) and allograft outcomes after liver transplantation. To answer this, I need to consider if there's an established relationship between donor liver steatosis and either HCV immunity or transplant outcomes.\\n\\nBased on medical literature, donor graft steatosis has been associated with poorer outcomes in liver transplantation generally, including increased risk of primary non-function and delayed graft function. Regarding HCV specifically, there is evidence suggesting that donor steatosis may accelerate HCV recurrence and fibrosis progression after transplantation. Some studies have shown that steatotic grafts transplanted into HCV-positive recipients have worse outcomes compared to non-steatotic grafts.\\n\\nThe question specifically asks about 'immunity to HCV' - steatosis has been shown to affect HCV replication and progression, potentially by altering the liver microenvironment and inflammatory responses. This could indirectly affect the immune response to HCV.\\n\\nSo yes, donor graft steatosis does appear to influence both immunity to HCV and allograft outcomes after liver transplantation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16512753",
    "question": "Is the extent of alveolar bone loss associated with impaired glucose tolerance in Japanese men?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about a specific association between alveolar bone loss and impaired glucose tolerance in Japanese men. To answer this accurately, I would need to know about specific research studies that have examined this relationship in this population. Without having access to specific research on this topic, I cannot definitively state whether there is an association. Some studies in various populations have shown links between periodontal disease (which includes alveolar bone loss) and diabetes/glucose intolerance, but I don't have specific information about this relationship in Japanese men specifically.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24548820",
    "question": "Does cyclooxygenase metabolism mediate vasorelaxation to 2-arachidonoylglycerol ( 2-AG ) in human mesenteric arteries?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries. To answer this, I would need to know if scientific studies have shown that the cyclooxygenase pathway is involved in how 2-AG causes relaxation of human mesenteric arteries. 2-AG is an endocannabinoid, and its vasodilatory effects could potentially be mediated through various pathways. Without specific scientific evidence about the role of cyclooxygenase in 2-AG's effects specifically in human mesenteric arteries, I cannot provide a definitive answer. This would require knowledge of specific research findings in this area.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26778339",
    "question": "Does the odd-carbon medium-chain fatty triglyceride triheptanoin reduce hepatic steatosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether triheptanoin, which is an odd-carbon medium-chain fatty triglyceride, reduces hepatic steatosis (fatty liver disease). To answer this, I need to consider what is known about triheptanoin's effects on the liver.\\n\\nTriheptanoin is a triglyceride composed of three 7-carbon fatty acid chains (heptanoic acid). It's used as a medical food for certain metabolic disorders because it can provide anaplerotic substrates to the TCA cycle.\\n\\nRegarding its effect on hepatic steatosis specifically:\\n- Some research suggests that medium-chain triglycerides (MCTs) may have beneficial effects on liver fat accumulation compared to long-chain triglycerides\\n- Triheptanoin specifically has been studied for various metabolic conditions\\n- However, the evidence specifically showing that triheptanoin reduces hepatic steatosis is limited\\n\\nBased on the current scientific literature, while there are theoretical reasons why it might be beneficial, there isn't robust clinical evidence establishing that triheptanoin specifically reduces hepatic steatosis.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "16670691",
    "question": "Does vitamin B6 supplementation increase immune responses in critically ill patients?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether vitamin B6 supplementation increases immune responses in critically ill patients. To answer this, I need to consider the scientific evidence on this specific relationship. While vitamin B6 is known to play a role in immune function in general, the specific claim about supplementation improving immune responses in critically ill patients requires evidence from clinical studies. Based on my knowledge, there is limited conclusive evidence showing that vitamin B6 supplementation specifically enhances immune responses in critically ill patients. Some studies have examined micronutrient supplementation in critical illness, but the evidence for vitamin B6 alone having a significant impact on immune function in this specific population is not strongly established in the scientific literature.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27229529",
    "question": "Is dynamic contrast-enhanced MRI coupled with a subtraction technique useful for treatment response evaluation of malignant melanoma hepatic metastasis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if dynamic contrast-enhanced MRI coupled with a subtraction technique is useful for evaluating treatment response in hepatic (liver) metastases from malignant melanoma. \\n\\nDynamic contrast-enhanced (DCE) MRI is an advanced imaging technique that captures multiple images over time as contrast material flows through blood vessels and tissues. Subtraction technique involves digitally subtracting pre-contrast images from post-contrast images to better visualize enhancing lesions.\\n\\nFor melanoma hepatic metastases specifically, DCE-MRI with subtraction has been shown to be valuable in several ways:\\n1. It can detect small metastases that might be missed on conventional imaging\\n2. It helps characterize lesions based on their enhancement patterns\\n3. It can quantitatively assess changes in tumor vascularity and perfusion after treatment\\n4. Subtraction techniques specifically help eliminate background signal and better visualize enhancement changes\\n\\nMultiple studies have demonstrated that DCE-MRI with subtraction techniques improves detection and characterization of liver lesions and can effectively monitor treatment response in various cancers including melanoma metastases. The technique helps distinguish viable tumor from necrotic tissue after treatments like chemotherapy, immunotherapy, or targeted therapies.\\n\\nBased on the medical literature, this combined approach is indeed useful for treatment response evaluation in this specific clinical scenario.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20160253",
    "question": "Is low to moderate alcohol intake associated with increased mortality after breast cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the association between low to moderate alcohol intake and increased mortality after breast cancer. I need to consider what the scientific evidence shows about this relationship.\\n\\nFrom the medical literature, most studies suggest that moderate alcohol consumption (typically defined as 1 drink per day for women) may be associated with a slightly increased risk of developing breast cancer initially. However, regarding mortality AFTER breast cancer diagnosis, the evidence is more mixed.\\n\\nSome studies have found no significant association between low to moderate alcohol consumption and breast cancer recurrence or mortality among survivors. Other studies have suggested that moderate alcohol consumption post-diagnosis might even be associated with slightly decreased all-cause mortality in some populations, though this remains controversial.\\n\\nThe most recent comprehensive reviews and meta-analyses generally do not support a strong association between low to moderate alcohol intake and increased mortality specifically among breast cancer survivors.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "25524049",
    "question": "Does increasing membrane cholesterol of neurons in culture recapitulate Alzheimer 's disease early phenotypes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether increasing membrane cholesterol of neurons in culture recapitulates Alzheimer's disease early phenotypes. To answer this, I need to consider whether there is scientific evidence showing that artificially increasing cholesterol in neuronal cell membranes in laboratory cultures produces the same early cellular and molecular changes that are observed in Alzheimer's disease.\\n\\nBased on scientific literature, increased membrane cholesterol has been linked to several Alzheimer's disease-related processes including:\\n1. Enhanced amyloid-beta production and aggregation\\n2. Altered APP processing\\n3. Changes in membrane fluidity that affect neuronal function\\n4. Increased tau phosphorylation in some models\\n\\nSeveral studies have shown that cholesterol loading in cultured neurons can induce some AD-like phenotypes, including increased Aβ production and altered APP processing. However, while increasing membrane cholesterol does reproduce some aspects of early AD pathology, it doesn't fully recapitulate the complex, multifactorial nature of early AD, which involves multiple pathways beyond just cholesterol-mediated effects.\\n\\nSo while there is a relationship between cholesterol and some AD phenotypes, saying it 'recapitulates' early AD would be an overstatement.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25919376",
    "question": "Does a Browser-Server-Based Tele-audiology System That support Multiple Hearing Test Modalities?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if a browser-server-based tele-audiology system supports multiple hearing test modalities. This is asking about capabilities of a specific type of system. However, the question is too vague and doesn't specify which particular system is being referred to. There are various tele-audiology systems that exist, and they have different capabilities. Some browser-server-based tele-audiology systems do support multiple hearing test modalities, while others might be more limited. Without specifying a particular system, I cannot give a definitive yes or no answer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26173184",
    "question": "Is kupffer cell-monocyte communication essential for initiating murine liver progenitor cell-mediated liver regeneration?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if kupffer cell-monocyte communication is essential for initiating murine liver progenitor cell-mediated liver regeneration. To answer this accurately, I would need specific scientific evidence about the role of kupffer cell-monocyte communication in liver progenitor cell activation during liver regeneration in mice. Without specific research findings on this particular interaction, I cannot make a definitive claim. While kupffer cells (liver resident macrophages) and monocytes are known to play roles in liver regeneration and inflammation, whether their communication is specifically 'essential' for initiating progenitor cell-mediated regeneration is a precise scientific claim that requires evidence from liver biology research.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27822011",
    "question": "Does ursolic acid sensitize cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question. It's asking about a specific mechanism: whether ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin by inhibiting the Nrf2/ARE pathway. To answer this accurately, I would need to know if research has demonstrated this specific mechanism. HepG2/DDP cells are cisplatin-resistant liver cancer cells, and the Nrf2/ARE pathway is known to be involved in drug resistance mechanisms. While ursolic acid has been studied for potential anticancer properties, I need to determine if this specific mechanism of action (inhibiting Nrf2/ARE pathway in HepG2/DDP cells) has been established in research. Based on published literature, ursolic acid has indeed been shown to sensitize cisplatin-resistant HepG2/DDP cells to cisplatin by inhibiting the Nrf2/ARE pathway. This mechanism has been documented in research studies examining how ursolic acid can overcome cisplatin resistance in hepatocellular carcinoma cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17880684",
    "question": "Is sinomenine , a natural dextrorotatory morphinan analog , anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question. The question is asking whether sinomenine, which is described as a natural dextrorotatory morphinan analog, has anti-inflammatory and neuroprotective effects specifically through the mechanism of inhibiting microglial NADPH oxidase. \\n\\nTo answer this accurately, I would need to know if research has established this specific mechanism of action for sinomenine. Based on my knowledge, sinomenine does have anti-inflammatory and immunosuppressive properties, and some studies have investigated its neuroprotective effects. However, I need to determine if these effects have been specifically linked to inhibition of microglial NADPH oxidase.\\n\\nSome research has shown that sinomenine can inhibit microglial activation and reduce inflammatory responses in the central nervous system. There is evidence suggesting that sinomenine may inhibit NADPH oxidase activity in microglia, which would reduce oxidative stress and neuroinflammation, thereby providing neuroprotection.\\n\\nBased on scientific literature, sinomenine has been shown to inhibit microglial NADPH oxidase, which contributes to its anti-inflammatory and neuroprotective effects.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24180672",
    "question": "Are lifesaving emergency obstetric services inadequate in south-west Ethiopia : a formidable challenge to reducing maternal mortality in Ethiopia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether lifesaving emergency obstetric services are inadequate in south-west Ethiopia, and whether this presents a significant challenge to reducing maternal mortality in Ethiopia. To answer this, I would need specific data about the quality and availability of emergency obstetric services in south-west Ethiopia, as well as information about how this impacts maternal mortality rates. Without having specific research or data on this topic, I cannot provide a definitive yes or no answer based on factual information. The question appears to be phrased as a title of a research paper or article that would present findings on this topic.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27358048",
    "question": "Do genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether genomic alterations (changes in DNA) are responsible for a metabolic shift that occurs across multiple cancer types (pan-cancer) that is associated with tumor hypoxia (low oxygen conditions in tumors). \\n\\nTo answer this, I need to consider what is known about cancer metabolism and hypoxia:\\n\\n1. Tumor hypoxia is a common feature in many solid tumors due to abnormal vasculature and rapid growth\\n2. Cancer cells often exhibit a metabolic shift known as the Warburg effect (increased glycolysis even in the presence of oxygen)\\n3. There is evidence that genomic alterations in cancer cells can affect metabolic pathways\\n4. Multiple studies have shown that hypoxia-inducible factors (HIFs) regulate metabolic reprogramming in cancer\\n5. Genomic alterations in genes like VHL, IDH, SDH, and FH have been linked to metabolic reprogramming and hypoxia response\\n\\nBased on the scientific literature, there is substantial evidence that genomic alterations do underlie metabolic shifts associated with tumor hypoxia across multiple cancer types. Mutations in oncogenes and tumor suppressor genes can activate hypoxia response pathways even in normoxic conditions (pseudohypoxia) and drive metabolic reprogramming.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24808759",
    "question": "Does modern applications for a total sulfur reduction distillation method - what 's old is new again?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if there are modern applications for a total sulfur reduction distillation method, with the phrase 'what's old is new again' suggesting that an older technique might be finding new applications. To answer this properly, I need to determine if total sulfur reduction distillation methods that were used in the past are now being applied in modern contexts. Without specific information about this particular method and its current applications, I cannot definitively say yes or no. However, in many scientific and industrial fields, older techniques are often rediscovered and applied with modern technology, especially in areas like petroleum processing, environmental remediation, and analytical chemistry where sulfur reduction is important. But I don't have specific evidence about this particular method's modern applications.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19152190",
    "question": "Are plasma free metanephrines superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of phaeochromocytoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether plasma free metanephrines are superior to other tests (urine and plasma catecholamines, and urine catecholamine metabolites) for investigating phaeochromocytoma, which is a rare tumor of the adrenal glands.\\n\\nBased on medical literature, plasma free metanephrines are indeed considered the most sensitive and specific test for diagnosing phaeochromocytoma. They have higher diagnostic accuracy compared to the other mentioned tests because:\\n\\n1. Plasma free metanephrines have higher sensitivity (often >95%) and specificity compared to other tests\\n2. They are less affected by medications, stress, and dietary factors than plasma catecholamines\\n3. They provide more consistent results as phaeochromocytomas continuously produce metanephrines even when catecholamine secretion is episodic\\n4. Multiple clinical guidelines recommend plasma free metanephrines as the first-line biochemical test for phaeochromocytoma\\n\\nTherefore, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15474066",
    "question": "Do cultured human endometrial epithelial cells produce thymus and activation-regulated chemokine with stimulation of interleukin-4 and interleukin-13?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether cultured human endometrial epithelial cells produce thymus and activation-regulated chemokine (TARC) when stimulated with interleukin-4 (IL-4) and interleukin-13 (IL-13). To answer this, I would need to know if there is scientific evidence showing that human endometrial epithelial cells in culture respond to IL-4 and IL-13 by producing TARC. Without specific research knowledge on this topic, I cannot provide a definitive answer. However, it is known that TARC (also known as CCL17) is often induced by Th2 cytokines like IL-4 and IL-13 in various epithelial cell types. Whether this specifically occurs in endometrial epithelial cells would require knowledge of specific studies on this cell type.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16153428",
    "question": "Are salutary effects of androstenediol on hepatic function after trauma-hemorrhage mediated via peroxisome proliferators-activated receptor gamma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the beneficial (salutary) effects of androstenediol on liver (hepatic) function after trauma-hemorrhage are mediated through the peroxisome proliferator-activated receptor gamma (PPARγ) pathway. To answer this, I would need to know if scientific research has established this specific mechanism. Without specific research knowledge on this topic, I cannot definitively say whether androstenediol's hepatoprotective effects after trauma-hemorrhage work through PPARγ signaling. This is a very specific scientific question about a biochemical mechanism that requires evidence from research studies.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16540899",
    "question": "Does nasal vaccination with CpG oligodeoxynucleotide induce protective immunity against non-typeable Haemophilus influenzae in the nasopharynx?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx. To answer this, I need to consider whether there is scientific evidence supporting this specific claim.\\n\\nCpG oligodeoxynucleotides (CpG ODNs) are known immunostimulatory agents that can act as adjuvants in vaccines by activating Toll-like receptor 9 (TLR9). They have been studied in various vaccination strategies.\\n\\nNon-typeable Haemophilus influenzae (NTHi) is a common respiratory pathogen that can cause otitis media, sinusitis, and exacerbations of chronic obstructive pulmonary disease.\\n\\nThere have been studies examining the use of CpG ODNs as adjuvants in vaccines against respiratory pathogens, including NTHi. Some research has shown that intranasal administration of CpG ODN along with NTHi antigens can enhance mucosal and systemic immune responses against NTHi.\\n\\nBased on the scientific literature, there is evidence supporting that nasal vaccination strategies incorporating CpG ODN can induce protective immunity against NTHi in the nasopharynx in experimental models.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25064138",
    "question": "Do high progesterone levels in women with high ovarian response affect clinical outcomes : a retrospective cohort study?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if high progesterone levels in women with high ovarian response affect clinical outcomes, and it mentions this is based on a retrospective cohort study. This appears to be the title of a research paper or study, not a yes/no question that I can directly answer. The title itself is posing a research question that the study aims to investigate, but doesn't provide the conclusion. Without knowing the results of the study, I cannot say yes or no to whether high progesterone levels affect clinical outcomes.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "19246214",
    "question": "Do two-lung high-frequency jet ventilation as an alternative ventilation technique during transthoracic esophagectomy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether two-lung high-frequency jet ventilation is used as an alternative ventilation technique during transthoracic esophagectomy. Let me analyze this:\n\nHigh-frequency jet ventilation (HFJV) is indeed sometimes used as an alternative ventilation technique during certain surgical procedures. In transthoracic esophagectomy (surgical removal of the esophagus through the chest), various ventilation strategies may be employed.\n\nTraditional ventilation during transthoracic esophagectomy often involves one-lung ventilation (OLV) to collapse the lung on the operative side, providing better surgical access. However, HFJV can be used as an alternative in some cases.\n\nTwo-lung HFJV specifically refers to applying high-frequency jet ventilation to both lungs simultaneously. This technique has been described in the literature as an alternative approach during certain thoracic procedures, including some esophageal surgeries.\n\nSo yes, two-lung high-frequency jet ventilation can be used as an alternative ventilation technique during transthoracic esophagectomy, though it's not the most common approach.\", \n\"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19100393",
    "question": "Does high serum level of the soluble CD30 identify Chinese kidney transplant recipients at high risk of unfavorable outcome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if high serum levels of soluble CD30 can identify Chinese kidney transplant recipients who are at high risk of unfavorable outcomes. To answer this, I would need to know if there are studies showing a correlation between elevated soluble CD30 levels and poor transplant outcomes specifically in Chinese kidney transplant patients. Without specific information about studies conducted on Chinese populations showing this relationship, I cannot definitively answer. However, soluble CD30 has been studied as a potential biomarker for transplant rejection and graft failure in various populations. Some studies have indeed suggested that elevated soluble CD30 levels can predict adverse outcomes in kidney transplantation, but whether this applies specifically to Chinese patients would require population-specific evidence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19509021",
    "question": "Do the retinoblastoma protein and its homolog p130 regulate the G1/S transition in pancreatic beta-cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the retinoblastoma protein (Rb) and its homolog p130 regulate the G1/S transition in pancreatic beta-cells specifically. Let me analyze what I know about this topic.\\n\\nThe retinoblastoma protein (Rb) and its family members (including p130) are well-known cell cycle regulators that control the G1/S transition in many cell types. They typically function by binding to E2F transcription factors and preventing the expression of genes required for S phase entry.\\n\\nHowever, the question specifically asks about their role in pancreatic beta-cells. Based on research literature, there is evidence that Rb and related proteins do regulate cell cycle progression in pancreatic beta-cells. Studies have shown that inactivation of Rb pathway components can lead to beta-cell proliferation, suggesting they normally restrict beta-cell cycle progression at the G1/S checkpoint.\\n\\nSpecific research has demonstrated that Rb and p130 are expressed in pancreatic beta-cells and that they do function to regulate the G1/S transition in these specific cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20959640",
    "question": "Does acetylcholine receptor agonist reduce brain damage induced by hypoxia-ischemia in newborn rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether acetylcholine receptor agonists reduce brain damage caused by hypoxia-ischemia in newborn rats. To answer this, I need to consider what is known about acetylcholine receptor agonists and their neuroprotective effects in this specific context.\\n\\nAcetylcholine receptor agonists have been studied for their potential neuroprotective effects in various models of brain injury. There is research suggesting that activation of certain acetylcholine receptors (particularly nicotinic and muscarinic receptors) can have protective effects against excitotoxicity, oxidative stress, and inflammation - all mechanisms involved in hypoxic-ischemic brain injury.\\n\\nSpecifically for newborn rats with hypoxia-ischemia, studies have shown that acetylcholine receptor agonists (such as nicotine, choline, or specific muscarinic agonists) can reduce the extent of brain damage, improve neurological outcomes, and decrease neuronal death in experimental models. These agents appear to work through various mechanisms including anti-inflammatory effects, anti-apoptotic pathways, and modulation of excitotoxicity.\\n\\nBased on the published literature in this field, there is evidence supporting the neuroprotective effects of acetylcholine receptor agonists in hypoxic-ischemic brain injury models in neonatal rats.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22431132",
    "question": "Does a novel amino acid substitution Ala-122-Tyr in ALS confer high-level and broad resistance across ALS-inhibiting herbicides?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a specific amino acid substitution, Ala-122-Tyr (alanine to tyrosine at position 122) in the ALS (acetolactate synthase) enzyme confers high-level and broad resistance across ALS-inhibiting herbicides. To answer this, I need to consider what's known about this specific mutation in ALS. \\n\\nALS (acetolactate synthase) is an enzyme targeted by several classes of herbicides. Mutations in the ALS gene can confer resistance to these herbicides. Position 122 is a known mutation site in ALS that can confer herbicide resistance. \\n\\nThe specific Ala-122-Tyr substitution has been documented in scientific literature to confer resistance to ALS-inhibiting herbicides. However, the question specifically asks about \\\"high-level and broad resistance across ALS-inhibiting herbicides.\\\" \\n\\nBased on research, the Ala-122-Tyr substitution typically confers resistance to imidazolinone herbicides (one class of ALS inhibitors) but not necessarily high-level resistance to all classes of ALS inhibitors (such as sulfonylureas, triazolopyrimidines, etc.). Different substitutions at different positions confer different resistance patterns.\\n\\nTherefore, while this substitution does confer resistance, it doesn't provide high-level, broad-spectrum resistance across all ALS-inhibiting herbicide classes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17416110",
    "question": "Does intraoperative small-dose ketamine reduce pain or analgesic consumption during perioperative opioid analgesia in children after tonsillectomy?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the efficacy of small-dose ketamine in reducing pain or analgesic consumption in children who have undergone tonsillectomy and are receiving opioid analgesia. Let me analyze the evidence for this specific clinical scenario.\\n\\nKetamine is an NMDA receptor antagonist that has been studied for its analgesic properties at sub-anesthetic doses. For the specific context of pediatric tonsillectomy:\\n\\nThere have been several studies examining ketamine's adjuvant role in pediatric tonsillectomy pain management. A meta-analysis by Dahmani et al. (2011) found that intraoperative low-dose ketamine reduced pain scores and analgesic requirements in the first 24 hours after tonsillectomy in children.\\n\\nStudies by O'Flaherty and Lin (2003) and Elhakim et al. (2003) specifically showed that small-dose ketamine reduced opioid consumption and pain scores when added to standard opioid analgesia after tonsillectomy in children.\\n\\nA Cochrane review by Bell et al. also supported that perioperative ketamine reduces opioid consumption and pain intensity.\\n\\nBased on the available evidence, there appears to be support for the efficacy of small-dose ketamine in reducing pain and/or analgesic consumption when used as an adjunct to opioid analgesia in children undergoing tonsillectomy.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "18180022",
    "question": "Are electrocardiographic factors playing a role in ischemic ventricular fibrillation in ST elevation myocardial infarction related to the culprit artery?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if electrocardiographic factors play a role in ischemic ventricular fibrillation in ST elevation myocardial infarction (STEMI) related to the culprit artery. To answer this, I need to consider whether ECG factors are associated with ventricular fibrillation in STEMI cases, specifically in relation to which coronary artery is occluded (the culprit artery).\\n\\nBased on medical literature, electrocardiographic factors do indeed play a role in predicting and characterizing ventricular fibrillation in STEMI. Different ECG patterns can be associated with different culprit arteries, and these patterns may influence the risk and characteristics of ventricular fibrillation. For example, anterior ST elevation (often associated with left anterior descending artery occlusion) has different electrophysiological consequences than inferior ST elevation (often associated with right coronary artery occlusion).\\n\\nThere is evidence that the location of the infarct (determined by which artery is occluded) affects the ECG presentation and the risk of ventricular arrhythmias including ventricular fibrillation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "14697105",
    "question": "Do glucocorticoids reduce cardiac dysfunction after cardiopulmonary bypass and circulatory arrest in neonatal piglets?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the effects of glucocorticoids on cardiac dysfunction in a specific experimental model - neonatal piglets that have undergone cardiopulmonary bypass and circulatory arrest. To answer this, I would need to know if there is scientific evidence showing that glucocorticoids have a protective effect on cardiac function in this specific experimental setup. Without specific research data on this particular model, I cannot give a definitive answer. However, glucocorticoids are known to have anti-inflammatory effects and have been studied in various cardiac surgery models. Some studies have shown beneficial effects of glucocorticoids in reducing inflammatory responses and improving cardiac function after cardiopulmonary bypass in various models, but I would need specific evidence about neonatal piglets to answer with certainty.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12491505",
    "question": "Is advanced age at diagnosis an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if advanced age at diagnosis independently predicts time to death from prostate carcinoma specifically for patients who are treated with external beam radiation therapy for clinically localized prostate cancer. To answer this, I would need to know if studies have shown that age itself, separate from other factors, affects survival time after this specific treatment. Without specific research data provided in the question, I need to consider what is generally known about age as a prognostic factor in cancer treatment outcomes. While age is often associated with overall survival in cancer patients, the question specifically asks about it being an 'independent predictor' for this specific treatment modality and cancer stage. Based on general medical knowledge, advanced age is typically associated with higher mortality in cancer patients, but whether it's an independent predictor specifically for radiation-treated localized prostate cancer patients would require specific studies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24481743",
    "question": "Does zhuanggu Jianxi Decoction ( ) limit interleukin-1 β-induced degeneration chondrocytes via the caveolin-p38 MAPK signal pathway?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if zhuanggu Jianxi Decoction limits interleukin-1β-induced degeneration of chondrocytes via the caveolin-p38 MAPK signal pathway. To answer this, I would need specific scientific evidence about this particular decoction and its mechanism of action. Without having access to specific research papers or scientific literature that demonstrates this particular pathway for this specific Chinese herbal formula, I cannot confirm this claim. The question contains very specific molecular pathway details (caveolin-p38 MAPK signal pathway) in relation to a specific traditional Chinese medicine preparation, which would require evidence from published research to verify.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22442926",
    "question": "Does prevalence and correlate for self-reported sleep problems among nursing students?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether there is a prevalence and correlates for self-reported sleep problems among nursing students. This is asking about whether there is evidence or research showing how common sleep problems are among nursing students and what factors are associated with these sleep problems. This is a factual question about research findings, not something I can answer with a simple yes or no without referring to specific studies. The question itself seems to be grammatically incomplete - it should probably be 'Does prevalence and correlates for self-reported sleep problems exist among nursing students?' or 'What is the prevalence and what are the correlates for self-reported sleep problems among nursing students?'\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23284855",
    "question": "Are time trends in pediatric hospitalizations for varicella infection associated with climatic changes : a 22-year retrospective study in a tertiary Greek referral center?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question appears to be asking if I believe there is an association between climate changes and trends in pediatric hospitalizations for varicella (chickenpox) infections, specifically referencing a 22-year retrospective study conducted at a tertiary Greek referral center. The question is phrased as if it's asking about the findings or conclusions of this specific study. Without having access to the actual study and its results, I cannot definitively state whether this particular study found an association between climate changes and varicella hospitalization trends. The question is asking about what a specific study found, not asking for my general knowledge about varicella and climate.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27756261",
    "question": "Does inhibition of eEF-2 kinase sensitize human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether inhibiting eEF-2 kinase makes human nasopharyngeal carcinoma cells more sensitive to lapatinib-induced apoptosis, specifically through the Src and Erk pathways. To answer this, I would need specific research evidence showing this relationship. Without having access to specific studies demonstrating this relationship, I cannot definitively answer. However, this appears to be a specific scientific claim about a molecular mechanism that would require empirical evidence to support. I don't have sufficient information to confirm whether inhibition of eEF-2 kinase specifically sensitizes nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through these particular pathways.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22105462",
    "question": "Does central nervous system regeneration occur?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The central nervous system (CNS), which consists of the brain and spinal cord, has limited regenerative capacity in mammals including humans. Unlike the peripheral nervous system, which can regenerate to some extent after injury, the CNS has poor regenerative abilities. This is due to several factors including the inhibitory environment created after injury, the presence of myelin-associated inhibitors, and the formation of glial scars that prevent axon regrowth. While there is some evidence of limited neurogenesis (the birth of new neurons) in specific regions of the adult brain such as the hippocampus and subventricular zone, this is not sufficient for functional recovery after significant CNS damage. Research is ongoing to develop therapies to promote CNS regeneration, but currently, substantial spontaneous regeneration does not occur in the CNS after injury.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "8015128",
    "question": "Do a citation analysis of the impact of blinded peer review?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking me to perform a citation analysis of the impact of blinded peer review. A citation analysis would involve examining and analyzing citation patterns and metrics to evaluate how blinded peer review affects scholarly impact. This would require collecting data on papers reviewed under blinded vs. non-blinded conditions, analyzing citation counts, and drawing conclusions about differences in impact. This is a complex research task that would require access to citation databases, statistical analysis tools, and significant time to complete properly. I cannot perform an actual citation analysis as requested.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12371965",
    "question": "Is compensatory renal hypertrophy mediated by a cell cycle-dependent mechanism?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Compensatory renal hypertrophy (CRH) occurs when one kidney enlarges to compensate for the loss or damage of the other kidney. The question asks whether this process is mediated by a cell cycle-dependent mechanism. \\n\\nFrom scientific literature, CRH involves both hypertrophy (increase in cell size) and hyperplasia (increase in cell number). The initial phase is primarily hypertrophic, with cells increasing in size without dividing. This process involves protein synthesis and cell growth that doesn't require cells to progress through the complete cell cycle. Later phases may involve some hyperplasia with cell proliferation.\\n\\nThe key point is that the primary mechanism of compensatory renal hypertrophy, especially in its initial and most significant phase, is not dependent on cell cycle progression or cell division. The cells grow larger without completing the cell cycle. Therefore, CRH is not primarily mediated by a cell cycle-dependent mechanism.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19574207",
    "question": "Is pre-treatment serum lactate dehydrogenase level an important prognostic factor in high-grade extremity osteosarcoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if pre-treatment serum lactate dehydrogenase (LDH) level is an important prognostic factor in high-grade extremity osteosarcoma. To answer this, I need to consider what is known in medical literature about prognostic factors for osteosarcoma. Elevated serum LDH has been identified in multiple studies as a significant prognostic factor in osteosarcoma. High LDH levels before treatment have been associated with poorer outcomes, increased risk of metastasis, and lower overall survival rates in patients with high-grade osteosarcoma of the extremities. It is often included in prognostic models alongside other factors such as tumor size, presence of metastasis at diagnosis, and response to chemotherapy. Based on established medical literature, pre-treatment serum LDH is indeed considered an important prognostic marker in this specific type of cancer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15750921",
    "question": "Does fibroblast growth factor-10 serve a regulatory role in duodenal development?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, I need to consider what is known about fibroblast growth factor-10 (FGF-10) and its role in duodenal development.\\n\\nFGF-10 is a member of the fibroblast growth factor family that plays important roles in embryonic development, particularly in epithelial-mesenchymal interactions during organogenesis.\\n\\nIn terms of gastrointestinal development:\\n- FGF-10 is known to be critical for proper development of several organs including the lungs, limbs, and parts of the gastrointestinal tract\\n- It has been well-established that FGF-10 plays key roles in pancreatic development\\n- Studies have shown that FGF-10 is involved in stomach development\\n\\nSpecifically regarding duodenal development:\\n- The duodenum is the first part of the small intestine, connecting to the stomach\\n- Research has demonstrated that FGF-10 signaling is important for proper intestinal development\\n- FGF-10 knockout mice show abnormalities in intestinal development, including the duodenum\\n- FGF-10 has been shown to regulate epithelial cell proliferation and differentiation in the developing intestine, including the duodenal region\\n\\nBased on the scientific literature, FGF-10 does serve a regulatory role in duodenal development as part of its broader function in gastrointestinal tract development.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11755292",
    "question": "Does growth hormone correct vascular dysfunction in patients with chronic heart failure?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if growth hormone corrects vascular dysfunction in patients with chronic heart failure. To answer this, I need to consider the established medical evidence about growth hormone's effects on vascular function specifically in heart failure patients.\\n\\nGrowth hormone has been studied in heart failure, with some research showing potential benefits on cardiac function, exercise capacity, and hemodynamics. However, regarding specific correction of vascular dysfunction, the evidence is more limited.\\n\\nSome studies have shown that growth hormone can improve endothelial function and reduce peripheral vascular resistance in some settings. In heart failure specifically, there have been small studies suggesting potential improvements in endothelial function and vascular reactivity with growth hormone therapy.\\n\\nHowever, these effects have not been consistently demonstrated in larger clinical trials, and growth hormone is not an established or approved therapy for vascular dysfunction in heart failure. The improvements seen in some studies have been modest and variable.\\n\\nBased on the current state of evidence, growth hormone cannot be said to definitively \\\"correct\\\" vascular dysfunction in chronic heart failure patients, though it may have some beneficial effects on vascular function in certain contexts.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17348989",
    "question": "Does dutasteride improve male pattern hair loss in a randomized study in identical twins?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if dutasteride improves male pattern hair loss in a randomized study specifically conducted on identical twins. To answer this, I need to recall if there is evidence of such a specific study. While dutasteride is used to treat male pattern baldness (similar to finasteride but more potent as it inhibits both types of 5α-reductase), I don't recall a specific randomized controlled trial that used identical twins as the study population. Using identical twins would be methodologically valuable as it would control for genetic factors, but I don't believe such a specific study design with dutasteride has been published in the scientific literature.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15473349",
    "question": "Does passive movement of hip and knee joints decrease the amplitude of soleus H-reflex in stroke patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether passive movement of hip and knee joints decreases the amplitude of soleus H-reflex in stroke patients. The soleus H-reflex is a measure of spinal reflex excitability, particularly in the soleus muscle of the calf. In neurophysiology research, modulation of this reflex during movement is studied to understand neural control mechanisms. \\n\\nTo answer this question accurately, I need to consider what's known about H-reflex modulation in stroke patients. In healthy individuals, passive movement of proximal joints (hip and knee) typically causes some inhibition of the soleus H-reflex due to proprioceptive feedback. However, stroke patients often have altered reflex modulation due to damage to descending inhibitory pathways.\\n\\nResearch has shown that stroke patients typically have hyperexcitable reflexes and reduced modulation of reflexes during movement. Several studies have demonstrated that passive movement of proximal joints (hip and knee) does indeed decrease soleus H-reflex amplitude in stroke patients, though this modulation may be reduced compared to healthy controls. This inhibition is thought to occur through propriospinal pathways and is part of normal sensorimotor integration that remains at least partially intact after stroke.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20920278",
    "question": "Do nicotinic receptors on rat alveolar macrophages dampen ATP-induced increase in cytosolic calcium concentration?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"I need to analyze whether nicotinic receptors on rat alveolar macrophages dampen ATP-induced increase in cytosolic calcium concentration. This is a specific scientific question about cellular signaling mechanisms.\\n\\nNicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels that can modulate calcium signaling in various cell types. ATP can bind to purinergic receptors (P2X and P2Y) and trigger increases in cytosolic calcium.\\n\\nResearch has shown that in rat alveolar macrophages, activation of α7 nicotinic acetylcholine receptors can indeed inhibit ATP-induced calcium responses. This cholinergic anti-inflammatory pathway serves as a mechanism to regulate excessive inflammatory responses. Studies have demonstrated that nicotine or other nAChR agonists can reduce the calcium influx that would normally occur in response to ATP stimulation in these cells.\\n\\nTherefore, nicotinic receptors on rat alveolar macrophages do dampen ATP-induced increases in cytosolic calcium concentration.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20699741",
    "question": "Does prestorage leukoreduction ameliorate the effects of aging on banked blood?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether prestorage leukoreduction (the removal of white blood cells from blood before storage) helps to reduce the negative effects that occur when blood is stored for periods of time before transfusion. \\n\\nTo answer this, I need to consider whether there is evidence that leukoreduction before storage helps preserve blood quality and reduces the storage lesions that develop in aging banked blood.\\n\\nBased on medical literature, prestorage leukoreduction has been shown to reduce cytokine production, decrease inflammatory mediators, and minimize some of the biochemical changes associated with storage. Studies have demonstrated that leukoreduction can reduce the accumulation of bioactive substances released by white blood cells during storage, which contribute to storage lesions. This process has been shown to better preserve red blood cell function and reduce some of the negative effects associated with older stored blood.\\n\\nSo yes, prestorage leukoreduction does ameliorate some of the effects of aging on banked blood, though it doesn't eliminate all storage-related changes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27515722",
    "question": "Does trends and correlate of substance use disorders among probationers and parolees in the United States 2002-2014?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether trends and correlate of substance use disorders among probationers and parolees in the United States 2002-2014. This seems to be asking if there exists a study or data about trends and correlates of substance use disorders among probationers and parolees in the United States from 2002 to 2014. The question is not properly formed as a yes/no question - it's missing a verb like 'exist' or 'show'. Without more context, I cannot determine if specific trends or correlates exist in this population during this time period.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17123520",
    "question": "Are embryo morphology and development dependent on the chromosomal complement?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether the physical appearance (morphology) and developmental processes of an embryo are influenced by its chromosomal makeup (complement). To answer this, I need to consider whether changes in chromosomes affect how embryos look and develop.\\n\\nChromosomal abnormalities like trisomies (e.g., Down syndrome/trisomy 21), monosomies (e.g., Turner syndrome), or other structural chromosomal changes are known to significantly affect embryonic development. These chromosomal variations lead to distinct morphological features and developmental trajectories. For example:\\n\\n- Embryos with chromosomal abnormalities often show altered growth rates\\n- Many chromosomal abnormalities result in specific morphological features\\n- Some chromosomal abnormalities are so severe they cause early embryonic death\\n- Sex chromosomes (XX vs XY) influence sexual differentiation during development\\n\\nThe evidence from developmental biology, genetics, and embryology clearly shows that the chromosomal complement directly influences embryo morphology and development.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "7487459",
    "question": "Is except for alanine , muscle protein catabolism influenced by alterations in glucose metabolism during sepsis?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether muscle protein catabolism (breakdown of muscle proteins) during sepsis is influenced by changes in glucose metabolism, with the exception of alanine. \\n\\nTo answer this, I need to consider what's known about the relationship between glucose metabolism and muscle protein breakdown during sepsis. During sepsis (a severe inflammatory response to infection), there are significant metabolic changes including altered glucose metabolism and increased muscle protein breakdown. \\n\\nThe question specifically excludes alanine, which is an amino acid released during muscle protein breakdown that can be used for gluconeogenesis (production of glucose). \\n\\nBased on established medical knowledge, during sepsis there is indeed a relationship between glucose metabolism and muscle protein catabolism. Alterations in glucose utilization, insulin resistance, and increased gluconeogenesis during sepsis do influence the rate of muscle protein breakdown. This relationship exists beyond just the alanine pathway - it involves multiple amino acids and metabolic signaling pathways.\\n\\nSo yes, muscle protein catabolism during sepsis is influenced by alterations in glucose metabolism, and this relationship extends beyond just the metabolism of alanine.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "26346930",
    "question": "Do probiotics Clostridium butyricum and Bacillus subtilis ameliorate intestinal tumorigenesis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the probiotics Clostridium butyricum and Bacillus subtilis ameliorate (improve) intestinal tumorigenesis (the formation of tumors in the intestine). To answer this accurately, I would need to consider scientific evidence about these specific bacterial strains and their effects on intestinal tumor formation. Based on scientific literature, both C. butyricum and B. subtilis have shown anti-tumor properties in some studies. C. butyricum produces butyrate which has anti-inflammatory and anti-tumor effects, while B. subtilis has been shown to have immunomodulatory effects that may inhibit tumor development. Several studies have demonstrated that these probiotics can reduce intestinal inflammation and potentially suppress colorectal cancer development in animal models and some clinical studies. Therefore, there is scientific evidence supporting that these probiotics can ameliorate intestinal tumorigenesis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18668148",
    "question": "Does polyQ-expanded ataxin-3 interact with full-length ataxin-3 in a polyQ length-dependent manner?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether polyQ-expanded ataxin-3 interacts with full-length ataxin-3 in a polyQ length-dependent manner. To answer this, I need to consider what is known about ataxin-3 interactions.\\n\\nAtaxin-3 is a protein involved in spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease. The disease is caused by an expansion of CAG trinucleotide repeats in the ATXN3 gene, resulting in an expanded polyglutamine (polyQ) tract in the ataxin-3 protein.\\n\\nResearch has shown that ataxin-3 can self-associate and form aggregates, particularly when the polyQ tract is expanded. Studies have demonstrated that the interaction between polyQ-expanded ataxin-3 and normal (wild-type) ataxin-3 does indeed depend on the length of the polyQ tract. Longer polyQ expansions typically result in stronger interactions and more pronounced aggregation.\\n\\nThis polyQ length-dependent interaction is a key feature of the pathogenic mechanism in SCA3, as it can lead to the sequestration of normal ataxin-3 into aggregates, potentially contributing to cellular dysfunction.\\n\\nBased on the scientific literature, polyQ-expanded ataxin-3 does interact with full-length ataxin-3 in a manner that depends on the length of the polyQ tract.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10964165",
    "question": "Does semi-starvation alter myofibrillar mRNA concentrations to expedite rapid recovery of muscle protein stores following feeding?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether semi-starvation (a state of reduced caloric intake but not complete starvation) causes changes in myofibrillar mRNA concentrations that would help muscles quickly rebuild protein stores when food becomes available again. Myofibrillar mRNAs are the messenger RNAs that code for the proteins that make up muscle fibers. The question is specifically about whether these mRNA levels change during semi-starvation as a preparatory mechanism for rapid protein synthesis when feeding resumes. Based on research in this area, there is evidence that during periods of nutritional deprivation, the body does develop adaptive mechanisms to more efficiently utilize nutrients when they become available again. Some studies have shown that mRNA levels for certain muscle proteins can be upregulated during recovery from starvation, but whether this is specifically pre-adapted during the semi-starvation period itself is less clear. The research suggests that while protein synthesis machinery may become more efficient during refeeding, the specific mechanism of myofibrillar mRNA concentration changes during semi-starvation as a preparatory mechanism is not strongly established in the scientific literature.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11141532",
    "question": "Does risk factors and correlate of violence among acutely ill adult psychiatric inpatients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether risk factors correlate with violence among acutely ill adult psychiatric inpatients. This is asking about a relationship between risk factors and violence in a specific population (psychiatric inpatients). The question seems to have a grammatical issue - it should probably be 'Do risk factors correlate with violence among acutely ill adult psychiatric inpatients?' Research has shown that certain risk factors (such as history of violence, substance abuse, specific diagnoses, etc.) do correlate with increased risk of violence among psychiatric inpatients. So based on established psychiatric research, the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19949033",
    "question": "Do severity of CIND and MCI predict incidence of dementia in an ischemic stroke cohort?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the severity of Cognitive Impairment No Dementia (CIND) and Mild Cognitive Impairment (MCI) predict the incidence of dementia in patients who have had an ischemic stroke. To answer this, I would need to know if there are studies showing that more severe forms of CIND or MCI are associated with higher rates of progression to dementia specifically in stroke patients. Without specific research data provided in the question, I need to consider what is generally known about these conditions. Both CIND and MCI are recognized as potential precursors to dementia, and their severity can indeed be predictive of progression to dementia in general populations. In stroke patients specifically, cognitive impairment is common and can increase dementia risk. Research has shown that the severity of post-stroke cognitive impairment is associated with higher risk of developing dementia. So based on available evidence, the severity of these cognitive impairments would likely predict dementia incidence in an ischemic stroke cohort.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20970244",
    "question": "Are stress proteins and cytokines urinary biomarkers for diagnosis and staging of bladder cancer?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if stress proteins and cytokines are urinary biomarkers for diagnosis and staging of bladder cancer. To answer this, I need to consider whether these specific molecular markers are established biomarkers in urine samples for detecting and determining the stage of bladder cancer.\\n\\nStress proteins (like heat shock proteins) and cytokines (inflammatory mediators) have been investigated as potential biomarkers in various cancers. For bladder cancer specifically, there has been research into urinary biomarkers including various proteins, DNA markers, and RNA markers. While some studies have investigated stress proteins and cytokines in this context, they are not widely established or FDA-approved as standard urinary biomarkers for bladder cancer diagnosis and staging in current clinical practice. The most commonly used urinary markers for bladder cancer include tests like NMP22, BTA, and urine cytology, rather than specific stress proteins or cytokines panels.\\n\\nWhile these molecules may have potential and are being researched, they are not currently established as standard urinary biomarkers for routine bladder cancer diagnosis and staging.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "8636782",
    "question": "Does analysis of cumulative probabilities show that the efficacy of 5HT3 antagonist prophylaxis is not maintained?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about whether analysis of cumulative probabilities shows that the efficacy of 5HT3 antagonist prophylaxis is not maintained. To answer this, I would need specific research data on cumulative probability analyses of 5HT3 antagonist efficacy over time. 5HT3 antagonists are commonly used as antiemetics to prevent nausea and vomiting, particularly in chemotherapy patients. Without specific studies or data mentioned in the question, I cannot determine if cumulative probability analyses have shown a lack of maintained efficacy. The question presupposes a specific finding from statistical analyses that I don't have access to.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17543073",
    "question": "Is gastric mucin expressed in a subset of endocervical tunnel clusters : type A tunnel clusters of gastric phenotype?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether gastric mucin is expressed in a specific subset of endocervical tunnel clusters, specifically type A tunnel clusters of gastric phenotype. To answer this, I need to consider what is known about endocervical tunnel clusters and their phenotypes. The term 'gastric phenotype' in the context of 'type A tunnel clusters' suggests that these clusters express markers or have characteristics similar to gastric tissue. Since the question specifically mentions 'type A tunnel clusters of gastric phenotype,' this strongly implies that these particular tunnel clusters do express gastric mucin - that's likely part of what defines them as having a 'gastric phenotype' in the first place. The gastric phenotype would typically include expression of gastric-type mucins.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "9355594",
    "question": "Does the use of heparin and normal saline flush in neonatal intravenous catheters?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether heparin and normal saline flush are used in neonatal intravenous catheters. This is asking about a clinical practice in neonatal care. Both heparin and normal saline flushes are indeed used in neonatal IV catheters, with different protocols in different hospitals. Heparin is often used to maintain patency of central venous catheters, while normal saline is commonly used for peripheral IV lines. So the answer would be yes, these substances are used in neonatal IV catheter maintenance.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11271084",
    "question": "Does sampling rate cause bias in APACHE II and SAPS II scores?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if sampling rate causes bias in APACHE II and SAPS II scores. These are both severity of illness scoring systems used in intensive care units to predict mortality. The question is specifically about whether the frequency of data collection (sampling rate) affects the accuracy or introduces bias into these scoring systems. \\n\\nAPACHE II (Acute Physiology and Chronic Health Evaluation II) and SAPS II (Simplified Acute Physiology Score II) both use the worst physiological values within the first 24 hours of ICU admission. If sampling is done infrequently, extreme values might be missed, potentially leading to underestimation of illness severity. \\n\\nResearch has shown that sampling frequency can indeed affect these scores. Studies have demonstrated that less frequent sampling (e.g., once per day versus hourly) can lead to lower scores, which would underestimate mortality risk. This is because infrequent sampling may miss transient physiological derangements that would contribute to higher scores.\\n\\nTherefore, sampling rate can cause bias in APACHE II and SAPS II scores.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "14662716",
    "question": "Are nitric oxide and beta-adrenergic stimulation major regulators of preprandial and postprandial subcutaneous adipose tissue blood flow in humans?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if nitric oxide and beta-adrenergic stimulation are major regulators of subcutaneous adipose tissue blood flow in humans, specifically during preprandial (before eating) and postprandial (after eating) states.\\n\\nLet me analyze what we know about adipose tissue blood flow regulation:\\n\\n1. Beta-adrenergic stimulation is indeed a well-established regulator of adipose tissue blood flow. The sympathetic nervous system, through beta-adrenergic receptors, plays a significant role in regulating blood flow to adipose tissue both before and after meals.\\n\\n2. Nitric oxide (NO) is a vasodilator that affects blood flow in many tissues. Research has shown that NO does contribute to the regulation of adipose tissue blood flow, but whether it's a 'major' regulator specifically in the pre and postprandial states requires careful consideration.\\n\\nBased on the scientific literature, both nitric oxide and beta-adrenergic stimulation do play important roles in regulating subcutaneous adipose tissue blood flow in humans during fasting and fed states. Beta-adrenergic mechanisms are particularly important, and nitric oxide appears to be involved in mediating some of the vascular responses. Together, they are considered among the major physiological regulators of adipose tissue perfusion in relation to nutritional state.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22899388",
    "question": "Are blood pressure responses to acute and chronic exercise related in prehypertension?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between blood pressure responses to acute exercise (immediate, short-term exercise) and chronic exercise (regular, long-term exercise) specifically in people with prehypertension (blood pressure that is elevated but not yet at hypertension levels). To answer this, I would need to know if research has established a correlation between how someone with prehypertension responds to a single exercise session versus how their blood pressure changes with ongoing exercise training. Without specific research studies cited in the question, I need to consider what the scientific literature generally indicates about this relationship. There is some evidence suggesting that acute blood pressure responses can sometimes predict chronic training effects, but the relationship is complex and not always consistent. For prehypertension specifically, some studies have shown correlations between acute responses and chronic adaptations, while others show more independent mechanisms.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18029369",
    "question": "Is aldosterone-mediated apical targeting of ENaC subunits blunted in rats with streptozotocin-induced diabetes mellitus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether aldosterone-mediated apical targeting of ENaC (epithelial sodium channel) subunits is blunted in rats with streptozotocin-induced diabetes mellitus. To answer this, I need to determine if research has shown that diabetes mellitus induced by streptozotocin in rats impairs the normal aldosterone-mediated trafficking of ENaC subunits to the apical membrane of epithelial cells. This is a specific physiological question about the interaction between diabetes and the aldosterone-ENaC pathway. Based on research in this area, it has been demonstrated that streptozotocin-induced diabetes does indeed impair aldosterone-mediated ENaC trafficking to the apical membrane in rats, showing a blunted response compared to non-diabetic controls.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26661323",
    "question": "Does copeptin predict coronary artery disease cardiovascular and total mortality?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if copeptin can predict coronary artery disease cardiovascular and total mortality. Copeptin is a surrogate marker for arginine vasopressin (AVP) and has been studied as a biomarker in various cardiovascular conditions. To answer this question accurately, I need to consider the current scientific evidence.\\n\\nBased on medical literature, copeptin has been investigated as a prognostic marker in patients with acute coronary syndromes and heart failure. Several studies have shown that elevated copeptin levels are associated with increased risk of mortality in patients with heart failure and after myocardial infarction. Some research has demonstrated that copeptin can independently predict adverse outcomes, including cardiovascular mortality and all-cause mortality in certain patient populations.\\n\\nHowever, while there is evidence supporting copeptin as a predictor of mortality in specific cardiovascular conditions, the question specifically asks about coronary artery disease cardiovascular and total mortality prediction. The evidence suggests that copeptin does have predictive value for mortality outcomes in patients with coronary artery disease and other cardiovascular conditions.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26652024",
    "question": "Does wNT5A transform intestinal CD8αα⁺ IELs into an unconventional phenotype with pro-inflammatory features?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question. It's asking about the effect of wNT5A on intestinal CD8αα⁺ IELs (intraepithelial lymphocytes). Specifically, it's asking whether wNT5A transforms these cells into an unconventional phenotype with pro-inflammatory features. To answer this, I would need to know about research on wNT5A's effects on these specific immune cells. Without specific knowledge of studies showing this transformation, I cannot confidently say yes. However, WNT5A is known to be involved in various inflammatory processes and can modulate immune cell functions, so this is plausible. Let me check if I have specific knowledge about this particular transformation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23253171",
    "question": "Does edaravone protect HT22 neurons from H2O2-induced apoptosis by inhibiting the MAPK signaling pathway?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question. I need to determine if edaravone protects HT22 neurons from H2O2-induced apoptosis specifically by inhibiting the MAPK signaling pathway. This is a specific scientific claim about a mechanism of action. Without specific scientific literature or evidence presented in the question, I cannot confirm whether this particular mechanism (MAPK pathway inhibition) is how edaravone exerts its protective effects in this specific neuronal cell line against H2O2-induced apoptosis. While edaravone is known to have neuroprotective properties as a free radical scavenger, confirming this specific mechanism would require scientific evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22578019",
    "question": "Are the genetic variants at the HLA-DRB1 gene associated with primary IgA nephropathy in Han Chinese?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the association between genetic variants at the HLA-DRB1 gene and primary IgA nephropathy specifically in Han Chinese population. To answer this, I need to consider what is known about genetic associations with IgA nephropathy in this population.\\n\\nHLA-DRB1 is part of the human leukocyte antigen (HLA) complex, which plays a crucial role in immune function. IgA nephropathy is an autoimmune kidney disease.\\n\\nMultiple studies have indeed identified associations between HLA-DRB1 alleles and IgA nephropathy in Han Chinese populations. For example, genome-wide association studies (GWAS) have consistently identified the HLA region, including HLA-DRB1, as a susceptibility locus for IgA nephropathy in Han Chinese. Specific HLA-DRB1 alleles have been found to either increase risk or provide protection against the disease in this population.\\n\\nBased on the scientific literature, there is substantial evidence supporting an association between HLA-DRB1 genetic variants and primary IgA nephropathy in Han Chinese.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24650177",
    "question": "Is individual migration timing of common nightingales tuned with vegetation and prey phenology at breeding sites?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between the migration timing of common nightingales and the phenology (seasonal timing) of vegetation and prey at their breeding sites. To answer this, I would need to know if scientific research has established that nightingales time their migration to coincide with optimal vegetation growth and prey availability at their breeding grounds. This would be an example of phenological matching, which is common in migratory birds. Based on ecological principles, this seems plausible, but I need to recall specific research on common nightingales (Luscinia megarhynchos). Research has indeed shown that many migratory songbirds, including nightingales, time their arrival at breeding grounds to coincide with peak food availability and suitable habitat conditions. Studies have demonstrated that nightingales' arrival at breeding sites is synchronized with the development of vegetation and the emergence of their insect prey, which provides optimal conditions for breeding.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20668721",
    "question": "Is minocycline cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP , survivin , and Bcl-2?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if minocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes specifically through a mechanism of increasing expression of XIAP, survivin, and Bcl-2. To answer this, I would need to know if research has confirmed this specific mechanism of action. Without specific research evidence showing that minocycline increases these particular anti-apoptotic proteins (XIAP, survivin, and Bcl-2) in these specific cell types (human trabecular meshwork cells and optic nerve head astrocytes), I cannot confirm this as a fact. While minocycline has been shown to have neuroprotective effects in various contexts, the question asks about a very specific mechanism in specific cell types.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23463873",
    "question": "Is cortical thinning associated with disease stages and dementia in Parkinson 's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, I need to consider whether there is scientific evidence linking cortical thinning to Parkinson's disease progression and dementia.\n\nCortical thinning refers to the reduction in thickness of the cerebral cortex, which can be measured using neuroimaging techniques like MRI.\n\nResearch has shown that:\n1. Parkinson's disease is associated with cortical thinning in various brain regions\n2. This thinning tends to be more pronounced in advanced disease stages\n3. Parkinson's disease patients with dementia show greater cortical thinning compared to those without cognitive impairment\n4. Longitudinal studies have demonstrated progressive cortical thinning that correlates with disease progression and cognitive decline\n\nMultiple studies have found that cortical thinning patterns can help differentiate between Parkinson's disease patients with and without dementia, and the extent of thinning correlates with disease duration and severity.\n\nBased on the scientific literature, there is a clear association between cortical thinning and both disease stages and dementia in Parkinson's disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12471200",
    "question": "Are mutations of the UMOD gene responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 (MCKD2) and familial juvenile hyperuricaemic nephropathy (FJHN). Let me analyze this based on medical genetics knowledge.\\n\\nThe UMOD gene encodes for uromodulin (also known as Tamm-Horsfall protein), which is the most abundant protein in normal urine. Mutations in this gene have indeed been identified as the cause of several kidney disorders.\\n\\nSpecifically, mutations in the UMOD gene have been established as the genetic cause of:\\n1. Medullary cystic kidney disease type 2 (MCKD2)\\n2. Familial juvenile hyperuricaemic nephropathy (FJHN)\\n\\nThese conditions are now often collectively referred to as uromodulin-associated kidney disease (UAKD) because they share the same genetic cause and have overlapping clinical features including progressive kidney failure, hyperuricemia, and gout.\\n\\nThe scientific literature clearly establishes that mutations in the UMOD gene are responsible for both MCKD2 and FJHN.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "8891624",
    "question": "Does long term lipid-based parenteral nutrition cause pulmonary hypertension in pigs?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if long-term lipid-based parenteral nutrition causes pulmonary hypertension in pigs. To answer this, I need to consider what is known about the effects of lipid-based parenteral nutrition on the pulmonary vasculature in pigs specifically.\\n\\nLipid-based parenteral nutrition has been associated with pulmonary vascular complications in some studies, particularly in neonates and infants. The mechanism proposed involves lipid microemboli or inflammatory responses to lipid particles affecting pulmonary circulation.\\n\\nHowever, for pigs specifically, there is research showing that long-term lipid-based parenteral nutrition can indeed lead to pulmonary hypertension. Studies have demonstrated that pigs receiving prolonged lipid-based parenteral nutrition developed increased pulmonary arterial pressure and pulmonary vascular resistance, which are hallmarks of pulmonary hypertension. The pathophysiology appears to involve both direct effects of lipid emulsions on the pulmonary vasculature and indirect effects through inflammatory mediators.\\n\\nBased on the available scientific evidence, long-term lipid-based parenteral nutrition does cause pulmonary hypertension in pigs.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27273718",
    "question": "Does hydrogen Sulfide contribute to Retinal Neovascularization in Ischemia-Induced Retinopathy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if hydrogen sulfide (H2S) contributes to retinal neovascularization in ischemia-induced retinopathy. To answer this, I need to consider the known effects of H2S on blood vessel formation in the retina under ischemic conditions.\\n\\nH2S is a gasotransmitter that has been studied in various physiological and pathological processes. In the context of retinal ischemia, research has shown that H2S can actually have protective effects against ischemic damage in some contexts. However, regarding neovascularization specifically (the formation of new blood vessels), studies have demonstrated that H2S can promote angiogenesis through various mechanisms including activation of VEGF (Vascular Endothelial Growth Factor) pathways.\\n\\nIn ischemia-induced retinopathy, pathological neovascularization is a key feature, and there is evidence in the scientific literature suggesting that H2S can indeed contribute to this process. Studies have shown that H2S can stimulate retinal angiogenesis under hypoxic conditions, which would occur in ischemic retinopathy.\\n\\nBased on the available scientific evidence, hydrogen sulfide does appear to contribute to retinal neovascularization in ischemia-induced retinopathy.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19190685",
    "question": "Does initial bradykinin trigger calcium-induced calcium release in C6 glioma cells and its significance?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if initial bradykinin triggers calcium-induced calcium release (CICR) in C6 glioma cells, and what the significance of this process is. To answer this, I need to determine if there's established scientific evidence that bradykinin initiates CICR specifically in C6 glioma cells. \\n\\nBradykinin is a peptide that can activate B2 receptors, which are G-protein coupled receptors that can lead to IP3 production and calcium release from intracellular stores. Calcium-induced calcium release is a process where initial calcium release triggers further calcium release from internal stores (particularly from the endoplasmic reticulum).\\n\\nWhile bradykinin is known to increase intracellular calcium in various cell types, the specific mechanism of whether it triggers CICR in C6 glioma cells would require specific research evidence. Without citing specific studies that demonstrate this pathway in C6 glioma cells, I cannot definitively answer 'yes'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24648012",
    "question": "Is a Halloween gene shadow a potential target for RNA-interference-based pest management in the small brown planthopper Laodelphax striatellus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"I need to determine if a Halloween gene shadow is a potential target for RNA-interference-based pest management in the small brown planthopper Laodelphax striatellus. Let me analyze this question:\\n\\nThe Halloween genes are a group of genes involved in ecdysteroid biosynthesis in insects. 'shadow' is one of these Halloween genes. RNA interference (RNAi) is a technique used to silence specific genes by introducing double-stranded RNA that targets and degrades the corresponding mRNA.\\n\\nTo answer this question accurately, I need to know if research has shown that the shadow gene in Laodelphax striatellus (small brown planthopper) can be effectively targeted by RNAi for pest management purposes.\\n\\nBased on scientific literature, the Halloween genes including shadow (encoding cytochrome P450 enzymes) have been identified in various insect species and have been shown to be potential targets for RNAi-based pest management strategies. Specifically for Laodelphax striatellus, research has demonstrated that targeting the shadow gene via RNAi can disrupt the insect's development and reproduction, making it a viable target for pest control.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20522804",
    "question": "Does smad3 signaling critically regulate fibroblast phenotype and function in healing myocardial infarction?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the role of Smad3 signaling in regulating fibroblast phenotype and function specifically in the context of healing myocardial infarction (heart attack). Smad3 is a transcription factor that mediates TGF-β signaling, which is known to be important in fibrosis and tissue repair. \\n\\nBased on scientific literature, Smad3 signaling does play a critical role in regulating cardiac fibroblast activation, differentiation into myofibroblasts, and extracellular matrix production during myocardial infarction healing. Studies have shown that Smad3 knockout or inhibition significantly alters the fibrotic response after myocardial infarction. Smad3 signaling regulates fibroblast proliferation, migration, and production of collagen and other extracellular matrix proteins that are essential for scar formation and healing after myocardial infarction.\\n\\nTherefore, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "9738553",
    "question": "Does abnormally high nourishment during sensitive periods result in body weight changes across generations?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether excessive nutrition during critical developmental periods can lead to changes in body weight that are passed down to future generations. This is a question about transgenerational epigenetic inheritance related to metabolic programming. Research has shown that nutritional status during critical developmental windows (like fetal development or early childhood) can affect epigenetic markers that influence metabolism. Some studies in animal models have demonstrated that maternal overnutrition can lead to offspring with altered metabolic profiles and predisposition to obesity, which can persist for multiple generations even without continued exposure to the original nutritional stimulus. Human epidemiological studies have also suggested similar patterns. So there is scientific evidence supporting the concept that abnormally high nourishment during sensitive periods can result in body weight changes that persist across generations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26908452",
    "question": "Does the BMP inhibitor DAND5 in serum predict poor survival in breast cancer?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if DAND5, which is a BMP (Bone Morphogenetic Protein) inhibitor, in serum can predict poor survival in breast cancer patients. To answer this, I would need to know if there is scientific evidence showing that elevated or decreased levels of DAND5 in blood serum correlate with worse outcomes in breast cancer patients. Without specific research studies demonstrating this relationship, I cannot confirm that DAND5 is an established biomarker for breast cancer prognosis. Based on my knowledge, while various BMP pathway components have been studied in cancer, I don't have definitive evidence that serum DAND5 specifically has been validated as a predictor of poor survival in breast cancer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25056338",
    "question": "Is sex difference in leukocyte telomere length ablated in opposite-sex co-twins?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether the typical sex difference in leukocyte telomere length (LTL) disappears or is eliminated in opposite-sex co-twins. Typically, females have longer telomeres than males, but the question is asking if this difference is 'ablated' (eliminated) when looking at opposite-sex co-twins specifically. To answer this, I would need to know about research on telomere length in opposite-sex twin pairs. Without specific research data on this topic, I cannot provide a definitive answer. However, based on general knowledge of telomere biology, genetic factors, and twin studies, there's no strong evidence suggesting that the sex difference in LTL would be completely eliminated in opposite-sex twins. Twin studies have shown that while shared environmental factors can influence telomere length, the fundamental biological differences between males and females that contribute to telomere length differences likely persist even in opposite-sex twins.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26917237",
    "question": "Are glycolysis and the pentose phosphate pathway differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the differential association of two metabolic pathways (glycolysis and the pentose phosphate pathway) with the regulation of two cellular processes (migration and proliferation) in glioblastoma cells, specifically whether they have dichotomous (opposing or contrasting) regulatory effects. To answer this accurately, I would need to know if research has established that these metabolic pathways differentially regulate these processes in glioblastoma - with one pathway potentially promoting migration while the other promotes proliferation, or if they have opposing effects on the same process. Based on current research in cancer metabolism, there is evidence that glycolysis and the pentose phosphate pathway can have distinct roles in cancer progression, but whether they specifically have dichotomous effects on migration versus proliferation in glioblastoma would require specific studies demonstrating this relationship. While both pathways are important in glioblastoma metabolism, I don't have definitive evidence that they have established dichotomous regulatory roles for these specific cellular processes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11740193",
    "question": "Does prednisolone prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if prednisolone prevents hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine. To answer this, I need to consider whether there is established evidence that prednisolone (a corticosteroid) is effective in preventing hypersensitivity reactions specifically to abacavir and/or nevirapine in HIV treatment regimens. \\n\\nAbacavir is known to cause hypersensitivity reactions in some patients, particularly those with the HLA-B*5701 allele. Nevirapine can also cause hypersensitivity reactions. However, the standard approach to preventing these reactions is genetic screening (for abacavir) or careful clinical monitoring and dosing strategies (for nevirapine), not prophylactic prednisolone administration.\\n\\nTo my knowledge, prednisolone is not recommended or proven as a preventive measure for hypersensitivity reactions to these antiretroviral medications. While corticosteroids might be used to treat hypersensitivity reactions once they occur, they are not standardly used prophylactically to prevent such reactions from occurring in the first place.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "21509465",
    "question": "Do measurements of serum cystatin C concentrations underestimate renal dysfunction in pediatric patients with chronic kidney disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if measurements of serum cystatin C concentrations underestimate renal dysfunction in pediatric patients with chronic kidney disease. To answer this, I need to consider what is known about cystatin C as a biomarker for kidney function in children with CKD.\\n\\nCystatin C is generally considered a more sensitive marker of kidney function than creatinine, especially in pediatric populations. This is because cystatin C is produced at a constant rate by all nucleated cells, freely filtered by the glomerulus, and not significantly affected by muscle mass (which varies greatly in children).\\n\\nMost research suggests that cystatin C is actually a more accurate marker than creatinine in detecting mild to moderate renal dysfunction in children, and it tends to detect kidney dysfunction earlier than creatinine-based methods.\\n\\nTherefore, the evidence suggests that cystatin C measurements do not underestimate renal dysfunction in pediatric CKD patients - in fact, they may be more sensitive than traditional markers.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17119983",
    "question": "Does peritoneal instillation of taurolidine or polihexanide modulate intestinal microcirculation in experimental endotoxemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether peritoneal instillation of taurolidine or polihexanide modulates intestinal microcirculation in experimental endotoxemia. To answer this, I would need to know about specific research studies that have investigated this relationship. This is a very specific scientific question about the effects of particular antiseptic solutions (taurolidine and polihexanide) on intestinal blood flow in a model of endotoxemia (systemic inflammatory response to bacterial endotoxins). Without access to relevant scientific literature on this specific topic, I cannot definitively answer whether these substances have been shown to modulate intestinal microcirculation in this context.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25006181",
    "question": "Is leaf hydraulic vulnerability to drought linked to site water availability across a broad range of species and climates?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if leaf hydraulic vulnerability to drought is linked to site water availability across a broad range of species and climates. To answer this, I need to consider whether research has established a connection between how vulnerable a plant's leaf hydraulic system is to drought stress and the typical water availability in its environment, considering diverse plant species and climate conditions. Research in plant ecophysiology has indeed shown that plants from drier environments often develop adaptations that make their hydraulic systems more resistant to drought, while plants from wetter environments may be more vulnerable to hydraulic failure during drought. This pattern has been observed across different biomes and plant functional types, suggesting a link between leaf hydraulic vulnerability and site water availability.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21338523",
    "question": "Does a multi-centre cohort study show no association between experienced violence and labour dystocia in nulliparous women at term?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a multi-centre cohort study shows no association between experienced violence and labour dystocia in nulliparous women at term. To answer this, I would need to know the results of such a study. Without specific information about this study, I cannot determine whether it showed an association or not. The question assumes I have knowledge about a specific study's findings, but I don't have this information in my knowledge base. I cannot confirm or deny what a specific study showed without reference to its actual findings.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24576065",
    "question": "Does over-expression of PRAS40 enhance insulin sensitivity in skeletal muscle?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze what the question is asking. The question is about whether over-expression of PRAS40 enhances insulin sensitivity in skeletal muscle. PRAS40 (Proline-rich Akt substrate of 40 kDa) is a protein involved in the insulin signaling pathway. The question is asking about the specific effect of having higher-than-normal levels (over-expression) of this protein on how skeletal muscle responds to insulin (insulin sensitivity). \\n\\nBased on scientific literature, PRAS40 is indeed known to be involved in insulin signaling and metabolism. Studies have shown that over-expression of PRAS40 can enhance insulin sensitivity in skeletal muscle by promoting glucose uptake and glycogen synthesis. PRAS40 is a substrate of Akt (also known as protein kinase B), which is a key mediator of insulin signaling. When PRAS40 is over-expressed, it can lead to increased activation of the insulin signaling pathway in skeletal muscle cells, resulting in enhanced insulin sensitivity.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23983429",
    "question": "Are sessile serrated adenomas in the proximal colon likely to be flat , large and occur in smokers?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question about sessile serrated adenomas (SSAs) in the proximal colon:\\n\\n1. Morphology: SSAs are indeed typically flat or slightly elevated lesions rather than protruding polyps.\\n\\n2. Size: SSAs in the proximal colon often tend to be larger lesions (frequently >10mm).\\n\\n3. Risk factors: Smoking is a recognized risk factor for serrated polyps, including SSAs.\\n\\nThe question asks if SSAs in the proximal colon are likely to be flat, large, and occur in smokers. Based on medical literature, all three characteristics are correct - SSAs in the proximal colon are typically flat, often larger in size, and smoking is a risk factor for their development.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23121166",
    "question": "Does insulin resistance predict sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if insulin resistance is an independent predictor of sustained virological response (SVR) to treatment of chronic hepatitis C, specifically independent of the IL28b rs12979860 polymorphism. To answer this, I would need to know if research has shown that insulin resistance affects SVR outcomes regardless of a patient's IL28b genotype. Without specific studies or data provided in the question, I cannot make a definitive determination. The IL28b polymorphism is a known strong predictor of treatment response in hepatitis C, but whether insulin resistance has an independent effect beyond this genetic factor requires evidence from clinical studies.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26087195",
    "question": "Does dDX3 as a strongest prognosis marker and its downregulation promote metastasis in colorectal cancer?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question about dDX3 in colorectal cancer. The question asks two things: 1) whether dDX3 is the strongest prognosis marker in colorectal cancer, and 2) whether its downregulation promotes metastasis. \\n\\nI don't have specific information confirming that dDX3 is definitively the 'strongest' prognosis marker for colorectal cancer - this would require comparative studies against all other markers. Additionally, while DDX3 (assuming this is what is meant by dDX3) has been studied in colorectal cancer, I cannot confirm with certainty that its downregulation specifically promotes metastasis without access to the latest research on this specific relationship.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "10396242",
    "question": "Do sulphomucins favour adhesion of Helicobacter pylori to metaplastic gastric mucosa?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between sulphomucins and Helicobacter pylori adhesion to metaplastic gastric mucosa. Sulphomucins are a type of acidic mucin containing sulphate groups. Helicobacter pylori is a bacterium that can colonize the stomach and is associated with various gastric diseases. Metaplastic gastric mucosa refers to abnormal changes in the stomach lining where one cell type is replaced by another that's not normally found in that location.\\n\\nTo answer this question accurately, I need to recall whether scientific evidence indicates that sulphomucins promote (favor) H. pylori adhesion to metaplastic gastric tissue. Based on my knowledge of gastroenterology research, sulphomucins actually tend to inhibit rather than favor H. pylori adhesion. Studies have shown that areas with sulphomucin expression often have reduced H. pylori colonization compared to areas expressing neutral mucins. The sulphate groups in sulphomucins appear to create an unfavorable environment for H. pylori attachment.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24719141",
    "question": "Are cOPD patients with exertional desaturation at a higher risk of rapid decline in lung function?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if COPD patients who experience oxygen desaturation during exertion (physical activity) have a higher risk of rapid decline in their lung function compared to COPD patients who don't experience such desaturation.\\n\\nBased on medical research, COPD patients with exertional desaturation (drop in oxygen levels during activity) do tend to have worse outcomes in several respects. Studies have shown that exertional desaturation in COPD is associated with increased mortality, more frequent exacerbations, and poorer exercise capacity.\\n\\nSpecifically regarding the rate of lung function decline, research has indicated that patients who desaturate during exercise tend to have more rapid deterioration in pulmonary function over time. This is because exertional desaturation often reflects more severe disease, ventilation-perfusion mismatch, and potentially ongoing inflammation that contributes to accelerated decline in lung function.\\n\\nSo yes, there is evidence supporting that COPD patients with exertional desaturation are at higher risk of experiencing more rapid decline in their lung function.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "7877228",
    "question": "Does the anastomosis angle do change the flow fields at vascular end-to-side anastomoses in vivo?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the anastomosis angle affects flow fields at vascular end-to-side anastomoses in vivo (in living organisms). Based on fluid dynamics principles and vascular surgery research, the angle at which vessels are joined in an end-to-side anastomosis does significantly impact flow patterns. Different angles create varying degrees of flow disturbance, recirculation zones, and wall shear stress distributions. These hemodynamic effects have been documented in both computational models and in vivo studies, as they can influence clinical outcomes such as intimal hyperplasia and graft patency rates. The evidence from vascular surgery and hemodynamic research supports that anastomosis angle is indeed a critical factor that alters flow fields at vascular junctions in living subjects.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23832513",
    "question": "Does donepezil markedly improve long-term survival in rats with chronic heart failure after extensive myocardial infarction?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if donepezil markedly improves long-term survival in rats with chronic heart failure after extensive myocardial infarction. To answer this, I would need to know about specific research studies on donepezil's effects in this particular rat model. Donepezil is primarily known as an acetylcholinesterase inhibitor used for Alzheimer's disease treatment. While there may be some research exploring its cardiovascular effects, I don't have specific knowledge about definitive studies showing it 'markedly improves' long-term survival specifically in rats with chronic heart failure after extensive myocardial infarction. Without clear evidence of this specific effect, I should answer 'no'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25395238",
    "question": "Is percutaneous cholecystostomy an effective treatment option for acute calculous cholecystitis : a 10-year experience?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether percutaneous cholecystostomy is an effective treatment option for acute calculous cholecystitis based on a 10-year experience. This appears to be the title of a research paper or study, not a yes/no question that I can directly answer. The question itself is presenting a research topic that would require examining the specific 10-year experience data to determine effectiveness. Without access to the specific study results or data from this 10-year experience, I cannot provide a definitive yes or no answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22815550",
    "question": "Are multifocal visual evoked potentials influenced by variable contrast stimulation in MS?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether multifocal visual evoked potentials (mfVEPs) are influenced by variable contrast stimulation specifically in multiple sclerosis (MS) patients. To answer this, I need to consider what is known about mfVEPs in MS patients and how contrast changes affect these measurements.\\n\\nMultifocal VEPs are a technique used to measure visual pathway function across the visual field. In MS, demyelination can affect the visual pathways, which can be detected using VEPs. \\n\\nContrast sensitivity is often impaired in MS patients, and varying the contrast of visual stimuli is known to affect VEP measurements in general. Research has shown that MS patients typically show abnormal VEP responses, including delayed latencies and reduced amplitudes, and these abnormalities can be more pronounced when using lower contrast stimuli.\\n\\nStudies have specifically demonstrated that mfVEPs with variable contrast stimulation can reveal abnormalities in MS patients that might not be detected with standard high-contrast stimuli. The contrast-dependent changes in mfVEP responses can help identify subtle visual pathway dysfunction in MS.\\n\\nSo yes, multifocal visual evoked potentials are influenced by variable contrast stimulation in MS patients, and this relationship is actually clinically useful for detecting visual pathway abnormalities in MS.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21632168",
    "question": "Is systolic blood pressure below 110 mm Hg associated with increased mortality in blunt major trauma patients : multicentre cohort study?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether systolic blood pressure below 110 mm Hg is associated with increased mortality in blunt major trauma patients, and it mentions a multicentre cohort study. To answer this, I would need to know the results of the specific study mentioned. Without access to the study's findings, I cannot definitively say whether this association exists. However, in general trauma literature, hypotension (typically defined as systolic BP < 90 mmHg) is associated with worse outcomes. The threshold of 110 mmHg mentioned here is higher than the traditional definition of hypotension, so I would need to see the specific study results to know if this particular threshold shows an association with increased mortality.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23890048",
    "question": "Does ticagrelor inhibit human platelet aggregation via adenosine in addition to P2Y12 antagonism?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Ticagrelor is an antiplatelet medication that primarily works as a P2Y12 receptor antagonist, inhibiting platelet aggregation by blocking ADP-induced platelet activation. The question asks whether ticagrelor also inhibits platelet aggregation through an adenosine-mediated mechanism in addition to its P2Y12 antagonism. Research has shown that ticagrelor does have adenosine-related effects - it can inhibit cellular adenosine uptake via the equilibrative nucleoside transporter 1 (ENT1), which increases extracellular adenosine levels. This adenosine-mediated effect contributes to ticagrelor's overall antiplatelet activity and may explain some of its unique clinical effects compared to other P2Y12 inhibitors. So yes, ticagrelor does inhibit human platelet aggregation via adenosine-related mechanisms in addition to its primary P2Y12 antagonism.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27650328",
    "question": "Does montelukast Maintain Symptom Remission After Topical Steroid Therapy for Eosinophilic Esophagitis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if montelukast maintains symptom remission after topical steroid therapy for eosinophilic esophagitis. To answer this, I need to consider the evidence about montelukast's efficacy in this specific clinical scenario. Montelukast is a leukotriene receptor antagonist commonly used for asthma and allergic conditions. While it has anti-inflammatory properties, its specific efficacy in maintaining remission in eosinophilic esophagitis after topical steroid therapy is not well-established in major clinical guidelines. Limited studies have examined this specific use case, and the evidence does not strongly support montelukast as an effective maintenance therapy after topical steroid treatment for eosinophilic esophagitis. Most guidelines recommend continued topical steroids, dietary modifications, or in some cases biologic therapies for maintenance, but not specifically montelukast.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "25271072",
    "question": "Is diffuse idiopathic skeletal hyperostosis ( DISH ) a risk factor for further surgery in short-segment lumbar interbody fusion?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether diffuse idiopathic skeletal hyperostosis (DISH) is a risk factor for requiring further surgery after a patient has undergone short-segment lumbar interbody fusion. To answer this accurately, I would need to know if there's evidence in medical literature that shows DISH increases the likelihood of revision surgery or additional procedures following this specific type of spinal fusion. Without specific studies or data on this relationship, I cannot make a definitive claim. Based on general knowledge, DISH can cause stiffening of the spine and might affect adjacent segments after fusion, but whether this specifically increases the risk for further surgery in short-segment lumbar interbody fusion cases is not something I can state with certainty without evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15773273",
    "question": "Do computerized general practice databases provide quick and cost-effective information on the prevalence of angina pectoris?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether computerized general practice databases provide quick and cost-effective information on the prevalence of angina pectoris. To answer this, I need to consider what is known about general practice databases and their utility for epidemiological research, particularly for conditions like angina pectoris.\\n\\nGeneral practice databases typically contain large amounts of patient data collected during routine clinical care. These databases can indeed be used to estimate disease prevalence without the need for expensive and time-consuming primary data collection through surveys or dedicated studies. For angina pectoris specifically, which is a common cardiovascular condition typically managed in primary care, these databases would likely contain relevant diagnostic codes and treatment information.\\n\\nThe advantages of using such databases include:\\n1. Data is already collected as part of routine care (cost-effective)\\n2. Large sample sizes are available (statistical power)\\n3. Data can be queried and analyzed relatively quickly compared to setting up new studies\\n4. Longitudinal data may be available\\n\\nThese characteristics suggest that computerized general practice databases would provide a quick and cost-effective method for determining angina pectoris prevalence compared to alternatives like population surveys or dedicated epidemiological studies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10572382",
    "question": "Is dilinoleoylphosphatidylcholine the active antioxidant of polyenylphosphatidylcholine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"I need to determine if dilinoleoylphosphatidylcholine is the active antioxidant component of polyenylphosphatidylcholine (PPC). Polyenylphosphatidylcholine is a mixture of phosphatidylcholines with polyunsaturated fatty acids. Dilinoleoylphosphatidylcholine (DLPC) is a specific phosphatidylcholine with two linoleic acid chains. Based on scientific literature, DLPC is indeed considered the main active component of PPC with antioxidant properties. It's often described as the most abundant and biologically active constituent of PPC, responsible for many of its therapeutic effects including antioxidant activity.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12431278",
    "question": "Do chromosomal aberrations in patients with head and neck squamous cell carcinoma vary based on severity of tobacco/alcohol exposure?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question asks whether chromosomal aberrations (genetic changes/mutations) in patients with head and neck squamous cell carcinoma (HNSCC) differ depending on how much tobacco or alcohol the patient has consumed. To answer this, I need to consider whether research has shown that different levels of tobacco/alcohol exposure correlate with different patterns or frequencies of chromosomal changes in HNSCC patients.\\n\\nResearch has indeed shown that tobacco and alcohol are major risk factors for HNSCC, and studies have demonstrated that these carcinogens can cause specific genetic alterations. Multiple studies have found that the frequency and pattern of chromosomal aberrations in HNSCC do correlate with the intensity and duration of tobacco and alcohol exposure. For example, heavy smokers often show different mutation signatures and more extensive chromosomal damage compared to light smokers or non-smokers with HNSCC. Similarly, combined heavy tobacco and alcohol use has been associated with distinct patterns of genetic alterations compared to patients with less exposure.\\n\\nBased on the scientific literature, there is evidence supporting that chromosomal aberrations in HNSCC patients do vary based on the severity of tobacco/alcohol exposure.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "17255536",
    "question": "Does cholesterol enhance thrombin-induced release of fibroblast growth factor-2 in human vascular smooth muscle cells?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if cholesterol enhances thrombin-induced release of fibroblast growth factor-2 (FGF-2) in human vascular smooth muscle cells. This is a specific biochemical question about the interaction between cholesterol, thrombin, and FGF-2 release in a particular cell type. Without specific scientific literature or studies on this particular interaction, I cannot definitively answer this question. This would require knowledge of specific research findings in vascular biology.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24567803",
    "question": "Is starting glargine in insulin-naïve type 2 diabetic patients based on body mass index safe?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the safety of starting glargine (a long-acting insulin) in insulin-naïve type 2 diabetic patients (patients who have never used insulin before) based on their body mass index (BMI). \\n\\nTo answer this question, I need to consider whether using BMI as a criterion for initiating insulin glargine therapy is considered safe medical practice.\\n\\nBased on medical literature, insulin glargine is generally considered safe for type 2 diabetic patients who need insulin therapy, regardless of BMI. While dosing may be adjusted based on weight (which correlates with BMI), using BMI as a factor in deciding whether to initiate insulin therapy is standard practice. Higher BMI patients may require higher initial doses, but the practice of considering BMI when starting insulin therapy is well-established and considered safe when done with appropriate medical supervision.\\n\\nThere are no major contraindications to using glargine based solely on BMI, though individual factors beyond BMI must be considered for each patient.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21886079",
    "question": "Is cA-125 level associated with right ventricular echocardiographic parameters in patients with COPD?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if cA-125 (carbohydrate antigen 125) level is associated with right ventricular echocardiographic parameters in patients with COPD (Chronic Obstructive Pulmonary Disease). To answer this, I need to consider whether there is established evidence in medical literature for this specific association. CA-125 is a biomarker often used in ovarian cancer monitoring, but it can be elevated in other conditions including heart failure. COPD can lead to right ventricular dysfunction due to pulmonary hypertension. There are studies showing CA-125 correlations with heart failure and cardiac function, but I need to determine if there's specific evidence linking CA-125 to right ventricular parameters specifically in COPD patients. Based on medical literature, there are indeed studies showing that elevated CA-125 levels correlate with right ventricular dysfunction and pulmonary hypertension in COPD patients. Some research has demonstrated associations between CA-125 and parameters like right ventricular diameter, TAPSE (Tricuspid Annular Plane Systolic Excursion), and pulmonary artery pressure in this patient population.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24220649",
    "question": "Is there no benefit to universal carotid artery duplex screening before a major cardiac surgical procedure?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether there is no benefit to universal carotid artery duplex screening before major cardiac surgery. To answer this, I need to consider whether such screening provides any benefits.\\n\\nCarotid artery duplex screening is used to detect carotid artery stenosis, which is a risk factor for perioperative stroke during cardiac surgery. Selective screening for patients with risk factors (like history of stroke, carotid bruits, peripheral vascular disease, advanced age) is common practice.\\n\\nHowever, universal screening (screening all patients regardless of risk factors) is more controversial. Some studies suggest that universal screening may identify patients with asymptomatic carotid stenosis who might benefit from intervention before cardiac surgery, potentially reducing stroke risk. Other studies question the cost-effectiveness and clinical utility of screening all patients.\\n\\nSince there is evidence suggesting at least some potential benefit to identifying carotid stenosis before cardiac surgery (even if the benefit may be modest or debated), I cannot say there is 'no benefit' to universal screening.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22179339",
    "question": "Does the neurological wake-up test increase stress hormone levels in patients with severe traumatic brain injury?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the neurological wake-up test increases stress hormone levels in patients with severe traumatic brain injury. Let me think about what I know about this topic. The neurological wake-up test involves temporarily reducing sedation to assess a patient's neurological status. Research has shown that this procedure can trigger a stress response in patients with traumatic brain injury, including increases in catecholamines, cortisol, and other stress hormones. Studies have documented elevations in intracranial pressure, blood pressure, and stress hormone levels during these tests in TBI patients. So based on the medical literature, there is evidence supporting that neurological wake-up tests do increase stress hormone levels in patients with severe TBI.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19053924",
    "question": "Are endotoxin levels associated with high-density lipoprotein , triglycerides , and troponin in patients with acute coronary syndrome and angina : possible contributions from periodontal sources?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether endotoxin levels are associated with high-density lipoprotein (HDL), triglycerides, and troponin in patients with specific cardiovascular conditions (acute coronary syndrome and angina), and whether these endotoxins might come from periodontal (gum/oral) sources. This appears to be a specific scientific/medical research question about correlations between these biomarkers and a potential source of inflammation. I don't have specific data on this particular association, so I cannot definitively answer yes or no based on established scientific evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15863522",
    "question": "Does phosphodiesterase type 5 inhibition reverse endothelial dysfunction in patients with coronary heart disease?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether phosphodiesterase type 5 (PDE5) inhibitors can reverse endothelial dysfunction in patients with coronary heart disease. Endothelial dysfunction is a pathological state of the endothelium (the inner lining of blood vessels) and is associated with reduced nitric oxide availability, increased oxidative stress, and pro-inflammatory state. It's an early marker for atherosclerosis and is present in patients with coronary heart disease.\\n\\nPDE5 inhibitors like sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra) work by inhibiting the PDE5 enzyme, which breaks down cyclic guanosine monophosphate (cGMP). This leads to increased levels of cGMP, promoting vasodilation through the nitric oxide pathway.\\n\\nBased on scientific literature, PDE5 inhibitors have been shown to improve endothelial function in various cardiovascular conditions. Several studies have demonstrated that PDE5 inhibitors can improve flow-mediated dilation (a measure of endothelial function) in patients with coronary artery disease. They appear to work by enhancing nitric oxide signaling and reducing oxidative stress.\\n\\nSo, based on current evidence, the answer would be yes - PDE5 inhibition can reverse endothelial dysfunction in patients with coronary heart disease.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "15983963",
    "question": "Does oxidative metabolism appear to be reduced in long-term hemodialysis patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if oxidative metabolism appears to be reduced in long-term hemodialysis patients. To answer this, I need to consider what is known about metabolic changes in patients undergoing long-term hemodialysis treatment. Hemodialysis patients often experience various metabolic alterations, including mitochondrial dysfunction, which can affect oxidative metabolism. Research has shown that chronic kidney disease and hemodialysis treatment are associated with increased oxidative stress, mitochondrial dysfunction, and impaired energy metabolism. Studies have demonstrated reduced activity of mitochondrial enzymes involved in oxidative phosphorylation in skeletal muscle of hemodialysis patients. There is evidence of decreased oxygen consumption and ATP production in tissues of these patients. Therefore, based on the scientific literature, oxidative metabolism does appear to be reduced in long-term hemodialysis patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22194980",
    "question": "Are hTLV-1 and HIV-2 infection associated with increased mortality in a rural West African community?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if hTLV-1 and HIV-2 infections are associated with increased mortality in a rural West African community. To answer this, I need to consider what is known about these viruses and their impact on mortality in this specific setting. HTLV-1 (Human T-cell Leukemia Virus type 1) is a retrovirus that can cause adult T-cell leukemia/lymphoma and HTLV-1-associated myelopathy, but many infected individuals remain asymptomatic. HIV-2 is a less virulent form of HIV compared to HIV-1, but it still causes AIDS and increased mortality, though typically with slower progression. Without specific studies from rural West African communities showing mortality data for these infections, I cannot make a definitive claim. However, based on the general understanding of these viruses, HIV-2 is known to increase mortality, though less dramatically than HIV-1. HTLV-1 can increase mortality in some infected individuals who develop associated diseases. Since the question asks about association with increased mortality in a specific setting (rural West African community), and I don't have specific data for this context, I should be cautious in my answer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "14501601",
    "question": "Does onset of estrogen replacement have a critical effect on synaptic density of CA1 hippocampus in ovariectomized adult rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about whether the onset of estrogen replacement has a critical effect on synaptic density in the CA1 region of the hippocampus in ovariectomized adult rats. To answer this, I need to consider what research has shown about estrogen replacement timing and its effects on hippocampal synaptic density.\\n\\nResearch has demonstrated that estrogen replacement in ovariectomized rats can increase synaptic density in the CA1 region of the hippocampus. However, the question specifically asks about whether the 'onset' (timing) of replacement has a 'critical' effect. Studies have indeed shown that there appears to be a critical window for estrogen replacement after ovariectomy - if estrogen is replaced soon after ovariectomy, it can maintain or increase synaptic density, but if replacement is delayed significantly, the beneficial effects on synaptic density may be diminished or absent. This suggests that the timing of estrogen replacement onset is indeed critical for its effects on CA1 hippocampal synaptic density.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24844616",
    "question": "Do kinematic differences exist between transtibial amputee fallers and non-fallers during downwards step transitioning?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether there are kinematic differences between transtibial amputee fallers and non-fallers specifically during downwards step transitioning. To answer this, I need to consider whether research has identified distinct movement patterns or biomechanical differences between amputees who have a history of falls versus those who don't when navigating steps downward. Research in this area typically examines variables like joint angles, step length, step width, trunk position, and center of mass movement. Based on the literature, there are indeed documented kinematic differences between fallers and non-fallers in the transtibial amputee population during this specific task. Studies have shown differences in parameters such as increased trunk flexion, altered weight transfer strategies, different foot placement patterns, and compensatory movements in fallers compared to non-fallers when descending steps.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15037685",
    "question": "Is indian Agarwal megalencephalic leukodystrophy with cysts caused by a common MLC1 mutation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Indian Agarwal megalencephalic leukodystrophy with cysts (MLC) is a genetic disorder characterized by macrocephaly, deterioration of motor functions, and white matter abnormalities. Let me analyze whether it's caused by a common MLC1 mutation.\\n\\nResearching this condition, I recall that MLC in the Agarwal community in India has been associated with a founder mutation in the MLC1 gene. Specifically, there is a common mutation (c.135insC or p.C46Lfs*34) that has been identified in this population. This mutation is considered a founder mutation in the Agarwal community and accounts for the majority of MLC cases in this specific ethnic group.\\n\\nSo yes, Indian Agarwal megalencephalic leukodystrophy with cysts is indeed caused by a common MLC1 mutation that is prevalent in this particular community.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20546595",
    "question": "Does high-throughput sequencing identify STAT3 as the DNA-associated factor for p53-NF-kappaB-complex-dependent gene expression in human heart failure?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if high-throughput sequencing identifies STAT3 as the DNA-associated factor for p53-NF-kappaB-complex-dependent gene expression in human heart failure. To answer this, I would need specific information from research studies that used high-throughput sequencing to examine the role of STAT3 in this specific context. Without having access to such specific research findings, I cannot confirm whether high-throughput sequencing has identified STAT3 in this particular role. The question contains several specific elements (high-throughput sequencing, STAT3, p53-NF-kappaB-complex, gene expression, human heart failure) that would require evidence from published research to answer definitively.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "10966266",
    "question": "Does surfactant treatment impair gas exchange in a canine model of acute lung injury?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether surfactant treatment impairs gas exchange in a canine model of acute lung injury. To answer this, I need to consider what is known about surfactant treatment in acute lung injury models.\\n\\nSurfactant is a substance that reduces surface tension in the lungs and helps keep alveoli open. In acute lung injury, there is often surfactant dysfunction or deficiency. Surfactant treatment is generally used to improve lung function and gas exchange in various lung injury models.\\n\\nIn canine models of acute lung injury, surfactant treatment is typically found to improve, not impair, gas exchange. Surfactant therapy is used to restore surfactant function, reduce surface tension, improve lung compliance, and enhance gas exchange.\\n\\nThe scientific literature generally supports that exogenous surfactant administration in animal models of acute lung injury improves oxygenation and gas exchange rather than impairing it.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20492040",
    "question": "Does community-based interventions to reduce fall among older adults in Taiwan - long time follow-up randomised controlled study?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether there are community-based interventions to reduce falls among older adults in Taiwan that involve long-time follow-up randomized controlled studies. However, the question is phrased as a statement with a question mark at the end, making it unclear what exactly is being asked. It seems to be asking if such studies exist, but it could also be asking if a specific study is a long-time follow-up RCT. Without more context, I need to determine if the question is asking about the existence of such studies in general. Based on the phrasing, I'll interpret it as asking whether community-based interventions for fall reduction in Taiwan typically involve long-term follow-up RCTs.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20054565",
    "question": "Do incisions simply sum?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether incisions simply add up or sum together. In the context of mathematics, incisions might refer to cuts or divisions in a space or object. In the context of surgery or medicine, incisions refer to surgical cuts.\\n\\nIn neither context do incisions simply 'sum' in a straightforward mathematical way. Surgical incisions have complex healing properties that don't linearly add up. In mathematics, cuts or divisions in spaces often have complex topological implications that aren't captured by simple addition.\\n\\nThe question is likely referring to a specific mathematical or theoretical concept, but in general, incisions don't simply sum or add together in a straightforward way.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "22697265",
    "question": "Do yeast glucose pathways converge on the transcriptional regulation of trehalose biosynthesis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether yeast glucose pathways ultimately lead to or affect the transcriptional regulation of genes involved in trehalose biosynthesis. Trehalose is a disaccharide that serves as a stress protectant and energy reserve in yeast. \\n\\nIn yeast, glucose metabolism and signaling pathways do indeed affect the transcriptional regulation of many genes, including those involved in trehalose metabolism. Specifically, glucose repression pathways (like Snf1/Mig1) and glucose induction pathways (like PKA and TOR) converge on the regulation of genes involved in trehalose biosynthesis. When glucose is abundant, trehalose synthesis genes are generally repressed, while under glucose limitation or stress conditions, these genes are induced. \\n\\nKey transcription factors like Msn2/Msn4 and Hsf1, which respond to glucose signaling, directly regulate the expression of trehalose biosynthesis genes. The TPS1 and TPS2 genes, which encode key enzymes in trehalose synthesis, are known to be transcriptionally regulated in response to glucose availability.\\n\\nSo yes, yeast glucose pathways do converge on the transcriptional regulation of trehalose biosynthesis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16251561",
    "question": "Does local application of volatile anesthetics attenuate the response to a mechanical stimulus in humans?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether local application of volatile anesthetics reduces (attenuates) the response to mechanical stimuli in humans. Volatile anesthetics are typically gases like isoflurane, sevoflurane, and desflurane that are usually administered through inhalation for general anesthesia. When applied locally (topically to a specific area), research has shown that volatile anesthetics can have local anesthetic effects by blocking sodium channels and inhibiting nerve conduction. Studies have demonstrated that local application of volatile anesthetics can reduce pain and sensitivity to mechanical stimuli in humans. For example, topical application of these agents can decrease the perception of pressure, touch, and pain in the applied area. So yes, local application of volatile anesthetics does attenuate the response to mechanical stimuli in humans.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26445407",
    "question": "Are determinants encoding fimbriae type 1 in fecal Escherichia coli associated with increased frequency of bacteriocinogeny?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about a potential association between determinants encoding fimbriae type 1 in fecal E. coli and increased frequency of bacteriocinogeny. Bacteriocinogeny refers to the ability to produce bacteriocins, which are antimicrobial peptides produced by bacteria to inhibit the growth of similar or closely related bacterial strains. Fimbriae type 1 are adhesive surface structures in E. coli that help in attachment to host cells. \\n\\nTo answer this question accurately, I would need specific scientific evidence showing a correlation between these two traits. Without specific studies or data referenced in the question, I cannot definitively state whether such an association exists. This would require examination of research literature on the genetic linkage or co-occurrence of these two traits in fecal E. coli populations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12202858",
    "question": "Does the endothelin antagonist BQ123 reduce pulmonary vascular resistance after surgical intervention for congenital heart disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To answer this question, I need to determine if there is evidence that BQ123 (an endothelin antagonist) reduces pulmonary vascular resistance (PVR) specifically after surgical intervention for congenital heart disease.\\n\\nBQ123 is a selective endothelin-A receptor antagonist. Endothelin is a potent vasoconstrictor, and blocking its action can cause vasodilation and potentially reduce vascular resistance.\\n\\nHowever, the question is very specific about:\\n1. The context: after surgical intervention for congenital heart disease\\n2. The outcome: reduction in pulmonary vascular resistance\\n\\nBased on my knowledge, while BQ123 has been studied in various cardiovascular conditions and can reduce pulmonary vascular resistance in some settings, I don't have specific evidence that it has been proven to reduce pulmonary vascular resistance specifically in the post-surgical congenital heart disease setting. There may be studies on this topic, but I don't have definitive information showing this specific effect in this specific clinical scenario.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25223800",
    "question": "Does urotensin II increase foam cell formation by repressing ABCA1 expression through the ERK/NF-κB pathway in THP-1 macrophages?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific molecular mechanism: whether urotensin II increases foam cell formation by repressing ABCA1 expression through the ERK/NF-κB pathway in THP-1 macrophages. To answer this, I would need to know if research has established this specific pathway. Urotensin II is a peptide that can affect various cellular processes. ABCA1 is a cholesterol efflux regulatory protein. Foam cells are lipid-laden macrophages that are important in atherosclerosis. The ERK/NF-κB pathway is a signaling pathway involved in inflammation and other cellular responses. THP-1 is a human monocytic cell line used to study macrophage functions. This appears to be asking about a specific research finding that would require specialized knowledge in molecular biology and cardiovascular research. Without specific knowledge of this research, I cannot confidently answer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10522879",
    "question": "Do mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether mice that lack the enzyme cytosolic copper/zinc superoxide dismutase (SOD1) show a distinctive motor axonopathy (a pathological condition affecting motor axons). \\n\\nSOD1 is an important antioxidant enzyme that helps protect cells from oxidative damage. Mutations in the SOD1 gene are associated with some forms of amyotrophic lateral sclerosis (ALS), a motor neuron disease. \\n\\nBased on scientific literature, mice lacking SOD1 (SOD1 knockout mice) do indeed develop a progressive motor axonopathy. Studies have shown that these mice exhibit age-dependent degeneration of motor axons, particularly in the distal portions of motor neurons. This axonopathy has distinctive features including axonal swellings, mitochondrial vacuolization, and denervation of neuromuscular junctions.\\n\\nSo yes, mice lacking cytosolic copper/zinc superoxide dismutase do display a distinctive motor axonopathy.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17762651",
    "question": "Do src family tyrosine kinases mediate contraction of rat isolated tail arteries in response to a hyposmotic stimulus?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific physiological mechanism: whether src family tyrosine kinases are involved in mediating contraction of rat isolated tail arteries when those arteries are exposed to a hyposmotic stimulus. To answer this, I would need to know about experimental evidence showing whether inhibiting src family tyrosine kinases prevents or reduces this specific contractile response in this specific tissue. Without having specific research data on this particular mechanism in rat tail arteries, I cannot provide a definitive answer. However, src family kinases are known to be involved in various smooth muscle contractile mechanisms, so it's plausible, but I don't have the specific evidence about rat tail arteries and hyposmotic stimuli.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26829552",
    "question": "Does recombinant Mouse β-Defensin 3 protect against Coxsackievirus B3-Induced Myocarditis in Mice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if recombinant Mouse β-Defensin 3 protects against Coxsackievirus B3-Induced Myocarditis in Mice. To answer this, I would need specific research evidence showing that recombinant Mouse β-Defensin 3 has been tested against Coxsackievirus B3-induced myocarditis in mouse models and demonstrated protective effects. Without specific studies cited in the question, I cannot confirm this specific relationship. While β-defensins are antimicrobial peptides with known antiviral properties, and some defensins may have activity against certain viruses, I don't have evidence of this specific defensin protecting against this specific virus-induced condition.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26309593",
    "question": "Does unilateral vagus nerve stimulation improve ventricular autonomic nerve distribution and functional imbalance in a canine heart failure model?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if unilateral vagus nerve stimulation improves ventricular autonomic nerve distribution and functional imbalance in a canine heart failure model. To answer this, I need to consider whether there is scientific evidence supporting this specific claim about vagus nerve stimulation in dogs with heart failure. This is a very specific scientific/medical question about an experimental intervention in animal models. Without specific research papers or evidence presented in the question, I cannot definitively state whether this intervention has been proven to have this effect. I don't have access to the complete scientific literature on this topic, and this appears to be a specialized research question that would require specific studies to answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20338826",
    "question": "Is spinal cord injuries containing asymmetrical damage in the ventrolateral funiculus associated with a higher incidence of at-level allodynia?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the association between asymmetrical damage in the ventrolateral funiculus in spinal cord injuries and the incidence of at-level allodynia. To answer this, I need to consider what is known about spinal cord injury pathophysiology and pain syndromes.\\n\\nThe ventrolateral funiculus contains important ascending sensory pathways including the spinothalamic tract, which is critical for pain and temperature sensation. Asymmetrical damage to this area could potentially disrupt normal sensory processing.\\n\\nAllodynia refers to pain caused by a stimulus that does not normally provoke pain, and 'at-level' allodynia occurs at the neurological level of the spinal cord injury.\\n\\nBased on neuroanatomical principles, asymmetrical damage could potentially create imbalances in sensory processing that might contribute to neuropathic pain phenomena like allodynia. However, to definitively answer whether there is a higher incidence specifically associated with asymmetrical ventrolateral funiculus damage, I would need to refer to clinical research studies that have specifically examined this correlation.\\n\\nWithout specific research evidence on this particular association, I cannot confidently answer yes or no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19076205",
    "question": "Does efficacy of the fractional photothermolysis system with dynamic operating mode on acne scars and enlarged facial pore?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether the fractional photothermolysis system with dynamic operating mode is effective for treating acne scars and enlarged facial pores. This is asking about the efficacy (effectiveness) of a specific treatment modality for specific skin conditions. The question is phrased as a yes/no question, but it's grammatically incomplete - it should be 'Does the fractional photothermolysis system with dynamic operating mode have efficacy on acne scars and enlarged facial pores?' Based on medical literature, fractional photothermolysis systems have shown efficacy in treating acne scars and can help with pore size reduction, though results vary by individual. The dynamic operating mode is a specific technical variation of this treatment.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25284058",
    "question": "Does resolution of chronic bacterial-induced prostatic inflammation reverse established fibrosis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if resolving chronic bacterial-induced prostatic inflammation can reverse fibrosis that has already been established in the prostate. To answer this, I need to consider what is known about prostatic fibrosis and whether it's reversible after bacterial inflammation is resolved.\\n\\nFibrosis is the formation of excess fibrous connective tissue in an organ or tissue, which can occur as part of the repair process following inflammation. Once fibrosis is established, it typically represents a permanent structural change in the tissue architecture. In many organs, established fibrosis is considered largely irreversible, even after the initial inflammatory stimulus is removed.\\n\\nIn the specific case of bacterial-induced prostatic inflammation leading to fibrosis, the scientific literature generally indicates that while treating the bacterial infection can prevent further fibrosis development, the fibrotic changes that have already occurred (established fibrosis) typically remain. The collagen deposition and tissue remodeling that characterize fibrosis are generally permanent structural changes.\\n\\nTherefore, based on current understanding of tissue fibrosis mechanisms, resolution of the bacterial inflammation would likely stop progression of fibrosis but would not typically reverse fibrotic changes that have already become established.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21302330",
    "question": "Do dry matter content and fruit size affect flavour and texture of novel Actinidia deliciosa genotypes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether dry matter content and fruit size affect flavor and texture of novel Actinidia deliciosa genotypes (kiwifruit). To answer this, I need to consider what scientific evidence suggests about these relationships. Dry matter content in kiwifruit is known to correlate with sugar content and flavor intensity. Fruit size can affect texture characteristics and sometimes flavor concentration. For Actinidia deliciosa specifically (the common green kiwifruit species), these relationships have been studied and documented in horticultural research. Both parameters are important quality traits that breeders and producers monitor. Based on established horticultural science, these physical characteristics do influence sensory attributes in kiwifruit, including novel genotypes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19508998",
    "question": "Does genome-wide association study in premature ovarian failure patients suggest ADAMTS19 as a possible candidate gene?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if genome-wide association study (GWAS) in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene. To answer this, I need to recall if there is evidence from GWAS studies linking ADAMTS19 to premature ovarian failure (POF). ADAMTS19 is a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family of proteins. Based on my knowledge, there have indeed been GWAS studies that identified ADAMTS19 as a potential candidate gene associated with premature ovarian failure. For example, some studies have found genetic variants in or near ADAMTS19 that show significant association with POF, suggesting this gene may play a role in ovarian function and its dysfunction could contribute to premature ovarian failure. Therefore, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23087431",
    "question": "Are t-helper 17 cells associated with pathology in human schistosomiasis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, I need to consider whether there is evidence linking T-helper 17 (Th17) cells to pathological processes in human schistosomiasis infection.\\n\\nSchistosomiasis is a parasitic disease caused by blood flukes of the genus Schistosoma. The pathology in schistosomiasis is largely related to the immune response to parasite eggs trapped in tissues, which leads to granuloma formation and fibrosis, particularly in the liver and intestines (for S. mansoni and S. japonicum) or urogenital tract (for S. haematobium).\\n\\nTh17 cells are a subset of CD4+ T cells characterized by the production of IL-17 and other pro-inflammatory cytokines. They play roles in inflammatory conditions and autoimmune diseases.\\n\\nResearch has shown that Th17 cells and IL-17 contribute to the immunopathology in schistosomiasis. Studies have demonstrated elevated levels of IL-17 in patients with schistosomiasis, particularly those with more severe disease manifestations. Th17 responses have been associated with granulomatous inflammation and fibrosis in the liver and other affected organs in human schistosomiasis.\\n\\nFor example, research has shown that patients with hepatosplenic schistosomiasis (a severe form with liver fibrosis) often have higher levels of Th17-related cytokines compared to patients with intestinal schistosomiasis (a milder form).\\n\\nBased on the scientific literature, there is evidence supporting the association between Th17 cells and pathology in human schistosomiasis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22401324",
    "question": "Does population-based study of severe hypoglycemia requiring emergency medical service assistance reveal unique findings?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a population-based study of severe hypoglycemia requiring emergency medical service assistance reveals unique findings. To answer this, I would need to know about specific studies on this topic and their findings. Without specific information about such studies, I cannot determine if they revealed unique findings compared to other research approaches. The question doesn't provide details about any particular study or its results, so I cannot make a determination about uniqueness of findings.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21979112",
    "question": "Does a high body mass index in esophageal cancer patients influence postoperative outcome or long-term survival?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether a high body mass index (BMI) in esophageal cancer patients influences postoperative outcome or long-term survival. To answer this, I need to consider the medical research on this topic.\\n\\nThere is evidence in medical literature suggesting that BMI can impact surgical outcomes and survival rates in esophageal cancer patients. Some studies indicate that high BMI may be associated with increased postoperative complications such as anastomotic leaks, pulmonary complications, and longer hospital stays. High BMI can make the surgery technically more challenging.\\n\\nRegarding long-term survival, the relationship is complex. Some studies suggest that while obesity may increase surgical risks, patients with higher BMI might actually have better nutritional reserves to withstand the catabolic stress of cancer and its treatments, potentially influencing long-term survival.\\n\\nBased on the available medical evidence, high BMI does appear to influence both postoperative outcomes and potentially long-term survival in esophageal cancer patients, though the exact nature and extent of this influence may vary based on other factors.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "25530820",
    "question": "Is nucleosome positioning unaltered at MLH1 splice site mutations in cells derived from Lynch syndrome patients?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether nucleosome positioning remains unchanged (unaltered) at MLH1 splice site mutations in cells derived from Lynch syndrome patients. To answer this, I need to consider what is known about Lynch syndrome, MLH1 gene mutations, and their effects on nucleosome positioning.\\n\\nLynch syndrome is a hereditary cancer predisposition syndrome caused by germline mutations in DNA mismatch repair genes, including MLH1. Splice site mutations in MLH1 can affect how the gene is expressed.\\n\\nRegarding nucleosome positioning specifically at MLH1 splice site mutations in Lynch syndrome patients' cells, research has shown that mutations can indeed alter nucleosome positioning. Mutations in splice sites can affect chromatin structure and nucleosome organization around those sites. Studies have demonstrated that certain mutations associated with Lynch syndrome can lead to changes in nucleosome positioning, which can further impact gene expression and splicing efficiency.\\n\\nTherefore, nucleosome positioning is typically NOT unaltered (meaning it IS altered) at MLH1 splice site mutations in cells from Lynch syndrome patients.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "10520219",
    "question": "Does depletion of NK cell activity result in growth of hepatic micrometastases in a murine ocular melanoma model?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if depletion of NK (Natural Killer) cell activity leads to growth of hepatic (liver) micrometastases in a murine (mouse) ocular melanoma model. To answer this, I need to consider what's known about NK cells and their role in cancer surveillance. NK cells are part of the innate immune system and play a critical role in eliminating cancer cells, particularly metastatic cells. In many cancer models, depletion of NK cells does lead to increased metastatic burden. For ocular melanoma specifically, there is research showing that NK cells help control metastatic spread, and the liver is a common site for ocular melanoma metastasis. However, without specific research citation in the question, I need to rely on general immunological principles. Based on the immunosurveillance role of NK cells, it would be consistent with current understanding that depleting NK cells would result in increased growth of hepatic micrometastases in this model.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25123222",
    "question": "Do low levels of low-density lipoprotein-C associated with proprotein convertase subtilisin kexin 9 inhibition increase the risk of hemorrhagic transformation?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if low levels of low-density lipoprotein-C (LDL-C) associated with proprotein convertase subtilisin kexin 9 (PCSK9) inhibition increase the risk of hemorrhagic transformation. This is asking about a potential side effect or risk of PCSK9 inhibitors, which are medications used to lower LDL cholesterol levels. Hemorrhagic transformation refers to bleeding into an area of ischemic infarction, particularly in the brain after a stroke. I need to determine if there is an established causal relationship between very low LDL-C levels achieved through PCSK9 inhibition and increased risk of hemorrhagic transformation. Based on current medical literature, while there have been some concerns about very low LDL-C levels and bleeding risk, the evidence specifically linking PCSK9 inhibition to increased hemorrhagic transformation risk is not conclusively established. Most large clinical trials of PCSK9 inhibitors have not shown a significant increase in hemorrhagic stroke or transformation.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "10727925",
    "question": "Are spinally elicited peripheral nerve responses sensory rather than motor?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the nature of spinally elicited peripheral nerve responses - specifically whether they are sensory rather than motor. Let me think about this carefully.\\n\\nPeripheral nerves can carry both sensory information (from sensory receptors to the spinal cord and brain) and motor commands (from the spinal cord to muscles). When we talk about 'spinally elicited' responses, we're referring to responses that originate from the spinal cord.\\n\\nSpinally elicited peripheral nerve responses are primarily motor in nature. The classic example is the spinal reflex arc, where sensory information enters the spinal cord, is processed at the spinal level, and then motor commands are sent out via motor neurons to the periphery. The H-reflex and other spinal reflexes involve motor output from the spinal cord through peripheral nerves to muscles.\\n\\nWhile sensory information travels in peripheral nerves, the direction of 'spinally elicited' responses is from the spinal cord outward, which is the motor pathway. Sensory pathways carry information to the spinal cord, not from it.\\n\\nSo spinally elicited peripheral nerve responses are motor rather than sensory.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15154944",
    "question": "Do patients and nurses determine variation in adherence to guidelines at Dutch hospitals more than internists or settings?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether patients and nurses determine variation in adherence to guidelines at Dutch hospitals more than internists or settings. To answer this, I would need specific research or data about guideline adherence in Dutch hospitals and the relative impact of different stakeholders (patients, nurses, internists) and settings on adherence variation. Without such specific evidence about the Dutch healthcare system and comparative influence of these factors, I cannot make a definitive determination about which factors have more influence on guideline adherence variation.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11490154",
    "question": "Is hev b 8 , the Hevea brasiliensis latex profilin , a cross-reactive allergen of latex , plant foods and pollen?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if hev b 8, which is the Hevea brasiliensis latex profilin, is a cross-reactive allergen across latex, plant foods, and pollen. Cross-reactivity means that an allergen from one source can trigger allergic reactions to similar proteins in other sources due to structural similarities. \\n\\nHev b 8 is indeed known to be a profilin, and profilins are well-documented pan-allergens that show cross-reactivity across multiple sources. Specifically, latex profilin (hev b 8) has been shown to cross-react with profilins from various plant foods and pollens. This is part of what's known as latex-fruit syndrome or latex-pollen syndrome, where individuals allergic to latex may also react to certain fruits, vegetables, or pollens due to these cross-reactive proteins.\\n\\nBased on the scientific literature, hev b 8 is a cross-reactive allergen across latex, plant foods, and pollen.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23064817",
    "question": "Is dietary quality related to frailty in community-dwelling older adults?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the relationship between dietary quality and frailty in community-dwelling older adults. Based on scientific research, there is evidence supporting that dietary quality is indeed related to frailty in older adults living in the community. Multiple studies have shown that better dietary quality (such as adherence to Mediterranean diet, higher protein intake, and consumption of fruits and vegetables) is associated with lower risk of frailty and better physical function in older adults. Poor nutritional status and inadequate intake of essential nutrients have been linked to increased frailty risk. Therefore, there is a relationship between dietary quality and frailty in community-dwelling older adults.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11213894",
    "question": "Are changes in cognitive abilities over a 4-year period unfavorably affected in elderly diabetic subjects : results of the Epidemiology of Vascular Aging Study?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the results of a specific study called the 'Epidemiology of Vascular Aging Study'. The question specifically asks whether this study found that elderly diabetic subjects experienced unfavorable changes in cognitive abilities over a 4-year period compared to non-diabetic elderly subjects. Without having access to the specific results of this study, I cannot definitively answer whether the study found such an association. However, based on how the question is phrased, it seems to be implying that the study did find that diabetes unfavorably affected cognitive changes in the elderly over time. Many studies have found associations between diabetes and accelerated cognitive decline in older adults, but I would need to know the specific findings of this particular study to answer with certainty.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11290857",
    "question": "Does prolonged ethanol treatment enhance lipopolysaccharide/phorbol myristate acetate-induced tumor necrosis factor-alpha production in human monocytic cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the effect of prolonged ethanol treatment on the production of tumor necrosis factor-alpha (TNF-α) in human monocytic cells when these cells are stimulated with lipopolysaccharide (LPS) or phorbol myristate acetate (PMA). \\n\\nTo answer this, I need to consider what is known about ethanol's effects on cytokine production in monocytes/macrophages. Research has shown that chronic ethanol exposure can actually enhance pro-inflammatory cytokine production, including TNF-α, when monocytes are subsequently stimulated with LPS. This is part of the mechanism by which alcoholism leads to liver inflammation and damage.\\n\\nThe specific combination mentioned in the question - prolonged ethanol treatment followed by LPS/PMA stimulation - has been studied, and research indicates that chronic ethanol exposure does indeed enhance TNF-α production in human monocytic cells when they are subsequently stimulated with LPS or PMA.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19331151",
    "question": "Are tissue microarrays reliable tools for the clinicopathological characterization of lung cancer tissue?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if tissue microarrays are reliable tools for clinicopathological characterization of lung cancer tissue. To answer this, I need to consider what tissue microarrays are and their established reliability in lung cancer research and diagnosis.\\n\\nTissue microarrays (TMAs) are laboratory tools that allow for the simultaneous analysis of multiple tissue samples on a single slide. They are widely used in cancer research, including lung cancer studies, to analyze protein expression, gene amplification, and other molecular markers across many samples at once.\\n\\nIn the context of lung cancer specifically, TMAs have been validated in numerous studies and are generally considered reliable tools for clinicopathological characterization. They allow researchers to efficiently analyze biomarkers across large sample sets while using minimal tissue and reagents. Multiple studies have shown good concordance between TMA results and whole-section analyses for many biomarkers in lung cancer.\\n\\nHowever, TMAs do have some limitations, particularly related to tumor heterogeneity - small cores may not always represent the entire tumor. This is often addressed by using multiple cores from different regions of each tumor.\\n\\nOverall, the scientific consensus supports that tissue microarrays are reliable tools for the clinicopathological characterization of lung cancer tissue, though with some acknowledged limitations that researchers account for in study design.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12204320",
    "question": "Are vitamin E and depressive symptoms related . The Rotterdam Study?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if there's a relationship between vitamin E and depressive symptoms in the context of the Rotterdam Study. The Rotterdam Study is a large prospective cohort study conducted in the Netherlands that investigates various health conditions in the elderly population. To answer this question accurately, I would need to know if the Rotterdam Study specifically found a relationship between vitamin E levels and depressive symptoms. Without having specific data from the Rotterdam Study about vitamin E and depression, I cannot definitively answer yes or no.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "16213896",
    "question": "Do normal human fibroblasts enable melanoma cells to induce angiogenesis in type I collagen?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the role of normal human fibroblasts in enabling melanoma cells to induce angiogenesis (the formation of new blood vessels) specifically in type I collagen environments. To answer this accurately, I need to consider what's known about tumor-stromal interactions in melanoma.\\n\\nResearch has shown that fibroblasts can play important roles in the tumor microenvironment, often becoming cancer-associated fibroblasts (CAFs) that support tumor progression. In melanoma specifically, there is evidence that fibroblasts can promote melanoma growth and invasion through various mechanisms.\\n\\nRegarding angiogenesis specifically in type I collagen, studies have demonstrated that normal human fibroblasts can indeed enable or enhance the ability of melanoma cells to induce angiogenesis when cultured in type I collagen matrices. Fibroblasts secrete various factors that can modify the extracellular matrix and produce pro-angiogenic factors like VEGF when co-cultured with melanoma cells in collagen environments.\\n\\nSo based on the scientific literature, normal human fibroblasts do enable melanoma cells to induce angiogenesis in type I collagen matrices.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24975235",
    "question": "Do investigation into the applicability and optimization of the Dutch matrix sentence test for use with cochlear implant users?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if I should 'Do investigation into the applicability and optimization of the Dutch matrix sentence test for use with cochlear implant users'. This is phrased as a command or suggestion rather than a yes/no question. The question is asking if I should perform or conduct an investigation, which is asking about an action rather than asking for a factual yes/no response. Since this isn't actually a yes/no question but rather a directive or suggestion, I cannot answer with a simple yes or no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22269635",
    "question": "Does arl6ip1 play a role in proliferation during zebrafish retinogenesis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if arl6ip1 plays a role in proliferation during zebrafish retinogenesis. To answer this, I need to determine if there is evidence in the scientific literature that the gene arl6ip1 is involved in cell proliferation specifically during the development of the retina in zebrafish.\\n\\nArl6ip1 (ADP-ribosylation factor-like 6 interacting protein 1) is a protein that has been studied in various contexts. For zebrafish retinogenesis specifically, I need to recall if there are published studies showing that this gene affects proliferation of retinal progenitor cells or other aspects of cell division during eye development in zebrafish.\\n\\nBased on my knowledge, there have been studies showing that arl6ip1 is expressed in the developing zebrafish retina and that knockdown or mutation of this gene affects retinal development. Specifically, research has demonstrated that arl6ip1 plays a role in regulating the proliferation of retinal progenitor cells during zebrafish retinal development. When arl6ip1 function is disrupted, there are observable defects in cell proliferation in the developing retina, indicating that this gene is important for proper proliferative processes during retinogenesis in zebrafish.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25189569",
    "question": "Do elevated circulating lipocalin-2 levels independently predict incident cardiovascular events in men in a population-based cohort?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether elevated circulating lipocalin-2 levels independently predict incident cardiovascular events in men in a population-based cohort. To answer this, I would need specific research evidence showing that lipocalin-2 (also known as NGAL) has been demonstrated to be an independent predictor of cardiovascular events in men in population-based studies. Without specific research citations or evidence provided in the question, I cannot make a definitive determination about whether this biomarker has been proven to independently predict cardiovascular events in men specifically. There have been studies examining lipocalin-2 as a biomarker in cardiovascular disease, but whether it's been established as an independent predictor specifically in men in population-based cohorts requires specific research evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18455779",
    "question": "Is magnetic resonance imaging a complementary method to stereological measurement of testicular volume?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if magnetic resonance imaging (MRI) is a complementary method to stereological measurement of testicular volume. Let me analyze this:\n\nStereological measurement of testicular volume is a technique that uses systematic random sampling to estimate volume. It's considered highly accurate but typically requires tissue samples and is often used in research settings.\n\nMagnetic resonance imaging (MRI) is a non-invasive imaging technique that can visualize soft tissues in the body, including the testes. MRI can provide volumetric measurements of the testes without requiring tissue samples.\n\nThese two methods approach testicular volume measurement differently - stereology through direct tissue analysis and MRI through non-invasive imaging. They can be used together, with MRI providing in vivo measurements and stereology providing more detailed histological information when tissue is available.\n\nSo yes, MRI can be considered complementary to stereological measurements of testicular volume, as they provide different but potentially synergistic information.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25530341",
    "question": "Do aerobic exercise and cold pressor test induce hypoalgesia in active and inactive men and women?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether aerobic exercise and cold pressor test both induce hypoalgesia (reduced sensitivity to pain) in both active and inactive men and women. Hypoalgesia refers to decreased sensitivity to painful stimuli. \\n\\nTo answer this question accurately, I would need to know if research has shown that both aerobic exercise and cold pressor tests consistently produce pain-reducing effects across all these demographic groups (active men, inactive men, active women, inactive women).\\n\\nBased on exercise physiology research, aerobic exercise typically does induce some degree of hypoalgesia (exercise-induced hypoalgesia or EIH) in most populations, though the magnitude may vary. Cold pressor tests (immersing a body part in cold water) are actually often used to induce pain rather than reduce it, though they can activate certain pain modulation systems.\\n\\nThe question asks if BOTH interventions induce hypoalgesia in ALL the specified groups. Without specific research showing consistent hypoalgesia effects from both interventions across all these demographic categories, I cannot confidently answer 'yes.'\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22087417",
    "question": "Do secondary closure of an extraction socket using the double-membrane guided bone regeneration technique with immediate implant placement?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether one should perform a secondary closure of an extraction socket using the double-membrane guided bone regeneration (GBR) technique with immediate implant placement. This is a complex dental procedure question. \\n\\nA secondary closure typically refers to closing a wound after it has been left open initially. In the context of dental implants, this would mean closing the extraction socket after some time has passed since the extraction.\\n\\nHowever, the question also mentions 'immediate implant placement' which means placing the implant at the same time as the tooth extraction. These two concepts (secondary closure and immediate implant) seem contradictory - secondary closure implies a delay, while immediate implant placement implies no delay.\\n\\nThe double-membrane GBR technique is a valid approach for bone regeneration around implants, but whether it should be used with secondary closure and immediate implant placement depends on specific clinical circumstances.\\n\\nSince this is a complex clinical decision that depends on the specific patient case, bone quality, extraction socket condition, and other factors, there isn't a universal 'yes' or 'no' answer that would apply to all situations. The question as phrased seems to contain contradictory elements (secondary closure vs. immediate placement).\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25311378",
    "question": "Is short sleep duration dose-dependently related to job strain and burnout in nurses : a cross sectional survey?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question appears to be asking if a specific research study or finding exists that shows a dose-dependent relationship between short sleep duration and job strain/burnout specifically in nurses, as examined in a cross-sectional survey. The phrasing suggests this might be the title of a research paper. To answer accurately, I would need to know if such a specific study exists. Without being able to search academic databases, I cannot confirm if this exact research exists. The question is very specific about: 1) the population (nurses), 2) the methodology (cross-sectional survey), 3) the variables (sleep duration, job strain, burnout), and 4) the relationship type (dose-dependent). While the relationship between sleep and burnout in healthcare workers has been studied, I cannot confirm this exact study exists.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26356037",
    "question": "Are major depressive disorder , personality disorders , and coping strategies independent risk factors for lower quality of life in non-metastatic breast cancer patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if major depressive disorder, personality disorders, and coping strategies are independent risk factors for lower quality of life in non-metastatic breast cancer patients. To answer this, I need to consider what research has shown about these factors.\\n\\nMajor depressive disorder has been consistently associated with lower quality of life in breast cancer patients. Studies have shown that depression independently predicts worse quality of life outcomes, even when controlling for other variables.\\n\\nPersonality disorders have also been linked to poorer quality of life outcomes in cancer patients, with research suggesting they can independently affect how patients cope with their diagnosis and treatment.\\n\\nCoping strategies are known to significantly impact quality of life in cancer patients. Maladaptive coping strategies (like avoidance or denial) have been shown to independently predict worse quality of life outcomes.\\n\\nResearch in psycho-oncology generally supports that all three factors can independently contribute to quality of life outcomes in breast cancer patients, rather than just being correlated or dependent on other factors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21470412",
    "question": "Is a common polymorphism rs3781637 in MTNR1B associated with type 2 diabetes and lipids levels in Han Chinese individuals?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about a specific genetic polymorphism (rs3781637) in the MTNR1B gene and whether it's associated with type 2 diabetes and lipid levels specifically in Han Chinese individuals. To answer this, I would need to know about studies that have investigated this specific polymorphism in this specific population. Without having specific research data about rs3781637 in MTNR1B and its associations in Han Chinese individuals, I cannot make a definitive statement. While MTNR1B variants have been associated with type 2 diabetes in some populations, I don't have specific information about this particular polymorphism (rs3781637) in Han Chinese individuals.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22024477",
    "question": "Does preoperative inhalation of milrinone attenuate inflammation in patients undergoing cardiac surgery with cardiopulmonary bypass?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether preoperative inhalation of milrinone attenuates inflammation in patients undergoing cardiac surgery with cardiopulmonary bypass. To answer this, I need to consider what is known about milrinone and its effects when administered via inhalation before cardiac surgery.\\n\\nMilrinone is a phosphodiesterase-3 inhibitor that has inotropic and vasodilator properties. It's typically used to treat heart failure and is usually administered intravenously. There is some research on inhaled milrinone in cardiac surgery settings, primarily focused on its effects on pulmonary hypertension and right ventricular function.\\n\\nRegarding specifically whether inhaled milrinone attenuates inflammation in cardiac surgery with cardiopulmonary bypass patients, I need to consider if there's established evidence for this anti-inflammatory effect. While cardiopulmonary bypass is known to trigger inflammatory responses, and various interventions have been studied to reduce this inflammation, I don't recall specific evidence that preoperative inhaled milrinone has a proven anti-inflammatory effect in this context.\\n\\nWithout specific evidence supporting that preoperative inhaled milrinone attenuates inflammation in this patient population, I cannot answer 'yes'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24920473",
    "question": "Does nicotine exposure increase the complexity of dopamine neurons in the parainterfascicular nucleus ( PIF ) sub-region of VTA?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether nicotine exposure increases the complexity of dopamine neurons specifically in the parainterfascicular nucleus (PIF) sub-region of the ventral tegmental area (VTA). To answer this, I would need specific scientific evidence about nicotine's effects on dopamine neuron complexity in this particular sub-region. Without having access to specific studies that have examined this precise relationship, I cannot provide a definitive answer. The question is very specific about both the effect (increased complexity of dopamine neurons) and the exact anatomical location (PIF sub-region of VTA). While nicotine is known to affect dopamine systems in the brain more generally, this specific claim requires evidence about this particular sub-region.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16122471",
    "question": "Does blood cardioplegia provide superior protection in infant cardiac surgery?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if blood cardioplegia provides superior protection in infant cardiac surgery compared to other methods. To answer this accurately, I need to consider the current scientific evidence. Blood cardioplegia (using blood as the base solution for delivering cardioprotective agents) is commonly used in cardiac surgery, but whether it provides 'superior' protection specifically in infants is a specific clinical claim that would require strong evidence. The research on this topic shows mixed results, with some studies suggesting benefits of blood cardioplegia in pediatric populations while others show comparable outcomes between blood and crystalloid cardioplegia. There isn't a clear consensus in the literature that blood cardioplegia is definitively superior for infant cardiac surgery. Without overwhelming evidence supporting superiority, I cannot confidently answer 'yes' to this question.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23569141",
    "question": "Does peroxisome proliferator-activated receptor-γ agonist rosiglitazone reduce secondary damage in experimental spinal cord injury?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether rosiglitazone, which is a peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist, reduces secondary damage in experimental spinal cord injury. To answer this, I need to consider whether there is scientific evidence supporting this specific effect of rosiglitazone in spinal cord injury models.\\n\\nRosiglitazone is primarily known as an anti-diabetic drug that acts as a PPAR-γ agonist. PPAR-γ agonists have been studied for their anti-inflammatory and neuroprotective properties in various neurological conditions.\\n\\nThere is research indicating that PPAR-γ agonists, including rosiglitazone, can reduce secondary damage in experimental models of spinal cord injury. Studies have shown that rosiglitazone treatment after experimental spinal cord injury can reduce inflammation, oxidative stress, and apoptosis, which are key components of secondary damage. It has been demonstrated to improve functional recovery and reduce lesion size in animal models.\\n\\nBased on the existing scientific literature, rosiglitazone does appear to reduce secondary damage in experimental spinal cord injury models.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22528550",
    "question": "Does cC-chemokine ligand 4/macrophage inflammatory protein-1β participate in the induction of neuropathic pain after peripheral nerve injury?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether cC-chemokine ligand 4 (CCL4), also known as macrophage inflammatory protein-1β (MIP-1β), plays a role in the development of neuropathic pain following peripheral nerve injury. To answer this, I need to consider what is known about the role of chemokines, particularly CCL4/MIP-1β, in neuroinflammatory processes and pain signaling after nerve damage.\\n\\nResearch has shown that after peripheral nerve injury, there is an inflammatory response involving various immune cells and inflammatory mediators. Chemokines, including CCL4/MIP-1β, are known to be upregulated in response to nerve injury and contribute to the recruitment of immune cells to the site of injury and in the dorsal root ganglia and spinal cord. CCL4/MIP-1β specifically has been implicated in neuroinflammatory processes.\\n\\nStudies have demonstrated that CCL4/MIP-1β levels increase after peripheral nerve injury, and this chemokine can contribute to the development of neuropathic pain by promoting macrophage infiltration and microglial activation. These immune cells release pro-inflammatory cytokines and other mediators that sensitize nociceptors and enhance pain signaling.\\n\\nBased on the scientific literature, CCL4/MIP-1β does participate in the induction of neuropathic pain following peripheral nerve injury.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20608885",
    "question": "Does chemokine CCL18 predict intraventricular hemorrhage in very preterm infants?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether chemokine CCL18 predicts intraventricular hemorrhage (IVH) in very preterm infants. To answer this, I would need to know if there are scientific studies establishing CCL18 as a biomarker or predictor for IVH in this specific population. Based on my knowledge, while various inflammatory markers have been studied in relation to complications in preterm infants, I don't have specific evidence that CCL18 in particular has been established as a predictor for intraventricular hemorrhage in very preterm infants. Without specific research confirming this relationship, I cannot say that CCL18 predicts IVH in very preterm infants.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21128846",
    "question": "Does telehealth-assisted care coordination of older veterans with type 2 diabetes lower coronary heart disease risk despite clinical inertia?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if telehealth-assisted care coordination of older veterans with type 2 diabetes lowers coronary heart disease risk despite clinical inertia. This is asking about a specific research finding or medical outcome. To answer this accurately, I would need to know the results of studies on this specific intervention with this specific population. Without having access to such specific medical research data, I cannot make a definitive claim about whether this intervention lowers coronary heart disease risk in this population. The question contains several specific elements: telehealth-assisted care coordination, older veterans specifically, type 2 diabetes patients, coronary heart disease risk reduction, and the presence of clinical inertia. This is too specific to answer without relevant research evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25443020",
    "question": "Does twenty-four hour in-hospital congenital cardiac surgical coverage improve perioperative ECMO support outcomes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether having 24-hour in-hospital congenital cardiac surgical coverage improves outcomes for patients receiving ECMO (Extracorporeal Membrane Oxygenation) support in the perioperative period. To answer this, I would need specific research or evidence that compares outcomes between hospitals with 24-hour surgical coverage versus those without such coverage. Without being provided specific studies or data on this topic, I cannot make a definitive claim about whether such coverage improves outcomes. The question is asking for a causal relationship between a specific staffing model and patient outcomes, which would require empirical evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15486775",
    "question": "Is the medial canthal tendon composed of anterior and posterior lobes in Japanese eyes and fixes the eyelid complementarily with Horner 's muscle?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the structure of the medial canthal tendon in Japanese eyes specifically, and whether it has anterior and posterior lobes that work complementarily with Horner's muscle to fix the eyelid.\\n\\nThe medial canthal tendon (MCT) does have anterior and posterior limbs (or lobes) in human eyes generally. This is a normal anatomical feature across human populations. The MCT attaches to the medial orbital wall and helps anchor the eyelids. \\n\\nHorner's muscle (also called the tensor tarsi or pars lacrimalis muscle) is part of the orbicularis oculi muscle that attaches to the lacrimal sac and helps with tear drainage.\\n\\nWhile there may be some ethnic variations in eyelid anatomy, the basic structure of the medial canthal tendon having anterior and posterior components is consistent across populations, including Japanese eyes. These structures work together in eyelid function.\\n\\nSo yes, the medial canthal tendon is composed of anterior and posterior lobes in Japanese eyes (as in all human eyes) and does work complementarily with Horner's muscle in eyelid fixation and function.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26936023",
    "question": "Does deletion of SIP1 promote liver regeneration and lipid accumulation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"I need to analyze whether deletion of SIP1 promotes liver regeneration and lipid accumulation based on scientific evidence. SIP1 (Smad-interacting protein 1, also known as ZEB2) is a transcription factor involved in various biological processes. Let me consider what's known about SIP1's role in liver biology:\\n\\nRegarding liver regeneration:\\nSome studies suggest that SIP1/ZEB2 can act as a negative regulator of epithelial proliferation in certain contexts. If this applies to hepatocytes, then deletion could potentially enhance regenerative capacity.\\n\\nRegarding lipid accumulation:\\nThere is research indicating that ZEB2/SIP1 may be involved in metabolic regulation, but I need to recall if there's specific evidence about its role in hepatic lipid metabolism.\\n\\nBased on my knowledge, there have been studies showing that SIP1/ZEB2 deletion in the liver can indeed promote liver regeneration after injury and is associated with increased lipid accumulation in hepatocytes. The absence of SIP1 appears to alter metabolic pathways that favor lipogenesis while also enhancing proliferative capacity of liver cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25897213",
    "question": "Is dual-tasking over an extended walking distance associated with falls among community-dwelling older adults?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if dual-tasking (performing two tasks simultaneously) over an extended walking distance is associated with falls among community-dwelling older adults. To answer this, I need to consider research on dual-task performance, walking, and fall risk in older adults.\\n\\nResearch has shown that dual-task performance while walking (such as walking while performing a cognitive task) can significantly affect gait parameters in older adults. When older adults have to divide their attention between walking and another task, their gait often becomes more unstable, with increased variability in step length and timing, reduced walking speed, and poorer balance control. These changes in gait are known risk factors for falls.\\n\\nMultiple studies have demonstrated that dual-task costs (the decline in performance when doing two tasks simultaneously compared to doing each task alone) are higher in older adults who have a history of falls or who go on to experience falls in follow-up periods. The ability to maintain stable gait while performing a secondary task is considered an important predictor of fall risk.\\n\\nSpecifically regarding \\\"extended walking distance,\\\" longer dual-task walking tests may reveal fatigue effects or declining compensation strategies that aren't apparent in shorter tests, potentially making them more sensitive measures of fall risk.\\n\\nBased on the scientific literature, there is a positive association between dual-tasking performance over walking distances and falls in community-dwelling older adults.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15921701",
    "question": "Does moderate hyperoxia ( 40 % ) increase antioxidant levels in mouse tissue?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether moderate hyperoxia (40%) increases antioxidant levels in mouse tissue. To answer this, I need to consider what hyperoxia means and its known effects on antioxidant systems.\\n\\nHyperoxia refers to an excess of oxygen in tissues and organs. When tissues are exposed to higher than normal oxygen levels, this can lead to increased production of reactive oxygen species (ROS). In response to increased ROS, biological systems often upregulate antioxidant defense mechanisms as a protective measure.\\n\\nHowever, the specific percentage mentioned (40%) is important. This appears to be referring to 40% oxygen concentration, which would be considered moderate hyperoxia compared to normal atmospheric oxygen (about 21%). The question is whether this specific level of hyperoxia is sufficient to trigger increased antioxidant production in mouse tissue.\\n\\nBased on general principles of oxidative stress and antioxidant response, it's plausible that even moderate hyperoxia could increase antioxidant levels as a protective mechanism. However, without specific research data on 40% oxygen exposure in mice, I cannot make a definitive claim. The exact response would depend on duration of exposure, specific tissue type, and the particular antioxidant systems being measured.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21037017",
    "question": "Does slug confer resistance to the epidermal growth factor receptor tyrosine kinase inhibitor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether slug confers resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). Slug (also known as SNAI2) is a transcription factor involved in epithelial-mesenchymal transition (EMT). Research has shown that Slug expression is associated with resistance to EGFR TKIs in some cancer types. For example, in non-small cell lung cancer (NSCLC), increased Slug expression has been linked to resistance to EGFR TKIs like gefitinib and erlotinib. Slug promotes EMT, which is a process associated with drug resistance in cancer cells. So based on scientific literature, Slug does appear to confer resistance to EGFR TKIs.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16889848",
    "question": "Does transplantation of mesenchymal stem cells from human bone marrow improve damaged heart function in rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether mesenchymal stem cells (MSCs) derived from human bone marrow can improve heart function in rats with damaged hearts when transplanted. To answer this, I need to consider the scientific evidence on this specific type of stem cell therapy.\\n\\nMesenchymal stem cells from human bone marrow have been studied extensively in animal models of heart damage, including rats. Research has shown that these cells can differentiate into cardiac-like cells, secrete paracrine factors that promote tissue repair, reduce inflammation, and stimulate angiogenesis (formation of new blood vessels).\\n\\nNumerous studies have demonstrated that transplantation of human bone marrow-derived MSCs into rats with experimentally induced myocardial infarction or other heart damage does improve various parameters of heart function, including:\\n- Left ventricular ejection fraction\\n- Cardiac output\\n- Reduction in infarct size\\n- Improved survival rates\\n- Reduced cardiac remodeling\\n\\nThese positive effects have been documented in multiple peer-reviewed studies using rat models of heart damage. So based on the scientific literature, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10533610",
    "question": "Does overexpression of long or short FGFR-1 result in FGF-2-mediated proliferation in neonatal cardiac myocyte cultures?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the effect of overexpressing long or short FGFR-1 (Fibroblast Growth Factor Receptor-1) on FGF-2-mediated proliferation in neonatal cardiac myocyte cultures. To answer this, I need to consider what is known about FGFR-1 variants and their role in cardiac myocyte proliferation.\\n\\nFGFR-1 exists in different isoforms, including long and short variants. The question specifically asks whether overexpressing either of these variants results in FGF-2-mediated proliferation in neonatal cardiac myocyte cultures.\\n\\nWithout specific research data on this exact experimental setup, I cannot definitively state whether overexpression of long or short FGFR-1 results in FGF-2-mediated proliferation in this specific cell type. The question requires knowledge of particular experimental results rather than general biological principles.\\n\\nSince I don't have access to specific studies showing this result, and this appears to be a specific research question rather than general knowledge, I cannot confidently answer yes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21436266",
    "question": "Does overexpression of human γC-crystallin 5 bp duplication disrupt lens morphology in transgenic mice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if overexpression of human γC-crystallin with a 5 bp duplication disrupts lens morphology in transgenic mice. To answer this, I need to determine if there's evidence that this specific genetic modification causes lens morphology problems in mice models.\\n\\nI don't have specific information about this particular genetic modification and its effects. The question refers to a specific research finding about human γC-crystallin with a 5 bp duplication being overexpressed in transgenic mice and whether this causes lens morphology disruption. Without access to the relevant scientific literature or studies on this specific genetic modification, I cannot provide a definitive answer based on factual evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21553143",
    "question": "Does butylidenephthalide suppress human telomerase reverse transcriptase ( TERT ) in human glioblastomas?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas. To answer this, I need to know if there's scientific evidence showing that butylidenephthalide has an inhibitory effect on TERT expression or activity specifically in glioblastoma cells. Without specific knowledge of research studies on this particular compound and its effects on TERT in glioblastomas, I cannot provide a definitive answer. However, some natural compounds have been shown to have TERT-suppressing properties in various cancer types, so it's plausible but not something I can confirm without specific evidence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19273570",
    "question": "Are higher maternal TSH levels in pregnancy associated with increased risk for miscarriage , fetal or neonatal death?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between maternal TSH (thyroid-stimulating hormone) levels during pregnancy and adverse pregnancy outcomes, specifically miscarriage, fetal death, or neonatal death. \\n\\nBased on medical literature, elevated maternal TSH levels (subclinical or overt hypothyroidism) during pregnancy have been associated with increased risks of adverse pregnancy outcomes, including miscarriage and fetal/neonatal death. Multiple studies have shown that women with higher TSH levels (even within subclinical hypothyroidism range) have higher rates of pregnancy loss and complications compared to euthyroid women.\\n\\nThe American Thyroid Association and other medical organizations recognize this association and recommend monitoring thyroid function during pregnancy, particularly in high-risk women.\\n\\nTherefore, the answer would be 'yes' - higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10594779",
    "question": "Does 22-Oxacalcitriol ameliorate high-turnover bone and marked osteitis fibrosa in rats with slowly progressive nephritis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if 22-Oxacalcitriol ameliorates (improves) high-turnover bone and marked osteitis fibrosa in rats with slowly progressive nephritis. To answer this, I would need specific research evidence about this compound's effects in this particular rat model. Without having specific studies on this topic in my knowledge base, I cannot definitively answer whether 22-Oxacalcitriol has this therapeutic effect in this specific condition. I don't have conclusive information about this specific relationship.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24345846",
    "question": "Does a 4-polymorphism risk score predict steatohepatitis in children with nonalcoholic fatty liver disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease (NAFLD). To answer this, I would need specific research evidence about this particular risk score and its validated predictive value for steatohepatitis in pediatric NAFLD patients. Without being provided specific research or evidence in the question, I cannot determine if this specific 4-polymorphism risk score has been proven to predict steatohepatitis in children with NAFLD. There are various genetic risk scores being studied in NAFLD, but I cannot confirm this specific one without more information.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15123529",
    "question": "Does short-acting beta-adrenergic antagonist esmolol given at reperfusion improve survival after prolonged ventricular fibrillation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the effect of esmolol (a short-acting beta-adrenergic antagonist) on survival when administered at the time of reperfusion following prolonged ventricular fibrillation. To answer this, I need to consider the medical evidence on this specific intervention.\\n\\nEsmolol is indeed a short-acting beta-blocker that can reduce heart rate and contractility. There is some research suggesting that beta-blockers given at reperfusion might reduce reperfusion injury and improve outcomes in certain cardiac scenarios.\\n\\nSpecifically for prolonged ventricular fibrillation, there have been animal studies and some clinical research suggesting that beta-blockade at reperfusion may reduce myocardial injury and potentially improve survival outcomes. Some studies have shown that esmolol given at reperfusion can reduce post-resuscitation myocardial dysfunction and improve hemodynamic recovery after prolonged cardiac arrest.\\n\\nBased on the available evidence, there appears to be support for the premise that esmolol given at reperfusion can improve survival after prolonged ventricular fibrillation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16809419",
    "question": "Does inhibition of macrophage function prevent intestinal inflammation and postoperative ileus in rodents?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if inhibiting macrophage function prevents intestinal inflammation and postoperative ileus in rodents. To answer this, I need to consider what scientific research shows about the relationship between macrophage function and these conditions in rodent models.\\n\\nPostoperative ileus is a temporary impairment of gastrointestinal motility after surgery, and intestinal inflammation is often associated with it. Macrophages are immune cells that play important roles in inflammation.\\n\\nBased on scientific literature, there is evidence that resident macrophages in the intestinal muscularis are activated during abdominal surgery and contribute to postoperative ileus through inflammatory pathways. Several studies in rodent models have shown that inhibiting or depleting macrophages can reduce intestinal inflammation and improve postoperative ileus.\\n\\nFor example, research has demonstrated that selective inhibition of macrophage activation or depletion of muscularis macrophages in mice and rats can prevent the inflammatory cascade that leads to postoperative ileus. These interventions have been shown to reduce pro-inflammatory cytokine production, decrease neutrophil infiltration, and improve gastrointestinal transit time after surgery.\\n\\nTherefore, based on the available scientific evidence, the answer appears to be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12014674",
    "question": "Do interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase ( IDO ) activity in human osteosarcoma cell lines independently from interferon-gamma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if interleukin-12 (IL-12) and interleukin-18 (IL-18) can induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines without the involvement of interferon-gamma (IFN-γ). To answer this, I need to consider whether these interleukins have a direct effect on IDO activity or if they work through IFN-γ signaling.\\n\\nIDO is an enzyme that catalyzes the first and rate-limiting step in tryptophan catabolism. It's well established that IFN-γ is a potent inducer of IDO. The question is specifically asking if IL-12 and IL-18 can induce IDO independently of IFN-γ in human osteosarcoma cells.\\n\\nBased on the scientific literature, IL-12 and IL-18 are known to stimulate IFN-γ production in various immune cells, and many of their downstream effects are mediated through this IFN-γ induction. In most cell systems, IL-12 and IL-18 do not directly induce IDO but rather work through the induction of IFN-γ, which then induces IDO.\\n\\nIn human osteosarcoma cell lines specifically, there isn't strong evidence that IL-12 and IL-18 can directly induce IDO activity without the involvement of IFN-γ. The IDO induction in these cells typically requires IFN-γ signaling, even when stimulated by IL-12 and IL-18.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17066416",
    "question": "Does artesunate-induced depletion of embryonic erythroblasts precede embryolethality and teratogenicity in vivo?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if artesunate-induced depletion of embryonic erythroblasts occurs before (precedes) embryolethality and teratogenicity in vivo. To answer this, I need to consider what is known about the mechanism of action of artesunate on embryonic development. Artesunate is an antimalarial drug derived from artemisinin. Research has shown that artesunate can cause embryotoxicity in animal models. The specific question is about the temporal relationship between erythroblast depletion and other adverse developmental outcomes. Based on published research, artesunate does indeed first cause a rapid depletion of embryonic erythroblasts (primitive red blood cells), which then leads to subsequent embryolethality (death of the embryo) and teratogenicity (birth defects). This sequence has been demonstrated in various in vivo models, showing that the erythroblast depletion is an early event that precedes the other adverse outcomes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15836546",
    "question": "Is posttreatment 13C-urea breath test predictive of antimicrobial resistance to H. pylori after failed therapy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if posttreatment 13C-urea breath test can predict antimicrobial resistance to H. pylori after failed therapy. To answer this, I need to consider whether this specific diagnostic test (13C-urea breath test) has been shown to predict patterns of antimicrobial resistance in H. pylori strains after a treatment failure. The 13C-urea breath test is commonly used to detect the presence of H. pylori infection by measuring the breakdown of labeled urea by the bacterial urease enzyme. However, this test only detects the presence of the bacteria, not its antimicrobial susceptibility patterns. Determining antimicrobial resistance typically requires culture and sensitivity testing or molecular methods that directly analyze resistance genes. The breath test cannot distinguish between resistant and susceptible strains of H. pylori. Therefore, while a positive posttreatment breath test indicates treatment failure, it cannot predict which antibiotics the bacteria might be resistant to.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9597405",
    "question": "Are increased fibrinogen levels associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease. To answer this, I would need specific scientific evidence from medical research studies that have investigated this potential association. Without access to specific medical literature on this topic, I cannot definitively state whether such an association exists. This would require evidence from epidemiological or clinical studies that have measured both fibrinogen levels and persistent C. pneumoniae infection in patients with unstable coronary artery disease, and analyzed whether there is a statistically significant correlation between these factors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27636232",
    "question": "Is self-reported obstructive sleep apnea associated with nonresponse to antidepressant pharmacotherapy in late-life depression?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking about a potential association between self-reported obstructive sleep apnea (OSA) and nonresponse to antidepressant medications specifically in elderly patients with depression (late-life depression). To answer this accurately, I would need to know if research has established such a connection. While sleep disorders can complicate depression treatment, and OSA specifically can impact mood and treatment outcomes, I don't have specific evidence about self-reported OSA (as opposed to clinically diagnosed OSA) being linked to antidepressant nonresponse specifically in elderly populations. Without clear evidence of this specific association, I should be cautious in my answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20709738",
    "question": "Is the PI3K/Akt/mTOR pathway activated in murine lupus nephritis and downregulated by rapamycin?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the PI3K/Akt/mTOR pathway in murine (mouse) lupus nephritis, specifically whether it is activated in this condition and whether rapamycin downregulates it. Let me analyze what we know about this pathway and disease model:\\n\\n1. The PI3K/Akt/mTOR pathway is a signaling pathway involved in cell growth, proliferation, and survival.\\n2. Lupus nephritis is kidney inflammation caused by systemic lupus erythematosus (SLE), an autoimmune disease.\\n3. Murine lupus nephritis refers to this condition in mouse models.\\n4. Rapamycin (sirolimus) is a known inhibitor of mTOR (mechanistic target of rapamycin).\\n\\nBased on scientific literature, the PI3K/Akt/mTOR pathway is indeed activated in murine lupus nephritis models. Studies have shown increased phosphorylation of components of this pathway in kidney tissues from lupus-prone mice. Furthermore, rapamycin has been demonstrated to downregulate this pathway in these models, which is consistent with its known mechanism of action as an mTOR inhibitor. This downregulation by rapamycin has been associated with improvement in nephritis symptoms in mouse models of lupus.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22592198",
    "question": "Does nerve growth factor increase electrical activity of neural cells derived from murine bone marrow stromal cells?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether nerve growth factor (NGF) increases electrical activity in neural cells that are derived from murine (mouse) bone marrow stromal cells.\\n\\nTo answer this, I need to consider what is known about NGF's effects on neural cells, particularly those derived from bone marrow stromal cells.\\n\\nNGF is a neurotrophic factor that promotes the growth, maintenance, and survival of certain neurons. It's known to play roles in neuronal differentiation and can affect the electrical properties of neurons.\\n\\nHowever, the specific claim about NGF increasing electrical activity in neural cells derived specifically from murine bone marrow stromal cells is quite specific. Without specific research evidence showing this particular effect in this particular cell type, I cannot confidently say yes.\\n\\nWhile NGF generally promotes neuronal function and can enhance electrical activity in many neuronal cell types, I don't have definitive evidence that it specifically increases electrical activity in neural cells derived from mouse bone marrow stromal cells.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27433090",
    "question": "Is urotensin II-induced insulin resistance mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species (ROS) in HepG2 cells. To answer this, I need to determine if there is scientific evidence establishing this specific mechanism.\\n\\nUrotensin II is a vasoactive peptide that can induce insulin resistance in various tissues. The question specifically asks about the mechanism in HepG2 cells (a human liver cancer cell line commonly used in research) and whether NADPH oxidase-derived ROS are the mediators of this effect.\\n\\nBased on scientific literature, there are studies showing that urotensin II can induce insulin resistance, and that NADPH oxidase activation and subsequent ROS production can be involved in insulin resistance mechanisms. Specifically for HepG2 cells, research has demonstrated that urotensin II can indeed induce insulin resistance through NADPH oxidase activation, leading to increased ROS production, which then interferes with insulin signaling pathways.\\n\\nSo the answer would be yes, as this specific mechanism has been documented in scientific research.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17545551",
    "question": "Does curcumin inhibit tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking if curcumin inhibits tumor growth and angiogenesis (formation of new blood vessels) in ovarian carcinoma specifically by targeting the NF-κB pathway. To answer this accurately, I would need to know if research has demonstrated this specific mechanism of action for curcumin in ovarian cancer. There is research showing curcumin has anti-cancer properties and can inhibit NF-κB in various cancers, but I need to be precise about whether this specific pathway has been confirmed in ovarian carcinoma. Based on scientific literature, curcumin has been shown to inhibit tumor growth and angiogenesis in ovarian cancer models by targeting multiple pathways, including the NF-κB pathway. Studies have demonstrated that curcumin can suppress NF-κB activation in ovarian cancer cells, which leads to reduced expression of genes involved in tumor growth and angiogenesis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17098546",
    "question": "Does adenoviral urokinase-type plasminogen activator ( uPA ) gene transfer enhance venous thrombus resolution?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution. To answer this, I need to consider what is known about uPA and its effects on thrombus (blood clot) resolution.\\n\\nuPA is a serine protease that activates plasminogen to plasmin, which then degrades fibrin clots. In theory, increasing uPA expression through gene transfer could enhance thrombolysis (clot breakdown).\\n\\nStudies have shown that adenoviral-mediated uPA gene transfer can indeed enhance thrombolysis in various experimental models. Research has demonstrated that local delivery of adenoviral vectors expressing uPA can accelerate venous thrombus resolution in animal models by increasing fibrinolytic activity at the thrombus site.\\n\\nBased on the scientific literature, adenoviral uPA gene transfer has been shown to enhance venous thrombus resolution in experimental settings.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "9109744",
    "question": "Does cerebellar atrophy decrease the threshold of carbamazepine toxicity in patients with chronic focal epilepsy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether cerebellar atrophy decreases the threshold of carbamazepine toxicity in patients with chronic focal epilepsy. To answer this, I need to consider if there's established evidence that cerebellar atrophy makes patients more susceptible to carbamazepine toxicity at lower doses than would normally be expected.\\n\\nCerebellar atrophy refers to the loss of neurons and neural tissue in the cerebellum, which can affect motor coordination and certain cognitive functions. Carbamazepine is an anticonvulsant medication commonly used to treat epilepsy, including focal epilepsy.\\n\\nThere is some biological plausibility to this hypothesis since:\\n1. The cerebellum can be involved in drug metabolism and clearance pathways\\n2. Cerebellar atrophy might affect blood-brain barrier function\\n3. Patients with pre-existing cerebellar damage might be more sensitive to the neurological side effects of carbamazepine\\n\\nHowever, to definitively answer \\\"yes,\\\" I would need specific clinical evidence establishing this relationship. Based on my knowledge, while there are studies on carbamazepine toxicity and studies on cerebellar atrophy in epilepsy patients, there isn't well-established clinical evidence specifically demonstrating that cerebellar atrophy consistently lowers the threshold for carbamazepine toxicity in chronic focal epilepsy patients.\\n\\nWithout specific evidence establishing this relationship, I cannot confirm this as a recognized clinical phenomenon.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11061052",
    "question": "Does emergent angioplasty prevent left ventricular dilation in patients with acute anterior wall myocardial infarction and cardiogenic shock?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether emergent angioplasty (a procedure to restore blood flow in blocked coronary arteries) prevents left ventricular dilation (enlargement of the left ventricle) in a specific patient population: those with acute anterior wall myocardial infarction (heart attack affecting the front wall of the heart) who also have cardiogenic shock (a condition where the heart suddenly can't pump enough blood).\\n\\nTo answer this accurately, I would need to rely on clinical research evidence. Based on medical literature, emergent angioplasty (also called primary PCI) is indeed associated with improved outcomes in patients with acute myocardial infarction complicated by cardiogenic shock. Early revascularization helps preserve myocardial tissue and function, which can limit adverse remodeling including left ventricular dilation. Studies have shown that timely reperfusion therapy can limit infarct size and preserve left ventricular function, potentially preventing pathological ventricular dilation.\\n\\nHowever, while emergent angioplasty can reduce the risk and extent of left ventricular dilation compared to no intervention, it doesn't completely prevent it in all patients. Some patients may still experience some degree of ventricular remodeling despite successful angioplasty, especially if there was significant myocardial damage before the procedure was performed.\\n\\nSince the question asks for a yes/no answer about whether it prevents (not just reduces) left ventricular dilation, and prevention isn't absolute in all cases, I should answer 'no.'\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25554260",
    "question": "Do geographical analysis of socioeconomic factors in risk of domestic burn injury in London 2007-2013?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if I can provide a geographical analysis of socioeconomic factors related to the risk of domestic burn injuries in London during the period 2007-2013. This appears to be a request for a specific analysis or research task, not a yes/no question. The question is phrased as if asking me to perform an analysis, rather than asking if something is true or false. Since I'm being asked to perform a specific analytical task rather than answer a factual yes/no question, I should answer 'no'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18379916",
    "question": "Are changes in pulse character and mental status late responses to central hypovolemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether changes in pulse character and mental status are late responses to central hypovolemia. Central hypovolemia refers to reduced blood volume in the central circulation (heart, lungs, and great vessels). When someone experiences central hypovolemia, the body goes through a series of compensatory mechanisms. Early responses typically include tachycardia (increased heart rate) and peripheral vasoconstriction to maintain blood pressure. Changes in pulse character (such as weak, thready pulse) and mental status alterations (such as confusion, lethargy) are indeed considered late signs of hypovolemia, occurring after the body's initial compensatory mechanisms begin to fail. By the time these signs appear, the patient is often in advanced stages of shock. Therefore, these are late responses to central hypovolemia.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26207725",
    "question": "Does plasma apolipoprotein A1 associate with age at onset and motor severity in early Parkinson 's disease patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about a specific association between plasma apolipoprotein A1 and two clinical features (age at onset and motor severity) in early Parkinson's disease patients. To answer this, I would need to know if research studies have demonstrated such an association. Without specific research data or references provided in the question, I cannot determine if this association has been established in the scientific literature. However, there have been studies examining various biomarkers including apolipoproteins in Parkinson's disease. Some research suggests apolipoprotein A1 may be altered in PD patients, but whether it specifically associates with age of onset and motor severity in early PD requires specific evidence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23860789",
    "question": "Does bony impingement depend on the bone morphology of the hip after total hip arthroplasty?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether bony impingement depends on the bone morphology of the hip after total hip arthroplasty (THA). Bony impingement after THA refers to abnormal contact between the femoral component (or femoral neck) and the acetabular component (or acetabular rim) during hip movement. This impingement can lead to limited range of motion, pain, and potentially implant failure or dislocation.\\n\\nThe bone morphology of the hip after THA is indeed a critical factor that can affect impingement. This includes:\\n1. The native bone structure that remains after the surgery\\n2. How the components are positioned relative to the bone\\n3. The relationship between the femoral neck and the acetabular rim\\n\\nFactors such as acetabular component orientation (inclination and anteversion), femoral component positioning, offset, and neck-shaft angle all influence the risk of impingement. Additionally, residual bone prominences or osteophytes can cause impingement even with well-positioned components.\\n\\nSo yes, bony impingement does depend on the bone morphology of the hip after total hip arthroplasty.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19228761",
    "question": "Does endometrial secretion analysis identify a cytokine profile predictive of pregnancy in IVF?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if endometrial secretion analysis can identify a cytokine profile that predicts pregnancy success in IVF (in vitro fertilization). To answer this, I need to consider whether there is established scientific evidence showing that analyzing cytokines in endometrial secretions can reliably predict which IVF cycles will result in pregnancy. While there have been studies investigating various biomarkers in endometrial fluid, including cytokines, to my knowledge there isn't yet a validated, clinically established cytokine profile in endometrial secretions that definitively predicts IVF success. Some research has shown correlations between certain cytokine patterns and receptivity or pregnancy outcomes, but these findings haven't translated into a standardized predictive tool used routinely in clinical practice. The evidence remains preliminary and sometimes contradictory.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12771737",
    "question": "Does the New York University nerve sparing algorithm decrease the rate of positive surgical margins following radical retropubic prostatectomy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the New York University nerve sparing algorithm decreases the rate of positive surgical margins following radical retropubic prostatectomy. To answer this, I would need specific research data or clinical studies that evaluated this algorithm's effectiveness in reducing positive surgical margins. Without being provided specific evidence about this algorithm's outcomes, I cannot make a determination about whether it decreases positive surgical margin rates. I don't have access to specific medical research data about this algorithm's effectiveness.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15051600",
    "question": "Are postprandial variations in fibrinolytic activity in middle-aged men modulated by plasminogen activator inhibitor I 4G-675/5G genotype but not by the fat content of a meal?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question. The question is asking whether postprandial (after meal) variations in fibrinolytic activity in middle-aged men are modulated by the plasminogen activator inhibitor I 4G-675/5G genotype but not by the fat content of a meal. This is a specific scientific question about the relationship between genetics, meal composition, and blood clotting factors.\\n\\nTo answer this accurately, I would need to be familiar with specific research on this topic. The question is phrased in a way that suggests there might be research indicating that the PAI-1 genotype does modulate fibrinolytic activity after meals, while the fat content does not. However, without specific knowledge of this research, I cannot confidently answer yes or no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25190128",
    "question": "Is neutrophil-lymphocyte ratio a simple and novel biomarker for prediction of survival after radioembolization for metastatic colorectal cancer?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if neutrophil-lymphocyte ratio is a simple and novel biomarker for predicting survival after radioembolization for metastatic colorectal cancer. To answer this, I need to consider whether there is established evidence that neutrophil-lymphocyte ratio (NLR) serves this specific purpose. NLR is a known inflammatory marker that has been studied as a prognostic indicator in various cancers. While it may have been investigated in the context of colorectal cancer and various treatments, I don't have specific evidence that it has been definitively established as a validated biomarker specifically for predicting survival after radioembolization for metastatic colorectal cancer. Without specific evidence confirming this application, I cannot confidently say 'yes'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19317994",
    "question": "Is elevated breast cancer mortality in women younger than age 40 years compared with older women attributed to poorer survival in early-stage disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the higher breast cancer mortality in women under 40 compared to older women is due to poorer survival rates specifically in early-stage disease. To answer this accurately, I need to consider what research shows about breast cancer outcomes by age group. While younger women with breast cancer generally have worse outcomes, I need to determine if this is specifically due to poorer survival in early-stage disease. Research indicates that younger women often present with more aggressive tumor biology, higher grade tumors, and more advanced disease at diagnosis. However, even when controlling for stage, younger women tend to have worse outcomes for early-stage disease specifically. Studies have shown that younger women with stage I or II breast cancer have lower survival rates than older women with the same stage disease, suggesting that age is an independent prognostic factor even in early-stage disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "9507885",
    "question": "Are kidneys derived from mice transgenic for human complement blockers protected in an in vivo model of hyperacute rejection?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether kidneys from mice that have been genetically modified to express human complement blockers (proteins that inhibit the complement system, which is part of the immune response) are protected from hyperacute rejection in an in vivo model. Hyperacute rejection is a rapid and severe form of transplant rejection that occurs when preformed antibodies in the recipient react with antigens on the donor organ, activating the complement system and causing immediate organ failure. The question is asking if the transgenic modification provides protection against this rejection process. Without specific experimental data from a study that tested this exact scenario, I cannot definitively answer. However, the theoretical basis suggests this could be plausible, as human complement blockers could potentially inhibit the complement activation that drives hyperacute rejection. But I need to be careful not to assume the experimental outcome without evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27264955",
    "question": "Do sTAT5A and STAT5B have opposite correlations with drug response gene expression?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether STAT5A and STAT5B have opposite correlations with drug response gene expression. To answer this, I need to consider what is known about these two proteins and their relationships to drug response genes.\\n\\nSTAT5A and STAT5B are closely related transcription factors that belong to the STAT (Signal Transducer and Activator of Transcription) family. They share approximately 93% amino acid identity and have overlapping functions in many biological processes. Both are activated by similar cytokines and growth factors.\\n\\nWhile STAT5A and STAT5B do have some distinct biological functions due to differences in their C-terminal domains and expression patterns in different tissues, there is no established scientific consensus that they have systematically opposite correlations with drug response gene expression. In fact, in many contexts, they work cooperatively rather than antagonistically.\\n\\nResearch has shown that in some specific contexts, they might regulate certain genes differently, but this doesn't translate to a general pattern of opposite correlations with drug response genes across the board.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25489401",
    "question": "Is cholesterol-induced inflammation and macrophage accumulation in adipose tissue reduced by a low carbohydrate diet in guinea pigs?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific research finding related to cholesterol-induced inflammation and macrophage accumulation in adipose tissue, and whether these effects are reduced by a low carbohydrate diet specifically in guinea pigs. To answer this accurately, I would need to know if there is scientific evidence showing that low carbohydrate diets reduce cholesterol-induced inflammation and macrophage accumulation in adipose tissue in guinea pig models. Without specific research citations or established scientific consensus on this particular relationship in guinea pigs, I cannot confidently say yes. The question is very specific to guinea pigs as the animal model, a particular diet intervention (low carbohydrate), and specific physiological outcomes (cholesterol-induced inflammation and macrophage accumulation in adipose tissue).\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19352201",
    "question": "Does the nucleoside backbone affect durability of efavirenz- or nevirapine-based highly active antiretroviral therapy in antiretroviral-naive individuals?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about whether the nucleoside backbone (the specific nucleoside reverse transcriptase inhibitors or NRTIs used) affects the durability of HAART (highly active antiretroviral therapy) regimens that contain either efavirenz or nevirapine (which are non-nucleoside reverse transcriptase inhibitors or NNRTIs). Specifically, it's asking if the choice of nucleoside backbone affects how long patients can stay on these regimens before needing to switch due to failure, toxicity, etc. in treatment-naive individuals (people who haven't taken HIV medications before). To answer this properly, I would need to know if research has shown that different NRTI backbones (like abacavir/lamivudine vs. tenofovir/emtricitabine) affect the durability of efavirenz or nevirapine-based regimens. Based on HIV treatment research, there is evidence that the choice of nucleoside backbone can indeed affect treatment durability, with some combinations showing better tolerability and longer-term outcomes than others when paired with efavirenz or nevirapine.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27228545",
    "question": "Is iL-10 gene polymorphism associated with preschool atopy and early-life recurrent wheezing after bronchiolitis in infancy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about a specific association between IL-10 gene polymorphism and two conditions (preschool atopy and early-life recurrent wheezing) following bronchiolitis in infancy. To answer this, I would need to know if research has established such an association. Without specific research data or medical literature references provided in the question, I cannot determine if this specific genetic association has been scientifically established. This is a specialized medical genetics question that requires evidence from published research.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20602797",
    "question": "Does miR-183 inhibit TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific molecular mechanism in human hepatocellular carcinoma cells. Specifically, it's asking if miR-183 inhibits TGF-beta1-induced apoptosis by downregulating PDCD4 expression. To answer this, I would need to know about research findings on miR-183, its interaction with PDCD4, and its effects on TGF-beta1-induced apoptosis in liver cancer cells. Based on scientific literature, miR-183 has been found to target PDCD4 (programmed cell death 4) in hepatocellular carcinoma, and this interaction does appear to inhibit TGF-beta1-induced apoptosis. There are studies showing that miR-183 overexpression reduces PDCD4 levels and subsequently protects hepatocellular carcinoma cells from TGF-beta1-induced cell death.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10398275",
    "question": "Does novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibit colony growth of prostate cancer cells?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells. To answer this, I need to determine if there is evidence supporting this specific combination's effect on prostate cancer cell colonies. Without specific research papers or data provided in the question, I cannot confirm whether this particular combination has been shown to markedly inhibit colony growth of prostate cancer cells. While both vitamin D analogs and retinoic acid have been studied for anti-cancer properties individually, I don't have definitive information about this specific combination's effects on prostate cancer colony growth.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18471737",
    "question": "Is hemorrhagic shock and resuscitation-mediated tissue water distribution normalized by adjunctive peritoneal resuscitation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether adjunctive peritoneal resuscitation normalizes tissue water distribution that has been affected by hemorrhagic shock and resuscitation. To answer this, I need to consider what peritoneal resuscitation is and its effects on tissue water distribution after hemorrhagic shock.\\n\\nPeritoneal resuscitation is a technique that involves the intraperitoneal instillation of a clinical peritoneal dialysis solution to improve microvascular blood flow and tissue perfusion. Research has shown that adjunctive peritoneal resuscitation can help normalize the distribution of tissue water after hemorrhagic shock and conventional resuscitation. It helps reduce tissue edema and improves microcirculation, which helps restore normal fluid distribution in tissues that was disrupted during hemorrhagic shock.\\n\\nStudies have demonstrated that peritoneal resuscitation can reduce intestinal edema, improve splanchnic perfusion, and normalize fluid shifts that occur during hemorrhagic shock and conventional resuscitation. This technique addresses the third-spacing of fluids that occurs during shock states.\\n\\nBased on the available medical literature, adjunctive peritoneal resuscitation does appear to normalize tissue water distribution that has been disrupted by hemorrhagic shock and resuscitation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23360921",
    "question": "Is survival associated with genetic variation in inflammatory pathway genes among patients with resected and unresected pancreatic cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether survival in pancreatic cancer patients (both those who had surgery to remove the cancer and those who didn't) is associated with genetic variations in genes related to inflammatory pathways. To answer this, I would need specific research data showing a correlation between genetic variations in inflammatory pathway genes and survival outcomes in pancreatic cancer patients. Without being given specific studies or data in the prompt, I cannot make a definitive claim about this association. However, based on general medical knowledge, there is research suggesting that inflammatory pathways play a role in cancer progression and survival outcomes, and genetic variations in these pathways could potentially influence survival. But I should not make a specific claim without evidence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "14623945",
    "question": "Is the 5-yr HAQ-disability related to the first year 's changes in the narrowing , rather than erosion score in patients with recent-onset rheumatoid arthritis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether 5-year HAQ-disability (Health Assessment Questionnaire disability) in patients with recent-onset rheumatoid arthritis is related to changes in the narrowing score rather than the erosion score during the first year. This is a specific medical research question about the relationship between radiographic progression measures and long-term disability outcomes in rheumatoid arthritis. Without access to specific research studies on this topic, I cannot definitively answer whether this relationship has been established in the medical literature. The question appears to be referencing a specific research finding or hypothesis about which radiographic measure (joint space narrowing vs. erosion) better predicts long-term disability in RA patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19796579",
    "question": "Is distraction osteogenesis inhibited by cancer radiotherapy with Co 60?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Distraction osteogenesis is a surgical process used to reconstruct or lengthen bones by gradually separating bone segments, allowing new bone to form in the gap. This process relies on the body's natural healing and bone formation capabilities. Radiotherapy with Cobalt-60 (Co 60) is a form of radiation therapy used to treat cancer. Radiation therapy is known to potentially impair bone healing and regeneration by damaging osteoprogenitor cells and vascular structures necessary for bone formation. Studies have shown that radiotherapy can negatively impact bone healing processes, including distraction osteogenesis. The radiation can decrease the viability of cells involved in bone formation and impair vascularization, which is crucial for successful distraction osteogenesis. Therefore, cancer radiotherapy with Co 60 would likely inhibit the process of distraction osteogenesis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12024135",
    "question": "Is automated graphic assessment of respiratory activity superior to pulse oximetry and visual assessment for the detection of early respiratory depression during therapeutic upper endoscopy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if automated graphic assessment of respiratory activity is superior to pulse oximetry and visual assessment for detecting early respiratory depression during therapeutic upper endoscopy. To answer this, I need to consider whether there's established evidence that automated graphic assessment provides better detection capabilities than the other two methods specifically in this context. Without specific studies comparing these methods directly, I cannot make a definitive claim about superiority. The question is asking for a factual comparison of medical monitoring techniques, and I don't have sufficient evidence to confirm that automated graphic assessment is definitively superior to the other methods mentioned.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12131021",
    "question": "Is continuous vectorcardiography superior to standard electrocardiography in the prediction of long-term outcome after thrombolysis in patients with acute myocardial infarction?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if continuous vectorcardiography is superior to standard electrocardiography for predicting long-term outcomes after thrombolysis in acute myocardial infarction patients. To answer this, I would need specific research evidence comparing these two monitoring techniques in this particular clinical context. Without being provided specific studies or data comparing the predictive value of these two methods, I cannot make a definitive claim about superiority. The question requires comparative clinical evidence that I don't have access to in this prompt.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15825076",
    "question": "Does loss of Klf4 in mice cause altered proliferation and differentiation and precancerous changes in the adult stomach?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the effects of Klf4 loss in mice, specifically whether it causes altered proliferation and differentiation and precancerous changes in the adult stomach. To answer this, I need to consider what is known about Klf4 (Krüppel-like factor 4) function in the stomach epithelium. Klf4 is a zinc finger transcription factor that plays important roles in cell differentiation, proliferation, and survival. Research has shown that Klf4 deletion in mice leads to altered gastric epithelial homeostasis, with increased proliferation, decreased differentiation, and development of precancerous changes in the adult stomach. Studies have demonstrated that Klf4 functions as a tumor suppressor in the stomach, and its loss contributes to gastric carcinogenesis. Therefore, based on published research, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18842065",
    "question": "Is sLC2A9 a high-capacity urate transporter in humans?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"I need to determine if SLC2A9 is a high-capacity urate transporter in humans. SLC2A9 (Solute Carrier Family 2 Member 9) is also known as GLUT9 (Glucose Transporter 9). Based on scientific literature, SLC2A9 has been identified as a major urate transporter in humans. Research has shown that it functions as a high-capacity urate transporter and plays a significant role in regulating serum urate levels. Mutations in this gene are associated with hypouricemia (abnormally low uric acid levels) and can affect urate handling in the kidneys. So yes, SLC2A9 is indeed a high-capacity urate transporter in humans.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12011554",
    "question": "Does tissue plasminogen activator administration result in clinically relevant neuropsychological dysfunction in patients with myocardial ischemia?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether tissue plasminogen activator (tPA) administration causes clinically relevant neuropsychological dysfunction in patients with myocardial ischemia (heart attack or related conditions). tPA is a thrombolytic agent used to dissolve blood clots in conditions like myocardial infarction and ischemic stroke. While tPA can cause bleeding complications including intracranial hemorrhage (which could potentially lead to neuropsychological dysfunction), there is no well-established evidence in the medical literature that tPA administration for myocardial ischemia typically results in clinically relevant neuropsychological dysfunction. The risk of intracranial bleeding with tPA in myocardial infarction is relatively low (less than 1%), and most patients receiving tPA for heart attacks do not experience neuropsychological effects. The neuropsychological risks are more commonly discussed in the context of stroke treatment rather than myocardial ischemia treatment.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "16949314",
    "question": "Does hC-gp39 contribute to chondrocyte differentiation by inducing SOX9 and type II collagen expressions?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if hC-gp39 (also known as YKL-40 or chitinase-3-like protein 1) contributes to chondrocyte differentiation by inducing SOX9 and type II collagen expressions. To answer this, I need to consider what is known about hC-gp39's role in chondrocyte biology.\\n\\nSOX9 is a key transcription factor in chondrocyte differentiation, and type II collagen is a major component of cartilage matrix whose expression is characteristic of the chondrocyte phenotype.\\n\\nBased on scientific literature, hC-gp39 has been shown to promote chondrocyte proliferation and is expressed in cartilage, but there is evidence that it specifically induces SOX9 and type II collagen expression as part of chondrocyte differentiation. Research has demonstrated that hC-gp39 can activate signaling pathways that lead to increased expression of SOX9 and type II collagen in chondrocytes, which are critical markers of chondrocyte differentiation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27853838",
    "question": "Are pre-procedural scout radiographs unnecessary for routine pediatric fluoroscopic examinations?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if pre-procedural scout radiographs are unnecessary for routine pediatric fluoroscopic examinations. To answer this, I need to consider the current medical evidence and guidelines regarding pediatric fluoroscopic procedures.\\n\\nPre-procedural scout radiographs (also called preliminary or scout films) are sometimes taken before fluoroscopic examinations to help plan the procedure. However, in pediatric radiology, there's been a growing emphasis on minimizing radiation exposure following the ALARA principle (As Low As Reasonably Achievable).\\n\\nBased on medical literature, many institutions have moved away from routine scout films before fluoroscopic procedures in children because:\\n1. Modern fluoroscopic equipment provides adequate visualization without preliminary films\\n2. Eliminating unnecessary images reduces radiation exposure\\n3. Studies have shown that diagnostic quality and procedural success are not compromised when omitting scout films in routine cases\\n\\nHowever, scout films may still be necessary in certain non-routine cases or complex procedures. Since the question specifically asks about \\\"routine\\\" pediatric fluoroscopic examinations, the evidence suggests that pre-procedural scout radiographs are indeed generally unnecessary for standard procedures.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19229529",
    "question": "Does torasemide significantly reduce thiazide-induced potassium and magnesium loss despite supra-additive natriuresis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the effects of torasemide (a loop diuretic) when combined with thiazide diuretics, specifically whether torasemide reduces the potassium and magnesium loss that thiazides typically cause, even though the combination produces enhanced sodium excretion (supra-additive natriuresis). To answer this, I need to consider the pharmacological properties of torasemide. While loop diuretics like torasemide can cause potassium and magnesium loss on their own, the question is specifically asking if torasemide reduces the electrolyte loss caused by thiazides. Based on my knowledge of diuretic pharmacology, torasemide does not reduce thiazide-induced potassium and magnesium loss. In fact, when loop diuretics and thiazides are combined, they typically cause additive or synergistic electrolyte losses, including potassium and magnesium, along with the enhanced sodium excretion.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16354161",
    "question": "Do cytoskeletal and motor proteins facilitate trafficking of AQP1-containing vesicles in cholangiocytes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the role of cytoskeletal and motor proteins in the trafficking of aquaporin-1 (AQP1) containing vesicles specifically in cholangiocytes (bile duct epithelial cells). To answer this, I need to consider what's known about AQP1 trafficking in these specific cells.\\n\\nAQP1 is a water channel protein that facilitates water transport across cell membranes. In many cell types, vesicular trafficking of aquaporins involves cytoskeletal elements (like microtubules and actin filaments) and motor proteins (like kinesins, dyneins, and myosins) that move vesicles along these cytoskeletal tracks.\\n\\nIn cholangiocytes specifically, research has shown that AQP1 is expressed and undergoes regulated trafficking. Studies have demonstrated that in cholangiocytes, like in other cell types, the cytoskeleton and associated motor proteins are involved in the trafficking of AQP1-containing vesicles. This includes both constitutive trafficking to the plasma membrane and regulated trafficking in response to various stimuli.\\n\\nTherefore, based on the scientific literature, cytoskeletal and motor proteins do facilitate trafficking of AQP1-containing vesicles in cholangiocytes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20495014",
    "question": "Does myocardial infarction preclude electrical and hemodynamic benefits of cardiac resynchronization therapy in dyssynchronous canine hearts?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether myocardial infarction prevents (precludes) the electrical and hemodynamic benefits of cardiac resynchronization therapy (CRT) in dyssynchronous canine hearts. To answer this, I would need to know if research shows that dogs with myocardial infarction can still benefit from CRT despite the infarction. Without specific research data, I cannot definitively answer. However, based on general medical knowledge, myocardial infarction creates scarred tissue that may interfere with electrical conduction, potentially reducing CRT effectiveness. But this doesn't necessarily mean CRT provides no benefit at all. The question requires specific research on canine hearts with both MI and dyssynchrony treated with CRT.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "22407313",
    "question": "Is endoscopic tumor length an independent prognostic factor in esophageal squamous cell carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether endoscopic tumor length is an independent prognostic factor in esophageal squamous cell carcinoma (ESCC). To answer this, I need to consider whether research has established that the length of a tumor as measured during endoscopy has been shown to independently predict outcomes in ESCC patients, after controlling for other known prognostic factors.\\n\\nBased on medical literature, endoscopic tumor length has indeed been identified as an independent prognostic factor in ESCC in multiple studies. Research has shown that longer tumor length is associated with worse survival outcomes, independent of other factors like TNM stage, lymph node involvement, or depth of invasion. Several multivariate analyses have confirmed that tumor length maintains its prognostic significance even when accounting for these other variables.\\n\\nFor example, studies have demonstrated that patients with longer endoscopic tumor lengths tend to have poorer overall survival and disease-free survival rates compared to those with shorter tumor lengths, even when matched for other prognostic factors. This suggests that endoscopic tumor length provides additional prognostic information beyond what is captured by the standard staging systems.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25997853",
    "question": "Does iFN Regulatory Factor-1 modulate the Function of Dendritic Cells in Patients with Acute Coronary Syndrome?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if Interferon Regulatory Factor-1 (IRF-1) modulates the function of dendritic cells in patients with Acute Coronary Syndrome (ACS). To answer this accurately, I would need to review scientific literature on this specific relationship. Based on my knowledge, IRF-1 is a transcription factor involved in immune responses and can affect dendritic cell function in various conditions. However, without specific evidence linking IRF-1 to dendritic cell modulation specifically in ACS patients, I cannot confidently answer 'yes'. The question appears to be about a specific scientific finding that would require evidence from research studies.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26654189",
    "question": "Is a low cortisol response to stress associated with musculoskeletal pain combined with increased pain sensitivity in young adults : a longitudinal cohort study?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question appears to be asking if I can confirm whether a specific scientific finding is true - specifically whether a low cortisol response to stress is associated with musculoskeletal pain combined with increased pain sensitivity in young adults, according to a longitudinal cohort study. The question is phrased as if it's the title of a research paper, and is asking me to confirm if this is indeed a finding from research. Without access to the specific study or scientific literature on this topic, I cannot definitively confirm whether this association has been established by research. I should answer 'no' since I cannot verify this specific scientific claim.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16030032",
    "question": "Does leukocyte phenotype and function predict infection risk in renal transplant recipients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if leukocyte phenotype and function can predict infection risk in renal transplant recipients. To answer this, I need to consider whether there is established evidence that characteristics of white blood cells (leukocytes) can be used as predictive markers for infection in kidney transplant patients.\\n\\nRenal transplant recipients are immunosuppressed to prevent organ rejection, which increases their susceptibility to infections. Research has shown that various leukocyte parameters (including counts, ratios, and functional assays) can indeed correlate with infection risk in these patients. Studies have demonstrated that certain T-cell subsets, neutrophil function, and other immune cell characteristics can help identify patients at higher risk for opportunistic infections after transplantation.\\n\\nThere is substantial evidence in the transplantation literature supporting that leukocyte parameters can be predictive biomarkers for infection risk in this population.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26440419",
    "question": "Does regulation of the NR2B-CREB-CRTC1 Signaling Pathway contribute to Circadian Pain in Murine Model of Chronic Constriction Injury?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the regulation of the NR2B-CREB-CRTC1 signaling pathway contributes to circadian pain in a murine model of chronic constriction injury. To answer this, I need to determine if there's established evidence linking this specific signaling pathway to circadian pain patterns in this particular injury model.\\n\\nNR2B is an NMDA receptor subunit, CREB is a transcription factor (cAMP response element-binding protein), and CRTC1 is a CREB transcriptional coactivator. These are all involved in neuronal signaling and plasticity. Chronic constriction injury (CCI) is a common model for neuropathic pain in mice.\\n\\nWithout specific research papers or evidence provided in the question, I cannot definitively confirm that this particular signaling pathway has been established as contributing to circadian pain variations in the CCI model. While NMDA receptors and CREB signaling are generally implicated in pain processing, and circadian variations in pain sensitivity exist, the specific connection between NR2B-CREB-CRTC1 pathway and circadian pain in CCI models would require specific research evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17331246",
    "question": "Does progesterone reduce erectile dysfunction in sleep-deprived spontaneously hypertensive rats?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether progesterone reduces erectile dysfunction in sleep-deprived spontaneously hypertensive rats. This is a specific scientific question about the effect of a hormone (progesterone) on a specific condition (erectile dysfunction) in a specific animal model (sleep-deprived spontaneously hypertensive rats). To answer this accurately, I would need to be aware of specific research studies that have investigated this particular relationship. I don't have knowledge of specific studies examining progesterone's effects on erectile dysfunction in this particular rat model. Without specific evidence supporting this claim, I cannot confirm that progesterone has this effect.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26329857",
    "question": "Do obesity-associated metabolic changes influence resting and peak heart rate in women and men?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if obesity-associated metabolic changes influence resting and peak heart rate in women and men. To answer this, I need to consider whether there is evidence that metabolic changes that occur with obesity (such as insulin resistance, altered lipid profiles, inflammation, etc.) affect heart rate parameters in both sexes. Research has shown that obesity is associated with autonomic nervous system dysfunction, which can influence heart rate. Studies have demonstrated that obese individuals often have higher resting heart rates and potentially altered peak heart rate responses during exercise, which may be attributed to metabolic changes. These effects have been observed in both women and men, though there may be some sex-specific differences in the magnitude or mechanisms. Based on the scientific literature, there is evidence supporting that obesity-associated metabolic changes do influence heart rate parameters in both sexes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12324904",
    "question": "Is smoking associated with renal impairment and proteinuria in the normal population : the AusDiab kidney study . Australian Diabetes , Obesity and Lifestyle Study?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether smoking is associated with renal impairment and proteinuria in the normal population, specifically referring to the AusDiab kidney study (Australian Diabetes, Obesity and Lifestyle Study). To answer this accurately, I would need to know the findings of this specific study. Since I don't have the specific results of the AusDiab kidney study in my knowledge base, I cannot definitively say whether this particular study found an association between smoking and renal impairment/proteinuria. However, in general medical literature, smoking has been associated with kidney damage and increased risk of proteinuria in multiple studies. But without knowing the specific findings of the AusDiab study, I should answer 'no' as I cannot confirm this specific association in this particular study.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11466191",
    "question": "Are dipstick measurements of urine specific gravity unreliable?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if dipstick measurements of urine specific gravity are unreliable. Let me analyze this based on medical knowledge.\\n\\nDipstick measurements of urine specific gravity are known to have limitations compared to refractometer measurements, which are considered more accurate. Dipstick methods can be affected by various factors including:\\n\\n1. Presence of glucose, protein, or contrast media in urine\\n2. Highly alkaline urine\\n3. Highly concentrated or dilute urine\\n4. User technique and interpretation variability\\n\\nThese limitations do make dipstick measurements less precise than refractometer measurements. However, calling them 'unreliable' might be too strong. They are still clinically useful for screening purposes and can provide adequate information in many clinical settings when interpreted properly.\\n\\nThe consensus in medical literature is that dipstick measurements of urine specific gravity have limitations and are less accurate than refractometer methods, but they are not completely unreliable when used appropriately and with an understanding of their limitations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25659654",
    "question": "Does cXC chemokine ligand 12a enhance chondrocyte proliferation and maturation during endochondral bone formation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the role of cXC chemokine ligand 12a (CXCL12a) in chondrocyte proliferation and maturation during endochondral bone formation. To answer this, I need to consider what is known about CXCL12a (also known as stromal cell-derived factor 1 or SDF-1) in the context of cartilage development and endochondral ossification.\\n\\nCXCL12/SDF-1 and its receptor CXCR4 have been shown in multiple studies to play important roles in skeletal development. Specifically, research has demonstrated that CXCL12 signaling:\\n- Promotes chondrocyte proliferation in growth plates\\n- Regulates chondrocyte maturation and hypertrophy\\n- Is involved in the recruitment of osteoclast precursors during endochondral ossification\\n- Contributes to vascular invasion of the growth plate\\n\\nStudies in mouse models and in vitro experiments have confirmed that CXCL12a enhances both the proliferation of chondrocytes and their maturation during the process of endochondral bone formation. This chemokine acts as a regulatory factor in the complex signaling network that controls the transition from cartilage to bone during skeletal development.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16397025",
    "question": "Does meta-analysis of the p53 mutation database for mutant p53 biological activity reveal a methodologic bias in mutation detection?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether a meta-analysis of the p53 mutation database reveals a methodologic bias in how p53 mutations are detected. To answer this, I would need to know about specific meta-analyses conducted on the p53 mutation database and their findings regarding methodological biases. Without specific information about such a meta-analysis and its conclusions, I cannot definitively answer whether such a bias was revealed. The question appears to be asking about a specific scientific finding that would require knowledge of particular research papers or analyses.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20044065",
    "question": "Is prenatal intraabdominal bowel dilation associated with postnatal gastrointestinal complications in fetuses with gastroschisis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if prenatal intraabdominal bowel dilation is associated with postnatal gastrointestinal complications in fetuses with gastroschisis. Gastroschisis is a congenital abdominal wall defect where the intestines protrude outside the abdomen. The question specifically asks about a potential correlation between bowel dilation observed before birth (prenatally) inside the abdominal cavity and complications of the gastrointestinal tract after birth (postnatally) in these cases. Based on medical literature, there is evidence suggesting that prenatal intraabdominal bowel dilation can be a predictor of postnatal complications in gastroschisis cases, including longer time to full enteral feeding, increased risk of intestinal atresia, and longer hospital stays. Several studies have found this association to be statistically significant.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23642821",
    "question": "Does lacidipine improve endothelial repair capacity of endothelial progenitor cells from patients with essential hypertension?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if lacidipine (a calcium channel blocker used to treat hypertension) improves the endothelial repair capacity of endothelial progenitor cells (EPCs) specifically in patients with essential hypertension. To answer this, I would need to know if there are studies showing that lacidipine enhances the ability of EPCs from hypertensive patients to repair damaged endothelium. Without specific research information provided in the question, I cannot determine if this specific effect has been demonstrated. However, some calcium channel blockers have been shown to have beneficial effects on endothelial function and EPC activity in hypertensive patients, but I would need specific evidence about lacidipine to answer definitively.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26313687",
    "question": "Does characterization of the Transcriptome of the Xerophyte Ammopiptanthus mongolicus leave under Drought Stress by 454 Pyrosequencing?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question. The question is asking whether the characterization of the transcriptome of Ammopiptanthus mongolicus (a xerophyte plant) under drought stress was performed using 454 pyrosequencing technology. 454 pyrosequencing is a specific DNA sequencing technology that was commonly used for transcriptome analysis before being largely replaced by newer sequencing methods. Without specific information about the actual study methodology, I cannot definitively say whether this particular plant's transcriptome under drought stress was characterized using 454 pyrosequencing specifically. The question appears to be asking if a specific methodology (454 pyrosequencing) was used for a specific study purpose (characterizing the transcriptome of A. mongolicus under drought stress). Since I don't have information confirming this specific methodology was used for this specific study, I cannot answer 'yes' with certainty.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15485683",
    "question": "Does aspirin inhibit ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells. To answer this, I need to know if there's scientific evidence showing that aspirin has this specific inhibitory effect on LOX-1 expression and metalloproteinase-1 that is induced by oxidized low-density lipoprotein (ox-LDL) in human coronary endothelial cells.\\n\\nBased on my knowledge of medical literature, aspirin (acetylsalicylic acid) is known to have anti-inflammatory and anti-platelet effects. There is research showing that aspirin can inhibit various inflammatory pathways in vascular cells. Specifically regarding LOX-1 (lectin-like oxidized LDL receptor-1) and metalloproteinase-1 (MMP-1), there are studies that have investigated aspirin's effects on these molecules in the context of ox-LDL stimulation.\\n\\nResearch has shown that aspirin can indeed inhibit ox-LDL-induced LOX-1 expression in vascular cells, including human coronary endothelial cells. Additionally, aspirin has been demonstrated to reduce MMP-1 expression that is upregulated by ox-LDL. These effects are part of aspirin's cardioprotective mechanisms.\\n\\nTherefore, based on the available scientific evidence, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11597556",
    "question": "Is p63 protein expression rare in prostate adenocarcinoma : implications for cancer diagnosis and carcinogenesis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether p63 protein expression is rare in prostate adenocarcinoma, and what implications this might have for cancer diagnosis and carcinogenesis. To answer this accurately, I need to consider what is known about p63 expression patterns in prostate tissue.\\n\\nIn normal prostate tissue, p63 is expressed in basal cells of the prostatic glands. However, in prostate adenocarcinoma, there is typically a loss of the basal cell layer. This means that prostate adenocarcinomas generally lack p63 expression, which is actually one of the diagnostic features used to distinguish adenocarcinoma from benign conditions.\\n\\nThe absence or rarity of p63 expression in prostate adenocarcinoma is well-established in the pathology literature and is used diagnostically - immunohistochemical staining for p63 is often used alongside other markers to confirm the diagnosis of prostate cancer. The loss of p63-positive basal cells is considered a hallmark of prostatic adenocarcinoma.\\n\\nSo yes, p63 protein expression is indeed rare in prostate adenocarcinoma.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22812704",
    "question": "Does continuing exposure to low-dose nonylphenol aggravate adenine-induced chronic renal dysfunction and role of rosuvastatin therapy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether continuing exposure to low-dose nonylphenol worsens chronic renal dysfunction that was induced by adenine, and whether rosuvastatin therapy plays a role in this context. This appears to be a specific scientific/medical research question, likely referencing a study or potential research question about these specific compounds and their interactions. The question is asking for a factual determination about whether nonylphenol aggravates adenine-induced renal problems and whether rosuvastatin affects this relationship. Without specific scientific evidence or research findings, I cannot provide a definitive yes or no answer to this scientific question.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24646507",
    "question": "Is propionyl-L-Carnitine Efficacious in Ulcerative Colitis Through its Action on the Immune Function and Microvasculature?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question asks about the efficacy of propionyl-L-carnitine in ulcerative colitis, specifically whether it works through mechanisms involving immune function and microvasculature. To answer this, I need to consider the scientific evidence about propionyl-L-carnitine's mechanisms of action in ulcerative colitis.\\n\\nPropionyl-L-carnitine is a naturally occurring derivative of L-carnitine that has been studied for various conditions. There is some research suggesting it may have beneficial effects on vascular function and energy metabolism.\\n\\nRegarding ulcerative colitis specifically, there have been some studies investigating propionyl-L-carnitine's potential benefits. Research has indicated that it may have anti-inflammatory properties and could improve microvascular function, which are relevant to ulcerative colitis pathophysiology.\\n\\nThere is evidence suggesting that propionyl-L-carnitine can modulate immune responses and improve microvascular blood flow, which could theoretically benefit ulcerative colitis patients. Some studies have demonstrated that it can reduce inflammatory markers and improve endothelial function.\\n\\nBased on the available scientific literature, there is evidence supporting that propionyl-L-carnitine may be efficacious in ulcerative colitis through mechanisms involving both immune function modulation and improvements in microvasculature.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25410892",
    "question": "Is genetic variation in Otos associated with cisplatin-induced ototoxicity?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if genetic variation in Otos is associated with cisplatin-induced ototoxicity. Cisplatin is a chemotherapy drug known to cause ototoxicity (hearing damage) as a side effect. Otos likely refers to a gene. To answer this question, I need to consider whether there is established evidence linking variations in the Otos gene specifically to differences in susceptibility to hearing damage from cisplatin treatment. Without specific research knowledge about this particular gene association, I cannot make a definitive claim. However, there are several genes that have been associated with cisplatin-induced ototoxicity, including TPMT, COMT, and others. I would need to verify if Otos is among the genes with established associations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26054589",
    "question": "Does human urine kininogenase attenuate balloon-induced intimal hyperplasia in rabbit carotid artery through transforming growth factor β1/Smad2/3 signaling pathway?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific mechanism of action for human urine kininogenase in preventing intimal hyperplasia (thickening of blood vessel walls) in rabbit carotid arteries. Specifically, it's asking if this effect occurs through the TGF-β1/Smad2/3 signaling pathway.\\n\\nTo answer this accurately, I would need to be familiar with specific research on human urine kininogenase and its effects on balloon-induced intimal hyperplasia in rabbit models, particularly studies examining the TGF-β1/Smad2/3 pathway.\\n\\nThere is research showing that kininogenase (also known as kallikrein) can have protective effects on vascular systems, but without specific knowledge of studies demonstrating this exact mechanism in this exact model, I cannot confidently say 'yes'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23363687",
    "question": "Is familial liability to psychosis associated with attenuated dopamine stress signaling in ventromedial prefrontal cortex?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific scientific finding related to psychosis. It's asking whether there is an association between familial liability to psychosis (i.e., having family members with psychosis, suggesting genetic risk) and attenuated (reduced) dopamine stress signaling specifically in the ventromedial prefrontal cortex (a specific brain region).\\n\\nTo answer this accurately, I would need to be familiar with research findings in this specific area of neuroscience and psychiatry. This is asking about a very specific neurobiological relationship. Based on my knowledge, there is research showing that relatives of individuals with psychosis show alterations in dopamine function, and the prefrontal cortex is involved in psychosis. However, I cannot confidently state whether the specific relationship between familial liability and attenuated dopamine stress signaling in the ventromedial prefrontal cortex specifically has been established in the scientific literature.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22793020",
    "question": "Is the correlation between the hyperacusis questionnaire and uncomfortable loudness levels dependent on emotional exhaustion?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the correlation between the hyperacusis questionnaire and uncomfortable loudness levels depends on emotional exhaustion. To answer this, I would need specific research or evidence showing that emotional exhaustion moderates or influences the relationship between hyperacusis questionnaire scores and uncomfortable loudness level measurements. Without being provided specific studies or data on this relationship, I cannot make a definitive claim about whether emotional exhaustion affects this correlation. There are studies on hyperacusis that examine psychological factors, but I don't have evidence specifically showing emotional exhaustion as a moderating variable for this particular correlation.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15286530",
    "question": "Does gender alter the high-density lipoprotein cholesterol response to cardiac rehabilitation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether gender affects how high-density lipoprotein (HDL) cholesterol levels change in response to cardiac rehabilitation programs. To answer this, I need to consider whether there is scientific evidence showing different HDL responses between men and women undergoing cardiac rehabilitation. Research has shown that men and women can have different baseline HDL levels and may respond differently to exercise interventions. Several studies have demonstrated that gender is a factor that can influence HDL changes during cardiac rehabilitation, with women often showing different patterns of HDL improvement compared to men. The physiological differences between genders, including hormonal factors, can affect lipid metabolism and response to exercise therapy.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16548856",
    "question": "Does post-operative unwashed shed blood transfusion modify the cellular immune response to surgery for total knee replacement?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether post-operative unwashed shed blood transfusion affects the cellular immune response in patients who have undergone total knee replacement surgery. To answer this, I would need to know if there is evidence showing that this specific type of transfusion (unwashed shed blood collected after surgery) has immunomodulatory effects on cellular immunity in the context of knee replacement. Without specific research data on this topic, I cannot give a definitive answer. However, based on general medical knowledge, blood transfusions can have immunomodulatory effects, and autologous blood (the patient's own blood) transfusions may have different immunological impacts compared to allogeneic (from donors) transfusions. The question is very specific about unwashed shed blood in the context of total knee replacement, which suggests there may be research on this particular topic.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "17617118",
    "question": "Does mild donor liver steatosis have no impact on hepatitis C virus fibrosis progression following liver transplantation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation. To answer this, I need to consider what is known about the relationship between donor liver steatosis and HCV fibrosis progression post-transplant.\\n\\nDonor liver steatosis (fatty liver) is a condition where fat accumulates in the liver cells. When such livers are used for transplantation in HCV patients, there is a concern about how this might affect disease progression.\\n\\nBased on medical literature, mild donor liver steatosis (typically <30% fat) has been shown to have some impact on HCV recurrence and fibrosis progression after liver transplantation. Studies have indicated that even mild steatosis can accelerate fibrosis progression in HCV-infected transplant recipients compared to non-steatotic donor livers.\\n\\nTherefore, it would be incorrect to say that mild donor liver steatosis has NO impact on HCV fibrosis progression.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25496212",
    "question": "Is reduced Myeloid-derived Suppressor Cells in the Blood and Endometrium Associated with Early Miscarriage?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if reduced Myeloid-derived Suppressor Cells (MDSCs) in the blood and endometrium are associated with early miscarriage. To answer this, I need to consider what the scientific literature says about this relationship.\\n\\nMDSCs are immunosuppressive cells that play a role in immune tolerance. During pregnancy, immune tolerance is crucial for preventing rejection of the fetus. If MDSCs are reduced, this could potentially lead to reduced immune tolerance.\\n\\nBased on current research, there is evidence suggesting that reduced levels of MDSCs in both blood and endometrial tissue are indeed associated with early pregnancy loss. Several studies have shown that women experiencing early miscarriage have significantly lower MDSC counts compared to women with normal pregnancies. The immunosuppressive function of MDSCs appears to be important for maintaining maternal-fetal tolerance, and their reduction may contribute to pregnancy complications including miscarriage.\\n\\nTherefore, the answer would be 'yes' - reduced MDSCs in blood and endometrium are associated with early miscarriage according to current scientific understanding.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24887106",
    "question": "Does exercise training during normobaric hypoxic confinement alter hormonal appetite regulation?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether exercise training during normobaric hypoxic confinement alters hormonal appetite regulation. Normobaric hypoxic confinement refers to a condition where individuals are exposed to reduced oxygen levels (hypoxia) but at normal atmospheric pressure (normobaric). This is often used to simulate altitude training for athletes.\\n\\nTo answer this question, I need to consider whether there is evidence that such conditions affect hormones that regulate appetite, such as leptin, ghrelin, peptide YY, glucagon-like peptide-1, and others.\\n\\nResearch has shown that hypoxic conditions alone can affect appetite-regulating hormones, typically reducing hunger. Exercise also independently affects these hormones. When combined, exercise training during hypoxic conditions has been shown to have effects on hormonal appetite regulation that differ from either condition alone.\\n\\nStudies have demonstrated that exercise in hypoxic conditions can lead to alterations in leptin and ghrelin levels, which are key hormones in appetite regulation. These changes can be different from those observed during exercise in normoxic (normal oxygen) conditions.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "21436391",
    "question": "Does single session of transcranial direct current stimulation transiently increase knee extensor force in patients with hemiparetic stroke?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether a single session of transcranial direct current stimulation (tDCS) transiently increases knee extensor force in patients with hemiparetic stroke. To answer this, I would need to know if there's scientific evidence showing that a single application of tDCS produces a temporary increase in knee extensor muscle strength specifically in stroke patients with hemiparesis. Without specific research data provided in the question, I cannot make a definitive claim about this specific effect. While tDCS has been studied for various motor improvements in stroke patients, the specific effect on knee extensor force after a single session would require evidence from clinical studies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19664212",
    "question": "Does treatment with ephrin B2 positively impact the abnormal metabolism of human osteoarthritic chondrocytes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if ephrin B2 treatment has a positive impact on the abnormal metabolism of human osteoarthritic chondrocytes. To answer this, I would need specific research evidence about ephrin B2's effects on osteoarthritic chondrocyte metabolism. Without specific studies or data provided in the question, I cannot determine whether ephrin B2 has been shown to positively impact the abnormal metabolism of human osteoarthritic chondrocytes. The question requires knowledge of specific research findings in this area of medical science.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11286825",
    "question": "Does elevated cyclooxygenase-2 expression correlate with diminished survival in carcinoma of the cervix treated with radiotherapy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if elevated cyclooxygenase-2 (COX-2) expression is correlated with diminished survival in cervical cancer patients who received radiotherapy treatment. To answer this, I need to consider what is known about COX-2 expression as a prognostic marker in cervical cancer specifically in the context of radiotherapy treatment outcomes. COX-2 is an enzyme involved in inflammation and has been studied as a potential biomarker in various cancers. In cervical cancer, several studies have investigated whether COX-2 overexpression is associated with worse outcomes after radiotherapy. Based on the medical literature, there is evidence suggesting that elevated COX-2 expression is indeed associated with poorer survival rates in cervical cancer patients treated with radiotherapy. Multiple studies have shown that patients with high COX-2 expression tend to have worse treatment responses to radiation and shorter overall survival compared to those with low COX-2 expression. This correlation has been documented in clinical research, suggesting that COX-2 may play a role in radioresistance mechanisms.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17980256",
    "question": "Does transplantation of human embryonic stem cell-derived cardiomyocytes improve myocardial performance in infarcted rat hearts?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether transplanting cardiomyocytes (heart muscle cells) that were derived from human embryonic stem cells improves heart function in rats that have had heart attacks (myocardial infarction). To answer this, I need to consider what scientific research has shown about this specific intervention.\\n\\nHuman embryonic stem cell-derived cardiomyocytes (hESC-CMs) have been studied in various animal models of heart disease. Research has shown that when these cells are transplanted into infarcted rat hearts, they can:\\n1. Survive in the host myocardium\\n2. Form grafts\\n3. Improve cardiac function\\n4. Reduce infarct size\\n5. Promote angiogenesis (formation of new blood vessels)\\n\\nMultiple studies have demonstrated that transplantation of hESC-CMs can improve left ventricular function, reduce remodeling, and enhance overall myocardial performance in rat models of myocardial infarction. The transplanted cells can integrate with host tissue and contribute to functional improvement.\\n\\nBased on the scientific literature, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23374641",
    "question": "Does phasic mesolimbic dopamine release track reward seeking during expression of Pavlovian-to-instrumental transfer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific neuroscientific finding related to dopamine release in the mesolimbic pathway during a particular behavioral paradigm called Pavlovian-to-instrumental transfer (PIT). PIT is a phenomenon where Pavlovian conditioned stimuli that predict rewards can enhance instrumental reward-seeking behaviors. The question specifically asks whether phasic (brief, transient) dopamine release in the mesolimbic pathway tracks (correlates with or follows) reward-seeking behavior during PIT expression. To answer this accurately, I would need to know the specific research findings on this topic. Based on neuroscience literature, there is evidence that dopamine release in the nucleus accumbens (part of the mesolimbic pathway) does indeed increase during PIT and correlates with the enhanced reward-seeking behavior. Studies using fast-scan cyclic voltammetry and other techniques have shown that cue-evoked dopamine release occurs during PIT and tracks the motivational value that drives the instrumental response. So the evidence supports that phasic mesolimbic dopamine release does track reward seeking during PIT expression.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15102670",
    "question": "Do polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about whether polymorphisms (genetic variations) in genes that are involved in homologous recombination repair (a DNA repair mechanism) can interact with each other to increase the risk of developing acute myeloid leukemia (AML, a type of blood cancer). To answer this, I need to consider the scientific evidence on this specific interaction. There is research suggesting that defects in DNA repair pathways, including homologous recombination repair, can contribute to leukemogenesis. Some studies have found associations between polymorphisms in DNA repair genes and AML risk. However, the question specifically asks about interaction effects between multiple polymorphisms in homologous recombination repair genes. Based on the scientific literature, there is evidence supporting that polymorphisms in DNA repair genes, including those involved in homologous recombination, can interact to modify AML risk. For example, studies have found that combinations of certain polymorphisms in DNA repair genes can have synergistic effects on cancer risk, including AML.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21493015",
    "question": "Is gleason pattern 5 the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation. Gleason pattern 5 is indeed associated with more aggressive prostate cancer and worse outcomes, but to determine if it's the 'greatest' risk factor, I need to consider other potential risk factors like PSA level, clinical stage, tumor volume, genomic markers, etc. Based on medical literature, while Gleason pattern 5 is a very significant risk factor, it's typically considered alongside other factors in risk stratification systems. Multiple studies have shown that the presence of Gleason pattern 5 is strongly associated with worse outcomes, but I cannot definitively state it is the single greatest risk factor without comparing the relative risk contributions of all potential factors.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20565889",
    "question": "Do the CaaX specificities of Arabidopsis protein prenyltransferases explain era1 and ggb phenotypes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether the CaaX specificities (the specific C-terminal motifs recognized by protein prenyltransferases) of Arabidopsis protein prenyltransferases can explain the phenotypes observed in era1 and ggb mutants. ERA1 encodes the β-subunit of farnesyltransferase (FTase), while GGB encodes the β-subunit of geranylgeranyltransferase-I (GGTase-I). These enzymes have different but overlapping substrate specificities for CaaX motifs.\\n\\nTo answer this question properly, I would need to know whether the phenotypic differences between era1 and ggb mutants can be directly attributed to the different CaaX specificities of these enzymes. This would require evidence that the specific proteins that fail to be prenylated in each mutant (due to the distinct CaaX specificities) are responsible for the observed phenotypes.\\n\\nBased on the literature, while CaaX specificities do determine which proteins are modified by each enzyme, the complete explanation of the phenotypes likely involves additional factors beyond just CaaX specificity, such as expression patterns, redundancy, and downstream signaling pathways. The phenotypes are complex and probably cannot be explained solely by CaaX specificities.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24645968",
    "question": "Does daidzein stimulate collagen synthesis by activating the TGF-β/smad signal pathway?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"I need to analyze whether daidzein stimulates collagen synthesis through the TGF-β/smad signaling pathway. Daidzein is an isoflavone found in soybeans and other legumes. The TGF-β/smad pathway is a well-known signaling pathway involved in collagen synthesis. Let me consider what is known about daidzein's mechanisms of action.\\n\\nBased on scientific literature, daidzein has been shown to have effects on various cellular pathways. There is research indicating that daidzein can indeed stimulate collagen synthesis in certain contexts. Some studies have specifically demonstrated that daidzein activates the TGF-β/smad signaling pathway, which is a key regulatory pathway for collagen production. This activation leads to increased expression of collagen genes and enhanced collagen synthesis in fibroblasts and other cell types.\\n\\nFor example, research has shown that daidzein treatment increases phosphorylation of Smad2/3 proteins, which are downstream effectors of TGF-β signaling, and this activation correlates with increased collagen production. The evidence supports that daidzein's effects on collagen synthesis are at least partially mediated through the TGF-β/smad pathway.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24567814",
    "question": "Does ketamine reduce the induced spinal p38 MAPK and pro-inflammatory cytokines in a neuropathic rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if ketamine reduces induced spinal p38 MAPK and pro-inflammatory cytokines in neuropathic rats. To answer this, I need to consider what is known about ketamine's effects in neuropathic pain models.\\n\\nKetamine is an NMDA receptor antagonist that has been studied for its analgesic and anti-inflammatory properties. Research has shown that ketamine can inhibit the activation of p38 MAPK (mitogen-activated protein kinase) signaling pathways in the spinal cord of neuropathic pain models. The p38 MAPK pathway is involved in the production of pro-inflammatory cytokines.\\n\\nStudies have demonstrated that ketamine administration can reduce levels of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 in the spinal cord of rats with neuropathic pain. This anti-inflammatory effect is part of ketamine's mechanism in alleviating neuropathic pain.\\n\\nBased on the scientific literature, ketamine does reduce both spinal p38 MAPK activation and the levels of pro-inflammatory cytokines in neuropathic rat models.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24373781",
    "question": "Is psoriasis independently associated with nonalcoholic fatty liver disease in patients 55 years old or older : Results from a population-based study?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether psoriasis is independently associated with nonalcoholic fatty liver disease (NAFLD) in patients 55 years old or older, based on results from a population-based study. This is asking about a specific scientific finding from a specific study. Without having access to the actual study being referenced, I cannot determine whether this association was found or not. The question appears to be the title or a summary of a research paper, but I don't have information about the results of this particular study.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24140250",
    "question": "Does activation of cyclic AMP/PKA pathway inhibit bladder cancer cell invasion by targeting MAP4-dependent microtubule dynamics?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific molecular mechanism in bladder cancer. Let me analyze what's being asked:\\n\\n1. Does activation of cyclic AMP/PKA pathway inhibit bladder cancer cell invasion?\\n2. If so, does it do this specifically by targeting MAP4-dependent microtubule dynamics?\\n\\nThis is a very specific scientific question about cancer biology and molecular mechanisms. To answer this accurately, I would need to be familiar with research showing that:\\n- cAMP/PKA pathway activation inhibits bladder cancer cell invasion\\n- This inhibition works through MAP4 (microtubule-associated protein 4)\\n- The mechanism involves changes to microtubule dynamics\\n\\nThere is research showing that cAMP/PKA signaling can inhibit cancer cell migration and invasion in various cancer types, and some studies have linked MAP4 to microtubule dynamics in cancer contexts. However, without specific knowledge of studies demonstrating this exact mechanism in bladder cancer, I cannot confidently answer 'yes'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24849868",
    "question": "Is tissue near infra red spectroscopy change correlated with patients ' outcome in elective cardiac surgery?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if tissue near infrared spectroscopy (NIRS) changes are correlated with patient outcomes in elective cardiac surgery. To answer this, I would need to know if there is established evidence in medical literature showing a correlation between NIRS measurements and clinical outcomes for patients undergoing planned cardiac surgical procedures. Without specific studies or data provided in the question, I cannot make a definitive determination about whether such a correlation exists. The question is asking for a factual relationship in medical science that would require evidence-based research to confirm.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "16506918",
    "question": "Does association between limb conformation and retention of sow through the second parity?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether there is an association between limb conformation (the structure or form of a sow's limbs) and the retention of sows through their second parity (meaning whether they are kept in the breeding herd for a second litter). To answer this question accurately, I would need specific research or data that establishes such a correlation. Without being provided specific studies or evidence in the question, I cannot definitively say whether such an association exists. The question is also grammatically incomplete, which makes it harder to interpret precisely what is being asked. Based on the limited information, I cannot provide a clear yes or no answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21846671",
    "question": "Is long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count influenced by UGT2B7 and CYP2B6 genotypes among HIV patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients. This is asking about a specific pharmacogenetic relationship in HIV treatment. To answer this, I would need to know if there is evidence that these specific genetic variants (UGT2B7 and CYP2B6) affect how efavirenz's autoinduction impacts drug levels and CD4 counts over time. CYP2B6 is known to be involved in efavirenz metabolism, and genetic variants can affect efavirenz plasma concentrations. UGT2B7 is also involved in drug metabolism. Based on existing pharmacogenetic research, there is evidence that CYP2B6 genotypes influence efavirenz plasma concentrations and potentially its long-term effects. So the answer appears to be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18497687",
    "question": "Do extracellular matrix protein-coated scaffolds promote the reversal of diabetes after extrahepatic islet transplantation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether extracellular matrix protein-coated scaffolds promote the reversal of diabetes after extrahepatic islet transplantation. To answer this, I need to consider what scientific evidence exists about this specific approach to diabetes treatment.\\n\\nExtracellular matrix (ECM) proteins are known to provide structural and biochemical support to cells, and in tissue engineering, coating scaffolds with ECM proteins can enhance cell attachment, survival, and function. In islet transplantation, which is a potential treatment for type 1 diabetes, the survival and function of transplanted islets are critical for reversing diabetes.\\n\\nThere is research showing that ECM protein-coated scaffolds can improve islet survival and function after transplantation. Studies have demonstrated that scaffolds coated with ECM proteins like collagen, laminin, or fibronectin can enhance islet engraftment, vascularization, and insulin secretion in extrahepatic sites (sites outside the liver, which is the traditional site for islet transplantation).\\n\\nSeveral studies have reported successful reversal of diabetes in animal models using ECM protein-coated scaffolds for extrahepatic islet transplantation. These scaffolds have been shown to create a more favorable microenvironment for islets, leading to better glycemic control and diabetes reversal.\\n\\nBased on the scientific literature, there is evidence supporting that ECM protein-coated scaffolds can promote the reversal of diabetes after extrahepatic islet transplantation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26450623",
    "question": "Is bovine herpesvirus 4 DNA detected in free-ranging domestic cats from California , Colorado or Florida?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if bovine herpesvirus 4 DNA has been detected in free-ranging domestic cats from California, Colorado, or Florida. To answer this, I need to consider whether there is evidence of this specific virus (bovine herpesvirus 4) being found in domestic cats in these specific U.S. states. Bovine herpesvirus 4 primarily affects cattle, as the name suggests. While viruses can sometimes cross species barriers, I don't have specific information about bovine herpesvirus 4 being detected in domestic cats in California, Colorado, or Florida. Without specific evidence confirming such detection, I should answer no.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "24005232",
    "question": "Is absence of FLICE-inhibitory protein a novel independent prognostic marker for very short survival in pancreatic ductal adenocarcinoma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the absence of FLICE-inhibitory protein is a novel independent prognostic marker for very short survival in pancreatic ductal adenocarcinoma. To answer this, I would need to know if research has established that the absence of FLICE-inhibitory protein independently predicts very short survival in pancreatic ductal adenocarcinoma patients, and whether this finding is novel. Without specific research papers or evidence provided in the question, I cannot determine if this is an established prognostic marker. The question appears to be asking about a specific research finding in oncology that would require reference to medical literature to answer definitively.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25099550",
    "question": "Does repetitive electric brain stimulation reduce food intake in humans?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if repetitive electric brain stimulation reduces food intake in humans. To answer this, I need to consider the scientific evidence on whether applying repetitive electrical stimulation to the brain has been shown to decrease how much food people consume.\\n\\nBased on my knowledge, there is some research showing that certain forms of brain stimulation, such as transcranial direct current stimulation (tDCS) or repetitive transcranial magnetic stimulation (rTMS) targeting specific brain regions (particularly the dorsolateral prefrontal cortex) can reduce food cravings and food intake in some experimental settings. Several studies have demonstrated modest effects on reducing food consumption or cravings when these techniques are applied.\\n\\nHowever, the evidence is still developing, with varying results across different studies, and the effects may be temporary or context-dependent. The clinical significance and long-term efficacy of these techniques for sustained reduction in food intake are still being investigated.\\n\\nStill, there is sufficient evidence from controlled human studies to indicate that repetitive electric brain stimulation can reduce food intake in humans, at least in experimental settings.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16713952",
    "question": "Does functional genomics identify TOR-regulated genes that control growth and division?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question. Functional genomics is a field that focuses on understanding the functions of genes and other parts of the genome, often using high-throughput methods to study gene expression, protein interactions, and other molecular activities. TOR (Target of Rapamycin) is a conserved protein kinase that regulates cell growth, proliferation, and metabolism in response to nutrients, growth factors, and cellular energy status. The question asks whether functional genomics approaches are used to identify genes that are regulated by the TOR pathway and that control growth and division. Based on the scientific literature, functional genomics approaches including transcriptomics, proteomics, and genetic screens have indeed been used to identify TOR-regulated genes involved in growth control. For example, researchers have used microarray analysis, RNA-seq, and other genomic approaches to identify genes whose expression changes in response to TOR inhibition or activation. These studies have identified numerous genes involved in ribosome biogenesis, protein synthesis, nutrient transport, autophagy, and cell cycle progression that are regulated by TOR and contribute to growth and division control.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27131187",
    "question": "Do multiple gait parameters derived from iPod accelerometry predict age-related gait changes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether multiple gait parameters that are derived from iPod accelerometry can predict age-related changes in gait. To answer this, I need to consider whether there is evidence that measurements from iPod accelerometers (which can measure movement and acceleration) can be used to predict how a person's walking pattern changes as they age. Without specific research studies cited in the question, I need to determine if this is a validated approach in gait analysis. Based on my knowledge, while accelerometry in general (from various devices) has been used to analyze gait parameters, and some studies have examined age-related gait changes using accelerometry, I don't have specific evidence that multiple parameters from iPod accelerometry specifically have been validated to predict age-related gait changes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "14673956",
    "question": "Is proliferation of prostate cancer cells and activity of neutral endopeptidase regulated by bombesin and IL-1beta with IL-1beta acting as a modulator of cellular differentiation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if proliferation of prostate cancer cells and activity of neutral endopeptidase are regulated by bombesin and IL-1beta, with IL-1beta specifically acting as a modulator of cellular differentiation. To answer this, I need to determine if scientific evidence supports these specific regulatory relationships. \\n\\nBased on scientific literature, bombesin is known to stimulate growth of prostate cancer cells, and neutral endopeptidase (NEP) is involved in inactivating neuropeptides like bombesin. IL-1beta is a pro-inflammatory cytokine that can affect various cellular processes. \\n\\nWhile both bombesin and IL-1beta may individually affect prostate cancer cells and NEP activity, the specific claim that IL-1beta acts as a modulator of cellular differentiation in this context requires specific evidence. The question contains a complex, specific scientific claim that would need to be supported by research studies showing this particular relationship. Without access to specific studies demonstrating this exact relationship, I cannot confidently confirm this specific scientific claim.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20949044",
    "question": "Is let-7 microRNA family selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the let-7 microRNA family is selectively secreted into the extracellular environment via exosomes specifically in a metastatic gastric cancer cell line. To answer this, I need to consider whether there is evidence in the scientific literature for this specific selective secretion mechanism of let-7 microRNAs in the context of metastatic gastric cancer.\\n\\nThere have been studies showing that microRNAs, including members of the let-7 family, can be selectively packaged into exosomes in various cancer types. In particular, some research has demonstrated that let-7 miRNAs can be selectively sorted into exosomes in certain cancer cell lines, including gastric cancer. For example, a study by Ohshima et al. (2010) showed that let-7 microRNAs were selectively secreted into exosomes in a metastatic gastric cancer cell line (AZ-P7a) compared to less metastatic counterparts.\\n\\nBased on this published evidence, the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27664902",
    "question": "Does host sphingosine kinase 1 worsen pancreatic cancer peritoneal carcinomatosis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if host sphingosine kinase 1 worsens pancreatic cancer peritoneal carcinomatosis. To answer this, I need to consider whether there is evidence that sphingosine kinase 1 (SK1) in the host (as opposed to in the tumor cells) contributes to the progression or severity of peritoneal carcinomatosis in pancreatic cancer.\\n\\nPeritoneal carcinomatosis refers to the spread of cancer cells to the peritoneum (the membrane lining the abdominal cavity), which is a serious complication in pancreatic cancer.\\n\\nSphingosine kinase 1 is an enzyme that catalyzes the phosphorylation of sphingosine to form sphingosine-1-phosphate (S1P), which is involved in various cellular processes including proliferation, migration, and angiogenesis.\\n\\nThere is research suggesting that SK1 and S1P signaling can promote cancer progression in various cancers including pancreatic cancer. However, the specific question asks about 'host' SK1 (meaning SK1 in non-cancer cells of the patient) and its effect specifically on peritoneal carcinomatosis.\\n\\nBased on my knowledge, there are studies showing that SK1 in the tumor microenvironment can contribute to cancer progression, but I don't have specific information about host SK1 worsening pancreatic cancer peritoneal carcinomatosis specifically. Without clear evidence for this specific relationship, I should answer 'no'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25933295",
    "question": "Does hGF Gene Modification in Mesenchymal Stem Cells reduce Radiation-Induced Intestinal Injury by Modulating Immunity?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if hGF (hepatocyte Growth Factor) gene modification in Mesenchymal Stem Cells reduces radiation-induced intestinal injury specifically through modulating immunity. To answer this accurately, I would need to know if research has demonstrated that this specific mechanism (immune modulation) is how hGF-modified MSCs protect against radiation intestinal damage. While MSCs in general have immunomodulatory properties, and hGF has tissue-protective effects, I need to determine if studies have specifically shown that immune modulation is the mechanism for intestinal radioprotection in this specific case.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21467131",
    "question": "Is high urinary excretion of kidney injury molecule-1 an independent predictor of end-stage renal disease in patients with IgA nephropathy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if high urinary excretion of kidney injury molecule-1 (KIM-1) is an independent predictor of end-stage renal disease (ESRD) in patients with IgA nephropathy. To answer this, I would need to know if research studies have demonstrated that KIM-1 levels in urine can independently predict progression to ESRD specifically in IgA nephropathy patients, after controlling for other known risk factors. While KIM-1 is a biomarker of kidney tubular injury that has been studied in various kidney diseases, I don't have specific evidence showing it's been validated as an independent predictor specifically for ESRD in IgA nephropathy. Without clear evidence from clinical studies establishing this independent predictive relationship, I cannot confidently answer 'yes'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20717902",
    "question": "Do statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if statins reduce androgen sensitivity and cell proliferation by decreasing androgen receptor protein in prostate cancer cells. I need to consider if there's scientific evidence supporting this specific mechanism of action for statins in prostate cancer.\\n\\nStatins are primarily HMG-CoA reductase inhibitors used to lower cholesterol. Some research has investigated their potential anti-cancer effects, including in prostate cancer. There are studies suggesting statins may have anti-proliferative effects on prostate cancer cells and may influence androgen signaling pathways.\\n\\nHowever, the specific mechanism mentioned in the question - that statins reduce androgen sensitivity and cell proliferation specifically by decreasing the androgen receptor protein - is a precise molecular claim. While statins may affect prostate cancer cells through various pathways, including potentially influencing androgen signaling, the specific mechanism of decreasing androgen receptor protein levels as the primary way they reduce androgen sensitivity is not universally established as their main mechanism of action in prostate cancer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26526883",
    "question": "Does apparent diffusion coefficient measurement covering complete tumor area better predict rectal cancer response to neoadjuvant chemoradiotherapy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether measuring the apparent diffusion coefficient (ADC) across the entire tumor area provides better prediction of how rectal cancer will respond to neoadjuvant chemoradiotherapy compared to other measurement approaches. To answer this, I would need to know if research studies have demonstrated that whole-tumor ADC measurements are superior to partial measurements or other imaging biomarkers for predicting treatment response. Without specific research evidence cited in the question, I need to consider what is generally known in medical imaging for rectal cancer. Complete tumor ADC measurements would theoretically capture heterogeneity better than sampling just portions of the tumor, which could provide more comprehensive information about tumor characteristics and potential response to therapy. However, I cannot make a definitive claim without specific evidence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17701297",
    "question": "Is 3-D Nanofibrous electrospun multilayered construct an alternative ECM mimicking scaffold?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if a 3-D Nanofibrous electrospun multilayered construct can serve as an alternative scaffold that mimics the extracellular matrix (ECM). To answer this, I need to consider what I know about electrospun nanofibrous scaffolds and ECM mimicry.\\n\\nElectrospun nanofibrous scaffolds are known for their ability to mimic the fibrous structure of native ECM due to their high porosity, high surface-to-volume ratio, and fiber dimensions that can be similar to ECM components. The 3-D multilayered aspect would further enhance the structural similarity to natural ECM, which is three-dimensional and has multiple layers with different compositions and orientations.\\n\\nThese constructs are widely researched in tissue engineering specifically because they can provide physical and topographical cues similar to native ECM, supporting cell adhesion, proliferation, and differentiation. The nanofibrous nature allows for control over fiber diameter, orientation, and porosity, which are critical parameters for mimicking different types of ECM.\\n\\nBased on the established literature in tissue engineering and biomaterials, 3-D nanofibrous electrospun multilayered constructs are indeed designed and used as ECM-mimicking scaffolds.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15295338",
    "question": "Does marginal maternal vitamin B12 status increase the risk of offspring with spina bifida?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between maternal vitamin B12 status and the risk of spina bifida in offspring. Spina bifida is a neural tube defect that occurs during fetal development. \\n\\nVitamin B12 (cobalamin) is important in folate metabolism and DNA synthesis. Research has shown that low or marginal maternal vitamin B12 status is associated with increased risk of neural tube defects, including spina bifida. This is because vitamin B12 deficiency can lead to functional folate deficiency, even when folate intake is adequate, affecting neural tube closure during early embryonic development.\\n\\nStudies have demonstrated that women with marginal or deficient vitamin B12 levels have a higher risk of having children with neural tube defects compared to women with normal B12 levels. This relationship exists independently of folate status, though the two nutrients work together in important metabolic pathways.\\n\\nBased on the scientific evidence, I can answer yes to this question.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27448153",
    "question": "Does structural and Functional Brain correlate of Cognitive Impairment in Euthymic Patients with Bipolar Disorder?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether there are structural and functional brain correlates (i.e., observable brain changes or differences) associated with cognitive impairment in euthymic patients with bipolar disorder. Euthymic refers to a stable mood state in bipolar disorder, neither manic nor depressed.\\n\\nResearch has indeed shown that even during euthymic states, bipolar disorder patients can experience cognitive impairments, and these impairments have been associated with observable differences in brain structure and function compared to healthy controls. Studies have found alterations in prefrontal cortex, hippocampus, amygdala, and other regions, as well as changes in functional connectivity between brain regions.\\n\\nSo yes, there are structural and functional brain correlates of cognitive impairment in euthymic patients with bipolar disorder.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25147937",
    "question": "Does selenite enhance immune response against Pseudomonas aeruginosa PA14 via SKN-1 in Caenorhabditis elegans?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific scientific relationship: whether selenite enhances immune response against a specific bacterial strain (Pseudomonas aeruginosa PA14) via a specific pathway (SKN-1) in a specific organism (C. elegans, a nematode worm). To answer this accurately, I would need to know if there is scientific evidence demonstrating this specific relationship. Without access to the latest scientific literature, I cannot definitively confirm whether this specific mechanism has been established. The question contains several specific elements that would require precise scientific validation: 1) selenite's effect on immune response in C. elegans, 2) specifically against P. aeruginosa PA14, and 3) mediation through the SKN-1 pathway. Without specific knowledge of studies showing this relationship, I cannot confidently answer 'yes'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19167522",
    "question": "Are not all side effects associated with tricyclic antidepressant therapy true side effects?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether all side effects associated with tricyclic antidepressant (TCA) therapy are true side effects. This requires understanding the distinction between true side effects and other effects that might be attributed to TCAs but are not directly caused by them. In pharmacology, 'true side effects' typically refer to unwanted effects that are directly caused by the medication's mechanism of action. Some effects attributed to medications may actually be symptoms of the underlying condition, nocebo effects, or coincidental occurrences. With TCAs specifically, some reported 'side effects' might be symptoms of depression itself (like sleep disturbances or fatigue) or might be misattributed to the medication. So not all reported or associated side effects would be considered 'true' pharmacological side effects of the medication.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25908253",
    "question": "Does meloxicam prevent COX-2-mediated post-surgical inflammation but not pain following laparotomy in mice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if meloxicam prevents COX-2-mediated post-surgical inflammation but not pain following laparotomy in mice. Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that preferentially inhibits COX-2 over COX-1. It is used to treat pain and inflammation. In general, NSAIDs like meloxicam work by inhibiting cyclooxygenase enzymes (COX), which are involved in the production of prostaglandins that mediate inflammation and pain. Meloxicam's mechanism of action involves inhibiting COX-2, which would reduce inflammation. However, by the same mechanism, it should also reduce pain, as prostaglandins are mediators of both inflammation and pain. So it would be unusual for meloxicam to prevent inflammation but not pain. Without specific research showing this selective effect in mice following laparotomy, I cannot confirm this claim.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18697757",
    "question": "Does a novel mechanism by which silica defend grasses against herbivory?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if silica provides a defense mechanism for grasses against herbivory. This is actually a well-established scientific fact. Grasses accumulate silica in their tissues, which creates a physical defense by making the plant tissues more abrasive and difficult to digest for herbivores. This silica accumulation reduces palatability and digestibility of grass tissues, effectively deterring herbivores. So yes, silica does defend grasses against herbivory through a mechanical defense mechanism.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17986107",
    "question": "Does calcitonin gene-related peptide mediate acid-induced lung injury in mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether calcitonin gene-related peptide (CGRP) mediates acid-induced lung injury in mice. To answer this, I need to consider what is known about CGRP's role in lung injury mechanisms, particularly in the context of acid-induced damage.\\n\\nBased on scientific literature, CGRP is a neuropeptide that can have both pro-inflammatory and anti-inflammatory effects depending on the context. In some models of lung injury, CGRP has been shown to have protective effects, while in others it may contribute to inflammation.\\n\\nSpecifically regarding acid-induced lung injury in mice, research has shown that CGRP does play a mediating role. Studies have demonstrated that CGRP is released following acid aspiration and contributes to the inflammatory cascade and subsequent lung damage. Experiments with CGRP receptor antagonists or in CGRP-knockout mice have shown reduced lung injury following acid exposure, supporting its role as a mediator in this specific type of injury.\\n\\nTherefore, the evidence supports that CGRP does mediate acid-induced lung injury in mice.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15337874",
    "question": "Is anti-platelet effect of aspirin substantially reduced after administration of heparin during carotid endarterectomy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether the anti-platelet effect of aspirin is substantially reduced after heparin administration during carotid endarterectomy. To answer this, I need to consider the pharmacological interaction between aspirin and heparin. Aspirin works by irreversibly inhibiting cyclooxygenase enzymes, preventing platelet aggregation. Heparin is an anticoagulant that works through a different mechanism - it potentiates antithrombin III activity, inhibiting thrombin and factor Xa in the coagulation cascade. Based on their different mechanisms of action, heparin administration should not directly interfere with aspirin's anti-platelet effects. While both drugs affect hemostasis, they do so through different pathways. Scientific literature does not support a substantial reduction in aspirin's anti-platelet effect due to heparin administration during carotid endarterectomy.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16631142",
    "question": "Does chronic ethanol drinking reduce native T-type calcium current in the thalamus of nonhuman primates?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether chronic ethanol drinking reduces native T-type calcium current in the thalamus of nonhuman primates. To answer this, I need to consider whether there is established scientific evidence showing this specific effect of chronic ethanol consumption on T-type calcium currents specifically in the thalamus of nonhuman primates. This is a very specific neurophysiological question about the effects of alcohol on a particular ion channel in a specific brain region in nonhuman primates. Without specific research studies demonstrating this effect, I cannot confirm this relationship. I don't have evidence of studies showing that chronic ethanol drinking reduces native T-type calcium current in the thalamus of nonhuman primates specifically.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27439335",
    "question": "Does exosome-mediated Transfer of αvβ3 Integrin from Tumorigenic to Nontumorigenic Cells promote a Migratory Phenotype?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific biological mechanism: whether exosome-mediated transfer of αvβ3 integrin from tumorigenic (cancer) cells to nontumorigenic (normal) cells promotes a migratory phenotype in the recipient cells.\\n\\nExosomes are small extracellular vesicles that can transfer proteins, lipids, and nucleic acids between cells. Integrins, including αvβ3, are cell adhesion molecules that play important roles in cell migration.\\n\\nBased on scientific literature, it has been shown that cancer cells can transfer integrins, including αvβ3, via exosomes to recipient cells. When nontumorigenic cells receive αvβ3 integrin through exosomes from tumorigenic cells, this transfer has been documented to enhance their migratory capabilities - essentially giving normal cells more cancer-like mobility properties.\\n\\nThis phenomenon has been observed in studies examining how cancer cells can influence their microenvironment and potentially promote metastasis by altering the behavior of surrounding normal cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19474272",
    "question": "Is the association between parathyroid hormone and mortality in dialysis patients modified by wasting?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether the relationship between parathyroid hormone (PTH) levels and mortality risk in dialysis patients is affected or modified by the presence of wasting syndrome (protein-energy wasting or malnutrition). \\n\\nTo answer this properly, I would need to know if research has demonstrated that the impact of PTH levels on mortality differs between dialysis patients with wasting compared to those without wasting. This would be considered an interaction or effect modification in epidemiological terms.\\n\\nSeveral studies have indeed suggested that the association between PTH and mortality in dialysis patients follows a U-shaped curve, with both very low and very high levels associated with increased mortality. Some research has indicated that this relationship can be modified by nutritional status, with malnutrition/wasting potentially altering how PTH levels affect survival outcomes.\\n\\nFor example, some studies have shown that in patients with signs of wasting or malnutrition, the harmful effects of high PTH may be amplified, or the optimal PTH range may be different compared to well-nourished patients. This suggests that wasting does modify the PTH-mortality association.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24829967",
    "question": "Is heart rate variability severely impaired among type 2 diabetic patients with hypertension?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between heart rate variability (HRV) and type 2 diabetic patients who also have hypertension. HRV is a physiological measure of the variation in time between heartbeats, and reduced HRV is often associated with various cardiovascular and metabolic conditions. \\n\\nBased on medical literature, both type 2 diabetes and hypertension independently are associated with reduced heart rate variability. When these conditions co-exist, there tends to be a more pronounced impairment in HRV. Multiple studies have shown that patients with both type 2 diabetes and hypertension exhibit significantly lower HRV parameters compared to healthy controls and even compared to patients with only one of these conditions.\\n\\nThe term 'severely impaired' suggests a significant, clinically meaningful reduction. The research evidence does support that there is indeed a severe impairment of HRV in this patient population, with studies showing substantial reductions across various HRV parameters in diabetic hypertensive patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15544692",
    "question": "Is restoration of CD4 T-cell responses to cytomegalovirus short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether the restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients who are responding to highly active antiretroviral therapy (HAART). To answer this, I need to determine if the research indicates that such restoration is temporary or short-term rather than sustained over time. Without specific research data provided in the question, I cannot make a definitive determination. However, based on the phrasing of the question, it seems to be suggesting that the restoration might be short-lived. Since I don't have concrete evidence either way from the question itself, I should be cautious in my answer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10801255",
    "question": "Is growth in use of statins after trials targeted to most appropriate patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether the growth in the use of statins (cholesterol-lowering medications) after clinical trials has been appropriately targeted to the patients who would benefit most from them. To answer this, I would need specific data about statin prescription patterns following major clinical trials, and information about whether these prescriptions align with evidence-based guidelines for appropriate patient selection. Without this specific information, I cannot make a definitive determination. The question implies there has been growth in statin use after trials, but doesn't provide evidence about the appropriateness of patient targeting. Research suggests that both underuse in high-risk patients and overuse in low-risk patients can occur with statins, so the answer is not straightforward without specific data.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "27792966",
    "question": "Is a genetic variant in miRNA binding site of glutamate receptor 4 , metabotropic ( GRM4 ) associated with increased risk of major depressive disorder?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about a specific genetic variant in the miRNA binding site of GRM4 (glutamate receptor 4, metabotropic) and whether it's associated with increased risk of major depressive disorder (MDD). To answer this accurately, I would need to know if there is established scientific evidence showing this association. Without specific studies or references provided in the question, I need to consider what's generally known about GRM4 and depression. While glutamate receptors have been implicated in mood disorders, and some genetic variants in various neurotransmitter systems have been associated with depression risk, I don't have specific information about a validated association between a miRNA binding site variant in GRM4 and major depressive disorder. Without clear evidence supporting this specific association, I should answer 'no'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17880717",
    "question": "Does association with the origin recognition complex suggest a novel role for histone acetyltransferase Hat1p/Hat2p?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the association of histone acetyltransferase Hat1p/Hat2p with the origin recognition complex suggests a novel role for Hat1p/Hat2p. To answer this, I need to consider whether this association represents a new or previously unknown function for this histone acetyltransferase complex.\\n\\nHat1p/Hat2p is known to be a type B histone acetyltransferase that typically acetylates newly synthesized histone H4 before chromatin assembly. If the question is suggesting that Hat1p/Hat2p associates with the origin recognition complex (ORC), which is involved in DNA replication initiation, this could indeed suggest a novel role beyond its canonical histone modification function.\\n\\nThe association with ORC might implicate Hat1p/Hat2p in processes like DNA replication, cell cycle regulation, or specialized chromatin assembly at replication origins - functions that would extend beyond its traditional role in histone acetylation.\\n\\nSince this association would connect Hat1p/Hat2p to DNA replication machinery and potentially assign it new functional significance, the answer would be 'yes'.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15585610",
    "question": "Does the radioisotope contribute significantly to the activity of radioimmunotherapy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether radioisotopes contribute significantly to the activity of radioimmunotherapy. Radioimmunotherapy (RIT) is a targeted therapy that combines the specificity of monoclonal antibodies with the cytotoxic effects of radiation. The radioisotope is the component that delivers the radiation to the target cells. Without the radioisotope, there would be no radiation delivered to the target cells, which is the primary therapeutic mechanism of radioimmunotherapy. The radioisotope (such as iodine-131, yttrium-90, or lutetium-177) emits the radiation that damages the DNA of the target cells, leading to cell death. Therefore, the radioisotope is absolutely essential to the activity and efficacy of radioimmunotherapy.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19398455",
    "question": "Does lysostaphin eradicate established Staphylococcus aureus biofilms in jugular vein catheterized mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice. To answer this, I need to know if there is scientific evidence showing that lysostaphin effectively eliminates S. aureus biofilms in this specific mouse model with jugular vein catheters. Without specific knowledge of studies testing lysostaphin in this exact model, I cannot provide a definitive answer. However, lysostaphin is known to have anti-biofilm activity against S. aureus in various models, so it's plausible but not certain without specific evidence for this particular model.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21135555",
    "question": "Are serum brain-derived neurotrophic factor levels specifically associated with memory performance among Alzheimer 's disease cases?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question asks about a specific relationship between serum brain-derived neurotrophic factor (BDNF) levels and memory performance, specifically in Alzheimer's disease patients. To answer this, I would need to know if research has established a specific association between serum BDNF levels and memory performance in AD cases. \\n\\nBDNF is a protein that supports the survival of existing neurons and encourages growth of new neurons and synapses. It's known to be important for learning and memory. Some studies have examined BDNF levels in AD patients, but whether there is a specific association with memory performance (as opposed to other cognitive domains or general disease progression) requires specific evidence.\\n\\nWithout citing specific research that demonstrates this specific relationship, I cannot confidently say 'yes'. The question asks for a specific association, not just a general relationship between BDNF and Alzheimer's disease. While BDNF is involved in memory processes and is studied in AD, confirming a specific association with memory performance (rather than other cognitive domains) in AD cases would require specific research evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26490796",
    "question": "Does epigenetic screening of salivary gland mucoepidermoid carcinoma identify hypomethylation of CLIC3 as a common alteration?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if epigenetic screening of salivary gland mucoepidermoid carcinoma identifies hypomethylation of CLIC3 as a common alteration. To answer this, I would need specific information from scientific literature about epigenetic studies on this particular type of carcinoma and whether they consistently show hypomethylation of the CLIC3 gene. Without having access to this specific scientific information, I cannot provide a definitive answer based on established research findings.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19499314",
    "question": "Does high-dose dexamethasone inhibit BAFF expression in patients with immune thrombocytopenia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if high-dose dexamethasone inhibits BAFF (B-cell activating factor) expression in patients with immune thrombocytopenia (ITP). To answer this, I need to consider what is known about dexamethasone's mechanism of action in ITP treatment.\\n\\nDexamethasone is a corticosteroid commonly used to treat ITP. Research has shown that high-dose dexamethasone can indeed inhibit BAFF expression in ITP patients. BAFF is a cytokine that plays a role in B-cell survival and maturation, and elevated BAFF levels have been associated with autoimmune disorders including ITP. Studies have demonstrated that successful treatment of ITP with high-dose dexamethasone is associated with reduced BAFF levels, suggesting that part of dexamethasone's therapeutic effect in ITP involves suppression of BAFF expression.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23370914",
    "question": "Does pathogenic bacteria colonizing the airways in asymptomatic neonates stimulate topical inflammatory mediator release?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether pathogenic bacteria that colonize the airways in asymptomatic neonates (newborns without symptoms) stimulate the release of inflammatory mediators locally (topically). To answer this, I need to consider what research shows about the relationship between bacterial colonization and inflammatory responses in asymptomatic neonates.\\n\\nResearch has shown that pathogenic bacteria colonizing the airways of neonates, even when they're asymptomatic, can trigger immune responses including the release of inflammatory mediators. This is part of the normal immune surveillance and response system. When pathogenic bacteria are present, even without causing clinical symptoms, the body's immune cells recognize them and release various inflammatory mediators locally as part of the innate immune response.\\n\\nStudies have demonstrated elevated levels of inflammatory cytokines and other mediators in the airways of colonized neonates compared to non-colonized ones, even in the absence of clinical symptoms. This inflammatory response is typically controlled and doesn't lead to clinical disease in asymptomatic carriers, but the mediator release does occur.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27435398",
    "question": "Does the Efficacy of Oncolytic Adenovirus be Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the efficacy of oncolytic adenovirus is mediated by T-cell responses against both the virus and tumor in a Syrian hamster model. Based on scientific literature, oncolytic adenoviruses are viruses engineered to selectively replicate in and kill cancer cells, and their efficacy is indeed often mediated by immune responses, including T-cell responses. Syrian hamsters are commonly used as models for studying oncolytic adenoviruses because they are semi-permissive to human adenovirus replication, unlike mice. Research has shown that T-cell responses play a significant role in the anti-tumor effects of oncolytic adenoviruses in hamster models, with both anti-viral and anti-tumor T-cell responses contributing to tumor clearance. So the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11702094",
    "question": "Do cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system. To answer this, I need to know if there's established research showing that knocking out or deficiency of cholecystokinin2 receptors affects dopamine function in the brain of mice. Cholecystokinin (CCK) is a peptide hormone that can act as a neurotransmitter, and CCK2 receptors are found in the brain. There is research suggesting interactions between CCK and dopamine systems, but I need to determine if specifically CCK2 receptor deficiency has been shown to alter dopaminergic function. Based on scientific literature, CCK2 receptor knockout mice do show alterations in dopaminergic neurotransmission, including changes in dopamine release, metabolism, and behavioral responses to dopaminergic drugs. Studies have demonstrated that CCK2 receptor deficiency affects dopamine-related behaviors and neurochemistry in mice.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17228054",
    "question": "Is short sleep duration associated with reduced leptin levels and increased adiposity : Results from the Quebec family study?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether short sleep duration is associated with reduced leptin levels and increased adiposity, specifically referencing results from the Quebec family study. To answer this, I would need to know the specific findings of the Quebec family study regarding the relationship between sleep duration, leptin levels, and adiposity. Without having access to the specific results of this study, I cannot provide a definitive answer. The question appears to be referencing a specific scientific study and its findings, which I don't have detailed information about.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11430539",
    "question": "Does growth hormone affect albumin synthesis in the critically ill?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the relationship between growth hormone and albumin synthesis specifically in critically ill patients. Growth hormone is known to have anabolic effects in the body, including protein synthesis. Albumin is a protein produced by the liver, and hypoalbuminemia (low albumin levels) is common in critically ill patients. Research has shown that growth hormone administration can increase albumin synthesis rates in critically ill patients, helping to counteract the catabolic state often seen in critical illness. Studies have demonstrated that growth hormone treatment can stimulate hepatic albumin production even during the stress response of critical illness. So based on the scientific evidence, growth hormone does affect albumin synthesis in the critically ill.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "20230657",
    "question": "Is emotion-modulated startle in anxiety disorders blunted by co-morbid depressive episodes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if emotion-modulated startle in anxiety disorders is blunted by co-morbid depressive episodes. This is a specific scientific question about the interaction between anxiety disorders, depression, and the startle response. To answer this accurately, I would need to be familiar with research on how startle responses (which are typically potentiated or enhanced in anxiety disorders) are affected when depression co-occurs with anxiety. Some research suggests that while anxiety tends to enhance startle responses, depression can have a blunting effect on emotional reactivity, including startle. So there's a theoretical basis for the claim, but I need to consider if this is established in the scientific literature as a consistent finding.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25366137",
    "question": "Is hypertensive renal injury associated with gene variation affecting immune signaling?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, I need to determine if there's a connection between hypertensive renal injury and genetic variations that affect immune signaling pathways.\\n\\nHypertensive renal injury refers to kidney damage caused by high blood pressure. The immune system plays a significant role in the pathophysiology of hypertension and associated organ damage.\\n\\nResearch has shown that:\\n1. Immune cells (T cells, macrophages) contribute to hypertensive kidney damage\\n2. Inflammatory cytokines and immune signaling are involved in hypertensive nephropathy\\n3. Several genetic variants affecting immune signaling pathways (like TNF-α, IL-6, TLR4, etc.) have been associated with susceptibility to hypertensive renal injury\\n4. GWAS studies have identified immune-related gene polymorphisms that modify risk of hypertensive kidney damage\\n\\nFor example, variations in genes encoding components of the NLRP3 inflammasome, certain cytokines, and immune cell receptors have been linked to differential susceptibility to hypertensive kidney injury.\\n\\nBased on the scientific literature, there is substantial evidence supporting an association between hypertensive renal injury and genetic variations that affect immune signaling pathways.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21196688",
    "question": "Is radionuclide hysterosalpingography a reliable tool for investigation of fallopian tube transport -- a controlled randomized study using particles of two sizes during three different parts of the menstrual cycle?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if a specific study exists: a controlled randomized study that investigated whether radionuclide hysterosalpingography is a reliable tool for examining fallopian tube transport, where the study used particles of two different sizes during three different parts of the menstrual cycle. This appears to be asking about a very specific research design with particular parameters. Without access to a medical research database, I cannot confirm if this exact study exists. The question is phrased as if it might be a title or description of a specific paper, but I don't have information to verify if such a study has been conducted and published.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "14985962",
    "question": "Do heat shock protein 72 and apoptosis indicate cardiac decompensation during early multiple organ failure in sheep?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether heat shock protein 72 (HSP72) and apoptosis are indicators of cardiac decompensation during the early stages of multiple organ failure in sheep. To answer this, I would need to know if there is scientific evidence showing that HSP72 expression and apoptotic markers correlate with or predict cardiac decompensation specifically in sheep models of multiple organ failure. Without specific research data on this relationship in sheep, I cannot provide a definitive answer. There are studies on HSP72 as a stress response protein and apoptosis in cardiac tissue during various pathological conditions, but whether they specifically indicate cardiac decompensation during early multiple organ failure in sheep would require specific veterinary research evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23233659",
    "question": "Do high-dimensional immunomonitoring models of HIV-1-specific CD8 T-cell responses accurately identify subjects achieving spontaneous viral control?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking if high-dimensional immunomonitoring models of HIV-1-specific CD8 T-cell responses can accurately identify individuals who achieve spontaneous viral control of HIV-1 without antiretroviral therapy. This refers to research on HIV controllers or elite controllers - rare individuals who maintain undetectable or very low viral loads without treatment. To answer this, I need to consider if there's evidence that these complex immunological models can reliably distinguish controllers from non-controllers based on CD8 T-cell response patterns. Based on scientific literature, several studies have shown that multidimensional analyses of CD8 T-cell functionality (including polyfunctionality, exhaustion markers, transcriptional profiles, etc.) can indeed differentiate controllers from non-controllers with good accuracy. Research has demonstrated that certain qualitative aspects of the CD8 T-cell response correlate strongly with viral control, and machine learning approaches using these high-dimensional datasets have shown promising predictive ability.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23810205",
    "question": "Are acute and chronic MRI changes in the spine and spinal cord after surgical stem cell grafting in patients with definite amyotrophic lateral sclerosis : post-infusion injuries unrelated with clinical impairment?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether acute and chronic MRI changes in the spine and spinal cord after surgical stem cell grafting in ALS patients are post-infusion injuries that are unrelated to clinical impairment. To answer this, I need to determine if there's evidence that these MRI changes are disconnected from clinical outcomes.\\n\\nThe question itself contains a premise that there are MRI changes after stem cell grafting in ALS patients, but doesn't provide evidence about whether these changes correlate with clinical impairment or not. Without specific data showing that these MRI changes are unrelated to clinical outcomes, I cannot confirm this claim. In fact, in most medical contexts, structural changes visible on MRI often do have some relationship with clinical manifestations, though the correlation isn't always straightforward.\\n\\nWithout specific studies demonstrating that these MRI changes are definitively unrelated to clinical impairment, I should answer 'no' to this question.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19582820",
    "question": "Does modification of approach for totally implantable venous access device decrease rate of complications?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if modifying the approach for inserting a totally implantable venous access device (TIVAD) leads to a decrease in complication rates. To answer this, I would need specific information about what modification is being referred to and evidence comparing complication rates between different approaches. Without this specific information in the question, I cannot determine if a particular modification decreases complications. The question is too general as stated, as there are many possible modifications to TIVAD placement techniques (ultrasound guidance, different insertion sites, various catheter types, etc.) and each might have different effects on complication rates.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12436059",
    "question": "Does alcohol suppress insulin-like growth factor-1 gene expression in prepubertal transgenic female mice overexpressing the bovine growth hormone gene?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether alcohol suppresses insulin-like growth factor-1 (IGF-1) gene expression specifically in prepubertal transgenic female mice that overexpress the bovine growth hormone gene. This is a very specific scientific question about the interaction between alcohol, IGF-1 gene expression, and a particular transgenic mouse model. Without specific scientific studies on this exact interaction, I cannot provide a definitive answer. This would require experimental evidence from studies that specifically examined alcohol's effects on IGF-1 gene expression in this particular transgenic mouse model.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12747450",
    "question": "Does the putative collagen-binding peptide P-15 promote fibroblast attachment to root shavings but not hydroxyapatite?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze the question. The question is asking whether the putative collagen-binding peptide P-15 promotes fibroblast attachment to root shavings but not to hydroxyapatite. To answer this, I would need specific information about the binding properties of P-15 peptide with respect to these two different substrates. Without specific research data on this topic, I cannot make a definitive determination. The question implies a differential effect - that P-15 would promote attachment to root shavings (which contain collagen) but not to hydroxyapatite (a calcium phosphate mineral). Given that P-15 is described as a collagen-binding peptide, it would make sense that it might preferentially promote attachment to collagen-containing substrates rather than mineral substrates like hydroxyapatite, but I don't have the specific experimental evidence to confirm this particular differential effect.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21343153",
    "question": "Does fast track management reduce the systemic inflammatory response and organ failure following elective infrarenal aortic aneurysm repair?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if fast track management reduces the systemic inflammatory response and organ failure following elective infrarenal aortic aneurysm repair. To answer this, I would need specific medical research evidence about the effects of fast track management protocols on inflammatory markers and organ function outcomes specifically in the context of infrarenal aortic aneurysm repair. Without having access to specific studies on this topic, I cannot make a definitive claim. The question is quite specific to a particular surgical procedure and outcome measure, requiring evidence-based medical literature to answer properly.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15564706",
    "question": "Does angiotensin II receptor blocker prevent increased arterial stiffness in patients with essential hypertension?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if angiotensin II receptor blockers (ARBs) prevent increased arterial stiffness in patients with essential hypertension. To answer this, I need to consider the evidence about ARBs' effects on arterial stiffness specifically.\\n\\nARBs are known to lower blood pressure by blocking the action of angiotensin II, which causes vasoconstriction. Beyond their blood pressure-lowering effects, studies have shown that ARBs can have beneficial effects on vascular structure and function.\\n\\nThere is evidence from clinical studies that ARBs can reduce arterial stiffness in hypertensive patients. This effect appears to be partly independent of their blood pressure-lowering action, suggesting direct effects on vascular remodeling. ARBs have been shown to improve endothelial function, reduce vascular inflammation, and decrease collagen deposition in arterial walls - all factors that contribute to arterial stiffness.\\n\\nMultiple studies have demonstrated that ARBs like valsartan, candesartan, and olmesartan can reduce measures of arterial stiffness such as pulse wave velocity in patients with essential hypertension.\\n\\nBased on the available evidence, ARBs do appear to prevent increased arterial stiffness in patients with essential hypertension.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19232441",
    "question": "Are gene-environment interactions between HLA B7/A2 , EBV antibodies associated with MRI injury in multiple sclerosis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific scientific relationship in the context of multiple sclerosis (MS) research. Let me break it down:\\n\\n1. It's asking about gene-environment interactions, specifically:\\n   - Genetic factors: HLA B7/A2 (human leukocyte antigen types, which are genetic markers)\\n   - Environmental factors: EBV (Epstein-Barr virus) antibodies\\n\\n2. It's asking if these interactions are associated with MRI-detectable injury in multiple sclerosis patients.\\n\\nTo answer this accurately, I would need to be familiar with the specific research literature on this topic. While I know that:\\n- HLA genes (particularly certain DRB1 alleles) are known risk factors for MS\\n- EBV infection has been strongly linked to MS risk\\n- MRI is used to detect and monitor MS lesions\\n\\nI don't have specific knowledge about studies examining the particular interaction between HLA B7/A2 and EBV antibodies in relation to MRI findings in MS. Without being able to cite specific research that establishes this association, I cannot confidently say 'yes'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19146655",
    "question": "Do the representation of the verb 's argument structure as disclosed by fMRI?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether fMRI (functional Magnetic Resonance Imaging) can disclose or reveal the representation of a verb's argument structure in the brain. Argument structure refers to the syntactic and semantic relationships between a verb and its arguments (subject, object, etc.). The question is asking if brain imaging techniques like fMRI can show how verb argument structures are represented in neural activity. Based on neurolinguistic research, while fMRI can show brain regions activated during language processing, including verb processing, it's not clear that it can specifically disclose the representation of argument structure in a detailed way. The question is somewhat ambiguous in its phrasing, but I believe it's asking if fMRI has been shown to reveal how verb argument structures are represented in the brain.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21124911",
    "question": "Are the preferred substrates for transglutaminase 2 in a complex wheat gluten digest Peptide fragments harboring celiac disease T-cell epitopes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether transglutaminase 2 (TG2) preferentially targets peptide fragments containing celiac disease T-cell epitopes within wheat gluten digests. This is a specific scientific question about the relationship between TG2 activity and celiac disease pathogenesis.\\n\\nTransglutaminase 2 is known to modify gluten peptides by deamidating specific glutamine residues, which enhances their binding to HLA-DQ2/8 molecules and increases their immunogenicity in celiac disease. Research has shown that TG2 does indeed preferentially modify peptides containing sequences that are recognized as T-cell epitopes in celiac disease patients.\\n\\nStudies have demonstrated that TG2 has sequence specificity, preferring glutamine residues in certain sequence contexts (like QXP motifs) which are enriched in gluten peptides that trigger celiac disease. The enzyme's substrate specificity does align with many of the immunodominant gluten epitopes in celiac disease.\\n\\nBased on the scientific literature, it appears that yes, the preferred substrates for TG2 in complex wheat gluten digests are indeed peptide fragments harboring celiac disease T-cell epitopes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21775920",
    "question": "Is cyst fluid carcinoembryonic antigen an accurate diagnostic marker of pancreatic mucinous cysts?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if cyst fluid carcinoembryonic antigen (CEA) is an accurate diagnostic marker for pancreatic mucinous cysts. Based on medical literature, CEA levels in cyst fluid are indeed considered one of the most useful markers for differentiating mucinous from non-mucinous pancreatic cysts. Elevated CEA levels in cyst fluid (typically >192 ng/mL) have been shown to have good sensitivity and specificity for identifying mucinous cysts, including mucinous cystic neoplasms (MCNs) and intraductal papillary mucinous neoplasms (IPMNs). While not perfect (there can be false positives and negatives), it is widely accepted in clinical practice as an accurate diagnostic marker for this purpose.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "9386185",
    "question": "Is functional compartmentalization of ATP involved in angiotensin II-mediated closure of cardiac ATP-sensitive K+ channels?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the role of functional compartmentalization of ATP in angiotensin II-mediated closure of cardiac ATP-sensitive K+ channels. To answer this, I need to consider what is known about the mechanism of angiotensin II's effect on these channels. ATP-sensitive K+ (KATP) channels are regulated by intracellular ATP levels, and angiotensin II is known to affect cardiac function through various signaling pathways. The specific question is whether functional compartmentalization of ATP (localized pools of ATP with different concentrations in different cellular compartments) is involved in this process. Based on research in cardiac physiology, angiotensin II has been shown to close KATP channels through protein kinase C-dependent pathways and by increasing local ATP concentration near the channels through metabolic effects. Studies have demonstrated that angiotensin II can increase glycolysis and oxidative phosphorylation in cardiac cells, leading to localized increases in ATP concentration in subsarcolemmal compartments where KATP channels are located. This compartmentalization of ATP production and concentration is indeed a key mechanism by which angiotensin II mediates the closure of these channels.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25619762",
    "question": "Does the lamprey pallium provide a blueprint of the mammalian motor projections from cortex?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether the lamprey pallium provides a blueprint of the mammalian motor projections from cortex. To answer this, I need to consider what is known about the lamprey pallium and its relationship to mammalian cortical motor projections.\\n\\nLampreys are jawless fish that diverged from the vertebrate lineage about 560 million years ago. They have a relatively simple brain structure compared to mammals. The pallium in lampreys is a primitive structure that is considered homologous to parts of the telencephalon in higher vertebrates.\\n\\nWhile there are some studies suggesting that the lamprey pallium contains neurons that project to motor regions, and that there may be some conserved features between lamprey and mammalian brains, the lamprey pallium is significantly different from the complex six-layered mammalian neocortex with its sophisticated motor projection systems.\\n\\nThe mammalian motor cortex and its projections are highly specialized structures that evolved much later than the lamprey lineage diverged from other vertebrates. While the lamprey pallium may contain some basic elements that were elaborated upon during evolution, it would be an overstatement to say it provides a 'blueprint' for the complex mammalian motor cortical projections.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25548850",
    "question": "Is injecting botulinum toxin at different depths effective for the correction of eyebrow asymmetry?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the effectiveness of injecting botulinum toxin (commonly known as Botox) at different depths for correcting eyebrow asymmetry. To answer this, I need to consider whether there is evidence supporting this specific technique for this particular condition.\\n\\nBotulinum toxin is commonly used in cosmetic procedures to address facial asymmetries and for eyebrow shaping. When treating eyebrow asymmetry specifically, practitioners may indeed use different injection depths to target different muscle groups that affect eyebrow position. The frontalis muscle elevates the eyebrows, while the orbicularis oculi and corrugator supercilii can depress them. By injecting at varying depths to selectively weaken certain muscles more than others, practitioners can potentially achieve more balanced eyebrow positioning.\\n\\nBased on clinical practice and literature in aesthetic medicine, this technique of using different injection depths is considered effective for addressing eyebrow asymmetry. The ability to precisely target specific muscles at their appropriate anatomical depths allows for customized treatment of asymmetrical features.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "23626704",
    "question": "Does ecological specialization to fluctuating resources prevent long-distance migratory raptors from becoming sedentary on islands?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether ecological specialization to fluctuating resources prevents long-distance migratory raptors from becoming sedentary on islands. To answer this, I need to consider whether there's evidence that raptors that specialize in fluctuating resources cannot settle permanently on islands.\\n\\nMigratory behavior in raptors is typically driven by seasonal resource availability. When raptors migrate, they're often following food sources that vary seasonally. On islands, resources might be more limited or less seasonally variable.\\n\\nThe question suggests a hypothesis: that raptors specialized to track fluctuating resources across large distances cannot easily adapt to the more constrained and potentially stable resource base of islands.\\n\\nBased on ecological theory and observed patterns, this is generally correct. Raptors that have evolved to track specific fluctuating resources (like rodent population booms) across continents often maintain migratory behavior even when some individuals reach islands. Their specialized foraging strategies and physiological adaptations for migration make it difficult to transition to sedentary island life. Examples include species like Eleonora's falcon that maintains migration even when breeding on Mediterranean islands.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19727816",
    "question": "Is expression of multidrug resistance-associated ABC transporters in B-CLL independent of ZAP70 status?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether the expression of multidrug resistance-associated ABC transporters in B-CLL (B-cell chronic lymphocytic leukemia) is independent of ZAP70 status. To answer this, I need to determine if there's a relationship between ABC transporters expression and ZAP70 status in B-CLL cells.\\n\\nZAP70 (zeta-chain-associated protein kinase 70) is a prognostic marker in B-CLL, with ZAP70-positive patients generally having a worse prognosis. ABC transporters (ATP-binding cassette transporters) are involved in drug efflux and can contribute to multidrug resistance in cancer cells.\\n\\nBased on research literature, there is evidence that ABC transporter expression in B-CLL can correlate with ZAP70 status. Studies have shown that ZAP70-positive B-CLL cells often have different expression patterns of ABC transporters compared to ZAP70-negative cells. This suggests that the expression of these transporters is not independent of ZAP70 status but is actually associated with it in many cases.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18470749",
    "question": "Does chronic non-thermal exposure of modulated 2450 MHz microwave radiation alter thyroid hormones and behavior of male rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific scientific study or effect: whether chronic non-thermal exposure to modulated 2450 MHz microwave radiation alters thyroid hormones and behavior in male rats. To answer this accurately, I would need to know the results of specific scientific studies on this topic. There have been studies examining the effects of microwave radiation on thyroid function and behavior in rats, but I need to determine if there's scientific consensus specifically about modulated 2450 MHz radiation causing these effects. Without citing specific research, I cannot definitively answer this question.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22672418",
    "question": "Does sildenafil promote neuroprotection of the pelvic ganglia neurones after bilateral cavernosal nerve resection in the rat?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about whether sildenafil (commonly known as Viagra) has neuroprotective effects specifically on pelvic ganglia neurons after bilateral cavernosal nerve resection in rats. To answer this, I need to consider what scientific evidence shows about sildenafil's effects in this specific context.\\n\\nSildenafil is a PDE5 inhibitor that increases cGMP levels. There is research suggesting that sildenafil may have neuroprotective effects in various contexts through mechanisms involving nitric oxide/cGMP pathways. Some studies have specifically examined its effects after cavernosal nerve injury, which is a model used to study nerve damage that occurs during radical prostatectomy.\\n\\nResearch by Mulhall et al. and others has shown that sildenafil administration after cavernosal nerve injury in rats can preserve neural integrity in the major pelvic ganglia, reduce apoptosis of neurons, and promote nerve regeneration. These studies demonstrated that sildenafil treatment resulted in greater preservation of nitric oxide synthase-containing neurons in the pelvic ganglia compared to controls after bilateral cavernosal nerve injury.\\n\\nBased on the published literature, sildenafil does appear to have neuroprotective effects on pelvic ganglia neurons after bilateral cavernosal nerve resection in rat models.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22587433",
    "question": "Is prostatic relaxation induced by agmatine decreased in spontaneously hypertensive rats?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if prostatic relaxation induced by agmatine is decreased in spontaneously hypertensive rats (SHR). To answer this, I need to determine if there's evidence that agmatine-induced relaxation of the prostate is lower in SHR compared to normotensive rats. Without specific research information provided in the question, I cannot make a definitive determination based on the given context. However, many studies do show altered relaxation responses in various tissues of SHR models, so it's plausible this could apply to prostatic tissue as well. But without explicit evidence about agmatine's effects specifically on prostatic relaxation in SHR, I cannot confirm this statement.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22850264",
    "question": "Is poor self-rated health significantly associated with elevated C-reactive protein levels in women , but not in men , in the Japanese general population?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the association between poor self-rated health and elevated C-reactive protein (CRP) levels, specifically whether this association is significant in women but not in men in the Japanese general population. To answer this, I would need to know about studies examining this specific relationship in the Japanese population. Without specific data or research findings presented in the question, I cannot determine whether such a gender-specific association exists. The question appears to be asking about a specific research finding, but I don't have access to this particular information about CRP levels, self-rated health, and gender differences in Japan.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23833303",
    "question": "Do bRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the relationship between mutation load and UV damage signatures in bRAF/NRAS wild-type melanomas. To answer this, I need to consider what's known about this melanoma subtype.\\n\\nBRAF and NRAS are common driver mutations in melanoma. Melanomas that are wild-type for both (meaning they don't have mutations in either gene) represent a distinct molecular subtype.\\n\\nResearch has shown that many bRAF/NRAS wild-type melanomas do indeed have high mutation burdens that correlate with UV signature mutations (C>T transitions at dipyrimidine sites). These melanomas often show histologic evidence of chronic sun damage as well.\\n\\nIn fact, some studies have found that bRAF/NRAS wild-type melanomas can have even higher mutation loads than BRAF-mutant melanomas, and these mutations frequently bear the hallmarks of UV-induced DNA damage.\\n\\nSo based on the scientific literature, bRAF/NRAS wild-type melanomas typically do have high mutation loads that correlate with UV damage signatures.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12173202",
    "question": "Is cardioprotection by sevoflurane against reperfusion injury after cardioplegic arrest in the rat independent of three types of cardioplegia?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether cardioprotection by sevoflurane against reperfusion injury after cardioplegic arrest in the rat is independent of three types of cardioplegia. To answer this, I would need to know if studies have shown that sevoflurane provides cardioprotection regardless of which type of cardioplegia is used. Without specific research data showing that sevoflurane's protective effects work equally well across all three types of cardioplegia mentioned, I cannot definitively answer yes. If studies have shown variation in sevoflurane's effectiveness depending on the cardioplegia type, then the answer would be no. Since this is a very specific scientific question requiring knowledge of particular research findings, and I don't have access to this specific information, I cannot provide a confident answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25233229",
    "question": "Do specific matrix metalloproteinases play different roles in intraplaque angiogenesis and plaque instability in rabbits?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if specific matrix metalloproteinases (MMPs) play different roles in intraplaque angiogenesis and plaque instability in rabbits. To answer this, I need to consider whether there is evidence showing that different MMPs have distinct functions in these processes specifically in rabbit models of atherosclerosis. MMPs are enzymes that can degrade extracellular matrix components and are known to be involved in vascular remodeling, angiogenesis, and plaque destabilization in atherosclerosis. Research has shown that different MMPs (such as MMP-1, MMP-2, MMP-3, MMP-9, etc.) can have distinct roles in vascular pathology. There are studies using rabbit models of atherosclerosis that have demonstrated differential expression and functions of specific MMPs in relation to plaque angiogenesis and stability. For example, some studies have shown that MMP-2 and MMP-9 may have different temporal expression patterns and roles in rabbit atherosclerotic plaques, with some MMPs more associated with angiogenesis and others with matrix degradation leading to plaque instability.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23949477",
    "question": "Does response of brain oxygen to therapy correlate with long-term outcome after subarachnoid hemorrhage?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if there is a correlation between how the brain's oxygen levels respond to therapy and the long-term outcomes for patients who have suffered a subarachnoid hemorrhage (bleeding in the space between the brain and surrounding tissues). To answer this, I would need to know if research has established such a correlation. Without specific research data provided in the question, I cannot make a definitive statement about whether such a correlation exists. Medical literature would need to be consulted to determine if studies have shown that brain oxygen response to treatment is predictive of long-term outcomes in subarachnoid hemorrhage patients. Since I don't have access to this specific medical research information, I cannot provide a yes or no answer with confidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23161787",
    "question": "Does association between glioma susceptibility loci and tumour pathology define specific molecular etiologies?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if there is a proven association between glioma susceptibility loci (genetic variants that increase risk for glioma) and tumor pathology that definitively defines specific molecular etiologies (causes/origins) of gliomas. To answer this, I need to consider the current state of scientific knowledge in this area.\\n\\nWhile research has identified various genetic loci associated with glioma risk, and there are known molecular subtypes of gliomas with different pathological features, the complete picture linking specific susceptibility loci to defined molecular etiologies is still evolving. Some associations have been found between certain genetic variants and glioma subtypes, but these typically represent risk factors rather than definitive causal pathways.\\n\\nThe field of glioma genetics is complex, with multiple genetic and environmental factors likely contributing to tumor development. Current evidence suggests some correlations between susceptibility loci and pathological features, but these associations don't yet fully define specific molecular etiologies in a comprehensive or conclusive manner.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15218473",
    "question": "Does perivascular delivery of losartan with surgical fibrin glue prevent neointimal hyperplasia after arterial injury?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury. To answer this, I need to consider what is known about losartan (an angiotensin II receptor blocker), fibrin glue as a delivery vehicle, and their combined effect on neointimal hyperplasia (the abnormal thickening of the innermost layer of a blood vessel) following arterial injury. Without specific research studies cited in the question, I need to determine if there is established evidence for this specific intervention and outcome. Based on my knowledge, while losartan has been studied for vascular effects and fibrin glue has been used as a drug delivery vehicle in various applications, I don't have conclusive evidence that this specific combination definitively prevents neointimal hyperplasia after arterial injury.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11920957",
    "question": "Is anoikis regulated by BCL-2-independent pathways in human prostate carcinoma cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether anoikis (a form of programmed cell death that occurs when cells detach from the extracellular matrix) is regulated by BCL-2-independent pathways specifically in human prostate carcinoma cells. To answer this, I need to consider what's known about anoikis regulation in these specific cells.\\n\\nBCL-2 is a well-known anti-apoptotic protein that can inhibit cell death. If anoikis in prostate carcinoma cells can proceed through pathways that don't involve BCL-2 (i.e., BCL-2-independent), then the answer would be 'yes'.\\n\\nIn prostate cancer cells, research has shown that anoikis can be regulated through multiple pathways. While BCL-2 family proteins are important regulators, there are also other mechanisms involved, including:\\n\\n1. Integrin signaling pathways\\n2. Death receptor pathways\\n3. Various kinase cascades (FAK, Src, PI3K/Akt)\\n4. Caspase-independent mechanisms\\n\\nStudies have demonstrated that prostate cancer cells can undergo anoikis through mechanisms that don't necessarily require BCL-2 regulation. For example, some pathways directly activate executioner caspases or involve other death mechanisms that bypass the mitochondrial pathway where BCL-2 primarily functions.\\n\\nBased on the scientific literature, anoikis in human prostate carcinoma cells can indeed be regulated by pathways that are independent of BCL-2.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25388423",
    "question": "Does myoblast-mediated gene therapy improve functional collateralization in chronic cerebral hypoperfusion?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether myoblast-mediated gene therapy improves functional collateralization in chronic cerebral hypoperfusion. To answer this, I need to consider what is known about myoblast-mediated gene therapy in the context of cerebral hypoperfusion. Myoblasts are precursors to muscle cells, and in gene therapy, they can be engineered to express therapeutic genes. Chronic cerebral hypoperfusion refers to reduced blood flow to the brain over time, which can lead to cognitive impairment and is associated with conditions like vascular dementia. Functional collateralization refers to the development of alternative blood vessels to compensate for blocked or narrowed vessels. Based on my knowledge, while there are various experimental approaches to treating cerebral hypoperfusion, including promoting angiogenesis and collateral vessel formation, I don't have specific evidence that myoblast-mediated gene therapy has been proven to improve functional collateralization in chronic cerebral hypoperfusion.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26438688",
    "question": "Does foxO4 promote early inflammatory response upon myocardial infarction via endothelial Arg1?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To answer this question, I need to analyze whether there's evidence that foxO4 promotes early inflammatory response after myocardial infarction specifically through endothelial Arg1 (Arginase 1).\\n\\nFoxO4 is a transcription factor in the forkhead box O family that regulates various cellular processes including stress resistance, metabolism, and inflammation.\\n\\nArg1 (Arginase 1) is an enzyme that can influence inflammatory responses by affecting L-arginine metabolism, which impacts nitric oxide production and immune cell function.\\n\\nWhile both foxO4 and Arg1 have roles in inflammatory processes, the specific relationship where foxO4 promotes early inflammatory response after myocardial infarction through endothelial Arg1 is not a well-established mechanism in the scientific literature. This would require evidence showing:\\n1. FoxO4 upregulates or activates Arg1 specifically in endothelial cells\\n2. This pathway is active during early inflammatory response after myocardial infarction\\n3. This mechanism contributes to promoting inflammation\\n\\nBased on current scientific literature, this specific mechanistic relationship has not been conclusively demonstrated.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25409711",
    "question": "Does high mobility group A1 protein expression reduce the sensitivity of colon and thyroid cancer cells to antineoplastic drugs?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether high mobility group A1 (HMGA1) protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs. To answer this, I need to consider what is known about HMGA1's role in cancer drug resistance.\\n\\nHMGA1 is an architectural transcription factor that has been implicated in various aspects of cancer biology. Research has shown that HMGA1 overexpression is associated with aggressive cancer phenotypes and poor prognosis in multiple cancer types.\\n\\nRegarding drug sensitivity specifically, several studies have demonstrated that HMGA1 overexpression contributes to chemoresistance in various cancers. For colon cancer, research has shown that HMGA1 expression can reduce sensitivity to 5-fluorouracil and other chemotherapeutic agents. In thyroid cancer, HMGA1 has been linked to resistance to conventional treatments.\\n\\nThe mechanisms by which HMGA1 promotes drug resistance include activation of anti-apoptotic pathways, enhancement of DNA repair mechanisms, and modulation of drug efflux transporters.\\n\\nBased on the scientific literature, HMGA1 expression does reduce the sensitivity of both colon and thyroid cancer cells to antineoplastic drugs.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24732862",
    "question": "Are gSK-3β and vitamin D receptor involved in β-catenin and snail signaling in high glucose-induced epithelial-mesenchymal transition of mouse podocytes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question about the involvement of gSK-3β and vitamin D receptor in β-catenin and snail signaling during high glucose-induced EMT in mouse podocytes.\\n\\nThe question is asking about specific molecular mechanisms in epithelial-mesenchymal transition (EMT) of podocytes (kidney cells) under high glucose conditions, which is relevant to diabetic kidney disease research.\\n\\nSpecifically, it asks if two proteins - gSK-3β (glycogen synthase kinase-3β) and vitamin D receptor - are involved in β-catenin and snail signaling pathways during this process.\\n\\nBased on scientific literature, GSK-3β is known to regulate β-catenin stability and is involved in the Wnt/β-catenin pathway, which can influence EMT. GSK-3β also regulates Snail, a transcription factor that promotes EMT. The vitamin D receptor has been shown to interact with the Wnt/β-catenin pathway in various contexts.\\n\\nResearch has demonstrated that high glucose conditions can induce EMT in podocytes through various signaling pathways, and both GSK-3β and vitamin D receptor have been implicated in these processes. Studies have shown that GSK-3β inhibition can affect β-catenin stability and Snail expression in podocytes under diabetic conditions. Similarly, vitamin D receptor activation has been shown to modulate Wnt/β-catenin signaling in kidney cells.\\n\\nTherefore, based on the scientific evidence, the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26433762",
    "question": "Does a genome-wide association study of bipolar disorder with comorbid eating disorder replicate the SOX2-OT region?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether a genome-wide association study (GWAS) that specifically looked at bipolar disorder with comorbid eating disorder found replication evidence for the SOX2-OT region. SOX2-OT is a long non-coding RNA gene that overlaps the SOX2 gene. To answer this question accurately, I would need to know about specific GWAS studies that examined this particular comorbidity and whether they specifically found evidence supporting the SOX2-OT region. Without specific study details or references in the question, I cannot determine if such replication occurred. The question assumes a specific scientific finding that I cannot verify from the information provided.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16159605",
    "question": "Is measurement of flow-mediated dilatation of the brachial artery affected by local elastic vessel wall properties in high-risk patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether the measurement of flow-mediated dilatation (FMD) of the brachial artery is affected by local elastic vessel wall properties in high-risk patients. To answer this, I need to consider what is known about FMD measurements and how vessel elasticity might influence these measurements in patients with high cardiovascular risk.\\n\\nFlow-mediated dilatation is a non-invasive technique used to assess endothelial function by measuring the change in artery diameter in response to increased blood flow. The measurement involves the brachial artery's ability to dilate in response to shear stress.\\n\\nLocal elastic vessel wall properties refer to the elasticity or stiffness of the arterial wall. In high-risk patients (such as those with hypertension, diabetes, or atherosclerosis), arterial stiffness is often increased.\\n\\nResearch has shown that arterial stiffness can indeed affect FMD measurements. When vessel walls are less elastic (more stiff), they have a reduced ability to dilate in response to increased blood flow. This mechanical property can confound the interpretation of FMD as a measure of endothelial function.\\n\\nIn high-risk patients, who often have increased arterial stiffness, the FMD measurement can be affected by these altered elastic properties, potentially leading to lower FMD values that may not solely reflect endothelial dysfunction but also the mechanical limitation of stiffer vessels.\\n\\nBased on the physiological principles and available research, the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "7574932",
    "question": "Is mixed reflux of gastric and duodenal juices more harmful to the esophagus than gastric juice alone . The need for surgical therapy re-emphasized?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the comparative harm of mixed reflux (gastric and duodenal juices together) versus gastric juice alone on the esophagus, and whether this comparison emphasizes the need for surgical therapy. Based on medical literature, mixed reflux containing both gastric acid and duodenal contents (which include bile salts and pancreatic enzymes) is generally considered more damaging to the esophageal mucosa than gastric acid alone. The synergistic effect of bile and acid can cause more severe esophagitis and is associated with higher risks of Barrett's esophagus and esophageal adenocarcinoma. This understanding has influenced surgical approaches that aim to prevent both gastric and duodenal reflux. So yes, mixed reflux is considered more harmful, and this understanding has reinforced the importance of surgical interventions in certain cases of reflux disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23057582",
    "question": "Are ethnic differences and parental beliefs important for overweight prevention and management in children : a cross-sectional study in the Netherlands?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether ethnic differences and parental beliefs are important for overweight prevention and management in children, specifically in the context of a cross-sectional study conducted in the Netherlands. This appears to be the title of a research paper or study, and the question is asking about the findings or conclusions of this study. Without having access to the actual study or its results, I cannot definitively answer whether the study found that ethnic differences and parental beliefs are important factors. The question is phrased as if it's asking for the conclusion of this specific study.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17199719",
    "question": "Does brain-derived neurotrophic factor enhance glucose utilization in peripheral tissues of diabetic mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if brain-derived neurotrophic factor (BDNF) enhances glucose utilization in peripheral tissues of diabetic mice. To answer this, I need to consider what is known about BDNF's effects on glucose metabolism in diabetic mouse models.\\n\\nBDNF is primarily known as a neurotrophin that supports neuronal survival and plasticity. However, research has shown that BDNF also has metabolic effects outside the nervous system. Several studies have demonstrated that BDNF administration can improve glucose metabolism in diabetic mice. Specifically, BDNF has been shown to enhance glucose utilization in peripheral tissues such as skeletal muscle and liver in diabetic mouse models. It appears to increase glucose uptake in these tissues and improve insulin sensitivity.\\n\\nStudies have shown that systemic BDNF treatment reduces blood glucose levels in diabetic mice and increases glucose disposal in peripheral tissues. BDNF appears to act through mechanisms that are partly independent of insulin, making it potentially valuable for treating insulin resistance.\\n\\nBased on the scientific literature, BDNF does enhance glucose utilization in peripheral tissues of diabetic mice.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27343953",
    "question": "Are donor oocytes associated with preterm birth when compared to fresh autologous in vitro fertilization cycles in singleton pregnancies?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if donor oocytes are associated with preterm birth compared to fresh autologous IVF cycles in singleton pregnancies. To answer this, I need to consider what the medical literature shows about this comparison.\\n\\nDonor oocyte (egg donation) pregnancies have been associated with higher risks of certain pregnancy complications compared to autologous IVF (using the woman's own eggs). Several studies and meta-analyses have shown that donor oocyte pregnancies are associated with increased risks of pregnancy-induced hypertension, preeclampsia, and other complications.\\n\\nSpecifically regarding preterm birth in singleton pregnancies, the evidence does suggest that donor oocyte pregnancies have higher rates of preterm birth compared to autologous IVF pregnancies. Multiple studies have demonstrated this association, with donor egg pregnancies showing approximately 1.5-2 times higher risk of preterm delivery compared to autologous IVF, even after controlling for maternal age and other factors.\\n\\nThis is thought to be related to immunological factors, as the fetus derived from donor eggs is more immunologically foreign to the mother than one from her own eggs, potentially triggering different maternal responses that could affect placentation and pregnancy outcomes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12198378",
    "question": "Does estriol enhance lipopolysaccharide-induced increases in nitric oxide production by Kupffer cells via mechanisms dependent on endotoxin?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question. It's asking about the relationship between estriol, lipopolysaccharide (LPS, an endotoxin), nitric oxide production, and Kupffer cells (liver macrophages). Specifically, it asks if estriol enhances LPS-induced increases in nitric oxide production by Kupffer cells, and whether this enhancement depends on endotoxin mechanisms.\\n\\nTo answer this, I need to consider whether estriol potentiates the effect of LPS on nitric oxide production in Kupffer cells, and whether this potentiation requires endotoxin-dependent pathways.\\n\\nBased on research literature, estriol has been shown to modulate immune responses, including those in macrophages. LPS is known to stimulate nitric oxide production in Kupffer cells through toll-like receptor 4 (TLR4) signaling. Some studies suggest that estrogens can enhance LPS-induced inflammatory responses in certain contexts.\\n\\nHowever, the specific interaction between estriol and LPS in Kupffer cells regarding nitric oxide production, and whether this is dependent on endotoxin mechanisms, is a very specific question. The question essentially asks if estriol's enhancement of LPS-induced NO production in Kupffer cells requires endotoxin-dependent mechanisms, which would be a yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22907416",
    "question": "Does sustained delivery of IL-1Ra from pluronic F127-based thermosensitive gel prolong its therapeutic potentials?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether sustained delivery of IL-1Ra (Interleukin-1 receptor antagonist) from pluronic F127-based thermosensitive gel prolongs its therapeutic potentials. To answer this, I need to consider what is known about sustained delivery systems, particularly pluronic F127 thermosensitive gels, and their effects on therapeutic proteins like IL-1Ra.\\n\\nPluronic F127 is a thermosensitive polymer that exists as a liquid at low temperatures but forms a gel at body temperature. This property makes it useful for sustained drug delivery systems. When a therapeutic protein like IL-1Ra is incorporated into such a gel, it typically releases slowly over time rather than all at once.\\n\\nThe sustained release generally extends the bioavailability of the therapeutic agent in the body, reducing the frequency of administration needed and maintaining therapeutic concentrations for longer periods. This controlled release often prolongs the therapeutic effects compared to immediate release formulations.\\n\\nFor IL-1Ra specifically, which has a relatively short half-life in its free form, incorporation into a sustained delivery system like pluronic F127 gel would likely extend its presence in the body and therefore prolong its therapeutic potential.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23148716",
    "question": "Does pre-capture multiplexing improve efficiency and cost-effectiveness of targeted genomic enrichment?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if pre-capture multiplexing improves efficiency and cost-effectiveness of targeted genomic enrichment. Pre-capture multiplexing refers to the process of pooling multiple DNA samples together before the hybridization capture step in targeted sequencing. This approach allows multiple samples to be processed simultaneously during the expensive capture step, potentially reducing reagent usage and processing time. Research has shown that pre-capture multiplexing can maintain data quality while reducing per-sample costs and increasing throughput compared to post-capture multiplexing or processing samples individually. Studies have demonstrated that this approach can reduce costs by up to 50% while maintaining comparable coverage metrics and variant detection capabilities.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22504236",
    "question": "Is insulin need in gestational diabetes associated with a worse cardiovascular risk profile after pregnancy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether women who needed insulin to manage their gestational diabetes have worse cardiovascular risk profiles after their pregnancy compared to those who didn't need insulin. To answer this, I need to consider the medical evidence on this topic. Research has shown that women who require insulin therapy for gestational diabetes often have more severe glucose intolerance and may have a higher risk of developing type 2 diabetes after pregnancy. Studies have also indicated that insulin requirement during gestational diabetes can be associated with more adverse metabolic parameters postpartum, including lipid abnormalities, higher blood pressure, and other cardiovascular risk factors. The need for insulin therapy in gestational diabetes is generally considered a marker of more severe metabolic dysfunction, which can persist after pregnancy and contribute to long-term cardiovascular risk. Based on the medical literature, there is evidence supporting an association between insulin need in gestational diabetes and worse cardiovascular risk profiles after pregnancy.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "8222190",
    "question": "Does nafamostat mesilate reduce blood loss during open heart surgery?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to determine if nafamostat mesilate reduces blood loss during open heart surgery. Nafamostat mesilate is a serine protease inhibitor that has anticoagulant properties. In cardiac surgery, blood loss is a significant concern, and various agents are used to reduce bleeding. Let me consider what I know about nafamostat mesilate's clinical applications.\\n\\nNafamostat mesilate has been studied for use in extracorporeal circulation as an anticoagulant alternative to heparin in some settings. It has been used in Japan and some other Asian countries for specific applications including hemodialysis in patients at high risk of bleeding.\\n\\nHowever, regarding its specific use to reduce blood loss during open heart surgery, I need to consider if there is established evidence for this application. While it has anticoagulant properties that might theoretically be relevant, I don't recall specific evidence demonstrating that nafamostat mesilate is established as an agent that reduces blood loss during open heart surgery compared to standard approaches. Its primary use has been as an alternative anticoagulant in specific situations rather than as a hemostatic agent to reduce surgical bleeding.\\n\\nBased on my knowledge, I don't believe there is established evidence that nafamostat mesilate reduces blood loss during open heart surgery.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16478293",
    "question": "Does nicotinamide protect against ethanol-induced apoptotic neurodegeneration in the developing mouse brain?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether nicotinamide (a form of vitamin B3) provides protection against neuronal cell death (apoptotic neurodegeneration) caused by ethanol exposure in developing mouse brains.\\n\\nTo answer this accurately, I would need to know specific research findings on this topic. There have been studies examining the neuroprotective effects of nicotinamide in various contexts, including ethanol-induced damage. Some research has shown that nicotinamide can indeed protect against ethanol-induced apoptotic neurodegeneration in the developing brain by preventing caspase-3 activation and inhibiting oxidative stress pathways.\\n\\nFor example, a well-known study by Ieraci and Herrera demonstrated that nicotinamide administration significantly reduced ethanol-induced apoptotic neurodegeneration in the developing mouse brain. The research showed nicotinamide could prevent the neuronal loss typically seen after ethanol exposure during critical developmental periods.\\n\\nBased on the published scientific literature, the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24801687",
    "question": "Is intravenous ilaprazole more potent than oral ilaprazole against gastric lesions in rats?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if intravenous ilaprazole is more potent than oral ilaprazole against gastric lesions in rats. To answer this, I would need specific research data comparing the potency of these two administration routes of ilaprazole in rat models of gastric lesions. Without being provided specific studies or data in the question, I cannot make a definitive determination about the relative potency of intravenous versus oral ilaprazole in this specific context. I don't have access to comprehensive pharmacological data that would allow me to answer this specific comparative efficacy question.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27383327",
    "question": "Does vitamin E promote breast cancer cell proliferation by reducing ROS production and p53 expression?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether vitamin E promotes breast cancer cell proliferation by reducing ROS (reactive oxygen species) production and p53 expression. Let me analyze what scientific evidence indicates about this relationship.\\n\\nVitamin E is generally known as an antioxidant that can reduce ROS. However, the relationship between vitamin E, ROS reduction, p53 expression, and breast cancer cell proliferation is complex.\\n\\nSome studies have suggested that high doses of vitamin E supplements might have unexpected effects in certain contexts. However, the scientific consensus does not support that vitamin E specifically promotes breast cancer cell proliferation through the mechanism of reducing ROS production and p53 expression.\\n\\nIn fact, some research suggests that vitamin E may have anti-cancer properties in certain contexts. The relationship between antioxidants like vitamin E and cancer is complex and context-dependent.\\n\\nBased on current scientific understanding, there isn't strong evidence supporting the specific mechanism described in the question.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23676267",
    "question": "Does risk factors for fall with use of acid-suppressive drugs?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether acid-suppressive drugs are risk factors for falls. Acid-suppressive drugs include proton pump inhibitors (PPIs) and H2 receptor antagonists, which are commonly used to treat conditions like acid reflux, GERD, and peptic ulcers. Some research has suggested that these medications may be associated with increased fall risk, particularly in elderly patients, possibly due to effects on vitamin B12, calcium absorption, or other mechanisms that could affect balance or bone strength. However, I need to be careful about making a definitive statement without citing specific research. Based on existing medical literature, there does appear to be some association between acid-suppressive drugs and increased fall risk, particularly in older adults.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27591677",
    "question": "Does the angiogenic switch lead to a metabolic shift in human glioblastoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the angiogenic switch leads to a metabolic shift in human glioblastoma. The angiogenic switch refers to the point at which a tumor begins to promote angiogenesis (formation of new blood vessels) to support its growth. A metabolic shift would refer to changes in how the tumor cells process energy and nutrients. \\n\\nTo answer this accurately, I need to consider the established relationship between angiogenesis and metabolism in glioblastoma specifically. Research has shown that as glioblastomas grow and promote angiogenesis, they do indeed undergo metabolic reprogramming. The hypoxic (low oxygen) environment that triggers angiogenesis also induces metabolic adaptations, including increased glycolysis (Warburg effect), altered lipid metabolism, and changes in amino acid utilization. These metabolic changes help the tumor cells survive in challenging conditions and continue proliferating.\\n\\nThe literature supports that angiogenesis and metabolic reprogramming are closely linked processes in glioblastoma progression, with hypoxia-inducible factors (HIFs) playing key regulatory roles in both processes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25451608",
    "question": "Does negative affectivity predict decreased pain tolerance during low-grade inflammation in healthy women?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific relationship between negative affectivity (a personality trait characterized by the tendency to experience negative emotions) and pain tolerance during low-grade inflammation in healthy women. To answer this accurately, I would need to know about specific research studies that have examined this relationship. Without specific research evidence, I cannot definitively say whether negative affectivity predicts decreased pain tolerance in this specific context. The question is asking about a causal or predictive relationship between these specific variables in a specific population under specific conditions, which requires empirical evidence to answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18487478",
    "question": "Do one-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if one-hour plasma glucose concentration and the metabolic syndrome can identify people who are at high risk for developing type 2 diabetes in the future. To answer this, I need to consider what medical research shows about these two factors as predictors of diabetes risk.\\n\\nOne-hour plasma glucose concentration refers to blood sugar levels measured one hour after consuming glucose during a glucose tolerance test. Research has shown that elevated one-hour glucose levels, even when fasting and two-hour glucose levels are normal, can predict future diabetes risk.\\n\\nMetabolic syndrome is a cluster of conditions (including high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels) that occur together, increasing risk of heart disease, stroke, and diabetes.\\n\\nBoth of these factors have been shown in medical literature to be significant predictors of future type 2 diabetes risk. Multiple studies have demonstrated that elevated one-hour glucose levels and the presence of metabolic syndrome are independently associated with increased risk of developing type 2 diabetes.\\n\\nSo yes, both one-hour plasma glucose concentration and metabolic syndrome can identify subjects at high risk for future type 2 diabetes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21489300",
    "question": "Is thrombomodulin phenotype of a distinct monocyte subtype an independent prognostic marker for disseminated intravascular coagulation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether thrombomodulin phenotype of a distinct monocyte subtype is an independent prognostic marker for disseminated intravascular coagulation (DIC). To answer this, I would need specific research evidence showing that thrombomodulin expression on a particular monocyte subpopulation has been validated as an independent predictor of DIC outcomes in statistical analyses (likely through multivariate analysis controlling for other factors). Without specific research cited in the question, I cannot determine if this specific relationship has been established in the medical literature. While thrombomodulin is known to be involved in coagulation pathways and DIC pathophysiology, whether a specific monocyte subtype's thrombomodulin phenotype serves as an independent prognostic marker requires specific evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26110110",
    "question": "Does hippocampal volume correlate with attenuated negative psychotic symptoms irrespective of antidepressant medication?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This is a complex scientific question about the relationship between hippocampal volume and negative psychotic symptoms, with a specific condition about whether this relationship holds regardless of antidepressant medication use.\\n\\nTo answer this accurately, I would need to be familiar with the current neuropsychiatric research literature on this specific topic. The question asks about a correlation between:\\n1. Hippocampal volume (a brain structure measurement)\\n2. Attenuated (reduced) negative psychotic symptoms\\n3. Whether this correlation exists independently of antidepressant medication effects\\n\\nI don't have access to comprehensive and current research data on this specific relationship. This would require knowledge of recent meta-analyses or systematic reviews on this topic. Without that specific knowledge, I cannot confidently state whether such a correlation exists irrespective of medication effects.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27349531",
    "question": "Is `` The Record Our Work Tool ! `` -Physicians ' Framing of a Patient Portal in Sweden?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if the phrase 'The Record Our Work Tool!' is how physicians in Sweden framed a patient portal. To answer this, I would need to know if this specific phrase was used by Swedish physicians to describe or frame a patient portal system in Sweden. Without specific information about Swedish physicians' framing of patient portals, I cannot confirm that this particular phrase was used by them. The question appears to be referencing a specific study or article about how physicians in Sweden conceptualized or described a patient portal, but I don't have enough information to verify if this exact phrasing was used.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25784627",
    "question": "Are concussions associated with decreased batting performance among Major League Baseball players?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question asks about the relationship between concussions and batting performance in MLB players. To answer this accurately, I would need to consider research studies on this topic. There have been studies showing that concussions can negatively impact various cognitive and motor skills that are important for baseball performance, including visual tracking, reaction time, and hand-eye coordination. Research specifically on MLB players has found evidence that concussions are associated with decreased batting performance in the period following return to play. For example, studies have shown lower batting averages, slugging percentages, and on-base percentages among players who have returned from concussion compared to their pre-concussion performance. This evidence supports a 'yes' answer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18706114",
    "question": "Does vascular function assessed with cardiovascular magnetic resonance predict survival in patients with advanced chronic kidney disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether vascular function assessed with cardiovascular magnetic resonance (CMR) predicts survival in patients with advanced chronic kidney disease (CKD). To answer this, I need to consider whether there is established evidence that CMR measurements of vascular function (such as arterial stiffness, flow-mediated dilation, or other vascular parameters) have been shown to be predictive of mortality or survival outcomes specifically in the advanced CKD population. Based on medical literature, there are studies showing that various CMR parameters can predict cardiovascular events and mortality in CKD patients. For example, aortic stiffness measured by CMR has been associated with increased mortality in CKD patients. Several studies have demonstrated that CMR-derived measures like pulse wave velocity, aortic distensibility, and flow measurements correlate with outcomes in this population. So yes, there is evidence supporting that vascular function assessed with CMR can predict survival in advanced CKD patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24747991",
    "question": "Do reactive oxygen species regulate the quiescence of CD34-positive cells derived from human embryonic stem cells?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if reactive oxygen species (ROS) regulate the quiescence of CD34-positive cells derived from human embryonic stem cells. To answer this, I need to consider what is known about ROS and stem cell quiescence.\\n\\nROS are chemically reactive molecules containing oxygen that are generated during cellular metabolism. They can act as signaling molecules in various cellular processes.\\n\\nStem cell quiescence refers to a reversible state of cellular dormancy where stem cells are not actively dividing but retain the ability to re-enter the cell cycle.\\n\\nSpecifically for CD34-positive cells derived from human embryonic stem cells, I need to determine if there is established evidence that ROS play a regulatory role in maintaining or exiting the quiescent state.\\n\\nBased on the scientific literature, there is evidence that ROS levels can influence stem cell quiescence in various stem cell populations, including hematopoietic stem cells (which are often CD34+). However, specifically for CD34+ cells derived from human embryonic stem cells, there isn't conclusive evidence widely established in the scientific consensus that ROS definitively regulate their quiescence. While ROS signaling is important in stem cell biology generally, the specific regulatory relationship between ROS and quiescence in this particular cell population isn't firmly established enough to answer 'yes' with confidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18632229",
    "question": "Does persistent maternal anxiety affect the interaction between mothers and their very low birthweight children at 24 months?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the relationship between persistent maternal anxiety and mother-child interaction specifically for very low birthweight children at 24 months of age. To answer this, I would need to know if research has established a connection between maternal anxiety that persists over time and how these mothers interact with their very low birthweight children at this specific developmental stage. Without being given specific research findings in the prompt, I cannot make a definitive claim. However, research in developmental psychology generally suggests that maternal mental health, including anxiety, can affect parent-child interactions. The question is specifically about persistent anxiety (not just temporary) and about a specific population (mothers of very low birthweight children) at a specific age (24 months). Since I don't have specific evidence about this precise relationship, I should answer conservatively.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15827799",
    "question": "Are the results of frozen section , touch preparation , and cytological smear comparable for intraoperative examination of sentinel lymph nodes : a study in 133 breast cancer patients?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question appears to be asking if three different methods (frozen section, touch preparation, and cytological smear) produce comparable results when used for intraoperative examination of sentinel lymph nodes in breast cancer patients. The question specifically mentions a study involving 133 breast cancer patients. However, the question itself doesn't provide the results of this study or any data comparing these methods. Without knowing the actual findings of the study, I cannot determine if these methods were found to be comparable or not. The question is phrased as if it's a title of a research paper rather than a question seeking a yes/no answer based on established facts.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19717245",
    "question": "Do non-treatment laboratory stress- and cue-reactivity studies are associated with decreased substance use among drug-dependent individuals?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether non-treatment laboratory stress- and cue-reactivity studies are associated with decreased substance use among drug-dependent individuals. This is asking about a potential relationship between participating in laboratory studies that expose drug-dependent individuals to stress or drug cues (without providing treatment) and subsequent reductions in their substance use. To answer this, I would need evidence showing that merely participating in such laboratory studies leads to decreased substance use. Without specific research evidence showing this effect, I cannot confirm that such an association exists. Laboratory stress- and cue-reactivity studies are typically designed to measure responses to triggers, not as interventions to reduce drug use. While exposure therapy (which involves controlled exposure to cues) can be used as a treatment approach, the question specifically refers to 'non-treatment' studies, suggesting these are research protocols rather than therapeutic interventions.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "14725904",
    "question": "Is treosulfan-induced apoptosis in acute myeloid leukemia cells accompanied by translocation of protein kinase C delta and enhanced by bryostatin-1?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question. It's asking about a specific mechanism of apoptosis (programmed cell death) in acute myeloid leukemia cells. Specifically, it asks whether treosulfan-induced apoptosis involves:\n1. Translocation of protein kinase C delta (PKC-δ)\n2. Enhancement by bryostatin-1\n\nBased on research literature, treosulfan is an alkylating agent used in chemotherapy that can induce apoptosis in leukemia cells. Protein kinase C delta (PKC-δ) is known to be involved in apoptotic signaling in various cell types, and its translocation from the cytosol to the membrane or other cellular compartments is often associated with its activation during apoptosis. Bryostatin-1 is a PKC modulator that can affect PKC signaling pathways.\n\nThere is evidence in the scientific literature that treosulfan-induced apoptosis in acute myeloid leukemia cells does involve PKC-δ translocation, and that bryostatin-1 can enhance this effect. This has been documented in studies examining the mechanisms of treosulfan's anti-leukemic activity.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20454776",
    "question": "Is a family history of diabetes associated with reduced physical fitness in the Prevalence , Prediction and Prevention of Diabetes ( PPP ) -Botnia study?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study. To answer this, I would need to know the specific findings of this study regarding the relationship between family history of diabetes and physical fitness levels. Without having access to the results of this particular study, I cannot determine whether such an association was found. I don't have information about the PPP-Botnia study's specific findings on this relationship.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16508762",
    "question": "Do housing and rank status of male Long-Evans rats modify ethanol 's effect on open-field behaviors?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether housing and rank status of male Long-Evans rats modify ethanol's effect on open-field behaviors. To answer this, I need to determine if there's evidence that different housing conditions (like individual vs. group housing) and social rank status (dominant vs. subordinate) among male Long-Evans rats influence how ethanol affects their behaviors in open-field tests. Without specific research data provided in the question, I need to consider if this is a plausible scientific relationship. Given that both housing conditions and social hierarchies are known to affect stress levels, hormone production, and behavior in rats, and ethanol's effects can be modulated by these physiological factors, it seems reasonable that these variables could interact. Research in behavioral neuroscience often examines such interactions.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24158199",
    "question": "Are brain-type natriuretic peptide and right ventricular end-diastolic volume index measurements imprecise estimates of circulating blood volume in critically ill subjects?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if brain-type natriuretic peptide (BNP) and right ventricular end-diastolic volume index (RVEDVI) measurements are imprecise estimates of circulating blood volume in critically ill subjects. Let me analyze this:\n\nBNP is a hormone released by the heart in response to stretching of the heart muscle cells, typically due to increased volume or pressure. While it can be elevated in conditions of volume overload, it's primarily a marker of cardiac stress rather than a direct measure of blood volume.\n\nRVEDVI measures the volume of blood in the right ventricle at the end of diastole, indexed to body size. While this can provide information about preload and right heart function, it's not a direct measure of total circulating blood volume.\n\nBoth of these measurements are indirect indicators that can be influenced by many factors beyond just blood volume, including cardiac function, pulmonary pressures, renal function, and various disease states. In critically ill patients, these confounding factors are often present.\n\nDirect measurement of circulating blood volume typically requires techniques like indicator dilution methods. BNP and RVEDVI are surrogate markers that can be affected by multiple physiological variables, making them imprecise as specific measures of circulating blood volume.\n\nBased on this analysis, yes, these measurements would be considered imprecise estimates of circulating blood volume in critically ill subjects.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22423055",
    "question": "Is peripheral retinal ischaemia , as evaluated by ultra-widefield fluorescein angiography , associated with diabetic macular oedema?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the association between peripheral retinal ischemia (as evaluated by ultra-widefield fluorescein angiography) and diabetic macular edema. To answer this, I need to consider whether there is evidence in the medical literature supporting a relationship between these two conditions.\\n\\nDiabetic macular edema (DME) is a complication of diabetic retinopathy characterized by fluid accumulation in the macula, while peripheral retinal ischemia refers to inadequate blood supply to the peripheral regions of the retina.\\n\\nResearch studies have indeed shown that peripheral retinal ischemia, when assessed using ultra-widefield fluorescein angiography, is associated with diabetic macular edema. Several studies have demonstrated that patients with DME often have more extensive peripheral retinal ischemia compared to those without DME. The peripheral ischemia is thought to contribute to the pathogenesis of DME through the release of vascular endothelial growth factor (VEGF) and other inflammatory mediators.\\n\\nTherefore, there is evidence supporting an association between peripheral retinal ischemia and diabetic macular edema.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25998097",
    "question": "Do identification and evaluation of cochlear implant candidates with asymmetrical hearing loss?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if I, as an AI, perform identification and evaluation of cochlear implant candidates with asymmetrical hearing loss. This is a medical procedure that would require medical training, physical presence, and the ability to perform medical examinations. As an AI language model, I cannot perform physical medical evaluations or procedures. I can provide information about such procedures, but I cannot actually perform them.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "10727660",
    "question": "Does sphingosine 1-phosphate induce sinus tachycardia and coronary vasoconstriction in the canine heart?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to determine if sphingosine 1-phosphate (S1P) induces sinus tachycardia and coronary vasoconstriction in the canine heart. Let me analyze what I know about S1P's effects on the canine cardiovascular system.\\n\\nS1P is a bioactive sphingolipid that acts as a signaling molecule in various physiological processes. In the cardiovascular system, S1P has been shown to have various effects depending on the species, concentration, and specific vascular bed.\\n\\nRegarding its effects on the canine heart specifically:\\n1. Sinus tachycardia: S1P has been reported to cause bradycardia (slowing of heart rate) rather than tachycardia in many species through activation of S1P receptors. In dogs specifically, S1P typically causes bradycardia, not tachycardia.\\n\\n2. Coronary vasoconstriction: S1P has been shown to cause coronary vasoconstriction in canine coronary arteries. Studies have demonstrated that S1P can induce coronary vasoconstriction in isolated canine coronary artery preparations and in vivo models.\\n\\nBased on the available scientific literature, S1P does cause coronary vasoconstriction in canine hearts, but it typically induces bradycardia rather than sinus tachycardia. Therefore, the statement is partially true but not entirely accurate.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25551405",
    "question": "Does anodal Transcranial Direct Current Stimulation prolong the Cross-education of Strength and Corticomotor Plasticity?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if anodal Transcranial Direct Current Stimulation (tDCS) prolongs the cross-education of strength and corticomotor plasticity. Cross-education refers to the phenomenon where training one limb leads to strength gains in the untrained contralateral limb. To answer this question accurately, I would need to know if there is scientific evidence showing that anodal tDCS specifically extends the duration of these cross-education effects. Based on the current neuroscience literature, while tDCS can enhance various aspects of motor learning and potentially influence cross-education effects, there isn't conclusive evidence specifically showing that it prolongs (extends the duration of) these effects. Most studies focus on whether tDCS enhances the magnitude rather than the duration of cross-education effects.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "10320477",
    "question": "Does kinase-independent activity of Cdc2/cyclin A prevent the S phase in the Drosophila cell cycle?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking about the role of kinase-independent activity of Cdc2/cyclin A in the Drosophila cell cycle, specifically whether it prevents the S phase. To answer this, I need to consider what is known about Cdc2/cyclin A function in Drosophila.\\n\\nCdc2 (also known as Cdk1) is a cyclin-dependent kinase that typically functions with cyclins to regulate cell cycle progression. In most systems, Cdc2/cyclin A is actually involved in promoting S phase entry and progression, not preventing it. The kinase activity of Cdc2/cyclin A complexes is generally associated with driving the cell cycle forward.\\n\\nWhile there may be some kinase-independent functions of cyclin-CDK complexes, I'm not aware of established evidence that kinase-independent activity of Cdc2/cyclin A specifically prevents S phase in Drosophila. In fact, in Drosophila as in other organisms, cyclin A-CDK complexes are typically required for proper S phase progression.\\n\\nWithout specific evidence supporting this claim, I would conclude that kinase-independent activity of Cdc2/cyclin A preventing S phase is not an established mechanism in the Drosophila cell cycle.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22966017",
    "question": "Does quantitative immunofluorescence reveal the signature of active B-cell receptor signaling in diffuse large B-cell lymphoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if quantitative immunofluorescence reveals the signature of active B-cell receptor signaling in diffuse large B-cell lymphoma (DLBCL). To answer this, I need to consider what scientific literature shows about this specific technique being used to detect B-cell receptor (BCR) signaling in DLBCL.\\n\\nQuantitative immunofluorescence is an imaging technique that can measure protein expression and activation states in tissue samples. B-cell receptor signaling is an important pathway in B-cell lymphomas including DLBCL.\\n\\nBased on scientific literature, quantitative immunofluorescence has indeed been used to detect and measure active BCR signaling components in DLBCL. Studies have used this technique to visualize and quantify phosphorylated signaling proteins downstream of the BCR, such as pSYK, pBTK, and pPLCγ2, which serve as markers of active BCR signaling in DLBCL tissue samples. This approach has helped identify BCR-dependent DLBCL subtypes and patients who might benefit from BCR pathway inhibitors.\\n\\nSo yes, quantitative immunofluorescence can reveal the signature of active BCR signaling in DLBCL.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "9733464",
    "question": "Do chemically modified non-antimicrobial tetracyclines inhibit activity of phospholipases A2?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if chemically modified non-antimicrobial tetracyclines inhibit the activity of phospholipases A2. To answer this, I need to recall if there's evidence in the scientific literature about this specific interaction.\\n\\nPhospholipases A2 (PLA2) are enzymes that hydrolyze phospholipids. Tetracyclines are a class of antibiotics, but some have been chemically modified to remove their antimicrobial properties while retaining other biological activities.\\n\\nThere is scientific literature showing that chemically modified tetracyclines (CMTs), particularly those that lack antimicrobial activity, do indeed inhibit matrix metalloproteinases (MMPs). And importantly, there are studies demonstrating that these non-antimicrobial tetracyclines also inhibit phospholipases A2 activity. This property is part of why they're investigated for anti-inflammatory applications even when their antibiotic properties are removed.\\n\\nSo based on the scientific evidence, chemically modified non-antimicrobial tetracyclines do inhibit phospholipases A2 activity.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23805819",
    "question": "Do periodontal fibroblasts modulate proliferation and osteogenic differentiation of embryonic stem cells through production of fibroblast growth factors?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether periodontal fibroblasts affect embryonic stem cells in two specific ways (proliferation and osteogenic differentiation) through a specific mechanism (production of fibroblast growth factors or FGFs). Let me analyze what we know about this interaction:\\n\\n1. Periodontal fibroblasts are cells found in the periodontal ligament that connects teeth to the alveolar bone.\\n2. These fibroblasts do produce various growth factors, including FGFs.\\n3. FGFs are known to play roles in stem cell proliferation and differentiation in various contexts.\\n4. The specific question is whether periodontal fibroblasts modulate embryonic stem cells (ESCs) through FGF production.\\n\\nBased on scientific literature, periodontal fibroblasts have been shown to produce FGFs that can influence various cell types. There is evidence that periodontal fibroblasts can affect mesenchymal stem cells and dental stem cells. However, for the specific case of embryonic stem cells, while it's plausible that periodontal fibroblast-derived FGFs could affect ESCs (as FGFs generally can influence ESC behavior), I'm not aware of definitive studies showing this specific interaction pathway between periodontal fibroblasts and embryonic stem cells mediated specifically by FGFs produced by the fibroblasts.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21079618",
    "question": "Does obesity predict persistence of pain in children with functional gastrointestinal disorders?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether obesity predicts persistence of pain in children with functional gastrointestinal disorders (FGIDs). To answer this, I would need to know if there is scientific evidence showing that children who are obese and have FGIDs are more likely to experience persistent pain compared to non-obese children with FGIDs. Based on medical literature, obesity has been associated with various gastrointestinal issues, but the specific relationship between obesity and pain persistence in pediatric FGID cases requires examination of research studies. Some studies have suggested associations between obesity and symptom severity in certain FGIDs, while others have found mixed or no significant correlations. Without citing specific research that definitively establishes this predictive relationship, I cannot confidently answer yes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24053127",
    "question": "Does calcarea carbonica induce apoptosis in cancer cells in p53-dependent manner via an immuno-modulatory circuit?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific mechanism of action for calcarea carbonica (a homeopathic preparation) in cancer cells. Specifically, it's asking if calcarea carbonica induces apoptosis (programmed cell death) in cancer cells through a p53-dependent pathway via an immuno-modulatory circuit.\\n\\nTo answer this accurately, I would need to know if there is scientific evidence showing that calcarea carbonica has this specific mechanism of action. While there may be some alternative medicine claims about calcarea carbonica and cancer, the specific mechanism involving p53-dependent apoptosis through immuno-modulation is a very specific scientific claim that would require peer-reviewed research to substantiate.\\n\\nTo my knowledge, there is no robust scientific evidence demonstrating that calcarea carbonica (a homeopathic remedy typically made from calcium carbonate from oyster shells) induces apoptosis in cancer cells through p53-dependent pathways. Homeopathic preparations are generally extremely diluted, often to the point where no molecules of the original substance remain, making a specific molecular mechanism like p53 activation scientifically implausible.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24115762",
    "question": "Do classification tree analyses reveal limited potential for early targeted prevention against childhood overweight?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether classification tree analyses reveal limited potential for early targeted prevention against childhood overweight. To answer this, I would need to know what specific classification tree analyses have shown regarding early prevention of childhood overweight. Without specific studies or data referenced in the question, I cannot make a definitive determination about what classification tree analyses collectively reveal about the potential for early targeted prevention of childhood overweight. Classification tree analyses are statistical methods that can identify risk factors and subgroups, but their conclusions about prevention potential would depend on the specific studies, variables included, and findings. Some studies might show promise for targeted interventions while others might reveal limitations. Without specific evidence cited, I cannot say whether these analyses broadly reveal limited potential or not.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21303632",
    "question": "Is self-monitoring of cardiac autonomic function at home feasible?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if self-monitoring of cardiac autonomic function at home is feasible. To answer this, I need to consider whether there are technologies and methods available that allow individuals to monitor their own cardiac autonomic function (which includes heart rate variability, blood pressure regulation, etc.) in a home setting.\\n\\nThere are several consumer devices that can measure aspects of cardiac autonomic function:\\n- Heart rate monitors and smartwatches that track heart rate variability (HRV)\\n- Home blood pressure monitors\\n- ECG/EKG devices designed for home use (like Apple Watch, KardiaMobile)\\n- Various apps paired with these devices that can track and analyze the data\\n\\nThese technologies have become increasingly accessible, affordable, and user-friendly, allowing individuals to monitor various aspects of their cardiac autonomic function without needing to visit a healthcare facility.\\n\\nWhile home monitoring may not be as comprehensive or precise as clinical monitoring, the technology has advanced to a point where meaningful self-monitoring is indeed feasible for the average person.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15208502",
    "question": "Does radiolabelling morpholinos with 188Re tricarbonyl provide improved in vitro and in vivo stability to re-oxidation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about whether radiolabelling morpholinos with 188Re tricarbonyl improves stability to re-oxidation both in vitro and in vivo. To answer this, I need to consider what research shows about this specific radiolabelling technique and its effects on morpholino stability.\\n\\nMorpholinos are synthetic oligonucleotides used in molecular biology. Radiolabelling them with various compounds can be done for imaging or therapeutic purposes. The specific question is about using 188Re tricarbonyl for this purpose and whether it improves stability against re-oxidation.\\n\\nWhile 188Re (rhenium-188) is known to be used in radiopharmaceuticals, and tricarbonyl complexes can provide certain stability benefits, I don't have specific information about this particular combination with morpholinos and its effects on oxidative stability. Without specific research evidence showing that radiolabelling morpholinos with 188Re tricarbonyl provides improved stability to re-oxidation both in vitro and in vivo, I cannot confidently answer 'yes'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27546472",
    "question": "Does the Femoral Head Center shift in a Mediocaudal Direction During Aging?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the femoral head center shifts in a mediocaudal direction during aging. To answer this, I need to consider what research shows about age-related changes in hip joint anatomy. Mediocaudal would mean the femoral head center moves medially (toward the midline of the body) and caudally (downward or inferiorly) as people age. Based on anatomical studies, there is evidence that the femoral head can undergo positional changes with aging due to factors like bone remodeling, changes in bone mineral density, and alterations in the femoral neck angle. Some research suggests that there can be a slight medialization and inferior displacement of the femoral head with aging, which would constitute a mediocaudal shift. However, I should be careful about making a definitive statement without citing specific research.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25879819",
    "question": "Is premonitory urge to tic in Tourette 's associated with interoceptive awareness?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the relationship between premonitory urge to tic in Tourette's syndrome and interoceptive awareness. Premonitory urges are the uncomfortable sensations that many people with Tourette's experience before a tic occurs. Interoceptive awareness refers to the ability to sense and interpret internal bodily sensations. Research has indeed shown associations between premonitory urges in Tourette's and heightened interoceptive awareness. Studies have found that individuals with Tourette's who experience premonitory urges often show increased sensitivity to internal bodily sensations. This relationship has been documented in multiple studies examining the neurocognitive basis of Tourette's syndrome.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20221843",
    "question": "Do flavonoid combinations cause synergistic inhibition of proinflammatory mediator secretion from lipopolysaccharide-induced RAW 264.7 cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether combinations of flavonoids (plant compounds with antioxidant properties) work synergistically to inhibit the secretion of proinflammatory mediators from RAW 264.7 cells (a mouse macrophage cell line) when these cells are stimulated with lipopolysaccharide (LPS, which typically induces inflammation). \\n\\nTo answer this, I need to consider whether there's evidence that flavonoid combinations produce greater inhibitory effects than would be expected from their individual effects added together (which would constitute synergy).\\n\\nBased on scientific literature, there are studies showing that certain flavonoid combinations do exhibit synergistic effects in inhibiting proinflammatory mediator secretion from LPS-stimulated RAW 264.7 cells. For example, research has demonstrated that combinations of flavonoids like quercetin with other flavonoids can produce greater than additive effects on reducing nitric oxide, TNF-α, and other inflammatory mediators in this cell model.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18924502",
    "question": "Does [ Evaluation of growth hormone treatment result in children with chronic renal failure -- one center experience ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if a specific paper or study titled 'Evaluation of growth hormone treatment result in children with chronic renal failure -- one center experience' exists. However, this appears to be a title of a research paper rather than a question. The title itself doesn't actually ask anything - it's just describing what the paper is about (an evaluation of growth hormone treatment in children with chronic renal failure, based on experience from one medical center). The question doesn't make logical sense as phrased with 'Does [title]?' since a title itself doesn't 'do' anything.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18393326",
    "question": "Does androgen deprivation fall as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population. This is asking about a correlation between two medical procedures (androgen deprivation therapy and orchiectomy) following reimbursement changes in Medicare. Without specific data or studies on this relationship, I cannot definitively answer whether one falls as the other rises. The question assumes there is a known relationship between these rates following Medicare reimbursement changes, but I don't have enough information to confirm this relationship.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20544396",
    "question": "Does pinX1 inhibit telomerase activity in gastric cancer cells through Mad1/c-Myc pathway?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if pinX1 inhibits telomerase activity in gastric cancer cells through the Mad1/c-Myc pathway. To answer this, I need to consider what's known about pinX1's role in telomerase regulation in gastric cancer specifically.\\n\\nPinX1 is known to be a telomerase inhibitor and tumor suppressor. Research has shown that pinX1 can inhibit telomerase activity in various cancer types. In some studies, pinX1 has been shown to regulate telomerase through the Mad1/c-Myc pathway in certain cancers.\\n\\nSpecifically for gastric cancer, there is evidence that pinX1 does inhibit telomerase activity, and some research has linked this inhibition to the Mad1/c-Myc pathway. Studies have shown that pinX1 can upregulate Mad1 expression, which in turn suppresses c-Myc, leading to decreased hTERT (human telomerase reverse transcriptase) expression and reduced telomerase activity in gastric cancer cells.\\n\\nBased on the scientific literature, it appears that pinX1 does inhibit telomerase activity in gastric cancer cells through the Mad1/c-Myc pathway.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19875743",
    "question": "Does a citywide prehospital protocol increase access to stroke thrombolysis in Toronto?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a citywide prehospital protocol increases access to stroke thrombolysis in Toronto. To answer this, I would need specific information about:\n1. Whether Toronto has implemented a citywide prehospital protocol for stroke care\n2. Whether there is evidence that this protocol has increased access to thrombolysis treatment\n\nWithout specific data or studies about Toronto's stroke protocols and their outcomes, I cannot make a definitive determination. The question appears to be asking about a specific intervention and its effects in a specific city, which would require evidence-based information to answer accurately.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19390186",
    "question": "Are transient ischemic attack patients with fluctuations at highest risk for early stroke?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if patients with transient ischemic attack (TIA) who experience fluctuations in their symptoms are at the highest risk for early stroke compared to other TIA patients. To answer this accurately, I would need to refer to current medical research and clinical guidelines. Based on medical literature, while TIA patients in general have an elevated risk of subsequent stroke, especially in the days and weeks following the TIA, those with fluctuating or crescendo TIAs (where symptoms worsen or fluctuate) are indeed considered a higher-risk subgroup. However, whether they are at the 'highest' risk compared to all other risk factors (such as age, hypertension, diabetes, or specific imaging findings) is not definitively established. Other factors like ABCD2 score, presence of large vessel occlusion, or certain imaging findings might confer similar or higher risks. So while fluctuations are a concerning sign, I cannot conclusively state they represent the single highest risk factor.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22685586",
    "question": "Does therapeutic plasma exchange decrease levels of routinely used cardiac and inflammatory biomarkers?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if therapeutic plasma exchange (TPE) decreases levels of routinely used cardiac and inflammatory biomarkers. To answer this, I need to consider what TPE does. TPE is a procedure that removes plasma from the blood and replaces it with a substitute. Since plasma contains many proteins and biomarkers, including inflammatory markers and potentially cardiac markers, removing plasma would likely decrease the levels of these biomarkers in the blood temporarily. This is actually one of the therapeutic goals of TPE in certain conditions - to remove pathogenic antibodies, immune complexes, and inflammatory mediators. So TPE would be expected to decrease levels of inflammatory biomarkers, and potentially cardiac biomarkers as well if they are present in the plasma being exchanged.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25487600",
    "question": "Is overexpression of GYS1 , MIF , and MYC associated with adverse outcome and poor response to azacitidine in myelodysplastic syndromes and acute myeloid leukemia?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if overexpression of three specific genes (GYS1, MIF, and MYC) is associated with adverse outcomes and poor response to azacitidine treatment in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). To answer this, I would need specific research evidence showing a correlation between these gene expressions and treatment outcomes. Without having access to specific studies on this exact relationship, I cannot definitively answer. However, MYC is a well-known oncogene associated with poor prognosis in many cancers, and gene expression profiles can affect treatment response. I don't have sufficient information to confirm this specific association with these three genes and azacitidine response.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23365676",
    "question": "Does oblique bile duct predispose to the recurrence of bile duct stones?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if an oblique bile duct predisposes to the recurrence of bile duct stones. To answer this, I need to consider whether there's established medical evidence that an obliquely oriented bile duct increases the risk of stone recurrence after initial treatment.\\n\\nIn biliary anatomy, an oblique or angulated bile duct can potentially create conditions favorable for stone formation or recurrence by:\\n1. Causing bile stasis (slowed flow)\\n2. Creating difficulty in complete stone clearance during procedures\\n3. Potentially serving as a mechanical factor that impedes normal bile flow\\n\\nBased on medical literature, bile duct angulation or obliquity is indeed considered a risk factor for stone recurrence. Studies have shown that anatomical factors including bile duct angulation, dilation, or strictures can predispose patients to recurrent stone formation after initial treatment. The altered bile flow dynamics in an oblique duct can promote stone formation and recurrence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18669815",
    "question": "Does airway bypass improve the mechanical properties of explanted emphysematous lungs?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if airway bypass improves the mechanical properties of explanted emphysematous lungs. To answer this, I need to consider what airway bypass is and its effects on emphysematous lungs that have been removed (explanted) from the body.\\n\\nAirway bypass is a bronchoscopic procedure that creates extra pathways for trapped air to escape from emphysematous lungs. It involves creating holes in the airway walls and placing small stents to maintain patency of these new passages.\\n\\nIn emphysema, air gets trapped in the distal airways and alveoli due to loss of elastic recoil and airway collapse during exhalation. This trapped air causes hyperinflation and poor mechanical function.\\n\\nThe question specifically asks about explanted lungs - meaning lungs that have been removed from the body. In this ex vivo setting, studies have shown that creating bypass tracts can indeed improve mechanical properties by reducing gas trapping and improving expiratory flow. Research has demonstrated that airway bypass in explanted emphysematous lungs can reduce lung volumes and improve mechanical properties like compliance and resistance.\\n\\nBased on the scientific literature, airway bypass does improve the mechanical properties of explanted emphysematous lungs.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24759636",
    "question": "Do mRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if MRI biomarkers can identify differential responses of glioblastoma multiforme (GBM) to anti-angiogenic therapy. Based on current medical research, MRI biomarkers have indeed been studied and shown to be useful in identifying and monitoring the response of GBM to anti-angiogenic therapies like bevacizumab. Various MRI techniques including perfusion imaging, diffusion imaging, and spectroscopy can detect changes in tumor vascularity, cellularity, and metabolism that correlate with treatment response. These biomarkers can help distinguish between true response, pseudoresponse, and progression in patients receiving anti-angiogenic therapy. So yes, MRI biomarkers can identify differential responses of GBM to anti-angiogenic therapy.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24368438",
    "question": "Is cancer death related to high palmitoleic acid in serum and to polymorphisms in the SCD-1 gene in healthy Swedish men?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about a specific relationship between cancer death, high palmitoleic acid in serum, and polymorphisms in the SCD-1 gene, specifically in healthy Swedish men. This appears to be asking about a specific scientific study or finding. To answer this accurately, I would need to know if there is established scientific evidence showing this relationship in this specific population. Without access to comprehensive medical literature, I cannot confirm if such a specific relationship has been established. The question is very specific about the population (healthy Swedish men), the biomarker (palmitoleic acid), the genetic factor (SCD-1 gene polymorphisms), and the outcome (cancer death). This level of specificity suggests it may be referring to a particular research finding.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21691065",
    "question": "Does l-NAME treatment enhance exercise-induced content of myocardial heat shock protein 72 ( Hsp72 ) in rats?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question. I need to determine if l-NAME (N-nitro-L-arginine methyl ester, a nitric oxide synthase inhibitor) treatment enhances the exercise-induced content of myocardial heat shock protein 72 (Hsp72) in rats.\\n\\nBased on scientific literature, l-NAME is known to inhibit nitric oxide production. Some studies have investigated the relationship between nitric oxide inhibition and heat shock protein expression during exercise. \\n\\nFrom what I recall of the research, l-NAME treatment actually tends to attenuate or reduce exercise-induced increases in Hsp72 in cardiac tissue, rather than enhance it. This is because nitric oxide signaling is often involved in the upregulation of heat shock proteins during stress conditions like exercise.\\n\\nTherefore, l-NAME treatment would likely not enhance but rather diminish the exercise-induced content of myocardial Hsp72 in rats.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17065507",
    "question": "Does intracorneal instillation of latex beads induce macrophage-dependent protection against Acanthamoeba keratitis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether intracorneal instillation of latex beads induces macrophage-dependent protection against Acanthamoeba keratitis. To answer this, I need to consider whether there is established scientific evidence showing that latex beads introduced into the cornea can trigger a protective response against Acanthamoeba keratitis that specifically depends on macrophages.\\n\\nAcanthamoeba keratitis is a serious corneal infection caused by Acanthamoeba parasites. Some studies have explored various methods to enhance immune protection against this infection.\\n\\nLatex beads are sometimes used in research to study phagocytosis and macrophage function, as they can be phagocytosed by macrophages. However, I'm not aware of specific evidence showing that intracorneal latex bead instillation specifically induces macrophage-dependent protection against Acanthamoeba keratitis.\\n\\nWithout specific scientific literature supporting this claim, I cannot confirm that this protective mechanism exists.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24622074",
    "question": "Does farnesyltransferase regulate neutrophil recruitment and tissue damage in acute pancreatitis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if farnesyltransferase regulates neutrophil recruitment and tissue damage in acute pancreatitis. To answer this, I need to consider whether there is established scientific evidence linking farnesyltransferase to these specific processes in acute pancreatitis.\\n\\nFarnesyltransferase is an enzyme involved in protein prenylation, particularly the addition of farnesyl groups to proteins like Ras. While farnesyltransferase inhibitors have been studied in various inflammatory conditions and cancers, the specific role of farnesyltransferase in neutrophil recruitment and tissue damage specifically in acute pancreatitis is not well-established in mainstream scientific literature.\\n\\nThere are studies on various signaling pathways in acute pancreatitis inflammation, but a direct regulatory role of farnesyltransferase in neutrophil recruitment and tissue damage in this specific disease context is not a widely confirmed scientific finding.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24725474",
    "question": "Are high STAT1 mRNA levels but not its tyrosine phosphorylation associated with macrophage infiltration and bad prognosis in breast cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question. It's asking about the relationship between STAT1 mRNA levels, STAT1 tyrosine phosphorylation, macrophage infiltration, and breast cancer prognosis. Specifically, it's asking whether high STAT1 mRNA levels (but not STAT1 tyrosine phosphorylation) are associated with macrophage infiltration and poor prognosis in breast cancer.\\n\\nThis is a specific scientific claim about breast cancer biology. The question is phrased in a way that suggests there might be research showing that high STAT1 mRNA expression (independent of its phosphorylation status) correlates with increased macrophage infiltration and worse outcomes in breast cancer patients.\\n\\nBased on scientific literature, STAT1 (Signal Transducer and Activator of Transcription 1) is indeed studied in breast cancer contexts, and there is research examining relationships between STAT1 expression, immune cell infiltration, and cancer outcomes. Some studies have found that STAT1 expression patterns can be associated with different immune profiles in the tumor microenvironment.\\n\\nThe specific claim that high STAT1 mRNA (but not its phosphorylation) correlates with macrophage infiltration and poor prognosis appears to be consistent with some research findings in breast cancer biology.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12499882",
    "question": "Is erythropoiesis after nonmyeloablative stem-cell transplantation impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether erythropoiesis (red blood cell production) after nonmyeloablative stem-cell transplantation is impaired by inadequate erythropoietin production in the same way that it is after conventional allogeneic transplantation.\\n\\nTo answer this, I need to know whether the scientific literature has established that:\\n1. Conventional allogeneic transplantation is associated with inadequate erythropoietin production that impairs erythropoiesis\\n2. Nonmyeloablative stem-cell transplantation shows the same pattern\\n\\nThe question itself contains the premise that inadequate erythropoietin production is observed after conventional allogeneic transplantation and impairs erythropoiesis. It's asking if the same mechanism applies to nonmyeloablative transplantation.\\n\\nWithout specific medical literature to reference, I cannot make a definitive scientific determination about whether the same impairment mechanism exists in both transplantation types. This would require specific research studies comparing erythropoietin levels and erythropoiesis between these two transplantation methods.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "25967962",
    "question": "Does chronic-leptin attenuate Cisplatin cytotoxicity in MCF-7 breast cancer cell line?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if chronic-leptin attenuates (reduces) the cytotoxicity (cell-killing ability) of Cisplatin specifically in MCF-7 breast cancer cells. To answer this, I would need to know if there is evidence showing that long-term exposure to leptin reduces the effectiveness of Cisplatin in killing MCF-7 breast cancer cells. Without specific research data on this interaction, I cannot provide a definitive answer. However, there is research suggesting leptin can promote breast cancer cell survival pathways and potentially interfere with chemotherapy effectiveness in some contexts. For MCF-7 cells specifically with Cisplatin, I would need to see studies directly examining this relationship.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12450899",
    "question": "Is contribution of intestinal microbial lysine to lysine homeostasis reduced in minipigs fed a wheat gluten-based diet?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the contribution of intestinal microbial lysine to lysine homeostasis is reduced in minipigs fed a wheat gluten-based diet. To answer this, I need to consider what is known about wheat gluten diets and their effect on intestinal microbiota and lysine metabolism.\\n\\nWheat gluten is known to be low in lysine, which is an essential amino acid. When animals are fed a wheat gluten-based diet, they typically receive less dietary lysine than they would on other diets. \\n\\nIntestinal microbiota can synthesize amino acids, including lysine, which can contribute to the host's amino acid pool. However, the extent of this contribution depends on various factors including the diet composition.\\n\\nWhen an animal is fed a diet low in lysine (like wheat gluten), there might be compensatory mechanisms where the intestinal microbiota increases lysine production. Alternatively, the limited nutrients in the diet might also restrict the microbiota's ability to synthesize lysine.\\n\\nWithout specific research data on minipigs fed wheat gluten diets and measurements of microbial lysine contribution, I cannot make a definitive statement. However, based on general principles of nutrition and microbial metabolism, it's plausible that a wheat gluten diet, being low in lysine, might affect the intestinal microbiota's ability to contribute to lysine homeostasis.\\n\\nSince I don't have specific research data on this exact scenario, I should answer 'no' to indicate that I don't have evidence that the contribution is reduced.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22739633",
    "question": "Is the association of rs4307059 and rs35678 markers with autism spectrum disorders replicated in Italian families?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether the association of rs4307059 and rs35678 markers with autism spectrum disorders has been replicated in Italian families. To answer this, I need to determine if there is evidence in the text that specifically mentions a replication study of these genetic markers in an Italian population.\\n\\nLooking at the question, it's asking about specific genetic markers (rs4307059 and rs35678) and whether their association with autism spectrum disorders has been confirmed in studies involving Italian families. Without any provided text or context about genetic studies in Italian populations, I cannot determine if this replication has occurred.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26296758",
    "question": "Is campylobacter group II phage CP21 the prototype of a new subgroup revealing a distinct modular genome organization and host specificity?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if campylobacter group II phage CP21 is the prototype of a new subgroup with distinct modular genome organization and host specificity. To answer this accurately, I would need specific scientific information about phage CP21's genomic classification and characteristics. Without having access to specialized virology databases or recent research papers on bacteriophage taxonomy, I cannot make a definitive determination about whether CP21 has been officially designated as a prototype for a new subgroup with these specific characteristics.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17962640",
    "question": "Does gene transfer of extracellular superoxide dismutase ameliorate pulmonary hypertension in rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if gene transfer of extracellular superoxide dismutase (SOD) ameliorates pulmonary hypertension in rats. To answer this, I need to know if there's scientific evidence showing that transferring the gene for extracellular SOD into rats with pulmonary hypertension improves their condition. Extracellular SOD is an antioxidant enzyme that catalyzes the dismutation of superoxide radicals, and oxidative stress is implicated in pulmonary hypertension pathogenesis. There have been studies showing that gene transfer of extracellular SOD can reduce oxidative stress and improve pulmonary hypertension in animal models, including rats. For example, research has demonstrated that adenovirus-mediated gene transfer of extracellular SOD attenuates pulmonary hypertension in rat models by reducing oxidative stress in the pulmonary vasculature. Based on the published scientific literature, the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12668498",
    "question": "Do aT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Let me analyze what we know about this relationship:\\n\\nPreeclampsia is a pregnancy complication characterized by high blood pressure and signs of damage to other organ systems. Research has shown that women with preeclampsia often have autoantibodies that act as agonists (activators) of the angiotensin II type 1 (AT1) receptor.\\n\\nNADPH oxidase is an enzyme complex that produces reactive oxygen species (ROS). \\n\\nThe scientific literature indicates that AT1 receptor agonistic antibodies from preeclamptic women can indeed activate NADPH oxidase, leading to increased oxidative stress. This is one of the proposed mechanisms by which these autoantibodies contribute to the pathophysiology of preeclampsia. Studies have demonstrated that these antibodies stimulate NADPH oxidase activity in various cell types, including vascular smooth muscle cells and trophoblasts.\\n\\nBased on the established scientific evidence, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19513075",
    "question": "Is the association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drug dependent on the p53 mutational status in cellular models?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drugs, specifically whether this association depends on p53 mutational status in cellular models. To answer this, I would need specific scientific evidence about this relationship. MDM2 is a negative regulator of p53, and polymorphisms in MDM2 could potentially affect p53 function and thus drug sensitivity. However, without specific studies showing that the T309G polymorphism's effect on drug sensitivity varies based on whether p53 is mutated or wild-type in cellular models, I cannot confirm this relationship. The question requires specific scientific evidence about this three-way interaction (MDM2 T309G polymorphism, anticancer drug sensitivity, and p53 mutation status) in cellular models, which I don't have definitive information about.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24686354",
    "question": "Are laparoscopic repair of ventral hernia in a laparoscopic experienced surgical center : low recurrence rate , morbidity , and chronic pain achievable?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether laparoscopic repair of ventral hernia in a laparoscopic experienced surgical center can achieve low recurrence rate, morbidity, and chronic pain. This is asking about the feasibility of achieving good outcomes (specifically low rates of negative outcomes) when performing this procedure in centers with appropriate expertise. Based on current medical literature, laparoscopic ventral hernia repair in experienced centers is generally associated with lower recurrence rates, reduced morbidity, and less chronic pain compared to traditional open repairs. The question is phrased in a way that asks if these positive outcomes are achievable, and the evidence suggests they are.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22309452",
    "question": "Does cardiovascular magnetic resonance by non contrast T1-mapping allow assessment of severity of injury in acute myocardial infarction?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if non-contrast T1-mapping in cardiovascular magnetic resonance (CMR) can be used to assess the severity of injury in acute myocardial infarction. Based on medical literature, non-contrast T1-mapping is indeed a technique that can detect and quantify myocardial injury in acute myocardial infarction. T1 values are typically elevated in regions of acute myocardial injury, and the degree of T1 elevation has been shown to correlate with the severity of myocardial damage. This technique allows for tissue characterization without the need for gadolinium contrast agents. Multiple studies have demonstrated that native (non-contrast) T1-mapping can differentiate between normal and infarcted myocardium and can provide information about the extent and severity of myocardial injury in acute myocardial infarction.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26629403",
    "question": "Do adipocyte progenitor cells initiate monocyte chemoattractant protein-1-mediated macrophage accumulation in visceral adipose tissue?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific biological mechanism: whether adipocyte progenitor cells (cells that can develop into adipocytes or fat cells) initiate a process involving monocyte chemoattractant protein-1 (MCP-1) that leads to macrophage accumulation in visceral adipose tissue (fat tissue around internal organs).\\n\\nTo answer this accurately, I would need to know if research has established that adipocyte progenitor cells are the specific cell type that initiates or triggers MCP-1 secretion that then leads to macrophage recruitment in visceral fat.\\n\\nBased on my knowledge of adipose tissue biology, while MCP-1 (also known as CCL2) is indeed involved in recruiting macrophages to adipose tissue during obesity and inflammation, it's typically mature adipocytes and resident immune cells (not specifically adipocyte progenitor cells) that are the primary sources of MCP-1 in this context. Adipocyte progenitor cells may contribute to this process but are not generally considered the initiators of this specific pathway.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "8213238",
    "question": "Do elderly outpatients respond favorably to a physician-initiated advance directive discussion?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether elderly outpatients have a positive reaction when physicians initiate discussions about advance directives (documents that specify a person's wishes for medical care if they become unable to make decisions). To answer this, I would need evidence from studies on patient reactions to such discussions. Without specific research data provided in the question, I cannot make a definitive claim. However, research generally shows that many patients appreciate the opportunity to discuss advance care planning with their physicians, though individual responses vary. The question specifically asks about 'elderly outpatients' and their response being 'favorable' to 'physician-initiated' discussions, which are specific parameters.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25522432",
    "question": "Does manganese-enhanced magnetic resonance imaging reveal differential long-term neuroadaptation after methamphetamine and the substituted cathinone 4-methylmethcathinone ( mephedrone )?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if manganese-enhanced magnetic resonance imaging (MEMRI) shows different long-term neuroadaptations when comparing methamphetamine and mephedrone (4-methylmethcathinone). This is a specific scientific question about neuroimaging findings comparing these two substances. To answer this accurately, I would need to know if studies using MEMRI have indeed found differential neuroadaptations between these two substances. Without specific knowledge of such studies, I cannot definitively answer yes or no. However, based on the phrasing, it seems to be referencing a specific research finding. Since I don't have definitive knowledge about this specific research question, I should answer 'no' to avoid making an unsupported claim.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18191989",
    "question": "Does early treatment reduce the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether early treatment reduces cardiovascular risk factors in newly diagnosed rheumatoid arthritis (RA) patients. To answer this, I need to consider what is known about the relationship between RA, cardiovascular risk, and the timing of treatment.\\n\\nIt is well-established in medical literature that RA is associated with increased cardiovascular risk. This is due to the systemic inflammation that characterizes RA, which can accelerate atherosclerosis and affect cardiovascular health. \\n\\nRegarding early treatment, there is evidence that early aggressive treatment of RA with disease-modifying antirheumatic drugs (DMARDs) and biologics can reduce systemic inflammation. By controlling inflammation early in the disease course, these treatments may help reduce cardiovascular risk factors.\\n\\nMultiple studies have shown that effective control of RA disease activity is associated with improvements in lipid profiles, endothelial function, and other cardiovascular risk markers. Early intervention strategies that achieve better control of inflammation appear to have beneficial effects on cardiovascular risk parameters.\\n\\nBased on the current medical evidence, early treatment of RA does appear to reduce cardiovascular risk factors in newly diagnosed patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25862596",
    "question": "Is early menarche associated with increased risk of asthma : Prospective population-based study of twins?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if early menarche (the first occurrence of menstruation) is associated with increased risk of asthma, specifically in a prospective population-based study of twins. To answer this, I would need to know the results of this specific study. The question appears to be referencing a particular research paper or study that examined the relationship between early menarche and asthma risk in twins. Without having access to this specific study or its findings, I cannot definitively say whether the study found an association between early menarche and increased asthma risk.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17408650",
    "question": "Do enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if enteric glia regulate intestinal barrier function and inflammation through the release of S-nitrosoglutathione. Let me analyze what we know about enteric glia and their functions.\\n\\nEnteric glia are glial cells found in the enteric nervous system of the gut. They do play important roles in maintaining intestinal homeostasis, including barrier function and inflammatory responses.\\n\\nRegarding S-nitrosoglutathione specifically: S-nitrosoglutathione (GSNO) is a nitric oxide donor and has been implicated in some signaling pathways. However, based on current scientific literature, while enteric glia do release various factors that influence intestinal barrier function and inflammation, S-nitrosoglutathione is not well-established as a primary mediator released by enteric glia for these functions.\\n\\nThe main signaling molecules released by enteric glia that affect intestinal barrier function include glial-derived neurotrophic factor (GDNF), transforming growth factor beta (TGF-β), and certain pro-resolving mediators. S-nitrosoglutathione is not typically cited as a major factor in this process.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17766092",
    "question": "Is anemonin a natural bioactive compound that can regulate tyrosinase-related proteins and mRNA in human melanocytes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to determine if anemonin has been shown to regulate tyrosinase-related proteins and mRNA in human melanocytes. Anemonin is a natural bioactive compound found in plants of the Ranunculaceae family. It has various biological activities including anti-inflammatory and anti-cancer properties. However, to answer this specific question, I need to recall if there's evidence that anemonin specifically regulates tyrosinase-related proteins and mRNA in human melanocytes. Tyrosinase is a key enzyme in melanin production in melanocytes. Based on my knowledge, while anemonin has several bioactivities, I don't recall specific evidence showing it regulates tyrosinase-related proteins and mRNA in human melanocytes. There are other natural compounds like arbutin, kojic acid, and certain plant extracts that have been well-documented to affect tyrosinase activity, but anemonin is not typically cited in this specific context.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24571676",
    "question": "Are rAS mutations in early age leukaemia modulated by NQO1 rs1800566 ( C609T ) associated with second-hand smoking exposures?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question step by step:\\n\\n1. The question asks about a relationship between several factors:\\n   - rAS mutations in early age leukemia\\n   - NQO1 rs1800566 (C609T) polymorphism\\n   - Second-hand smoking exposures\\n\\n2. Specifically, it's asking if rAS mutations are modulated (influenced or affected) by the NQO1 genetic variant in the context of second-hand smoking exposure.\\n\\n3. To answer this definitively, I would need specific research evidence showing this three-way interaction.\\n\\nWhile there is research on:\\n- NQO1 polymorphisms and cancer risk\\n- Smoking and leukemia risk\\n- RAS mutations in leukemia\\n\\nI don't have definitive evidence of this specific three-way interaction where NQO1 rs1800566 modulates the relationship between second-hand smoking and rAS mutations in early age leukemia. Without specific research demonstrating this relationship, I cannot confirm this as established scientific fact.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20722034",
    "question": "Does the proteasome inhibitor bortezomib drastically affect inflammation and bone disease in adjuvant-induced arthritis in rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats. To answer this, I need to consider what is known about bortezomib's effects in this specific model.\\n\\nBortezomib (Velcade) is a proteasome inhibitor that has been studied in various inflammatory conditions. In the context of adjuvant-induced arthritis (AIA) in rats, which is a model of rheumatoid arthritis, research has shown that bortezomib does have significant effects.\\n\\nStudies have demonstrated that bortezomib treatment in AIA rat models results in:\\n1. Significant reduction in joint inflammation\\n2. Protection against bone erosion and cartilage destruction\\n3. Suppression of inflammatory cytokine production\\n4. Inhibition of osteoclast formation and activity\\n\\nThese effects are considered drastic as they substantially alter the disease progression and severity in this model. The therapeutic effects on both the inflammatory component and the bone destruction component of the disease are well-documented in the literature.\\n\\nSo yes, bortezomib does drastically affect both inflammation and bone disease in this rat model.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22548688",
    "question": "Does histology obtained by needle biopsy give additional information on the prognosis of hepatocellular carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether histology obtained by needle biopsy provides additional prognostic information for hepatocellular carcinoma (HCC). To answer this, I need to consider what is known about needle biopsy histology in HCC prognosis.\\n\\nNeedle biopsy can provide histological information about HCC including:\\n- Tumor grade/differentiation\\n- Presence of vascular invasion\\n- Histological subtypes\\n- Molecular markers\\n\\nThese histological features obtained from needle biopsy samples can indeed provide prognostic information. For example:\\n- Poorly differentiated tumors generally have worse prognosis\\n- Presence of microvascular invasion is associated with higher recurrence rates\\n- Certain histological variants have different prognostic implications\\n- Molecular markers identified in biopsy samples can predict treatment response\\n\\nWhile imaging and clinical parameters are important for HCC prognosis, histology from needle biopsy does provide additional information that can help refine prognostic assessment and guide treatment decisions. Therefore, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23382627",
    "question": "Does combined early fluid resuscitation and hydrogen inhalation attenuate lung and intestine injury?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if combined early fluid resuscitation and hydrogen inhalation attenuates (reduces) lung and intestine injury. To answer this, I need to consider if there's scientific evidence supporting this specific combination therapy for reducing damage to lungs and intestines.\\n\\nBased on medical literature, hydrogen gas has been studied for its potential anti-inflammatory and antioxidant properties, and there is some research suggesting it may have protective effects against organ damage in certain conditions. Fluid resuscitation is a standard treatment for various conditions involving shock or severe fluid loss.\\n\\nSome studies have investigated hydrogen's protective effects on organs including lungs and intestines in models of ischemia-reperfusion injury, sepsis, and other conditions. There is research suggesting that hydrogen inhalation may reduce inflammation and oxidative stress in lung and intestinal tissues.\\n\\nThere are indeed studies that have examined the combined effect of fluid resuscitation and hydrogen therapy, finding that this combination may provide better protection against organ damage than either treatment alone in certain experimental models of injury. The combination appears to help maintain tissue perfusion while simultaneously reducing oxidative damage and inflammation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12807232",
    "question": "Is parametrial spread a prognostic factor in endometrial carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Parametrial spread refers to the extension of cancer cells from the endometrium into the parametrium, which is the connective tissue surrounding the uterus. In endometrial carcinoma, parametrial involvement indicates advanced disease. To answer this question, I need to consider whether parametrial spread affects prognosis (survival outcomes, recurrence rates, etc.) in endometrial cancer patients.\\n\\nIn gynecologic oncology, parametrial spread is generally considered an adverse prognostic factor because:\\n1. It indicates more extensive disease beyond the uterine corpus\\n2. It represents a more advanced stage (FIGO stage III or IV)\\n3. It often requires more aggressive treatment\\n4. It is associated with higher rates of recurrence and poorer survival\\n\\nNumerous studies have shown that parametrial involvement in endometrial cancer is associated with decreased overall survival and disease-free survival. It is one of several factors (along with depth of myometrial invasion, lymphovascular space invasion, histologic grade, and lymph node metastasis) that help determine prognosis and guide treatment decisions.\\n\\nTherefore, parametrial spread is indeed a prognostic factor in endometrial carcinoma.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19133994",
    "question": "Does acute hypertension reveal depressor and vasodilator effects of cannabinoids in conscious rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats. To answer this, I need to consider whether there is scientific evidence showing that when rats experience acute hypertension, cannabinoids demonstrate blood pressure-lowering (depressor) and blood vessel-dilating (vasodilator) effects. This is a specific scientific claim about cannabinoid pharmacology in a particular experimental model. Without specific research knowledge on this topic, I cannot definitively answer. However, based on general pharmacological principles, cannabinoids (particularly CB1 receptor agonists) have been shown to affect cardiovascular function in various models. The question appears to be referencing a specific research finding about how these effects manifest particularly during acute hypertensive states in conscious (non-anesthetized) rats.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24614698",
    "question": "Does meconium microbiome analysis identify bacteria correlated with premature birth?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if meconium microbiome analysis identifies bacteria correlated with premature birth. Meconium is the first stool of a newborn, and microbiome analysis refers to studying the microbial communities present in the meconium. Research has indeed shown that the meconium microbiome can differ between preterm and full-term infants, and some studies have identified specific bacterial signatures or compositions that correlate with premature birth. For example, some research has found differences in Enterobacteriaceae, Lactobacillus, and other bacterial taxa between preterm and full-term infants' meconium. These differences may reflect in utero exposures or development that relate to preterm birth. So yes, meconium microbiome analysis has identified bacteria that correlate with premature birth in scientific studies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "14606072",
    "question": "Does serum from rabbit orally administered cobra venom inhibit growth of implanted hepatocellular carcinoma cells in mice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether serum from rabbits that were orally given cobra venom can inhibit the growth of implanted liver cancer cells (hepatocellular carcinoma) in mice. This is asking about a specific scientific finding. To answer this accurately, I would need to know if there are studies showing that serum from rabbits that consumed cobra venom has anti-cancer properties specifically against hepatocellular carcinoma cells in mouse models. Without specific scientific literature on this exact experimental setup, I cannot confirm this claim. While cobra venom has been studied for potential anti-cancer properties, this specific preparation method (oral administration to rabbits) and its effect on hepatocellular carcinoma in mice is a very specific claim that requires evidence from published research.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "8595534",
    "question": "Does drug utilization evaluation identify costs associated with high use of beta-adrenergic agonists?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if drug utilization evaluation identifies costs associated with high use of beta-adrenergic agonists. Drug utilization evaluation (DUE) is a systematic process designed to assess the appropriateness, medical necessity, and efficiency of medication use. It typically involves reviewing patterns of drug prescribing, dispensing, administration, and use against predetermined criteria and standards. While DUE can certainly identify patterns of high use of medications like beta-adrenergic agonists, the question specifically asks about identifying costs associated with such high use. DUE programs often do include cost analysis components, as they are frequently implemented to improve both clinical outcomes and cost-effectiveness of drug therapy. So yes, a comprehensive DUE would typically identify costs associated with high utilization patterns of any medication class, including beta-adrenergic agonists.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26742787",
    "question": "Do x. couchianus and X. hellerii genome models provide genomic variation insight among Xiphophorus species?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if x. couchianus and X. hellerii genome models provide genomic variation insight among Xiphophorus species. To answer this, I need to determine if these specific genome models have been used to study genomic variation within the Xiphophorus genus.\\n\\nXiphophorus is a genus of freshwater fish that includes swordtails and platyfish. Genomic studies of these species can reveal evolutionary relationships and genetic variation.\\n\\nBased on scientific literature, both X. couchianus (a platyfish) and X. hellerii (a swordtail) have had their genomes sequenced and assembled as reference genome models. These genome models have indeed been used in comparative genomic studies to identify genetic variations, structural differences, and evolutionary patterns among Xiphophorus species.\\n\\nResearchers have used these genome models to study species-specific genetic elements, gene duplications, deletions, and other structural variations that provide insights into the genomic diversity within the Xiphophorus genus.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21865999",
    "question": "Does functioning free gracilis myocutaneous flap transfer provide a reliable single-stage facial reconstruction and reanimation following tumor ablation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if functioning free gracilis myocutaneous flap transfer provides a reliable single-stage facial reconstruction and reanimation following tumor ablation. Let me analyze this based on medical knowledge about this procedure.\\n\\nThe free gracilis myocutaneous flap is indeed used in facial reconstruction and reanimation after tumor removal. It involves transferring the gracilis muscle (usually from the thigh) with its blood supply and nerve to the face. When it's described as 'functioning,' it means the transferred muscle can be innervated to provide movement.\\n\\nHowever, the key question is whether this provides a 'reliable single-stage' solution. Based on medical literature, while free gracilis transfer is an established technique for facial reanimation, it typically requires:\\n1. A complex microsurgical procedure\\n2. Often needs nerve coaptation to facial nerve branches or cross-facial nerve grafting\\n3. May require a period of rehabilitation and nerve regeneration\\n\\nImportantly, many cases of facial reanimation, especially after tumor ablation where the facial nerve may be compromised, are performed in multiple stages rather than as a single-stage procedure. The first stage might involve nerve grafting, and the second stage the actual muscle transfer.\\n\\nSo while free gracilis myocutaneous flap transfer is a valuable technique for facial reconstruction and reanimation, it is not consistently performed as a reliable single-stage procedure in all cases following tumor ablation.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27639796",
    "question": "Is impaired Sleep Quality Associated with More Significant Lower Urinary Tract Symptoms in Male Shift Workers?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if impaired sleep quality is associated with more significant lower urinary tract symptoms (LUTS) in male shift workers. To answer this, I need to consider the research evidence on this specific relationship. \\n\\nShift work is known to disrupt circadian rhythms and sleep patterns. Poor sleep quality has been linked to various health issues. Lower urinary tract symptoms include issues like frequent urination, urgency, weak stream, etc.\\n\\nThere is research suggesting that disrupted sleep patterns can affect urinary function. Studies have shown associations between poor sleep quality and increased nocturia (nighttime urination) and other LUTS. Shift workers often experience poorer sleep quality than those with regular daytime schedules.\\n\\nSpecifically for male shift workers, some studies have found that those with disrupted sleep patterns report higher rates and severity of LUTS compared to those with better sleep quality. The physiological mechanisms may involve hormonal changes, autonomic nervous system effects, and inflammatory processes that connect sleep disruption to urinary symptoms.\\n\\nBased on the available scientific literature, there does appear to be an association between impaired sleep quality and more significant LUTS specifically in male shift workers.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23190762",
    "question": "Does preinfarction angina affect infarct size in STEMI patients undergoing primary angioplasty?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether preinfarction angina (angina that occurs before a heart attack) affects the size of the infarct (area of dead heart tissue) in patients with ST-elevation myocardial infarction (STEMI) who are undergoing primary angioplasty (a procedure to open blocked coronary arteries).\\n\\nTo answer this question, I need to consider the medical literature on this topic. Research has shown that preinfarction angina can have a cardioprotective effect through ischemic preconditioning, where brief episodes of ischemia before a major ischemic event can reduce the final infarct size. Several studies have demonstrated that patients with preinfarction angina often have smaller infarct sizes, better left ventricular function, and improved clinical outcomes after STEMI, even when treated with primary angioplasty.\\n\\nThis phenomenon has been observed in various clinical settings, including in patients undergoing primary percutaneous coronary intervention (PCI)/angioplasty for STEMI.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "16299032",
    "question": "Do four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if I should 'do four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort'. This appears to be asking if I should perform or conduct a medical research study that follows patients with primary biliary cirrhosis over a four-year period, specifically tracking their fatigue symptoms, within a geographically defined area. As an AI assistant, I cannot physically conduct medical research or clinical studies, as I don't have a physical presence, cannot interact with patients, cannot collect data over time, and don't have the capability to run medical studies.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9065136",
    "question": "Are elevated endothelin levels associated with increased placental resistance?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the relationship between elevated endothelin levels and placental resistance. Endothelin is a potent vasoconstrictor peptide that can cause blood vessel constriction. In the context of pregnancy and placental function, endothelin has been studied for its potential role in various pregnancy complications. Elevated endothelin levels have indeed been associated with vasoconstriction in the placental vasculature, which can lead to increased placental vascular resistance. This relationship has been documented in conditions like preeclampsia, where elevated endothelin levels contribute to the increased placental resistance observed in this disorder. So based on the medical literature, there is an association between elevated endothelin levels and increased placental resistance.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "8159379",
    "question": "Do umbilical artery steal syndrome and distal gangrene in a case of twin-twin transfusion syndrome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking if umbilical artery steal syndrome and distal gangrene occur in twin-twin transfusion syndrome (TTTS). TTTS is a complication of monochorionic twin pregnancies where abnormal placental vascular anastomoses lead to unequal blood flow between twins. Umbilical artery steal syndrome can occur in TTTS, where blood is diverted from one twin to the other through the placental anastomoses. This can lead to compromised blood flow to the extremities of the donor twin, potentially resulting in distal gangrene in severe cases. So yes, umbilical artery steal syndrome and distal gangrene can occur in cases of twin-twin transfusion syndrome.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17206669",
    "question": "Is patchy distribution of mucosal lesions in ileal Crohn 's disease linked to differences in the dominant mucosa-associated bacteria : a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether a specific research study titled 'Is patchy distribution of mucosal lesions in ileal Crohn's disease linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis?' exists. This appears to be the title of a scientific paper that investigates the relationship between the patchy distribution of mucosal lesions in ileal Crohn's disease and differences in the dominant mucosa-associated bacteria, using specific techniques (fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis). Since this is phrased as a complete title of a research paper rather than asking about the scientific finding itself, the question is asking if this study exists.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "19661720",
    "question": "Are oxygen uptake kinetics during and after exercise useful markers of coronary artery disease in patients with exercise electrocardiography suggesting myocardial ischemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether oxygen uptake kinetics (how the body takes up and utilizes oxygen) during and after exercise can serve as useful markers for identifying coronary artery disease (CAD) in a specific patient population - those whose exercise electrocardiography (ECG) results suggest myocardial ischemia (reduced blood flow to the heart muscle).\\n\\nTo answer this question accurately, I would need to know whether research has established a reliable connection between oxygen uptake patterns and coronary artery disease specifically in patients who already show ECG signs of ischemia during exercise testing.\\n\\nBased on medical literature, oxygen uptake kinetics (including parameters like VO2 recovery, oxygen deficit, etc.) have been shown to be altered in patients with coronary artery disease. Slower oxygen uptake kinetics during exercise and delayed recovery after exercise are characteristic findings in CAD patients. These abnormalities reflect impaired oxygen delivery and utilization due to compromised coronary blood flow.\\n\\nIn patients who already show ECG changes suggesting ischemia, oxygen uptake kinetics can provide complementary physiological information about the functional impact of coronary artery disease. This can be particularly useful as an additional marker for disease severity and functional capacity.\\n\\nSo yes, oxygen uptake kinetics during and after exercise are useful markers of coronary artery disease in patients with exercise electrocardiography suggesting myocardial ischemia.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10617751",
    "question": "Is skin-to-skin contact analgesic in healthy newborns?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether skin-to-skin contact has pain-relieving (analgesic) effects in healthy newborns. Based on scientific research, skin-to-skin contact (also called kangaroo care) has been shown to reduce pain responses in newborns during painful procedures like heel lances or vaccinations. Multiple studies have demonstrated that when healthy newborns are held skin-to-skin with their parents (typically mothers) during painful procedures, they show reduced behavioral and physiological indicators of pain compared to infants who don't receive skin-to-skin contact. This effect has been well-documented in the scientific literature.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12234293",
    "question": "Does iGF-1-induced lipid accumulation impair mesangial cell migration and contractile function?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question. It's asking about the effects of iGF-1-induced lipid accumulation on mesangial cells, specifically whether it impairs two functions: migration and contractile function. Mesangial cells are found in the kidneys and play a role in regulating glomerular filtration. IGF-1 (insulin-like growth factor 1) is a hormone that can affect cell metabolism. The question is asking if when IGF-1 causes lipid accumulation in these cells, does it negatively impact their ability to migrate and contract. Based on research in this area, IGF-1-induced lipid accumulation has been shown to impair mesangial cell function, including both migration and contractility. This is part of the pathophysiology in certain kidney diseases.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25062877",
    "question": "Is small intestinal bacterial overgrowth common both among patients with alcoholic and idiopathic chronic pancreatitis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if small intestinal bacterial overgrowth (SIBO) is common in both alcoholic chronic pancreatitis and idiopathic chronic pancreatitis patients. To answer this, I need to consider whether SIBO is a frequent finding in both these specific types of chronic pancreatitis.\\n\\nBased on medical literature, SIBO is indeed associated with chronic pancreatitis in general due to several factors including pancreatic enzyme insufficiency, altered intestinal motility, and structural changes. Studies have shown that SIBO occurs with increased frequency in chronic pancreatitis patients regardless of etiology.\\n\\nSpecifically, both alcoholic chronic pancreatitis (the most common form) and idiopathic chronic pancreatitis (where the cause is unknown) have been associated with increased rates of SIBO compared to healthy controls. The mechanisms causing SIBO appear similar across different etiologies of chronic pancreatitis.\\n\\nTherefore, yes, SIBO is common in both alcoholic and idiopathic forms of chronic pancreatitis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26087952",
    "question": "Are hemoglobin levels and blood pressure associated in rural black africans?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a potential association between hemoglobin levels and blood pressure specifically in rural Black African populations. To answer this accurately, I would need to be familiar with medical research studies conducted on this specific population. There have been studies showing associations between hemoglobin levels and blood pressure in various populations, with some research suggesting that higher hemoglobin levels can be associated with higher blood pressure. However, I need to be careful about generalizing findings from other populations to specifically rural Black African populations, as there could be genetic, environmental, dietary, or other factors that influence this relationship differently in this specific group. Based on general medical knowledge, there is some evidence suggesting an association between these two physiological parameters across different populations, but I should be specific about the evidence for this particular population.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23801613",
    "question": "Does [ Aminoguanidine suppress methylglyoxal-mediated oxygen-glucose deprivation injury in human brain microvascular endothelial cells ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether aminoguanidine suppresses methylglyoxal-mediated oxygen-glucose deprivation injury in human brain microvascular endothelial cells. To answer this, I need to analyze what is known about aminoguanidine's effects on methylglyoxal-mediated injury in this specific cell type.\\n\\nAminoguanidine is known to be an inhibitor of advanced glycation end products (AGEs) formation and is often used to prevent methylglyoxal-induced damage in various experimental settings. Methylglyoxal is a reactive dicarbonyl compound that can cause cellular damage, and oxygen-glucose deprivation is a model used to simulate ischemic conditions.\\n\\nHowever, without specific research evidence about aminoguanidine's effects on methylglyoxal-mediated oxygen-glucose deprivation injury specifically in human brain microvascular endothelial cells, I cannot definitively answer this question. The question appears to be asking about a specific research finding that I don't have information about.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12763763",
    "question": "Does angiotensin II inhibit endothelial cell motility through an AT1-dependent oxidant-sensitive decrement of nitric oxide availability?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific mechanism of action for angiotensin II on endothelial cells. Let me break down the components of this question:\\n\\n1. Does angiotensin II inhibit endothelial cell motility?\\n2. If so, is this inhibition through an AT1-dependent mechanism?\\n3. Does this mechanism involve an oxidant-sensitive decrement of nitric oxide availability?\\n\\nThis is a very specific scientific question about cellular and molecular mechanisms. Without specific scientific literature or data on this topic, I cannot definitively answer whether this particular mechanism has been established. The question appears to be referencing a specific research finding or hypothesis in cardiovascular or vascular biology research.\\n\\nBased on general knowledge, angiotensin II is known to have effects on endothelial function, AT1 receptors are a known target of angiotensin II, and nitric oxide is important for endothelial function. However, the specific mechanistic pathway described is too detailed to confirm without reference to specific research.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16785261",
    "question": "Does a relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles lead to lower live birth rates?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether a relative reduction in mid-follicular LH (luteinizing hormone) concentrations during GnRH (gonadotropin-releasing hormone) agonist IVF/ICSI (in vitro fertilization/intracytoplasmic sperm injection) cycles leads to lower live birth rates.\\n\\nTo answer this question, I need to consider whether there is established evidence in reproductive medicine that shows a causal relationship between reduced mid-follicular LH levels specifically in GnRH agonist protocols and decreased live birth outcomes.\\n\\nWhile GnRH agonists do suppress LH levels as part of their mechanism of action, the current scientific consensus does not strongly support that moderate reductions in mid-follicular LH during controlled ovarian stimulation with GnRH agonist protocols directly cause lower live birth rates. Most studies show that as long as LH is present at minimal threshold levels, follicular development and oocyte quality can be maintained. Modern protocols often supplement with exogenous gonadotropins to ensure adequate follicular development.\\n\\nThe evidence does not conclusively demonstrate that relative reductions in mid-follicular LH concentrations during GnRH agonist cycles directly lead to lower live birth rates.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15361285",
    "question": "Does rac1 regulate the release of Weibel-Palade Bodies in human aortic endothelial cells?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To answer this question, I need to determine if there's evidence that rac1 (a small GTPase) regulates the release of Weibel-Palade Bodies (WPBs) in human aortic endothelial cells specifically.\\n\\nWeibel-Palade Bodies are endothelial cell-specific organelles that store and release von Willebrand factor (vWF) and other proteins involved in inflammation and hemostasis.\\n\\nRac1 is known to be involved in various cellular processes including cytoskeletal reorganization and vesicle trafficking in endothelial cells.\\n\\nFrom my knowledge base, there is evidence that small GTPases including Rac1 are involved in regulating exocytosis in various cell types. However, for WPB release specifically in human aortic endothelial cells, the literature shows that RhoA and Rac1 have been implicated in regulating endothelial barrier function and some secretory processes, but I don't recall specific studies demonstrating that Rac1 directly regulates WPB release in human aortic endothelial cells specifically.\\n\\nWhile Rac1 may be involved in general endothelial cell function, without specific evidence linking it to WPB release in human aortic endothelial cells, I cannot confirm this relationship.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24719804",
    "question": "Does saffron improve epididymal sperm parameters in rats exposed to cadmium?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if saffron improves epididymal sperm parameters in rats exposed to cadmium. To answer this, I would need to know if there are scientific studies showing that saffron has a protective or ameliorative effect on sperm parameters (like count, motility, morphology) in rats that have been exposed to cadmium, which is known to have reproductive toxicity. Without specific scientific evidence about this particular interaction between saffron, cadmium exposure, and rat sperm parameters, I cannot make a definitive claim. However, there are studies suggesting saffron has antioxidant properties that may protect against various toxicants in reproductive systems, so it's plausible but I need to be careful not to overstate the evidence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23186644",
    "question": "Does a glucagon-like peptide-1 analog reverse the molecular pathology and cardiac dysfunction of a mouse model of obesity?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a glucagon-like peptide-1 (GLP-1) analog can reverse the molecular pathology and cardiac dysfunction in a mouse model of obesity. To answer this, I would need specific research evidence about GLP-1 analogs' effects on cardiac dysfunction in obese mice. While GLP-1 analogs (like liraglutide, semaglutide, etc.) are known to help with weight loss and have some cardiovascular benefits in humans with type 2 diabetes, the question specifically asks about reversing molecular pathology and cardiac dysfunction in an obesity mouse model. Without specific research evidence about this particular effect in mice, I cannot definitively say yes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12407932",
    "question": "Is leukocyte scintigraphy with 99mTc-exametazime-labeled leukocytes useful for follow-up of systemic vasculitis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if leukocyte scintigraphy with 99mTc-exametazime-labeled leukocytes is useful for follow-up of systemic vasculitis. To answer this, I need to consider whether this specific nuclear medicine imaging technique has established clinical utility in monitoring disease activity or treatment response in systemic vasculitis.\\n\\nLeukocyte scintigraphy involves labeling a patient's white blood cells with a radiotracer (in this case 99mTc-exametazime) and then detecting areas of inflammation where these labeled cells accumulate. While this technique is used for detecting infection and inflammation, its specific utility in systemic vasculitis follow-up is less established.\\n\\nBased on medical literature, PET/CT and MRI are more commonly used imaging modalities for vasculitis follow-up. While leukocyte scintigraphy can detect inflammation, it is not typically part of standard follow-up protocols for systemic vasculitis. There is limited evidence supporting its routine use specifically for monitoring vasculitis activity compared to other available techniques.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "11546913",
    "question": "Does bone morphogenetic protein-6 reduce ischemia-induced brain damage in rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if bone morphogenetic protein-6 (BMP-6) reduces ischemia-induced brain damage in rats. To answer this, I need to consider whether there is scientific evidence showing that BMP-6 has a protective effect against brain damage caused by ischemia (restricted blood supply) in rat models.\\n\\nBone morphogenetic proteins (BMPs) are growth factors known to play roles in various biological processes including tissue repair. Some BMPs have been studied for neuroprotective effects, but I need to specifically determine if BMP-6 has been shown to reduce ischemic brain damage in rats.\\n\\nBased on my knowledge, there are studies suggesting that BMP-6 has neuroprotective properties and can promote recovery after various types of neural injury. Some research has indicated that BMP-6 may protect against ischemic damage in rat models by reducing inflammation, promoting cell survival, or enhancing neurogenesis.\\n\\nSpecifically, there are studies showing that BMP-6 administration can reduce infarct size and improve functional outcomes in rat models of cerebral ischemia. The protective mechanisms may involve anti-inflammatory effects, anti-apoptotic actions, and promotion of angiogenesis.\\n\\nTherefore, based on the available scientific evidence, I can answer yes to this question.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17669215",
    "question": "Does depo-Provera abrogate attenuated lentivirus-induced protection in male rhesus macaques challenged intravenously with pathogenic SIVmac239?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific scientific study involving depo-Provera (a contraceptive), attenuated lentivirus vaccines, and SIV challenge in male rhesus macaques. Specifically, it's asking if depo-Provera negates the protection provided by attenuated lentivirus vaccines when male macaques are challenged with SIVmac239 intravenously.\\n\\nTo answer this accurately, I would need specific research data on this exact experimental setup. This is a very specific scientific question about the interaction between depo-Provera (typically used in females) and vaccine efficacy in male macaques. Without specific research data on this exact scenario, I cannot provide a definitive answer. There's no common knowledge about depo-Provera abrogating vaccine protection specifically in male macaques challenged intravenously with SIVmac239.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16635054",
    "question": "Are malaysian Indians genetically similar to Caucasians : CYP2C9 polymorphism?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about genetic similarity between Malaysian Indians and Caucasians, specifically regarding CYP2C9 polymorphism. CYP2C9 is a gene that encodes an enzyme involved in drug metabolism, and it has several known polymorphisms (genetic variations) that can differ across populations. To answer this accurately, I need to consider what research shows about CYP2C9 polymorphism distributions in Malaysian Indians compared to Caucasian populations. Malaysian Indians are generally descendants of people from the Indian subcontinent, and their genetic profile would be more closely related to South Asian populations than to Caucasian populations. Research on CYP2C9 polymorphisms has shown distinct distribution patterns across different ethnic groups, and Malaysian Indians would typically show patterns more similar to other South Asian populations than to Caucasians.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26070774",
    "question": "Do adipose-derived Mesenchymal Stem Cells Are Phenotypically Superior for Regeneration in the Setting of Osteonecrosis of the Femoral Head?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether adipose-derived Mesenchymal Stem Cells (MSCs) are phenotypically superior for regeneration in the setting of osteonecrosis of the femoral head compared to other types of MSCs (like bone marrow-derived MSCs). This is a comparative claim about the efficacy of a specific type of stem cells for a specific medical condition. To answer this definitively, I would need to review scientific literature comparing different sources of MSCs specifically for osteonecrosis of the femoral head treatment. Without specific studies showing that adipose-derived MSCs consistently outperform other MSC sources in this specific condition, I cannot confirm this claim as factually true. The question is phrased as a statement seeking confirmation, but I don't have sufficient evidence to make this determination.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "10439837",
    "question": "Is cD40 upregulation independent of HHV-8 in the pathogenesis of Kaposi 's sarcoma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether CD40 upregulation is independent of HHV-8 (Human Herpesvirus 8) in the pathogenesis of Kaposi's sarcoma. Kaposi's sarcoma is a cancer that forms in the lining of blood and lymph vessels and is strongly associated with HHV-8 infection, also known as Kaposi's sarcoma-associated herpesvirus (KSHV). CD40 is a costimulatory protein found on antigen-presenting cells and is required for their activation. To answer this question, I need to determine if CD40 upregulation in Kaposi's sarcoma occurs independently of HHV-8 infection or if it's directly linked to the virus. Based on the scientific literature, HHV-8 is actually known to encode viral proteins that can induce CD40 signaling pathways. The viral protein K13/vFLIP has been shown to mimic CD40 signaling and activate the NF-κB pathway. This suggests that CD40 upregulation in Kaposi's sarcoma is not independent of HHV-8 but is rather directly influenced by viral proteins. Therefore, CD40 upregulation is not independent of HHV-8 in the pathogenesis of Kaposi's sarcoma.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26938051",
    "question": "Does aCE2 antagonize VEGFa to Reduce Vascular Permeability During Acute Lung Injury?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if aCE2 (likely referring to angiotensin-converting enzyme 2) antagonizes VEGFa (vascular endothelial growth factor A) to reduce vascular permeability during acute lung injury. To answer this, I need to consider what's known about the relationship between ACE2 and VEGF in the context of lung injury.\\n\\nACE2 is known to have protective effects in acute lung injury models, as it converts angiotensin II to angiotensin-(1-7), which has anti-inflammatory and anti-fibrotic effects. VEGF is a signaling protein that promotes vascular permeability.\\n\\nThere is research suggesting that ACE2 can modulate the renin-angiotensin system in ways that might indirectly affect VEGF signaling. However, a direct antagonistic relationship where ACE2 specifically antagonizes VEGF to reduce vascular permeability is not well-established in the scientific literature.\\n\\nWhile both proteins are involved in pathways relevant to acute lung injury, the specific mechanism described in the question (direct antagonism of VEGFa by ACE2) is not a widely recognized or proven mechanism.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21071518",
    "question": "Do peritoneal albumin and protein losses predict outcome in peritoneal dialysis patients?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if peritoneal albumin and protein losses can predict outcomes in peritoneal dialysis patients. To answer this, I need to consider the medical research on this topic. Peritoneal dialysis involves the removal of waste products from the blood using the peritoneal membrane as a filter. During this process, some albumin and proteins can be lost into the dialysate. The question is whether these losses are predictive of patient outcomes.\\n\\nBased on medical literature, there is evidence that higher peritoneal protein losses are associated with increased mortality, cardiovascular events, and technique failure in peritoneal dialysis patients. Several studies have shown that peritoneal protein loss is an independent predictor of patient survival. Higher protein losses may reflect increased peritoneal membrane permeability, systemic inflammation, or other pathological processes that affect patient outcomes.\\n\\nSimilarly, peritoneal albumin loss has been associated with worse outcomes, including increased mortality and morbidity in peritoneal dialysis patients.\\n\\nSo yes, there is evidence in the medical literature supporting that peritoneal albumin and protein losses can predict outcomes in peritoneal dialysis patients.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "24936151",
    "question": "Does reduced expression of PinX1 correlate to progressive features in patients with prostate cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the correlation between reduced expression of PinX1 and progressive features in prostate cancer patients. To answer this, I would need to know if there are studies showing that when PinX1 expression is decreased, prostate cancer patients tend to show more advanced or aggressive disease characteristics. Without specific research data on this relationship, I cannot make a definitive claim. However, based on my knowledge, PinX1 (PIN2/TRF1-interacting telomerase inhibitor 1) has been studied as a tumor suppressor in various cancers, and its reduced expression has been associated with worse outcomes in some cancer types. For prostate cancer specifically, I need to recall if there are established correlations between PinX1 downregulation and disease progression.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18634161",
    "question": "Is tumor necrosis factor-alpha -1031 T/C polymorphism associated with smaller and more proatherogenic low density lipoprotein particles in patients with rheumatoid arthritis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if there is an association between tumor necrosis factor-alpha (TNF-α) -1031 T/C polymorphism and smaller, more proatherogenic low-density lipoprotein (LDL) particles specifically in rheumatoid arthritis (RA) patients. To answer this, I would need to know if research has established such a connection. Without specific research data on this particular polymorphism (-1031 T/C) and its effects on LDL particle size and atherogenicity in RA patients, I cannot provide a definitive answer. This would require knowledge of studies that have specifically examined this relationship in the RA population.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "1643888",
    "question": "Are plasma endothelin levels increased during septic shock?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, I need to recall what happens to endothelin levels during septic shock. Endothelin is a potent vasoconstrictor peptide produced by endothelial cells. In septic shock, there is typically widespread inflammation, vasodilation, and endothelial dysfunction. Research has shown that plasma endothelin levels are indeed elevated during septic shock, as part of the body's response to maintain blood pressure in the face of pathological vasodilation. Multiple studies have demonstrated increased circulating endothelin levels in patients with septic shock compared to healthy controls or non-septic patients. This elevation is thought to be part of the compensatory mechanism, although it may also contribute to organ dysfunction in prolonged cases.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21387259",
    "question": "Does activation of mammalian target of rapamycin pathway confer adverse outcome in nonsmall cell lung carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if activation of the mammalian target of rapamycin (mTOR) pathway leads to adverse outcomes in nonsmall cell lung carcinoma (NSCLC). To answer this, I need to consider what research shows about mTOR pathway activation in NSCLC.\\n\\nmTOR is a serine/threonine kinase that regulates cell growth, proliferation, and survival. In cancer, including NSCLC, the mTOR pathway is often dysregulated. Research has generally shown that activation of the mTOR pathway in NSCLC is associated with:\\n\\n1. Increased tumor growth and proliferation\\n2. Resistance to various therapies\\n3. Poor prognosis\\n4. Reduced overall survival\\n5. Increased metastatic potential\\n\\nMultiple studies have demonstrated that patients with NSCLC showing high mTOR pathway activation tend to have worse clinical outcomes compared to those with lower activation. This has led to the development of mTOR inhibitors as potential therapeutic agents for NSCLC.\\n\\nBased on the scientific literature, activation of the mTOR pathway does generally confer adverse outcomes in NSCLC patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17991148",
    "question": "Is wZS-pig a potential donor alternative in corneal xenotransplantation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if wZS-pig is a potential donor alternative in corneal xenotransplantation. Corneal xenotransplantation refers to the transplantation of corneal tissue from one species to another, typically from animals to humans. To answer this question, I need to determine if 'wZS-pig' is a recognized or established donor source in this field.\\n\\nI'm not familiar with a specific designation of 'wZS-pig' in the context of xenotransplantation research. While pigs in general are commonly studied as potential xenotransplantation donors (including for corneas), the specific 'wZS-pig' designation is not a standard or widely recognized term in the scientific literature that I'm aware of. It could be a specific genetic line or modified pig strain being researched, but without more context, I cannot confirm this is an established donor alternative.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19542263",
    "question": "Do measures in the first year of therapy predict the response to interferon beta in MS?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether measures taken in the first year of therapy can predict the response to interferon beta in multiple sclerosis (MS) patients. To answer this, I need to consider if there's established evidence that early measurements during interferon beta treatment correlate with long-term treatment outcomes in MS patients.\\n\\nBased on medical literature, there are indeed studies showing that certain parameters measured during the first year of interferon beta therapy (such as MRI lesions, relapse rates, neutralizing antibodies, and biomarkers) can have predictive value for long-term treatment response. For example, early MRI activity and breakthrough relapses in the first 6-12 months of treatment are often used as indicators of suboptimal response that might predict longer-term treatment failure.\\n\\nTherefore, the answer is yes - there is evidence that measures in the first year of therapy can predict the response to interferon beta in MS patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19065561",
    "question": "Does solder doped polycaprolactone scaffold enable reproducible laser tissue soldering?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if solder doped polycaprolactone scaffold enables reproducible laser tissue soldering. To answer this, I need to consider whether polycaprolactone (PCL) scaffolds that have been doped with solder material can consistently and reliably facilitate laser tissue soldering procedures. Laser tissue soldering is a technique for joining tissues using laser energy, often with a protein-based solder. PCL is a biodegradable polymer sometimes used as a scaffold material in tissue engineering. The question is specifically about whether combining these elements (PCL scaffold + solder doping) creates a reproducible laser tissue soldering process. Based on scientific literature, PCL scaffolds doped with albumin or other protein solders have indeed been shown to improve the reproducibility and mechanical strength of laser tissue soldering compared to liquid solders alone. The scaffold provides structural support and helps maintain the solder in position during the procedure, leading to more consistent results.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16085045",
    "question": "Is monocyte chemotactic protein-1 expression increased in human gestational tissues during term and preterm labor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, I need to determine if research shows that monocyte chemotactic protein-1 (MCP-1) expression increases in human gestational tissues during labor, both at term and preterm.\\n\\nMCP-1 (also known as CCL2) is a chemokine that regulates migration and infiltration of monocytes/macrophages. In the context of pregnancy and labor, inflammatory processes are known to play important roles.\\n\\nBased on scientific literature, MCP-1 expression has indeed been found to be increased in human gestational tissues during labor. Studies have shown elevated MCP-1 levels in the myometrium, cervix, fetal membranes (amnion and chorion), and placenta during both term and preterm labor compared to non-laboring tissues. This increased expression is consistent with the inflammatory nature of labor, as MCP-1 helps recruit immune cells to these tissues.\\n\\nResearch has demonstrated that this upregulation occurs in both term labor (labor at the normal time of delivery) and preterm labor (labor before 37 weeks of gestation), suggesting MCP-1 is part of the common pathway of labor regardless of timing.\\n\\nTherefore, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25565499",
    "question": "Are plasma interleukin-18 levels a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question asks whether plasma interleukin-18 (IL-18) levels serve as a biomarker for innate immune responses that can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS). To answer this, I would need to know if research has established IL-18 as a validated biomarker specifically for TB-IRIS prediction and characterization. Without specific research citations in the question, I cannot definitively confirm this relationship. However, IL-18 is known to be involved in innate immune responses and has been studied in the context of tuberculosis and inflammatory conditions. The question is whether it has been specifically established as a biomarker for TB-IRIS.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18974383",
    "question": "Does amiodarone inhibit arterial thrombus formation and tissue factor translation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to determine if amiodarone inhibits arterial thrombus formation and tissue factor translation. Amiodarone is primarily known as an antiarrhythmic medication used to treat and prevent irregular heartbeats. While it has multiple effects on cardiac electrophysiology, I need to check if it specifically has anti-thrombotic properties and effects on tissue factor translation.\\n\\nBased on my knowledge, amiodarone's primary mechanism of action involves blocking potassium channels and has effects on sodium and calcium channels, as well as alpha and beta adrenergic receptors. It's not primarily known as an anti-thrombotic agent or as having specific effects on tissue factor translation. While it may have some pleiotropic effects, inhibition of arterial thrombus formation and tissue factor translation are not among its well-established pharmacological properties.\\n\\nTherefore, I don't have evidence that amiodarone specifically inhibits arterial thrombus formation and tissue factor translation.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20140826",
    "question": "Do value of high-frequency miniprobes and conventional radial endoscopic ultrasound in the staging of early Barrett 's carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if high-frequency miniprobes and conventional radial endoscopic ultrasound have value in staging early Barrett's carcinoma. This is asking about the clinical utility or effectiveness of these two ultrasound techniques in determining the stage of Barrett's carcinoma in its early phase. To answer this properly, I would need to know if these techniques are indeed useful diagnostic tools for this specific purpose. Based on medical literature, both high-frequency miniprobes and conventional radial endoscopic ultrasound are used in the staging of early Barrett's carcinoma and do provide valuable information for determining the depth of tumor invasion and appropriate treatment planning. So they do have value in this clinical context.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19793166",
    "question": "Are interstitial cells of Cajal present in human extrahepatic bile ducts?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"I need to determine whether interstitial cells of Cajal (ICC) are present in human extrahepatic bile ducts. ICCs are specialized cells that act as pacemakers in the gastrointestinal tract, generating slow waves of electrical activity that coordinate smooth muscle contractions. They are well-documented in the intestines and stomach. For the bile ducts, I need to recall if research has confirmed their presence specifically in the extrahepatic (outside the liver) bile ducts in humans.\\n\\nBased on medical literature, ICCs have indeed been identified in human extrahepatic bile ducts. Studies have shown that c-kit positive (a marker for ICCs) cells are present in the wall of extrahepatic bile ducts, where they are thought to potentially regulate bile flow and duct motility. These cells have morphological and immunohistochemical characteristics similar to the ICCs found in the gastrointestinal tract.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20375495",
    "question": "Does cerebral perfusion affect the risk of ischemia during carotid artery stenting?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Cerebral perfusion refers to the blood flow to the brain. Ischemia is a condition where there is insufficient blood supply to tissues, leading to oxygen deprivation. Carotid artery stenting is a procedure to open narrowed carotid arteries, which are the main blood vessels carrying blood to the brain. During this procedure, there's a risk of reduced blood flow to the brain, which could lead to ischemia. The level of cerebral perfusion before, during, and after the procedure would logically affect the risk of ischemia. If cerebral perfusion is already compromised, the risk of ischemia during manipulation of the carotid artery would be higher. Similarly, if the procedure causes a significant drop in cerebral perfusion, the risk of ischemia increases. So yes, cerebral perfusion does affect the risk of ischemia during carotid artery stenting.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11466701",
    "question": "Does expression of tumor-associated antigen RCAS1 correlate significantly with poor prognosis in nonsmall cell lung carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma (NSCLC). To answer this, I would need to know if there are scientific studies showing a statistically significant correlation between RCAS1 expression and worse outcomes in NSCLC patients. Without specific research data provided in the question, I need to rely on my knowledge of cancer biology and published literature. RCAS1 (Receptor-binding Cancer Antigen expressed on SiSo cells) is known to be associated with poor prognosis in several cancer types, including some studies on lung cancer. However, I need to be specific about NSCLC and whether the correlation is statistically significant according to research.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21324485",
    "question": "Does ethyl pyruvate reduce acute lung injury via regulation of iNOS and HO-1 expression in endotoxemic rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if ethyl pyruvate reduces acute lung injury by regulating iNOS and HO-1 expression in rats with endotoxemia. To answer this, I need to consider whether there is scientific evidence supporting this specific mechanism of action for ethyl pyruvate. Ethyl pyruvate is known to have anti-inflammatory properties, and there are studies examining its effects on various inflammatory conditions including acute lung injury. Some research has investigated whether it works through pathways involving iNOS (inducible nitric oxide synthase) and HO-1 (heme oxygenase-1) in endotoxemic models. Based on published literature, there is evidence supporting that ethyl pyruvate can reduce acute lung injury and that it does affect iNOS and HO-1 expression in endotoxemic rats.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17069600",
    "question": "Does acute hyperglycemia induced by oral glucose loading suppress coronary microcirculation on transthoracic Doppler echocardiography in healthy young adults?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether acute hyperglycemia induced by oral glucose loading suppresses coronary microcirculation on transthoracic Doppler echocardiography in healthy young adults. To answer this, I need to determine if there's evidence that temporarily elevated blood glucose levels (from oral glucose loading) negatively impacts coronary microcirculation as measured by this specific imaging technique in young healthy people.\\n\\nBased on physiological principles, acute hyperglycemia can cause temporary endothelial dysfunction and oxidative stress, which might affect coronary microcirculation. However, the question is specifically about whether this effect has been demonstrated using transthoracic Doppler echocardiography in healthy young adults.\\n\\nStudies have shown that acute hyperglycemia can impair coronary flow reserve and microvascular function, but the specific methodology (transthoracic Doppler echocardiography), population (healthy young adults), and the acute nature of the hyperglycemia (induced by oral glucose loading) make this a very specific question.\\n\\nResearch has indeed demonstrated that acute hyperglycemia induced by oral glucose loading can transiently suppress coronary microcirculation as measured by transthoracic Doppler echocardiography, even in healthy young adults without diabetes or cardiovascular disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15765262",
    "question": "Does nicotine induce conditioned place preferences over a large range of doses in rats?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if nicotine induces conditioned place preferences over a large range of doses in rats. Conditioned place preference is a behavioral paradigm used to measure the rewarding or aversive effects of drugs. \\n\\nBased on scientific literature, nicotine has been shown to induce conditioned place preference in rats, but this effect is typically observed within a narrow dose range. At very low doses, nicotine may not produce significant place preference, while at high doses it can become aversive. The dose-response curve for nicotine in place preference paradigms tends to be an inverted U-shape, with moderate doses producing the strongest preference. \\n\\nSo nicotine does induce conditioned place preference in rats, but not over a 'large range' of doses as the question suggests.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9690658",
    "question": "Are receptors for BPH growth factors located in some neuroendocrine cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if receptors for BPH (benign prostatic hyperplasia) growth factors are located in some neuroendocrine cells. To answer this, I need to consider what is known about BPH growth factors and their receptors, and whether these receptors are expressed in neuroendocrine cells.\\n\\nBPH is a non-cancerous enlargement of the prostate gland. Various growth factors, including epidermal growth factor (EGF), fibroblast growth factor (FGF), insulin-like growth factor (IGF), and transforming growth factor-beta (TGF-β), are implicated in BPH development.\\n\\nNeuroendocrine cells are specialized cells that receive neuronal input and release hormones in response to that input. They are found in various tissues, including the prostate.\\n\\nResearch has shown that neuroendocrine cells in the prostate do express receptors for various growth factors, including some that are implicated in BPH. For example, neuroendocrine cells in the prostate have been found to express receptors for EGF and FGF, which are growth factors involved in BPH.\\n\\nTherefore, based on scientific literature, receptors for growth factors involved in BPH are indeed located in some neuroendocrine cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12631669",
    "question": "Are cARD15/NOD2 gene variants associated with familially occurring and complicated forms of Crohn 's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if cARD15/NOD2 gene variants are associated with familial (occurring in families) and complicated forms of Crohn's disease. To answer this, I need to consider what is known about the genetics of Crohn's disease.\\n\\nCARD15/NOD2 (Nucleotide-binding Oligomerization Domain-containing protein 2) gene variants have been extensively studied in relation to Crohn's disease. Multiple research studies have identified that mutations in the NOD2 gene are associated with an increased susceptibility to Crohn's disease, particularly in Western populations. These variants have been specifically linked to ileal (affecting the ileum) Crohn's disease and to more complicated disease courses including stricturing and penetrating phenotypes.\\n\\nFurthermore, there is evidence that these gene variants show familial clustering, with higher frequencies in families with multiple affected members. The NOD2 gene was actually one of the first genes identified as being associated with Crohn's disease susceptibility.\\n\\nBased on the scientific literature, cARD15/NOD2 gene variants are indeed associated with both familial forms of Crohn's disease and with more complicated disease phenotypes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21203561",
    "question": "Does the receptor tyrosine kinase FGFR4 negatively regulate NF-kappaB signaling?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the receptor tyrosine kinase FGFR4 (Fibroblast Growth Factor Receptor 4) negatively regulates NF-kappaB signaling. To answer this, I need to recall if there's established evidence in the scientific literature about FGFR4 having an inhibitory effect on the NF-kappaB pathway.\\n\\nFGFR4 is a receptor tyrosine kinase that binds fibroblast growth factors and activates various downstream signaling pathways. NF-kappaB is a transcription factor that regulates inflammation, immunity, and cell survival.\\n\\nBased on my knowledge, FGFR4 has been shown to activate various signaling pathways including MAPK, PI3K/AKT, and STAT3, but I don't recall specific evidence that it negatively regulates NF-kappaB signaling. In fact, some studies suggest that FGFR signaling may actually activate NF-kappaB in certain contexts.\\n\\nWithout clear evidence that FGFR4 specifically acts as a negative regulator of NF-kappaB signaling, I should answer 'no' to this question.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24126456",
    "question": "Does the histamine H4 receptor mediate inflammation and Th17 responses in preclinical models of arthritis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the histamine H4 receptor mediates inflammation and Th17 responses in preclinical models of arthritis. To answer this, I need to consider what is known about the histamine H4 receptor's role in inflammatory processes and specifically in arthritis models.\\n\\nHistamine H4 receptor is known to be expressed on immune cells and has been implicated in inflammatory conditions. Research has shown that H4 receptor antagonists can reduce inflammation in various disease models. Regarding arthritis specifically, there have been studies showing that H4 receptor antagonists can reduce inflammation and joint damage in animal models of arthritis. Additionally, the H4 receptor has been linked to Th17 cell responses, which are important in autoimmune conditions including arthritis.\\n\\nBased on published research, there is evidence supporting that the histamine H4 receptor does mediate inflammation and Th17 responses in preclinical models of arthritis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25691128",
    "question": "Does productivity Losses Associated with Head and Neck Cancer Using the Human Capital and Friction Cost approach?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether productivity losses are associated with head and neck cancer when using the Human Capital and Friction Cost approach. This seems to be asking about economic methodologies for calculating productivity losses due to illness. However, the question is incomplete or poorly formed. It doesn't actually ask a complete question - it starts with 'Does' but then just states a topic without forming a proper question. I need to interpret what's being asked. The question seems to be asking whether these economic approaches (Human Capital and Friction Cost) are used to measure productivity losses in head and neck cancer cases. Based on economic literature, both approaches are indeed used to measure productivity losses associated with various cancers including head and neck cancer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17875305",
    "question": "Are myeloperoxidase levels associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if myeloperoxidase (MPO) levels are associated with carotid atherosclerosis progression specifically in patients with familial hypercholesterolemia (FH). To answer this, I need to consider whether there is established evidence in medical literature showing a correlation between MPO levels and the progression of carotid atherosclerosis in this specific patient population.\\n\\nMPO is an enzyme produced by neutrophils and has been associated with inflammation and oxidative stress in cardiovascular disease. Familial hypercholesterolemia is a genetic disorder characterized by high LDL cholesterol levels and accelerated atherosclerosis.\\n\\nWhile MPO has been linked to atherosclerosis in general populations, and FH patients are known to have accelerated atherosclerosis, the specific association between MPO levels and carotid atherosclerosis progression in FH patients is a more specialized question.\\n\\nThere are studies showing associations between MPO and cardiovascular disease in general, and some research on biomarkers in FH patients, but without specific knowledge of studies examining this exact relationship, I cannot confidently say yes.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "16525237",
    "question": "Do personal digital assistants change management more often than paper texts and foster patient confidence?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if personal digital assistants (PDAs) change management more often than paper texts and foster patient confidence. This is a compound question with two parts: 1) Do PDAs change management more often than paper texts? and 2) Do PDAs foster patient confidence? To answer with a simple yes or no, I need to determine if both parts are true. There isn't enough evidence provided in the question to make a determination about either claim. Without specific studies or data comparing management changes between PDAs and paper texts, or measuring patient confidence with PDAs, I cannot provide a definitive answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21311604",
    "question": "Do effects of amniotic membrane suspension in the rat alkali burn model?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether amniotic membrane suspension has effects in the rat alkali burn model. This appears to be asking about a scientific research question related to whether amniotic membrane suspension (a biological material derived from the amniotic membrane) has therapeutic or healing effects when applied to alkali burns in rats (a common experimental model for studying burn treatments). However, the question is grammatically incomplete - it should be something like 'Do effects of amniotic membrane suspension exist in the rat alkali burn model?' or 'Does amniotic membrane suspension have effects in the rat alkali burn model?'\\n\\nBased on scientific literature, amniotic membrane has been studied for its healing properties in various wound models including burns. Research has shown that amniotic membrane and its derivatives do have anti-inflammatory, anti-scarring, and wound healing effects in various experimental models including alkali burns in rats. So the scientific evidence would support a 'yes' answer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24812024",
    "question": "Is smoking cessation followed by increases in serum bilirubin , an endogenous antioxidant associated with lower risk of lung cancer and cardiovascular disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether smoking cessation leads to increases in serum bilirubin levels, and notes that bilirubin is an endogenous antioxidant associated with lower risk of lung cancer and cardiovascular disease. \\n\\nTo answer this, I need to consider what happens to bilirubin levels when someone stops smoking. Research has shown that smoking is associated with lower levels of serum bilirubin, as cigarette smoke contains oxidants that can deplete antioxidants in the body. When someone quits smoking, their bilirubin levels typically increase as the body recovers from the oxidative stress of smoking. \\n\\nStudies have demonstrated that after smoking cessation, there is indeed a measurable increase in serum bilirubin levels as part of the body's recovery process. This increase in bilirubin, which has antioxidant properties, may contribute to the reduced risk of lung cancer and cardiovascular disease observed in former smokers compared to current smokers.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20181121",
    "question": "Are cerebrospinal fluid cortisol levels higher in patients with delirium versus controls?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the relationship between cerebrospinal fluid (CSF) cortisol levels and delirium. Specifically, it asks whether CSF cortisol levels are higher in patients with delirium compared to control subjects without delirium.\\n\\nTo answer this accurately, I need to consider the scientific evidence. Research has indeed shown that CSF cortisol levels are typically elevated in patients with delirium compared to non-delirious controls. This is consistent with the understanding that delirium involves dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, which controls cortisol production. Several studies have demonstrated higher CSF cortisol concentrations in delirious patients, supporting the neuroinflammatory and neuroendocrine theories of delirium pathophysiology.\\n\\nBased on the scientific literature, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22573353",
    "question": "Does integrative array-based approach identify MZB1 as a frequently methylated putative tumor suppressor in hepatocellular carcinoma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to determine if the statement about MZB1 being identified as a frequently methylated putative tumor suppressor in hepatocellular carcinoma through an integrative array-based approach is accurate. This is a specific scientific claim about cancer research findings. Without access to the relevant scientific literature or databases, I cannot verify whether this specific research finding has been published or established in the scientific community. The question asks about a very specific research outcome regarding MZB1 gene methylation in liver cancer (hepatocellular carcinoma) using a particular methodology (integrative array-based approach).\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26092099",
    "question": "Does cannabidiol cause endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if cannabidiol (CBD) causes endothelium-dependent vasorelaxation of human mesenteric arteries through CB1 receptor activation. To answer this accurately, I need to consider what's known about CBD's mechanism of action on blood vessels.\\n\\nCBD is a non-psychoactive cannabinoid that has been shown to have vasorelaxant properties in some studies. However, CBD has low affinity for CB1 receptors - it's not a direct CB1 agonist like THC. CBD typically works through other mechanisms including CB2 receptors, TRPV1 channels, GPR55, and other pathways.\\n\\nThe endothelium-dependent vasorelaxation caused by cannabinoids can occur through various mechanisms, but for CBD specifically, the evidence suggests it works primarily through CB1-independent mechanisms. Most studies indicate CBD's vascular effects are not mediated through direct CB1 activation.\\n\\nTherefore, while CBD may cause vasorelaxation in human mesenteric arteries, the current scientific consensus does not support that this occurs specifically via CB1 activation.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21584420",
    "question": "Is liver toxicity rare in rheumatoid arthritis patients using combination therapy with leflunomide and methotrexate?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To answer this question, I need to consider what is known about liver toxicity when leflunomide and methotrexate are used together in rheumatoid arthritis patients.\\n\\nBoth leflunomide and methotrexate individually are known to have potential hepatotoxic effects. When used in combination therapy, there is increased concern about liver toxicity.\\n\\nMultiple studies and clinical guidelines indicate that the combination of leflunomide and methotrexate can increase the risk of elevated liver enzymes and hepatotoxicity compared to either agent alone. This combination requires careful monitoring of liver function tests.\\n\\nThe literature suggests that liver toxicity is actually a relatively common concern with this combination therapy, not a rare occurrence. Regular monitoring of liver function is recommended specifically because of this known risk.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12033531",
    "question": "Does aldehyde dehydrogenase 2 ( ALDH2 ) genotype affect rectal cancer susceptibility due to alcohol consumption?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether there is a relationship between ALDH2 genotype, alcohol consumption, and rectal cancer susceptibility. ALDH2 is an enzyme involved in alcohol metabolism, and certain ALDH2 genotypes (particularly the ALDH2*2 allele common in East Asian populations) cause reduced ability to metabolize acetaldehyde, a toxic byproduct of alcohol metabolism. This can lead to alcohol flush reaction and potentially different cancer risks with alcohol consumption. \\n\\nTo answer this question accurately, I need to consider whether there is established scientific evidence showing that ALDH2 genotype specifically modifies rectal cancer risk in relation to alcohol consumption. Based on the scientific literature, while ALDH2 variants have been associated with upper aerodigestive tract cancers, esophageal cancer, and colorectal cancer broadly in some studies, the specific relationship between ALDH2 genotype, alcohol consumption, and rectal cancer (as distinct from colon cancer or colorectal cancer generally) is less clearly established. There is some evidence suggesting ALDH2 genotype may modify alcohol-related cancer risk, but the evidence specifically for rectal cancer is not as robust as for some other cancer types.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25047045",
    "question": "Does iGF-1 enhance cell proliferation and survival during early differentiation of mesenchymal stem cells to neural progenitor-like cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the role of IGF-1 (insulin-like growth factor 1) in enhancing cell proliferation and survival during the early differentiation of mesenchymal stem cells (MSCs) to neural progenitor-like cells. To answer this, I need to consider what is known about IGF-1's functions in stem cell differentiation, particularly in the neural lineage.\\n\\nIGF-1 is a growth factor that has been shown to play important roles in various cellular processes including proliferation, survival, and differentiation. In the context of stem cells, IGF-1 has been documented to promote proliferation and survival in multiple cell types.\\n\\nSpecifically regarding mesenchymal stem cells differentiating toward neural lineages, research has demonstrated that IGF-1 can enhance both proliferation and survival during this process. IGF-1 activates anti-apoptotic pathways and promotes cell cycle progression, which supports both the survival and proliferation of cells during the early stages of neural differentiation from MSCs.\\n\\nStudies have shown that IGF-1 supplementation during neural induction of MSCs increases the number of viable cells and enhances the expression of neural progenitor markers, indicating its positive effect on both proliferation and survival during this specific differentiation process.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21299896",
    "question": "Does the porcine circovirus type 1 capsid gene promoter improve antigen expression and immunogenicity in a HIV-1 plasmid vaccine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether the porcine circovirus type 1 (PCV1) capsid gene promoter improves antigen expression and immunogenicity in a HIV-1 plasmid vaccine. To answer this, I would need to know if there's scientific evidence showing that using the PCV1 capsid gene promoter in HIV-1 plasmid vaccines leads to better antigen expression and immune responses compared to other promoters. Without specific research data provided in the question, I need to consider if this is an established scientific finding. Based on my knowledge, there have been studies showing that the PCV1 capsid gene promoter can enhance expression in some vaccine constructs, including HIV vaccines. The PCV1 promoter has been used in some experimental HIV vaccine designs to improve antigen expression and subsequent immune responses.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19288270",
    "question": "Is substantially reduced expression of PIAS1 associated with colon cancer development?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, I need to determine if there's evidence linking reduced PIAS1 expression with colon cancer development. PIAS1 (Protein Inhibitor of Activated STAT1) is a protein that functions in the SUMO (Small Ubiquitin-like Modifier) pathway and can affect various cellular processes including transcription regulation and DNA repair. Let me consider what I know about PIAS1 and colon cancer:\\n\\nPIAS1 has been studied in relation to various cancers, and research has shown that it can function as both a tumor suppressor and oncogene depending on the context. For colon cancer specifically, studies have indicated that PIAS1 often shows reduced expression in colorectal cancer tissues compared to normal tissues. This downregulation has been associated with poorer prognosis and more aggressive tumor behavior in some studies. The reduced expression of PIAS1 has been linked to enhanced cell proliferation, migration, and invasion in colon cancer cell lines, suggesting it may play a tumor suppressor role in this context. Therefore, substantially reduced expression of PIAS1 does appear to be associated with colon cancer development based on available research.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10071271",
    "question": "Are age , sex , and smoking predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if age, sex, and smoking are predictors of circulating insulin-like growth factor 1 (IGF-1) and insulin-like growth factor-binding protein 3 (IGFBP-3). To answer this, I need to consider what scientific research has established about these relationships.\\n\\nAge: Research has consistently shown that IGF-1 levels decline with age in adults, making age a significant predictor of IGF-1 levels.\\n\\nSex: There are documented sex differences in IGF-1 and IGFBP-3 levels, with men typically having higher IGF-1 levels than women, particularly during certain life stages.\\n\\nSmoking: Studies have indicated that smoking can affect IGF-1 and IGFBP-3 levels, often showing lower levels in smokers compared to non-smokers.\\n\\nBased on established scientific literature, all three factors (age, sex, and smoking) have been shown to be associated with and can predict variations in circulating IGF-1 and IGFBP-3 levels.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22736200",
    "question": "Does dkk-1 promote angiogenic responses and cartilage matrix proteinase secretion in synovial fibroblasts from osteoarthritic joints?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question about dkk-1 and its effects on synovial fibroblasts from osteoarthritic joints.\\n\\nDkk-1 (Dickkopf-related protein 1) is a secreted protein that acts as an inhibitor of the Wnt signaling pathway. In the context of osteoarthritis, I need to determine whether dkk-1 specifically:\\n1. Promotes angiogenic responses in synovial fibroblasts from osteoarthritic joints\\n2. Promotes cartilage matrix proteinase secretion in these same cells\\n\\nBased on the scientific literature, dkk-1 has been shown to be elevated in osteoarthritic joints and can influence various cellular processes. Research indicates that dkk-1 can indeed promote angiogenesis (formation of new blood vessels) and increase the secretion of matrix metalloproteinases (MMPs) and other proteinases that degrade cartilage matrix in synovial fibroblasts from osteoarthritic joints. These effects contribute to the pathogenesis of osteoarthritis by enhancing inflammation, tissue destruction, and joint remodeling.\\n\\nTherefore, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27823974",
    "question": "Does the C-reactive protein/albumin ratio predict long-term outcomes of patients with operable non-small cell lung cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the C-reactive protein/albumin ratio (CAR) predicts long-term outcomes in patients with operable non-small cell lung cancer (NSCLC). Based on medical literature, CAR has been studied as a prognostic marker in various cancers including NSCLC. Several studies have shown that elevated CAR is associated with poor prognosis and survival outcomes in NSCLC patients who undergo surgical resection. Research indicates that CAR, as an inflammatory marker, can reflect the systemic inflammatory response which is linked to cancer progression and survival. Multiple studies have demonstrated that higher CAR values correlate with worse overall survival and disease-free survival in operable NSCLC patients, suggesting it has predictive value for long-term outcomes in this patient population.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21208768",
    "question": "Does postresuscitation autonomic nervous modulation after cardiac arrest resemble that of severe sepsis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the autonomic nervous system modulation after resuscitation from cardiac arrest is similar to what is observed in severe sepsis. To answer this, I need to consider what research shows about autonomic dysfunction in both conditions.\\n\\nIn post-cardiac arrest syndrome, there is often significant autonomic dysfunction characterized by decreased heart rate variability, impaired baroreflex sensitivity, and relative sympathetic predominance.\\n\\nIn severe sepsis, there is also autonomic dysfunction with decreased heart rate variability, impaired sympathetic and parasympathetic responses, and autonomic imbalance.\\n\\nResearch has shown similarities in the autonomic profiles of both conditions, including:\\n- Reduced heart rate variability\\n- Impaired autonomic balance with relative sympathetic predominance\\n- Correlation between autonomic dysfunction severity and mortality\\n- Similar inflammatory mediators affecting autonomic function\\n\\nStudies have demonstrated that post-cardiac arrest patients show autonomic patterns resembling those seen in severe sepsis, with both conditions showing evidence of a systemic inflammatory response that affects autonomic regulation.\\n\\nBased on the available medical literature, there are indeed significant similarities in autonomic nervous modulation between post-resuscitation states and severe sepsis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12764254",
    "question": "Is amyloid-beta found in drusen from some age-related macular degeneration retinas , but not in drusen from normal retinas?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if amyloid-beta is found in drusen from some age-related macular degeneration (AMD) retinas, but not in drusen from normal retinas. To answer this, I need to consider what is known about the composition of drusen in AMD versus normal aging.\\n\\nDrusen are extracellular deposits that accumulate between the retinal pigment epithelium (RPE) and Bruch's membrane in the eye. They are a hallmark feature of AMD.\\n\\nResearch has shown that amyloid-beta, a peptide known for its role in Alzheimer's disease, is indeed found in drusen from AMD patients. Studies have demonstrated that amyloid-beta is a component of drusen specifically in AMD retinas.\\n\\nImportantly, comparative studies have shown that while drusen can occur in normal aging retinas as well, the amyloid-beta component appears to be specifically associated with drusen in AMD retinas and is generally not found in drusen from normal aging retinas.\\n\\nTherefore, the statement is accurate.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21427651",
    "question": "Does transfection of human HGF plasmid DNA improve limb salvage in Buerger 's disease patients with critical limb ischemia?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if transfection of human HGF (Hepatocyte Growth Factor) plasmid DNA improves limb salvage in patients with Buerger's disease who have critical limb ischemia. To answer this, I need to consider whether there is established clinical evidence that this specific gene therapy approach has been proven effective for this particular condition.\\n\\nBuerger's disease (thromboangiitis obliterans) is a rare inflammatory vasculopathy that can lead to critical limb ischemia. HGF gene therapy has been studied for various forms of peripheral arterial disease and critical limb ischemia because HGF promotes angiogenesis (formation of new blood vessels).\\n\\nWhile there have been clinical trials examining HGF gene therapy for critical limb ischemia in general, I don't recall specific strong evidence from randomized controlled trials showing that HGF plasmid DNA transfection specifically improves limb salvage rates in the subset of patients with Buerger's disease. There may be some preliminary or small studies, but I don't believe there is conclusive evidence that this therapy definitively improves limb salvage in this specific patient population.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15200429",
    "question": "Does ouabain induce endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells specifically through a clathrin-dependent mechanism. To answer this, I need to recall what's known about ouabain's effects on Na/K-ATPase trafficking in this cell line.\\n\\nOuabain is a cardiac glycoside that binds to and inhibits Na/K-ATPase. In LLC-PK1 cells (a porcine kidney cell line), research has shown that ouabain binding to Na/K-ATPase can trigger endocytosis of the pump from the plasma membrane. The specific mechanism of this endocytosis has been studied, and multiple papers have demonstrated that ouabain-induced endocytosis of Na/K-ATPase in LLC-PK1 cells occurs through clathrin-coated pits and is dependent on clathrin. This has been shown through various methods including clathrin inhibition, colocalization studies with clathrin, and electron microscopy showing the formation of clathrin-coated vesicles containing Na/K-ATPase after ouabain treatment.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18830404",
    "question": "Does meltrin beta/ADAM19 interacting with EphA4 in developing neural cells participate in formation of the neuromuscular junction?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if meltrin beta/ADAM19 interacting with EphA4 in developing neural cells participates in formation of the neuromuscular junction. Let me analyze what we know about these proteins:\\n\\n1. Meltrin beta (also known as ADAM19) is a member of the ADAM (a disintegrin and metalloprotease) family of proteins.\\n\\n2. EphA4 is a receptor tyrosine kinase involved in various developmental processes including axon guidance.\\n\\n3. The neuromuscular junction (NMJ) is the synapse between motor neurons and skeletal muscle fibers.\\n\\nWhile both ADAM19 and EphA4 are involved in neural development, I need to determine if their specific interaction has been shown to participate in NMJ formation. Based on the scientific literature, ADAM19 has been implicated in cardiac development and EphA4 in axon guidance, but their interaction specifically in NMJ formation is not well-established. Some research suggests roles for various ADAM proteins and Eph receptors in synaptogenesis, but the specific interaction of ADAM19 with EphA4 in NMJ formation is not conclusively demonstrated in the scientific literature.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25701052",
    "question": "Is bone marrow fat increased in chronic kidney disease by magnetic resonance spectroscopy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether bone marrow fat is increased in chronic kidney disease (CKD) when measured by magnetic resonance spectroscopy (MRS). To answer this, I need to consider whether there is established evidence in medical literature that shows increased bone marrow fat content in CKD patients specifically when measured using MRS technique.\\n\\nBased on medical literature, there is evidence that chronic kidney disease is associated with altered bone metabolism and marrow composition. Studies have shown that patients with CKD often have abnormal bone turnover and mineral metabolism. However, the specific finding of increased bone marrow fat as measured by magnetic resonance spectroscopy in CKD patients is what I need to determine.\\n\\nThere are studies that have used MRS to evaluate bone marrow fat in various conditions including osteoporosis, diabetes, and aging. Some research has indeed found that CKD patients show increased bone marrow adiposity, which can be detected using MRS techniques. This is consistent with the bone abnormalities seen in CKD, often referred to as renal osteodystrophy.\\n\\nSo based on available medical evidence, it appears that bone marrow fat is indeed increased in chronic kidney disease when measured by magnetic resonance spectroscopy.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18471510",
    "question": "Is the bone morphogenetic protein pathway inactivated in the majority of sporadic colorectal cancers?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The bone morphogenetic protein (BMP) pathway is a signaling pathway that plays important roles in various cellular processes including cell growth, differentiation, and apoptosis. In the context of colorectal cancer, I need to determine if this pathway is inactivated in the majority of sporadic cases.\\n\\nResearch has shown that the BMP pathway is indeed frequently inactivated in colorectal cancers. Studies have demonstrated that mutations in BMP pathway components, particularly SMAD4 (a key downstream mediator of BMP signaling) and BMP receptors, are common in colorectal cancers. Additionally, epigenetic silencing of BMP pathway genes has been observed.\\n\\nHowever, when considering if this occurs in the 'majority' (more than 50%) of sporadic colorectal cancers, the evidence suggests that while BMP pathway alterations are common, they don't appear to be present in more than half of all cases. Complete inactivation of the pathway is seen in a significant subset, but not the majority of sporadic colorectal cancers.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11287016",
    "question": "Is cyclin-dependent kinase 5 expressed in both Sertoli cells and metaphase spermatocytes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to determine if cyclin-dependent kinase 5 (CDK5) is expressed in both Sertoli cells and metaphase spermatocytes. Let me analyze what is known about CDK5 expression in testicular cells.\\n\\nCDK5 is a serine/threonine kinase that, unlike other CDKs, is primarily involved in neuronal development and function rather than cell cycle regulation. However, it is also expressed in various non-neuronal tissues including the testes.\\n\\nIn the testes:\\n- CDK5 has been reported to be expressed in Sertoli cells, which are somatic cells that support spermatogenesis\\n- Regarding metaphase spermatocytes (germ cells undergoing meiotic division), the expression pattern of CDK5 is less clear from general knowledge\\n\\nBased on scientific literature, CDK5 is indeed expressed in Sertoli cells, but I don't have definitive information confirming its expression specifically in metaphase spermatocytes. Some studies suggest CDK5 expression in various stages of spermatogenic cells, but without confirming the specific expression in metaphase spermatocytes.\\n\\nWithout clear evidence for expression in both cell types mentioned, I cannot confirm that CDK5 is expressed in both Sertoli cells and metaphase spermatocytes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "10452867",
    "question": "Does cardiopulmonary bypass render patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between cardiopulmonary bypass (CPB) and multiple organ failure, specifically whether CPB increases risk through a mechanism involving early neutrophil priming followed by late neutrophil disability. \\n\\nCardiopulmonary bypass is a technique used during certain types of heart surgery where a machine temporarily takes over the function of the heart and lungs. Research has shown that CPB can trigger a systemic inflammatory response, and neutrophils (white blood cells) play a key role in this process.\\n\\nThere is scientific evidence supporting that CPB can cause neutrophil activation/priming in the early phase, followed by neutrophil dysfunction or 'disability' in later phases. This biphasic neutrophil response has been linked to post-operative complications including multiple organ failure.\\n\\nStudies have demonstrated that during CPB, neutrophils become primed and activated, releasing inflammatory mediators and reactive oxygen species. Later, these neutrophils can become dysfunctional, impairing the body's ability to fight infections. This sequence of events has been associated with increased risk of multiple organ failure following cardiac surgery with CPB.\\n\\nBased on the current scientific understanding, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21085490",
    "question": "Does protein kinase A bound and activates heat shock factor 1?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to determine if protein kinase A (PKA) binds to and activates heat shock factor 1 (HSF1). Let me analyze what is known about these interactions:\\n\\nProtein kinase A (PKA) is a cAMP-dependent protein kinase that phosphorylates various target proteins.\\n\\nHeat shock factor 1 (HSF1) is a transcription factor that regulates the expression of heat shock proteins in response to various stressors.\\n\\nBased on scientific literature, HSF1 can be regulated by various kinases including GSK3, ERK, JNK, p38, and CK2. However, PKA is not typically described as a major regulator of HSF1. While PKA might indirectly affect HSF1 activity through other signaling pathways, there isn't strong evidence that PKA directly binds to and activates HSF1 as a primary mechanism.\\n\\nThere are some studies suggesting PKA may phosphorylate HSF1 under certain conditions, but this doesn't necessarily mean direct binding and activation in the classical sense. The relationship between PKA and HSF1 is not as well-established as other kinase-HSF1 interactions.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15841779",
    "question": "Does voiding position affect uroflowmetric parameters and post-void residual urine volume in healthy volunteers?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the position a person is in when voiding (urinating) affects uroflowmetric parameters (measurements of urine flow) and post-void residual urine volume (amount of urine left in the bladder after urination) in healthy volunteers. To answer this, I need to consider whether scientific evidence shows that different voiding positions (e.g., sitting vs. standing for men, or different sitting positions) impact these urological measurements in people without urinary disorders. Based on urological research, voiding position does affect uroflowmetric parameters such as maximum flow rate, average flow rate, and can influence post-void residual volumes. For example, studies have shown that men typically have different flow rates when sitting versus standing, and women may have different measurements based on how they position themselves on the toilet.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "11037880",
    "question": "Does calcium pentosan polysulfate inhibit the catabolism of aggrecan in articular cartilage explant cultures?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if calcium pentosan polysulfate inhibits the catabolism (breakdown) of aggrecan in articular cartilage explant cultures. To answer this, I need to know if there's evidence that calcium pentosan polysulfate has this specific biochemical effect. Aggrecan is a major proteoglycan in articular cartilage, and its breakdown is associated with cartilage degradation in conditions like osteoarthritis. Without specific knowledge about calcium pentosan polysulfate's effects on aggrecan catabolism in explant cultures, I cannot provide a definitive answer based on my training data.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18661091",
    "question": "Do cortical and trabecular bone in the femoral neck both contribute to proximal femur failure load prediction?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether both cortical and trabecular bone in the femoral neck contribute to predicting the failure load of the proximal femur. To answer this, I need to consider what research shows about bone strength prediction models.\\n\\nCortical bone is the dense outer shell of bone, while trabecular bone is the spongy inner structure. The femoral neck is a critical region of the proximal femur that's often involved in hip fractures.\\n\\nResearch in biomechanics and osteoporosis has shown that both cortical and trabecular bone properties in the femoral neck are important determinants of overall proximal femur strength. Studies using finite element analysis, QCT (quantitative computed tomography), and mechanical testing have demonstrated that models incorporating both cortical and trabecular bone parameters provide more accurate predictions of femoral failure load than models using either component alone.\\n\\nThe cortical shell provides structural stability while the trabecular network distributes forces through the bone. Age-related bone loss affects both components, and their combined deterioration contributes to fracture risk.\\n\\nSo yes, both cortical and trabecular bone in the femoral neck contribute to proximal femur failure load prediction.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17172991",
    "question": "Do low back pain patients demonstrate increased hip extensor muscle activity during standardized submaximal rotation efforts?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific physiological response in low back pain patients. It's asking whether these patients show increased hip extensor muscle activity when performing standardized submaximal rotation efforts compared to people without low back pain. To answer this accurately, I would need to be familiar with research studies that have measured muscle activity in back pain patients during rotation tasks. Without specific research knowledge on this topic, I cannot provide a definitive answer. The question is quite specific about a biomechanical relationship between back pain and hip muscle activation patterns during a particular type of movement.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16762585",
    "question": "Is gluteus tendon rupture underrecognized by French orthopedic surgeons : results of a mail survey?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether gluteus tendon rupture is underrecognized by French orthopedic surgeons, and specifically references 'results of a mail survey'. This appears to be asking about the findings of a specific study that conducted a mail survey among French orthopedic surgeons regarding their recognition of gluteus tendon ruptures. Without knowing the specific study or its results, I cannot definitively answer whether the study found that gluteus tendon rupture is underrecognized by French orthopedic surgeons.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22395888",
    "question": "Does hydrocortisone stimulate neurite outgrowth from mouse retinal explants by modulating macroglial activity?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific mechanism of action for hydrocortisone in mouse retinal explants. Specifically, it's asking if hydrocortisone stimulates neurite outgrowth by modulating macroglial activity. To answer this, I would need to know about research that has investigated this specific pathway. Without specific knowledge of studies showing that hydrocortisone stimulates neurite outgrowth from mouse retinal explants via modulation of macroglial activity, I cannot confirm this mechanism. This is a very specific scientific claim that would require evidence from research studies. I don't have definitive information that establishes this particular mechanism of action for hydrocortisone in mouse retinal tissue.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26905747",
    "question": "Is prevalence of grade 1 , 2 and 3 thinness associated with lower socio-economic status in children in Shanghai , China?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if there is an association between prevalence of grade 1, 2, and 3 thinness and lower socio-economic status in children in Shanghai, China. To answer this, I would need specific research data or studies conducted in Shanghai that examined this relationship. Without being provided with such data in the question, I cannot make a definitive claim about whether such an association exists in this specific population. Research in other regions often shows socioeconomic disparities in childhood nutrition status, but I cannot automatically assume this pattern holds true for Shanghai without evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11756600",
    "question": "Do memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether memory complaints and the APOE-epsilon4 genetic variant accelerate cognitive decline in cognitively normal elderly individuals. To answer this, I need to consider the scientific evidence on this topic. \\n\\nMemory complaints (subjective cognitive decline) have been associated with increased risk of future cognitive decline in some studies. The APOE-epsilon4 allele is a well-established genetic risk factor for Alzheimer's disease and has been linked to faster cognitive decline in multiple studies.\\n\\nBased on the research literature, both memory complaints and APOE-epsilon4 carrier status have been shown to be associated with accelerated cognitive decline in cognitively normal elderly individuals. There is evidence that these factors, especially when combined, can predict future cognitive decline even in people who are currently functioning normally.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22877316",
    "question": "Do central tendency measure and wavelet transform combined in the non-invasive analysis of atrial fibrillation recordings?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if central tendency measure (CTM) and wavelet transform are combined in the non-invasive analysis of atrial fibrillation recordings. To answer this, I need to consider if these two specific signal processing techniques are used together in analyzing atrial fibrillation data obtained through non-invasive means (like surface ECG).\n\nIn the literature, both CTM and wavelet transform have been used separately for analyzing atrial fibrillation. CTM is a nonlinear technique that can quantify the degree of variability in signals, while wavelet transform is effective for time-frequency analysis of non-stationary signals like ECG.\n\nThere are indeed research papers that have combined these two approaches for analyzing atrial fibrillation. For example, some studies have used wavelet transform for preprocessing or feature extraction and then applied CTM for classification or characterization of atrial fibrillation patterns. This combined approach leverages the strengths of both techniques - the time-frequency localization capabilities of wavelets and the chaos/complexity quantification abilities of CTM.\n\nSo yes, these techniques have been combined in the non-invasive analysis of atrial fibrillation.\", \n\"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "1423947",
    "question": "Does positron emission tomography detect metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether positron emission tomography (PET) can detect metabolic viability in heart muscle (myocardium) that shows persistent defects on 24-hour single-photon emission computed tomography (SPECT) using thallium-201 (201Tl) as a tracer. \\n\\nPET and SPECT are different nuclear imaging techniques. PET typically uses different tracers (like FDG - fluorodeoxyglucose) that can detect metabolic activity in tissues. The question is specifically asking if PET can identify viable heart tissue in areas that appear as persistent defects (suggesting non-viable tissue) on 24-hour SPECT imaging with thallium-201.\\n\\nBased on medical literature, PET can indeed detect metabolic activity in myocardial regions that appear as fixed defects on SPECT imaging. This is because PET has higher sensitivity for detecting viable but hibernating myocardium that may appear non-viable on SPECT. This is one of the clinical values of PET in cardiac imaging - identifying potentially recoverable heart tissue that might be missed by other techniques.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24740204",
    "question": "Is rice consumption associated with risk of cardiovascular disease morbidity or mortality in Japanese men and women : a large population-based , prospective cohort study?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether rice consumption is associated with risk of cardiovascular disease morbidity or mortality in Japanese men and women, specifically in the context of a large population-based, prospective cohort study. This appears to be asking about the findings of a specific research study. Without having access to the specific study mentioned, I cannot definitively say what the results showed. However, the question is phrased in a way that suggests this is a title or description of a research paper, and is asking if such an association was found in that study.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "26022245",
    "question": "Does functional Polymorphism rs13306560 of the MTHFR Gene be Associated With Essential Hypertension in a Mexican-Mestizo Population?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether the functional polymorphism rs13306560 of the MTHFR gene is associated with essential hypertension specifically in a Mexican-Mestizo population. To answer this accurately, I would need to review scientific literature on this specific genetic variant in this specific population. Without access to specific studies on this association in Mexican-Mestizo populations, I cannot make a definitive claim about whether this association exists. Scientific questions like this require evidence from peer-reviewed research, and I don't have access to specific studies that would confirm or deny this association.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20605238",
    "question": "Does pregnancy accelerate biological valve degeneration?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if pregnancy accelerates biological valve degeneration. Biological valves in this context likely refers to heart valves, either native heart valves or bioprosthetic heart valves used in valve replacement surgeries. I need to consider whether pregnancy, with its associated hemodynamic changes, hormonal fluctuations, and increased cardiac output, has been shown to accelerate the degeneration of such valves. Based on medical literature, pregnancy does place additional stress on the cardiovascular system, but there isn't strong evidence that pregnancy specifically accelerates biological valve degeneration. While pregnancy can exacerbate existing valve disease and cause complications in women with valve disease, it doesn't appear to directly accelerate the degenerative process of biological valves in otherwise healthy women.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "22236307",
    "question": "Do blood-borne macrophage-neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain delivery?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific mechanism for delivering nanozymes to the brain. Let me break it down:\\n\\n1. Blood-borne macrophages: These are immune cells in the bloodstream\\n2. Macrophage-neural cell interactions: Interactions between macrophages and neural cells\\n3. Hitchhiking on endosome networks: Using cellular endosome pathways as a transport mechanism\\n4. For cell-based nanozyme brain delivery: To deliver nanozymes (enzyme-mimicking nanomaterials) to the brain\\n\\nThis is asking about a very specific biological mechanism. While macrophages can enter the brain and nanozymes are being researched for brain delivery, the specific mechanism described - where macrophage-neural interactions use endosome networks as a delivery pathway for nanozymes - is not a well-established or proven biological mechanism in the scientific literature. This appears to be a hypothetical or emerging research concept rather than an established biological fact.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22729295",
    "question": "Does guaragnaSCORE satisfactorily predict outcomes in heart valve surgery in a Brazilian hospital?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if guaragnaSCORE satisfactorily predicts outcomes in heart valve surgery in a Brazilian hospital. To answer this, I would need specific information about validation studies or clinical evidence showing that guaragnaSCORE has been evaluated and found to be a satisfactory predictor of outcomes for heart valve surgery patients in a Brazilian hospital setting. Without being provided any specific information about guaragnaSCORE's performance in this context, I cannot make a determination about its predictive accuracy or clinical utility in Brazilian heart valve surgery patients.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9278829",
    "question": "Does prolonged surgery increase the likelihood of admission of scheduled ambulatory surgery patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if prolonged surgery increases the likelihood of admission for patients who were scheduled for ambulatory surgery (outpatient surgery where patients are expected to go home the same day). Let me analyze what research shows about this relationship.\\n\\nProlonged surgery means the surgical procedure takes longer than expected or longer than the average time for that procedure. When surgeries take longer, there are several potential consequences:\\n\\n1. Increased anesthesia exposure\\n2. Greater surgical stress on the body\\n3. Higher risk of complications\\n4. Later completion time in the day\\n5. Less recovery time before facility closing\\n\\nResearch in perioperative medicine has consistently shown that unexpected prolonged surgical duration is a risk factor for unplanned hospital admission following ambulatory procedures. When surgeries run longer, patients may not have adequate time to recover to meet discharge criteria, may experience more pain or nausea, or may develop complications that require monitoring.\\n\\nSo based on medical literature and clinical practice guidelines, prolonged surgical duration is indeed associated with higher rates of unplanned admission following ambulatory surgery.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26820476",
    "question": "Does central proopiomelanocortin but not neuropeptide Y mediate sympathoexcitation and hypertension in fat fed conscious rabbits?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether central proopiomelanocortin (POMC) mediates sympathoexcitation and hypertension in fat-fed conscious rabbits, while neuropeptide Y (NPY) does not. To answer this accurately, I would need to know the specific research findings on this topic. This is a very specific neuroscience/physiology question about the differential roles of these two neuropeptides in the context of diet-induced hypertension in rabbits. Without specific knowledge of the research literature on this topic, I cannot provide a definitive answer. The question appears to be referencing a specific research finding or paper.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10801478",
    "question": "Does the 1.8 A crystal structure of catechol 1,2-dioxygenase reveal a novel hydrophobic helical zipper as a subunit linker?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the 1.8 A crystal structure of catechol 1,2-dioxygenase reveals a novel hydrophobic helical zipper as a subunit linker. To answer this, I would need specific information about this particular crystal structure study and its findings. Without having access to the specific research paper or structural data about this enzyme, I cannot determine if this specific structural feature was discovered in this particular study. The question appears to be referencing a specific scientific finding that would be documented in a research paper about the crystal structure of this enzyme. Since I don't have access to this specific information, I cannot confirm or deny if this novel structural feature was revealed in this study.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25741152",
    "question": "Does coexpression of MYC and BCL-2 predict prognosis in primary gastrointestinal diffuse large B-cell lymphoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma (DLBCL). To answer this, I need to consider what is known about these biomarkers in this specific type of lymphoma. MYC and BCL-2 coexpression (often called 'double expressors') is known to be associated with poor prognosis in DLBCL in general. However, the question specifically asks about primary gastrointestinal DLBCL, which is a specific anatomical subtype. Based on medical literature, MYC and BCL-2 coexpression has indeed been shown to be a predictor of poor prognosis in primary gastrointestinal DLBCL, similar to its prognostic value in other DLBCL subtypes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26013572",
    "question": "Do macroscopic optical physiological parameters correlate with microscopic proliferation and vessel area breast cancer signatures?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether there is a correlation between macroscopic optical physiological parameters and microscopic proliferation and vessel area signatures in breast cancer. To answer this, I need to consider whether research has established such correlations.\\n\\nMacroscopic optical physiological parameters typically refer to measurements obtained through optical imaging techniques like diffuse optical tomography (DOT) or near-infrared spectroscopy (NIRS), which can measure properties like tissue hemoglobin concentration, oxygen saturation, and water content.\\n\\nMicroscopic proliferation refers to cellular-level measurements of cancer cell division rates, often assessed through markers like Ki-67 or mitotic counts. Vessel area signatures refer to microscopic measurements of blood vessel density or area in tumor tissue, often assessed through CD31 or other endothelial markers.\\n\\nResearch has indeed shown correlations between these parameters. Studies have demonstrated that macroscopic optical measurements of tumor vascularity and oxygenation often correlate with microscopic measures of tumor angiogenesis and proliferation. For example, tumors with higher proliferation rates typically show increased vascularity and altered oxygenation that can be detected both microscopically and through macroscopic optical techniques.\\n\\nSeveral studies have specifically examined breast cancer and found correlations between optical parameters (like total hemoglobin, oxygen saturation) and histopathological features including proliferation markers and microvessel density.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20976174",
    "question": "Does iKKα contribute to canonical NF-κB activation downstream of Nod1-mediated peptidoglycan recognition?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if iKKα contributes to canonical NF-κB activation downstream of Nod1-mediated peptidoglycan recognition. Let me analyze what we know about this pathway:\\n\\n1. Nod1 is a pattern recognition receptor that recognizes peptidoglycan fragments from bacterial cell walls\\n2. Upon recognition, Nod1 triggers signaling pathways that can lead to NF-κB activation\\n3. The canonical NF-κB pathway typically involves the IKK complex, which consists of IKKα, IKKβ, and NEMO/IKKγ\\n4. In the canonical pathway, IKKβ is considered the primary kinase responsible for IκB phosphorylation\\n5. IKKα is more commonly associated with the non-canonical NF-κB pathway\\n\\nWhile IKKα is part of the IKK complex, in the canonical NF-κB pathway, IKKβ is the predominant kinase that phosphorylates IκB proteins, leading to their degradation and subsequent NF-κB activation. IKKα plays a more essential role in the non-canonical pathway.\\n\\nIn Nod1-mediated signaling specifically, research has shown that it primarily activates the canonical NF-κB pathway through RIP2, which leads to IKKβ activation. IKKα is not considered a major contributor to this specific canonical activation pathway downstream of Nod1.\\n\\nBased on the established understanding of these pathways, IKKα does not significantly contribute to canonical NF-κB activation downstream of Nod1-mediated peptidoglycan recognition.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23680913",
    "question": "Is amorfrutin B an efficient natural peroxisome proliferator-activated receptor gamma ( PPARγ ) agonist with potent glucose-lowering properties?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if amorfrutin B is an efficient natural PPARγ agonist with potent glucose-lowering properties. To answer this, I need to know if scientific research has established that amorfrutin B: 1) is a natural compound, 2) acts as an agonist for PPARγ receptors, 3) does so efficiently, and 4) has potent glucose-lowering effects. Based on scientific literature, amorfrutin B is indeed a natural compound derived from licorice and other plants that has been identified as a selective PPARγ modulator with partial agonist properties. Research has shown it can effectively lower glucose levels in diabetic mouse models with fewer side effects than full PPARγ agonists. Studies have demonstrated its ability to improve insulin sensitivity and reduce blood glucose levels, supporting its characterization as having potent glucose-lowering properties.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22525217",
    "question": "Do air-bone gap component of inner-ear origin in audiograms of cochlear implant candidates?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether an air-bone gap component of inner-ear origin appears in audiograms of cochlear implant candidates. An air-bone gap typically refers to the difference between air conduction and bone conduction thresholds in audiometric testing. In normal hearing or sensorineural hearing loss, there should be no significant air-bone gap. Air-bone gaps are typically associated with conductive or mixed hearing loss, which involve the outer or middle ear, not the inner ear. Cochlear implant candidates typically have severe to profound sensorineural hearing loss, which is of inner-ear origin. However, by definition, a true air-bone gap is not of inner-ear origin. Inner ear pathology causes sensorineural hearing loss where both air and bone conduction are equally affected. Therefore, an air-bone gap component specifically of inner-ear origin would be contradictory to established audiological principles.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20063047",
    "question": "Are nitrous oxide and isoflurane synergistic with respect to amplitude and latency effects on sensory evoked potentials?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if nitrous oxide and isoflurane have synergistic effects on sensory evoked potentials, specifically regarding amplitude and latency. To answer this, I need to consider whether these two anesthetic agents, when used together, produce effects on sensory evoked potentials that are greater than the sum of their individual effects (which would indicate synergy). Based on medical literature, both nitrous oxide and isoflurane individually can affect sensory evoked potentials by decreasing amplitude and increasing latency. However, research has shown that their combined effect is generally additive rather than synergistic. Studies examining their interaction on sensory evoked potentials specifically have not demonstrated a true synergistic relationship for either amplitude or latency measurements.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25744409",
    "question": "Does aRHGAP21 prevent abnormal insulin release through actin rearrangement in pancreatic islets from neonatal mice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if aRHGAP21 prevents abnormal insulin release through actin rearrangement in pancreatic islets from neonatal mice. To answer this, I need to know if there's established scientific evidence showing that aRHGAP21 has this specific function in neonatal mice pancreatic islets. Without specific knowledge of research demonstrating this relationship between aRHGAP21, actin rearrangement, and insulin release in neonatal mice, I cannot confirm this claim. The question contains a very specific scientific claim about a molecular mechanism that would require evidence from research studies. Since I don't have information confirming this specific relationship, I should answer 'no'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25572873",
    "question": "Do ultrasound features of polycystic ovaries relate to degree of reproductive and metabolic disturbance in polycystic ovary syndrome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question asks about the relationship between ultrasound features of polycystic ovaries and the severity of reproductive and metabolic problems in polycystic ovary syndrome (PCOS). Based on medical research, there is evidence that ultrasound features (such as ovarian volume, follicle number, and distribution) do correlate with the degree of reproductive dysfunction (like menstrual irregularity, anovulation) and metabolic disturbances (like insulin resistance, dyslipidemia) in PCOS patients. Studies have shown that women with more pronounced ultrasound features often have more severe hormonal imbalances and metabolic abnormalities. Therefore, there is a relationship between the ultrasound appearance and the clinical/biochemical manifestations of the syndrome.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16102835",
    "question": "Does severe ocular injuries from pointed door handle in children?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking if severe ocular (eye) injuries occur in children from pointed door handles. To answer this, I need to consider whether door handles, particularly pointed ones, are a documented cause of serious eye injuries in pediatric populations. Based on medical literature, there are indeed case reports of children suffering eye injuries from various household objects including door handles, especially those with pointed or protruding designs. Children's height often puts their eyes at the same level as door handles, increasing risk. So yes, pointed door handles can cause severe ocular injuries in children.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23419380",
    "question": "Does metabolomics disclose potential biomarkers for the noninvasive diagnosis of idiopathic portal hypertension?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if metabolomics reveals potential biomarkers that could be used for noninvasive diagnosis of idiopathic portal hypertension. To answer this, I need to consider whether there is evidence in the scientific literature supporting the use of metabolomics to identify biomarkers for this specific condition. Idiopathic portal hypertension is a condition where there is increased pressure in the portal vein without cirrhosis or other known causes. Metabolomics is the study of small molecule metabolites in biological samples. Research has shown that metabolomics approaches have identified potential biomarkers for various liver diseases and portal hypertension. Several studies have demonstrated that metabolomic profiling can distinguish patients with idiopathic portal hypertension from healthy controls and from patients with other liver diseases, identifying specific metabolic signatures that could serve as noninvasive diagnostic markers. Therefore, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19339791",
    "question": "Is triiodothyronine an indicator of nutritional status in adolescent girls with eating disorders?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if triiodothyronine (T3, a thyroid hormone) is an indicator of nutritional status in adolescent girls with eating disorders. Based on medical literature, T3 levels are indeed affected by nutritional status, particularly in conditions like anorexia nervosa and other eating disorders. Low T3 syndrome (or euthyroid sick syndrome) is commonly observed in malnutrition states, including those caused by eating disorders. T3 levels typically decrease during starvation or severe caloric restriction as a physiological adaptation to conserve energy. Therefore, T3 is considered a useful biomarker for assessing nutritional status in patients with eating disorders, including adolescent girls.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16487911",
    "question": "Does high dietary methionine intake increase the risk of acute coronary events in middle-aged men?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between high dietary methionine intake and the risk of acute coronary events (like heart attacks) specifically in middle-aged men.\\n\\nTo answer this accurately, I would need to know what the scientific evidence shows about this specific relationship. Methionine is an essential amino acid found in protein-rich foods. Some studies have examined connections between various amino acids and cardiovascular outcomes, but I need to consider whether there's established evidence specifically for methionine and acute coronary events in this demographic.\\n\\nBased on my knowledge, while there have been studies on methionine metabolism (particularly homocysteine) and heart disease risk, I don't recall definitive evidence establishing that high dietary methionine intake directly increases acute coronary event risk in middle-aged men. Some research has examined methionine restriction (not high intake) for potential health benefits.\\n\\nWithout specific studies showing a clear causal relationship between high methionine intake and increased acute coronary events in middle-aged men, I should answer 'no' to this specific claim.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19358743",
    "question": "Do gC-1 mRHBDD1 knockdown spermatogonia cells lose their spermatogenic capacity in mouse seminiferous tubules?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the effect of gC-1 mRHBDD1 knockdown on spermatogonia cells, specifically whether they lose spermatogenic capacity in mouse seminiferous tubules. To answer this, I need to determine if there's evidence that knocking down mRHBDD1 in gC-1 spermatogonia cells causes them to lose their ability to develop into mature sperm cells when in mouse seminiferous tubules. Without specific research information about this particular gene knockdown and its effects, I cannot provide a definitive answer based on scientific evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24499394",
    "question": "Does cognitive-behavioural group therapy improve a psychophysiological marker of stress in caregivers of patients with Alzheimer 's disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if cognitive-behavioural group therapy improves a psychophysiological marker of stress in caregivers of patients with Alzheimer's disease. To answer this, I would need specific research evidence showing that cognitive-behavioural group therapy has been tested on caregivers of Alzheimer's patients and that it demonstrated improvement in some measurable physiological marker of stress (like cortisol levels, heart rate variability, blood pressure, etc.). Without being provided specific research evidence in the question, I cannot make a definitive claim about this specific therapeutic intervention's effect on physiological stress markers in this particular population.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24192537",
    "question": "Are melanocortin 1 Receptor-derived peptides efficiently recognized by cytotoxic T lymphocytes from melanoma patients?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about whether melanocortin 1 Receptor (MC1R)-derived peptides are efficiently recognized by cytotoxic T lymphocytes (CTLs) from melanoma patients. To answer this, I need to consider what is known about MC1R peptides and their interaction with the immune system in melanoma patients.\\n\\nMC1R is a protein involved in regulating pigmentation and is often associated with melanoma risk, particularly in individuals with certain variants. The question specifically asks about peptides derived from MC1R and whether they are efficiently recognized by CTLs from melanoma patients.\\n\\nBased on scientific literature, MC1R-derived peptides have been studied in the context of melanoma immunology. Some research has shown that certain MC1R-derived peptides can be presented by MHC molecules and recognized by T cells. However, the efficiency of this recognition by CTLs specifically from melanoma patients is what's being asked.\\n\\nFrom my knowledge, while MC1R peptides can be recognized by T cells, the efficiency of this recognition by CTLs from melanoma patients is generally not considered high or robust. MC1R is not typically among the most immunogenic melanoma antigens like MART-1, gp100, or NY-ESO-1 that elicit strong CTL responses in melanoma patients. The recognition of MC1R peptides by CTLs from melanoma patients is generally considered suboptimal or inefficient compared to other melanoma antigens.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11753043",
    "question": "Is connective tissue growth factor involved in pancreatic repair and tissue remodeling in human and rat acute necrotizing pancreatitis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if connective tissue growth factor (CTGF) is involved in pancreatic repair and tissue remodeling in both human and rat acute necrotizing pancreatitis. To answer this, I need to consider what is known about CTGF's role in pancreatic tissue repair mechanisms.\\n\\nCTGF is a matricellular protein that plays important roles in tissue repair, fibrosis, and remodeling in various organs. In the context of pancreatitis, especially acute necrotizing pancreatitis, CTGF has been studied for its potential involvement in the repair process following tissue damage.\\n\\nResearch has shown that CTGF expression is upregulated during pancreatic injury and inflammation. Studies in rat models of acute pancreatitis have demonstrated increased CTGF expression during the recovery phase. Similarly, human studies have shown elevated CTGF levels in pancreatic tissues from patients with pancreatitis.\\n\\nCTGF promotes fibroblast proliferation, extracellular matrix production, and angiogenesis - all critical processes in tissue repair following pancreatic necrosis. It works in concert with other growth factors like TGF-β to orchestrate the repair process.\\n\\nBased on the available scientific literature, CTGF does appear to be involved in pancreatic repair and tissue remodeling in both human and rat models of acute necrotizing pancreatitis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25257293",
    "question": "Is reduced left executive control network functional connectivity associated with alcohol use disorders?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between reduced left executive control network functional connectivity and alcohol use disorders. To answer this, I need to consider what research shows about brain connectivity patterns in people with alcohol use disorders.\\n\\nThe executive control network (ECN) is a brain network involved in cognitive control, decision-making, and goal-directed behavior. Functional connectivity refers to the temporal correlation between spatially remote neurophysiological events, which is thought to reflect neural communication.\\n\\nResearch has indeed shown that individuals with alcohol use disorders often display altered functional connectivity in various brain networks, including the executive control network. Specifically, studies have found reduced functional connectivity in the left executive control network in individuals with alcohol use disorders compared to healthy controls. This reduced connectivity is thought to contribute to impaired cognitive control and decision-making processes that characterize addiction.\\n\\nTherefore, based on the existing neuroimaging literature on alcohol use disorders, there is evidence supporting an association between reduced left executive control network functional connectivity and alcohol use disorders.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24314266",
    "question": "Does antifungal activity of cinnamic acid derivatives involve inhibition of benzoate 4-hydroxylase ( CYP53 )?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the antifungal activity of cinnamic acid derivatives involves inhibition of benzoate 4-hydroxylase (CYP53). To answer this, I need to consider what is known about the mechanism of action of cinnamic acid derivatives as antifungals.\\n\\nCinnamic acid derivatives are known to have antifungal properties, but their specific mechanisms of action can vary. CYP53 (benzoate 4-hydroxylase) is a cytochrome P450 enzyme that is specific to fungi and is involved in the detoxification of aromatic compounds. It has been identified as a potential antifungal drug target.\\n\\nThere is research indicating that some cinnamic acid derivatives can indeed inhibit CYP53. Studies have shown that these compounds can bind to the active site of CYP53 and prevent it from functioning properly, which contributes to their antifungal activity. The structural similarity between cinnamic acid derivatives and the natural substrates of CYP53 allows them to act as competitive inhibitors.\\n\\nSo based on the scientific literature, yes, inhibition of benzoate 4-hydroxylase (CYP53) is one of the mechanisms through which cinnamic acid derivatives exert their antifungal activity.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18416823",
    "question": "Do raisins and additional walking have distinct effects on plasma lipids and inflammatory cytokines?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if raisins and additional walking have distinct effects on plasma lipids and inflammatory cytokines. To answer this, I need to consider whether scientific evidence shows these two interventions affect these biomarkers differently.\\n\\nRaisins are a food that may affect blood lipids and inflammatory markers through their nutritional components (fiber, antioxidants, etc.).\\n\\nWalking is a form of physical activity that can affect metabolism, including lipid profiles and inflammatory markers through different physiological mechanisms than dietary interventions.\\n\\nBased on physiological principles and research, these two interventions would work through different pathways - dietary components versus exercise-induced metabolic changes - suggesting they would have distinct effects on plasma lipids and inflammatory cytokines.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22264502",
    "question": "Does the prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulate apoptosis and proliferation through reciprocal regulation of androgen receptor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking if PlncRNA-1 (a long noncoding RNA that is up-regulated in prostate cancer) modulates apoptosis and proliferation through reciprocal regulation of the androgen receptor (AR). To answer this, I need to consider what's known about PlncRNA-1's mechanisms of action.\\n\\nBased on scientific literature, PlncRNA-1 has been shown to interact with the androgen receptor signaling pathway in prostate cancer. Studies have demonstrated that PlncRNA-1 can protect AR from miRNA-mediated suppression, particularly from miR-34c and miR-297. This interaction leads to increased AR expression and activity.\\n\\nFurthermore, research has shown that PlncRNA-1 knockdown can induce apoptosis and inhibit proliferation in prostate cancer cells, while its overexpression has the opposite effects. These cellular effects appear to be mediated, at least in part, through its regulation of AR signaling.\\n\\nThe term 'reciprocal regulation' implies a two-way relationship where PlncRNA-1 regulates AR and AR regulates PlncRNA-1. There is evidence that AR can bind to the promoter region of PlncRNA-1 and regulate its expression, completing this reciprocal regulatory loop.\\n\\nSo yes, PlncRNA-1 does modulate apoptosis and proliferation through reciprocal regulation of the androgen receptor in prostate cancer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25066015",
    "question": "Is the anxiolytic effects of a Valerian extract based on valerenic acid?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Valerian (Valeriana officinalis) is a herbal supplement often used for its anxiolytic (anxiety-reducing) effects. The question asks whether these effects are based on valerenic acid, which is one of the active compounds in valerian. \\n\\nValerian extracts do contain valerenic acid, which is considered one of the bioactive constituents. Research suggests that valerenic acid may contribute to valerian's anxiolytic effects through interaction with GABA-A receptors in the brain. However, valerian contains multiple bioactive compounds including valepotriates, lignans, flavonoids, and other sesquiterpenes that may also contribute to its effects. \\n\\nWhile valerenic acid is often used as a marker compound for standardization of valerian extracts and has demonstrated anxiolytic properties in some studies, it's not accurate to say the anxiolytic effects are based solely on this one compound. The anxiolytic effects likely result from multiple constituents working together.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21484216",
    "question": "Does hLA-DRB1 reduce the risk of type 2 diabetes mellitus by increased insulin secretion?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if hLA-DRB1 reduces the risk of type 2 diabetes mellitus specifically through increased insulin secretion. HLA-DRB1 is a gene that encodes for a protein that is part of the major histocompatibility complex class II, which is involved in immune system function. While there are studies that have investigated associations between HLA-DRB1 variants and type 2 diabetes risk, I don't have definitive evidence that it specifically reduces risk through increased insulin secretion. The mechanisms by which HLA genes might influence diabetes risk are more likely related to autoimmunity and inflammation rather than directly affecting insulin secretion. Without specific research confirming this particular mechanism, I cannot say yes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17327954",
    "question": "Does valproic acid improve psychotic agitation without influencing plasma risperidone levels in schizophrenic patients?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question. It's asking whether valproic acid has two specific effects in schizophrenic patients: 1) improving psychotic agitation, and 2) not influencing plasma risperidone levels. To answer this accurately, I would need to know about the pharmacological interactions between valproic acid and risperidone, and clinical evidence about valproic acid's effects on psychotic agitation in schizophrenia. Valproic acid is commonly used as a mood stabilizer, and risperidone is an antipsychotic medication. The question is asking about a specific clinical finding that would require research evidence. Without specific studies showing that valproic acid both improves psychotic agitation AND does not affect risperidone levels, I cannot confidently answer 'yes'. The most accurate answer would be 'no' because this specific dual claim requires evidence, and there are known drug interactions between many psychiatric medications.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25522183",
    "question": "Are high faecal calprotectin levels in intestinal tuberculosis associated with granulomas in intestinal biopsies?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about a correlation between high faecal calprotectin levels and the presence of granulomas in intestinal biopsies specifically in patients with intestinal tuberculosis. To answer this accurately, I would need specific research evidence that establishes this association. Intestinal tuberculosis is known to cause granulomas in intestinal tissue, and calprotectin is a marker of intestinal inflammation. However, without specific studies demonstrating that high faecal calprotectin levels correlate with the presence of granulomas in intestinal TB biopsies, I cannot confirm this association. While both are features of intestinal TB, their direct correlation is not well-established in the literature I'm familiar with.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11408770",
    "question": "Does expression of VLA-4 on eosinophils decrease in patients with eosinophilia?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the expression of VLA-4 (Very Late Antigen-4, an integrin) on eosinophils decreases in patients with eosinophilia. Eosinophilia is a condition characterized by elevated levels of eosinophils in the blood. VLA-4 is an adhesion molecule that plays a role in eosinophil trafficking and recruitment to tissues.\\n\\nTo answer this question accurately, I need to recall what research shows about VLA-4 expression on eosinophils in eosinophilic conditions. Based on the scientific literature, VLA-4 expression on eosinophils typically increases (not decreases) in various eosinophilic conditions. This increased expression helps facilitate eosinophil adhesion to endothelium and migration into tissues, which is a key part of the pathophysiology of eosinophilic disorders. In fact, therapies targeting VLA-4 (like natalizumab) have been studied for eosinophilic conditions precisely because VLA-4 expression is elevated, not reduced.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18311184",
    "question": "Does gabapentin activate ROMK1 channels by a protein kinase A ( PKA ) -dependent mechanism?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if gabapentin activates ROMK1 channels through a PKA-dependent mechanism. To answer this, I need to consider what is known about gabapentin's mechanism of action. Gabapentin is primarily known to bind to the α2δ subunit of voltage-gated calcium channels, which reduces calcium influx and subsequently reduces the release of excitatory neurotransmitters. It does not have well-established direct effects on ROMK1 (renal outer medullary potassium) channels, which are primarily involved in potassium homeostasis in the kidney. Furthermore, gabapentin is not generally known to act through PKA-dependent mechanisms. Without specific evidence in the scientific literature indicating that gabapentin activates ROMK1 channels via a PKA-dependent mechanism, the answer would be no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16597320",
    "question": "Do xenopus death-domain-containing proteins FADD and RIP1 synergistically activate JNK and NF-kappaB?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if xenopus death-domain-containing proteins FADD and RIP1 synergistically activate JNK and NF-kappaB. To answer this, I need to consider what is known about these specific proteins in xenopus (African clawed frog) and their interaction. FADD (Fas-associated protein with death domain) and RIP1 (Receptor-interacting protein kinase 1) are death domain-containing proteins involved in cell death and inflammatory signaling pathways. In mammalian systems, these proteins can be involved in signaling pathways that lead to JNK and NF-kappaB activation. However, the question specifically asks about synergistic activation in xenopus. Without specific research evidence showing that xenopus FADD and RIP1 work together synergistically to activate these pathways, I cannot confirm this relationship. Based on general knowledge of these signaling pathways, I don't have definitive evidence that these specific xenopus proteins synergistically activate JNK and NF-kappaB.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27493725",
    "question": "Do essential amino acid ratios and mTOR affect lipogenic gene networks and miRNA expression in bovine mammary epithelial cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between essential amino acid ratios, mTOR (mammalian target of rapamycin), lipogenic gene networks, and miRNA expression specifically in bovine mammary epithelial cells. To answer this, I need to consider what's known in the scientific literature about these relationships. \\n\\nEssential amino acids (EAAs) are known to activate mTOR signaling in various cell types. mTOR is a key regulator of cellular metabolism, including lipid metabolism. In bovine mammary epithelial cells specifically, there is research showing that amino acid availability and ratios can affect milk fat synthesis and gene expression related to lipid metabolism. Additionally, mTOR signaling has been shown to regulate miRNA expression in various cell types.\\n\\nBased on the scientific literature, there is evidence that essential amino acid ratios can affect mTOR signaling, which in turn can influence lipogenic gene networks and miRNA expression in bovine mammary epithelial cells. This is particularly relevant in the context of milk production and milk fat synthesis in dairy cows.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17637913",
    "question": "Is obesity a modifier of autonomic cardiac responses to fine metal particulates?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether obesity affects (modifies) how the autonomic nervous system of the heart responds to exposure to fine metal particles in the air. To answer this, I would need to know if research has established that obesity changes how the heart's autonomic regulation responds to metal particulate exposure. While there is research on how air pollution affects cardiovascular function, and separate research on how obesity affects autonomic cardiac function, I don't have specific evidence that obesity specifically modifies the cardiac autonomic response to fine metal particulates in particular. Without clear evidence from medical literature establishing this specific relationship, I cannot confidently answer 'yes'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18766029",
    "question": "Do comparison of breast implant deflation for mentor anterior and posterior valve designs in aesthetic and reconstructive patients?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if I can provide a comparison of breast implant deflation rates between Mentor anterior and posterior valve designs in both aesthetic and reconstructive patients. This seems to be a request for specific medical comparison data about different types of breast implants. I'm being asked to compare deflation rates between two specific valve designs (anterior vs posterior) made by the company Mentor, and to do this comparison across two patient populations (aesthetic breast augmentation patients vs breast reconstruction patients). This is a request for specific medical research information, not a yes/no question about my capabilities or a factual statement I can verify as true or false.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9180101",
    "question": "Does long-term estrogen therapy improve vascular function in male to female transsexuals?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether long-term estrogen therapy improves vascular function in male to female transsexuals. To answer this, I need to consider what the scientific literature says about the effects of estrogen therapy on vascular function specifically in this population. \\n\\nEstrogen therapy in male to female transgender individuals (now more commonly referred to as transgender women) has several cardiovascular effects. While estrogen can have some beneficial effects on lipid profiles, there is evidence suggesting it may increase risk of venous thromboembolism and potentially other cardiovascular issues. However, regarding specific vascular function improvements (such as endothelial function, arterial stiffness, or vasodilation capacity), the evidence is mixed and limited.\\n\\nSome studies suggest potential improvements in certain vascular parameters, while others indicate neutral or potentially negative effects. There isn't a clear scientific consensus that long-term estrogen therapy definitively improves vascular function in this population. The cardiovascular effects are complex and may depend on the type of estrogen, administration route, duration, and individual factors.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23726117",
    "question": "Are development of radiation pneumopathy and generalised radiological changes after radiotherapy independent negative prognostic factors for survival in non-small cell lung cancer patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if two factors are independent negative prognostic factors for survival in non-small cell lung cancer patients: 1) development of radiation pneumopathy and 2) generalized radiological changes after radiotherapy. To answer this, I would need to know if research has established that these two factors independently predict worse survival outcomes in NSCLC patients who have undergone radiotherapy. Without specific research data provided in the question, I need to consider what's generally known about these factors. Radiation pneumopathy (lung injury from radiation) and generalized radiological changes can be consequences of treatment that might affect prognosis, but whether they are established as independent negative prognostic factors requires specific evidence. Since the question is asking for a factual determination about established prognostic factors in oncology, and I don't have sufficient evidence provided to make this determination, I should be cautious in my answer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23272112",
    "question": "Does chronic Schistosoma japonicum infection reduce immune response to vaccine against hepatitis B in mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether chronic Schistosoma japonicum infection reduces immune response to hepatitis B vaccine in mice. To answer this, I need to determine if there's established scientific evidence showing this specific immunological interaction. Schistosoma japonicum is a parasitic flatworm that causes schistosomiasis, and chronic infections with parasites can sometimes modulate host immune responses. However, without specific research data on this particular interaction between S. japonicum and hepatitis B vaccine response in mice, I cannot make a definitive claim. Based on general immunology principles, some parasitic infections can downregulate Th1 responses which might affect vaccine efficacy, but this is not sufficient to make a specific claim about S. japonicum and hepatitis B vaccine.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18704673",
    "question": "Does interval double transfer improve treatment success in patients with repeated IVF/ET failures?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether interval double transfer improves treatment success in patients with repeated IVF/ET failures. To answer this, I need to consider if there's established evidence that interval double transfer (a technique where embryos are transferred at different times within the same cycle) improves outcomes specifically for patients who have had multiple failed IVF/embryo transfer attempts.\\n\\nBased on my knowledge, while there have been some studies investigating interval double transfer as a potential strategy for patients with recurrent implantation failure, the evidence is not conclusive or strong enough to definitively state that it improves success rates. Some studies show modest improvements, while others show no significant benefit compared to standard protocols. This technique remains experimental rather than a proven intervention that reliably improves outcomes for patients with repeated failures.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25711469",
    "question": "Does hydrogen sulphide induce vasoconstriction of rat coronary artery via activation of Ca ( 2+ ) influx?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if hydrogen sulphide (H2S) induces vasoconstriction of rat coronary artery through activation of Ca2+ influx. To answer this, I need to consider the known physiological effects of H2S on vascular smooth muscle. Based on scientific literature, H2S is generally recognized as a vasodilator rather than a vasoconstrictor in most vascular beds, including coronary arteries. H2S typically causes hyperpolarization of vascular smooth muscle cells and inhibits calcium influx, leading to relaxation rather than constriction. The mechanism of H2S-induced vasodilation often involves activation of KATP channels and inhibition of voltage-gated Ca2+ channels, which would reduce rather than activate Ca2+ influx. Therefore, the premise of the question appears to be incorrect.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24606022",
    "question": "Is blood eosinophil count a useful biomarker to identify patients with severe eosinophilic asthma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question asks about the utility of blood eosinophil count as a biomarker for identifying patients with severe eosinophilic asthma. Eosinophilic asthma is a subtype of asthma characterized by elevated levels of eosinophils (a type of white blood cell) in the airways and sometimes in the blood. Severe eosinophilic asthma is a more serious form that is often resistant to standard treatments.\\n\\nBlood eosinophil count is indeed widely used as a biomarker to help identify patients with eosinophilic asthma. Multiple clinical guidelines and research studies support the use of blood eosinophil counts as a biomarker for identifying patients who may have eosinophilic asthma and who might benefit from targeted therapies like anti-IL5 treatments (such as mepolizumab, reslizumab) or anti-IL5R treatments (benralizumab).\\n\\nElevated blood eosinophil counts (typically >300 cells/μL) are associated with increased risk of asthma exacerbations and can predict response to therapies targeting the eosinophilic pathway. While not perfect (as some patients may have normal blood eosinophils but elevated airway eosinophils), it is considered a useful, accessible, and non-invasive biomarker for clinical practice.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18657492",
    "question": "Is endothelial nitric oxide synthase ( eNOS ) upregulated in gastric mucosa of Helicobacter pylori ( H. pylori ) -positive patients with type 2 diabetes mellitus?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To answer this question, I need to determine if there's evidence that eNOS (endothelial nitric oxide synthase) is upregulated in the gastric mucosa specifically in H. pylori-positive patients who also have type 2 diabetes mellitus.\\n\\nThe question is asking about a specific molecular relationship between:\\n1. eNOS expression levels\\n2. H. pylori infection status (positive)\\n3. In patients with type 2 diabetes mellitus\\n4. Specifically in gastric mucosa tissue\\n\\nWithout specific research studies or data provided in the question, I cannot definitively state whether eNOS is upregulated in this specific clinical scenario. This would require evidence from medical literature studying the intersection of H. pylori infection, diabetes, and eNOS expression in gastric tissue. \\n\\nSince I don't have access to specific studies demonstrating this relationship, and this appears to be a specific scientific question requiring empirical evidence, I cannot confirm that eNOS is upregulated in this specific scenario.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "20484451",
    "question": "Does maternal gestational zinc supplementation influence multiple aspects of child development at 54 mo of age in Peru?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if maternal gestational zinc supplementation influences multiple aspects of child development at 54 months of age in Peru. To answer this, I need to determine if there's evidence that giving zinc supplements to pregnant women in Peru affects various developmental outcomes in their children when they reach 54 months (4.5 years) of age. This would be based on research studies conducted in Peru that specifically examined this relationship. Without specific research citations in the question, I need to consider if this is a well-established finding in the scientific literature. Based on my knowledge, there have been studies examining zinc supplementation during pregnancy and its effects on child development, including some conducted in Peru. The specific age of 54 months and the mention of 'multiple aspects' of development suggests this may be referring to a particular study.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "20089945",
    "question": "Does thalamic integrity underlie executive dysfunction in traumatic brain injury?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if thalamic integrity (the structural health of the thalamus in the brain) is the underlying cause of executive dysfunction in traumatic brain injury (TBI). To answer this, I need to consider whether there's a direct causal relationship where thalamic damage specifically explains executive function problems after TBI.\\n\\nWhile research has shown that thalamic damage can occur in TBI and may contribute to cognitive deficits including executive dysfunction, it would be an oversimplification to say thalamic integrity is THE underlying cause. Executive dysfunction in TBI is typically multifactorial, involving damage to various brain regions including but not limited to:\\n- Frontal lobes (particularly prefrontal cortex)\\n- White matter tracts\\n- Various subcortical structures including the thalamus\\n- Diffuse axonal injury affecting connectivity\\n\\nThe thalamus plays an important role as a relay center and in cognitive networks, but executive dysfunction in TBI cannot be reduced to thalamic integrity alone. It's one contributing factor among many.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21221223",
    "question": "Do augmented repair of acute tendo Achilles ruptures with gastrosoleus turn down flap?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether augmented repair of acute Achilles tendon ruptures involves using a gastrosoleus turn down flap as part of the surgical technique. The gastrosoleus turn down flap is a surgical technique where a portion of the gastrocnemius-soleus muscle complex is turned down to reinforce the repair of an Achilles tendon rupture. In augmented repair of acute Achilles tendon ruptures, various techniques can be used, and the gastrosoleus turn down flap is indeed one of the established methods for augmentation. This technique uses the patient's own tissue to strengthen the primary repair, potentially improving healing and reducing re-rupture rates. So yes, gastrosoleus turn down flap is one method used for augmented repair of acute Achilles tendon ruptures.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18540916",
    "question": "Is differential neural response to alcohol priming and alcohol taste cues associated with DRD4 VNTR and OPRM1 genotypes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether there is an association between differential neural responses to alcohol priming and taste cues and specific genetic variants - specifically the DRD4 VNTR (dopamine D4 receptor variable number tandem repeat) and OPRM1 (mu-opioid receptor) genotypes. To answer this, I would need to know if research has established such associations. This is a specific scientific question about neurogenetics and alcohol response. Without specific research knowledge on this topic, I cannot definitively answer. However, there is research suggesting that both DRD4 and OPRM1 variants can influence reward processing and responses to alcohol, so such an association is plausible. The most accurate answer would depend on specific studies that have examined these neural responses in relation to these genetic variants.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16813529",
    "question": "Is disease status in autosomal dominant osteopetrosis type 2 determined by osteoclastic properties?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Autosomal dominant osteopetrosis type 2 (ADO2), also known as Albers-Schönberg disease, is characterized by increased bone density due to defective osteoclast function. The disease is caused by mutations in the CLCN7 gene, which encodes a chloride channel that is essential for osteoclast-mediated bone resorption. The disease status is indeed determined by the functional properties of osteoclasts - specifically, their inability to properly resorb bone due to the genetic mutation affecting the chloride channel. This leads to the characteristic increased bone density seen in the condition. So yes, the disease status in ADO2 is determined by osteoclastic properties.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23702660",
    "question": "Does circulating blood endothelial nitric oxide synthase contribute to the regulation of systemic blood pressure and nitrite homeostasis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the role of endothelial nitric oxide synthase (eNOS) in blood circulation, specifically whether it contributes to regulating systemic blood pressure and nitrite homeostasis. eNOS is an enzyme that produces nitric oxide (NO) in the endothelium (the inner lining of blood vessels). NO is a vasodilator that relaxes blood vessels, which can lower blood pressure. When NO is produced, it can be oxidized to form nitrite in the blood. Scientific research has established that eNOS-derived NO does play an important role in vascular tone and blood pressure regulation. Additionally, eNOS activity affects nitrite levels in the circulation, contributing to nitrite homeostasis. Based on established physiological understanding, circulating blood endothelial nitric oxide synthase does contribute to both blood pressure regulation and nitrite homeostasis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26991449",
    "question": "Does actein protect against methylglyoxal-induced oxidative damage in osteoblastic MC3T3-E1 cells?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if actein protects against methylglyoxal-induced oxidative damage in osteoblastic MC3T3-E1 cells. To answer this, I would need specific scientific evidence from research studies that have investigated this particular compound (actein) in this specific cell line (MC3T3-E1) against methylglyoxal-induced damage. Without access to scientific databases or specific papers on this topic, I cannot definitively state whether actein has this protective effect. This appears to be a very specific biochemical question that would require evidence from published research.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22801072",
    "question": "Does renal function have an effect on cardiovascular mortality in patients with dilated cardiomyopathy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question asks about the relationship between renal function and cardiovascular mortality specifically in patients with dilated cardiomyopathy. To answer this, I need to consider the medical evidence.\\n\\nRenal dysfunction is known to be associated with worse outcomes in many cardiovascular conditions. In dilated cardiomyopathy specifically:\\n\\n1. Impaired renal function is a known predictor of poor outcomes in heart failure patients in general\\n2. Dilated cardiomyopathy is a form of heart failure characterized by enlargement of the heart chambers and impaired contraction\\n3. The cardiorenal syndrome describes the bidirectional relationship between heart and kidney dysfunction\\n4. Multiple studies have shown that decreased glomerular filtration rate (GFR) and other markers of renal dysfunction are independent predictors of mortality in dilated cardiomyopathy patients\\n5. Renal dysfunction can affect fluid balance, electrolyte levels, medication clearance, and neurohormonal activation - all of which can impact cardiovascular function and mortality\\n\\nBased on established medical literature, renal function does have a significant effect on cardiovascular mortality in patients with dilated cardiomyopathy.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24508720",
    "question": "Are high levels of physical activity and cardiorespiratory fitness associated with good self-rated health in adolescents?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question asks about the association between high levels of physical activity and cardiorespiratory fitness with self-rated health in adolescents. Research has generally shown positive associations between physical activity, fitness and self-perceived health in young people. Multiple studies have demonstrated that adolescents who engage in more physical activity and have better cardiorespiratory fitness tend to report better self-rated health. This relationship has been documented across different populations and settings. The evidence supports a positive association between these variables.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16332654",
    "question": "Does dietary carbohydrate modification enhance insulin secretion in persons with the metabolic syndrome?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether modifying carbohydrate intake in the diet can enhance insulin secretion specifically in people who have metabolic syndrome. To answer this accurately, I need to consider the established scientific evidence on this relationship.\\n\\nMetabolic syndrome is characterized by insulin resistance, abdominal obesity, hypertension, dyslipidemia, and elevated blood glucose. \\n\\nResearch has shown that carbohydrate modification (such as reducing refined carbohydrates, lowering glycemic load, or changing carbohydrate quality) can improve insulin sensitivity in people with metabolic syndrome. However, improving insulin sensitivity is different from enhancing insulin secretion.\\n\\nEnhancing insulin secretion specifically refers to increasing the amount of insulin produced and released by pancreatic beta cells. The evidence that dietary carbohydrate modification directly enhances insulin secretion (as opposed to improving insulin sensitivity) in metabolic syndrome is not strongly established in the scientific literature.\\n\\nIn fact, many dietary interventions for metabolic syndrome aim to reduce the demand on insulin secretion rather than enhance it, since hyperinsulinemia is often already present in metabolic syndrome.\\n\\nBased on the current scientific understanding, I cannot confidently state that carbohydrate modification enhances insulin secretion in metabolic syndrome.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27213678",
    "question": "Do social complexity beliefs predict posttraumatic growth in survivors of a natural disaster?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between social complexity beliefs and posttraumatic growth in natural disaster survivors. Social complexity beliefs refer to the understanding that social issues have multiple causes and solutions. Posttraumatic growth refers to positive psychological changes experienced as a result of struggling with highly challenging life circumstances. \\n\\nTo answer this question accurately, I would need to refer to specific research studies that have examined this relationship in natural disaster survivors. Without specific research evidence, I cannot make a definitive claim. However, there is research suggesting that various cognitive factors, including beliefs about the world and meaning-making processes, can predict posttraumatic growth. Whether social complexity beliefs specifically predict posttraumatic growth in natural disaster survivors would depend on empirical evidence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24777651",
    "question": "Does analytical function for beta and gamma absorbed fractions of iodine-131 in spherical and ellipsoidal volumes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if there is an analytical function for beta and gamma absorbed fractions of iodine-131 in spherical and ellipsoidal volumes. This is asking about a specific mathematical function or formula that describes how beta and gamma radiation from iodine-131 is absorbed in geometrical volumes of specific shapes (spheres and ellipsoids). To answer this properly, I would need to know if such analytical functions exist in radiation physics or nuclear medicine. While there are computational models and Monte Carlo simulations for calculating absorbed fractions, whether there exists a closed-form analytical function specifically for iodine-131 in these geometries is not clear from the question alone. The question itself is also not a complete sentence - it seems to be asking 'Does [something] exist?' but is missing the verb. Since I don't have definitive information about the existence of such specific analytical functions, I cannot confidently answer yes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21169531",
    "question": "Does dissection of chromosome 16p12 linkage peak suggest a possible role for CACNG3 variants in age-related macular degeneration susceptibility?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if dissection of chromosome 16p12 linkage peak suggests a possible role for CACNG3 variants in age-related macular degeneration (AMD) susceptibility. I need to determine if there is evidence in the scientific literature connecting CACNG3 variants on chromosome 16p12 to AMD risk.\\n\\nTo my knowledge, the major genetic risk factors for AMD include variants in genes like CFH, ARMS2/HTRA1, C3, C2/CFB, and several others. The main chromosomal regions implicated in AMD are typically 1q31 (CFH), 10q26 (ARMS2/HTRA1), and others on chromosomes 6, 19, and 22.\\n\\nChromosome 16p12 and specifically CACNG3 (which encodes a voltage-dependent calcium channel gamma subunit) are not commonly cited as major AMD susceptibility loci in the established literature. CACNG3 is more typically associated with neurological functions rather than retinal pathology.\\n\\nWithout specific evidence linking chromosome 16p12 linkage peak or CACNG3 variants to AMD susceptibility, I cannot confirm this association.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26016495",
    "question": "Do aNP and CNP activate CFTR expressed in Xenopus laevis oocytes by direct activation of PKA?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if aNP (atrial natriuretic peptide) and CNP (C-type natriuretic peptide) activate CFTR (cystic fibrosis transmembrane conductance regulator) expressed in Xenopus laevis oocytes through direct activation of PKA (protein kinase A). To answer this, I need to consider the known signaling pathways of natriuretic peptides and CFTR activation. Natriuretic peptides typically signal through particulate guanylyl cyclase receptors, increasing cGMP levels, which can activate PKG (protein kinase G). CFTR is known to be activated by PKA phosphorylation. The question is whether aNP and CNP directly activate PKA in this specific expression system. Based on the established signaling pathways, natriuretic peptides primarily signal through cGMP/PKG rather than directly activating PKA. Therefore, it's unlikely that they directly activate PKA to regulate CFTR in Xenopus oocytes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26981205",
    "question": "Do arctic ground squirrel neuronal progenitor cells resist oxygen and glucose deprivation-induced death?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if arctic ground squirrel neuronal progenitor cells resist oxygen and glucose deprivation-induced death. Arctic ground squirrels are known for their hibernation abilities and have adaptations to survive low oxygen and low glucose conditions. Research has shown that their neuronal cells have special protective mechanisms against ischemic conditions (oxygen and glucose deprivation). Specifically, studies have demonstrated that neural progenitor cells from arctic ground squirrels show enhanced resistance to oxygen and glucose deprivation compared to similar cells from non-hibernating species. This resistance to cell death under these conditions is part of the arctic ground squirrel's adaptation to survive hibernation, when metabolic rate and body temperature drop dramatically.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11894976",
    "question": "Does alcohol ingestion decrease both diurnal and nocturnal secretion of leptin in healthy individuals?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether alcohol ingestion decreases both diurnal (daytime) and nocturnal (nighttime) secretion of leptin in healthy individuals. To answer this, I need to consider what is known about alcohol's effects on leptin secretion patterns.\\n\\nLeptin is a hormone primarily produced by adipose tissue that helps regulate energy balance by inhibiting hunger. Its secretion typically follows a circadian rhythm with higher levels at night.\\n\\nBased on scientific literature, alcohol consumption has been shown to acutely suppress leptin levels. However, the question specifically asks about both diurnal AND nocturnal secretion patterns. While some studies have shown that alcohol can reduce leptin levels overall, I don't have definitive evidence that it specifically decreases leptin during both day and night periods in healthy individuals. Some research suggests alcohol may disrupt the normal circadian pattern of leptin secretion, but this doesn't necessarily mean decreases in both periods.\\n\\nWithout specific evidence that alcohol decreases leptin secretion during both diurnal and nocturnal periods, I cannot confidently answer 'yes' to this question.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25112839",
    "question": "Does basic fibroblastic growth factor affect the osteogenic differentiation of dental pulp stem cells in a treatment-dependent manner?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether basic fibroblastic growth factor (bFGF) affects the osteogenic differentiation of dental pulp stem cells (DPSCs) in a treatment-dependent manner. To answer this, I need to consider whether there's evidence that different treatments or doses of bFGF have different effects on the osteogenic differentiation of DPSCs. Without specific research information provided in the question, I cannot determine if bFGF affects DPSCs in a treatment-dependent manner. The question requires specific scientific evidence about varying effects based on different treatment protocols, which is not provided.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21536322",
    "question": "Is inflammation in common variable immunodeficiency associated with a distinct CD8 ( + ) response to cytomegalovirus?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if inflammation in common variable immunodeficiency (CVID) is associated with a distinct CD8+ response to cytomegalovirus (CMV). To answer this, I would need to know if research has established a specific or unique CD8+ T-cell response to CMV in CVID patients with inflammation that differs from those without inflammation or from healthy individuals. Without specific knowledge of research demonstrating this association, I cannot confidently answer yes. The question is asking about a specific immunological relationship that would require evidence from medical literature.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21354446",
    "question": "Do iL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C. IL28B polymorphisms (particularly rs12979860) have been associated with treatment response to pegylated interferon and ribavirin therapy in chronic hepatitis C. However, the specific timing of this effect - whether it predicts viral decline from the very first day of therapy - requires specific evidence. Based on research literature, IL28B polymorphisms are indeed associated with early viral kinetics, including the first-phase decline that occurs within the first 24-48 hours of treatment. Studies have shown that favorable IL28B genotypes (CC for rs12979860) are associated with more rapid early viral decline, including from the first day of therapy. Therefore, there is evidence supporting that IL28B polymorphisms do predict reduction of HCV RNA from the first day of therapy.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11937133",
    "question": "Does aromatase inhibition improve ovarian response to follicle-stimulating hormone in poor responders?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether aromatase inhibition improves ovarian response to follicle-stimulating hormone (FSH) in poor responders. Poor responders typically refer to women undergoing fertility treatments who don't respond well to standard ovarian stimulation protocols. Aromatase inhibitors (like letrozole) are sometimes used in fertility treatments to potentially enhance ovarian response. \\n\\nTo answer this question accurately, I need to consider the current scientific evidence. Based on my knowledge, there is some evidence suggesting that adding aromatase inhibitors to FSH stimulation protocols may improve ovarian response in poor responders by: 1) increasing intraovarian androgen levels which may enhance follicular sensitivity to FSH, 2) reducing estrogen levels which can lead to increased endogenous gonadotropin release, and 3) potentially reducing the total FSH dose needed. Several studies have shown modest improvements in response rates and pregnancy outcomes when aromatase inhibitors are added to stimulation protocols for poor responders, though results are not universally positive across all studies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19691981",
    "question": "Does stasis predispose ileal pouch inflammation in a rat model of ileal pouch-anal anastomosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether stasis (slowing or stopping of normal flow) predisposes ileal pouch inflammation in a rat model of ileal pouch-anal anastomosis (IPAA). IPAA is a surgical procedure often performed after removal of the colon and rectum. To answer this question accurately, I would need to know about specific research studies that examined the relationship between stasis and inflammation in rat models of IPAA. Without specific research evidence cited in the question, I cannot definitively answer whether stasis predisposes to inflammation in this specific model.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15182623",
    "question": "Do [ The change of the erythrocyte chemokine receptor binding activity in the shock stage of burn rats ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if '[The change of the erythrocyte chemokine receptor binding activity in the shock stage of burn rats]?' This appears to be a title or description of a scientific study about changes in chemokine receptor binding activity in red blood cells (erythrocytes) during the shock stage in rats that have been burned. However, the question is incomplete or unclear. It starts with 'Do' but doesn't complete the question - it's just stating a research topic without asking anything specific about it. Without a clear question, I cannot provide a yes or no answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23532890",
    "question": "Does tivantinib ( ARQ197 ) display cytotoxic activity that is independent of its ability to bind MET?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether tivantinib (ARQ197) has cytotoxic activity that is independent of its ability to bind MET. To answer this, I need to consider what is known about tivantinib's mechanism of action. Tivantinib was initially developed as a MET inhibitor, but research has shown that it can kill cells through mechanisms unrelated to MET inhibition. Several studies have demonstrated that tivantinib can cause cell death even in cells that don't express MET or where MET is knocked down, suggesting it has off-target cytotoxic effects. The drug has been shown to disrupt microtubule dynamics and induce cell cycle arrest, which appears to be its primary cytotoxic mechanism rather than MET inhibition. Based on the scientific literature, tivantinib does indeed display cytotoxic activity independent of its MET-binding ability.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26208964",
    "question": "Does standard chemoradiation for glioblastoma result in progressive brain volume loss?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether standard chemoradiation for glioblastoma results in progressive brain volume loss. Glioblastoma is a type of aggressive brain cancer, and standard treatment typically includes surgery followed by radiation therapy and chemotherapy (usually temozolomide), known collectively as chemoradiation. Research has shown that radiation therapy to the brain can cause damage to normal brain tissue over time, leading to what's called radiation-induced brain injury. This can manifest as progressive brain volume loss (brain atrophy) that continues even after treatment has ended. Studies have documented that patients who undergo chemoradiation for glioblastoma often experience progressive reduction in brain volume that can be detected on follow-up MRI scans. This volume loss is distinct from tumor effects and represents treatment-related toxicity to normal brain tissue.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24332649",
    "question": "Is quality of physician-patient relationships associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if there's an association between the quality of physician-patient relationships and how influential physician treatment recommendations are for prostate cancer patients who specifically chose active surveillance (rather than immediate treatment). To answer this, I would need evidence from research studies that examined this specific relationship. While there is general research showing that physician-patient relationships affect treatment adherence and satisfaction, the question is very specific to: 1) prostate cancer patients, 2) who chose active surveillance, and 3) whether relationship quality affects how influential the doctor's recommendations are for this specific population. Without specific research evidence addressing this precise relationship, I cannot confidently answer yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23985987",
    "question": "Do duration of shoot elongation in Scots pine varies within the crown and between years?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the duration of shoot elongation in Scots pine varies within the crown and between years. Based on botanical knowledge, shoot elongation in trees like Scots pine typically does show variation both within different parts of the crown (e.g., top vs. bottom, sun-exposed vs. shaded) and between different growing seasons depending on climate conditions, tree age, and other factors. Research has documented that shoot growth duration in conifers is not uniform throughout the crown and can vary significantly from year to year based on environmental conditions.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21849801",
    "question": "Do monocyte- and endothelial-derived microparticles induce an inflammatory phenotype in human podocytes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether microparticles derived from monocytes and endothelial cells cause inflammation in human podocytes. Podocytes are specialized cells in the kidney's glomerulus. To answer this, I need to consider if there's evidence that these specific microparticles induce inflammatory responses in podocytes.\\n\\nBased on research in nephrology and vascular biology, microparticles (MPs) from activated or damaged cells can indeed transfer biological information to recipient cells. Studies have shown that both monocyte-derived MPs and endothelial-derived MPs can activate inflammatory pathways in various cell types. Specifically for podocytes, research has demonstrated that these microparticles can induce pro-inflammatory cytokine production, upregulate adhesion molecules, and activate inflammatory signaling pathways in human podocytes. This has been documented in contexts of kidney diseases like diabetic nephropathy and other glomerular disorders.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22727941",
    "question": "Does sufentanil postconditioning protect the myocardium from ischemia-reperfusion via PI3K/Akt-GSK-3β pathway?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if sufentanil postconditioning protects the myocardium (heart muscle) from ischemia-reperfusion injury through the PI3K/Akt-GSK-3β signaling pathway. This is a specific scientific question about a pharmacological mechanism. Sufentanil is a synthetic opioid analgesic, and postconditioning refers to interventions applied after an ischemic event. The PI3K/Akt-GSK-3β pathway is a known cardioprotective signaling cascade. Based on existing research literature, sufentanil postconditioning has indeed been shown to protect against myocardial ischemia-reperfusion injury, and studies have demonstrated that this protection is mediated, at least in part, through the PI3K/Akt-GSK-3β pathway. Multiple studies have shown that inhibitors of this pathway block the protective effects of sufentanil, confirming the mechanism.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15946995",
    "question": "Is in a flexible antagonist protocol , earlier , criteria-based initiation of GnRH antagonist associated with increased pregnancy rates in IVF?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether in a flexible antagonist protocol for IVF (in vitro fertilization), earlier criteria-based initiation of GnRH antagonist is associated with increased pregnancy rates. To answer this, I would need to know if research studies have demonstrated that starting GnRH antagonists earlier in a flexible protocol leads to higher pregnancy rates compared to later initiation. Without specific research evidence provided in the question, I cannot make a definitive claim about this association. Based on my knowledge, while timing of GnRH antagonist administration is important in IVF protocols, I don't have conclusive evidence that earlier initiation specifically increases pregnancy rates in flexible antagonist protocols.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25929259",
    "question": "Is antibiotic treatment of diarrhoea associated with decreased time to the next diarrhoea episode among young children in Vellore , India?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if antibiotic treatment of diarrhea is associated with decreased time to the next diarrhea episode among young children in Vellore, India. To answer this, I would need specific research data from studies conducted in Vellore, India that examined this relationship. Without access to such specific research findings, I cannot determine whether antibiotics shortened the time between diarrhea episodes in this specific population. The question is asking about a specific association in a specific geographic location with a specific demographic group, requiring evidence-based research results.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23162237",
    "question": "Do a comparative study of the effect of different topical agents on burn wound infections?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking me to perform a comparative study of the effect of different topical agents on burn wound infections. This is a request for me to conduct research or create a comprehensive analysis comparing various topical treatments for burn wounds and their effectiveness in preventing or treating infections. This is not a yes/no question - it's a request for a complex research task or analysis. The question is phrased as an imperative statement (a command to do something) rather than a question that can be answered with yes or no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21515469",
    "question": "Is [ Cellular memory of high glucose exposure in normoglycemia probably mediated by reactive oxygen species in INS-1 cells ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether the statement 'Cellular memory of high glucose exposure in normoglycemia probably mediated by reactive oxygen species in INS-1 cells' is true. This appears to be a scientific claim about a biological mechanism. Without specific scientific knowledge about this particular cellular process in INS-1 cells, I cannot verify whether this statement is factually accurate. The question is asking for a yes/no answer about a specific scientific finding that would require specialized knowledge in cell biology or diabetes research to answer correctly.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23139277",
    "question": "Does topical administration of peroxiredoxin-6 on the cornea suppress inflammation and neovascularization induced by ultraviolet radiation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if topical administration of peroxiredoxin-6 on the cornea suppresses inflammation and neovascularization induced by ultraviolet radiation. To answer this, I would need specific scientific evidence from research studies that have investigated this particular relationship. Without having access to such specific research data, I cannot definitively say whether peroxiredoxin-6 has this effect on UV-induced corneal inflammation and neovascularization. While peroxiredoxin-6 is known to have antioxidant properties and may play roles in cellular protection, the specific claim about topical application suppressing UV-induced corneal inflammation and neovascularization requires direct experimental evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19706567",
    "question": "Is adolescent prescription ADHD medication abuse rising along with prescriptions for these medications?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if adolescent prescription ADHD medication abuse is rising in parallel with the increase in prescriptions for these medications. To answer this, I need to consider whether there's evidence that as more ADHD medications are being prescribed to adolescents, there is also a corresponding increase in the misuse or abuse of these medications by adolescents. This would require data on both prescription rates and abuse rates over time. Based on my knowledge, while there has been an increase in ADHD medication prescriptions over the years, the evidence about whether abuse has risen proportionally is mixed. Some studies suggest that diversion and misuse have increased in certain populations, while others indicate that improved formulations and monitoring may have mitigated abuse potential. Without clear evidence of a consistent correlation between prescription increases and abuse increases, I cannot confidently say 'yes' to this question.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21518461",
    "question": "Is iron overload in polytransfused patients without heart failure associated with subclinical alterations of systolic left ventricular function using cardiovascular magnetic resonance tagging?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether iron overload in polytransfused patients who don't have heart failure is associated with subclinical (not clinically apparent) alterations in systolic left ventricular function, specifically when measured using cardiovascular magnetic resonance tagging. To answer this, I need to consider whether studies have shown such an association. Based on medical literature, iron overload cardiomyopathy is a known complication in patients receiving multiple blood transfusions, and cardiovascular magnetic resonance (CMR) tagging is a sensitive technique that can detect subtle changes in myocardial function before overt heart failure develops. Studies have indeed shown that even in the absence of clinical heart failure, patients with transfusional iron overload can exhibit subclinical systolic dysfunction when assessed with sensitive techniques like CMR tagging.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18487264",
    "question": "Does the comparative ability of eight functional mobility tests for predicting fall in community-dwelling older people?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether the comparative ability of eight functional mobility tests predicts falls in community-dwelling older people. This is not a complete question - it's phrased as a statement with a question mark at the end. The question is missing a verb - it should be something like 'Does the comparative ability of eight functional mobility tests *predict* falls in community-dwelling older people?' Without a clear question, I cannot provide a yes or no answer. The question as stated is incomplete and grammatically incorrect.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19788954",
    "question": "Do sequential design with boundaries approach in pediatric intervention research reduces sample size?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if sequential design with boundaries approach in pediatric intervention research reduces sample size. Sequential designs allow for interim analyses and potential early stopping of trials when there is sufficient evidence of efficacy, futility, or safety concerns. By incorporating predefined boundaries for decision-making, these designs can indeed lead to smaller sample sizes compared to traditional fixed-sample designs, especially when treatment effects are larger than anticipated. In pediatric research, where recruitment can be challenging and ethical considerations are heightened, sequential designs with boundaries (like group sequential designs or adaptive designs) are particularly valuable as they can minimize the number of children exposed to experimental treatments while maintaining statistical rigor. So yes, sequential design with boundaries approach typically reduces sample size in pediatric intervention research compared to traditional fixed-sample designs.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25591955",
    "question": "Is angiotensin II-induced Egr-1 expression suppressed by peroxisome proliferator-activated receptor-γ ligand 15d-PGJ₂ in macrophages?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze the question. It's asking about a specific molecular pathway: whether angiotensin II-induced Egr-1 expression is suppressed by peroxisome proliferator-activated receptor-γ (PPAR-γ) ligand 15d-PGJ₂ in macrophages. \\n\\nTo answer this, I need to consider what's known about these interactions:\\n- Angiotensin II is known to induce Egr-1 expression in various cell types\\n- 15d-PGJ₂ is a PPAR-γ ligand with anti-inflammatory properties\\n- PPAR-γ activation often suppresses inflammatory pathways\\n\\nBased on scientific literature, 15d-PGJ₂ has been shown to suppress angiotensin II-induced Egr-1 expression in macrophages through PPAR-γ-dependent mechanisms. Studies have demonstrated that PPAR-γ ligands like 15d-PGJ₂ can inhibit the signaling pathways activated by angiotensin II, including those leading to Egr-1 expression in macrophages.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24920856",
    "question": "Does functional connectivity in the basal ganglia network differentiate PD patients from controls?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether functional connectivity in the basal ganglia network can differentiate Parkinson's disease (PD) patients from healthy controls. To answer this, I need to consider what is known about functional connectivity patterns in the basal ganglia of PD patients compared to controls.\\n\\nResearch has consistently shown that PD is associated with altered functional connectivity in the basal ganglia network. Multiple neuroimaging studies using fMRI, MEG, and other techniques have demonstrated abnormal connectivity patterns within the basal ganglia-thalamocortical circuits in PD patients. These alterations include changes in connectivity strength, network organization, and synchronization patterns that differ significantly from healthy controls.\\n\\nSpecifically, PD patients typically show decreased connectivity within the basal ganglia network, particularly involving the putamen and substantia nigra, as well as altered connectivity between the basal ganglia and cortical regions. These connectivity changes correlate with motor symptoms and disease progression.\\n\\nThese distinct patterns of functional connectivity have been used in classification studies to differentiate PD patients from controls with relatively high accuracy, supporting the diagnostic value of functional connectivity measures in the basal ganglia network.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26342495",
    "question": "Does electrolyte supplementation during severe energy restriction increase exercise capacity in the heat?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether electrolyte supplementation during severe energy restriction increases exercise capacity in the heat. This is a specific scientific question about the relationship between electrolyte supplementation, energy restriction, and exercise performance in hot conditions. To answer this accurately, I would need to know about research studies that have specifically examined this relationship. Without specific scientific evidence on this particular combination of factors (electrolytes + severe energy restriction + heat + exercise capacity), I cannot provide a definitive yes or no answer. The question requires knowledge of specific research findings rather than general principles.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12006438",
    "question": "Is the incidence and the risk of pneumothorax and chest tube placement after percutaneous CT-guided lung biopsy : the angle of the needle trajectory a novel predictor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether 'the angle of the needle trajectory' is a novel predictor for the incidence and risk of pneumothorax and chest tube placement after percutaneous CT-guided lung biopsy. This appears to be the title or part of a title of a research paper or study. The question is asking if this specific factor (needle trajectory angle) is being presented as a new/novel predictor of complications in this procedure. Without seeing the actual paper or having more context, I can't definitively answer, but the phrasing suggests that this is indeed presenting the angle of needle trajectory as a novel predictor.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11300434",
    "question": "Is recurrent unstable angina after directional coronary atherectomy related to the extent of initial coronary plaque inflammation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if recurrent unstable angina after directional coronary atherectomy is related to the extent of initial coronary plaque inflammation. To answer this, I need to consider whether there's established evidence linking the degree of inflammation in coronary plaques before atherectomy to the likelihood of experiencing unstable angina after the procedure.\\n\\nDirectional coronary atherectomy is a procedure that removes atherosclerotic plaque from coronary arteries. Plaque inflammation is known to be a factor in plaque instability and rupture, which can lead to acute coronary syndromes including unstable angina.\\n\\nResearch has shown that inflammatory markers in coronary plaques can predict future cardiovascular events. Studies have demonstrated that the degree of inflammation in coronary plaques before intervention can influence outcomes after procedures like atherectomy. Specifically, plaques with higher inflammatory activity may be more prone to recurrent instability even after mechanical intervention.\\n\\nTherefore, based on the pathophysiology of coronary artery disease and available clinical evidence, there is a relationship between the extent of initial plaque inflammation and the risk of recurrent unstable angina following directional coronary atherectomy.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11343974",
    "question": "Is bronchiolitis obliterans the primary cause of death in pediatric living donor lobar lung transplant recipients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To answer this question, I need to determine if bronchiolitis obliterans is indeed the primary cause of death in pediatric living donor lobar lung transplant recipients. Bronchiolitis obliterans is a known complication after lung transplantation that involves inflammation and fibrosis of the small airways. However, whether it's the primary cause of death specifically in pediatric living donor lobar lung transplant recipients requires specific medical evidence. Based on the medical literature, while bronchiolitis obliterans syndrome (BOS) is a significant complication and cause of chronic rejection in lung transplant recipients, it is not clearly established as the primary cause of death specifically in the pediatric living donor lobar lung transplant population. Other causes such as primary graft dysfunction, infection, and acute rejection also contribute significantly to mortality in this population.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "19789962",
    "question": "Do `` Soft '' calcium crosslinks enable highly efficient gene transfection using TAT peptide?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if 'Soft' calcium crosslinks enable highly efficient gene transfection using TAT peptide. To answer this, I need to analyze whether there is evidence that soft calcium crosslinks specifically enhance gene transfection efficiency when using TAT peptide as a delivery vehicle.\\n\\nTAT peptide is a cell-penetrating peptide derived from the HIV-1 TAT protein that can facilitate cellular uptake of various cargoes, including genes. Calcium crosslinks can be used in some gene delivery systems to stabilize complexes.\\n\\nHowever, without specific scientific literature or data provided in the question, I cannot definitively state whether 'soft' calcium crosslinks (as opposed to rigid or other types of crosslinks) specifically enable highly efficient gene transfection with TAT peptide. This appears to be a specific scientific claim that would require evidence from research studies.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18842799",
    "question": "Does effect of moderate alcohol consumption on liver enzymes increase with increasing body mass index?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index (BMI). This is asking about a specific interaction between alcohol consumption and BMI in affecting liver enzyme levels.\\n\\nTo answer this accurately, I need to consider the scientific evidence. Research has shown that both alcohol consumption and higher BMI can independently affect liver enzyme levels. However, there is evidence suggesting that there is indeed a synergistic effect - individuals with higher BMI who consume alcohol tend to show greater elevations in liver enzymes than would be expected from either factor alone. This is consistent with the understanding that fatty liver disease (associated with higher BMI) and alcoholic liver disease share pathways of liver injury, potentially amplifying each other's effects.\\n\\nStudies have demonstrated that the impact of a given amount of alcohol consumption on liver enzymes (like ALT, AST, and GGT) is generally more pronounced in individuals with higher BMI. This suggests a positive interaction between these risk factors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12717240",
    "question": "Does immunosuppression with FTY720 and cyclosporine A inhibit rejection of adult porcine islet xenografts in rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats. To answer this, I need to determine if there's evidence that this specific combination of immunosuppressive drugs (FTY720 and cyclosporine A) is effective in preventing rejection when adult pig islets are transplanted into rats.\\n\\nFTY720 (fingolimod) is a sphingosine 1-phosphate receptor modulator that prevents lymphocyte egress from lymphoid tissues. Cyclosporine A is a calcineurin inhibitor that suppresses T-cell activation. Both are immunosuppressive agents used in transplantation.\\n\\nWithout specific research data provided in the question, I need to consider whether this combination has been shown to be effective in this specific xenotransplantation model (pig-to-rat islet transplantation). Based on general transplantation immunology, this combination would likely have some immunosuppressive effect, but whether it completely inhibits rejection in this specific model requires specific experimental evidence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19751293",
    "question": "Does carbon dioxide laser irradiation stimulate mineralization in rat dental pulp cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if carbon dioxide laser irradiation stimulates mineralization in rat dental pulp cells. To answer this, I would need to know if there is scientific evidence showing that CO2 laser treatment has a stimulatory effect on mineralization processes in dental pulp cells extracted from rats. Without specific research papers or studies to reference, I cannot make a definitive claim. However, there is research showing that certain laser treatments can stimulate mineralization in dental tissues, and CO2 lasers specifically have been studied for various dental applications. Some studies have shown that laser irradiation can enhance differentiation of dental pulp cells and promote mineralization, but I would need to verify if CO2 lasers specifically have this effect on rat dental pulp cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15685551",
    "question": "Do metabotropic glutamate receptors inhibit mechanosensitivity in vagal sensory neurons?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether metabotropic glutamate receptors inhibit mechanosensitivity in vagal sensory neurons. To answer this, I need to consider what is known about metabotropic glutamate receptors (mGluRs) and their effects on vagal sensory neurons, specifically regarding mechanosensitivity.\\n\\nMetabotropic glutamate receptors are G-protein coupled receptors that modulate neuronal excitability and synaptic transmission through second messenger systems, unlike ionotropic glutamate receptors which are ligand-gated ion channels.\\n\\nResearch has shown that mGluRs, particularly group II and III mGluRs, do indeed inhibit mechanosensitivity in vagal sensory neurons. Studies have demonstrated that activation of these receptors reduces the mechanical sensitivity of vagal afferents, which are important for sensing mechanical stimuli in various organs innervated by the vagus nerve, including the gastrointestinal tract and respiratory system.\\n\\nThis inhibitory effect is part of the modulatory role these receptors play in sensory processing and can be physiologically relevant in conditions involving altered mechanosensitivity.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "8266369",
    "question": "Does angiotensin II administration improve cerebral blood flow in cardiopulmonary arrest in swine?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether angiotensin II administration improves cerebral blood flow during cardiopulmonary arrest in swine (pigs). To answer this, I need to consider what is known about angiotensin II's effects on cerebral blood flow specifically during cardiac arrest conditions in animal models.\\n\\nAngiotensin II is a potent vasoconstrictor that raises blood pressure. In normal physiological conditions, it typically causes vasoconstriction, which could potentially reduce cerebral blood flow. However, during cardiopulmonary arrest, the dynamics may be different.\\n\\nBased on the research literature, angiotensin II has been studied as a vasopressor during resuscitation efforts, but its specific effects on cerebral blood flow during cardiopulmonary arrest in swine models show that it does not improve cerebral blood flow. In fact, some studies suggest that angiotensin II administration during cardiac arrest may actually reduce cerebral perfusion due to its vasoconstrictor effects on cerebral vessels, despite increasing systemic blood pressure.\\n\\nThe evidence indicates that while angiotensin II effectively increases systemic vascular resistance and blood pressure, it does not selectively improve cerebral blood flow during cardiopulmonary arrest in swine models.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24884738",
    "question": "Are pulmonary symptoms and diagnoses associated with HIV in the MACS and WIHS cohorts?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if pulmonary symptoms and diagnoses are associated with HIV in the MACS (Multicenter AIDS Cohort Study) and WIHS (Women's Interagency HIV Study) cohorts. To answer this, I need to consider whether there is evidence that HIV infection is linked to respiratory/lung conditions in these specific research cohorts.\\n\\nMACS and WIHS are two major longitudinal cohort studies that have followed HIV-positive and HIV-negative individuals over time. Research from these cohorts has indeed shown associations between HIV and various pulmonary conditions, including increased risk of pneumonia, COPD, asthma, and other respiratory issues. HIV infection can compromise immune function, making individuals more susceptible to opportunistic respiratory infections and chronic lung diseases.\\n\\nNumerous publications from these cohorts have documented higher rates of pulmonary complications in HIV-positive participants compared to HIV-negative controls, even in the era of effective antiretroviral therapy. These findings have been consistently reported in both the predominantly male MACS cohort and the female WIHS cohort.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18467724",
    "question": "Does quantitative analysis of methylation of genomic loci in early-stage rectal cancer predict distant recurrence?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if quantitative analysis of methylation of genomic loci in early-stage rectal cancer can predict distant recurrence. To answer this, I need to consider whether there is established scientific evidence showing that methylation patterns in genomic regions of early-stage rectal cancer have predictive value for distant metastasis or recurrence. \\n\\nWithout specific studies cited in the question, I need to rely on my knowledge of cancer epigenetics. While DNA methylation is known to play a role in cancer progression and some methylation markers have been investigated as potential biomarkers in various cancers, I cannot definitively state that quantitative methylation analysis specifically in early-stage rectal cancer has been conclusively proven to predict distant recurrence. There are studies exploring methylation biomarkers in colorectal cancers, but whether these specifically apply to early-stage rectal cancer and distant recurrence prediction with sufficient clinical validity would require specific evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20027117",
    "question": "Do field strength and diffusion encoding technique affect the apparent diffusion coefficient measurements in diffusion-weighted imaging of the abdomen?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if field strength and diffusion encoding technique affect ADC measurements in abdominal DWI. Based on diffusion MRI physics and literature, field strength (e.g., 1.5T vs 3T) can affect signal-to-noise ratio and susceptibility artifacts, which may influence ADC measurements. Different diffusion encoding techniques (like monopolar vs bipolar gradients, or different b-value selections) can also affect the measured ADC values due to differences in motion sensitivity, eddy currents, and diffusion time. Multiple studies have shown that technical parameters including field strength and encoding methods can lead to systematic differences in ADC values in abdominal imaging. Therefore, these factors do affect ADC measurements in abdominal DWI.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "9639122",
    "question": "Is liver biopsy a useful predictor of response to interferon therapy in chronic hepatitis C?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C. To answer this, I need to consider whether liver biopsy findings (such as degree of fibrosis, inflammation, or other histological features) have been established as reliable predictors of how patients with chronic hepatitis C will respond to interferon-based treatments. Based on medical literature, liver biopsy results - particularly the degree of fibrosis and inflammation - have been shown to have some predictive value for treatment response. Patients with early-stage fibrosis generally have better response rates to interferon therapy compared to those with advanced fibrosis or cirrhosis. However, with the development of newer direct-acting antivirals, the predictive value of liver biopsy has diminished somewhat in modern HCV treatment algorithms. Still, historically and in some current contexts, liver biopsy findings do provide useful predictive information about interferon response.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22648462",
    "question": "Does sport-specific fitness testing differentiate professional from amateur soccer players where VO2max and VO2 kinetics do not?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if sport-specific fitness testing can differentiate between professional and amateur soccer players in cases where VO2max (maximal oxygen uptake) and VO2 kinetics (how quickly oxygen uptake adjusts to exercise) do not show differences. To answer this, I need to consider whether there's evidence that sport-specific tests (like agility tests, repeated sprint ability, soccer-specific endurance tests) can reveal differences between professional and amateur players even when these traditional physiological measures don't. Research has shown that sport-specific tests like the Yo-Yo Intermittent Recovery Test, agility tests, and technical skill assessments often do differentiate between playing levels even when VO2max is similar. Professional players typically perform better on tests that mimic the specific demands of soccer, reflecting their superior sport-specific conditioning, technical abilities, and tactical understanding. So while two players might have similar aerobic capacity as measured by VO2max, the professional player would likely outperform the amateur in tests designed specifically for soccer performance.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12131296",
    "question": "Does individual prostate biopsy core embedding facilitate maximal tissue representation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if individual prostate biopsy core embedding facilitates maximal tissue representation. Based on pathology practices, when prostate biopsy cores are embedded individually (each core in its own cassette or section) rather than multiple cores together, it does allow for better tissue representation. Individual embedding prevents cores from folding over each other, reduces tissue loss, and allows for more accurate assessment of each core's features and tumor extent. This practice is generally recommended in pathology guidelines for optimal prostate cancer diagnosis and staging.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15714140",
    "question": "Is regeneration of tubular complex promoted by a free space?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether regeneration of tubular complex is promoted by a free space. In biological contexts, regeneration of tubular structures (like blood vessels, renal tubules, etc.) can be influenced by various factors. Free space could potentially allow for expansion and growth of regenerating structures. However, regeneration of tubular complexes typically depends on multiple factors including signaling molecules, stem cells, extracellular matrix components, and proper cellular organization. While spatial constraints can inhibit regeneration, simply having free space is not typically considered the primary promoting factor for tubular complex regeneration. The regeneration process is more dependent on the presence of appropriate biological signals and cellular mechanisms rather than just available space.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26124811",
    "question": "Does anti-inflammatory and antioxidant properties of Eriobotrya japonica leave extracts?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether Eriobotrya japonica (commonly known as loquat) leaf extracts have anti-inflammatory and antioxidant properties. To answer this, I need to consider what is known about the biological activities of these leaf extracts.\\n\\nEriobotrya japonica leaf extracts have been studied in various research papers and have been found to contain bioactive compounds like triterpenes, flavonoids, and tannins. Scientific literature has documented that these extracts do indeed possess both anti-inflammatory effects (reducing inflammation markers in various experimental models) and antioxidant properties (scavenging free radicals and reducing oxidative stress).\\n\\nMultiple studies have confirmed these properties through in vitro and in vivo experiments. The leaves have been traditionally used in Asian medicine for treating inflammatory conditions, which aligns with these scientific findings.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23138189",
    "question": "Is plasma cyclophilin A a novel biomarker for coronary artery disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, I need to determine if plasma cyclophilin A has been established as a novel biomarker for coronary artery disease based on scientific evidence.\\n\\nCyclophilin A (CyPA) is an immunophilin that has been studied in relation to various cardiovascular conditions. Research has shown that CyPA is secreted from vascular smooth muscle cells and inflammatory cells in response to oxidative stress and can contribute to vascular inflammation and atherosclerosis.\\n\\nThere have been studies indicating that plasma levels of CyPA are elevated in patients with coronary artery disease compared to healthy controls, and that these levels correlate with disease severity. For example, a study by Satoh et al. published in 2013 demonstrated that plasma CyPA levels were significantly higher in patients with coronary artery disease and could predict the development of adverse cardiac events.\\n\\nBased on the available scientific literature, plasma cyclophilin A has indeed been identified and proposed as a novel biomarker for coronary artery disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19230848",
    "question": "Does treatment with FTY720 during the induction or effector phase suppress the development of experimental allergic conjunctivitis in mice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether treatment with FTY720 during either the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice. To answer this, I need to determine if there's evidence that FTY720 has this specific effect.\\n\\nFTY720 (fingolimod) is a sphingosine-1-phosphate receptor modulator that's used in multiple sclerosis treatment. It affects lymphocyte trafficking and can have immunomodulatory effects.\\n\\nHowever, without specific research information provided in the question, I cannot definitively state whether FTY720 suppresses experimental allergic conjunctivitis in mice during these specific phases. The question appears to be asking about a specific research finding that I don't have information about.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19675671",
    "question": "Is vitamin D status positively correlated with regulatory T cell function in patients with multiple sclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis (MS). To answer this, I need to consider the scientific evidence about the relationship between vitamin D levels and regulatory T cell (Treg) function specifically in MS patients.\\n\\nVitamin D is known to have immunomodulatory effects, and there is research suggesting that vitamin D can enhance regulatory T cell function in general. Multiple sclerosis is an autoimmune disease where regulatory T cell dysfunction is one of the pathological features.\\n\\nStudies have shown that vitamin D supplementation in MS patients can increase the number and function of regulatory T cells. Research has demonstrated that higher vitamin D levels are associated with improved Treg function in MS patients, showing a positive correlation between vitamin D status and regulatory T cell activity in this specific patient population.\\n\\nBased on the current scientific literature, there is evidence supporting a positive correlation between vitamin D status and regulatory T cell function in MS patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21533942",
    "question": "Is expression of bone morphogenic protein-4 inversely related to prevalence of lymph node metastasis in gastric adenocarcinoma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between bone morphogenic protein-4 (BMP-4) expression and lymph node metastasis in gastric adenocarcinoma. Specifically, it's asking if there's an inverse relationship, meaning as BMP-4 expression increases, the prevalence of lymph node metastasis decreases (or vice versa). To answer this accurately, I would need to be familiar with specific research studies on this topic. Based on my knowledge, there have been studies suggesting that BMP-4 can have tumor suppressive effects in some contexts, but I don't have specific information about its relationship with lymph node metastasis in gastric adenocarcinoma. Without being able to cite specific research on this particular relationship, I cannot confidently answer yes or no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "7646853",
    "question": "Does inhibition of growth of a murine squamous cell carcinoma by a cyclooxygenase inhibitor increase leukotriene B4 production?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if inhibiting the growth of a murine squamous cell carcinoma using a cyclooxygenase inhibitor increases leukotriene B4 production. To answer this, I need to consider the relationship between cyclooxygenase (COX) inhibition and leukotriene production.\\n\\nCyclooxygenase is an enzyme that converts arachidonic acid to prostaglandins. When COX is inhibited, arachidonic acid metabolism can be shunted toward the lipoxygenase pathway, which produces leukotrienes, including leukotriene B4 (LTB4). This is sometimes called the 'shunting phenomenon.'\\n\\nSo theoretically, inhibiting COX could increase LTB4 production. However, I need to be careful not to assume this happens in all contexts without specific evidence for this particular case of murine squamous cell carcinoma.\\n\\nBased on general principles of arachidonic acid metabolism, COX inhibition often does lead to increased leukotriene production, including LTB4, due to the shunting of arachidonic acid toward the lipoxygenase pathway. This phenomenon has been observed in various experimental models.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15497510",
    "question": "Is lispro superior to regular insulin in transient intensive insulin therapy in type 2 diabetes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if lispro insulin is superior to regular insulin specifically in the context of transient intensive insulin therapy for type 2 diabetes patients. To answer this, I need to consider the evidence about lispro (a rapid-acting insulin analog) compared to regular insulin in this specific therapeutic context. Lispro has a faster onset and shorter duration of action than regular insulin, which can provide better postprandial glucose control and potentially reduce hypoglycemia risk. However, whether this translates to superiority in transient intensive insulin therapy (short-term aggressive insulin treatment) for type 2 diabetes specifically is not definitively established in the literature. While lispro may offer some pharmacokinetic advantages, clinical outcomes in this specific context don't show overwhelming superiority. The evidence doesn't support a clear 'yes' that lispro is categorically superior in this specific therapeutic approach for type 2 diabetes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12187272",
    "question": "Is cyclooxygenase-2 expression up-regulated in obstructed human ureter?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if cyclooxygenase-2 (COX-2) expression is up-regulated in obstructed human ureter. To answer this, I need to consider what is known about COX-2 expression patterns in urinary tract obstruction conditions. COX-2 is an enzyme involved in prostaglandin synthesis and inflammation. Research has shown that in ureteral obstruction, there are inflammatory and remodeling processes that occur. Several studies have demonstrated that COX-2 expression is indeed increased in obstructed ureters compared to normal ureters. This up-regulation is part of the inflammatory response to obstruction and plays a role in the pathophysiology of obstructive uropathy. Based on the medical literature, COX-2 expression is up-regulated in obstructed human ureters.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19064516",
    "question": "Is eating rate a heritable phenotype related to weight in children?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if eating rate is a heritable phenotype related to weight in children. To answer this, I need to consider whether there is scientific evidence that: 1) eating rate (how fast someone eats) is heritable (can be passed from parents to children genetically), and 2) whether this trait is related to weight in children.\\n\\nBased on scientific research, eating rate does appear to be a heritable trait, with genetic factors influencing how quickly someone consumes food. Studies have shown that faster eating rates are associated with increased weight and obesity risk in children. Twin and family studies have demonstrated that eating behaviors, including eating speed, have a heritable component. Additionally, research has found associations between faster eating rates and higher BMI or weight status in pediatric populations.\\n\\nTherefore, the evidence supports that eating rate is both heritable and related to weight in children.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24588739",
    "question": "Are molecular abnormalities of the B cell in systemic lupus erythematosus candidates for functional inhibition treatments?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether molecular abnormalities found in B cells in systemic lupus erythematosus (SLE) could be potential targets for treatments that work by functionally inhibiting these abnormalities. SLE is an autoimmune disease where B cells play a critical role in pathogenesis through autoantibody production and other immune dysregulation. Research has identified various B cell abnormalities in SLE, including hyperactive signaling pathways, abnormal receptor expression, and dysregulated cytokine production. The question is whether these molecular abnormalities could be targeted therapeutically through functional inhibition. Based on current research and clinical approaches, B cell-targeted therapies including inhibitors of B cell signaling pathways (like BTK inhibitors), B cell depleting agents (like rituximab), and inhibitors of B cell survival factors (like belimumab targeting BAFF) have been developed or are in development for SLE. This suggests that molecular abnormalities in B cells are indeed considered viable targets for functional inhibition in SLE treatment.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12752330",
    "question": "Are frequency and intensity of responses to mite patch tests lower in nonatopic subjects with respect to patients with atopic dermatitis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the comparison of frequency and intensity of responses to mite patch tests between two groups: nonatopic subjects and patients with atopic dermatitis. To answer this, I need to determine if nonatopic subjects generally show lower frequency and intensity of responses to mite patch tests compared to those with atopic dermatitis. \\n\\nAtopic dermatitis is a chronic inflammatory skin condition associated with heightened immune responses, particularly to environmental allergens like dust mites. Patch tests are used to evaluate delayed hypersensitivity reactions to allergens applied to the skin.\\n\\nBased on immunological principles, patients with atopic dermatitis typically have increased sensitivity to allergens including dust mites, which would manifest as more frequent and more intense reactions to mite patch tests compared to nonatopic individuals (who by definition don't have the atopic condition). \\n\\nTherefore, it would be expected that nonatopic subjects would show lower frequency and intensity of responses to mite patch tests compared to patients with atopic dermatitis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22427771",
    "question": "Is half-dose , long-acting gonadotropin-releasing hormone agonist ( Diphereline ) comparable with daily injections of short-acting gonadotropin-releasing hormone agonist ( Suprefact ) in IVF/ICSI cycles?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if half-dose, long-acting GnRH agonist (Diphereline) is comparable to daily injections of short-acting GnRH agonist (Suprefact) in IVF/ICSI cycles. To answer this, I would need to know if clinical studies have shown similar efficacy, safety profiles, and outcomes between these two protocols in fertility treatments. Without specific clinical evidence comparing these exact protocols, I cannot definitively answer. However, there are studies comparing various GnRH agonist protocols (long-acting vs. short-acting) in IVF, with some showing comparable results when dosing is appropriately adjusted. Since the question specifically asks about half-dose Diphereline versus daily Suprefact, I would need specific comparative data for these exact protocols.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "8887905",
    "question": "Do short-chain fatty acids increase proglucagon and ornithine decarboxylase messenger RNAs after intestinal resection in rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the effect of short-chain fatty acids (SCFAs) on specific messenger RNAs (mRNAs) after intestinal resection in rats. Specifically, it's asking whether SCFAs increase the levels of proglucagon mRNA and ornithine decarboxylase mRNA following intestinal resection in rats.\\n\\nTo answer this question accurately, I would need specific research data on this topic. This is a very specific scientific question about molecular biology and surgical outcomes in animal models. Without access to the relevant scientific literature, I cannot provide a definitive answer. However, there is research suggesting that SCFAs can influence gene expression in intestinal cells, and both proglucagon and ornithine decarboxylase are important in intestinal adaptation after resection. Some studies have shown that SCFAs can stimulate intestinal adaptation after resection, which might involve upregulation of these mRNAs, but I would need to verify this with specific studies on these exact mRNAs in this exact model.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18579215",
    "question": "Do behavioral measures and event-related potentials reveal different aspects of sentence processing and comprehension in patients with major depression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether behavioral measures and event-related potentials (ERPs) reveal different aspects of sentence processing and comprehension in patients with major depression. To answer this, I need to consider whether there is evidence that these two measurement approaches (behavioral vs. neurophysiological) capture distinct aspects of language processing in depressed individuals.\\n\\nBehavioral measures typically include reaction times, accuracy rates, and other overt responses, while ERPs are electrophysiological measurements of brain activity in response to specific stimuli. Research has shown that depression can affect language processing, but I need to determine if the literature supports that these two measurement approaches reveal different or complementary information.\\n\\nBased on research in psycholinguistics and clinical neuroscience, there is evidence that ERPs can detect subtle processing differences that may not be apparent in behavioral measures alone. For instance, patients with depression might show normal behavioral performance (e.g., comprehension accuracy) but abnormal ERP components (e.g., N400, P600) that reflect different aspects of semantic and syntactic processing. The temporal resolution of ERPs allows detection of processing differences that may be compensated for behaviorally.\\n\\nSo yes, behavioral measures and ERPs do typically reveal different aspects of sentence processing in depression, with ERPs often capturing implicit processing differences not evident in behavioral outcomes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22612416",
    "question": "Is the oligopeptide DT-2 a specific PKG I inhibitor only in vitro , not in living cells?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question about the oligopeptide DT-2 and its properties as a PKG I inhibitor.\\n\\nThe question asks whether DT-2 is a specific PKG I inhibitor only in vitro (in laboratory test conditions outside of living organisms) but not in living cells.\\n\\nTo answer this accurately, I need to consider what's known about DT-2:\\n\\nDT-2 is a peptide inhibitor that was developed to target PKG I (Protein Kinase G type I). The literature indicates that DT-2 is actually membrane-permeable and was specifically designed to be cell-penetrating to allow it to function in living cells. Studies have demonstrated that DT-2 can inhibit PKG I both in vitro and in intact cells.\\n\\nThe question contains a premise that DT-2 works only in vitro but not in living cells, which is incorrect based on the scientific literature. DT-2 has been shown to be effective as a PKG I inhibitor in cellular systems as well as in vitro preparations.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25345732",
    "question": "Do lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder. To answer this, I need to consider whether there is established scientific evidence for this specific relationship. While lithium is a common treatment for bipolar disorder and GSK-3β (glycogen synthase kinase-3 beta) is a target of lithium's action, and there is research on genetic variations in the GSK-3β promoter region, I would need to know if studies have specifically demonstrated that these genetic variants influence cortical gray matter volumes in bipolar disorder patients. Without specific research evidence showing this relationship, I cannot confidently say yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20955362",
    "question": "Are anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia mediated via TGFβ1 regulation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question asks about the mechanism of anti-inflammatory effects of levetiracetam (an anticonvulsant drug) on astroglia. Specifically, it asks whether these effects on electrophysiological properties are mediated via TGFβ1 regulation. To answer this, I would need specific scientific evidence showing that levetiracetam's effects on astroglia electrophysiology work through TGFβ1 pathways. Without citing specific studies that demonstrate this relationship, I cannot confirm this specific mechanism. Based on my knowledge, while levetiracetam may have anti-inflammatory effects and may affect astroglia, the specific pathway involving TGFβ1 regulation as the mediator for electrophysiological changes is not established as a confirmed mechanism.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23276122",
    "question": "Does cognitive change predict symptom reduction with cognitive therapy for posttraumatic stress disorder?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether cognitive change predicts symptom reduction with cognitive therapy for posttraumatic stress disorder (PTSD). This is asking about a specific empirical relationship in clinical psychology research. To answer this accurately, I would need to know what the research evidence shows about the relationship between cognitive changes (like changes in maladaptive beliefs or thought patterns) and symptom reduction when people with PTSD undergo cognitive therapy. Without specific research citations or data, I cannot make a definitive claim about this predictive relationship. However, cognitive therapy for PTSD is based on the theoretical premise that changing maladaptive cognitions should lead to symptom reduction, and there is research supporting this mechanism of change. The most accurate answer based on the cognitive model of PTSD and existing research would be 'yes.'\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21659644",
    "question": "Does moderate caveolin-1 downregulation prevent NADPH oxidase-dependent endothelial nitric oxide synthase uncoupling by angiotensin II in endothelial cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether moderate caveolin-1 downregulation prevents NADPH oxidase-dependent endothelial nitric oxide synthase (eNOS) uncoupling by angiotensin II in endothelial cells. To answer this, I need to analyze what the research shows about the relationship between caveolin-1, NADPH oxidase, eNOS uncoupling, and angiotensin II.\\n\\nBased on my knowledge of vascular biology, angiotensin II can induce eNOS uncoupling through NADPH oxidase activation, which leads to oxidative stress. Caveolin-1 is a protein that can regulate eNOS activity and is found in caveolae membrane domains.\\n\\nResearch has shown that moderate caveolin-1 downregulation can actually protect against angiotensin II-induced oxidative stress by preventing NADPH oxidase activation and subsequent eNOS uncoupling. When caveolin-1 is moderately reduced, it appears to disrupt the pathway through which angiotensin II activates NADPH oxidase, thereby preventing the oxidative stress that leads to eNOS uncoupling.\\n\\nSo based on the scientific literature, moderate caveolin-1 downregulation does appear to prevent NADPH oxidase-dependent eNOS uncoupling caused by angiotensin II in endothelial cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12746833",
    "question": "Is glutathione S-transferase pi upregulated in the stromal compartment of hormone independent prostate cancer?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the expression of glutathione S-transferase pi (GSTP1) in the stromal compartment specifically of hormone-independent prostate cancer. To answer this accurately, I need to recall what is known about GSTP1 expression patterns in prostate cancer.\\n\\nGSTP1 is actually known to be silenced through promoter hypermethylation in prostate cancer epithelial cells, which is one of the most common epigenetic alterations in prostate cancer. This silencing occurs early in prostate carcinogenesis.\\n\\nHowever, the question specifically asks about the stromal compartment (not epithelial cells) and specifically in hormone-independent prostate cancer. Some studies have examined differential expression between tumor-associated stroma and normal stroma, but I don't recall definitive evidence showing GSTP1 upregulation specifically in the stromal compartment of hormone-independent prostate cancer. Most research has focused on its downregulation in epithelial cells rather than upregulation in stroma.\\n\\nWithout specific evidence supporting stromal upregulation of GSTP1 in hormone-independent prostate cancer, I cannot confirm this as true.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16382263",
    "question": "Does heparin therapy lead to platelet activation and prolongation of PFA-100 closure time?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question about heparin therapy and its effects on platelets and PFA-100 closure time.\\n\\nHeparin is an anticoagulant that inhibits thrombin and factor Xa. Regarding its effects:\\n\\n1. Platelet activation: Heparin can actually cause platelet activation in some cases, particularly in a condition called heparin-induced thrombocytopenia (HIT), where heparin forms complexes with platelet factor 4 leading to platelet activation. However, this is a pathological response, not the typical therapeutic effect.\\n\\n2. PFA-100 closure time: The PFA-100 is a test that measures platelet function. Prolongation of closure time indicates decreased platelet function or effectiveness. Heparin typically does not directly prolong PFA-100 closure time. In fact, heparin has minimal effect on the PFA-100 test results, which is why this test can be used in patients on heparin therapy.\\n\\nSo while heparin can cause platelet activation in specific pathological conditions (HIT), it does not typically prolong PFA-100 closure time. The question asks if it does both, so the answer would be no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22258333",
    "question": "Does dOCA-salt hypertension require the ouabain-sensitive binding site of the α2 Na , K-ATPase?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether dOCA-salt hypertension (deoxycorticosterone acetate-salt induced hypertension) requires the ouabain-sensitive binding site of the α2 Na,K-ATPase. To answer this, I need to consider whether this specific binding site is necessary for the development of this form of hypertension.\\n\\nBased on research literature, there have been studies showing that mice with a genetic modification of the ouabain-binding site in the α2 Na,K-ATPase (α2 Na,K-ATPase ouabain-resistant mice) are resistant to developing hypertension when treated with dOCA-salt. This suggests that the ouabain-sensitive binding site of the α2 Na,K-ATPase is indeed required for dOCA-salt hypertension to develop.\\n\\nSpecifically, studies have shown that when the ouabain-binding site of the α2 Na,K-ATPase is mutated to make it ouabain-resistant, animals do not develop hypertension in response to dOCA-salt treatment, indicating that this site is necessary for this form of hypertension.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "19541679",
    "question": "Does addition of clonidine or dexmedetomidine to bupivacaine prolong caudal analgesia in children?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether adding clonidine or dexmedetomidine to bupivacaine extends the duration of caudal analgesia in pediatric patients. Based on medical literature, both clonidine and dexmedetomidine are alpha-2 adrenergic agonists that have been studied as adjuvants to local anesthetics in caudal blocks. Multiple studies have shown that when either of these medications is added to bupivacaine for caudal analgesia in children, they do prolong the duration of analgesia compared to bupivacaine alone. This effect has been demonstrated in randomized controlled trials and meta-analyses, showing longer time to first analgesic request and lower pain scores in the groups receiving the adjuvants.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17070195",
    "question": "Is polymorphism in HSD17B6 associated with key features of polycystic ovary syndrome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if polymorphism in the HSD17B6 gene is associated with key features of polycystic ovary syndrome (PCOS). HSD17B6 (17β-hydroxysteroid dehydrogenase type 6) is an enzyme involved in androgen metabolism. PCOS is a common endocrine disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. \\n\\nTo answer this question accurately, I need to consider whether there is established scientific evidence linking genetic variations in HSD17B6 to PCOS features. Based on research literature, there have been studies investigating associations between HSD17B6 polymorphisms and PCOS. Some research has found that certain variants of HSD17B6 may be associated with androgen levels and other features of PCOS in some populations. For example, a study by Jones et al. (2006) suggested that polymorphisms in HSD17B6 were associated with PCOS and androgen levels. However, not all studies have consistently confirmed this association across different populations.\\n\\nBased on the available scientific evidence, there does appear to be some association between HSD17B6 polymorphisms and features of PCOS, though the strength and consistency of this association may vary.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19058075",
    "question": "Are practice patterns in rectal cancer patient follow-up unaffected by surgeon age?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if practice patterns in rectal cancer patient follow-up are unaffected by surgeon age. To answer this, I would need to know if there's evidence showing whether surgeon age influences how they conduct follow-up care for rectal cancer patients. Without specific data or studies referenced in the question, I cannot make a definitive determination. However, in medical practice, many factors including physician age, experience, training era, and familiarity with newer guidelines can influence practice patterns. Surgeon age often correlates with differences in approach to patient care, adoption of new techniques, and adherence to evolving guidelines. Therefore, it would be unlikely that practice patterns would be completely unaffected by surgeon age.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11948060",
    "question": "Do changes in BP induced by passive leg raising predict response to fluid loading in critically ill patients?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if changes in blood pressure (BP) induced by passive leg raising (PLR) can predict how critically ill patients will respond to fluid loading. PLR is a maneuver where a patient's legs are elevated to temporarily increase venous return to the heart, simulating a fluid challenge. The question is asking about the predictive value of BP changes during this maneuver for actual fluid responsiveness.\\n\\nBased on medical literature, while PLR-induced changes in cardiac output and stroke volume are reliable predictors of fluid responsiveness, changes in blood pressure alone during PLR have been shown to be less reliable predictors. Blood pressure is influenced by many factors beyond preload, including vascular tone and compensatory mechanisms. Most studies indicate that BP changes during PLR have lower sensitivity and specificity for predicting fluid responsiveness compared to direct hemodynamic measurements like cardiac output.\\n\\nTherefore, the answer would be 'no' - changes in BP alone during PLR are not considered reliable predictors of fluid responsiveness in critically ill patients.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16797156",
    "question": "Does preoperative transcatheter arterial chemoembolization reduce long-term survival rate after hepatic resection for resectable hepatocellular carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether preoperative transcatheter arterial chemoembolization (TACE) reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma (HCC). To answer this, I need to consider the current medical evidence on this topic.\\n\\nBased on medical literature, preoperative TACE for resectable HCC has been a controversial topic. Several studies and meta-analyses have shown that preoperative TACE does not improve long-term survival outcomes and may actually be associated with worse outcomes in patients with resectable HCC. Some studies have found that preoperative TACE may delay definitive surgical treatment and potentially lead to progression of disease in some patients. Additionally, it may cause inflammatory changes that make surgery more difficult.\\n\\nMost current clinical guidelines do not recommend routine use of preoperative TACE for patients with resectable HCC, as it has not demonstrated survival benefits and may potentially be harmful in terms of long-term survival.\\n\\nTherefore, the evidence suggests that preoperative TACE may reduce long-term survival rates after hepatic resection for resectable HCC.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16249679",
    "question": "Does dural puncture with a 27-gauge Whitacre needle as part of a combined spinal-epidural technique improve labor epidural catheter function?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if dural puncture with a 27-gauge Whitacre needle as part of a combined spinal-epidural technique improves labor epidural catheter function. To answer this, I need to consider whether there's evidence that this specific technique enhances the function of epidural catheters during labor analgesia.\\n\\nThe dural puncture epidural (DPE) technique involves intentionally puncturing the dura with a spinal needle but without injecting medication intrathecally, followed by epidural catheter placement. Some studies have suggested that this technique may improve epidural catheter function by creating a conduit for epidural medications to reach the intrathecal space.\\n\\nSpecifically regarding a 27-gauge Whitacre needle in this context, research has shown that intentional dural puncture with a spinal needle (including Whitacre needles) prior to epidural catheter insertion can improve the spread of epidural medication and reduce the incidence of asymmetric blocks and epidural catheter failures compared to standard epidural technique.\\n\\nSo yes, there is evidence suggesting that dural puncture with a 27-gauge Whitacre needle as part of a combined spinal-epidural approach can improve labor epidural catheter function.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "23958185",
    "question": "Does early innate immunity determine outcome of Mycobacterium tuberculosis pulmonary infection in rabbits?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether early innate immunity determines the outcome of Mycobacterium tuberculosis pulmonary infection in rabbits. To answer this, I need to consider whether there is scientific evidence showing that the initial innate immune response in rabbits is a decisive factor in determining whether the infection will be cleared, contained, or progress to active disease. Without specific research papers or data provided in the question, I cannot make a definitive scientific claim about this specific relationship in rabbits. The question appears to be asking about a specific scientific finding related to tuberculosis infection in a rabbit model.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11753477",
    "question": "Does vitamin E ameliorate aflatoxin-induced biochemical changes in the testis of mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether vitamin E ameliorates (improves or mitigates) biochemical changes in the testis of mice that are induced by aflatoxin. This is a specific scientific question about the protective effect of vitamin E against aflatoxin toxicity in mouse testes. To answer this accurately, I would need to know specific research findings on this topic. Aflatoxins are mycotoxins produced by certain molds that can cause toxicity, and vitamin E is known for its antioxidant properties. Research has shown that vitamin E can protect against various toxins due to its antioxidant properties. There are studies indicating that vitamin E can ameliorate aflatoxin-induced damage in various tissues including reproductive organs. Based on scientific literature, vitamin E has been shown to have protective effects against aflatoxin-induced biochemical changes in testicular tissue of mice by reducing oxidative stress and preserving testicular function.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16131846",
    "question": "Does selective GABAA alpha5 benzodiazepine inverse agonist antagonize the neurobehavioral actions of alcohol?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if a selective GABAA alpha5 benzodiazepine inverse agonist antagonizes the neurobehavioral actions of alcohol. Let me analyze this based on pharmacological knowledge.\\n\\nGABAA alpha5 receptors are a subtype of GABA receptors in the brain. Benzodiazepine inverse agonists at this receptor would reduce GABA transmission at these specific receptors. Alcohol (ethanol) acts as a positive modulator of GABAA receptors broadly, enhancing inhibitory neurotransmission.\\n\\nResearch has shown that selective GABAA alpha5 inverse agonists can indeed counteract some of the cognitive and behavioral effects of alcohol. Studies have demonstrated that these compounds can antagonize alcohol-induced memory impairment, motor incoordination, and sedative effects. The selective targeting of the alpha5 subtype allows for antagonism of specific alcohol effects while avoiding unwanted side effects that would come from broader GABA antagonism.\\n\\nSo based on the pharmacological literature, selective GABAA alpha5 benzodiazepine inverse agonists do antagonize many of the neurobehavioral actions of alcohol.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15521095",
    "question": "Does fVIII gene delivery by muscle electroporation correct murine hemophilia A?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether fVIII gene delivery by muscle electroporation can correct murine hemophilia A. To answer this, I need to determine if there is evidence that this specific gene therapy approach (delivering factor VIII genes via muscle electroporation) has been shown to correct hemophilia A in mice. \\n\\nFactor VIII (fVIII) is the clotting factor missing in hemophilia A, and gene therapy approaches aim to deliver functional copies of this gene to treat the condition. Electroporation is a technique that uses electrical pulses to increase cell permeability and enhance gene delivery.\\n\\nBased on scientific literature, there have been successful demonstrations of fVIII gene delivery using muscle electroporation to correct hemophilia A in mouse models. Studies have shown that this approach can lead to expression of functional factor VIII protein and improvement in clotting parameters in hemophilic mice. The muscle tissue serves as a production site for the factor VIII protein, which is then secreted into the bloodstream.\\n\\nSo yes, fVIII gene delivery by muscle electroporation has been demonstrated to correct murine hemophilia A in experimental settings.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15014762",
    "question": "Do [ Study of sintering temperature of HN-97 porcelain stain ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if I 'do' or perform a study of sintering temperature of HN-97 porcelain stain. As an AI assistant, I don't conduct physical experiments or research studies. I don't have a physical form to perform laboratory work or materials science research. I can provide information about such topics, but I cannot personally conduct studies on porcelain stains or sintering processes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25283374",
    "question": "Is dCLK1 detectable in plasma of patients with Barrett 's esophagus and esophageal adenocarcinoma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether dCLK1 (a specific biomarker) is detectable in the plasma of patients with Barrett's esophagus and esophageal adenocarcinoma. To answer this, I would need specific scientific evidence about dCLK1 detection in plasma samples from these patient populations. Without having access to specific research studies on this topic, I cannot determine if dCLK1 has been successfully detected in plasma from these patients. The question is asking for a factual determination about a specific biomarker in specific medical conditions, which requires evidence from medical literature.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25818693",
    "question": "Does ethnomedicinal used of plants for the treatment of snake and scorpion bite in Northern Pakistan?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if ethnomedicinal plants are used for treating snake and scorpion bites in Northern Pakistan. To answer this accurately, I would need specific information about traditional medical practices in Northern Pakistan. Based on general knowledge, many regions with traditional medicine systems do use local plants for treating venomous bites, including snake and scorpion bites. Northern Pakistan has rich traditional knowledge systems and biodiversity, so it's plausible that ethnomedicinal plants are used there for these purposes. However, without specific evidence about Northern Pakistan's practices, I cannot definitively confirm this.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27068625",
    "question": "Does fibrosis of the Neonatal Mouse Heart After Cryoinjury be Accompanied by Wnt Signaling Activation and Epicardial-to-Mesenchymal Transition?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether fibrosis of the neonatal mouse heart after cryoinjury is accompanied by two specific biological processes: (1) Wnt signaling activation and (2) epicardial-to-mesenchymal transition. To answer this accurately, I would need to know the scientific evidence about these specific processes in the context of neonatal mouse heart cryoinjury. Based on cardiac regeneration literature, Wnt signaling is often activated during cardiac injury responses, and epicardial-to-mesenchymal transition (EMT) is a known process during cardiac development and repair. However, without specific studies confirming these exact processes in the neonatal mouse cryoinjury model, I cannot definitively answer. Since this requires specific scientific knowledge about a particular model system and molecular pathways, I should be cautious.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25486399",
    "question": "Is polysubstance use associated with deficits in substance-free reinforcement in college students?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between polysubstance use (using multiple substances) and deficits in substance-free reinforcement (natural rewards or pleasures that don't involve substances) specifically in college student populations. To answer this, I would need to know if research has established a connection between college students who use multiple substances and their ability to experience or seek out non-drug rewards. Research in addiction generally suggests that substance use can impair reward processing for natural reinforcers, but I need to be specific about whether this has been demonstrated for polysubstance use in college students specifically. Based on addiction research, there is evidence that substance use disorders are associated with reduced sensitivity to non-drug rewards, and this effect may be more pronounced with multiple substances. Several studies have found that college students who engage in polysubstance use show reduced engagement in substance-free activities and decreased pleasure from those activities compared to non-users or single-substance users.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22809227",
    "question": "Are ten SNPs of PAX6 , Lumican , and MYOC genes associated with high myopia in Han Chinese?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether ten specific single nucleotide polymorphisms (SNPs) in three genes (PAX6, Lumican, and MYOC) are associated with high myopia specifically in the Han Chinese population. To answer this accurately, I would need to review scientific literature on genetic studies of myopia in Han Chinese populations that specifically examined these genes and SNPs. Without specific studies to reference, I cannot make a definitive claim about these particular ten SNPs being associated with high myopia in Han Chinese. Some studies have examined associations between these genes and myopia in various populations, but the question is very specific about 'ten SNPs' across these three genes in the Han Chinese population specifically.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "19172244",
    "question": "Does the risk allele load accelerate the age-dependent decline in beta cell function?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the risk allele load accelerates the age-dependent decline in beta cell function. To answer this, I need to consider what is known about genetic risk factors for beta cell function and how they interact with aging. Beta cells in the pancreas produce insulin, and their function typically declines with age. Risk alleles are genetic variants associated with increased disease risk, particularly for conditions like type 2 diabetes. Research has shown that individuals with higher genetic risk scores (more risk alleles) for type 2 diabetes often show accelerated deterioration of beta cell function as they age compared to those with lower genetic risk. Multiple studies have demonstrated that the impact of diabetes risk variants becomes more pronounced with advancing age, suggesting that genetic susceptibility interacts with the aging process to hasten beta cell dysfunction.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20362656",
    "question": "Does kIOM-79 prevent methyglyoxal-induced retinal pericyte apoptosis in vitro and in vivo?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether kIOM-79 prevents methylglyoxal-induced retinal pericyte apoptosis both in laboratory cell cultures (in vitro) and in living organisms (in vivo). To answer this, I would need specific information about studies testing kIOM-79's effects on retinal pericytes exposed to methylglyoxal. Without being provided any specific research or data about kIOM-79 and its effects on methylglyoxal-induced apoptosis in retinal pericytes, I cannot determine whether this compound has demonstrated such protective effects.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20868426",
    "question": "Does oxytocin reduce satiety scores without affecting the volume of nutrient intake or gastric emptying rate in healthy subjects?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question. It's asking about the effects of oxytocin on:\n1. Satiety scores (feeling of fullness)\n2. Volume of nutrient intake\n3. Gastric emptying rate\n\nAnd specifically whether oxytocin reduces satiety scores without affecting the other two factors in healthy subjects.\n\nBased on research, oxytocin has been found to reduce food intake and body weight in animals and humans. Some studies suggest oxytocin reduces caloric intake and affects satiety, but the specific mechanism is complex. \n\nThe question asks if oxytocin reduces satiety scores (which would mean increasing hunger) without affecting nutrient intake or gastric emptying. This seems contradictory to most research findings, which suggest oxytocin typically increases satiety (feeling full) rather than reducing it.\n\nMost evidence indicates oxytocin actually increases satiety scores (not reduces them) and can reduce food intake in healthy individuals. It may also slow gastric emptying in some contexts.\n\nSince the question specifically asks if oxytocin reduces satiety scores (makes people feel less full) without affecting the other parameters, and this contradicts the general scientific consensus, the answer would be no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "14620949",
    "question": "Does long-term administration of pravastatin reduce serum lipoprotein ( a ) levels?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the effect of long-term pravastatin administration on serum lipoprotein(a) levels. Pravastatin is a statin medication primarily used to lower cholesterol. Lipoprotein(a), or Lp(a), is a specific type of lipoprotein that's considered an independent risk factor for cardiovascular disease. \\n\\nTo answer this question accurately, I need to consider what's known about statins' effects on Lp(a). While statins are effective at reducing LDL cholesterol, their effect on Lp(a) is different. Based on clinical research, statins including pravastatin generally have minimal to no significant effect on reducing Lp(a) levels. In fact, some studies suggest statins may slightly increase Lp(a) levels in some patients.\\n\\nSpecifically for pravastatin, the evidence does not support that it provides clinically meaningful reductions in Lp(a) with long-term use.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21745107",
    "question": "Are hypothyroidism and moderate subclinical hypothyroidism associated with increased all-cause mortality independent of coronary heart disease risk factors : a PreCIS database study?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality, independent of coronary heart disease risk factors, according to a study using the PreCIS database. To answer this, I would need to know the specific findings of this PreCIS database study. Without having access to the actual study results, I cannot definitively answer whether these conditions were found to be independently associated with increased all-cause mortality in this particular research. The question is asking for a factual outcome from a specific scientific study, not a general medical opinion.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15343022",
    "question": "Do adrenergic agents modify cerebral edema and microvessel ultrastructure in porcine sepsis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if adrenergic agents modify cerebral edema and microvessel ultrastructure in porcine sepsis. To answer this, I need to consider whether there is evidence that adrenergic agents (like epinephrine, norepinephrine, etc.) have effects on brain edema and the microscopic structure of blood vessels in the context of sepsis in pigs. This is a specific scientific question about pharmacological effects in a particular animal model of disease. Without specific research studies on this topic, I cannot definitively say whether adrenergic agents have these effects in porcine sepsis models. The question requires knowledge of specialized research in veterinary medicine, pharmacology, and sepsis pathophysiology.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19540852",
    "question": "Does hydrogen sulfide inhibit MPP ( + ) -induced apoptosis in PC12 cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether hydrogen sulfide inhibits MPP(+)-induced apoptosis in PC12 cells. To answer this, I need to determine if there's evidence that hydrogen sulfide has a protective effect against MPP(+)-induced cell death in PC12 cells, which are a cell line often used in neuroscience research. MPP(+) is a neurotoxin that can induce apoptosis (programmed cell death). \\n\\nBased on scientific literature, hydrogen sulfide (H2S) has been shown to have neuroprotective effects in various models. Specifically regarding MPP(+)-induced apoptosis in PC12 cells, research has demonstrated that H2S can indeed inhibit this process. Studies have shown that H2S donors can protect PC12 cells from MPP(+)-induced cell death by various mechanisms including reducing oxidative stress, maintaining mitochondrial function, and inhibiting apoptotic pathways. So the evidence supports that hydrogen sulfide does inhibit MPP(+)-induced apoptosis in PC12 cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19516905",
    "question": "Do viral suppressors of RNA silencing hinder exogenous and endogenous small RNA pathways in Drosophila?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether viral suppressors of RNA silencing (VSRs) hinder both exogenous and endogenous small RNA pathways in Drosophila. To answer this, I need to consider what is known about VSRs in Drosophila.\\n\\nViral suppressors of RNA silencing are viral proteins that counteract the host's RNA interference (RNAi) defense mechanisms. In Drosophila, there are distinct small RNA pathways:\\n- The exogenous siRNA pathway (primarily defends against viral infections)\\n- Endogenous small RNA pathways (including miRNA and endo-siRNA pathways that regulate gene expression)\\n\\nResearch has shown that VSRs like the Flock House Virus B2 protein and Cricket Paralysis Virus 1A protein can suppress the exogenous siRNA pathway in Drosophila, which is part of the antiviral defense. However, these VSRs also affect endogenous small RNA pathways in Drosophila. For example, they can interfere with miRNA processing and function, affecting developmental processes regulated by miRNAs.\\n\\nSo based on the scientific literature, viral suppressors of RNA silencing do hinder both exogenous and endogenous small RNA pathways in Drosophila.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15381035",
    "question": "Does glutamate transporter localization correspond to the temporary functional recovery and late degeneration after acute ocular ischemia in rats?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific scientific finding related to glutamate transporter localization and its relationship to temporary recovery and late degeneration after acute ocular ischemia in rats. To answer this accurately, I would need to know the specific research findings on this topic. The question is asking if there is a correspondence between glutamate transporter localization and the pattern of temporary recovery followed by late degeneration in this rat model of ocular ischemia. Without specific knowledge of the research literature on this topic, I cannot definitively answer yes or no.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "10608468",
    "question": "Does heredity for hypertension influence intra-uterine growth and the relation between fetal growth and adult blood pressure?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether heredity (genetic factors) for hypertension (high blood pressure) affects: 1) intra-uterine growth (how a fetus grows in the womb), and 2) the relationship between fetal growth and adult blood pressure. This is a scientific question about whether genetic predisposition to hypertension influences both fetal development and the established connection between birth weight/fetal growth and later-life blood pressure outcomes. Based on scientific literature, there is evidence that genetic factors for hypertension can influence both fetal growth patterns and modify the relationship between birth weight and adult blood pressure. Studies have shown that parental hypertension history can affect fetal growth restriction and that genetic factors may partly explain the inverse relationship between birth weight and adult blood pressure. So yes, heredity for hypertension does appear to influence these factors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20491769",
    "question": "Do plant cysteine proteases that evoke itch activate protease-activated receptors?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether plant cysteine proteases that cause itch sensations activate protease-activated receptors (PARs). Plant cysteine proteases like those found in pineapple (bromelain), papaya (papain), fig (ficin), and kiwi fruit are known to cause itch. Research has shown that these plant proteases can induce itch through mechanisms that are distinct from PARs. Instead, they typically activate other receptors like MrgprC11 (in mice) or MRGPRX2 (in humans). These plant proteases do not efficiently cleave and activate the PAR family of receptors (PAR1, PAR2, PAR3, PAR4) that are activated by mammalian proteases like thrombin and trypsin. So while plant cysteine proteases do cause itch, they generally do not do so through PAR activation.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23033845",
    "question": "Does novel splice-site mutation in ATP8B1 result in atypical progressive familial intrahepatic cholestasis type 1?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether a novel splice-site mutation in the ATP8B1 gene results in atypical progressive familial intrahepatic cholestasis type 1 (PFIC1). \\n\\nTo answer this, I need to consider what is known about ATP8B1 mutations and PFIC1:\\n\\n1. ATP8B1 gene mutations are known to cause PFIC1, which is also called Byler disease.\\n2. Typical PFIC1 is caused by various mutations in ATP8B1.\\n3. Splice-site mutations affect how genes are expressed by altering RNA splicing.\\n4. Novel mutations are previously undescribed variants.\\n5. 'Atypical' PFIC1 would suggest a variant form of the disease with some different clinical features from the classical presentation.\\n\\nBased on the scientific literature, mutations in ATP8B1 (including splice-site mutations) are indeed associated with PFIC1. Novel mutations in this gene can lead to atypical presentations of PFIC1, as different mutations can affect protein function in various ways, leading to different clinical manifestations of the disease. So yes, a novel splice-site mutation in ATP8B1 can result in atypical PFIC1.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21715181",
    "question": "Does passive peritoneal drainage improve fluid balance after surgery for congenital heart disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether passive peritoneal drainage improves fluid balance after surgery for congenital heart disease. To answer this, I need to consider the evidence about peritoneal drainage as a technique used after congenital heart surgery. Based on medical literature, peritoneal drainage has been shown to help with fluid management in pediatric cardiac patients. Studies have demonstrated that passive peritoneal drainage can help remove excess fluid, improve hemodynamics, and potentially reduce the duration of mechanical ventilation and intensive care unit stay after congenital heart surgery. The drainage helps maintain fluid balance by providing a route for excess fluid to leave the body, which can accumulate after cardiac surgery due to capillary leak, inflammatory responses, and other factors. So there is evidence supporting that passive peritoneal drainage does improve fluid balance after congenital heart surgery.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22752375",
    "question": "Is ki-67 a prognostic biomarker of survival after radiofrequency ablation of liver malignancies?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if ki-67 is a prognostic biomarker of survival after radiofrequency ablation (RFA) of liver malignancies. Ki-67 is a protein associated with cell proliferation and is often used as a marker for cell growth and division. It's commonly used in cancer diagnostics to assess tumor aggressiveness. To answer this question, I need to consider whether there is established evidence that ki-67 expression levels can predict survival outcomes specifically after RFA treatment of liver cancers. Based on medical literature, ki-67 is indeed used as a prognostic marker in many cancers including hepatocellular carcinoma and liver metastases. However, the specific context of post-RFA prognostication requires evidence that ki-67 status (measured before treatment) correlates with survival outcomes after this specific intervention. There are studies showing ki-67 has prognostic value in liver cancers generally, but I believe there is published research specifically examining ki-67 as a predictor of outcomes after RFA treatment of liver tumors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20531417",
    "question": "Does pregnane X receptor suppress proliferation and tumourigenicity of colon cancer cells?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether pregnane X receptor (PXR) suppresses proliferation and tumourigenicity of colon cancer cells. To answer this, I need to consider what is known about PXR's role in colon cancer.\\n\\nPXR (pregnane X receptor) is a nuclear receptor that regulates the expression of genes involved in drug metabolism and transport. In the context of colon cancer, research has shown that PXR can actually have varying effects depending on the context.\\n\\nSome studies have indicated that PXR activation can promote colon cancer cell growth and tumorigenesis by regulating cell cycle and apoptosis-related genes. Other research has suggested that PXR may have anti-proliferative effects in certain contexts.\\n\\nHowever, the predominant evidence in the literature suggests that PXR often promotes rather than suppresses colon cancer cell proliferation. Several studies have shown that PXR activation can enhance colon cancer cell growth, invasion, and drug resistance.\\n\\nTherefore, it would not be accurate to state that PXR suppresses proliferation and tumourigenicity of colon cancer cells. In fact, the opposite effect has been more commonly reported.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11372002",
    "question": "Are plasma concentrations of active lovastatin acid markedly increased by gemfibrozil but not by bezafibrate?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question about drug interactions. The question is asking whether plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate. This is asking about a specific pharmacokinetic interaction between lovastatin (a statin medication) and two fibrate drugs (gemfibrozil and bezafibrate). Based on pharmacological literature, gemfibrozil is known to significantly inhibit the metabolism of statins including lovastatin, leading to increased plasma concentrations of active lovastatin acid. In contrast, bezafibrate has much less effect on statin metabolism. This differential effect is well-documented in drug interaction studies and is the reason why gemfibrozil-statin combinations carry higher risk of myopathy than other fibrate-statin combinations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11916788",
    "question": "Does korean hand acupressure reduce postoperative nausea and vomiting after gynecological laparoscopic surgery?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether Korean hand acupressure reduces postoperative nausea and vomiting specifically after gynecological laparoscopic surgery. To answer this, I would need to know if there are clinical studies or evidence showing that Korean hand acupressure is effective for this specific type of surgery and its associated postoperative symptoms. Without specific research data on this particular application, I cannot provide a definitive yes or no answer. However, there are studies showing that various forms of acupressure can help with postoperative nausea and vomiting in general, including P6 (Neiguan) point stimulation. Korean hand acupressure specifically targets points on the hand that correspond to body regions according to Korean hand therapy principles. Some research supports acupressure for PONV, but I don't have conclusive evidence specifically for Korean hand acupressure after gynecological laparoscopic surgery.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21197709",
    "question": "Does toll-like receptor 4 contribute to small intestine allograft rejection?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the role of toll-like receptor 4 (TLR4) in small intestine allograft rejection. TLR4 is a pattern recognition receptor involved in innate immunity that recognizes lipopolysaccharide (LPS) from gram-negative bacteria. To answer this question, I need to consider whether there is evidence that TLR4 plays a role in the rejection of small intestine transplants.\\n\\nBased on immunological research, TLR4 has been implicated in various transplant rejection processes. For small intestine transplants specifically, studies have shown that TLR4 signaling can contribute to the inflammatory response that leads to allograft rejection. TLR4 activation can trigger production of pro-inflammatory cytokines and promote activation of adaptive immune responses against the transplanted tissue. The intestine is particularly relevant for TLR4 activity due to the high bacterial load and potential for translocation of bacterial products during transplantation procedures.\\n\\nResearch has demonstrated that TLR4 signaling pathways are upregulated during intestinal allograft rejection, and that TLR4 inhibition or deficiency can reduce rejection severity in experimental models. Therefore, there is scientific evidence supporting that TLR4 does contribute to small intestine allograft rejection.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27095008",
    "question": "Is persistently active disease common in patients with rheumatoid arthritis , particularly in women : a long-term inception cohort study?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if persistently active disease is common in patients with rheumatoid arthritis, particularly in women, according to a long-term inception cohort study. To answer this, I need to determine if the question contains a statement about findings from such a study. The question itself is phrased as an inquiry about research findings, not as a statement of fact. It's asking whether persistently active disease is common in RA patients (especially women) based on a specific type of study. The question doesn't actually assert that this is the case - it's asking if it is the case. Without additional information about the actual findings of such studies, I cannot confirm or deny the premise.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24498332",
    "question": "Does glucokinase regulatory protein gene polymorphism affect liver fibrosis in non-alcoholic fatty liver disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether glucokinase regulatory protein (GKRP) gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease (NAFLD). To answer this, I would need to know if there's established scientific evidence showing a relationship between GKRP gene variants and the progression or severity of liver fibrosis specifically in NAFLD patients. While GKRP is involved in glucose metabolism and some studies have linked certain GKRP polymorphisms (particularly the rs1260326 variant) to NAFLD risk and hepatic fat content, the specific relationship between GKRP polymorphisms and fibrosis progression in NAFLD is less clear from the general literature. Without specific studies demonstrating this relationship, I cannot confidently say 'yes'. However, I also don't have definitive evidence to rule out such a relationship, so I cannot confidently say 'no' either. Given the limitations of my knowledge and the specific nature of this question requiring recent research findings, I should acknowledge that I don't have sufficient information to provide a definitive answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27448478",
    "question": "Does school-based sleep education program improve sleep and academic performance of school-age children?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if school-based sleep education programs improve both sleep and academic performance in school-age children. To answer this, I need to consider the evidence on whether such programs have demonstrated positive effects on both sleep patterns and academic outcomes.\\n\\nBased on research literature, school-based sleep education programs have shown some evidence of improving sleep knowledge and sometimes sleep habits in children. However, the evidence for consistent improvements in academic performance as a direct result of these programs is more limited and mixed. While better sleep is generally associated with better academic performance, the direct causal link specifically from sleep education programs to improved academic outcomes is not strongly established in the research literature.\\n\\nSo while there is evidence these programs can improve sleep to some degree, the evidence for simultaneous improvement in academic performance is not as strong or consistent.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16449265",
    "question": "Is hyperglycaemia associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether hyperglycaemia (high blood sugar) is associated with poor outcomes in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease (COPD). \\n\\nBased on medical literature, hyperglycaemia has indeed been associated with worse clinical outcomes in patients admitted with COPD exacerbations. Several studies have shown that elevated blood glucose levels during hospitalization for COPD exacerbations are linked to longer hospital stays, increased risk of treatment failure, higher rates of readmission, and increased mortality. Stress hyperglycaemia in particular has been identified as a predictor of poor prognosis in these patients.\\n\\nThe association exists regardless of whether patients have pre-existing diabetes or develop stress hyperglycaemia during the acute illness. The mechanisms may involve increased susceptibility to infections, impaired immune response, and other metabolic effects that can complicate recovery from COPD exacerbations.\\n\\nSo yes, hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of COPD.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21907974",
    "question": "Does translational magnetic resonance spectroscopy reveal excessive central glutamate levels during alcohol withdrawal in humans and rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether translational magnetic resonance spectroscopy (MRS) shows excessive central glutamate levels during alcohol withdrawal in both humans and rats. To answer this, I need to consider what scientific evidence shows about glutamate levels during alcohol withdrawal as measured specifically by MRS technology.\\n\\nAlcohol withdrawal is known to involve glutamatergic hyperactivity, as chronic alcohol exposure leads to compensatory changes in glutamate receptors. When alcohol is removed, this can lead to excessive glutamate activity. However, the specific question is whether MRS studies have confirmed elevated glutamate levels in both humans and rats during withdrawal.\\n\\nBased on scientific literature, MRS studies have indeed shown elevated glutamate levels in the brain during alcohol withdrawal in both human subjects and in rat models. This has been documented in several translational studies that specifically used magnetic resonance spectroscopy to measure glutamate concentrations in brain regions like the prefrontal cortex and basal ganglia during withdrawal states. The findings across species support the glutamate hypothesis of alcohol withdrawal and dependence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18029383",
    "question": "Is innate production of tumour necrosis factor alpha and interleukin 10 associated with radiological progression of knee osteoarthritis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if there's an association between the innate production of two specific cytokines (tumor necrosis factor alpha and interleukin 10) and the radiological progression of knee osteoarthritis. To answer this, I would need to know if research has established a connection between these inflammatory markers and observable changes in knee osteoarthritis as seen on imaging studies. Without specific research data provided in the question, I need to consider what's generally known about these relationships. TNF-alpha is pro-inflammatory and IL-10 is anti-inflammatory, and both have been studied in osteoarthritis contexts. However, the specific question about 'innate production' and 'radiological progression' requires evidence of a direct correlation between baseline levels of these cytokines and worsening of knee OA as observed on X-rays or other imaging. Based on existing literature, there is some evidence suggesting associations between inflammatory cytokines and OA progression, but the specific relationship asked about is not firmly established enough to give a definitive 'yes'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26712708",
    "question": "Is the SNP rs9677 of VPAC1 gene associated with glycolipid control and heart function in female patients with type 2 diabetes : A follow-up study?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking if a specific study titled 'Is the SNP rs9677 of VPAC1 gene associated with glycolipid control and heart function in female patients with type 2 diabetes : A follow-up study?' exists. The title is phrased as a question, which is common for research papers. It appears to be describing a specific study that investigates the association between a single nucleotide polymorphism (SNP rs9677) in the VPAC1 gene and its effects on glycolipid control and heart function specifically in female patients with type 2 diabetes, and it seems to be a follow-up to a previous study. Based on the specific details provided, this appears to be a real study title rather than a hypothetical question.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18006474",
    "question": "Does targeting of phospholamban by peroxynitrite decrease beta-adrenergic stimulation in cardiomyocytes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether targeting of phospholamban by peroxynitrite decreases beta-adrenergic stimulation in cardiomyocytes. Let me analyze this:\n\nPhospholamban (PLB) is a protein that regulates the sarcoplasmic reticulum Ca²⁺-ATPase (SERCA) in cardiac muscle cells. In its unphosphorylated state, PLB inhibits SERCA, but when phosphorylated (often via beta-adrenergic stimulation), this inhibition is relieved.\n\nPeroxynitrite is a reactive nitrogen species that can modify proteins through nitration or oxidation.\n\nResearch has shown that peroxynitrite can indeed target phospholamban in cardiomyocytes, and this modification can interfere with normal phospholamban regulation. Studies have demonstrated that peroxynitrite-modified phospholamban is less responsive to phosphorylation signals that would normally come from beta-adrenergic stimulation.\n\nTherefore, when peroxynitrite targets phospholamban, it can impair the protein's normal response to beta-adrenergic stimulation, effectively decreasing the beta-adrenergic response in cardiomyocytes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23534616",
    "question": "Are non-invasive fibrosis biomarkers - APRI and Forns - associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the association between non-invasive fibrosis biomarkers (specifically APRI and Forns) and liver stiffness in HIV-monoinfected patients who are on antiretroviral therapy. To answer this, I need to consider whether there is evidence that these specific biomarkers correlate with liver stiffness measurements in this specific patient population. Based on medical literature, both APRI (AST to Platelet Ratio Index) and Forns index have been studied in HIV-monoinfected patients, and research has shown that these non-invasive markers do correlate with liver stiffness measurements as assessed by transient elastography (FibroScan) or other methods. Multiple studies have demonstrated significant associations between these biomarkers and liver stiffness in HIV patients without hepatitis co-infection who are on antiretroviral therapy.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23032324",
    "question": "Does endogenous and natural complement inhibitor attenuate myocardial injury and arterial thrombogenesis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if endogenous and natural complement inhibitor attenuates (reduces or lessens) myocardial injury (heart muscle damage) and arterial thrombogenesis (formation of blood clots in arteries). \\n\\nTo answer this, I need to consider what is known about natural complement inhibitors in the body. The complement system is part of the immune system, and there are indeed natural inhibitors of complement that help regulate this system. Research has shown that these natural complement inhibitors (like C1 inhibitor, CD55, CD59, factor H) can have protective effects against inflammatory damage in various tissues.\\n\\nSpecifically for myocardial injury, studies have demonstrated that complement activation contributes to heart damage during ischemia-reperfusion injury, and natural complement inhibitors can reduce this damage. Similarly, complement activation is involved in thrombosis (clot formation), and inhibition of complement can reduce arterial thrombogenesis.\\n\\nBased on the scientific literature, endogenous complement inhibitors do have protective effects against both myocardial injury and arterial thrombogenesis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23185201",
    "question": "Does the sound of a mobile phone ringing affect the complex reaction time of its owner?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the sound of a mobile phone ringing affects the complex reaction time of its owner. Complex reaction time refers to the time it takes for a person to respond when they need to make a decision between multiple possible responses. To answer this question, I need to consider whether there's evidence that hearing your phone ring impacts your cognitive processing speed for complex tasks.\\n\\nResearch in cognitive psychology has shown that notifications and sounds from mobile devices can create distractions that impact cognitive performance. When a phone rings, it creates an attentional shift, potentially disrupting ongoing cognitive processes. Studies have demonstrated that even the presence of a phone can reduce available cognitive capacity. When a phone rings, it typically triggers an urge to check it, which diverts attention and cognitive resources away from the current task.\\n\\nFor complex reaction time specifically, which requires decision-making processes beyond simple stimulus-response, the auditory distraction of a ringing phone would likely create interference in the cognitive processing pathway, potentially slowing down the reaction time as attention is divided between the task at hand and the ringing phone.\\n\\nBased on established principles of attention, cognitive load, and distraction effects, I can conclude that yes, the sound of a mobile phone ringing would affect (typically increase) the complex reaction time of its owner.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23994220",
    "question": "Is the fetal inflammatory response syndrome a risk factor for morbidity in preterm neonates?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if fetal inflammatory response syndrome (FIRS) is a risk factor for morbidity in preterm neonates. FIRS is a condition characterized by systemic inflammation in the fetus, often in response to intrauterine infection or inflammation. Research has shown that FIRS is associated with increased risk of adverse neonatal outcomes in preterm infants, including bronchopulmonary dysplasia, necrotizing enterocolitis, intraventricular hemorrhage, and neurodevelopmental impairment. Multiple studies have demonstrated that the presence of inflammatory markers in cord blood or amniotic fluid (indicators of FIRS) correlates with higher rates of neonatal morbidity in preterm infants. Therefore, FIRS is indeed considered a risk factor for morbidity in preterm neonates.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18599529",
    "question": "Is a1C but not serum glycated albumin elevated in late pregnancy owing to iron deficiency?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether a1C (glycated hemoglobin) is elevated in late pregnancy due to iron deficiency while serum glycated albumin is not. Let me analyze this based on medical literature:\\n\\n1. HbA1c (a1C) levels can be falsely elevated in iron deficiency anemia because red blood cells have a longer lifespan in iron deficiency, allowing more time for glycation.\\n\\n2. In pregnancy, particularly late pregnancy, iron deficiency is common due to increased iron demands.\\n\\n3. Serum glycated albumin is not affected by red blood cell lifespan or iron status, as it measures glycation of albumin protein in the serum rather than hemoglobin in red blood cells.\\n\\nSo yes, in late pregnancy with iron deficiency, a1C can be falsely elevated while serum glycated albumin would not be affected by the iron deficiency.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25721704",
    "question": "Are variants in ALOX5 , ALOX5AP and LTA4H associated with atherosclerotic plaque phenotypes : the Athero-Express Genomics Study?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether variants in the genes ALOX5, ALOX5AP, and LTA4H are associated with atherosclerotic plaque phenotypes, specifically in the context of the Athero-Express Genomics Study. To answer this, I would need to know the findings of this specific study regarding these gene variants and their relationship to atherosclerotic plaque characteristics. Without having access to the results of the Athero-Express Genomics Study, I cannot definitively answer whether these associations were found. The question appears to be asking about a specific scientific finding from a particular study, not a general scientific fact.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "10964837",
    "question": "Do ultrasound biomicroscopy of sclerotomy sites after pars plana vitrectomy for diabetic vitreous hemorrhage?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether to perform ultrasound biomicroscopy (UBM) of sclerotomy sites after pars plana vitrectomy (PPV) for diabetic vitreous hemorrhage. This appears to be asking for a medical recommendation or standard practice. UBM is an imaging technique that can be used to evaluate the sclerotomy sites after vitrectomy procedures to assess healing, potential complications, or structural changes. However, whether this is routinely indicated specifically after PPV for diabetic vitreous hemorrhage depends on clinical guidelines, the specific clinical scenario, and whether there are concerns about the sclerotomy sites. Without more context about a specific patient scenario or whether this is asking about standard protocol, I cannot provide a definitive yes or no recommendation for a clinical procedure.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9526981",
    "question": "Are hypertension , small size , and deep venous drainage associated with risk of hemorrhagic presentation of cerebral arteriovenous malformations?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if hypertension, small size, and deep venous drainage are associated with risk of hemorrhagic presentation of cerebral arteriovenous malformations (AVMs). Let me analyze each factor:\\n\\n1. Hypertension: Generally considered a risk factor for hemorrhage in many vascular conditions, including AVMs.\\n\\n2. Small size: Interestingly, smaller AVMs are often associated with higher hemorrhage risk, contrary to what might be intuitively expected. This is documented in medical literature.\\n\\n3. Deep venous drainage: AVMs with deep venous drainage patterns have been associated with higher hemorrhage risk in multiple studies.\\n\\nBased on medical literature, all three factors mentioned (hypertension, small AVM size, and deep venous drainage) are indeed associated with increased risk of hemorrhagic presentation in cerebral arteriovenous malformations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25634836",
    "question": "Does autonomic control of heart rate and QT interval variability influence arrhythmic risk in long QT syndrome type 1?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1 (LQTS1). LQTS1 is a genetic cardiac disorder characterized by prolonged QT intervals on ECG, which can lead to arrhythmias. The autonomic nervous system (sympathetic and parasympathetic) regulates heart rate and can affect QT intervals. Research has shown that in LQTS1 specifically, there is impaired adaptation of the QT interval to heart rate changes, particularly during sympathetic activation (like during exercise or emotional stress). Beta-adrenergic stimulation can trigger arrhythmias in LQTS1 patients, which is why beta-blockers are a standard treatment. So yes, autonomic control does influence arrhythmic risk in LQTS1.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18536059",
    "question": "Does telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflect ongoing cellular senescence?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether telomere shortening in damaged small bile ducts in primary biliary cirrhosis (PBC) reflects ongoing cellular senescence. To answer this, I need to consider what we know about telomere shortening and cellular senescence in PBC.\\n\\nTelomere shortening is a well-established marker of cellular senescence, which is a state where cells stop dividing but remain metabolically active. In PBC, a chronic autoimmune liver disease, there is progressive destruction of small bile ducts.\\n\\nResearch has shown that biliary epithelial cells in PBC patients exhibit features of cellular senescence, including telomere shortening. This telomere shortening in the damaged bile ducts is considered to be a reflection of the senescence process occurring in these cells as part of the disease pathology.\\n\\nStudies have demonstrated that senescent biliary epithelial cells in PBC express senescence-associated markers and have shortened telomeres, supporting the concept that telomere shortening in these damaged ducts does indeed reflect ongoing cellular senescence in PBC.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "9854555",
    "question": "Is compression ultrasonography for false femoral artery aneurysms : hypocoagulability a cause of failure?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether hypocoagulability (a state of decreased blood clotting ability) is a cause of failure when using compression ultrasonography to treat false femoral artery aneurysms (also called pseudoaneurysms). Compression ultrasonography is a technique where ultrasound-guided pressure is applied to compress and potentially thrombose (clot) a pseudoaneurysm. If a patient has hypocoagulability, their blood would have reduced ability to form clots, which could logically reduce the success rate of a procedure that relies on clot formation. Medical literature does support that anticoagulation status and coagulation disorders can affect the success rate of compression therapy for pseudoaneurysms. So yes, hypocoagulability would be a cause of failure for this procedure.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21623002",
    "question": "Are skin fibroblasts potent suppressors of inflammation in experimental arthritis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if skin fibroblasts are potent suppressors of inflammation in experimental arthritis. To answer this accurately, I need to consider what is known about skin fibroblasts and their role in inflammation, particularly in arthritis models.\\n\\nSkin fibroblasts are connective tissue cells that produce collagen and other extracellular matrix components. While fibroblasts can have immunomodulatory properties, skin fibroblasts specifically are not generally characterized as potent suppressors of inflammation in arthritis. In fact, in the context of arthritis, it's typically synovial fibroblasts that play a key role, and they are often pro-inflammatory rather than anti-inflammatory.\\n\\nResearch on experimental arthritis models typically focuses on synovial fibroblasts, mesenchymal stem cells, or regulatory immune cells as potential suppressors of inflammation, not skin fibroblasts. Skin fibroblasts are not widely reported or established as potent anti-inflammatory agents in arthritis models.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23744060",
    "question": "Has survival in systemic sclerosis with pulmonary arterial hypertension improved in the modern era?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether survival rates have improved in recent times for patients with systemic sclerosis (SSc) who also have pulmonary arterial hypertension (PAH). To answer this, I need to consider whether there is evidence of improved outcomes in the modern era compared to historical data.\\n\\nSystemic sclerosis is an autoimmune disease characterized by fibrosis of the skin and internal organs. When it's complicated by pulmonary arterial hypertension, it historically had a very poor prognosis. \\n\\nIn the modern era (roughly the past 10-20 years), there have been significant advances in:\\n1. Earlier detection of PAH in SSc patients through screening programs\\n2. Development of specific PAH therapies including prostacyclins, endothelin receptor antagonists, and phosphodiesterase-5 inhibitors\\n3. Combination therapy approaches\\n4. Better management of the underlying systemic sclerosis\\n\\nMultiple cohort studies and registry data have demonstrated improved survival rates for SSc-PAH patients in recent years compared to historical cohorts. For example, the REVEAL registry and other studies have shown that 1-year, 3-year, and 5-year survival rates have improved. While SSc-PAH still carries a worse prognosis than idiopathic PAH, there has been a measurable improvement in outcomes.\\n\\nBased on the medical literature, there is evidence that survival has indeed improved in the modern era for patients with SSc-PAH.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "21999758",
    "question": "Are facial phenotypes in subgroups of prepubertal boys with autism spectrum disorders correlated with clinical phenotypes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether facial phenotypes (physical facial characteristics) in subgroups of prepubertal boys with autism spectrum disorders are correlated with clinical phenotypes (symptoms or manifestations of the disorder). To answer this question, I would need to know if research has established such correlations. Some studies have investigated facial morphology in autism and potential correlations with clinical features, but I need to determine if there's scientific evidence specifically for prepubertal boys with ASD showing correlations between facial features and clinical symptoms. Based on existing research, there have been studies suggesting that certain facial phenotypes may be associated with specific clinical presentations in autism, particularly in younger males. So the answer would be yes, there is evidence for such correlations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16271102",
    "question": "Does bicarbonate inhibit the growth of Staphylococcus epidermidis in platelet concentrates by lowering the level of non-transferrin-bound iron?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if bicarbonate inhibits the growth of Staphylococcus epidermidis in platelet concentrates specifically by lowering the level of non-transferrin-bound iron. This is a very specific mechanism question about bacterial growth inhibition. To answer this accurately, I would need to know if research has established this particular mechanism. Without specific knowledge of studies showing that bicarbonate inhibits S. epidermidis growth in platelet concentrates through this specific iron-related mechanism, I cannot confirm this as true. This appears to be a specialized question in microbiology and transfusion medicine that would require specific research evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "8129795",
    "question": "Does transforming growth factor beta 1 regulate tissue inhibitor of metalloproteinases-1 expression in differentiated human articular chondrocytes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if transforming growth factor beta 1 (TGF-β1) regulates tissue inhibitor of metalloproteinases-1 (TIMP-1) expression in differentiated human articular chondrocytes. To answer this, I need to consider whether there is established scientific evidence for this regulatory relationship in this specific cell type.\\n\\nTGF-β1 is known to be an important growth factor that regulates many cellular processes including matrix production in cartilage. TIMP-1 is an inhibitor of matrix metalloproteinases (MMPs) that break down extracellular matrix components.\\n\\nBased on scientific literature, TGF-β1 has been shown to upregulate TIMP-1 expression in human articular chondrocytes. Multiple studies have demonstrated that when human articular chondrocytes are treated with TGF-β1, there is an increase in TIMP-1 expression at both mRNA and protein levels. This regulatory relationship is part of TGF-β1's role in maintaining cartilage homeostasis by promoting matrix preservation.\\n\\nTherefore, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23045565",
    "question": "Do mental health services use by children investigated by child welfare agencies?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether mental health services are used by children who are investigated by child welfare agencies. To answer this, I need to consider whether children who come under child welfare investigation typically receive or use mental health services as part of that process. Based on research and common practice in child welfare systems, children who are investigated by child welfare agencies often do receive mental health assessments and services. Many child welfare systems have protocols for mental health screening and referrals for children who have experienced trauma, abuse, or neglect. So mental health services are indeed used by many children who are investigated by child welfare agencies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27593595",
    "question": "Does measurement of liver function using hepatobiliary scintigraphy improve risk assessment in patients undergoing major liver resection?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether hepatobiliary scintigraphy, a nuclear medicine procedure that evaluates liver function, improves risk assessment for patients undergoing major liver resection. To answer this, I need to consider whether there is evidence that this specific imaging technique helps predict surgical outcomes or complications better than standard assessment methods. Based on medical literature, hepatobiliary scintigraphy (such as 99mTc-mebrofenin scan) can quantitatively assess segmental liver function and future liver remnant function, which has been shown to be valuable in predicting post-hepatectomy liver failure. Studies have demonstrated that functional assessment using this technique can identify patients at higher risk of complications who might not be identified by volumetric assessment alone. Therefore, there is evidence supporting that hepatobiliary scintigraphy does improve risk assessment in the context of major liver resection.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24790218",
    "question": "Does everolimus reduce ( 89 ) Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether everolimus reduces (89)Zr-Bevacizumab tumor uptake in patients with neuroendocrine tumors. To answer this, I would need specific research or clinical trial data about the interaction between everolimus (an mTOR inhibitor used in treating some neuroendocrine tumors) and (89)Zr-Bevacizumab (a radiolabeled monoclonal antibody used for PET imaging). Without being provided specific studies or data in the question, I cannot make a definitive determination about whether everolimus has this specific effect on (89)Zr-Bevacizumab tumor uptake in neuroendocrine tumor patients.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19948011",
    "question": "Do some putative prebiotics increase the severity of Salmonella enterica serovar Typhimurium infection in mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if some putative prebiotics increase the severity of Salmonella enterica serovar Typhimurium infection in mice. I need to determine if there's evidence that certain prebiotics can worsen Salmonella infections in mouse models.\\n\\nResearch has shown that certain prebiotics, particularly some types of fermentable fibers, can actually enhance Salmonella colonization and pathogenesis in mice. For example, studies have demonstrated that fructo-oligosaccharides (FOS) and other fermentable fibers can increase Salmonella Typhimurium translocation, colonization, and infection severity in mouse models. This occurs because these prebiotics can be utilized by Salmonella as growth substrates or can alter the gut environment in ways that benefit the pathogen.\\n\\nSo yes, there is scientific evidence showing that some putative prebiotics can increase the severity of Salmonella Typhimurium infection in mice.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19638917",
    "question": "Is lack of Insurance Associated With Increased Risk for Hernia Complications?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if lack of insurance is associated with increased risk for hernia complications. To answer this, I would need to know if there are studies showing a correlation between insurance status and hernia complication rates. Based on medical literature, patients without insurance often delay seeking care, may not receive timely surgical intervention for hernias, and might have limited access to follow-up care. These factors can lead to higher rates of hernia incarceration, strangulation, and other complications. Several studies have shown that uninsured patients are more likely to present with complicated hernias requiring emergency surgery rather than elective repair, which carries higher morbidity and mortality. So the evidence does suggest that lack of insurance is associated with increased risk for hernia complications.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25792467",
    "question": "Are acute symptoms during the course of head and neck radiotherapy or chemoradiation strong predictors of late dysphagia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether acute symptoms during head and neck radiotherapy or chemoradiation are strong predictors of late dysphagia. To answer this, I need to consider what the medical literature indicates about the relationship between acute symptoms during treatment and the development of late dysphagia (swallowing difficulties that persist long after treatment). While there is some association between acute radiation toxicity and late effects, I need to determine if acute symptoms specifically are considered 'strong predictors' of late dysphagia. Based on medical literature, acute symptoms during treatment (such as pain, mucositis, difficulty swallowing) do often correlate with development of late dysphagia, and many studies have identified acute symptoms as predictive factors for late swallowing dysfunction. This relationship is recognized in radiation oncology as 'consequential late effects' where severe acute reactions lead to chronic tissue damage and functional impairment.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25644355",
    "question": "Is soft drink consumption positively associated with increased waist circumference and 10-year incidence of abdominal obesity in Spanish adults?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between soft drink consumption and abdominal obesity measures in Spanish adults specifically. To answer this, I would need to know about epidemiological studies conducted in Spain that examined this association. While there is general evidence linking sugar-sweetened beverage consumption to obesity in many populations, I need to determine if there are specific findings for Spanish adults showing a positive association with waist circumference and 10-year incidence of abdominal obesity. Without specific studies on this population with these exact metrics, I cannot confidently answer yes. However, given the global trends and similar findings in other European populations, it's plausible but not definitively established without specific Spanish cohort data.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23950216",
    "question": "Is fecal miR-106a a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if fecal miR-106a is a useful marker for colorectal cancer patients who have false-negative results in immunochemical fecal occult blood tests (iFOBT). To answer this, I need to consider whether there is scientific evidence supporting miR-106a as a biomarker that can detect colorectal cancer in cases where the standard iFOBT fails to detect it. Research has shown that microRNAs, including miR-106a, can be detected in stool samples and have potential as non-invasive biomarkers for colorectal cancer. Some studies have specifically investigated miR-106a's ability to detect colorectal cancer in patients with negative iFOBT results. These studies have found that fecal miR-106a can indeed identify some colorectal cancer cases missed by iFOBT, suggesting it has complementary diagnostic value. Therefore, based on available evidence, fecal miR-106a appears to be a useful marker for colorectal cancer patients with false-negative iFOBT results.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19272411",
    "question": "Is mobility of the conserved glycine 155 required for formation of the active plasmodial Pdx1 dodecamer?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the role of glycine 155 in the formation of the active plasmodial Pdx1 dodecamer. To answer this, I need to determine if the mobility of this specific conserved glycine residue (G155) is a requirement for the proper assembly of the functional Pdx1 dodecamer in Plasmodium (the parasite that causes malaria). \\n\\nBased on the information provided in the question alone, I don't have specific scientific evidence about the role of glycine 155 in Pdx1 dodecamer formation. This would require knowledge from biochemical or structural biology studies that have specifically investigated this residue's role in the assembly or function of the Pdx1 complex.\\n\\nWithout additional context or information from research papers that have studied this specific question, I cannot provide a definitive yes or no answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25567327",
    "question": "Does bone morphogenetic protein 2 gene transduction enhance the osteogenic potential of human urine-derived stem cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether bone morphogenetic protein 2 (BMP-2) gene transduction enhances the osteogenic potential (ability to form bone) of human urine-derived stem cells (USCs). To answer this, I need to consider if there's established scientific evidence showing that introducing the BMP-2 gene into USCs increases their ability to differentiate into bone-forming cells or enhances bone formation. BMP-2 is known to be a potent osteoinductive factor that plays important roles in bone development and repair. Several studies have shown that BMP-2 gene transduction can enhance the osteogenic potential of various stem cell types. For human urine-derived stem cells specifically, research has demonstrated that BMP-2 gene transduction does indeed enhance their osteogenic differentiation and bone-forming capacity, making them more effective for bone tissue engineering applications.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10971324",
    "question": "Does nicotinamide increase biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if nicotinamide increases biosynthesis of ceramides and other stratum corneum lipids to improve the epidermal permeability barrier. Let me analyze what we know about nicotinamide's effects on skin barrier function.\\n\\nNicotinamide (also known as niacinamide) is a form of vitamin B3 that has been studied for various dermatological applications. Some research suggests it can improve barrier function, but I need to determine specifically if it works through increasing ceramide biosynthesis and other stratum corneum lipids.\\n\\nBased on scientific literature, nicotinamide has been shown to stimulate ceramide synthesis in human keratinocytes and can increase the production of other epidermal lipids. Studies have demonstrated that topical nicotinamide can improve barrier function by upregulating the synthesis of ceramides, free fatty acids, and cholesterol - all key components of the stratum corneum lipid matrix. This mechanism contributes to its ability to improve epidermal permeability barrier function.\\n\\nSo yes, there is scientific evidence supporting that nicotinamide increases biosynthesis of ceramides and other stratum corneum lipids, which contributes to improving the epidermal permeability barrier.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19304335",
    "question": "Is low serum concentration of apolipoprotein A-I an indicator of poor prognosis in cirrhotic patients with severe sepsis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if low serum concentration of apolipoprotein A-I indicates poor prognosis in cirrhotic patients with severe sepsis. To answer this, I need to consider what is known about apolipoprotein A-I in relation to liver cirrhosis and sepsis outcomes.\\n\\nApolipoprotein A-I (ApoA-I) is the major protein component of high-density lipoprotein (HDL) in plasma. It has anti-inflammatory and antioxidant properties. In the context of liver disease, the liver is the main site of ApoA-I synthesis, so cirrhosis can lead to decreased production.\\n\\nResearch has shown that low levels of ApoA-I are associated with increased mortality in patients with sepsis. In cirrhotic patients specifically, who already have compromised liver function, low ApoA-I levels have been found to correlate with disease severity and worse outcomes when they develop sepsis.\\n\\nStudies have demonstrated that ApoA-I levels can serve as a prognostic marker in cirrhotic patients with infections, including severe sepsis, with lower levels indicating higher risk of mortality and complications.\\n\\nBased on the medical literature, low serum concentration of apolipoprotein A-I is indeed considered an indicator of poor prognosis in cirrhotic patients with severe sepsis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18041485",
    "question": "Do zaleplon and zolpidem objectively alleviate sleep disturbances in mountaineers at a 3,613 meter altitude?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether zaleplon and zolpidem objectively alleviate sleep disturbances in mountaineers at a specific altitude (3,613 meters). To answer this, I would need to know if there are scientific studies that have specifically tested these sleep medications at this exact altitude with objective measurements of sleep quality in mountaineers. Without specific research on these medications at this precise altitude with objective measurements (like polysomnography, actigraphy, etc.), I cannot definitively say 'yes'. While these medications are hypnotics used for insomnia, altitude-related sleep disturbances have unique physiological mechanisms, and medication efficacy at high altitudes may differ from sea level. The question specifically asks about 'objective' alleviation, not subjective reports, and specifies a very precise altitude.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25472966",
    "question": "Is intravenous home inotropic use safe in pediatric patients awaiting transplantation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the safety of intravenous home inotropic use in pediatric patients who are waiting for transplantation. To answer this properly, I would need to consider the medical evidence on this specific treatment approach in this vulnerable population. Inotropic medications increase heart contractility and are sometimes used in advanced heart failure, but they carry risks including arrhythmias and other complications. Home administration adds additional complexity and risk factors compared to hospital administration. For pediatric patients specifically awaiting transplantation, the risk-benefit profile may be different than for adults or other populations. Without citing specific studies on safety outcomes in this exact population, I should be cautious about making a definitive safety claim.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19136374",
    "question": "Is acute lung injury reduced in fat-1 mice endogenously synthesizing n-3 fatty acids?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether acute lung injury is reduced in fat-1 mice that endogenously synthesize n-3 fatty acids. To answer this, I need to determine if there's evidence showing that fat-1 mice (which can convert n-6 to n-3 fatty acids due to the transgenic fat-1 gene) have reduced acute lung injury compared to wild-type mice.\\n\\nFat-1 mice are genetically modified mice that express the C. elegans fat-1 gene, which encodes an enzyme that can convert n-6 to n-3 fatty acids. This allows these mice to produce n-3 fatty acids endogenously.\\n\\nBased on scientific literature, there are studies showing that fat-1 mice exhibit reduced inflammatory responses and are protected against various inflammatory conditions. Specifically for acute lung injury, research has demonstrated that fat-1 mice show reduced severity of acute lung injury in experimental models, with decreased inflammatory markers, reduced neutrophil infiltration, and improved lung function compared to wild-type controls.\\n\\nThis protective effect is attributed to the increased tissue levels of n-3 fatty acids and their anti-inflammatory metabolites in these mice.\\n\\nSo yes, acute lung injury is reduced in fat-1 mice that endogenously synthesize n-3 fatty acids.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22179198",
    "question": "Is rUNX3 involved in caspase-3-dependent apoptosis induced by a combination of 5-aza-CdR and TSA in leukaemia cell lines?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if rUNX3 is involved in caspase-3-dependent apoptosis induced by a combination of 5-aza-CdR and TSA in leukaemia cell lines. To answer this, I need to consider whether there's established evidence linking rUNX3 to this specific apoptotic pathway under these specific treatment conditions.\\n\\nRUNX3 (Runt-related transcription factor 3) is known to be involved in various cellular processes including apoptosis in some contexts. 5-aza-CdR (5-aza-2'-deoxycytidine, also known as decitabine) is a DNA methyltransferase inhibitor, and TSA (Trichostatin A) is a histone deacetylase inhibitor. Both are epigenetic modifiers that can reactivate silenced genes.\\n\\nHowever, without specific research evidence linking RUNX3 to caspase-3-dependent apoptosis specifically in the context of combined 5-aza-CdR and TSA treatment in leukemia cell lines, I cannot confirm this relationship. The question appears to be asking about a very specific molecular pathway in a specific experimental context, and I don't have definitive information about this particular relationship.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25323821",
    "question": "Does triptolide inhibit human immunodeficiency virus type 1 replication by promoting proteasomal degradation of Tat protein?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the mechanism of action of triptolide against HIV-1, specifically whether it inhibits HIV-1 replication by causing the degradation of the viral Tat protein through the proteasome pathway. To answer this, I need to know if scientific research has established this specific mechanism. Triptolide is a compound derived from the Chinese herb Tripterygium wilfordii that has various biological activities including anti-inflammatory and anti-cancer properties. It may have anti-HIV properties, but the specific mechanism involving Tat protein degradation via the proteasome needs to be confirmed by research. Without specific knowledge of studies demonstrating this mechanism, I cannot confirm this is how triptolide works against HIV-1.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19820132",
    "question": "Does topical mupirocin/sodium hypochlorite reduce peritonitis and exit-site infection rates in children?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether the combination of topical mupirocin (an antibiotic ointment) and sodium hypochlorite (a disinfectant) reduces the rates of peritonitis (inflammation of the peritoneum) and exit-site infections in children, particularly those with peritoneal dialysis catheters. To answer this accurately, I would need to be familiar with specific clinical studies on this topic. While mupirocin is known to reduce Staphylococcus aureus infections in peritoneal dialysis patients, and sodium hypochlorite (bleach) solutions are sometimes used for exit-site care, I don't have definitive evidence about the combined efficacy specifically in children. Without being able to cite specific pediatric studies showing efficacy, I should be cautious in my answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25945234",
    "question": "Does alpha-lipoic acid loaded in chitosan conduit enhance sciatic nerve regeneration in rat?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether alpha-lipoic acid loaded in chitosan conduit enhances sciatic nerve regeneration in rat. To answer this, I would need to know about specific scientific studies that tested this combination. Alpha-lipoic acid is an antioxidant that has shown neuroprotective properties in some contexts. Chitosan conduits are used in nerve regeneration research as scaffolds. However, without specific research evidence about this particular combination and its effects on sciatic nerve regeneration in rats, I cannot definitively answer yes or no. Since I don't have access to specific studies testing this exact combination, I should answer 'no' as I cannot confirm this specific claim.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11413559",
    "question": "Do laser pulse impact on rat mesenteric blood vessels in relation to laser treatment of port wine stain?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if laser pulse impact on rat mesenteric blood vessels is related to laser treatment of port wine stain. Let me analyze this:\\n\\n1. Port wine stain (PWS) is a vascular birthmark treated with lasers that target blood vessels.\\n2. Research on laser-tissue interactions often uses animal models to understand mechanisms.\\n3. Rat mesenteric vessels are commonly used in vascular research as they're easily accessible and observable.\\n4. Studies on how laser pulses affect rat mesenteric vessels could provide insights into vessel response mechanisms that would be relevant to understanding or improving port wine stain treatments.\\n\\nBased on the scientific literature, researchers do study laser effects on rat mesenteric vessels to better understand vascular responses that can be applied to port wine stain treatment. These animal models help researchers understand vessel damage mechanisms, thermal effects, and optimal laser parameters that can be translated to clinical applications for PWS.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25020106",
    "question": "Is bradycardia associated with future cardiovascular diseases and death in men from the general population?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if bradycardia (abnormally slow heart rate) is associated with future cardiovascular diseases and death in men from the general population. Based on medical research, bradycardia has been associated with increased risk of cardiovascular events and mortality in some studies, particularly in elderly populations. However, the relationship is complex and depends on many factors including the cause of bradycardia, presence of underlying heart disease, and other comorbidities. In healthy individuals, bradycardia can actually be a sign of good cardiovascular fitness (as seen in athletes). To answer accurately, I need to consider whether there is established evidence showing bradycardia as an independent risk factor for cardiovascular disease and death specifically in men from the general population. Research has shown that asymptomatic bradycardia in otherwise healthy men from the general population can be associated with increased risk of cardiovascular events and mortality in the long term, so the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20065775",
    "question": "Does propranolol reduce risk for acute stress disorder in pediatric burn trauma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if propranolol reduces risk for acute stress disorder in pediatric burn trauma. To answer this, I need to consider the evidence about propranolol's effects specifically on acute stress disorder in children with burn injuries. Propranolol is a beta-blocker that has been studied for various trauma-related conditions, including PTSD. However, for the specific combination of: 1) propranolol, 2) acute stress disorder (not PTSD), 3) pediatric population, and 4) burn trauma context, the evidence is limited. While some research suggests propranolol may help with physiological stress responses, the specific claim about reducing acute stress disorder risk in pediatric burn patients is not supported by robust clinical evidence. There are some studies examining propranolol for burn patients, but they typically focus on metabolic benefits rather than psychiatric outcomes, especially in children.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "12482822",
    "question": "Do plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether plasminogen activator inhibitor 1 (PAI-1) and vitronectin protect against stenosis in a murine carotid artery ligation model. To answer this, I need to consider what's known about these proteins in vascular remodeling and stenosis.\\n\\nPAI-1 is a serine protease inhibitor that inhibits tissue plasminogen activator (tPA) and urokinase (uPA), thus inhibiting fibrinolysis and promoting thrombosis. Vitronectin is an adhesive glycoprotein that binds to PAI-1 and stabilizes it.\\n\\nIn vascular injury models, PAI-1 is generally considered pro-stenotic rather than protective. It promotes smooth muscle cell migration and proliferation, and inhibits matrix degradation, all of which contribute to neointima formation and stenosis. \\n\\nVitronectin similarly tends to promote rather than protect against stenosis by binding to PAI-1 and enhancing its activity, as well as through its own pro-adhesive and pro-migratory effects on vascular cells.\\n\\nIn murine carotid artery ligation models specifically, studies have shown that PAI-1 deficiency reduces neointimal formation, suggesting that PAI-1 promotes rather than protects against stenosis. Similarly, vitronectin deficiency has been associated with reduced stenosis in vascular injury models.\\n\\nBased on the established roles of these proteins in vascular biology, they would be expected to promote rather than protect against stenosis in a murine carotid artery ligation model.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19619351",
    "question": "Does inadequate reporting of trials compromise the applicability of systematic reviews?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether the poor or incomplete reporting of clinical trials can undermine the usefulness or validity of systematic reviews. Systematic reviews aim to synthesize evidence from multiple studies to answer specific research questions, but they depend on having complete and accurate information from the original trials. If trials are inadequately reported (missing data, selective reporting of outcomes, lack of methodological details), then systematic reviews that include these trials may have compromised conclusions. The inadequate reporting would mean that systematic reviews cannot properly assess the quality of evidence, may miss important data, or may include biased results. So yes, inadequate reporting of trials does compromise the applicability of systematic reviews.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21811608",
    "question": "Does silencing nuclear pore protein Tpr elicit a senescent-like phenotype in cancer cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question. It's asking about the effect of silencing the nuclear pore protein Tpr on cancer cells, specifically whether this induces a senescent-like phenotype. Senescence refers to a state where cells stop dividing but remain metabolically active, often characterized by specific morphological and biochemical changes. To answer this, I need to recall what's known about Tpr's function and its relationship to cellular senescence in cancer cells. Based on research literature, silencing of the nuclear pore protein Tpr has indeed been shown to induce senescence-like phenotypes in cancer cells. Studies have demonstrated that Tpr depletion can lead to cell cycle arrest, morphological changes characteristic of senescence, and expression of senescence-associated markers in various cancer cell lines.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25387896",
    "question": "Does vitamin C treatment attenuate hemorrhagic shock related multi-organ injuries through the induction of heme oxygenase-1?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether vitamin C treatment reduces (attenuates) multi-organ injuries caused by hemorrhagic shock, specifically through a mechanism involving the induction of heme oxygenase-1 (HO-1). To answer this, I need to consider whether there is scientific evidence supporting this specific mechanism of action for vitamin C in hemorrhagic shock.\\n\\nHemorrhagic shock is a condition of reduced blood perfusion to tissues causing cellular damage. Vitamin C is an antioxidant that can have protective effects in various injury models. Heme oxygenase-1 is an enzyme that has cytoprotective effects and can be induced by various stimuli.\\n\\nThere is some research suggesting vitamin C has protective effects in hemorrhagic shock models, and separately, there is research on HO-1 induction being protective in hemorrhagic shock. However, to answer specifically whether vitamin C's protective effects in hemorrhagic shock are mediated through HO-1 induction requires studies that have directly investigated this pathway.\\n\\nBased on the scientific literature, there are indeed studies showing that vitamin C can induce HO-1 expression in certain conditions, and some research has specifically examined the relationship between vitamin C treatment, HO-1 induction, and protection against hemorrhagic shock-induced organ damage. For example, some studies have shown that vitamin C treatment increases HO-1 expression in hemorrhagic shock models and that this correlates with reduced organ injury. Some studies have even used HO-1 inhibitors to demonstrate that the protective effects of vitamin C are diminished when HO-1 activity is blocked.\\n\\nTherefore, there is scientific evidence supporting that vitamin C treatment can attenuate hemorrhagic shock related multi-organ injuries, at least partly through the induction of heme oxygenase-1.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21868505",
    "question": "Is the response of children with asthma to ambient particulate modified by tobacco smoke exposure?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether tobacco smoke exposure modifies (changes or affects) how children with asthma respond to ambient particulate matter (airborne particles in the environment). To answer this, I need to consider what scientific research shows about the interaction between tobacco smoke exposure and ambient particulate matter in children with asthma.\\n\\nBased on scientific literature, tobacco smoke exposure does appear to modify the response of asthmatic children to ambient particulate matter. Studies have shown that children with asthma who are also exposed to tobacco smoke (secondhand smoke) often have worse responses to ambient air pollution, including particulate matter. The combination of tobacco smoke exposure and ambient particulate matter can lead to increased asthma symptoms, more frequent exacerbations, and potentially more severe respiratory effects compared to exposure to particulate matter alone.\\n\\nThis is because tobacco smoke can damage the respiratory epithelium and increase airway inflammation, making the airways more sensitive to other environmental triggers like particulate matter. This represents a modification of the response pathway.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20649976",
    "question": "Do cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific mechanism of cannabinoids in breast cancer treatment. It's asking whether cannabinoids reduce the progression of ErbB2-driven breast cancer specifically through the inhibition of Akt (a protein kinase that plays a key role in multiple cellular processes). \\n\\nTo answer this accurately, I would need to be familiar with specific research on cannabinoids, their effects on ErbB2-positive breast cancer, and whether Akt inhibition is the confirmed mechanism of action. \\n\\nBased on scientific literature, there is evidence that cannabinoids can have anti-tumor effects in various cancer models, including breast cancer. Some studies have shown that cannabinoids can inhibit the PI3K/Akt pathway in cancer cells, which is often hyperactivated in ErbB2-positive breast cancers. A study published in Molecular Cancer Therapeutics (Caffarel et al., 2010) demonstrated that THC reduced ErbB2-driven breast cancer progression in mice and reduced Akt activation. \\n\\nSo there is scientific evidence supporting that cannabinoids can reduce ErbB2-driven breast cancer progression, and that Akt inhibition is one of the mechanisms involved.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24581847",
    "question": "Does long-term curcumin treatment antagonize masseter muscle alterations induced by chronic unpredictable mild stress in rats?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if long-term curcumin treatment antagonizes (counteracts or prevents) masseter muscle alterations that are induced by chronic unpredictable mild stress in rats. To answer this, I would need to know about specific research that has studied this particular relationship. The question is about a specific experimental finding regarding curcumin's effects on stress-induced changes in the masseter muscle (a jaw muscle) in rats. Without having specific research information about this particular relationship, I cannot definitively answer. However, based on my knowledge, curcumin has been studied for its anti-inflammatory and antioxidant properties in various stress models, but I don't have specific information about its effects on masseter muscle alterations induced by chronic unpredictable mild stress in rats.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27511354",
    "question": "Do apitherapy products enhance the recovery of CCL4-induced hepatic damages in rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether apitherapy products enhance the recovery of CCL4-induced hepatic damages in rats. Apitherapy refers to the use of bee products (like honey, propolis, royal jelly, bee venom) for medicinal purposes. CCL4 (carbon tetrachloride) is a chemical that is commonly used in experimental models to induce liver damage in rats. \\n\\nTo answer this question accurately, I would need to know if there are scientific studies showing that bee products help in the recovery of liver damage caused by CCL4 in rat models. Based on my knowledge, there are indeed several studies that have investigated the hepatoprotective effects of various bee products against CCL4-induced liver damage in rats. For example, propolis and honey have been shown to have antioxidant properties that can help protect against oxidative stress in the liver caused by CCL4. Some studies have demonstrated that these bee products can reduce liver enzyme levels, decrease lipid peroxidation, and improve histopathological changes in CCL4-damaged rat livers.\\n\\nSo based on the scientific literature, there is evidence supporting that apitherapy products can enhance recovery from CCL4-induced hepatic damage in rats.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16832679",
    "question": "Does the CYP2C8 inhibitor gemfibrozil increase the plasma concentrations of zopiclone?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to determine if gemfibrozil, which is a CYP2C8 inhibitor, increases plasma concentrations of zopiclone. To answer this, I need to know if zopiclone is metabolized by CYP2C8, and if inhibiting this enzyme would affect zopiclone's plasma levels.\\n\\nZopiclone is primarily metabolized by CYP3A4 and to a lesser extent by CYP2C8. Gemfibrozil is known to inhibit CYP2C8. When a drug's metabolizing enzyme is inhibited, it typically leads to increased plasma concentrations of that drug due to decreased clearance.\\n\\nHowever, since CYP2C8 is not the primary metabolic pathway for zopiclone (CYP3A4 is), the impact of gemfibrozil on zopiclone plasma concentrations might be limited. I need to check if there are specific studies showing this interaction.\\n\\nBased on pharmacological principles, gemfibrozil could potentially increase zopiclone plasma concentrations to some degree by inhibiting CYP2C8, but the clinical significance might be limited since CYP3A4 is the main metabolic pathway. Without specific clinical evidence showing this interaction, I cannot definitively say yes.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "24507408",
    "question": "Is hypertriglyceridemia associated with development of metabolic glucose disorders , irrespective of glucose and insulin levels : a 15-year follow-up study?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether hypertriglyceridemia (high levels of triglycerides in the blood) is associated with the development of metabolic glucose disorders, regardless of glucose and insulin levels, based on a 15-year follow-up study.\\n\\nTo answer this question accurately, I would need to know the specific findings of the 15-year follow-up study being referenced. The question itself appears to be asking about the conclusion of a specific research study, but doesn't provide the results of that study.\\n\\nWithout knowing the specific findings of the study mentioned, I cannot definitively answer whether hypertriglyceridemia was found to be associated with metabolic glucose disorders independent of glucose and insulin levels in that particular 15-year follow-up study.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "10867726",
    "question": "Is early non-elective readmission for chronic obstructive pulmonary disease associated with weight loss?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if early non-elective readmission for chronic obstructive pulmonary disease (COPD) is associated with weight loss. To answer this, I need to consider whether there is an established relationship between weight loss and patients with COPD being readmitted to the hospital soon after discharge (non-electively).\\n\\nBased on medical literature, weight loss is indeed a common issue in COPD patients and can be a marker of disease severity or exacerbation. Low body weight and weight loss are recognized risk factors for poor outcomes in COPD, including increased risk of exacerbations that may lead to hospital readmissions. Several studies have shown that malnutrition and weight loss in COPD patients are associated with higher rates of hospital readmission.\\n\\nTherefore, there is evidence supporting an association between weight loss and early non-elective readmission for COPD.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18823340",
    "question": "Does dual antiplatelet therapy unmask distinct platelet reactivity in patients with coronary artery disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether dual antiplatelet therapy (DAPT) unmasks distinct platelet reactivity in patients with coronary artery disease (CAD). To answer this, I would need to know if there is evidence showing that when patients with CAD are treated with DAPT (typically aspirin plus a P2Y12 inhibitor like clopidogrel), it reveals different patterns of platelet reactivity among these patients that weren't apparent before treatment. This would suggest heterogeneity in response to antiplatelet therapy among CAD patients. Without specific research data provided in the question, I cannot make a definitive determination about whether DAPT unmasks distinct platelet reactivity patterns in CAD patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24890041",
    "question": "Does combination of 9-aminoacridine with Campath-1H provide effective therapy for a murine model of adult T-cell leukemia?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific combination therapy for adult T-cell leukemia in a mouse model. Let me analyze what I know about these components:\\n\\n1. 9-aminoacridine: This is a chemical compound with some anticancer properties\\n2. Campath-1H: This is a monoclonal antibody (also known as alemtuzumab) used in treating some leukemias\\n3. Adult T-cell leukemia: A type of blood cancer\\n4. Murine model: Mouse model of the disease\\n\\nThe question asks if this specific combination provides effective therapy in this specific context. To answer definitively, I would need to know about studies that specifically tested this combination in this model. I don't have specific knowledge of research showing that this particular combination is effective for adult T-cell leukemia in mice. Without specific evidence supporting this claim, I cannot confirm it's effective.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15040015",
    "question": "Is downregulation of retinoic acid receptor-beta ( 2 ) expression linked to aberrant methylation in esophageal squamous cell carcinoma cell lines?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether downregulation of retinoic acid receptor-beta (2) expression is linked to aberrant methylation in esophageal squamous cell carcinoma cell lines. To answer this, I would need to know if there is scientific evidence establishing a connection between reduced RAR-β2 expression and abnormal DNA methylation patterns specifically in esophageal squamous cell carcinoma cells. This is a specific scientific question about cancer epigenetics. Based on the scientific literature, there is evidence that RAR-β2 is frequently silenced by promoter hypermethylation in various cancers including esophageal squamous cell carcinoma. Multiple studies have demonstrated that aberrant methylation of the RAR-β2 promoter is associated with its downregulation in ESCC cell lines, and that treatment with demethylating agents can restore its expression. This indicates a causal relationship between methylation and expression levels.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23835111",
    "question": "Does glycine administration attenuate skeletal muscle wasting in a mouse model of cancer cachexia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether glycine administration attenuates (reduces) skeletal muscle wasting in a mouse model of cancer cachexia. Cancer cachexia is a wasting syndrome characterized by loss of skeletal muscle mass. To answer this question, I need to recall whether there is evidence that glycine supplementation helps prevent muscle wasting specifically in mouse models of cancer cachexia.\\n\\nBased on my knowledge, there have been studies showing that glycine has anti-inflammatory properties and can have protective effects in various conditions. However, regarding the specific question of whether glycine administration attenuates skeletal muscle wasting in mouse models of cancer cachexia, I believe there is research supporting this. Studies have shown that glycine supplementation can reduce inflammation and oxidative stress in cancer cachexia models, which helps preserve muscle mass. There is evidence that glycine can activate anti-catabolic pathways and reduce muscle protein breakdown in cancer cachexia mouse models.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25772627",
    "question": "Does family Nurture Intervention in preterm infants alter frontal cortical functional connectivity assessed by EEG coherence?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if family Nurture Intervention in preterm infants alters frontal cortical functional connectivity as measured by EEG coherence. To answer this, I need to determine if there's evidence that this specific intervention changes brain connectivity patterns in the frontal cortex of preterm babies, specifically using EEG coherence as the measurement method. \\n\\nResearch has shown that family Nurture Intervention (FNI), which focuses on emotional connection between mothers and preterm infants, does impact brain development. Studies have demonstrated that FNI can alter EEG-based measures of cortical function in preterm infants, including frontal EEG coherence. Specifically, research has found that preterm infants who received FNI showed increased EEG coherence in frontal brain regions compared to those who received standard care, indicating changes in functional connectivity. This suggests that the emotional and sensory experiences provided through FNI can influence the development of neural circuits in the frontal cortex of preterm infants.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24518659",
    "question": "Is the mammalian target of rapamycin signalling pathway involved in osteoblastic differentiation of vascular smooth muscle cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the mammalian target of rapamycin (mTOR) signaling pathway is involved in osteoblastic differentiation of vascular smooth muscle cells (VSMCs). This is asking about a specific molecular pathway (mTOR) and its role in a specific cellular process (osteoblastic differentiation of VSMCs). \\n\\nBased on scientific literature, mTOR signaling is indeed involved in the osteoblastic differentiation of VSMCs. This process is relevant in vascular calcification, where VSMCs undergo phenotypic switching to osteoblast-like cells. Research has shown that mTOR signaling regulates this transdifferentiation process, and inhibition of mTOR (such as with rapamycin) can reduce vascular calcification by preventing this osteoblastic conversion of VSMCs. Multiple studies have demonstrated that the mTOR pathway plays a regulatory role in the osteogenic differentiation of VSMCs, particularly in pathological conditions like atherosclerosis and chronic kidney disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10649206",
    "question": "Does the free radical spin trap alpha-phenyl-tert-butyl nitrone attenuate the cerebral response to deep hypothermic ischemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether alpha-phenyl-tert-butyl nitrone (PBN), which is a free radical spin trap, attenuates (reduces or lessens) the cerebral response to deep hypothermic ischemia. To answer this, I need to consider whether there is evidence that PBN has this specific effect on the brain during deep hypothermic ischemic conditions.\\n\\nPBN is known to be a free radical scavenger that can protect against oxidative damage. Deep hypothermic ischemia refers to a condition where the brain experiences reduced blood flow (ischemia) during a state of significantly lowered body temperature (hypothermia).\\n\\nBased on scientific literature, PBN has been shown to have neuroprotective effects in various models of cerebral ischemia. It can reduce oxidative stress and subsequent damage in the brain following ischemic events. Studies have demonstrated that PBN can attenuate the cerebral response to ischemia, including when combined with hypothermia.\\n\\nSo yes, there is evidence supporting that alpha-phenyl-tert-butyl nitrone does attenuate the cerebral response to deep hypothermic ischemia.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27834153",
    "question": "Is childhood trauma associated with increased brain responses to emotionally negative as compared with positive faces in patients with psychotic disorders?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about a specific scientific finding: whether childhood trauma is associated with increased brain responses to emotionally negative faces compared to positive faces, specifically in patients with psychotic disorders. To answer this, I would need to know about research studies examining the relationship between childhood trauma, emotional face processing, and brain activity in psychotic disorder populations. Without specific research citations or knowledge of this particular finding, I cannot definitively answer. However, there is research showing that childhood trauma can alter emotional processing and brain responses to emotional stimuli, and that patients with psychotic disorders often show altered processing of emotional faces. The specific relationship asked about (increased brain response to negative vs. positive faces in trauma-exposed psychosis patients) is plausible based on broader research but I need to be careful not to assume the specific finding exists without evidence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16529628",
    "question": "Does fMRI show atypical language lateralization in pediatric epilepsy patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if functional Magnetic Resonance Imaging (fMRI) shows atypical language lateralization in pediatric epilepsy patients. To answer this, I need to consider what is known about language lateralization in epilepsy patients, particularly children.\\n\\nIn typical development, language functions are predominantly lateralized to the left hemisphere in most individuals. However, in epilepsy patients, particularly those with early-onset or left-hemisphere epilepsy, there can be reorganization of language functions.\\n\\nResearch has consistently shown that fMRI can detect atypical language lateralization (either right-hemisphere dominance or bilateral representation) in pediatric epilepsy patients at higher rates than in the general population. This is especially true for children with left-hemisphere seizure foci or early onset epilepsy, as the developing brain may reorganize language functions to protect them from seizure activity.\\n\\nMultiple studies have documented this phenomenon, with fMRI being one of the primary neuroimaging techniques used to assess language lateralization in epilepsy patients, including for pre-surgical planning.\\n\\nBased on the established literature, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10663278",
    "question": "Does out-of-hospital cardiac arrest increase soluble vascular endothelial adhesion molecules and neutrophil elastase associated with endothelial injury?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if out-of-hospital cardiac arrest increases soluble vascular endothelial adhesion molecules and neutrophil elastase associated with endothelial injury. To answer this, I need to consider what happens during cardiac arrest and subsequent reperfusion.\\n\\nDuring cardiac arrest, there is a period of ischemia (lack of blood flow) followed by reperfusion when circulation is restored. This ischemia-reperfusion injury is known to trigger inflammatory responses and endothelial activation/injury. \\n\\nResearch has shown that cardiac arrest and resuscitation lead to systemic inflammation and endothelial dysfunction. Specifically:\\n1. Soluble vascular endothelial adhesion molecules (like sVCAM-1, sICAM-1, sE-selectin) are known to increase as markers of endothelial activation and injury following cardiac arrest\\n2. Neutrophil elastase is released from activated neutrophils during the inflammatory response to ischemia-reperfusion and can contribute to endothelial damage\\n\\nMultiple studies have demonstrated elevated levels of these markers in post-cardiac arrest patients, indicating endothelial injury as part of the post-cardiac arrest syndrome.\\n\\nBased on the established scientific literature, out-of-hospital cardiac arrest does increase soluble vascular endothelial adhesion molecules and neutrophil elastase associated with endothelial injury.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17722861",
    "question": "Is the distribution of interstitial cells of Cajal in the ileum altered by infection with Schistosoma mansoni?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether the distribution of interstitial cells of Cajal (ICC) in the ileum is altered by infection with Schistosoma mansoni. To answer this, I would need specific scientific evidence about the effects of S. mansoni infection on ICC distribution in the ileum. ICC are important cells in the gastrointestinal tract that regulate motility. S. mansoni is a parasitic flatworm that causes schistosomiasis, which can affect various organs including the intestines. While S. mansoni infection can cause intestinal pathology, I don't have specific information about whether it alters ICC distribution in the ileum specifically. Without clear scientific evidence on this specific relationship, I cannot confidently answer yes.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "25204316",
    "question": "Do omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether omega-3 fatty acids have an inhibitory effect on the up-regulation of endothelial chemokines specifically in patients undergoing maintenance hemodialysis. To answer this, I would need to know if scientific studies have demonstrated this specific biochemical effect in this particular patient population. Endothelial chemokines are signaling proteins that can be involved in inflammation, and hemodialysis patients often have inflammatory conditions. Some studies have shown that omega-3 fatty acids have anti-inflammatory properties in various contexts, but I need to determine if there's specific evidence for this particular effect in hemodialysis patients. Based on medical literature, there is some evidence that omega-3 supplementation can reduce inflammatory markers in hemodialysis patients, including certain chemokines produced by endothelial cells, though the research is not conclusive across all studies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26471185",
    "question": "Does miR-449a suppress the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if miR-449a suppresses the epithelial-mesenchymal transition (EMT) and metastasis of hepatocellular carcinoma (HCC) by targeting multiple targets. To answer this, I need to consider what is known about miR-449a's role in HCC.\\n\\nmiR-449a is a microRNA that has been studied in various cancers. In hepatocellular carcinoma specifically, research has shown that miR-449a does indeed function as a tumor suppressor. Studies have demonstrated that miR-449a can inhibit EMT in HCC cells, which is a critical process for cancer metastasis. \\n\\nRegarding the 'multiple targets' aspect, miR-449a has been shown to target several genes in HCC including FOS, NOTCH1, MET, SIRT1, and others. By targeting these multiple genes, miR-449a can suppress various oncogenic pathways that contribute to EMT and metastasis in HCC.\\n\\nBased on the published literature, miR-449a does suppress EMT and metastasis of HCC by targeting multiple genes/pathways.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11422743",
    "question": "Does adenovirus-mediated transfer of the 39 kD receptor-associated protein increase fibrinolytic capacity?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether adenovirus-mediated transfer of the 39 kD receptor-associated protein (RAP) increases fibrinolytic capacity. Fibrinolytic capacity refers to the ability to break down blood clots through the process of fibrinolysis.\\n\\nTo answer this question, I need to consider what is known about RAP and its effects on fibrinolysis. The 39 kD receptor-associated protein (RAP) is known to be an antagonist of the LDL receptor family, including LRP (LDL receptor-related protein), which plays a role in the clearance of tissue-type plasminogen activator (tPA) and other fibrinolytic factors.\\n\\nResearch has shown that RAP can inhibit the binding of tPA to LRP, which would reduce tPA clearance and potentially increase its availability in circulation. This could theoretically enhance fibrinolytic capacity by increasing the amount of tPA available to break down fibrin clots.\\n\\nStudies have demonstrated that adenovirus-mediated gene transfer of RAP can indeed increase plasma levels of tPA and reduce its clearance, leading to enhanced fibrinolytic activity in experimental models.\\n\\nBased on the scientific literature, adenovirus-mediated transfer of RAP does increase fibrinolytic capacity by interfering with the clearance of fibrinolytic factors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12793902",
    "question": "Is elevated mammaglobin ( h-MAM ) expression in breast cancer associated with clinical and biological features defining a less aggressive tumour phenotype?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features that define a less aggressive tumor phenotype. To answer this, I need to consider what is known about mammaglobin expression in breast cancer and its correlation with tumor aggressiveness. Based on medical literature, mammaglobin (h-MAM) is indeed considered a marker that is often associated with better differentiated, less aggressive breast cancers. Studies have shown that elevated mammaglobin expression is frequently associated with estrogen receptor positivity, lower histological grade, and better prognosis - all features that characterize less aggressive breast cancer phenotypes. Therefore, the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23534327",
    "question": "Does adhesiveness of various glass ionomer cement in cavities treated with Carisolv?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether the adhesiveness of various glass ionomer cements is affected in cavities that have been treated with Carisolv (a chemomechanical caries removal agent). However, the question is incomplete or grammatically incorrect. It should be phrased as 'Does Carisolv treatment affect the adhesiveness of various glass ionomer cements in cavities?' or similar. As it stands, the question doesn't have a complete predicate - it asks 'does adhesiveness...' but doesn't complete what about the adhesiveness. Since this is not a properly formed yes/no question, I cannot provide a definitive yes or no answer based on the information given.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23895888",
    "question": "Is complete metabolic response uniformly predictive of complete pathologic response after induction therapy for esophageal cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if complete metabolic response (CMR) is uniformly predictive of complete pathologic response (CPR) after induction therapy for esophageal cancer. To answer this, I need to consider whether there is a perfect correlation between CMR and CPR in esophageal cancer patients who have undergone induction therapy.\\n\\nIn medical literature, while CMR (typically assessed by PET imaging) is associated with higher rates of CPR, the correlation is not perfect or uniform. Studies have shown that some patients with CMR on imaging still have residual cancer cells found during pathological examination after surgery. Conversely, some patients without CMR may achieve CPR.\\n\\nThe predictive value of CMR for CPR varies across studies, with sensitivity and specificity that are good but not perfect. This imperfect correlation is due to limitations in imaging resolution, heterogeneity of tumor biology, and other factors that affect treatment response.\\n\\nTherefore, CMR is not uniformly (meaning in all cases or with 100% accuracy) predictive of CPR after induction therapy for esophageal cancer.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "18596379",
    "question": "Do biocompatibility and permeability of dialyzer membranes affect anemia , erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis : a prospective cohort study from the J-DOPPS II study?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether a specific study (J-DOPPS II) found that dialyzer membrane properties (biocompatibility and permeability) affected three specific outcomes (anemia, erythropoietin dosage, or mortality) in a specific population (Japanese patients on chronic non-reuse hemodialysis). To answer this accurately, I would need to know the results of this specific study. Without having access to the J-DOPPS II study results, I cannot definitively say whether the study found such associations. The question is phrased as if asking about the findings of a specific research paper, not about general medical knowledge.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "25001935",
    "question": "Does [ Vimentin gene transfection promote the invasion of bladder cancer SW780 cells ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if Vimentin gene transfection promotes the invasion of bladder cancer SW780 cells. To answer this, I would need specific scientific evidence about the effect of Vimentin gene transfection on SW780 bladder cancer cells. Without being provided specific studies or data in the question, I cannot make a definitive scientific determination about this specific cellular mechanism. This is a specialized question in cancer biology that requires empirical evidence from research studies.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18589762",
    "question": "Does [ Orthogonal experiment of the extraction of triterpenoids from stem of Hyptis suaveolens with microwave ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is incomplete. It asks 'Does [ Orthogonal experiment of the extraction of triterpenoids from stem of Hyptis suaveolens with microwave ]?' but doesn't specify what the orthogonal experiment does or what property is being asked about. The question is missing a predicate - it states a subject (the orthogonal experiment) but doesn't ask anything specific about it. Without a complete question, I cannot provide a yes or no answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23073687",
    "question": "Is esophageal acid-clearance physiology altered after Nissen-Collis gastroplasty?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if esophageal acid-clearance physiology is altered after Nissen-Collis gastroplasty. Nissen-Collis gastroplasty is a surgical procedure that combines elements of Nissen fundoplication (wrapping the stomach around the lower esophagus) with a Collis gastroplasty (lengthening the esophagus using stomach tissue). This procedure is typically performed to treat severe gastroesophageal reflux disease (GERD) and hiatal hernia.\\n\\nTo answer this question accurately, I would need to know if research has shown changes in how the esophagus clears acid after this specific surgical procedure. The procedure does physically alter the gastroesophageal junction and is designed to prevent acid reflux, so it would be reasonable to expect some changes in acid clearance physiology.\\n\\nBased on general knowledge of antireflux surgeries, they typically improve acid clearance by reducing reflux events, but the specific effects of Nissen-Collis gastroplasty on esophageal acid-clearance physiology would require specific research evidence. Without citing specific studies, the most reasonable answer would be 'yes' since the procedure physically alters the anatomy of the gastroesophageal junction specifically to address acid reflux issues.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11921420",
    "question": "Are serum IFN-gamma and IL-10 levels associated with disease progression in non-obese diabetic mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the association between serum IFN-gamma and IL-10 levels and disease progression in non-obese diabetic (NOD) mice. NOD mice are a common animal model for type 1 diabetes research. To answer this question accurately, I need to consider what is known about these cytokines in this specific mouse model.\\n\\nIFN-gamma (interferon-gamma) is a pro-inflammatory cytokine, while IL-10 is generally an anti-inflammatory cytokine. In autoimmune diabetes models like NOD mice, these cytokines have been studied extensively.\\n\\nBased on the scientific literature, serum levels of IFN-gamma have been shown to increase during disease progression in NOD mice, consistent with the pro-inflammatory environment that contributes to beta cell destruction. Similarly, changes in IL-10 levels have been documented during the course of disease development in these mice.\\n\\nMultiple studies have demonstrated that these cytokines not only change during disease progression but are mechanistically linked to the pathogenesis of diabetes in NOD mice. Interventions that alter these cytokine levels can affect disease progression, further supporting their association with the disease process.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12451245",
    "question": "Does transfer of the interleukin-1 receptor antagonist gene into rat liver abrogate hepatic ischemia-reperfusion injury?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether transferring the interleukin-1 receptor antagonist gene into rat liver prevents (abrogates) hepatic ischemia-reperfusion injury. To answer this, I would need to know about specific research studies that tested this intervention. Without specific information about research findings on this topic, I cannot definitively answer whether this gene transfer abrogates (completely eliminates) hepatic ischemia-reperfusion injury in rats. The question is asking for a factual answer about a specific scientific finding that I don't have clear information about.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "10856468",
    "question": "Is zona pellucida binding improvement effect of different sperm preparation techniques related to changes in sperm motility characterizations?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the zona pellucida binding improvement effect of different sperm preparation techniques is related to changes in sperm motility characterizations. To answer this, I need to consider whether there's an established relationship between how sperm preparation techniques affect both zona pellucida binding ability and sperm motility parameters.\\n\\nZona pellucida binding is a critical step in fertilization where sperm must bind to the zona pellucida surrounding the oocyte. Sperm preparation techniques (like swim-up, density gradient centrifugation, etc.) are used in assisted reproduction to select better quality sperm.\\n\\nResearch has shown that these preparation techniques can improve both zona pellucida binding capacity and sperm motility parameters. Studies have demonstrated correlations between improved motility characteristics (like progressive motility, hyperactivation, velocity) and enhanced zona pellucida binding. The mechanisms behind this relationship include the fact that both properties depend on similar sperm functions - membrane integrity, capacitation status, and overall sperm quality.\\n\\nTherefore, the evidence supports that the improvement in zona pellucida binding seen with different sperm preparation techniques is indeed related to the changes these techniques induce in sperm motility characteristics.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "15238093",
    "question": "Does minimal erythema dose after multiple UV exposures depend on pre-exposure skin pigmentation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the minimal erythema dose (MED) after multiple UV exposures depends on pre-exposure skin pigmentation. MED is the minimum amount of UV radiation that produces redness (erythema) on the skin. \\n\\nAfter multiple UV exposures, the skin typically develops a tan, which is a protective mechanism. People with different pre-exposure skin pigmentation (different skin types according to the Fitzpatrick scale) have different baseline MEDs. Those with darker skin typically have higher baseline MEDs than those with lighter skin.\\n\\nHowever, the question specifically asks about MED after multiple exposures. Research shows that regardless of initial skin type, repeated UV exposure leads to skin thickening and increased melanin production, which increases the MED for subsequent exposures. The degree of this adaptation does depend on pre-exposure pigmentation, with darker skin types generally showing different patterns of adaptation than lighter skin types.\\n\\nSo yes, the minimal erythema dose after multiple UV exposures does depend on pre-exposure skin pigmentation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22612999",
    "question": "Do oV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if oV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma (HCC). To answer this, I need to consider what is known about oV6⁺ cells in HCC.\\n\\nOV6 is a marker for hepatic progenitor cells and has been identified as a marker for tumor-initiating cells in HCC. Research has shown that oV6⁺ cells in HCC possess stem cell-like properties, including self-renewal and tumorigenicity. Studies have demonstrated that oV6⁺ cells contribute to tumor growth, metastasis, and invasion in HCC. They have been associated with worse clinical outcomes and more aggressive tumor behavior.\\n\\nMultiple studies have shown that oV6⁺ cells promote epithelial-mesenchymal transition (EMT), which is a key process in tumor invasion and metastasis. They have also been shown to be resistant to conventional chemotherapy, contributing to tumor recurrence.\\n\\nBased on the scientific literature, oV6⁺ tumor-initiating cells do contribute to tumor progression and invasion in human hepatocellular carcinoma.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19610139",
    "question": "Do peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether there is a correlation between peripheral T-lymphocyte subpopulations and HBV viral load across different clinical stages of chronic hepatitis B virus (HBV) infection. To answer this, I need to consider whether research has established a relationship between these immune cell populations and the amount of virus in patients with chronic HBV.\\n\\nBased on immunology research, there is evidence that T-lymphocyte subpopulations (like CD4+, CD8+ T cells) do show alterations in chronic HBV infection, and these changes often correlate with viral load. Multiple studies have demonstrated that T-cell function, exhaustion, and subset distribution change with different viral loads and disease stages. Higher viral loads are typically associated with more pronounced T-cell dysfunction, and the recovery of T-cell function often correlates with reduction in viral load. Therefore, there is a correlation between these immune parameters and viral burden in chronic HBV infection.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25447587",
    "question": "Does endothelin-Bone morphogenetic protein type 2 receptor interaction induce pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific molecular interaction and its effects in pulmonary arterial hypertension (PAH). Let me analyze what's being asked:\\n\\nThe question asks if the interaction between endothelin and Bone morphogenetic protein type 2 receptor (BMPR2) induces pulmonary artery smooth muscle cell (PASMC) hyperplasia in PAH.\\n\\nBased on scientific literature, endothelin-1 is a potent vasoconstrictor that plays a role in PAH pathogenesis. BMPR2 mutations are associated with PAH, and loss of BMPR2 signaling can lead to abnormal PASMC proliferation. However, the direct interaction between endothelin and BMPR2 causing PASMC hyperplasia is not well-established in the scientific consensus.\\n\\nWhile both pathways are implicated in PAH, the specific interaction between endothelin and BMPR2 as a direct mechanism causing PASMC hyperplasia is not conclusively demonstrated in the literature. These appear to be separate pathways that both contribute to PAH pathophysiology rather than a direct interaction between endothelin and BMPR2 causing PASMC hyperplasia.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9292800",
    "question": "Is exacerbation of adjuvant arthritis by adrenalectomy associated with reduced leukocyte lipocortin 1?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific relationship between adrenalectomy (surgical removal of adrenal glands), adjuvant arthritis (an experimental form of arthritis), and lipocortin 1 levels in leukocytes (white blood cells). Specifically, it's asking if the worsening (exacerbation) of adjuvant arthritis that occurs after adrenalectomy is associated with reduced levels of lipocortin 1 in leukocytes. This is a very specific scientific question about a biochemical relationship. Without specific knowledge of this research, I cannot definitively answer whether this association exists in the scientific literature. This would require knowledge of specific studies on this relationship.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27385416",
    "question": "Do alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether alterations in alpha5* nicotinic acetylcholine receptors lead to behavioral and neural impairments that are dependent on the midbrain and hippocampus. To answer this, I need to consider what research shows about the relationship between alpha5* nicotinic acetylcholine receptors and these brain regions.\\n\\nResearch has shown that alpha5* nicotinic acetylcholine receptors are expressed in both the midbrain and hippocampus, and they play important roles in various cognitive and behavioral functions. Studies with knockout mice lacking the alpha5 subunit have demonstrated impairments in attention, memory, and other cognitive processes that are associated with midbrain and hippocampal function. Additionally, alterations in these receptors have been linked to changes in neural activity and synaptic plasticity in these brain regions.\\n\\nSpecifically, in the midbrain, alpha5* receptors modulate dopaminergic neurotransmission, which is critical for reward processing and motivated behaviors. In the hippocampus, these receptors contribute to learning and memory processes. When these receptors are altered (through genetic knockout, pharmacological manipulation, or other means), both behavioral deficits and neural abnormalities have been observed that are specifically linked to dysfunction in these brain regions.\\n\\nBased on the scientific literature, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23917393",
    "question": "Does gefitinib enhance the effects of combined radiotherapy and 5-fluorouracil in a colorectal cancer cell line?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if gefitinib enhances the effects of combined radiotherapy and 5-fluorouracil in a colorectal cancer cell line. To answer this, I need to determine if there is evidence that gefitinib (an EGFR inhibitor) potentiates or increases the effectiveness of the combination of radiation therapy and 5-FU specifically in colorectal cancer cells. Without specific research studies or data provided in the question, I cannot definitively confirm this specific three-way interaction. While gefitinib is known to enhance radiation sensitivity in some cancer types, and there are studies on combining EGFR inhibitors with chemoradiation, I don't have specific evidence about gefitinib enhancing the specific combination of radiotherapy and 5-FU in colorectal cancer cell lines.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22040028",
    "question": "Does satellite cell pool enhancement in rat plantaris muscle by endurance training depend on intensity rather than duration?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether satellite cell pool enhancement in rat plantaris muscle by endurance training depends on intensity rather than duration. To answer this, I need to consider what scientific research shows about the relationship between exercise intensity vs. duration and satellite cell activation in rat plantaris muscle specifically.\\n\\nSatellite cells are muscle stem cells that contribute to muscle repair and growth. The question is specifically about whether the intensity of endurance training is more important than the duration for increasing the satellite cell pool in the plantaris muscle of rats.\\n\\nBased on exercise physiology research, there is evidence that high-intensity training can stimulate satellite cell activation more effectively than low-intensity, longer duration training in some muscle types. However, without specific studies on rat plantaris muscle that directly compare intensity vs. duration effects on satellite cell pools, I cannot definitively say that intensity is more important than duration for this specific muscle in rats.\\n\\nThe research literature shows mixed results, with some studies suggesting intensity is key for satellite cell activation, while others indicate that duration also plays an important role. Without citing specific studies that directly address this question for rat plantaris muscle, I cannot confidently answer 'yes'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9934582",
    "question": "Is cathepsin D in host stromal cells associated with more highly vascular and aggressive invasive breast carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the relationship between cathepsin D in host stromal cells and the characteristics of invasive breast carcinoma. Specifically, it asks whether cathepsin D in stromal cells is associated with more highly vascular and aggressive forms of invasive breast carcinoma. To answer this, I need to consider what is known about cathepsin D, its presence in stromal cells (not cancer cells themselves but surrounding supportive tissue), and its relationship to tumor vascularity and aggressiveness in breast cancer. Cathepsin D is a lysosomal protease that has been studied in cancer contexts. Research has shown that cathepsin D expression in tumor-associated stromal cells can promote angiogenesis (formation of new blood vessels) and contribute to more aggressive tumor behavior in breast cancer. Studies have demonstrated that stromal cathepsin D is associated with increased tumor vascularity and more aggressive phenotypes in invasive breast carcinoma. Therefore, the answer appears to be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26911327",
    "question": "Does the broad-spectrum chemokine inhibitor NR58-3.14.3 modulate macrophage-mediated inflammation in the diseased retina?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the broad-spectrum chemokine inhibitor NR58-3.14.3 modulates macrophage-mediated inflammation in the diseased retina. To answer this, I need to consider whether there is evidence that this specific chemokine inhibitor (NR58-3.14.3) has been shown to affect macrophage-mediated inflammatory processes specifically in retinal disease models or conditions. Without specific knowledge of studies demonstrating this particular inhibitor's effects in the retina, I cannot confidently answer 'yes'. However, as a chemokine inhibitor, it's designed to block chemokine signaling which is involved in macrophage recruitment and activation in inflammatory conditions. There may be studies showing its effects in retinal inflammation, but I don't have definitive information about this specific compound in this specific context.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17908957",
    "question": "Is a novel nuclear factor-kappaB gene signature differentially expressed in head and neck squamous cell carcinomas in association with TP53 status?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether there is a novel nuclear factor-kappaB (NF-κB) gene signature that is differentially expressed in head and neck squamous cell carcinomas (HNSCC) depending on the TP53 status of the tumor. To answer this, I would need to know if research has identified such a signature that shows different expression patterns in TP53 wild-type versus TP53 mutant HNSCC. Without specific research information provided in the question, I need to determine if this is an established finding in the scientific literature. Based on existing research, there are indeed studies showing that NF-κB pathway genes show differential expression patterns in HNSCC that correlate with TP53 mutation status, as TP53 and NF-κB pathways have known regulatory interactions in cancer. Therefore, the answer appears to be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11378262",
    "question": "Is serum soluble transferrin receptor concentration an accurate estimate of the mass of tissue receptors?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if serum soluble transferrin receptor (sTfR) concentration accurately estimates the mass of tissue receptors. sTfR is a truncated form of the cellular transferrin receptor that is released into circulation. While sTfR levels do correlate with total body transferrin receptor mass and are used clinically to assess erythropoietic activity and iron status, they don't provide a direct, accurate measurement of the total mass of tissue receptors throughout the body. sTfR primarily reflects erythroid precursor activity rather than the total mass of all transferrin receptors in all tissues. Additionally, various factors like inflammation can affect the relationship between serum levels and tissue receptor mass.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15200455",
    "question": "Is subclinical atherosclerosis increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria when evaluated by intima-media thickness and pulse wave velocity. This is asking about a specific medical relationship between diabetes with microalbuminuria and atherosclerosis markers. Without specific medical studies or data provided in the question, I need to consider what's generally known in medical literature. Research has shown that both type 2 diabetes and microalbuminuria are independent risk factors for atherosclerosis, and when combined, they likely have a synergistic effect. Studies have demonstrated that diabetic patients with microalbuminuria typically show increased carotid intima-media thickness and higher pulse wave velocity compared to diabetic patients without microalbuminuria, indicating more advanced subclinical atherosclerosis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "14691415",
    "question": "Does triple antiplatelet therapy increase femoral access bleeding with vascular closure devices?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about whether triple antiplatelet therapy increases the risk of femoral access bleeding when vascular closure devices are used. Triple antiplatelet therapy typically refers to the combination of aspirin, a P2Y12 inhibitor (like clopidogrel), and another antiplatelet agent. These medications reduce blood clotting. Vascular closure devices are used to seal the arterial puncture site after catheterization procedures. The question is specifically about whether using triple antiplatelet therapy increases bleeding complications at femoral access sites when closure devices are used. To answer this accurately, I would need to know if studies have shown increased bleeding rates in this specific scenario. Based on general medical knowledge, more potent antiplatelet regimens typically increase bleeding risk, but the specific interaction with closure devices requires evidence from clinical studies. Without citing specific studies showing this relationship, I should be cautious in my answer.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "19073764",
    "question": "Does dipeptidyl peptidase IV inhibition with MK0431 improve islet graft survival in diabetic NOD mice partially via T-cell modulation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if dipeptidyl peptidase IV (DPP-IV) inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially through T-cell modulation. To answer this, I need to determine if there's evidence that MK0431 (a DPP-IV inhibitor) has this specific effect in this particular model.\\n\\nNOD mice are a model for type 1 diabetes, and islet transplantation is a potential therapy for diabetes. DPP-IV inhibitors are known to affect glucose metabolism by preventing the degradation of incretin hormones, but they may also have immunomodulatory effects.\\n\\nWithout specific research data on MK0431's effect on T-cell modulation in NOD mice with islet grafts, I cannot definitively answer. However, there are studies suggesting DPP-IV inhibitors may have immunomodulatory effects that could influence T-cell function, which could theoretically impact islet graft survival in this model. But I don't have enough information to confirm this specific mechanism for MK0431 in this specific model.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20595688",
    "question": "Are one-hour postload plasma glucose levels associated with kidney dysfunction?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if one-hour postload plasma glucose levels are associated with kidney dysfunction. To answer this, I need to consider whether there is established scientific evidence linking elevated glucose levels measured one hour after a glucose load (typically in a glucose tolerance test) with impaired kidney function.\\n\\nBased on medical literature, there is evidence that elevated postload glucose levels, including those measured at one hour, can be associated with kidney dysfunction. High glucose levels can damage kidney blood vessels and nephrons over time, leading to conditions like diabetic nephropathy. Several studies have shown that postload hyperglycemia, even in the pre-diabetic range, can be associated with early kidney function decline and albuminuria.\\n\\nSpecifically, one-hour postload glucose has been studied as a potential early marker for metabolic dysfunction, and some research has found associations between elevated one-hour glucose values and early kidney function abnormalities, even when fasting glucose and two-hour postload values are normal.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22296872",
    "question": "Does sexual dimorphism modulate the impact of cancer cachexia on lower limb muscle mass and function?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether sexual dimorphism (biological differences between males and females) affects how cancer cachexia (a wasting syndrome characterized by weight loss, muscle atrophy, and weakness in cancer patients) impacts lower limb muscle mass and function. To answer this, I need to consider whether there's evidence that the effects of cancer cachexia on leg muscles differ between men and women. Based on research in this area, there is evidence that sexual dimorphism does influence how cachexia affects muscle mass and function, with differences in muscle loss patterns and functional impairments between males and females. Studies have shown that hormonal differences, baseline muscle mass differences, and metabolic variations between sexes can lead to different cachexia presentations and severity in lower limb muscles.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21115136",
    "question": "Do radiological imaging and gastrointestinal tonometry add value in diagnosis of chronic gastrointestinal ischemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether radiological imaging and gastrointestinal tonometry add value in diagnosing chronic gastrointestinal ischemia. To answer this, I need to consider the diagnostic utility of these methods for this specific condition.\\n\\nRadiological imaging (such as CT angiography, MR angiography, or Doppler ultrasound) is widely used to visualize vascular abnormalities in the mesenteric arteries that can cause chronic gastrointestinal ischemia. These techniques can detect stenosis, occlusions, and other vascular pathologies that may lead to intestinal hypoperfusion.\\n\\nGastrointestinal tonometry is a technique that measures intraluminal PCO2 to assess mucosal perfusion and detect tissue hypoxia. It can provide functional information about intestinal blood flow and oxygenation.\\n\\nBased on medical literature, radiological imaging is considered essential in the diagnostic workup for chronic gastrointestinal ischemia, as it can directly visualize the vascular abnormalities. Gastrointestinal tonometry has been used as a functional test to complement anatomical imaging, though its routine clinical use has decreased in recent years with advances in imaging technology.\\n\\nOverall, radiological imaging definitely adds value in diagnosis. Gastrointestinal tonometry may add some functional information but is less widely used in current practice. Since at least one of these methods (radiological imaging) clearly adds diagnostic value, the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24875618",
    "question": "Do asthmatic airway epithelial cells differentially regulate fibroblast expression of extracellular matrix components?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether asthmatic airway epithelial cells have a different regulatory effect on fibroblasts specifically regarding their expression of extracellular matrix (ECM) components, compared to non-asthmatic airway epithelial cells. To answer this, I need to consider what's known in the scientific literature about the interaction between airway epithelial cells from asthmatic patients and fibroblasts.\\n\\nResearch has shown that in asthma, there is often airway remodeling which involves changes in the ECM composition. Studies have demonstrated that epithelial cells from asthmatic patients can release different mediators (cytokines, growth factors) that affect fibroblast behavior. Specifically, asthmatic epithelial cells have been shown to promote fibroblast proliferation and differentiation into myofibroblasts, which produce more ECM proteins like collagens, fibronectin, and proteoglycans. This differential regulation has been documented in multiple studies showing that conditioned media from asthmatic epithelial cells induces different ECM expression patterns in fibroblasts compared to media from healthy epithelial cells.\\n\\nBased on the scientific evidence, asthmatic airway epithelial cells do differentially regulate fibroblast expression of ECM components.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19752040",
    "question": "Does m-Calpain antagonize RhoA overactivation and endothelial barrier dysfunction under disturbed shear conditions?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if m-Calpain antagonizes (opposes or counteracts) RhoA overactivation and endothelial barrier dysfunction specifically under disturbed shear conditions. To answer this, I need to consider what is known about m-Calpain's role in relation to RhoA signaling and endothelial barrier function in the context of disturbed flow.\\n\\nFrom the scientific literature, m-Calpain (also called Calpain-2) is a calcium-dependent protease that has been shown to regulate RhoA activity in some contexts. Some studies have demonstrated that m-Calpain can cleave RhoA or its regulators, potentially affecting its activity. In the context of endothelial barrier function, there is evidence that m-Calpain can have protective effects against barrier dysfunction in some conditions.\\n\\nSpecifically regarding disturbed shear conditions (which refers to non-laminar, oscillatory blood flow patterns that can occur at vessel bifurcations and are associated with atherosclerosis), research has shown that m-Calpain does indeed antagonize RhoA overactivation. Under disturbed flow, RhoA can become hyperactivated, leading to endothelial barrier disruption, but m-Calpain serves as a protective mechanism by limiting this RhoA overactivation and helping to maintain barrier integrity.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22006355",
    "question": "Does liver-directed therapy for neuroendocrine neoplasm hepatic metastasis prolong survival following progression after initial surgery?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if liver-directed therapy for neuroendocrine neoplasm hepatic metastasis prolongs survival after progression following initial surgery. This is a specific medical question about treatment efficacy for a particular condition (neuroendocrine tumor metastasis to the liver) in a specific scenario (after initial surgery with subsequent progression). To answer this accurately, I would need to be familiar with current medical literature and clinical trials on this topic. While liver-directed therapies (which may include hepatic resection, ablation, embolization, or radioembolization) are used for neuroendocrine liver metastases, whether they specifically prolong survival after progression following initial surgery is a nuanced clinical question that would depend on multiple factors including tumor grade, extent of disease, patient performance status, and specific treatments used. Without being able to cite specific medical evidence, I cannot provide a definitive yes or no answer to this specialized oncology question.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24030400",
    "question": "Does toll-like receptor 4-dependent microglial activation mediate spinal cord ischemia-reperfusion injury?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if toll-like receptor 4 (TLR4)-dependent microglial activation mediates spinal cord ischemia-reperfusion injury. To answer this, I need to consider the scientific evidence about the role of TLR4 in microglial activation and whether this specific pathway contributes to spinal cord ischemia-reperfusion injury.\\n\\nBased on scientific literature, TLR4 is indeed implicated in microglial activation following various types of CNS injuries. In the specific context of spinal cord ischemia-reperfusion injury, research has shown that TLR4 signaling in microglia plays a critical role in the inflammatory response that exacerbates tissue damage. Studies have demonstrated that TLR4 knockout or inhibition reduces microglial activation and subsequent neuroinflammation after spinal cord ischemia-reperfusion, resulting in improved outcomes. The evidence supports that TLR4-dependent microglial activation is a key mediator in the pathophysiology of spinal cord ischemia-reperfusion injury.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23529586",
    "question": "Is tumor protein D54 a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if tumor protein D54 (TPD54) is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma (OSCC) cell lines. To answer this, I need to consider what's known about TPD54's function in OSCC specifically.\\n\\nBased on scientific literature, TPD54 (also known as TPD52L2) has been studied in various cancers, but its specific role as a negative regulator of extracellular matrix-dependent migration and attachment in OSCC cell lines is not well-established in mainstream research. Some studies have shown TPD52 family proteins can be involved in cancer progression, but the specific regulatory role of TPD54 on extracellular matrix interactions in OSCC cells would require specific research evidence.\\n\\nWithout clear evidence from published research showing TPD54 specifically functions as a negative regulator of these processes in OSCC cell lines, I cannot confirm this claim.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16950629",
    "question": "Is survival in elderly patients with severe aortic stenosis dramatically improved by aortic valve replacement : Results from a cohort of 277 patients aged > or =80 years?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement, specifically referring to results from a cohort study of 277 patients aged 80 years or older. To answer this question accurately, I would need to know the actual results of this specific study. Without having access to the study results, I cannot definitively say whether the study showed a dramatic improvement in survival or not. The question appears to be asking about the conclusion of a specific research paper, but doesn't provide the results.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24948542",
    "question": "Does valproic acid protect septic mice from renal injury by reducing the inflammatory response?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if valproic acid protects septic mice from renal injury by reducing the inflammatory response. To answer this, I would need specific scientific evidence from studies that have investigated this relationship. Without being provided specific research papers or studies that demonstrate valproic acid has this protective effect in septic mice through an anti-inflammatory mechanism, I cannot make a definitive claim. This is a specific scientific claim about a pharmacological mechanism that requires evidence from experimental studies.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12057717",
    "question": "Does n-acetyl-cysteine treatment improve insulin sensitivity in women with polycystic ovary syndrome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether n-acetyl-cysteine (NAC) treatment improves insulin sensitivity in women with polycystic ovary syndrome (PCOS). To answer this, I need to consider the research evidence on this specific relationship. Several studies have investigated NAC's effects on metabolic parameters in PCOS patients. Some research has shown that NAC supplementation can improve insulin sensitivity in women with PCOS by reducing insulin resistance and improving glucose metabolism. For example, some clinical trials have demonstrated that NAC treatment led to significant improvements in insulin sensitivity measures compared to placebo in PCOS patients. The mechanism may involve NAC's antioxidant properties and its ability to enhance insulin receptor activity. Based on the available evidence from multiple studies, there appears to be support for the claim that NAC treatment can improve insulin sensitivity in women with PCOS.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26857965",
    "question": "Is cochlear implantation a therapeutic option for superficial siderosis patients with sensorineural hearing loss?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if cochlear implantation is a therapeutic option for patients with superficial siderosis who have sensorineural hearing loss. Superficial siderosis is a rare condition characterized by hemosiderin deposition in the central nervous system, which can cause progressive sensorineural hearing loss among other symptoms. \\n\\nBased on medical literature, cochlear implantation has been reported as a treatment option for patients with superficial siderosis who develop severe to profound sensorineural hearing loss. While there may be challenges due to the nature of the condition (such as potential auditory nerve damage), several case reports and small studies have shown that cochlear implantation can provide benefit to these patients, though results may vary. The procedure is considered a viable intervention when conventional hearing aids no longer provide adequate benefit.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15700269",
    "question": "Does the expression of Bcl-2 family proteins differ between nonsmall cell lung carcinoma subtypes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the expression of Bcl-2 family proteins differs between nonsmall cell lung carcinoma (NSCLC) subtypes. To answer this, I need to consider what is known about Bcl-2 family protein expression patterns across different NSCLC subtypes such as adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.\\n\\nBased on scientific literature, there are indeed documented differences in Bcl-2 family protein expression between NSCLC subtypes. For example, studies have shown that Bcl-2 itself tends to be more frequently expressed in squamous cell carcinoma compared to adenocarcinoma. Other Bcl-2 family members like Mcl-1, Bax, and Bcl-xL also show variable expression patterns across different NSCLC histological subtypes. These differences in expression profiles can have implications for prognosis and treatment response in different NSCLC subtypes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20693182",
    "question": "Do sevoflurane and propofol anaesthesia differentially modulate the effects of epinephrine and norepinephrine on microcirculatory gastric mucosal oxygenation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether two different types of anesthesia (sevoflurane and propofol) have different effects on how epinephrine and norepinephrine influence microcirculatory gastric mucosal oxygenation. To answer this, I would need to know if research has shown differential modulation between these two anesthetics on how these catecholamines affect gastric mucosal blood flow and oxygenation. Based on medical literature, sevoflurane (an inhalational anesthetic) and propofol (an intravenous anesthetic) do have different mechanisms of action and hemodynamic effects. Research has shown that they can differentially affect microcirculation and how the body responds to vasopressors like epinephrine and norepinephrine. Studies have demonstrated that these anesthetics can have different impacts on splanchnic perfusion and gastric mucosal oxygenation when combined with catecholamines.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18183647",
    "question": "Do immature and mature neurons coexist among glial scars after rat traumatic brain injury?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether immature and mature neurons coexist among glial scars after rat traumatic brain injury. To answer this, I need to consider what happens in the brain after traumatic injury in rats. After traumatic brain injury, glial scars form as part of the healing process, primarily composed of reactive astrocytes and other glial cells. The question is specifically about whether both immature neurons (newly formed or neuroblasts) and mature neurons can be found within these scar regions. Based on research literature, there is evidence of some neurogenesis (formation of new neurons) after brain injury, and some studies have shown that both immature neurons (DCX+ cells) and surviving mature neurons can be found in and around glial scars after traumatic brain injury in rat models. So yes, both types of neurons can coexist in these regions, though the extent varies based on injury severity, time post-injury, and brain region.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15968736",
    "question": "Is expression of macrophage migration inhibitory factor associated with enhanced angiogenesis and advanced stage in gastric carcinomas?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the relationship between macrophage migration inhibitory factor (MIF) expression and two factors in gastric carcinomas: 1) enhanced angiogenesis and 2) advanced stage disease. To answer this, I need to consider whether scientific evidence supports these associations. MIF is a pro-inflammatory cytokine that has been implicated in various cancer processes. In gastric cancer specifically, research has shown that MIF expression is often upregulated and correlates with increased tumor angiogenesis (formation of new blood vessels) through pathways like VEGF. Studies have also demonstrated that higher MIF expression tends to correlate with more advanced TNM staging, lymph node metastasis, and poorer prognosis in gastric cancer patients. Based on the published literature, there appears to be evidence supporting both associations mentioned in the question.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21489707",
    "question": "Does fibroblast growth factor-peptide improve barrier function and proliferation in human keratinocytes after radiation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether fibroblast growth factor-peptide improves barrier function and proliferation in human keratinocytes after radiation. To answer this, I would need specific scientific evidence from research studies that have tested this relationship. Without having access to specific studies on this topic, I cannot definitively say whether fibroblast growth factor-peptide has this effect on human keratinocytes after radiation exposure. This would require knowledge of published research that has specifically examined this relationship.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18710421",
    "question": "Does laser-capture microdissection of oropharyngeal epithelium indicate restriction of Epstein-Barr virus receptor/CD21 mRNA to tonsil epithelial cells?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if laser-capture microdissection of oropharyngeal epithelium indicates that Epstein-Barr virus receptor/CD21 mRNA is restricted to tonsil epithelial cells. To answer this, I would need specific scientific information about studies that used laser-capture microdissection to examine CD21 mRNA expression patterns in oropharyngeal tissues. Without having specific research findings on this topic, I cannot definitively answer whether such studies have shown that CD21 mRNA is restricted only to tonsil epithelial cells versus being present in other oropharyngeal epithelial cells as well. This would be a specific scientific finding from research in virology and molecular biology.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25801583",
    "question": "Do inhalative IL-10 treatment after bilateral femoral fractures affect pulmonary inflammation in mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether inhalative IL-10 treatment after bilateral femoral fractures affects pulmonary inflammation in mice. To answer this, I need to consider what is known about IL-10, its anti-inflammatory properties, and whether there's evidence for its effects when administered via inhalation in the specific context of bilateral femoral fractures in mice.\\n\\nIL-10 is a well-known anti-inflammatory cytokine that can suppress inflammatory responses. Bilateral femoral fractures can lead to systemic inflammatory responses that may affect the lungs (trauma-induced pulmonary inflammation). \\n\\nWhile I don't have specific studies directly addressing this exact experimental setup, based on the known biology:\\n1. IL-10 has anti-inflammatory properties\\n2. Inhalative delivery would target the lungs directly\\n3. Systemic inflammation from bilateral femoral fractures could affect the lungs\\n\\nIt's reasonable that inhalative IL-10 treatment would affect (likely reduce) pulmonary inflammation in this mouse model. Without specific contradictory evidence, the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17044945",
    "question": "Does the stem cell factor/c-kit receptor pathway enhance proliferation and invasion of pancreatic cancer cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells. To answer this, I need to consider what is known about this signaling pathway in the context of pancreatic cancer.\\n\\nThe stem cell factor (SCF) is a cytokine that binds to the c-kit receptor (also known as CD117), which is a receptor tyrosine kinase. This pathway is known to play important roles in cell survival, proliferation, and migration in various cell types.\\n\\nIn the context of pancreatic cancer, several studies have indeed shown that the SCF/c-kit pathway can promote cancer cell proliferation and invasion. Research has demonstrated that c-kit is expressed in certain pancreatic cancer cell lines and patient samples, and that activation of this pathway can enhance growth and invasive properties of these cells. Some studies have shown that blocking this pathway can reduce pancreatic cancer cell proliferation and metastatic potential.\\n\\nBased on the scientific literature, the SCF/c-kit receptor pathway does appear to enhance proliferation and invasion of pancreatic cancer cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17570222",
    "question": "Does hepatocyte-specific IKK gamma/NEMO expression determine the degree of liver injury?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury. To answer this, I need to consider what scientific evidence shows about the relationship between NEMO (NF-κB essential modulator) expression in hepatocytes and liver injury severity.\\n\\nNEMO is a regulatory component of the IKK complex that activates NF-κB, which is involved in inflammation and cell survival pathways. Research has shown that NEMO plays a role in liver homeostasis and disease:\\n\\n1. Studies have demonstrated that hepatocyte-specific deletion of NEMO in mice leads to spontaneous liver damage, hepatocyte apoptosis, and can progress to hepatocellular carcinoma.\\n\\n2. The level of NEMO expression in hepatocytes has been shown to influence inflammatory responses and susceptibility to liver injury in various models.\\n\\n3. NEMO regulates NF-κB activation in response to various stimuli, and this pathway is crucial for determining outcomes in liver injury.\\n\\nBased on scientific literature, hepatocyte-specific NEMO expression does appear to be an important determinant of the degree of liver injury, though it's one of several factors that influence liver injury severity.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18836356",
    "question": "Does mR findings of exaggerated fluid in facet joints predict instability?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether MR findings of exaggerated fluid in facet joints predict instability. Let me analyze this based on medical literature.\\n\\nIn radiology, facet joint fluid is sometimes observed on MRI scans. Increased or exaggerated fluid within the facet joints has been associated with degenerative changes and can sometimes be seen in conditions like spondylolisthesis. Some studies have suggested a correlation between increased facet joint fluid and segmental instability, particularly in the lumbar spine.\\n\\nHowever, while there is some association, the presence of exaggerated fluid in facet joints alone is not considered a definitive predictor of instability. It's one of several findings that might suggest instability, but it needs to be correlated with clinical symptoms and other imaging findings. The sensitivity and specificity of this finding for predicting instability are not high enough to use it as a standalone predictor.\\n\\nSo while there may be an association, the evidence doesn't support using facet joint fluid as a reliable predictor of instability.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18231583",
    "question": "Are mHC-IIB filament assembly and cellular localization governed by the rod net charge?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between the rod net charge of mHC-IIB (myosin heavy chain IIB) and two specific properties: filament assembly and cellular localization. To answer this, I need to consider what scientific literature tells us about myosin IIB regulation.\\n\\nMyosin II is a motor protein that forms filaments, and its assembly and localization are regulated by various factors. The rod domain of myosin II contains coiled-coil structures that are important for filament assembly. Research has shown that the net charge of the rod domain is indeed a critical determinant of myosin II filament assembly. Specifically, the electrostatic interactions mediated by the charge distribution in the rod domain affect the assembly properties.\\n\\nFurthermore, studies have demonstrated that the rod net charge also influences the cellular localization of myosin II isoforms, including mHC-IIB. The charge characteristics affect interactions with other cellular components and regulatory proteins, thereby determining where in the cell the myosin filaments localize.\\n\\nBased on the scientific evidence, the rod net charge does govern both the filament assembly and cellular localization of mHC-IIB.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18066549",
    "question": "Do two peptides derived from ras-p21 induce either phenotypic reversion or tumor cell necrosis of ras-transformed human cancer cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if two peptides derived from ras-p21 induce either phenotypic reversion or tumor cell necrosis of ras-transformed human cancer cells. To answer this, I need to determine if there is evidence that peptides derived from the ras-p21 protein have these specific effects on human cancer cells that have been transformed by ras mutations.\\n\\nBased on scientific literature, there have been studies showing that certain peptides derived from ras-p21 can interfere with ras signaling and affect cancer cells. Some research has demonstrated that synthetic peptides derived from ras-p21 can induce phenotypic reversion (returning cancer cells to a more normal phenotype) or cause tumor cell necrosis (cell death) specifically in human cancer cells that have ras mutations.\\n\\nFor example, peptides that mimic regions of ras-p21 involved in protein-protein interactions have been shown to block oncogenic ras function and induce reversion of the transformed phenotype. Other studies have shown that certain ras-derived peptides can trigger cell death pathways in ras-dependent tumors.\\n\\nSo yes, there is scientific evidence supporting that specific peptides derived from ras-p21 can induce either phenotypic reversion or tumor cell necrosis in ras-transformed human cancer cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12504821",
    "question": "Do reactive oxygen species regulate FLICE inhibitory protein ( FLIP ) and susceptibility to Fas-mediated apoptosis in cardiac myocytes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether reactive oxygen species (ROS) regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes. To answer this, I need to determine if there is evidence in the scientific literature supporting this regulatory relationship specifically in cardiac myocytes.\\n\\nFLIP is known to be an inhibitor of Fas-mediated apoptosis by interfering with caspase-8 activation. ROS are known to regulate various cellular processes including apoptosis in many cell types.\\n\\nResearch has shown that in cardiac myocytes, oxidative stress and ROS can modulate apoptotic pathways. Several studies have demonstrated that ROS can regulate the expression and function of FLIP in various cell types, including cardiac myocytes, thereby affecting susceptibility to Fas-mediated apoptosis. For example, studies have shown that oxidative stress can downregulate FLIP expression, making cells more susceptible to Fas-mediated apoptosis. Specifically in cardiac myocytes, ROS have been shown to modulate FLIP levels and consequently affect Fas-mediated apoptotic signaling.\\n\\nBased on the scientific evidence, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23532119",
    "question": "Do loads worn by soldiers predict episodes of low back pain during deployment to Afghanistan?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether there is a predictive relationship between the loads carried by soldiers and the occurrence of low back pain episodes during deployment in Afghanistan. To answer this, I would need to know if research studies have established a causal or correlational relationship between soldier load weight and back pain incidents specifically in the Afghanistan deployment context. Without specific research data on this relationship, I cannot make a definitive claim. However, there is general evidence in military medicine that heavy loads carried by soldiers can contribute to musculoskeletal injuries including low back pain. The question specifically asks about prediction, which implies a statistical relationship where load characteristics can be used to forecast which soldiers will develop low back pain during deployment.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27585595",
    "question": "Are pAPP-A , IGFBP-4 and IGF-II secreted by human adipose tissue cultures in a depot-specific manner?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if pAPP-A, IGFBP-4, and IGF-II are secreted by human adipose tissue cultures in a depot-specific manner. To answer this, I need to consider whether there is evidence that these proteins are secreted differently depending on the specific adipose tissue depot (e.g., subcutaneous vs. visceral fat). Without specific scientific literature or data provided in the question, I cannot make a definitive determination about the depot-specific secretion patterns of these proteins from human adipose tissue cultures.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19426590",
    "question": "Does [ Human cytomegalovirus-encoded US28 stimulate the CREB related transcriptional activity ]?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether human cytomegalovirus-encoded US28 stimulates CREB-related transcriptional activity. To answer this, I need to determine if there is a known relationship between US28 (a protein encoded by human cytomegalovirus) and CREB (cAMP response element-binding protein) transcriptional activity. US28 is a G protein-coupled receptor encoded by human cytomegalovirus that has been shown to activate various signaling pathways. CREB is a transcription factor that regulates gene expression. Based on scientific literature, US28 has been demonstrated to activate several signaling pathways including those that can lead to CREB phosphorylation and activation. Studies have shown that US28 can stimulate CREB-dependent transcriptional activity through various mechanisms including activation of the Gq/PLC/PKC pathway and the p38/MAPK pathway, which ultimately leads to CREB phosphorylation and increased transcriptional activity.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16316324",
    "question": "Do glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. To answer this, I need to consider what is known about the mechanism of action of glucocorticoids on podocytes.\\n\\nGlucocorticoids are known to have protective effects on podocytes, which are specialized cells in the kidney's glomerular filtration barrier. Research has shown that glucocorticoids can stabilize the actin cytoskeleton in podocytes, which is crucial for maintaining their structure and function.\\n\\nStudies have demonstrated that glucocorticoids like dexamethasone can prevent podocyte damage and promote recovery after injury by preserving the actin cytoskeleton. This occurs through various mechanisms including inhibition of actin-disrupting pathways and promotion of actin-stabilizing proteins.\\n\\nThe specific mention of 'cultured murine podocytes' indicates this is referring to experimental evidence from mouse podocyte cell cultures, where this mechanism has been observed.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22768756",
    "question": "Is [ Indian Hedgehog signaling involved in the stretch induced proliferation of osteoblast ]?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if Indian Hedgehog (IHH) signaling is involved in stretch-induced proliferation of osteoblasts. To answer this, I need to consider what is known about IHH signaling in bone biology.\\n\\nIndian Hedgehog is a protein that plays a key role in bone development and growth. It's known to be involved in chondrocyte differentiation and proliferation in the growth plate. IHH signaling is also known to regulate osteoblast differentiation and bone formation.\\n\\nRegarding stretch-induced proliferation specifically, mechanical stimulation (including stretch) has been shown to promote osteoblast proliferation through various signaling pathways. Some studies have demonstrated that mechanical stimulation can activate Hedgehog signaling in bone cells.\\n\\nThere is evidence in the scientific literature that IHH signaling is indeed activated by mechanical stimulation in bone cells, and this activation contributes to osteoblast proliferation in response to mechanical stretch. For example, studies have shown that mechanical strain increases IHH expression in osteoblasts and that blocking IHH signaling can inhibit stretch-induced osteoblast proliferation.\\n\\nBased on the available scientific evidence, IHH signaling does appear to be involved in stretch-induced proliferation of osteoblasts.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23777281",
    "question": "Do self-assembled peptide amphiphiles function as multivalent binder with increased hemagglutinin affinity?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if self-assembled peptide amphiphiles function as multivalent binders with increased hemagglutinin affinity. To answer this, I need to consider what is known about peptide amphiphiles and their binding properties.\\n\\nPeptide amphiphiles are molecules that contain both hydrophobic and hydrophilic components and can self-assemble into various nanostructures. When these molecules self-assemble, they can present multiple binding sites, potentially enabling multivalent interactions.\\n\\nHemagglutinin is a protein found on the surface of influenza viruses that binds to sialic acid receptors on host cells. Multivalent binding to hemagglutinin is a strategy that has been explored to increase binding affinity through avidity effects.\\n\\nResearch has shown that self-assembled peptide amphiphiles can indeed function as multivalent binders, and some studies have demonstrated increased affinity for various targets through multivalency. Specifically for hemagglutinin, there are published studies showing that self-assembled peptide-based nanostructures can bind to hemagglutinin with enhanced affinity compared to their monomeric counterparts due to multivalent presentation of binding motifs.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19120432",
    "question": "Are the rapid-acting properties of insulin aspart preserved in elderly people with type 2 diabetes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the rapid-acting properties of insulin aspart are preserved in elderly people with type 2 diabetes. To answer this, I need to consider whether there is evidence that insulin aspart works differently in elderly populations compared to younger adults with type 2 diabetes.\\n\\nInsulin aspart is a rapid-acting insulin analog designed to have a quick onset of action. Based on pharmacokinetic studies, insulin aspart generally maintains its rapid-acting profile in elderly patients, though there may be some minor differences in absorption or clearance rates due to age-related physiological changes. Clinical studies have generally shown that the essential rapid-acting characteristics of insulin aspart are preserved in elderly populations, though dosing adjustments might be needed due to other factors like renal function changes with age.\\n\\nThe scientific literature supports that while some dose adjustments might be necessary, the fundamental rapid-acting pharmacological properties of insulin aspart remain intact in elderly patients with type 2 diabetes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26573601",
    "question": "Is epstein-Barr virus positivity , not mismatch repair-deficiency , a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if Epstein-Barr virus (EBV) positivity is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer, while mismatch repair-deficiency is not. To answer this, I need to determine if EBV positivity is associated with reduced risk of lymph node metastasis in this specific type of gastric cancer.\\n\\nBased on medical literature, EBV-positive gastric cancers generally have distinct clinicopathological features and often show a better prognosis than EBV-negative cases. Several studies have indicated that EBV-positive gastric cancers have a lower rate of lymph node metastasis compared to EBV-negative cases, particularly in early-stage disease. This suggests that EBV positivity may indeed be a favorable factor (meaning it's associated with lower risk) for lymph node metastasis.\\n\\nRegarding mismatch repair deficiency (dMMR or MSI-high), the evidence is more mixed, but some studies suggest it may also be associated with lower rates of lymph node metastasis, though perhaps not as consistently as EBV positivity.\\n\\nBased on current evidence, I would say yes, EBV positivity appears to be a favorable risk factor (associated with lower risk) for lymph node metastasis in early gastric cancer including submucosa-invasive cases.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15548496",
    "question": "Do polymorphisms in neprilysin gene affect the risk of Alzheimer 's disease in Finnish patients?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question asks about a specific genetic relationship: whether polymorphisms (genetic variations) in the neprilysin gene affect Alzheimer's disease risk specifically in Finnish patients. To answer this accurately, I would need to know about studies that have specifically examined this relationship in Finnish populations. Neprilysin (also known as NEP or MME) is an enzyme that degrades amyloid-beta peptides, which are implicated in Alzheimer's disease pathology. While there have been studies examining neprilysin gene polymorphisms in relation to Alzheimer's disease in various populations, I don't have specific information about studies that have confirmed this relationship specifically in Finnish patients. Without evidence of studies specifically examining this relationship in Finnish populations, I cannot confirm this as true.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15770432",
    "question": "Does n-2-mercaptopropionylglycine , a scavanger of reactive oxygen species , modify the early antiarrhythmic effect of ischaemic preconditioning in anaesthetised dogs?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if n-2-mercaptopropionylglycine (MPG), which is a scavenger of reactive oxygen species, modifies the early antiarrhythmic effect of ischemic preconditioning in anesthetized dogs. To answer this question, I would need specific experimental evidence about MPG's effect on ischemic preconditioning in dogs, particularly focusing on its antiarrhythmic effects. Without specific information from studies that tested this exact relationship, I cannot provide a definitive answer. The question is very specific about the compound (MPG), its mechanism (scavenging ROS), the specific effect (early antiarrhythmic effect), the intervention (ischemic preconditioning), and the model (anesthetized dogs). I don't have sufficient information to determine whether MPG modifies this specific effect in this specific model.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "20808074",
    "question": "Are alterations in arterial pressure in patients with Type 1 diabetes associated with long-term poor metabolic control and a more atherogenic lipid profile?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between alterations in arterial pressure in Type 1 diabetes patients and two factors: long-term poor metabolic control and a more atherogenic lipid profile. Let me analyze the medical literature on this topic.\\n\\nIn Type 1 diabetes, research has shown that hypertension (elevated arterial pressure) is often associated with diabetic nephropathy and poor glycemic control over time. Studies have demonstrated that patients with Type 1 diabetes who have poor long-term metabolic control (as measured by elevated HbA1c levels over years) tend to develop hypertension more frequently.\\n\\nRegarding the lipid profile, there is evidence that Type 1 diabetes patients with altered arterial pressure often exhibit dyslipidemia, including elevated LDL cholesterol, decreased HDL cholesterol, and increased triglycerides - collectively representing a more atherogenic lipid profile.\\n\\nMultiple longitudinal studies have confirmed these associations, showing that poor glycemic control contributes to both hypertension and dyslipidemia in Type 1 diabetes. The DCCT/EDIC studies and other major research have established these connections.\\n\\nBased on the established medical literature, the answer is yes - alterations in arterial pressure in Type 1 diabetes patients are associated with both long-term poor metabolic control and a more atherogenic lipid profile.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "14704627",
    "question": "Does protease inhibitor leupeptin attenuate myocardial stunning in rat heart?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the protease inhibitor leupeptin attenuates myocardial stunning in rat heart. To answer this, I need to consider what is known about leupeptin's effects on myocardial stunning specifically in rat heart models.\\n\\nLeupeptin is a protease inhibitor that inhibits serine and cysteine proteases. Myocardial stunning refers to the temporary contractile dysfunction that occurs after a brief period of ischemia followed by reperfusion, even when no irreversible damage has occurred.\\n\\nBased on scientific literature, leupeptin has been shown to have protective effects against ischemia-reperfusion injury in various experimental models. Specifically for rat heart models, studies have demonstrated that leupeptin can attenuate myocardial stunning by inhibiting proteolytic degradation of contractile proteins during reperfusion.\\n\\nThere are published studies showing that leupeptin administration before or during ischemia-reperfusion reduces the severity and duration of myocardial stunning in rat heart preparations, improving post-ischemic contractile recovery.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22433619",
    "question": "Does insulin sensitivity deteriorate after short-term lifestyle intervention in the insulin sensitive phenotype of obesity?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether insulin sensitivity deteriorates after short-term lifestyle intervention in individuals who have obesity but are insulin sensitive. To answer this, I need to consider what research shows about the effects of lifestyle interventions on insulin sensitivity in this specific phenotype of obesity. Some people with obesity maintain normal insulin sensitivity (the 'insulin sensitive phenotype of obesity'), and the question is asking if their insulin sensitivity gets worse after lifestyle interventions like diet and exercise changes. Based on medical literature, short-term lifestyle interventions typically improve or maintain insulin sensitivity rather than deteriorate it, even in those who are already insulin sensitive. There's no established evidence suggesting that lifestyle interventions would cause a deterioration in insulin sensitivity in this population.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16115318",
    "question": "Is chloroquine a potent inhibitor of SARS coronavirus infection and spread?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if chloroquine is a potent inhibitor of SARS coronavirus infection and spread. I need to consider what is known about chloroquine's effects on SARS coronavirus specifically.\\n\\nChloroquine is an antimalarial drug that has shown some antiviral properties in research. For the original SARS-CoV-1 outbreak in 2003, there were indeed laboratory studies showing that chloroquine could inhibit SARS-CoV-1 infection in cell cultures. A 2005 study published in Virology Journal reported that chloroquine was effective in inhibiting the infection and spread of SARS-CoV-1 in cell culture.\\n\\nHowever, I should note that laboratory effectiveness doesn't always translate to clinical effectiveness in humans. For SARS-CoV-2 (which causes COVID-19), despite early hope and some in vitro studies, subsequent clinical trials did not support chloroquine or hydroxychloroquine as effective treatments.\\n\\nBut the specific question is about the original SARS coronavirus, not COVID-19. Based on the laboratory evidence for SARS-CoV-1, I can say yes to this specific question.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23040930",
    "question": "Does double-balloon cervical ripening catheter work well as an intrauterine balloon tamponade in post-abortion massive hemorrhage?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a double-balloon cervical ripening catheter is effective when used as an intrauterine balloon tamponade specifically for massive hemorrhage following an abortion. \\n\\nCervical ripening catheters (like the Foley catheter or Cook double-balloon catheter) are primarily designed to mechanically dilate the cervix before labor induction or certain gynecological procedures. They are not specifically designed for treating postpartum or post-abortion hemorrhage.\\n\\nIntrauterine balloon tamponade devices used for postpartum hemorrhage are typically purpose-designed devices like the Bakri balloon, BT-Cath, Ebb balloon, or condom catheters in resource-limited settings. These are specifically designed with appropriate volumes, pressure tolerances, and drainage capabilities for treating uterine hemorrhage.\\n\\nWhile a cervical ripening catheter might theoretically provide some tamponade effect in an emergency, it would not be considered optimal or \\\"working well\\\" for this purpose because:\\n1. It's not designed for the appropriate pressure needed for effective tamponade\\n2. It may not have sufficient volume capacity\\n3. It lacks proper drainage channels for monitoring ongoing bleeding\\n4. Medical literature and guidelines do not generally recommend cervical ripening catheters for this purpose\\n\\nTherefore, a double-balloon cervical ripening catheter would not work well as an intrauterine balloon tamponade for post-abortion massive hemorrhage compared to purpose-designed devices.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19422391",
    "question": "Do the local anaesthetics proadifen and adiphenine inhibit nicotinic receptors by different molecular mechanisms?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question about the molecular mechanisms of proadifen and adiphenine in inhibiting nicotinic receptors.\\n\\nProadifen (also known as SKF-525A) is a non-specific cytochrome P450 inhibitor that can also act as a local anesthetic. Adiphenine is another local anesthetic compound.\\n\\nRegarding their mechanisms of action on nicotinic receptors specifically:\\n\\nProadifen has been shown to act as a non-competitive antagonist of nicotinic acetylcholine receptors. It appears to block the ion channel of the receptor in its open state.\\n\\nAdiphenine also inhibits nicotinic receptors, but from my knowledge, it acts through a similar non-competitive mechanism, also binding to sites within the ion channel.\\n\\nBased on the pharmacological literature, both compounds appear to inhibit nicotinic receptors through similar molecular mechanisms - they are both non-competitive channel blockers that bind within the ion pore rather than at the acetylcholine binding site.\\n\\nTherefore, they do not inhibit nicotinic receptors by different molecular mechanisms, but rather through similar mechanisms.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22704725",
    "question": "Is the tetravalent meningococcal serogroups A , C , W-135 , and Y tetanus toxoid conjugate vaccine immunogenic with a clinically acceptable safety profile in subjects previously vaccinated with a tetravalent polysaccharide vaccine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether the tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and has an acceptable safety profile in subjects who previously received a tetravalent polysaccharide vaccine. To answer this, I would need specific clinical trial or study data that evaluated this particular scenario. Without being provided with any specific study results or data in the question, I cannot make a determination about the immunogenicity or safety profile of this vaccine in the specified population. The question is asking for a factual medical conclusion that requires evidence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27366350",
    "question": "Does coconut water of different maturity stages ameliorate inflammatory processes in model of inflammation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if coconut water from different maturity stages has anti-inflammatory effects in inflammation models. To answer this, I need to consider if there's scientific evidence showing that coconut water at various maturity stages can reduce inflammatory processes in experimental models of inflammation. Based on existing research, coconut water does contain compounds with anti-inflammatory properties, and studies have shown that coconut water from different maturity stages (young, mature) can have varying bioactive compound profiles that may affect inflammatory pathways differently. Several studies have demonstrated that coconut water can reduce markers of inflammation in various experimental models, including reducing pro-inflammatory cytokines and oxidative stress. The maturity stage does appear to influence these anti-inflammatory effects, with some research suggesting that younger coconut water may have different anti-inflammatory properties compared to more mature coconut water.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26636887",
    "question": "Does early Axonal Area Measurement predict Early Nerve Regeneration Outcomes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if early axonal area measurement predicts early nerve regeneration outcomes. To answer this, I need to consider whether there is established evidence in neuroscience research that measuring axonal area in the early stages of nerve injury or repair can reliably predict how well nerves will regenerate in the early recovery phase. Without specific research studies cited in the question, I need to rely on general knowledge about nerve regeneration biomarkers. While axonal area measurement is a technique used in nerve research, whether it specifically predicts early regeneration outcomes is not universally established. There are many factors that influence nerve regeneration, and a single measurement may not be sufficient as a predictor. Without clear evidence supporting this specific predictive relationship, I cannot confidently answer 'yes'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26088875",
    "question": "Is distal 10q trisomy with copy number gain in chromosome region 10q23.1-10q25.1 : the Wnt signaling pathway the most pertinent to the gene content in the region of copy number gain : a case report?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking if a specific paper or case report is about distal 10q trisomy with copy number gain in chromosome region 10q23.1-10q25.1, and specifically if it focuses on the Wnt signaling pathway as being most pertinent to the gene content in that region. To answer this, I would need to know if there exists such a case report that makes this specific claim about the Wnt signaling pathway. Based on the phrasing, it seems like the question is asking if a specific title or content of a paper matches this description. Without having access to the specific paper being referenced, I cannot definitively confirm if this is an accurate description of an existing case report.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26913578",
    "question": "Does moderate increase of reactive oxygen species trigger meiotic resumption in rat follicular oocytes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if a moderate increase of reactive oxygen species (ROS) triggers meiotic resumption in rat follicular oocytes. To answer this, I need to consider what scientific literature says about the relationship between ROS and meiotic resumption specifically in rat oocytes.\\n\\nBased on scientific research, moderate increases in reactive oxygen species have been shown to play a signaling role in oocyte maturation in various species. In rats specifically, studies have demonstrated that a moderate increase in ROS levels can indeed trigger meiotic resumption in follicular oocytes. ROS act as secondary messengers in the signaling pathways that regulate the transition from meiotic arrest to meiotic resumption. This has been demonstrated through experiments where antioxidants that scavenge ROS can prevent spontaneous meiotic resumption, while controlled introduction of oxidative stress can promote it.\\n\\nTherefore, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20880265",
    "question": "Is vitamin D status in patients with MS negatively correlated with depression , but not with fatigue?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question. It's asking about the relationship between vitamin D status in multiple sclerosis (MS) patients and two different symptoms: depression and fatigue. Specifically, it's asking whether vitamin D status is negatively correlated with depression (meaning lower vitamin D levels are associated with higher depression) but NOT correlated with fatigue.\\n\\nTo answer this accurately, I would need to know the scientific evidence on these relationships. Based on my knowledge of the medical literature, there is some evidence suggesting that lower vitamin D levels in MS patients are associated with higher depression scores, indicating a negative correlation. However, there is also evidence suggesting that vitamin D status may be associated with fatigue in MS patients. Several studies have found correlations between lower vitamin D levels and increased fatigue in MS patients.\\n\\nSo the statement that vitamin D is negatively correlated with depression but NOT with fatigue in MS patients does not align with the scientific literature, which suggests potential correlations with both symptoms.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22703782",
    "question": "Does direct peritoneal resuscitation augment ileal blood flow in necrotizing enterocolitis via a novel mechanism?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if direct peritoneal resuscitation (DPR) augments ileal blood flow in necrotizing enterocolitis (NEC) via a novel mechanism. To answer this, I need to consider whether there is established evidence that DPR increases blood flow to the ileum in NEC cases through a mechanism that is considered novel or previously unrecognized. While DPR is a technique used in some critical care settings to improve perfusion, I don't have specific evidence that it has been proven to augment ileal blood flow in NEC through a novel mechanism. Without clear evidence supporting this specific claim about a novel mechanism for DPR in NEC, I should answer 'no'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25289633",
    "question": "Does stable metabolic disease on FDG-PET provide information on response to endocrine therapy for breast cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether stable metabolic disease on FDG-PET (fluorodeoxyglucose positron emission tomography) provides information on response to endocrine therapy for breast cancer. \\n\\nFDG-PET is an imaging technique that measures glucose metabolism in tissues, which can be used to assess tumor activity. 'Stable metabolic disease' means that the metabolic activity of the tumor has not significantly changed on PET imaging.\\n\\nEndocrine therapy is a treatment for hormone receptor-positive breast cancers that works by blocking hormonal stimulation of tumor growth.\\n\\nIf a tumor shows stable metabolic disease on FDG-PET after endocrine therapy, this would indeed provide information about the tumor's response to treatment. Specifically, it would indicate that the therapy has prevented progression of the disease (which would show as increased metabolic activity) but has not caused significant reduction in tumor activity (which would show as decreased metabolic activity). This stable state provides clinically relevant information about the efficacy of the endocrine therapy being used.\\n\\nSo yes, stable metabolic disease on FDG-PET does provide information on response to endocrine therapy for breast cancer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20003246",
    "question": "Do iL4 gene polymorphism and previous malaria experiences manipulate anti-Plasmodium falciparum antibody isotype profiles in complicated and uncomplicated malaria?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether IL4 gene polymorphism and previous malaria experiences affect anti-Plasmodium falciparum antibody isotype profiles in different types of malaria (complicated and uncomplicated). This is a specific scientific question about immunological mechanisms in malaria. Based on immunological research, IL4 (Interleukin-4) is known to influence antibody isotype switching, and previous malaria exposure can shape immune responses. There is evidence in the scientific literature that both IL4 gene polymorphisms and previous malaria experiences can indeed influence antibody responses to P. falciparum, including isotype profiles, which may differ between complicated and uncomplicated malaria cases.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19737889",
    "question": "Do occurrence of physiologic gaze-evoked nystagmus at small angles of gaze?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Physiologic gaze-evoked nystagmus refers to a normal phenomenon where the eyes show nystagmus (rhythmic, involuntary eye movements) when looking at extreme angles of gaze. This is a normal finding in healthy individuals and typically occurs only at extreme lateral gaze positions (30-40 degrees or more from primary position). At small angles of gaze, physiologic gaze-evoked nystagmus should not occur - its presence at small angles would be considered pathological rather than physiological. So the question is asking if normal/physiologic gaze-evoked nystagmus occurs at small angles of gaze, which it does not.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11580144",
    "question": "Does macrophage inflammatory protein-2 induced by TNF-alpha play a pivotal role in concanavalin A-induced liver injury in mice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if macrophage inflammatory protein-2 (MIP-2) induced by TNF-alpha plays a pivotal role in concanavalin A (Con A)-induced liver injury in mice. To answer this, I need to analyze what's known about the mechanism of Con A-induced liver injury.\\n\\nCon A is known to induce T-cell mediated hepatitis in mice, which serves as a model for autoimmune hepatitis. In this model, several inflammatory mediators are involved, including TNF-alpha, interferon-gamma, and various chemokines.\\n\\nWhile TNF-alpha is indeed a key mediator in Con A-induced liver injury, and MIP-2 (also known as CXCL2) can be induced by TNF-alpha, the question specifically asks if MIP-2 induced by TNF-alpha plays a 'pivotal role' in this model.\\n\\nBased on the scientific literature, while MIP-2 may be involved in the inflammatory cascade, it is not generally considered to play a 'pivotal' role in Con A-induced liver injury. The primary mediators are typically considered to be TNF-alpha, IFN-gamma, and IL-4, with neutrophil and T-cell recruitment being important processes. MIP-2 may contribute to neutrophil recruitment, but it's not typically characterized as a pivotal mediator in this specific model.\\n\\nWithout specific studies demonstrating that MIP-2 induced by TNF-alpha is essential for Con A-induced liver injury, I cannot confirm this specific mechanistic relationship as pivotal.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15833551",
    "question": "Does gene gun particle encoding preproenkephalin cDNA produce analgesia against capsaicin-induced bladder pain in rats?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether a gene gun particle encoding preproenkephalin cDNA produces analgesia (pain relief) against capsaicin-induced bladder pain in rats. To answer this, I would need to know about specific research studies that tested this exact scenario. Preproenkephalin is a precursor to enkephalins, which are endogenous opioid peptides that can have analgesic effects. Gene gun technology can be used to deliver genetic material into cells. Capsaicin is known to induce pain when applied to the bladder. However, without specific knowledge of studies testing this particular intervention for this specific pain model in rats, I cannot confidently answer yes or no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20704648",
    "question": "Is in non-severe hemophilia A the risk of inhibitor after intensive factor treatment greater in older patients : a case-control study?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if in non-severe hemophilia A, the risk of inhibitor after intensive factor treatment is greater in older patients, and specifically mentions this is based on a case-control study. This appears to be asking about the findings or conclusion of a specific research study. Without having access to the specific case-control study mentioned, I cannot determine whether the study found that older patients with non-severe hemophilia A have a greater risk of inhibitor development after intensive factor treatment. The question is phrased as if it's the title or research question of a study, rather than asking for general medical knowledge.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17911138",
    "question": "Does hormonal contraceptive use modulate the local inflammatory response to bacterial vaginosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question asks whether hormonal contraceptive use affects (modulates) the local inflammatory response to bacterial vaginosis (BV). To answer this, I need to consider the scientific evidence on this specific interaction. Bacterial vaginosis is a common vaginal condition characterized by an imbalance in the vaginal microbiota. The inflammatory response to BV involves various immune mediators. The question is specifically about whether hormonal contraceptives (like birth control pills, patches, rings, injections, etc.) can alter this inflammatory response.\\n\\nBased on scientific literature, there is evidence that hormonal contraceptives can influence vaginal immunity and inflammation. Studies have shown that hormonal contraceptives can affect cytokine production, immune cell function, and other aspects of the local immune response in the female reproductive tract. Specifically regarding BV, some research has demonstrated that hormonal contraceptive use can modify the inflammatory markers associated with BV infection. For example, certain studies have found differences in pro-inflammatory cytokine levels in BV-positive women who use hormonal contraceptives compared to non-users.\\n\\nSo yes, there is scientific evidence supporting that hormonal contraceptive use can modulate the local inflammatory response to bacterial vaginosis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11723024",
    "question": "Does adenovirus-mediated heme oxygenase-1 gene delivery inhibit injury-induced vascular neointima formation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. This is a specific scientific question about a gene therapy approach using adenovirus vectors to deliver the heme oxygenase-1 (HO-1) gene, and whether this therapy can prevent the formation of neointima (new inner tissue layer) in blood vessels following injury. To answer this accurately, I would need to be familiar with research studies on this specific gene therapy approach. Based on scientific literature, HO-1 has been shown to have vascular protective effects, and several studies have demonstrated that adenovirus-mediated delivery of HO-1 can indeed inhibit neointimal hyperplasia following vascular injury in experimental models. For example, research has shown that HO-1 overexpression via adenoviral vectors can reduce smooth muscle cell proliferation and migration, which are key processes in neointima formation after vascular injury.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24444138",
    "question": "Are insulin-induced changes in microvascular vasomotion and capillary recruitment associated in humans?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the association between insulin-induced changes in microvascular vasomotion and capillary recruitment in humans. To answer this, I need to consider whether scientific evidence supports a relationship between these two physiological processes.\\n\\nMicrovascular vasomotion refers to the rhythmic contraction and dilation of small blood vessels, while capillary recruitment refers to the opening of previously non-perfused capillaries to increase blood flow.\\n\\nResearch has shown that insulin does influence both microvascular vasomotion and capillary recruitment. Studies in humans have demonstrated that insulin administration leads to changes in vasomotion patterns and increases capillary recruitment. These effects appear to be related, as they share common signaling pathways (primarily involving nitric oxide) and both contribute to insulin's metabolic actions by enhancing nutrient and hormone delivery to tissues.\\n\\nMultiple studies have shown correlations between insulin-induced changes in vasomotion patterns and the degree of capillary recruitment, suggesting these processes are indeed associated in humans.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20007170",
    "question": "Is continuity of diabetes care associated with avoidable hospitalizations : evidence from Taiwan 's National Health Insurance scheme?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether continuity of diabetes care is associated with avoidable hospitalizations, specifically referring to evidence from Taiwan's National Health Insurance scheme. This appears to be asking about a specific research finding or study conducted in Taiwan that examined the relationship between continuous diabetes care and preventable hospital admissions. To answer this accurately, I would need to know if such a study exists and what its findings were. Since this is phrased as a yes/no question about a specific empirical finding, I should determine if there is evidence supporting this association in the Taiwan context.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25245822",
    "question": "Does predicting success in regulatory approval from Phase I result?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether it's possible to predict success in regulatory approval based on the results of Phase I clinical trials. Phase I trials are primarily focused on safety and dosage, not efficacy, which is more thoroughly evaluated in Phase II and Phase III trials. While Phase I results can provide some early indicators, they are generally insufficient to reliably predict ultimate regulatory approval, which depends on comprehensive efficacy and safety data from later-phase trials. Many drug candidates that pass Phase I safely still fail in later phases due to lack of efficacy or unexpected safety issues in larger populations.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19273710",
    "question": "Does dPC4 gene status of the primary carcinoma correlate with patterns of failure in patients with pancreatic cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the correlation between dPC4 gene status in primary pancreatic carcinoma and patterns of failure (disease progression/recurrence patterns) in pancreatic cancer patients. To answer this, I would need specific research data showing whether dPC4 gene status (likely referring to DPC4/SMAD4 gene deletion or mutation) has been demonstrated to predict or correlate with specific patterns of treatment failure or disease recurrence. Without specific studies cited in the question, I need to consider whether there is established evidence in medical literature for such a correlation. Based on pancreatic cancer research, there is evidence that DPC4/SMAD4 gene status does correlate with patterns of failure, with DPC4 loss being associated with more widespread metastatic patterns versus more localized progression in DPC4-intact tumors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25792465",
    "question": "Are human mast cells major IL-22 producers in patients with psoriasis and atopic dermatitis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis. To answer this, I need to consider what's known about IL-22 production in these skin conditions.\\n\\nIL-22 is a cytokine involved in inflammatory skin diseases. In psoriasis and atopic dermatitis, the main cellular sources of IL-22 are typically:\\n- T cells (particularly Th17 and Th22 cells)\\n- Innate lymphoid cells (ILCs, particularly ILC3s)\\n- Some NK cells\\n\\nWhile mast cells are important in skin immunity and can produce various cytokines, they are not generally recognized as major producers of IL-22 in these conditions. The primary IL-22 sources in both psoriasis and atopic dermatitis are specialized T cell subsets and ILCs.\\n\\nTherefore, human mast cells are not considered major IL-22 producers in patients with psoriasis and atopic dermatitis.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22698444",
    "question": "Does knee effusion affect knee mechanics and muscle activity during gait in individuals with knee osteoarthritis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether knee effusion (fluid accumulation in the knee joint) affects knee mechanics and muscle activity during gait (walking) specifically in individuals with knee osteoarthritis. To answer this, I need to consider what is known about the relationship between these factors.\\n\\nKnee effusion is common in knee osteoarthritis and can alter joint mechanics by increasing intra-articular pressure. Research has shown that effusion can lead to altered muscle activation patterns, particularly quadriceps inhibition. During gait, individuals with knee effusion often demonstrate altered knee kinematics including reduced knee flexion during stance phase, changed loading patterns, and compensatory mechanisms. These changes in mechanics and muscle activity are documented in the literature on knee osteoarthritis with effusion.\\n\\nBased on the established evidence in biomechanics and clinical research, knee effusion does affect both knee mechanics and muscle activity during gait in individuals with knee osteoarthritis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18036649",
    "question": "Do phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase regulate induction of Mcl-1 and survival in glucocorticoid-treated human neutrophils?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if phosphatidylinositol 3-kinase (PI3K) and p38 mitogen-activated protein kinase (p38 MAPK) regulate the induction of Mcl-1 and survival in glucocorticoid-treated human neutrophils. To answer this, I need to determine if there is evidence that these specific kinases (PI3K and p38 MAPK) are involved in regulating Mcl-1 expression and neutrophil survival specifically in the context of glucocorticoid treatment. This is a specific scientific question about molecular signaling pathways in neutrophils. Without specific scientific literature on this exact relationship, I cannot definitively answer. However, both PI3K and p38 MAPK are known to be involved in various cell survival pathways, and Mcl-1 is an anti-apoptotic protein. Glucocorticoids typically promote neutrophil survival. The question appears to be asking about a specific research finding, but I don't have enough information to confirm this particular regulatory relationship.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18004242",
    "question": "Do paclitaxel-octreotide conjugates inhibit growth of human non-small cell lung cancer cells in vitro?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"I need to determine if paclitaxel-octreotide conjugates inhibit growth of human non-small cell lung cancer cells in vitro. Let me analyze what I know about this topic.\\n\\nPaclitaxel is a chemotherapy drug that is known to inhibit cancer cell growth by stabilizing microtubules and preventing cell division.\\n\\nOctreotide is a somatostatin analog that can bind to somatostatin receptors which are overexpressed in some cancer cells.\\n\\nA conjugate of these two would potentially combine the cytotoxic effects of paclitaxel with the targeting ability of octreotide.\\n\\nBased on scientific literature, paclitaxel-octreotide conjugates have been studied and have shown inhibitory effects on the growth of various cancer cells that express somatostatin receptors, including human non-small cell lung cancer cells in vitro. Studies have demonstrated that these conjugates can effectively deliver paclitaxel to cancer cells and inhibit their growth in laboratory settings.\\n\\nTherefore, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10864607",
    "question": "Does cSF sulfatide distinguish between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether cerebrospinal fluid (CSF) sulfatide levels can be used as a biomarker to differentiate between two neurological conditions: normal pressure hydrocephalus (NPH) and subcortical arteriosclerotic encephalopathy (SAE, also known as Binswanger's disease). \\n\\nTo answer this, I need to consider whether there is established evidence that sulfatide levels in CSF show distinct patterns or concentrations between these two conditions that would allow them to be reliably distinguished from each other.\\n\\nBased on medical literature, sulfatide is a glycosphingolipid that is a major component of myelin. Some studies have investigated CSF biomarkers for various neurological conditions, but there isn't strong evidence that CSF sulfatide levels specifically can reliably distinguish between NPH and SAE. While both conditions may show white matter changes and potentially altered sulfatide metabolism, the current scientific consensus doesn't support using CSF sulfatide as a definitive diagnostic marker to differentiate between these two conditions.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18096057",
    "question": "Does the presence of beta2-adrenoceptors sensitize alpha2A-adrenoceptors to desensitization after chronic epinephrine treatment?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific interaction between beta2-adrenoceptors and alpha2A-adrenoceptors after chronic epinephrine treatment. Specifically, it's asking whether the presence of beta2-adrenoceptors makes alpha2A-adrenoceptors more susceptible to desensitization (reduced response) when exposed to epinephrine over a long period.\\n\\nTo answer this, I would need to know about research showing that beta2-adrenoceptors influence the desensitization process of alpha2A-adrenoceptors. Based on adrenergic receptor biology, these are different receptor subtypes with distinct signaling pathways, though they both respond to epinephrine.\\n\\nThere is research showing that chronic catecholamine exposure can lead to desensitization of various adrenergic receptors, but the specific cross-talk between beta2 and alpha2A receptors in terms of one sensitizing the other to desensitization is a more specific claim.\\n\\nFrom the literature I'm familiar with, there is evidence that beta2-adrenoceptors can indeed influence alpha2A-adrenoceptor function through heterologous desensitization mechanisms, where activation of one receptor type can affect the sensitivity of another receptor type. Studies have shown that chronic epinephrine treatment can lead to desensitization of alpha2A-adrenoceptors, and this effect is enhanced when beta2-adrenoceptors are present.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17418737",
    "question": "Does universal leukocyte reduction of transfused red cells provide benefit to patients undergoing cardiac surgery?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether universal leukocyte reduction of transfused red cells provides benefit to patients undergoing cardiac surgery. To answer this, I need to consider the evidence about leukocyte reduction in cardiac surgery specifically.\\n\\nLeukocyte reduction (also called leukodepletion) is a process where white blood cells are removed from blood products before transfusion. This has been implemented universally in many countries.\\n\\nFor cardiac surgery patients specifically, there have been studies examining whether leukocyte reduction provides benefits such as reduced postoperative infections, decreased inflammatory responses, lower mortality, or reduced length of hospital stay.\\n\\nThe evidence has been somewhat mixed, but several randomized controlled trials and meta-analyses have shown that leukocyte reduction can provide benefits to cardiac surgery patients, including reduced postoperative infections, decreased inflammatory responses, and potentially improved outcomes. Some studies have shown reductions in postoperative complications and shorter hospital stays.\\n\\nBased on this evidence, I would say that yes, universal leukocyte reduction does provide benefit to patients undergoing cardiac surgery.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "27154159",
    "question": "Does high-Dose Methylprednisolone have No Benefit Over Moderate Dose for the Correction of Tetralogy of Fallot?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether high-dose methylprednisolone has no benefit over moderate dose specifically for the correction of Tetralogy of Fallot (a congenital heart defect). This is a specific medical claim comparing two dosing regimens of a corticosteroid medication in a specific cardiac surgical procedure. To answer this accurately, I would need specific clinical trial data or meta-analyses comparing these exact dosing regimens for this specific procedure. Without having access to such specific medical research data, I cannot make a definitive claim about whether high-dose methylprednisolone offers benefits over moderate dose in this particular cardiac surgical context.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12006522",
    "question": "Does pamidronate induce modifications of circulating angiogenetic factors in cancer patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if pamidronate induces modifications of circulating angiogenetic factors in cancer patients. To answer this, I need to consider whether there is evidence that pamidronate (a bisphosphonate drug used to treat bone diseases) affects the levels or activity of angiogenetic factors (substances that promote blood vessel formation) in the bloodstream of cancer patients.\\n\\nBased on medical literature, pamidronate has been shown to have anti-angiogenic properties and can reduce levels of vascular endothelial growth factor (VEGF) and other angiogenetic factors in cancer patients, particularly those with bone metastases or multiple myeloma. Studies have demonstrated that pamidronate treatment can lead to decreased serum levels of these factors, which may contribute to its therapeutic effects beyond just protecting bone.\\n\\nTherefore, the evidence supports that pamidronate does induce modifications (specifically, reductions) of circulating angiogenetic factors in cancer patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21125395",
    "question": "Are follicle-stimulating hormone and bioavailable estradiol less important than weight and race in determining bone density in younger postmenopausal women?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the relative importance of different factors in determining bone density in younger postmenopausal women. Specifically, it's asking whether follicle-stimulating hormone (FSH) and bioavailable estradiol are less important than weight and race in this context.\\n\\nTo answer this accurately, I would need to know the scientific consensus based on research studies that have compared these factors. Without specific studies to reference, I cannot make a definitive claim about the relative importance of these factors.\\n\\nHowever, research has generally shown that weight (or body mass) is a strong predictor of bone density, with higher weight typically associated with higher bone density. Race is also known to be a significant factor, with some racial groups having higher average bone density than others. Hormonal factors like FSH and estradiol are certainly relevant in postmenopausal women, but their relative importance compared to weight and race would depend on specific research findings.\\n\\nWithout being able to cite specific comparative studies on this question, I cannot confidently say whether FSH and bioavailable estradiol are less important than weight and race for bone density in younger postmenopausal women.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15987444",
    "question": "Is increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if increased levels of phosphorylated Akt (as measured by chemiluminescence-linked immunosorbent assay) is a predictor of poor prognosis in primary breast cancer that overexpresses ErbB-2 (also known as HER2).\\n\\nTo answer this accurately, I would need specific research evidence about this relationship. Phosphorylated Akt (p-Akt) is involved in cell survival pathways, and ErbB-2/HER2 overexpression is known to be associated with more aggressive breast cancer. There is research suggesting that activation of the PI3K/Akt pathway (indicated by phosphorylated Akt) in HER2-positive breast cancers may be associated with worse outcomes, but I need to be careful about making a definitive statement without specific evidence about this exact relationship as measured by the specific assay mentioned.\\n\\nWithout being able to cite specific studies that have demonstrated this exact relationship using chemiluminescence-linked immunosorbent assay specifically, I cannot confidently answer 'yes.'\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15198290",
    "question": "Does growth hormone improve body composition and motor development in infants with Prader-Willi syndrome after six months?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if growth hormone improves body composition and motor development in infants with Prader-Willi syndrome after six months of treatment. To answer this, I need to consider what's known about growth hormone therapy in Prader-Willi syndrome (PWS). PWS is a genetic disorder that causes various issues including poor muscle tone, short stature, and excessive appetite. Growth hormone therapy is indeed used in PWS treatment. Research has shown that growth hormone treatment in infants with PWS can improve body composition (by increasing lean body mass and decreasing fat mass) and can enhance motor development within a six-month timeframe. Multiple clinical studies have demonstrated these benefits even within the relatively short period of six months after initiating treatment.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20413786",
    "question": "Does silencing nox4 in the paraventricular nucleus improve myocardial infarction-induced cardiac dysfunction by attenuating sympathoexcitation and periinfarct apoptosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the effects of silencing the nox4 gene specifically in the paraventricular nucleus (PVN) of the brain, and whether this intervention improves cardiac dysfunction after myocardial infarction (heart attack). The question specifies two potential mechanisms: 1) attenuating sympathoexcitation (reducing overactivity of the sympathetic nervous system) and 2) reducing periinfarct apoptosis (programmed cell death in the area surrounding the infarct).\\n\\nTo answer this, I would need to know if research has demonstrated that silencing nox4 in the PVN has these specific effects. Nox4 is an NADPH oxidase that generates reactive oxygen species, and it's involved in various cardiovascular conditions. The PVN is a region in the hypothalamus that regulates sympathetic outflow.\\n\\nBased on my knowledge, there is research showing that nox4-derived reactive oxygen species in the PVN contribute to sympathoexcitation after myocardial infarction, and that inhibiting nox4 in this region can reduce sympathetic overactivity and improve cardiac function post-MI. There is also evidence that this intervention can reduce apoptosis in the periinfarct zone. So the scientific literature supports this claim.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27554118",
    "question": "Is p21 Responsible for Ionizing Radiation-induced Bypass of Mitosis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if p21 is responsible for ionizing radiation-induced bypass of mitosis. To answer this, I need to consider what is known about p21's role in cell cycle regulation and DNA damage response. p21 (also known as CDKN1A) is a cyclin-dependent kinase inhibitor that can induce cell cycle arrest in response to DNA damage. Ionizing radiation causes DNA damage, which can activate p21 through p53-dependent pathways. When activated, p21 can cause G1 and G2 cell cycle arrest, preventing cells from entering mitosis until DNA damage is repaired. However, 'bypass of mitosis' typically refers to a process where cells skip mitosis entirely and proceed to the next G1 phase, becoming tetraploid. While p21 can cause cell cycle arrest, it is not typically characterized as the primary factor responsible for mitosis bypass. Other factors like p53 and specific checkpoint kinases play more direct roles in this phenomenon. Based on the scientific literature, p21 contributes to cell cycle arrest but is not solely responsible for ionizing radiation-induced bypass of mitosis.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25032732",
    "question": "Does cOUP-TFII regulate metastasis of colorectal adenocarcinoma cells by modulating Snail1?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific molecular mechanism in cancer biology. I need to determine if cOUP-TFII (chicken ovalbumin upstream promoter-transcription factor II) regulates metastasis of colorectal adenocarcinoma cells specifically by modulating Snail1 (a transcription factor involved in epithelial-mesenchymal transition).\\n\\nBased on scientific literature, cOUP-TFII (also known as NR2F2) is a nuclear receptor that has been implicated in various cancer processes including angiogenesis and metastasis. Snail1 is a key transcription factor that promotes epithelial-mesenchymal transition (EMT), which is important for cancer metastasis.\\n\\nThere is research showing that cOUP-TFII can regulate various aspects of cancer progression, including in colorectal cancer. However, the specific mechanism asking whether cOUP-TFII regulates metastasis of colorectal adenocarcinoma cells by modulating Snail1 requires specific evidence.\\n\\nFrom my knowledge, there are studies showing that cOUP-TFII can regulate EMT and metastasis in some cancers, and Snail1 is a key regulator of EMT. However, I don't have definitive evidence that cOUP-TFII specifically regulates metastasis of colorectal adenocarcinoma cells by modulating Snail1 expression or activity.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19191900",
    "question": "Is the Helicobacter hepaticus hefA gene involved in resistance to amoxicillin?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to determine if the Helicobacter hepaticus hefA gene is involved in resistance to amoxicillin. Let me analyze what is known about this gene:\\n\\nHelicobacter hepaticus is a bacterial species related to H. pylori but primarily infects the liver of mice. The hefA gene in Helicobacter species typically encodes an efflux pump protein.\\n\\nIn H. pylori, efflux pumps can contribute to antibiotic resistance, but the specific relationship between hefA in H. hepaticus and amoxicillin resistance is what I need to determine.\\n\\nBased on scientific literature, while hefA in Helicobacter species can be involved in resistance to some compounds, there isn't strong evidence specifically linking the H. hepaticus hefA gene to amoxicillin resistance. Amoxicillin resistance in Helicobacter species is more commonly associated with mutations in penicillin-binding proteins rather than efflux pumps.\\n\\nWithout specific research demonstrating that the hefA gene in H. hepaticus confers resistance to amoxicillin, I cannot confirm this relationship.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27171207",
    "question": "Does an Early Passage Human Isolate of Kyasanur Forest Disease Virus show Acute Neuropathology in Experimentally Infected CD-1 Mice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if an early passage human isolate of Kyasanur Forest Disease Virus (KFDV) shows acute neuropathology in experimentally infected CD-1 mice. To answer this, I would need specific research data about this particular virus isolate and its effects on CD-1 mice. Without specific information from research studies that tested this exact scenario, I cannot make a definitive determination. Kyasanur Forest Disease Virus is known to cause hemorrhagic fever in humans and can have neurological manifestations, but whether a specific early passage human isolate shows acute neuropathology specifically in CD-1 mice is a very specific research question that requires experimental evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20832034",
    "question": "Do [ Characterization and outcome of renal cancers ≤ 4cm treated by surgery ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if I, as an AI, do or perform 'Characterization and outcome of renal cancers ≤ 4cm treated by surgery'. This appears to be asking if I personally conduct medical procedures or research on small renal cancers. As an AI language model, I don't have a physical form and cannot perform medical procedures, surgeries, or clinical research. I can provide information about such topics, but I don't actually do the characterization or treatment of renal cancers myself.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21481861",
    "question": "Is trainee participation associated with increased small adenoma detection?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether trainee participation is associated with increased small adenoma detection. To answer this, I would need to know if there are studies or evidence showing that when trainees (likely medical trainees or residents) participate in procedures like colonoscopies, there is a higher rate of detecting small adenomas compared to when only experienced physicians perform the procedures. Without specific data or research findings provided in the question, I cannot make a definitive determination based on the information given.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25928815",
    "question": "Does neonatal isoflurane exposure induce neurocognitive impairment and abnormal hippocampal histone acetylation in mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if neonatal isoflurane exposure induces neurocognitive impairment and abnormal hippocampal histone acetylation in mice. To answer this, I need to consider whether there is scientific evidence supporting this claim. Based on research literature, isoflurane is a commonly used anesthetic, and there have been studies examining its effects on developing brains. Some research has shown that early exposure to anesthetics like isoflurane can affect neurodevelopment in animal models. Specifically, studies have demonstrated that neonatal isoflurane exposure in mice can lead to cognitive deficits and changes in hippocampal histone acetylation patterns, which is an epigenetic modification that can affect gene expression. These findings suggest that isoflurane exposure during critical developmental periods may have lasting effects on brain function and structure in mice.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15711457",
    "question": "Is the effect of monocularly and binocularly induced astigmatic blur on depth discrimination orientation dependent?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the effect of astigmatic blur on depth discrimination depends on orientation, specifically comparing monocular versus binocular conditions. To answer this, I need to consider research on astigmatic blur and depth perception. Astigmatism causes blur along specific meridians, and the question is asking if the orientation of this blur affects depth discrimination differently when presented to one eye versus both eyes. Research has shown that astigmatic blur does have orientation-dependent effects on visual tasks, and these effects can differ between monocular and binocular viewing conditions. Studies have demonstrated that the meridional orientation of astigmatic blur can differentially impact depth perception tasks, and this orientation dependency can manifest differently under monocular versus binocular viewing conditions.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27789279",
    "question": "Does conditioned medium of olfactory ensheathing cells promote the functional recovery and axonal regeneration after contusive spinal cord injury?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether conditioned medium of olfactory ensheathing cells (OECs) promotes functional recovery and axonal regeneration after contusive spinal cord injury. To answer this, I need to consider what research shows about OEC conditioned medium effects on spinal cord injury recovery.\\n\\nOlfactory ensheathing cells are specialized glial cells found in the olfactory system that have been studied for their potential in spinal cord injury treatment. The conditioned medium refers to the growth medium in which these cells have been cultured, which contains various secreted factors from the cells.\\n\\nResearch has shown that OECs can promote axonal regeneration and functional recovery after spinal cord injury through various mechanisms including secretion of neurotrophic factors, reduction of glial scarring, and promotion of remyelination. Studies have demonstrated that transplantation of OECs can improve outcomes after spinal cord injury.\\n\\nSpecifically regarding conditioned medium (without the cells themselves), there is evidence that OEC-conditioned medium contains neurotrophic factors and other beneficial molecules that can promote neuronal survival and axonal growth in vitro and in vivo. Several studies have shown that OEC-conditioned medium can promote axonal regeneration and functional recovery in models of spinal cord injury, including contusive injury models.\\n\\nBased on the scientific literature, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17031319",
    "question": "Is home-based antiretroviral care associated with positive social outcomes in a prospective cohort in Uganda?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if home-based antiretroviral care is associated with positive social outcomes in a prospective cohort in Uganda. To answer this, I would need specific research evidence from a prospective cohort study conducted in Uganda that examined social outcomes of home-based antiretroviral therapy. Without being provided specific study details or research findings, I cannot determine whether such an association exists in the specific context mentioned. The question is asking about empirical research findings from a specific study, not a general opinion about whether home-based care might theoretically have benefits.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23086649",
    "question": "Does [ Sevoflurane preconditioning produce delayed cardioprotection effect through up-regulation of inducible nitric oxide synthase in rats ]?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether sevoflurane preconditioning produces delayed cardioprotection effect through up-regulation of inducible nitric oxide synthase in rats. This appears to be a specific scientific claim about a mechanism of action. Without specific scientific evidence or studies that confirm this exact relationship, I cannot definitively answer. However, the question is phrased as if it's referencing a specific research finding or paper title. If this is indeed a published finding, then the answer would be 'yes'. Since the question is formatted like a research paper title in brackets, I'll assume it's referring to an established scientific finding.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15886906",
    "question": "Are sentinel nodes identifiable in formalin-fixed specimens after surgeon-performed ex vivo sentinel lymph node mapping in colorectal cancer?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether sentinel nodes can be identified in formalin-fixed specimens after a specific procedure called 'surgeon-performed ex vivo sentinel lymph node mapping' in colorectal cancer cases. To answer this, I need to consider whether the dyes or tracers used in sentinel lymph node mapping remain visible after formalin fixation, and whether the surgeon's ex vivo mapping technique allows for identification after fixation. Based on medical literature, most sentinel node mapping techniques use dyes or radioactive tracers that can be affected by formalin fixation. Ex vivo mapping is done on the freshly resected specimen before fixation. Once the specimen is fixed in formalin, the dyes may fade or diffuse, making precise identification of sentinel nodes difficult. However, some studies have shown that if the sentinel nodes are properly marked or tagged before fixation, they can still be identified after fixation. Without specific information about the particular technique and marking method used, I cannot give a definitive answer, but generally, identification becomes more challenging after formalin fixation if special precautions aren't taken.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26836898",
    "question": "Does reduced Antiviral Interferon Production in Poorly Controlled Asthma be Associated With Neutrophilic Inflammation and High-Dose Inhaled Corticosteroids?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if reduced antiviral interferon production in poorly controlled asthma is associated with neutrophilic inflammation and high-dose inhaled corticosteroids. This is asking about a specific scientific relationship in asthma pathophysiology. To answer this accurately, I would need to know if research has established this connection. There is evidence in the scientific literature that high-dose inhaled corticosteroids can suppress interferon production, and that neutrophilic inflammation is a feature of some forms of poorly controlled asthma. The relationship between these factors has been studied, and research suggests there is indeed an association between reduced interferon responses, neutrophilic inflammation, and high-dose steroid use in certain asthma phenotypes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19515609",
    "question": "Do multiplex PCR tests sentinel the appearance of pandemic influenza viruses including H1N1 swine influenza?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if multiplex PCR tests can detect or monitor ('sentinel') the emergence of pandemic influenza viruses, specifically mentioning H1N1 swine influenza. Multiplex PCR tests are designed to simultaneously detect multiple pathogens or multiple strains of a pathogen in a single test. For influenza surveillance, multiplex PCR assays are indeed commonly used to detect various influenza subtypes, including pandemic strains like H1N1. These tests are a key component of influenza surveillance systems that monitor for the emergence and spread of novel influenza viruses. Multiplex PCR tests can detect the genetic material of influenza viruses and distinguish between different subtypes, making them effective tools for sentinel surveillance of pandemic influenza viruses including H1N1 swine influenza.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10947143",
    "question": "Does a systematic review of troponin T and I value as a prognostic tool for patients with chest pain?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a systematic review exists that evaluates troponin T and I as a prognostic tool for patients with chest pain. A systematic review is a type of research that comprehensively analyzes multiple studies on a specific topic. Troponin T and I are cardiac markers used to diagnose heart attacks and assess cardiac damage. The question doesn't specify a particular systematic review, but is asking if such a review exists or has been conducted. Without specific information about an actual systematic review on this topic, I cannot confirm its existence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20352385",
    "question": "Is femoral head-neck junction deformity related to osteoarthritis of the hip?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if femoral head-neck junction deformity is related to osteoarthritis of the hip. Based on medical literature, there is evidence supporting this relationship. Femoral head-neck junction deformities, such as those seen in femoroacetabular impingement (FAI), particularly cam-type deformities, have been associated with an increased risk of hip osteoarthritis. These deformities can lead to abnormal contact between the femoral head and acetabulum during hip movement, resulting in labral and cartilage damage over time, which can progress to osteoarthritis. Multiple studies have demonstrated this association, suggesting that these anatomical abnormalities are indeed risk factors for the development of hip osteoarthritis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23280292",
    "question": "Does contributions of aircraft arrivals and departures to ultrafine particle count near Los Angeles International Airport?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether aircraft arrivals and departures contribute to ultrafine particle count near Los Angeles International Airport. This is asking about a causal relationship between aircraft operations and air pollution measurements. Based on scientific research, aircraft operations do generate ultrafine particles through jet engine exhaust, and these particles can be measured in higher concentrations near airports. Multiple studies have documented elevated ultrafine particle counts in communities surrounding LAX that correlate with flight operations. So aircraft arrivals and departures do contribute to ultrafine particle counts near LAX.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18682975",
    "question": "Is expression of the SST receptor 2 in uveal melanoma a prognostic marker?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the expression of SST receptor 2 (somatostatin receptor 2) in uveal melanoma serves as a prognostic marker. To answer this, I would need to know if there is established evidence in medical literature that shows a correlation between SST receptor 2 expression levels and clinical outcomes in patients with uveal melanoma. Without specific knowledge of studies demonstrating this relationship, I cannot confidently say whether SST receptor 2 expression is a validated prognostic marker for uveal melanoma. Based on my knowledge limitations, I cannot provide a definitive answer to this specific medical question.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "12752815",
    "question": "Does starch in plasterboard sustain Streptomyces californicus growth and bioactivity of spores?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether starch in plasterboard (also known as drywall or gypsum board) can support the growth and bioactivity of Streptomyces californicus spores. Streptomyces californicus is a species of bacteria in the genus Streptomyces. To answer this question accurately, I need to consider whether there is scientific evidence showing that starch in plasterboard specifically serves as a nutrient source for this particular bacterial species. While plasterboard can contain starch as a binding agent, and many microorganisms can utilize starch as a carbon source, I don't have specific information about S. californicus using starch in plasterboard as a growth substrate. Without specific research evidence on this particular interaction, I cannot confirm this relationship.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24231599",
    "question": "Do patients with type 1 diabetes oxidize fat at a greater rate than age- and sex-matched controls?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about metabolic differences between patients with type 1 diabetes and matched controls, specifically regarding fat oxidation rates. Type 1 diabetes is characterized by insulin deficiency, which affects metabolic pathways. In the absence of sufficient insulin, the body tends to break down fat for energy more readily, resulting in increased lipolysis and fat oxidation. This is particularly evident during periods of poor glycemic control. Research has generally shown that patients with type 1 diabetes do have higher rates of fat oxidation compared to matched controls without diabetes, especially in uncontrolled states. This is part of the metabolic adaptation to insulin deficiency, where the body shifts from primarily using glucose as fuel to increasing reliance on fat metabolism.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18505764",
    "question": "Does extended-release metformin reduce the clomiphene citrate dose required to induce ovulation in polycystic ovary syndrome?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether extended-release metformin reduces the required dose of clomiphene citrate needed to induce ovulation in patients with polycystic ovary syndrome (PCOS). To answer this, I would need to know if there is clinical evidence showing that when extended-release metformin is used alongside clomiphene citrate in PCOS treatment, a lower dose of clomiphene citrate is effective compared to when clomiphene citrate is used alone. Based on medical literature, metformin (including extended-release formulations) is sometimes used as an adjunct therapy in PCOS to improve insulin sensitivity, which may enhance ovulation induction. However, whether it specifically reduces the required dose of clomiphene citrate is a more specific claim that would require evidence from clinical trials. Without specific studies showing dose reduction, I cannot definitively say yes.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "12945087",
    "question": "Is l-arginine-induced relaxation of the internal anal sphincter mediated by nitric oxide?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if l-arginine-induced relaxation of the internal anal sphincter is mediated by nitric oxide. L-arginine is a precursor to nitric oxide (NO) synthesis in the body, and NO is known to be a mediator of smooth muscle relaxation in various tissues. The internal anal sphincter is a smooth muscle structure. Research has shown that NO is indeed a major inhibitory neurotransmitter in the gastrointestinal tract, including the internal anal sphincter. Studies have demonstrated that l-arginine administration can lead to relaxation of the internal anal sphincter through the NO pathway. This occurs because l-arginine serves as a substrate for nitric oxide synthase (NOS), which converts it to NO, leading to smooth muscle relaxation. So based on established physiological mechanisms and research, l-arginine-induced relaxation of the internal anal sphincter is mediated by nitric oxide.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "22562022",
    "question": "Does selective ablation of peptide YY cells in adult mice reveal their role in beta cell survival?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if selective ablation of peptide YY cells in adult mice reveals their role in beta cell survival. To answer this, I need to determine if there is scientific evidence showing that when peptide YY (PYY) cells are selectively removed or destroyed in adult mice, this reveals information about how these cells affect the survival of beta cells (insulin-producing cells in the pancreas).\\n\\nWithout specific scientific literature references in the question, I cannot definitively state whether such experiments have been conducted and what they revealed. This is a very specific scientific question about experimental results that would require knowledge of particular research studies. I don't have enough information to determine if selective ablation of PYY cells has revealed their role in beta cell survival.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21981454",
    "question": "Does tRPV1 and TRPA1 stimulation induce MUC5B secretion in the human nasal airway in vivo?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if tRPV1 and TRPA1 stimulation induce MUC5B secretion in the human nasal airway in vivo. To answer this, I need to consider whether there is established scientific evidence showing that stimulation of these specific receptors (tRPV1 and TRPA1) leads to MUC5B mucin secretion specifically in human nasal airways in actual living subjects (in vivo). \\n\\nTRPV1 (transient receptor potential vanilloid 1) and TRPA1 (transient receptor potential ankyrin 1) are ion channels that can be activated by various irritants and inflammatory mediators. MUC5B is a gel-forming mucin that is a major component of airway mucus.\\n\\nWhile there is research on TRP channels in respiratory physiology and mucin production, I don't have specific evidence confirming that stimulation of these particular receptors definitively induces MUC5B secretion in human nasal airways in vivo. Without clear scientific evidence establishing this specific relationship in human subjects, I cannot confirm this as factual.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21474813",
    "question": "Does c-reactive protein level measurement improve mortality prediction when added to the spontaneous intracerebral hemorrhage score?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether adding c-reactive protein (CRP) level measurement to the spontaneous intracerebral hemorrhage (ICH) score improves mortality prediction. To answer this, I need to know if there's evidence that CRP levels provide additional prognostic value beyond what the standard ICH score already captures. The ICH score is a clinical grading scale used to predict 30-day mortality after intracerebral hemorrhage. Without specific research evidence showing that CRP improves this prediction model, I cannot definitively say yes. However, there are studies that have investigated inflammatory markers including CRP as potential prognostic factors in ICH. Some research suggests that elevated CRP levels are associated with poor outcomes in ICH patients, but whether this specifically improves the ICH score's predictive ability requires specific validation studies. Based on my knowledge, while CRP may be a prognostic marker, I don't have conclusive evidence that it significantly improves the established ICH score's mortality prediction.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22028224",
    "question": "Does toll-like receptor 4 contribute to poor outcome after intracerebral hemorrhage?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether toll-like receptor 4 (TLR4) contributes to poor outcomes after intracerebral hemorrhage (ICH). To answer this, I need to consider the scientific evidence about TLR4's role in ICH pathophysiology.\\n\\nTLR4 is a pattern recognition receptor involved in innate immunity and inflammatory responses. Research has shown that TLR4 becomes activated after ICH and contributes to inflammatory damage. Multiple studies have demonstrated that TLR4 activation after ICH leads to increased neuroinflammation, blood-brain barrier disruption, brain edema, and neuronal death - all of which contribute to worse functional outcomes.\\n\\nStudies using TLR4 knockout mice or TLR4 antagonists have shown improved outcomes after experimental ICH, supporting TLR4's detrimental role. Clinical studies have also found associations between TLR4 polymorphisms or expression levels and outcomes in ICH patients.\\n\\nBased on the scientific literature, there is substantial evidence that TLR4 signaling contributes to secondary brain injury and poor outcomes after ICH.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11821718",
    "question": "Does cilnidipine improve spontaneously hypertensive rat coronary hemodynamics without altering cardiovascular mass and collagen?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if cilnidipine improves coronary hemodynamics in spontaneously hypertensive rats without affecting cardiovascular mass and collagen. To answer this, I need to know if cilnidipine has these specific effects. Cilnidipine is a calcium channel blocker used to treat hypertension. Based on pharmacological knowledge, calcium channel blockers can improve hemodynamics, but the specific question about cilnidipine's effect on spontaneously hypertensive rats while not altering cardiovascular mass and collagen requires specific research evidence. Without access to specific studies on this particular effect of cilnidipine in this specific rat model, I cannot confidently answer yes or no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25733469",
    "question": "Is a healthy diet associated with less endothelial dysfunction and less low-grade inflammation over a 7-year period in adults at risk of cardiovascular disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between a healthy diet and two specific health markers (endothelial dysfunction and low-grade inflammation) over a 7-year period, specifically in adults who are at risk of cardiovascular disease.\\n\\nTo answer this, I need to consider what scientific evidence shows about this relationship. Generally, research does support that healthier diets (such as Mediterranean diet, DASH diet, or diets rich in fruits, vegetables, whole grains, and lean proteins) are associated with improved endothelial function and reduced inflammatory markers. These improvements can occur over time, including over periods of several years.\\n\\nFor adults at risk of cardiovascular disease specifically, dietary interventions are often studied as potential ways to improve vascular health and reduce inflammation, which are important factors in cardiovascular risk.\\n\\nBased on the scientific consensus, a healthy diet is indeed associated with less endothelial dysfunction and less low-grade inflammation over time, including over periods like 7 years, in populations at risk of cardiovascular disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27482349",
    "question": "Does colchicine protect rat skeletal muscle from ischemia/reperfusion injury by suppressing oxidative stress and inflammation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if colchicine protects rat skeletal muscle from ischemia/reperfusion injury by suppressing oxidative stress and inflammation. To answer this, I need to consider whether there is established scientific evidence showing that colchicine has this specific protective effect in rat skeletal muscle through these particular mechanisms.\\n\\nColchicine is an anti-inflammatory medication that inhibits microtubule polymerization and is used to treat gout and other inflammatory conditions. There have been studies examining its effects in various ischemia/reperfusion models, including cardiac tissue.\\n\\nHowever, without specific knowledge of studies demonstrating this particular effect in rat skeletal muscle models, I cannot confidently say 'yes'. The question asks about a specific mechanism (suppressing oxidative stress and inflammation) in a specific tissue (rat skeletal muscle) for a specific injury model (ischemia/reperfusion).\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26153118",
    "question": "Is prominent coronary artery flow with normal coronary artery anatomy a rare but ominous harbinger of poor outcome in the fetus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether prominent coronary artery flow with normal coronary artery anatomy is a rare but ominous sign of poor outcomes in fetuses. To answer this, I need to consider what medical literature indicates about this specific condition. Prominent coronary artery flow in a fetus with otherwise normal coronary anatomy is indeed considered an abnormal finding. It's typically associated with conditions that cause increased cardiac work or myocardial ischemia, such as severe aortic stenosis, pulmonary atresia with intact ventricular septum, or hypoplastic left heart syndrome. When this finding is present without structural abnormalities, it often indicates significant myocardial dysfunction or impending fetal heart failure. Medical literature does describe this as a rare finding that is associated with poor fetal outcomes, including progression to hydrops fetalis and fetal demise. So yes, this is considered a rare but concerning prognostic indicator.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20727886",
    "question": "Is abdominal visceral adipose tissue volume associated with increased risk of erosive esophagitis in men and women?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in both men and women. To answer this, I need to consider whether there's established evidence linking visceral fat (fat around internal organs in the abdomen) specifically to erosive esophagitis (inflammation and damage to the esophagus lining). \\n\\nVisceral adipose tissue has been linked to various metabolic disorders and inflammatory conditions. Erosive esophagitis is often associated with gastroesophageal reflux disease (GERD). Research has shown that abdominal obesity, particularly visceral fat, is a risk factor for GERD and its complications including erosive esophagitis. This association has been demonstrated in multiple studies across both male and female populations, though the strength of association may vary by sex. The mechanism likely involves increased intra-abdominal pressure affecting the lower esophageal sphincter function and potentially inflammatory mediators released by visceral fat.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24857926",
    "question": "Is spectrogram screening of adult EEGs sensitive and efficient?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the sensitivity and efficiency of spectrogram screening for adult EEGs. To answer this, I need to consider what evidence exists about this specific screening method for electroencephalograms in adults. Spectrograms are visual representations of the spectrum of frequencies in EEG signals as they vary with time. While spectrograms are used in EEG analysis, whether they are specifically 'sensitive and efficient' as a screening tool requires evidence from clinical studies. Based on my knowledge, while spectrograms can be useful in EEG analysis, there isn't conclusive evidence that spectrogram screening alone is both highly sensitive (able to correctly identify abnormalities) and efficient (quick, cost-effective, with minimal false positives) compared to comprehensive EEG interpretation by specialists. The question asks for both sensitivity AND efficiency to be confirmed.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12068244",
    "question": "Is ethanol sensitivity in ATP-gated P2X receptors subunit dependent?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if ethanol sensitivity in ATP-gated P2X receptors is subunit dependent. To answer this, I need to consider whether different P2X receptor subunits (P2X1-P2X7) respond differently to ethanol exposure. Based on research in this area, studies have shown that ethanol modulation of P2X receptor function varies significantly depending on the subunit composition. For example, P2X2 and P2X3 receptors show different sensitivity to ethanol, with P2X3 being more sensitive in some studies. P2X4 receptors are potentiated by ethanol at low concentrations but inhibited at higher concentrations. The heteromeric P2X2/3 receptors show different ethanol sensitivity compared to homomeric receptors. This differential response to ethanol based on subunit composition indicates that ethanol sensitivity in ATP-gated P2X receptors is indeed subunit dependent.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18945790",
    "question": "Does intra-arterial nicardipine infusion improve CT perfusion-measured cerebral blood flow in patients with subarachnoid hemorrhage-induced vasospasm?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether intra-arterial nicardipine infusion improves CT perfusion-measured cerebral blood flow in patients with subarachnoid hemorrhage-induced vasospasm. To answer this, I need to consider the medical evidence about nicardipine's effects when administered intra-arterially for cerebral vasospasm following subarachnoid hemorrhage, specifically looking at whether CT perfusion measurements show improved blood flow.\\n\\nNicardipine is a calcium channel blocker that can cause vasodilation, and it is sometimes used to treat cerebral vasospasm. When administered intra-arterially (directly into the affected arteries), studies have shown that it can effectively reduce angiographic vasospasm. However, the specific question asks about CT perfusion-measured cerebral blood flow improvements.\\n\\nBased on medical literature, intra-arterial nicardipine has been shown to improve angiographic vasospasm and can increase cerebral blood flow as measured by various techniques including CT perfusion in patients with subarachnoid hemorrhage-induced vasospasm. Studies have demonstrated that after intra-arterial nicardipine administration, there are measurable improvements in cerebral perfusion parameters on CT perfusion imaging.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10559732",
    "question": "Does occlusal refinement of mounted cast before crown fabrication to decrease clinical time required to adjust occlusion?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether occlusal refinement of mounted casts before crown fabrication reduces the clinical time needed to adjust the occlusion later. Occlusal refinement of mounted casts involves adjusting the bite relationship on dental models before the actual crown is made. This process allows the dental technician to create a crown that better matches the patient's bite from the start. When done properly, this pre-fabrication adjustment should result in a crown that requires less chairside adjustment when it's placed in the patient's mouth. So yes, occlusal refinement of mounted casts before crown fabrication does typically decrease the clinical time required to adjust occlusion when the crown is delivered to the patient.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19826522",
    "question": "Does calcium phosphate ceramics as bone graft substitute in filling bone tumor defects?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether calcium phosphate ceramics are used as bone graft substitutes specifically for filling bone tumor defects. Calcium phosphate ceramics (like hydroxyapatite and tricalcium phosphate) are indeed widely used as bone graft substitutes in orthopedic surgery because they have osteoconductive properties and chemical composition similar to natural bone mineral. They are commonly used in various bone defect applications, including those created after tumor resection. Clinical literature supports their use in filling bone voids after tumor removal, as they provide structural support and can integrate with native bone. So calcium phosphate ceramics do serve as bone graft substitutes specifically in the context of filling bone tumor defects.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27157057",
    "question": "Does transcranial Alternating Current Stimulation ( tACS ) differentially modulate speech perception in young and older adults?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether transcranial Alternating Current Stimulation (tACS) has different effects on speech perception between young and older adults. To answer this, I would need to know if research has shown age-dependent differences in how tACS affects speech perception abilities. Without specific research evidence showing differential effects between age groups, I cannot confidently say yes. However, there is research suggesting that aging affects neural oscillations and speech processing, and tACS targets neural oscillations, so it's plausible that age-related differences in neural activity could lead to differential effects of tACS. Some studies have investigated tACS effects on auditory and speech processing, and age-related differences in brain stimulation effects have been documented in other contexts. Based on the neurophysiological differences between young and older adults, it seems likely that tACS would have differential effects on speech perception between age groups, but I would need specific studies directly comparing these groups to give a definitive answer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12778449",
    "question": "Is [ Coding single nucleotide polymorphism an ideal marker for detecting gene imprinting by 5 ' nuclease assay ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if coding single nucleotide polymorphism (SNP) is an ideal marker for detecting gene imprinting using 5' nuclease assay. To answer this, I need to consider whether coding SNPs have the necessary characteristics to effectively detect gene imprinting in this specific assay context.\\n\\nGene imprinting is an epigenetic phenomenon where genes are expressed in a parent-of-origin-specific manner. To detect imprinting, we need markers that can distinguish between maternal and paternal alleles.\\n\\nCoding SNPs (cSNPs) are located in protein-coding regions of genes. While they can serve as markers for distinguishing alleles, they have some limitations for imprinting studies:\\n\\n1. Coding regions represent only a small portion of the genome, limiting the number of available markers\\n2. Coding regions are under selective pressure, so they typically have lower heterozygosity rates than non-coding regions\\n3. For imprinting detection, the ideal markers should be in regions that maintain parent-specific methylation patterns\\n\\nThe 5' nuclease assay (like TaqMan) can detect SNPs, but for imprinting studies, the markers need to be informative about parental origin. Typically, non-coding SNPs in imprinting control regions or differentially methylated regions (DMRs) would be more informative for imprinting studies.\\n\\nTherefore, while coding SNPs can be used in some cases, they are generally not considered ideal markers for detecting gene imprinting.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22813818",
    "question": "Is sacral nerve stimulation a valuable diagnostic tool in the management of anorectal and pelvic malformations?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if sacral nerve stimulation is a valuable diagnostic tool for anorectal and pelvic malformations. I need to consider what sacral nerve stimulation is and its applications. Sacral nerve stimulation (SNS) is primarily a therapeutic intervention used to treat various pelvic floor disorders like fecal incontinence, urinary incontinence, and certain types of constipation by modulating nerve activity. It involves implanting a device that delivers electrical impulses to the sacral nerves. However, SNS is not typically used as a diagnostic tool to identify or characterize anorectal or pelvic malformations. Diagnostic tools for these conditions would more commonly include imaging studies (MRI, CT, ultrasound), physical examination, and various functional tests. SNS might be used as a treatment after diagnosis, but not for the diagnostic process itself.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25563078",
    "question": "Does analysis of discordant Affymetrix probesets cast serious doubt on idea of microarray data reutilization?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if analysis of discordant Affymetrix probesets casts serious doubt on the idea of microarray data reutilization. To answer this, I need to consider what discordant Affymetrix probesets are and their implications for microarray data reuse.\\n\\nDiscordant probesets refer to probes within the same gene that give inconsistent or contradictory expression measurements. This can happen due to various reasons including probe design issues, alternative splicing, or cross-hybridization. \\n\\nWhile discordant probesets do present challenges for microarray data interpretation, they don't necessarily invalidate the entire concept of data reutilization. The scientific community has developed various methods to address these issues:\\n\\n1. Improved annotation and mapping of probes\\n2. Statistical methods to handle discordant signals\\n3. Cross-platform validation approaches\\n4. Meta-analysis techniques that can account for these inconsistencies\\n\\nThe existence of discordant probesets is a known limitation that researchers can account for when reusing microarray data. While it adds complexity and requires careful analysis, it doesn't fundamentally invalidate the practice of microarray data reutilization. The field has evolved to incorporate these considerations into analysis pipelines.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15851226",
    "question": "Do single cryothermia applications of less than five minutes produce permanent cavotricuspid isthmus block in humans?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if single cryothermia applications of less than five minutes can produce permanent cavotricuspid isthmus block in humans. Cavotricuspid isthmus (CTI) block is a procedure used in treating atrial flutter, where the isthmus between the tricuspid valve and inferior vena cava is blocked. Cryothermia (or cryoablation) is one method used to create this block. The question specifically asks about single applications lasting less than 5 minutes and whether they can produce permanent blocks. Based on medical literature, single short cryoablation applications (less than 5 minutes) typically do not create permanent lesions in the CTI. Effective CTI blocks usually require either longer duration applications or multiple applications. The standard protocols for cryoablation of the CTI typically involve applications of 4-8 minutes, often with multiple applications needed to achieve permanent block.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16434411",
    "question": "Is coronary endothelial dysfunction associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the association between coronary endothelial dysfunction, erectile dysfunction, and elevated asymmetric dimethylarginine (ADMA) in patients with early atherosclerosis. To answer this, I need to consider what is known about these conditions and their relationships.\\n\\nCoronary endothelial dysfunction refers to impaired function of the endothelium (inner lining) of coronary blood vessels. Erectile dysfunction involves difficulty achieving or maintaining an erection. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase, which can impair endothelial function.\\n\\nThere is scientific evidence suggesting that these conditions are indeed related. Endothelial dysfunction is considered a common pathophysiological mechanism in both coronary artery disease and erectile dysfunction. ADMA has been shown to be elevated in patients with endothelial dysfunction and is considered a marker for cardiovascular risk.\\n\\nStudies have demonstrated that patients with erectile dysfunction often have coronary endothelial dysfunction, even in early stages of atherosclerosis. Additionally, elevated ADMA levels have been found in patients with both conditions.\\n\\nBased on the medical literature, there appears to be an association between these three factors in patients with early atherosclerosis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21456066",
    "question": "Does suppression of glycogen synthase kinase 3 activity reduce tumor growth of prostate cancer in vivo?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the effect of suppressing glycogen synthase kinase 3 (GSK-3) activity on prostate cancer tumor growth in vivo (in living organisms, not just cell cultures). To answer this, I need to consider what's known about GSK-3 inhibition in prostate cancer models.\\n\\nGSK-3 is a serine/threonine protein kinase that plays roles in multiple cellular pathways including Wnt signaling, PI3K/Akt, and others. Its role in cancer is complex and sometimes contradictory.\\n\\nIn prostate cancer specifically, several studies have shown that GSK-3 inhibition can reduce tumor growth in animal models:\\n- Zhu et al. (2011) showed that GSK-3 inhibition reduced prostate cancer growth in mouse models\\n- Other studies have demonstrated that GSK-3 inhibitors like lithium chloride or SB216763 can suppress prostate tumor growth in vivo\\n- Mechanistically, GSK-3 inhibition has been shown to affect androgen receptor signaling and other pathways important in prostate cancer progression\\n\\nBased on the published literature, there is evidence supporting that suppression of GSK-3 activity can indeed reduce tumor growth of prostate cancer in vivo models.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23151702",
    "question": "Do a comparative evaluation of DIAGNOdent and caries detector dye in detection of residual caries in prepared cavities?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking me to perform a comparative evaluation of two methods for detecting residual caries in prepared cavities: DIAGNOdent (a laser fluorescence device) and caries detector dye. This would require me to analyze research studies comparing these two methods, evaluate their sensitivity, specificity, accuracy, and clinical utility, and provide a detailed comparison of their advantages and disadvantages. This is not a yes/no question but rather a request for a comprehensive analysis and comparison.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11273946",
    "question": "Does local anesthesia block mustard-oil-induced temporomandibular inflammation?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether local anesthesia blocks mustard-oil-induced temporomandibular inflammation. To answer this, I need to consider whether local anesthetics (which block nerve conduction) would prevent or reduce the inflammatory response caused by mustard oil application to the temporomandibular joint (TMJ). \\n\\nMustard oil (allyl isothiocyanate) is known to be a potent inflammatory agent that activates TRPA1 receptors, causing neurogenic inflammation. When applied to the TMJ, it induces inflammation through both direct tissue irritation and neurogenic mechanisms.\\n\\nLocal anesthetics work by blocking sodium channels in nerve membranes, preventing the generation and propagation of action potentials. This would block the neural component of inflammation (neurogenic inflammation) by preventing nociceptor activation and subsequent release of inflammatory neuropeptides like substance P and CGRP.\\n\\nHowever, local anesthesia would not completely block the direct tissue inflammatory effects of mustard oil. While it would prevent pain sensation and neurogenic inflammation, the direct chemical irritation and resulting non-neurogenic inflammatory cascade would still occur.\\n\\nBased on scientific literature, local anesthesia can reduce but not completely block mustard-oil-induced inflammation in the TMJ. It primarily blocks the neurogenic component while the direct inflammatory effects may still proceed.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "25700288",
    "question": "Does blood-brain barrier compromise predict perihematoma edema growth in intracerebral hemorrhage?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether blood-brain barrier compromise predicts perihematoma edema growth in intracerebral hemorrhage. To answer this, I need to consider the scientific evidence about the relationship between blood-brain barrier disruption and the development of edema around a brain hemorrhage.\\n\\nIntracerebral hemorrhage (ICH) is a type of stroke caused by bleeding within the brain tissue. After ICH occurs, the area surrounding the blood clot (perihematoma) often develops edema (swelling due to fluid accumulation). \\n\\nThe blood-brain barrier (BBB) is a selective semipermeable border that separates the circulating blood from the brain and extracellular fluid in the central nervous system. When this barrier is compromised or disrupted, it can allow substances that would normally be kept out to enter the brain tissue.\\n\\nResearch has shown that BBB disruption does occur after ICH and contributes to the development of perihematoma edema. Multiple studies have demonstrated that markers of BBB compromise correlate with edema growth. The breakdown of the BBB allows plasma proteins and fluid to leak into the brain tissue, contributing to edema formation and expansion.\\n\\nSo based on current scientific understanding, yes, blood-brain barrier compromise does predict perihematoma edema growth in intracerebral hemorrhage.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "25914168",
    "question": "Does a pharmacogenetic study implicate SLC9a9 in multiple sclerosis disease activity?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to determine if there is evidence that a pharmacogenetic study has implicated the SLC9a9 gene in multiple sclerosis disease activity. SLC9a9 (also known as NHE9) is a sodium/hydrogen exchanger gene. To answer this question accurately, I would need to know if there are published pharmacogenetic studies that have specifically found an association between SLC9a9 variants and multiple sclerosis disease activity or treatment response. Without specific information about such a study in the question, and without being able to search current scientific literature, I cannot confirm that such a study exists. Therefore, I cannot definitively say that a pharmacogenetic study has implicated SLC9a9 in multiple sclerosis disease activity.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9694089",
    "question": "Does temporary tracheal occlusion cause catch-up lung maturation in a fetal model of diaphragmatic hernia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if temporary tracheal occlusion causes catch-up lung maturation in a fetal model of diaphragmatic hernia. To answer this, I need to consider what is known about this medical intervention. Temporary tracheal occlusion (TO) is a fetal intervention that has been studied for congenital diaphragmatic hernia (CDH). The procedure involves temporarily blocking the fetal trachea, which prevents lung fluid from escaping. This retention of fluid creates pressure that stimulates lung growth. Research has shown that temporary tracheal occlusion can indeed promote accelerated lung growth and maturation in fetal models of diaphragmatic hernia, helping the hypoplastic lungs to 'catch up' in development. This approach has been studied in animal models and has been translated to human fetal therapy in severe cases of CDH.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15389533",
    "question": "Does cyclic AMP-dependent protein kinase A negatively modulate adherens junction integrity and differentiation of intestinal epithelial cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether cyclic AMP-dependent protein kinase A (PKA) negatively modulates adherens junction integrity and differentiation of intestinal epithelial cells. To answer this, I need to consider what is known about PKA's role in intestinal epithelial cells.\\n\\nPKA is known to be involved in various cellular processes, including regulation of cell-cell junctions. In intestinal epithelial cells specifically, research has shown that PKA activation can actually disrupt adherens junctions and impair differentiation. PKA has been demonstrated to phosphorylate proteins associated with adherens junctions, which can lead to junction disassembly. Additionally, PKA activation has been linked to reduced expression of differentiation markers in intestinal epithelial cells.\\n\\nSo based on the scientific literature, cyclic AMP-dependent protein kinase A does indeed negatively modulate adherens junction integrity and differentiation of intestinal epithelial cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12163087",
    "question": "Does pre-operative renal function predict development of chronic renal insufficiency after orthotopic heart transplantation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether pre-operative renal function is a predictor for developing chronic renal insufficiency after heart transplantation. To answer this, I would need to know if there's a statistically significant correlation between pre-transplant kidney function measurements and post-transplant chronic kidney problems. Based on medical literature, pre-transplant renal function is indeed one of the predictors of post-transplant renal outcomes. Patients with compromised kidney function before heart transplantation are at higher risk of developing chronic renal insufficiency afterward. Multiple studies have shown this association, as calcineurin inhibitors used in post-transplant immunosuppression can further damage already compromised kidneys.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19959238",
    "question": "Does the membrane attack complex of complement drive the progression of atherosclerosis in apolipoprotein E knockout mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the role of the membrane attack complex (MAC) of complement in the progression of atherosclerosis in apolipoprotein E knockout mice. The MAC is part of the complement system, which is involved in immune responses. Apolipoprotein E knockout mice are a common model for studying atherosclerosis. To answer this question accurately, I need to consider whether scientific evidence supports that MAC specifically drives atherosclerosis progression in this mouse model. While complement activation has been implicated in atherosclerosis, I need to determine if the MAC component specifically has been shown to drive disease progression in apoE knockout mice. Based on research literature, studies have shown that MAC deficiency (through C5 or C6 deficiency) reduces atherosclerosis in apoE knockout mice, suggesting that MAC does contribute to atherosclerosis progression in this model.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24721513",
    "question": "Does oncogenic BRAF inhibitor UAI-201 induce cell cycle arrest and autophagy in BRAF mutant glioma cells?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question. It's asking about the effects of UAI-201, which is described as an oncogenic BRAF inhibitor, on BRAF mutant glioma cells. Specifically, it asks whether UAI-201 induces two specific cellular processes: cell cycle arrest and autophagy in these cells.\\n\\nI need to determine if there is established evidence that UAI-201 causes these specific effects in BRAF mutant glioma cells. Without specific knowledge about UAI-201's mechanisms of action in this particular context, I cannot confirm that it induces cell cycle arrest and autophagy in BRAF mutant glioma cells. While BRAF inhibitors in general may affect cell cycle and potentially induce autophagy in some cancer cells, I don't have specific information about UAI-201's effects on these particular processes in glioma cells with BRAF mutations.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17929294",
    "question": "Does lipid-induced oxidative stress cause steatohepatitis in mice fed an atherogenic diet?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. To answer this, I need to consider what scientific research has shown about the relationship between oxidative stress from lipids and the development of steatohepatitis specifically in mice on atherogenic diets. Steatohepatitis is liver inflammation with fat accumulation, and atherogenic diets are high in cholesterol and fat that promote atherosclerosis. Research has generally shown that atherogenic diets in mice do lead to oxidative stress, and this oxidative stress is a key mechanism in the development of steatohepatitis. Multiple studies have demonstrated that lipid accumulation in the liver from atherogenic diets triggers oxidative stress pathways that damage hepatocytes and promote inflammation, leading to the histological features of steatohepatitis. So based on established scientific evidence, lipid-induced oxidative stress does appear to be a causal factor in steatohepatitis development in this mouse model.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24790143",
    "question": "Does von Willebrand factor directly interact with DNA from neutrophil extracellular traps?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Von Willebrand factor (vWF) is a blood glycoprotein involved in hemostasis. Neutrophil extracellular traps (NETs) are web-like structures composed of DNA and proteins that are released by neutrophils as part of the immune response. The question asks whether vWF directly interacts with the DNA component of NETs.\\n\\nBased on scientific literature, vWF has been shown to interact with NETs, but specifically with the DNA component? There is evidence that vWF can bind to NETs and that this interaction contributes to thrombosis. Studies have demonstrated that vWF can bind to histones and other NET components. More specifically, research has shown that vWF can directly bind to DNA from NETs. For example, studies have shown that vWF's A1 domain can interact with DNA, and this interaction can be important in thrombotic conditions.\\n\\nSo yes, vWF does directly interact with DNA from neutrophil extracellular traps.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26602914",
    "question": "Are optimal serum cholesterol concentrations associated with accelerated bone loss in African ancestry men?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific scientific finding: whether optimal serum cholesterol concentrations are associated with accelerated bone loss specifically in men of African ancestry. To answer this accurately, I would need to be familiar with the relevant medical research literature on this topic. The question is asking about a correlation between two specific health parameters (serum cholesterol and bone loss rate) in a specific demographic group. Without specific knowledge of studies that have examined this relationship in African ancestry men, I cannot confidently answer yes or no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27456478",
    "question": "Is maximal workload but not peak oxygen uptake decreased during immersed incremental exercise at cooler temperatures?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether maximal workload decreases during immersed incremental exercise at cooler temperatures, while peak oxygen uptake does not decrease. Let me analyze this carefully.\\n\\nWhen exercise is performed while immersed in water, the physiological responses can differ from land-based exercise. Temperature of the water can further affect these responses. \\n\\nThe question specifically asks about two parameters:\\n1. Maximal workload (the maximum power output or work rate achievable)\\n2. Peak oxygen uptake (VO2peak - the maximum rate of oxygen consumption)\\n\\nAnd it asks if cooler water temperatures cause a decrease in maximal workload but NOT in peak oxygen uptake.\\n\\nBased on exercise physiology research, cooler water temperatures typically cause increased cardiovascular strain due to peripheral vasoconstriction and increased central blood volume. This can lead to reduced maximal workload capacity. However, peak oxygen uptake is often maintained or only minimally affected because the body compensates through other mechanisms.\\n\\nSo yes, research generally supports that maximal workload decreases in cooler water temperatures during immersed exercise, while peak oxygen uptake is relatively preserved.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25323905",
    "question": "Does dNA hypomethylation-mediated overexpression of carbonic anhydrase 9 induce an aggressive phenotype in ovarian cancer cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether DNA hypomethylation-mediated overexpression of carbonic anhydrase 9 (CA9) induces an aggressive phenotype in ovarian cancer cells. To answer this, I need to consider what is known about CA9, DNA hypomethylation, and their relationship to ovarian cancer aggressiveness.\\n\\nCarbonic anhydrase 9 (CA9) is a hypoxia-inducible enzyme that helps regulate pH in tumor microenvironments. DNA hypomethylation is an epigenetic modification that typically leads to increased gene expression.\\n\\nThere is research showing that CA9 overexpression is associated with more aggressive phenotypes in various cancers, including promoting invasion, metastasis, and treatment resistance. In ovarian cancer specifically, some studies have linked CA9 expression to poor prognosis.\\n\\nRegarding the specific mechanism of DNA hypomethylation-mediated CA9 overexpression in ovarian cancer, there is evidence in the literature supporting this relationship. Studies have shown that hypomethylation of the CA9 promoter can lead to its overexpression in ovarian cancer cells, and this overexpression contributes to more aggressive cancer cell behaviors including increased proliferation, invasion, and resistance to therapy.\\n\\nBased on the available scientific literature, the answer appears to be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23233095",
    "question": "Does angiotensin ( 1-7 ) ameliorate angiotensin II-induced inflammation by inhibiting LOX-1 expression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if angiotensin (1-7) ameliorates (improves) inflammation caused by angiotensin II, specifically by inhibiting LOX-1 expression. To answer this, I need to consider what is known about the relationship between angiotensin (1-7), angiotensin II, inflammation, and LOX-1 expression.\\n\\nAngiotensin (1-7) is generally considered to have opposite effects to angiotensin II in the renin-angiotensin system. While angiotensin II is typically pro-inflammatory, angiotensin (1-7) often has anti-inflammatory effects.\\n\\nLOX-1 (Lectin-like oxidized low-density lipoprotein receptor-1) is a receptor that can be upregulated during inflammatory conditions and is associated with various cardiovascular pathologies.\\n\\nResearch has shown that angiotensin (1-7) can counteract many of the harmful effects of angiotensin II, including inflammation. Some studies have demonstrated that angiotensin (1-7) can inhibit LOX-1 expression that is induced by angiotensin II, thereby reducing inflammation.\\n\\nBased on the available scientific literature, it appears that angiotensin (1-7) does ameliorate angiotensin II-induced inflammation, and one of the mechanisms is through inhibition of LOX-1 expression.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22068169",
    "question": "Do tNFα inhibitors restrict T cell activation and cycling via Notch-1 signalling in inflammatory bowel disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the mechanism of action of TNFα inhibitors in inflammatory bowel disease (IBD), specifically whether they restrict T cell activation and cycling through Notch-1 signaling pathways. To answer this, I need to consider what's known about TNFα inhibitors' mechanisms in IBD.\\n\\nTNFα inhibitors (like infliximab, adalimumab, etc.) are known to work by neutralizing TNFα, a pro-inflammatory cytokine. Their primary mechanism involves blocking TNF-mediated inflammatory cascades. While they do affect T cell responses, the specific mechanism involving Notch-1 signaling is not widely established as their primary mode of action.\\n\\nThe Notch signaling pathway is important in T cell development and function, but whether TNFα inhibitors specifically work through this pathway to restrict T cell activation in IBD is a more specialized claim that would require specific research evidence.\\n\\nBased on general knowledge of TNFα inhibitors' mechanisms, they primarily work by directly blocking TNFα rather than specifically targeting Notch-1 signaling pathways, though downstream effects on various signaling pathways including Notch are possible. Without specific research demonstrating this particular mechanism, I cannot confirm this as an established mechanism of action.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "10328466",
    "question": "Does the Trp64Arg amino acid polymorphism of the beta3-adrenergic receptor gene contribute to the genetic susceptibility of diabetic microvascular complications in Caucasian type 1 diabetic patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the Trp64Arg amino acid polymorphism of the beta3-adrenergic receptor gene contributes to genetic susceptibility for diabetic microvascular complications specifically in Caucasian patients with type 1 diabetes. To answer this, I would need to know if research has established a clear connection between this specific genetic polymorphism and microvascular complications in this specific population. Without being provided specific research findings or data in the question, I cannot make a definitive determination about this specific genetic relationship. The question requires specialized knowledge about genetic associations in a specific ethnic group with a specific diabetes type.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "10613616",
    "question": "Are plasma tacrine concentrations significantly increased by concomitant hormone replacement therapy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if plasma tacrine concentrations are significantly increased when hormone replacement therapy (HRT) is given at the same time. To answer this, I would need specific research or clinical evidence about the interaction between tacrine (a cholinesterase inhibitor once used for Alzheimer's disease) and hormone replacement therapy. Without specific studies showing this interaction, I cannot confirm that plasma tacrine concentrations are significantly increased by HRT. There are many drug interactions in pharmacology, but not all medications interact with hormone therapy. I don't recall a well-established significant interaction between tacrine and HRT that would increase tacrine plasma concentrations.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9563859",
    "question": "Is bedside troponin T testing useful for early out-of-hospital diagnosis of myocardial infarction?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if bedside troponin T testing is useful for early out-of-hospital diagnosis of myocardial infarction. Troponin T is a cardiac marker that can indicate heart muscle damage, and it's commonly used in hospital settings to diagnose myocardial infarction (heart attack). The question specifically asks about 'bedside' testing in 'out-of-hospital' settings, which would refer to point-of-care testing that could be done by paramedics or in primary care settings before a patient reaches a hospital. \\n\\nBased on medical literature, point-of-care troponin T testing does exist and has been studied for pre-hospital or early diagnosis of myocardial infarction. These portable devices allow for faster results compared to laboratory testing. Studies have shown that such early testing can help with triage decisions and potentially reduce time to treatment. So yes, bedside troponin T testing can be useful for early out-of-hospital diagnosis of myocardial infarction, though it may not have the same sensitivity as laboratory tests performed in hospitals.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "22565620",
    "question": "Do microvascular dysfunction and pulse wave reflection characterize different vascular pathologies in patients at cardiovascular risk?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if microvascular dysfunction and pulse wave reflection characterize different vascular pathologies in patients at cardiovascular risk. To answer this, I need to consider whether these are distinct physiological phenomena that represent different types of vascular problems.\\n\\nMicrovascular dysfunction refers to problems in the small blood vessels (arterioles, capillaries) and involves impaired vasodilation, increased vascular resistance, and abnormal blood flow regulation at the microcirculation level.\\n\\nPulse wave reflection refers to the phenomenon where pressure waves traveling through arteries are reflected back from peripheral sites, particularly at points of branching or changes in vessel diameter. This is more related to arterial stiffness and is a characteristic of macrovascular (larger artery) pathology.\\n\\nThese phenomena involve different vascular beds (micro vs. macro), different physiological mechanisms, and represent distinct aspects of cardiovascular pathology. While they can coexist and interact in patients with cardiovascular risk, they characterize different vascular problems.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21730308",
    "question": "Is increased vertebral artery tortuosity index associated with adverse outcomes in children and young adults with connective tissue disorders?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the association between increased vertebral artery tortuosity index and adverse outcomes in children and young adults with connective tissue disorders. To answer this, I need to consider whether medical literature supports such an association.\\n\\nVertebral artery tortuosity refers to the abnormal twisting or winding of the vertebral arteries. The tortuosity index is a measurement of this abnormal vessel path. In connective tissue disorders like Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome, blood vessel abnormalities including tortuosity can occur due to defects in structural proteins.\\n\\nResearch has shown that increased arterial tortuosity, including in the vertebral arteries, is associated with a higher risk of adverse vascular outcomes in connective tissue disorders. These outcomes can include arterial dissection, aneurysm formation, and stroke. Studies have demonstrated that higher tortuosity indices correlate with increased risk of these complications in young patients with connective tissue disorders.\\n\\nSo based on the medical literature, there does appear to be an association between increased vertebral artery tortuosity index and adverse outcomes in the specified population.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22633524",
    "question": "Does liposomal amphotericin B induce nephrotoxicity or renal function impairment in premature neonates?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about whether liposomal amphotericin B causes nephrotoxicity or renal function impairment specifically in premature neonates. Liposomal amphotericin B is an antifungal medication that is a lipid formulation of conventional amphotericin B. It was developed specifically to reduce nephrotoxicity compared to conventional amphotericin B deoxycholate. While conventional amphotericin B is known for its nephrotoxic effects, liposomal amphotericin B has been shown to have significantly reduced nephrotoxicity in adults and children. In premature neonates specifically, studies have generally shown that liposomal amphotericin B has a favorable safety profile with minimal impact on renal function. The liposomal formulation was specifically designed to reduce nephrotoxicity while maintaining antifungal efficacy. Multiple studies and clinical experience have demonstrated that liposomal amphotericin B has significantly less nephrotoxicity compared to conventional amphotericin B in this vulnerable population. So the answer would be no.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "22008323",
    "question": "Do the efficacy of single-dose 5-fluorouracil therapy in experimental caustic esophageal burn?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if single-dose 5-fluorouracil therapy is effective in treating experimental caustic esophageal burns. To answer this properly, I would need to review scientific literature on this specific application of 5-fluorouracil. 5-fluorouracil (5-FU) is an antimetabolite drug commonly used in cancer treatment, but its application in caustic esophageal burns is a more specialized use. Without specific studies to reference, I cannot definitively state whether it has proven efficacy in this particular condition. The question is phrased in a way that suggests there might be research on this topic, but I don't have access to confirm the efficacy of this specific treatment for caustic esophageal burns.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23340394",
    "question": "Does north American Contact Dermatitis Group patch test result for 2007-2008?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking if there exists a North American Contact Dermatitis Group patch test result for the years 2007-2008. To answer this, I would need to know if such a report or data set was published or exists. Without specific information about this, I cannot definitively say yes or no. The North American Contact Dermatitis Group does regularly publish patch test results for specific time periods, so it's plausible that results for 2007-2008 exist, but I don't have confirmation of this specific time period.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19738126",
    "question": "Does amphiregulin and epiregulin mRNA expression in primary tumors predict outcome in metastatic colorectal cancer treated with cetuximab?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether amphiregulin and epiregulin mRNA expression in primary tumors can predict outcomes for patients with metastatic colorectal cancer who are treated with cetuximab. To answer this, I need to consider whether there is established evidence in medical literature showing a correlation between these specific biomarkers and treatment outcomes. \\n\\nBased on medical research, there are indeed studies showing that high expression of amphiregulin (AREG) and epiregulin (EREG) mRNA in primary colorectal tumors has been associated with better response to cetuximab therapy in patients with metastatic colorectal cancer. These genes encode ligands of the epidermal growth factor receptor (EGFR), which is the target of cetuximab. Higher expression of these ligands has been linked to increased dependency on EGFR signaling and thus greater sensitivity to EGFR inhibition by cetuximab. Multiple studies have demonstrated that patients with higher expression of these markers tend to have better progression-free survival and overall survival when treated with cetuximab-containing regimens.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25281655",
    "question": "Is hypotension during hospitalization for acute heart failure independently associated with 30-day mortality : findings from ASCEND-HF?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific finding from a study called ASCEND-HF, which appears to be a clinical trial or observational study on acute heart failure. The question specifically asks whether hypotension (low blood pressure) during hospitalization for acute heart failure was found to be independently associated with 30-day mortality in this study.\\n\\nTo answer this accurately, I would need to know the specific results of the ASCEND-HF study regarding this association. Without access to the study results or not having specific knowledge of this particular finding, I cannot provide a definitive yes or no answer based on my knowledge.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26353776",
    "question": "Do aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether aspirin and P2Y12 inhibition (a class of antiplatelet drugs) reduce the ability of platelets to promote invasion of ovarian cancer cells. To answer this, I need to consider the scientific evidence about these antiplatelet agents and their effects on platelet-mediated cancer cell invasion.\\n\\nAspirin is a well-known antiplatelet agent that inhibits cyclooxygenase enzymes and reduces platelet activation. P2Y12 inhibitors (like clopidogrel, prasugrel, and ticagrelor) are another class of antiplatelet drugs that work by blocking the P2Y12 receptor on platelets.\\n\\nThere is research suggesting that platelets can promote cancer cell invasion and metastasis through various mechanisms. Some studies have shown that antiplatelet agents can reduce this effect in various cancer types.\\n\\nSpecifically for ovarian cancer, there is evidence that platelets can enhance the invasive capabilities of ovarian cancer cells. Some research has demonstrated that both aspirin and P2Y12 inhibitors can reduce platelet-mediated effects on cancer progression, including in ovarian cancer models.\\n\\nBased on the scientific literature, there is evidence supporting that aspirin and P2Y12 inhibition can attenuate (reduce) platelet-induced ovarian cancer cell invasion.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25844692",
    "question": "Does pulmonary edema measured by MRI correlate with late-phase response to allergen challenge?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if pulmonary edema measured by MRI correlates with late-phase response to allergen challenge. To answer this, I need to consider whether there is established scientific evidence showing a correlation between these two specific phenomena. Pulmonary edema is fluid accumulation in the lungs that can be detected by MRI. The late-phase response to allergen challenge refers to the delayed inflammatory response that occurs hours after exposure to an allergen. I'm not aware of specific research establishing a clear correlation between MRI-measured pulmonary edema and late-phase allergic responses. While both involve inflammatory processes in the lungs, a direct correlation would require specific studies demonstrating this relationship, which to my knowledge hasn't been definitively established in the scientific literature.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26947008",
    "question": "Does hydroxytyrosol prevent chondrocyte death under oxidative stress by inducing autophagy through sirtuin 1-dependent and -independent mechanisms?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific mechanism of action for hydroxytyrosol in preventing chondrocyte death under oxidative stress. Specifically, it's asking if hydroxytyrosol prevents this cell death by inducing autophagy through both sirtuin 1-dependent and sirtuin 1-independent mechanisms. This is a very specific scientific claim that would require evidence from research studies. Without specific knowledge of studies showing that hydroxytyrosol works through both these specific pathways to induce autophagy and prevent chondrocyte death, I cannot confirm this claim. While hydroxytyrosol is known to have antioxidant properties, confirming this specific dual mechanism would require specialized research knowledge.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22743058",
    "question": "Does heat shock cognate 70 regulate the translocation and angiogenic function of nucleolin?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To answer this question, I need to determine if there's an established relationship between heat shock cognate 70 (HSC70) and nucleolin, specifically regarding nucleolin's translocation and angiogenic function.\\n\\nHeat shock cognate 70 (HSC70) is a constitutively expressed molecular chaperone of the heat shock protein family. Nucleolin is a multifunctional protein involved in various cellular processes including ribosome biogenesis, cell proliferation, and angiogenesis.\\n\\nBased on scientific literature, HSC70 has been shown to interact with various proteins and regulate their localization and function. However, to specifically answer whether HSC70 regulates nucleolin's translocation and angiogenic function, I would need to reference specific studies.\\n\\nWhile both proteins are important in cellular processes, without specific evidence from research papers demonstrating that HSC70 regulates nucleolin's translocation and angiogenic function, I cannot confirm this relationship.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26920097",
    "question": "Does fast Visual Field Progression be Associated with Depressive Symptoms in Patients with Glaucoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if fast visual field progression is associated with depressive symptoms in patients with glaucoma. This is asking about a potential correlation between the rate of visual field deterioration in glaucoma patients and the presence of depressive symptoms. Research has shown that glaucoma patients with more rapid visual field loss often experience higher rates of depression, as the accelerated loss of vision can have significant psychological impacts. Studies have demonstrated this association between faster disease progression and increased depressive symptoms in this patient population.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16950294",
    "question": "Do hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation induce atopic dermatitis-like skin lesions in Nishiki-nezumi Cinnamon/Nagoya mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation cause atopic dermatitis-like skin lesions in a specific mouse model called Nishiki-nezumi Cinnamon/Nagoya mice. This is a very specific scientific question about immunology and dermatology research. To answer this accurately, I would need to know about this specific mouse model and the research conducted on it. Without specific knowledge of this research, I cannot definitively answer. However, based on the phrasing, it seems to be referencing a specific research finding. Let me consider what I know about atopic dermatitis mechanisms: TH2 cells are indeed implicated in atopic dermatitis pathogenesis, and NF-κB signaling is involved in inflammatory skin conditions. But the specific claim about this particular mouse strain is what I need to verify.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18694994",
    "question": "Does vascular endothelial growth factor receptor-1 contribute to resistance to anti-epidermal growth factor receptor drugs in human cancer cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if vascular endothelial growth factor receptor-1 (VEGFR-1) contributes to resistance to anti-epidermal growth factor receptor (anti-EGFR) drugs in human cancer cells. To answer this, I need to consider if there is established scientific evidence showing that VEGFR-1 plays a role in resistance mechanisms against anti-EGFR therapies.\\n\\nVEGFR-1 is involved in angiogenesis pathways, while EGFR is part of a different signaling pathway involved in cell proliferation. There is research suggesting cross-talk between these pathways in cancer. Some studies have shown that activation of alternative receptor tyrosine kinases, including VEGFR family members, can provide bypass signaling that allows cancer cells to overcome EGFR inhibition. Specifically, VEGFR-1 upregulation has been observed in some cancer cells that develop resistance to anti-EGFR therapies.\\n\\nBased on published research, there is evidence that VEGFR-1 can contribute to resistance mechanisms against anti-EGFR drugs in human cancer cells through alternative pathway activation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12388912",
    "question": "Does mifepristone ( RU-486 ) impair post-surgical wound healing of the larynx?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to analyze whether mifepristone (RU-486) impairs post-surgical wound healing of the larynx specifically. Mifepristone is a progesterone receptor antagonist primarily used for medical abortions and other gynecological purposes. To answer this question accurately, I would need to know if there is established evidence in medical literature about mifepristone's effects specifically on laryngeal wound healing after surgery. To my knowledge, there is no well-established evidence or widely reported clinical finding that mifepristone specifically impairs wound healing of the larynx following surgery. While mifepristone may have various systemic effects, a specific connection to impaired laryngeal healing post-surgery is not a documented or established medical concern in the literature. Without specific evidence supporting this claim, I cannot confirm that mifepristone impairs post-surgical wound healing of the larynx.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27399571",
    "question": "Does 374 Modeling the Effects of Current Steering With Directional lead?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if '374 Modeling the Effects of Current Steering With Directional lead?'. This appears to be asking if a document, paper, or study numbered 374 about modeling current steering effects with directional leads to something. However, the question is incomplete - it doesn't specify what the document might lead to. Without a complete question that specifies what '374 Modeling the Effects of Current Steering With Directional' might lead to, I cannot provide a yes or no answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26731751",
    "question": "Does the presence of protective cytotoxic T lymphocytes correlate with shorter lifespans of productively infected cells in HIV-1 infection?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the correlation between protective cytotoxic T lymphocytes (CTLs) and the lifespan of productively infected cells in HIV-1 infection. Specifically, it asks whether the presence of these CTLs correlates with shorter lifespans of infected cells.\\n\\nCytotoxic T lymphocytes (CTLs) are immune cells that can recognize and kill virus-infected cells. In HIV-1 infection, CTLs target cells that are productively infected with HIV-1. When effective, these CTLs can recognize viral peptides presented on the surface of infected cells and induce cell death, thereby shortening the lifespan of these infected cells.\\n\\nResearch has shown that strong CTL responses are associated with better control of HIV-1 infection, and one mechanism for this control is the killing of productively infected cells before they can produce large amounts of virus. This killing effectively shortens the lifespan of the infected cells.\\n\\nSo yes, the presence of protective CTLs does correlate with shorter lifespans of productively infected cells in HIV-1 infection.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "27068267",
    "question": "Is soluble tumor necrosis factor receptor 1 associated with diminished estimated glomerular filtration rate in colombian patients with type 2 diabetes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if soluble tumor necrosis factor receptor 1 (sTNFR1) is associated with diminished estimated glomerular filtration rate (eGFR) specifically in Colombian patients with type 2 diabetes. To answer this, I would need specific research or studies conducted on Colombian patients with type 2 diabetes that examined the relationship between sTNFR1 and eGFR. Without having access to such specific research, I cannot definitively answer this question. In general medical literature, sTNFR1 has been associated with declining kidney function in diabetic patients in some populations, but I don't have information specific to Colombian patients.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16879219",
    "question": "Is lipopolysaccharide-induced decreased protein S expression in liver cells mediated by MEK/ERK signaling and NFkappaB activation : involvement of membrane-bound CD14 and toll-like receptor-4?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether lipopolysaccharide (LPS)-induced decreased protein S expression in liver cells is mediated by specific signaling pathways (MEK/ERK) and NFkappaB activation, and whether this process involves membrane-bound CD14 and toll-like receptor-4 (TLR4). To answer this, I would need to know if scientific research has established this specific mechanism. LPS is known to signal through TLR4 and CD14, and often activates MEK/ERK and NFkappaB pathways, but I need to determine if these specific pathways have been linked to decreased protein S expression in liver cells. Based on immunology research, this is a plausible mechanism, as LPS typically signals through TLR4/CD14 to activate these downstream pathways, but I cannot definitively say 'yes' without specific evidence for this particular relationship with protein S expression.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16397027",
    "question": "Does cXCL12 attract CXCR4+ human metastatic neuroblastoma cells : clinical implications?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if cXCL12 attracts CXCR4+ human metastatic neuroblastoma cells. CXCL12 (also known as SDF-1) is a chemokine that binds to the CXCR4 receptor. In the scientific literature, it is well-established that CXCL12 does attract cells that express the CXCR4 receptor through chemotaxis. Specifically for neuroblastoma, research has shown that CXCR4+ neuroblastoma cells are attracted to CXCL12 gradients, and this CXCL12/CXCR4 axis plays a role in neuroblastoma metastasis. This chemotactic mechanism has clinical implications for understanding and potentially targeting the metastatic spread of neuroblastoma.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "23415965",
    "question": "Does intraoperative frozen section of the prostate decrease positive margin rate while ensuring nerve sparing procedure during radical prostatectomy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether intraoperative frozen section analysis of the prostate during radical prostatectomy helps reduce positive surgical margins while still allowing for nerve-sparing techniques. This is a specific clinical question about a surgical technique in prostate cancer treatment. To answer this accurately, I would need to consider evidence from clinical studies that have evaluated this specific approach. Based on the surgical literature, intraoperative frozen section analysis has been studied as a method to evaluate margins during prostatectomy, with some studies suggesting it may help reduce positive margin rates while maintaining nerve preservation. However, the evidence is mixed, and there isn't a definitive consensus that this approach consistently achieves both goals across all clinical scenarios.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25033458",
    "question": "Does a mouse model of otitis media identify HB-EGF as a mediator of inflammation-induced mucosal proliferation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a mouse model of otitis media identifies HB-EGF (heparin-binding epidermal growth factor) as a mediator of inflammation-induced mucosal proliferation. To answer this, I would need to know if there are scientific studies using mouse models of ear infections (otitis media) that specifically identified HB-EGF as playing a role in the proliferation of mucosal tissue during inflammation. Without specific information about such studies, I cannot definitively answer this question. However, HB-EGF is known to be involved in tissue repair and proliferation in various contexts, so it's plausible that it could be identified in such a model, but I don't have enough information to confirm this specific claim.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18787808",
    "question": "Does angiotensin-converting enzyme D allele influence susceptibility to acute hypoxic respiratory failure in children?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether the D allele of the angiotensin-converting enzyme (ACE) gene influences susceptibility to acute hypoxic respiratory failure in children. To answer this, I would need to know if there are scientific studies showing a correlation between the ACE D allele and increased risk of acute hypoxic respiratory failure specifically in pediatric populations. Without specific research data on this relationship, I cannot provide a definitive answer. There are studies on ACE polymorphisms and various respiratory conditions, but I need to be careful not to overgeneralize from adult studies or from studies on other respiratory conditions. Since I don't have access to specific research establishing this link in children, I should answer 'no' to be conservative.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "25128737",
    "question": "Do interactome analyses of Salmonella pathogenicity islands reveal SicA indispensable for virulence?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if interactome analyses of Salmonella pathogenicity islands reveal that SicA is indispensable for virulence. To answer this, I would need specific scientific evidence from interactome studies that demonstrate SicA's role in Salmonella virulence. While SicA is known to be a chaperone protein involved in the type III secretion system of Salmonella and plays a role in pathogenicity, I don't have specific information about interactome analyses that definitively prove it is 'indispensable' for virulence. Without access to specific research papers or data on this topic, I cannot confirm whether interactome analyses have specifically revealed SicA to be indispensable for virulence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26593374",
    "question": "Does cu ( II ) complexation affect oxytocin action on pregnant human myometrium in vitro?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if copper (II) complexation affects oxytocin action on pregnant human myometrium in vitro. To answer this, I would need specific scientific evidence about studies examining the interaction between Cu(II) complexes and oxytocin in the context of pregnant human uterine smooth muscle tissue (myometrium) in laboratory settings. Without specific knowledge of such studies, I cannot provide a definitive answer. Let me check if I have information about this specific biochemical interaction.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "18715772",
    "question": "Are respiratory disorders more common in farmers . Results from a study on Icelandic animal farmers?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if respiratory disorders are more common in farmers, specifically referencing results from a study on Icelandic animal farmers. To answer this accurately, I would need to know the specific findings of this study. The question appears to be referencing a particular research study about Icelandic animal farmers and their rates of respiratory disorders compared to some control group or the general population. Without knowing the actual results of this study, I cannot determine whether respiratory disorders were found to be more common in these farmers or not.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "11559650",
    "question": "Does mIP-2 secreted by epithelial cells increase neutrophil and lymphocyte recruitment in the mouse intestine?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if mIP-2 (mouse macrophage inflammatory protein-2) secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine. To answer this, I need to consider what is known about mIP-2's function in the mouse intestine.\\n\\nmIP-2 is a chemokine (CXCL2) that is known to be a potent neutrophil chemoattractant in mice. It's the functional homolog of human IL-8. In inflammatory conditions, mIP-2 is indeed known to recruit neutrophils to sites of inflammation, including the intestine.\\n\\nRegarding lymphocyte recruitment specifically, while mIP-2 is strongly associated with neutrophil recruitment, it is not typically characterized as a primary lymphocyte chemoattractant. Lymphocyte recruitment is more commonly associated with other chemokines like CCL chemokines.\\n\\nSo while mIP-2 from epithelial cells would increase neutrophil recruitment in the mouse intestine, the claim that it also increases lymphocyte recruitment is not well-supported by the standard understanding of mIP-2's function.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21063745",
    "question": "Does intermittent high glucose promote expression of proinflammatory cytokines in monocytes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether intermittent high glucose levels can cause monocytes (a type of white blood cell) to express more proinflammatory cytokines (signaling molecules that promote inflammation). Based on scientific literature, intermittent high glucose or glucose fluctuations have been shown to increase oxidative stress and promote the expression of proinflammatory cytokines in monocytes and other immune cells. This is one of the mechanisms by which glycemic variability in diabetes can contribute to vascular complications. Studies have demonstrated that intermittent high glucose is more deleterious than constant high glucose and induces higher levels of cytokines like TNF-α, IL-6, and IL-1β in monocytes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19693969",
    "question": "Does [ Fetal bovine serum enhance expression of PEDF in epidermal keratinocytes and dermal fibroblasts ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if fetal bovine serum (FBS) enhances the expression of PEDF (Pigment Epithelium-Derived Factor) in epidermal keratinocytes and dermal fibroblasts. To answer this, I would need specific scientific evidence about the relationship between FBS and PEDF expression in these particular cell types. The question is presented in a format that suggests it might be a scientific paper title, but without access to the content of such a paper or other scientific literature on this specific relationship, I cannot determine whether FBS enhances PEDF expression in these cells. The question contains a specific scientific claim that I don't have verified information about.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17611252",
    "question": "Is laryngeal exposure during laryngoscopy better in the 25 degrees back-up position than in the supine position?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether laryngeal exposure during laryngoscopy is better in the 25 degrees back-up position compared to the supine position. This is a clinical question about airway management techniques. Research has shown that elevating the patient's head and upper body (back-up position) can improve laryngeal visualization during intubation compared to the traditional supine (flat) position. The 25-degree back-up position specifically has been studied and found to improve the view of the larynx during direct laryngoscopy by optimizing the alignment of the oral, pharyngeal, and laryngeal axes. This position is sometimes called the 'ramped' or 'head-elevated laryngoscopy position' (HELP) and has been demonstrated to be particularly beneficial in obese patients but also helpful in the general population.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26936716",
    "question": "Does airway tree reconstruction in expiration chest CT scan facilitated by information transfer from corresponding inspiration scans?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether airway tree reconstruction in expiration chest CT scans is facilitated by information transfer from corresponding inspiration scans. This is a specific technical question about medical imaging techniques. Airway trees are typically more visible and expanded during inspiration (when lungs are filled with air) compared to expiration (when lungs have less air volume). The question is asking if information from the inspiration scan (where airways are more visible) can be used to help reconstruct or better visualize the airway tree in expiration scans (where airways are narrower and potentially harder to segment). Without specific knowledge of this medical imaging technique, I cannot definitively answer whether this information transfer approach is used in practice. However, from a general image processing perspective, using information from a clearer image (inspiration) to help interpret a more challenging image (expiration) of the same structure would be a logical approach.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24912445",
    "question": "Do aBCC transporters mediate insect resistance to multiple Bt toxins revealed by bulk segregant analysis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if aBCC transporters mediate insect resistance to multiple Bt toxins as revealed by bulk segregant analysis. To answer this, I need to consider what is known about the role of ABC transporters in Bt toxin resistance mechanisms.\\n\\nABC transporters, particularly those in the ABCC subfamily, have been identified in multiple studies as receptors for Bt toxins and mutations in these transporters have been linked to resistance to Bt toxins in various insect species. Bulk segregant analysis is a genetic mapping technique that has been used to identify genomic regions associated with Bt resistance.\\n\\nResearch has shown that mutations in ABCC2 transporters can confer resistance to Cry1A toxins in several lepidopteran species. Additionally, studies have found that ABCC transporters can be involved in resistance to multiple Bt toxins, not just a single toxin type.\\n\\nSo yes, ABCC transporters have been shown to mediate insect resistance to multiple Bt toxins, and this has been revealed in some studies using bulk segregant analysis approaches.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15464472",
    "question": "Does proteasome inhibition sensitize non-small-cell lung cancer to gemcitabine-induced apoptosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether proteasome inhibition sensitizes non-small-cell lung cancer (NSCLC) to gemcitabine-induced apoptosis. To answer this, I need to consider whether there is evidence that inhibiting proteasomes (cellular structures that degrade proteins) makes NSCLC cells more susceptible to cell death (apoptosis) when treated with gemcitabine (a chemotherapy drug). This is a specific scientific question about cancer biology and drug interactions. Without specific research studies to reference, I cannot definitively answer this question based on general knowledge alone. However, there is research suggesting that proteasome inhibitors like bortezomib can sensitize various cancer types to chemotherapeutic agents by preventing the degradation of pro-apoptotic proteins. For NSCLC specifically and gemcitabine in particular, studies have shown that proteasome inhibition can indeed enhance gemcitabine-induced apoptosis in NSCLC cell lines.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26059100",
    "question": "Does comparative transcriptomics analysis reveal difference of key gene expression between banana and plantain in response to cold stress?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether comparative transcriptomics analysis reveals differences in key gene expression between banana and plantain in response to cold stress. To answer this, I need to consider whether there is scientific evidence showing that when banana and plantain are exposed to cold stress, transcriptomic studies have identified different patterns of gene expression between these two closely related crops. Without specific scientific papers or data mentioned in the question, I cannot make a definitive statement about what comparative transcriptomics has or hasn't revealed about these specific plants' cold stress responses. The question is asking for a factual determination about scientific findings, not an opinion.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26581435",
    "question": "Does mammographic density defined by higher than conventional brightness threshold better predict breast cancer risk for full-field digital mammograms?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether mammographic density defined by a higher-than-conventional brightness threshold is a better predictor of breast cancer risk specifically for full-field digital mammograms. To answer this, I would need to know if research has shown that raising the brightness threshold for defining mammographic density in digital mammograms improves risk prediction compared to conventional thresholds. Without specific studies or data provided in the question, I cannot determine if this modified approach to density measurement has been proven to better predict breast cancer risk in the context of full-field digital mammography. The question is asking about a specific technical modification to breast cancer risk assessment that would require evidence from comparative studies.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24533061",
    "question": "Is expansion of HAART coverage associated with sustained decreases in HIV/AIDS morbidity , mortality and HIV transmission : the `` HIV Treatment as Prevention '' experience in a Canadian setting?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether the expansion of HAART (Highly Active Antiretroviral Therapy) coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality, and HIV transmission, specifically referring to the 'HIV Treatment as Prevention' experience in a Canadian setting. \\n\\nThis appears to be asking about a specific research finding or study conducted in Canada that examined whether increasing access to HAART treatment led to sustained reductions in HIV/AIDS-related illness, death, and transmission rates. The question is framed in a way that suggests this is a documented case study or research finding.\\n\\nBased on the phrasing, this appears to be the title or summary of a research paper that found positive results from HAART expansion in Canada. The question is asking me to confirm whether this association exists according to this specific Canadian experience/study.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26318825",
    "question": "Are fatigue , dyspnea , and intermittent symptoms associated with treatment-seeking delay for symptoms of atrial fibrillation before diagnosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if fatigue, dyspnea (shortness of breath), and intermittent symptoms are associated with delays in seeking treatment for atrial fibrillation symptoms before an official diagnosis is made. To answer this, I need to consider what research shows about patient behavior with these specific symptoms.\\n\\nResearch in cardiovascular health has shown that patients with vague or non-specific symptoms like fatigue often delay seeking medical attention compared to those with more acute symptoms like severe chest pain. Dyspnea can be gradual in onset for atrial fibrillation patients. The intermittent nature of atrial fibrillation symptoms (coming and going) is also known to contribute to patients dismissing their importance.\\n\\nStudies have demonstrated that these particular symptoms (fatigue, dyspnea, and intermittent symptoms) are indeed associated with longer delays in seeking medical attention for atrial fibrillation, as patients may attribute them to aging, stress, or other less serious conditions.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26695085",
    "question": "Does treatment with geraniol ameliorate methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if geraniol treatment ameliorates (improves) non-alcoholic steatohepatitis (NASH) in rats that was induced by a methionine-choline-deficient diet. To answer this, I would need specific research evidence about geraniol's effects on this particular model of NASH. Without being provided specific research information in the prompt, I cannot make a definitive claim about whether geraniol has this therapeutic effect. However, there are studies in the scientific literature that have investigated geraniol's effects on various liver conditions including NASH models, and some research has shown that geraniol has hepatoprotective and anti-inflammatory properties that could potentially benefit NASH. But I should only answer 'yes' if there is clear evidence specifically about geraniol improving methionine-choline-deficient diet-induced NASH in rats.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25042160",
    "question": "Does tau reduction prevent disease in a mouse model of Dravet syndrome?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if tau reduction prevents disease in a mouse model of Dravet syndrome. Dravet syndrome is a severe form of epilepsy that begins in infancy and is typically caused by mutations in the SCN1A gene. Tau is a protein associated with neurodegenerative disorders like Alzheimer's disease. To answer this question, I need to consider whether there is evidence that reducing tau protein levels has been shown to prevent or ameliorate disease symptoms in mouse models of Dravet syndrome. Based on my knowledge, while tau reduction has been studied in models of epilepsy and other neurological conditions, I am not aware of specific evidence showing that tau reduction prevents disease in Dravet syndrome mouse models. The connection between tau pathology and Dravet syndrome is not well-established in the scientific literature I'm familiar with.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25052197",
    "question": "Do δ-Opioid receptors up-regulate excitatory amino acid transporters in mouse astrocytes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific biological mechanism: whether δ-Opioid receptors cause up-regulation of excitatory amino acid transporters in mouse astrocytes. To answer this, I would need to know if there's evidence showing that when δ-Opioid receptors are activated in mouse astrocytes, there is an increase (up-regulation) in the expression or activity of excitatory amino acid transporters (EAATs). This is a specific molecular interaction in neuroscience. Based on my knowledge, δ-Opioid receptors have been shown to modulate glutamate transport in some contexts, and there are studies showing that δ-Opioid receptor activation can indeed up-regulate glutamate transporters (which are a type of excitatory amino acid transporter) in mouse astrocytes. So there is evidence supporting this relationship.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23176301",
    "question": "Are cardiologists more willing to prescribe β-blockers than respiratory physicians : an Australasian clinical scenario survey?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking if cardiologists are more willing to prescribe β-blockers compared to respiratory physicians, specifically in the context of an Australasian clinical scenario survey. This appears to be referencing a specific research study or survey that compared the prescribing tendencies of these two medical specialties. Without having access to the specific survey results or study being referenced, I cannot definitively answer whether cardiologists were indeed found to be more willing to prescribe β-blockers than respiratory physicians in this particular Australasian survey. The question itself seems to be the title of a research paper or study, rather than a question with a known answer based on general medical knowledge.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17275846",
    "question": "Does statin pre-treatment protect brain against focal cerebral ischemia in diabetic mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether statin pre-treatment protects the brain against focal cerebral ischemia in diabetic mice. To answer this, I need to consider whether there is scientific evidence showing that administering statins before inducing focal cerebral ischemia in diabetic mouse models provides neuroprotection. Based on research literature, statins have been shown to have neuroprotective effects in various experimental models of stroke, including in diabetic conditions. Studies have demonstrated that pre-treatment with statins can reduce infarct size, improve neurological outcomes, and decrease inflammation after focal cerebral ischemia in diabetic mice. The protective mechanisms involve anti-inflammatory effects, improved endothelial function, and enhanced cerebral blood flow. Therefore, the evidence supports that statin pre-treatment does protect the brain against focal cerebral ischemia in diabetic mice.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26272756",
    "question": "Is endothelial Gαq/11 required for VEGF-induced vascular permeability and angiogenesis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the role of endothelial Gαq/11 in VEGF-induced vascular permeability and angiogenesis. VEGF (Vascular Endothelial Growth Factor) is known to promote angiogenesis (formation of new blood vessels) and increase vascular permeability. The question specifically asks if endothelial Gαq/11 (a G protein subunit) is required for these VEGF-induced effects.\\n\\nTo answer this, I need to consider what's known about VEGF signaling pathways. VEGF primarily signals through receptor tyrosine kinases (VEGFRs), particularly VEGFR2, which activates multiple downstream pathways. While G protein-coupled receptors (GPCRs) and G proteins like Gαq/11 can be involved in some aspects of vascular biology, the canonical VEGF signaling pathway operates primarily through receptor tyrosine kinases rather than through G proteins.\\n\\nBased on the established literature, VEGF can induce vascular permeability and angiogenesis through pathways that don't necessarily require Gαq/11. The primary signaling occurs through VEGFR2 activation, leading to PLCγ activation, calcium mobilization, and activation of various kinases like Src, FAK, and PI3K/Akt, which can promote these vascular effects independent of Gαq/11.\\n\\nTherefore, endothelial Gαq/11 is not absolutely required for VEGF-induced vascular permeability and angiogenesis, though it might contribute to or modulate these processes in some contexts.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16352625",
    "question": "Is isotonic better than hypotonic saline for intravenous rehydration of children with gastroenteritis : a prospective randomised study?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking me whether isotonic saline is better than hypotonic saline for IV rehydration in children with gastroenteritis, specifically referencing a prospective randomized study. The question is phrased as if it's a title of a research paper, and is asking me to make a factual determination about medical treatment efficacy. I cannot make definitive medical claims about which treatment is better, as this would require me to have access to the specific study mentioned and medical expertise to interpret it. Additionally, medical best practices can change over time with new research. Without access to the specific study referenced or the ability to evaluate current medical literature, I cannot answer 'yes' or 'no' to this medical efficacy question.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15593040",
    "question": "Are ceruloplasmin and acute phase protein levels associated with cardiovascular disease in chronic dialysis patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the association between ceruloplasmin and acute phase protein levels with cardiovascular disease specifically in chronic dialysis patients. To answer this, I need to consider the medical research on this topic. Ceruloplasmin is a copper-carrying protein in the blood that can act as an acute phase reactant. Acute phase proteins are proteins whose plasma concentrations increase or decrease in response to inflammation. Cardiovascular disease is a common complication in dialysis patients. Research has shown that inflammation markers, including acute phase proteins, are often elevated in dialysis patients and have been associated with cardiovascular outcomes. Several studies have specifically examined ceruloplasmin in this context and found it to be associated with cardiovascular disease risk in dialysis patients. For example, elevated ceruloplasmin has been linked to atherosclerosis, oxidative stress, and increased cardiovascular mortality in this population. Based on the existing medical literature, there does appear to be an association between these markers and cardiovascular disease in chronic dialysis patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21339823",
    "question": "Does pharmacologic modulation of serine/threonine phosphorylation highly sensitize PHEO in a MPC cell and mouse model to conventional chemotherapy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether pharmacologic modulation of serine/threonine phosphorylation highly sensitizes pheochromocytoma (PHEO) in a mouse pheochromocytoma (MPC) cell and mouse model to conventional chemotherapy. To answer this, I would need specific research evidence showing that modulating serine/threonine phosphorylation pathways increases the sensitivity of PHEO to chemotherapy in these models. Without specific studies or data referenced in the question, I cannot determine if this specific pharmacological approach has been proven to sensitize PHEO in MPC cell and mouse models to conventional chemotherapy.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25884593",
    "question": "Do thyroid hormones enhance the biomechanical functionality of scaffold-free neocartilage?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether thyroid hormones enhance the biomechanical functionality of scaffold-free neocartilage. To answer this, I need to consider what is known about thyroid hormones and their effects on cartilage tissue engineering, particularly scaffold-free approaches.\\n\\nThyroid hormones (T3 and T4) are known to play important roles in skeletal development and cartilage maturation. In tissue engineering research, there is evidence that thyroid hormones, particularly triiodothyronine (T3), can enhance the maturation and mechanical properties of engineered cartilage constructs. Studies have shown that T3 supplementation can increase collagen content, improve extracellular matrix organization, and enhance the compressive and tensile properties of engineered cartilage.\\n\\nSpecifically for scaffold-free neocartilage (where cells produce their own extracellular matrix without an artificial scaffold), research has demonstrated that thyroid hormone supplementation can significantly improve biomechanical properties including compressive modulus, tensile strength, and shear properties. These improvements are typically associated with enhanced collagen crosslinking and matrix organization.\\n\\nBased on the scientific literature, thyroid hormones do enhance the biomechanical functionality of scaffold-free neocartilage.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18837739",
    "question": "Does ursodeoxycholic acid reduce lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the effects of ursodeoxycholic acid (UDCA) on specific biochemical properties of gallbladder bile in patients with cholesterol gallstones. Specifically, it asks if UDCA reduces: 1) lipid peroxidation and 2) mucin secretagogue activity in the bile of these patients.\\n\\nUrsodeoxycholic acid is a bile acid that is used therapeutically to dissolve cholesterol gallstones and treat various liver diseases. Research has shown that UDCA can alter bile composition and has protective effects on biliary epithelium.\\n\\nStudies have demonstrated that UDCA treatment can reduce lipid peroxidation in bile of gallstone patients. Lipid peroxidation is a process where free radicals damage lipids, and this oxidative stress is implicated in gallstone formation.\\n\\nRegarding mucin secretagogue activity, research has shown that UDCA can decrease the secretion of mucin in the gallbladder. Mucin is a glycoprotein that can promote cholesterol crystal nucleation and gallstone formation. UDCA appears to reduce the activity of factors in bile that stimulate mucin secretion (secretagogues).\\n\\nBased on the scientific literature, UDCA does reduce both lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24584741",
    "question": "Does acute hypertriglyceridemia induce platelet hyperactivity that is not attenuated by insulin in polycystic ovary syndrome?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether acute hypertriglyceridemia (high levels of triglycerides in the blood) causes platelet hyperactivity (increased platelet activation/aggregation) that is not reduced by insulin specifically in patients with polycystic ovary syndrome (PCOS). To answer this accurately, I would need specific research evidence about this particular relationship in PCOS patients. This is a very specific medical question that requires evidence from clinical studies. Without citing specific research that has investigated this exact relationship, I cannot provide a definitive yes or no answer. The question contains multiple components: 1) whether acute hypertriglyceridemia induces platelet hyperactivity in PCOS, and 2) whether insulin fails to attenuate this hyperactivity in PCOS patients specifically. This is beyond my general knowledge without referring to specific studies.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27197581",
    "question": "Does high copy number of mitochondrial DNA predict poor prognosis in patients with advanced stage colon cancer?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether high copy number of mitochondrial DNA predicts poor prognosis in patients with advanced stage colon cancer. To answer this, I need to consider what scientific evidence shows about the relationship between mitochondrial DNA copy number and outcomes in advanced colon cancer patients.\\n\\nWithout specific scientific studies to reference, I cannot make a definitive claim about this relationship. Some studies have investigated associations between mitochondrial DNA copy number and various cancers, but the relationship is complex and can vary by cancer type. For colon cancer specifically, the literature shows mixed results, with some studies suggesting high mtDNA copy number may be associated with worse outcomes while others show different patterns or no clear association.\\n\\nWithout clear consensus in the scientific literature specifically addressing advanced stage colon cancer and mtDNA copy number as a prognostic marker, I cannot confidently answer yes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18806876",
    "question": "Do somatic 'soluble ' adenylyl cyclase isoforms are unaffected in Sacy tm1Lex/Sacy tm1Lex 'knockout ' mice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether somatic 'soluble' adenylyl cyclase isoforms are unaffected in Sacy tm1Lex/Sacy tm1Lex 'knockout' mice. To answer this, I need to consider what happens to these specific isoforms in this particular knockout mouse model.\\n\\nThe Sacy tm1Lex/Sacy tm1Lex notation indicates a homozygous knockout of the Sacy gene, which encodes soluble adenylyl cyclase. If this is a true knockout model, then by definition, the gene product (soluble adenylyl cyclase) would be affected or absent. \\n\\nHowever, the question specifically asks about 'somatic soluble adenylyl cyclase isoforms' - this suggests there might be different isoforms, and the question is asking if some isoforms remain unaffected despite the knockout.\\n\\nWithout specific information about the selectivity of this knockout model, the default assumption would be that a knockout of the Sacy gene would affect all isoforms of soluble adenylyl cyclase. Therefore, somatic soluble adenylyl cyclase isoforms would likely be affected in these knockout mice, not unaffected.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26232887",
    "question": "Is plasma Brain Natriuretic Peptide a Marker of Prognostic Functional Outcome in Non-Cardioembolic Infarction?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if plasma Brain Natriuretic Peptide (BNP) is a marker of prognostic functional outcome specifically in non-cardioembolic infarction. To answer this, I need to consider what is known about BNP in stroke contexts. BNP is a neurohormone secreted primarily by cardiac ventricular myocytes in response to volume expansion and pressure overload. While BNP has been studied as a biomarker in various cardiovascular conditions including stroke, the question specifically asks about its role as a prognostic marker for functional outcomes in the specific subset of non-cardioembolic strokes. Based on medical literature, BNP has been associated with functional outcomes after stroke in general, but its specific prognostic value in non-cardioembolic infarction as opposed to cardioembolic strokes is less clearly established in mainstream clinical practice. Some studies have suggested BNP may have prognostic value across stroke subtypes, but without specific evidence focusing on non-cardioembolic infarction, I cannot confidently answer yes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23826579",
    "question": "Do human bone marrow-derived mesenchymal stem cell gene expression patterns vary with culture conditions?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether the gene expression patterns of human bone marrow-derived mesenchymal stem cells (hBM-MSCs) change depending on the conditions in which they are cultured. Research has shown that culture conditions such as oxygen levels, growth factors, substrate stiffness, and cell density can indeed affect gene expression in MSCs. For example, hypoxic conditions can alter the expression of genes related to stemness and differentiation. Different media compositions can upregulate or downregulate various genes involved in proliferation and lineage commitment. Three-dimensional versus two-dimensional culture systems also result in different gene expression profiles. So there is substantial evidence that culture conditions do impact gene expression patterns in these cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16437714",
    "question": "Does overexpression of NK2 inhibit liver regeneration after partial hepatectomy in mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question about NK2 and liver regeneration. I need to determine if NK2 overexpression inhibits liver regeneration after partial hepatectomy in mice based on established scientific evidence.\\n\\nNK2 (also known as NK2 homeobox 2 or NKX2) is a transcription factor. In the context of liver biology, NK2 family members have been studied in relation to liver development and regeneration.\\n\\nBased on scientific literature, NK2 family members (particularly NKX2.8) have been shown to inhibit liver regeneration when overexpressed. Studies have demonstrated that overexpression of certain NK2 factors can suppress hepatocyte proliferation after partial hepatectomy in mouse models.\\n\\nSpecifically, research has shown that overexpression of NK2 factors can interfere with cell cycle progression in hepatocytes and impair the regenerative capacity of the liver following surgical resection in mouse models.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23305991",
    "question": "Does presynaptic leptin action suppress excitatory synaptic transmission onto ventral tegmental area dopamine neurons?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the effect of leptin on excitatory synaptic transmission to dopamine neurons in the ventral tegmental area (VTA). To answer this, I need to consider what scientific research has shown about leptin's actions at this specific neural location.\\n\\nLeptin is a hormone primarily produced by adipose tissue that regulates energy balance. It has various effects in the brain, including in reward-related areas like the VTA.\\n\\nResearch has shown that leptin can modulate synaptic transmission in the VTA, but the specific question is whether it suppresses excitatory transmission presynaptically onto VTA dopamine neurons.\\n\\nBased on scientific literature, leptin has been found to suppress excitatory synaptic transmission onto VTA dopamine neurons. Studies have demonstrated that leptin can reduce glutamatergic transmission onto these neurons, and this can occur through presynaptic mechanisms (reducing glutamate release probability). This is part of how leptin can reduce the rewarding value of food and other stimuli.\\n\\nSo the evidence supports that presynaptic leptin action does suppress excitatory synaptic transmission onto VTA dopamine neurons.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20953760",
    "question": "Do women with patellofemoral pain syndrome have quadriceps femoris volume and strength deficiency?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about whether women with patellofemoral pain syndrome (PFPS) have deficiencies in both quadriceps femoris muscle volume and strength compared to women without this condition. Let me analyze the research on this topic.\\n\\nPatellofemoral pain syndrome is a common knee condition characterized by pain around or behind the patella (kneecap). The quadriceps femoris is a group of muscles at the front of the thigh that are important for knee extension and stability.\\n\\nResearch has consistently shown that individuals with PFPS, including women specifically, tend to demonstrate quadriceps weakness compared to healthy controls. Multiple studies have found reduced quadriceps strength in women with PFPS.\\n\\nRegarding muscle volume, studies using imaging techniques like MRI have found that women with PFPS often show reduced quadriceps muscle volume or cross-sectional area compared to healthy controls.\\n\\nSo based on the scientific literature, women with PFPS do typically demonstrate both quadriceps strength deficits and reduced muscle volume/mass compared to women without the condition.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17942806",
    "question": "Are egg labeling methods for gastric emptying scintigraphy equivalent in producing a stable solid meal?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if different egg labeling methods for gastric emptying scintigraphy produce equally stable solid meals. Based on research in nuclear medicine, there are several methods for labeling eggs for this procedure (such as in-vivo labeling, in-vitro labeling, and different radiopharmaceuticals like Tc-99m sulfur colloid). Studies have shown that different labeling techniques can result in varying stability of the radiotracer binding to the egg component, which can affect the accuracy of the gastric emptying measurement. Some methods produce more stable binding than others, with factors like cooking method and pH affecting stability. Therefore, not all egg labeling methods are equivalent in producing a stable solid meal.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "24920160",
    "question": "Does granulocyte colony-stimulating factor promote neurogenesis after experimental intracerebral haemorrhage?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, I need to consider what is known about granulocyte colony-stimulating factor (G-CSF) and its effects on neurogenesis specifically in the context of intracerebral hemorrhage (ICH).\\n\\nG-CSF is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells. In recent years, it has been studied for potential neuroprotective and neurorestorative effects in various neurological conditions.\\n\\nResearch has shown that G-CSF can:\\n1. Promote neurogenesis in various brain injury models\\n2. Enhance proliferation of neural stem/progenitor cells\\n3. Support neuronal differentiation\\n4. Improve functional recovery after brain injury\\n\\nSpecifically regarding intracerebral hemorrhage, several experimental studies have demonstrated that G-CSF administration after experimental ICH in animal models promotes neurogenesis in the subventricular zone and hippocampus, enhances migration of neural progenitor cells to the injury site, and improves functional outcomes.\\n\\nFor example, studies by Park et al. (2005), Chu et al. (2008), and others have shown that G-CSF treatment after experimental ICH increases the number of newly generated neurons and improves neurological function.\\n\\nBased on the available scientific evidence, G-CSF does promote neurogenesis after experimental intracerebral hemorrhage.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "25538886",
    "question": "Is agenesis and not ectopia common in North Indian children with thyroid dysgenesis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if agenesis (complete absence of the thyroid gland) and not ectopia (abnormal positioning of the thyroid gland) is common in North Indian children with thyroid dysgenesis. Thyroid dysgenesis refers to abnormal development of the thyroid gland, which can include agenesis, ectopia, or hypoplasia. To answer this question accurately, I would need specific epidemiological data about the prevalence of different types of thyroid dysgenesis in North Indian children. Without specific data from studies on North Indian children with thyroid dysgenesis showing the relative frequencies of agenesis versus ectopia, I cannot make a definitive statement about which form is more common in this specific population.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27393627",
    "question": "Does irreversible electroporation enhance delivery of gemcitabine to pancreatic adenocarcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether irreversible electroporation (IRE) enhances the delivery of gemcitabine (a chemotherapy drug) to pancreatic adenocarcinoma (a type of pancreatic cancer). IRE is a non-thermal ablation technique that uses high-voltage electrical pulses to create nanopores in cell membranes, leading to cell death. Some research has investigated whether IRE can increase drug delivery to tumors by increasing permeability of tumor tissue. Let me consider what the evidence shows about IRE specifically enhancing gemcitabine delivery to pancreatic adenocarcinoma. Studies have shown that IRE can increase drug penetration into tissues by disrupting cell membranes and potentially disrupting tumor stroma. There is research demonstrating that IRE combined with gemcitabine shows improved efficacy in pancreatic cancer models compared to either treatment alone, suggesting enhanced drug delivery. Based on published literature, IRE does appear to enhance delivery of gemcitabine to pancreatic adenocarcinoma.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26009788",
    "question": "Does differential activation of airway eosinophils induce IL-13-mediated allergic Th2 pulmonary responses in mice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if differential activation of airway eosinophils induces IL-13-mediated allergic Th2 pulmonary responses in mice. This is asking about a specific immunological mechanism in mice - whether activated airway eosinophils trigger IL-13-mediated allergic Th2 responses in the lungs. To answer this accurately, I would need to know if research has established this causal relationship. While eosinophils are known to be involved in allergic responses and IL-13 is a key cytokine in Th2 responses, I don't have specific evidence that differential activation of airway eosinophils specifically induces IL-13-mediated allergic Th2 pulmonary responses in mice. Without specific research confirming this mechanism, I cannot definitively say yes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17937387",
    "question": "Do glycine N-methyltransferase-/- mice develop chronic hepatitis and glycogen storage disease in the liver?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to determine if glycine N-methyltransferase-/- (GNMT-/-) mice develop chronic hepatitis and glycogen storage disease in the liver. Let me analyze what's known about this knockout mouse model.\\n\\nGNMT is an enzyme involved in methionine and folate metabolism. GNMT-/- mice have been studied as models for liver disease. Based on scientific literature, GNMT-/- mice do develop chronic hepatitis - they show liver inflammation, abnormal liver enzyme levels, and progressive liver damage. They also develop steatosis (fatty liver).\\n\\nRegarding glycogen storage disease specifically, GNMT-/- mice have metabolic abnormalities, but I don't recall specific evidence that they develop glycogen storage disease (abnormal accumulation of glycogen in the liver). The primary pathologies are hepatic steatosis, fibrosis, and eventually hepatocellular carcinoma. Glycogen storage disease is characterized by specific enzymatic defects in glycogen metabolism, which is not the primary defect in GNMT-/- mice.\\n\\nSo while these mice develop chronic hepatitis, they don't specifically develop glycogen storage disease in the liver.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17954090",
    "question": "Does laparoscopic clam shell partial fundoplication achieve effective reflux control with reduced postoperative dysphagia and gas bloating?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether laparoscopic clam shell partial fundoplication achieves effective reflux control while reducing postoperative dysphagia and gas bloating compared to other procedures. To answer this, I would need to know about clinical studies comparing this specific technique with other fundoplication approaches. Clam shell partial fundoplication is a type of partial fundoplication procedure, and partial fundoplications in general (like Toupet or Dor) are often associated with lower rates of dysphagia and gas bloating compared to complete fundoplications (like Nissen), while still providing reasonable reflux control. However, without specific evidence about the 'clam shell' technique in particular, I cannot make a definitive claim about its effectiveness and side effect profile.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18071608",
    "question": "Is eUS-FNA of the left adrenal gland safe and useful?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if eUS-FNA (endoscopic ultrasound-guided fine needle aspiration) of the left adrenal gland is safe and useful. To answer this, I need to consider the medical evidence about this procedure's safety profile and clinical utility.\\n\\nEndoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of the left adrenal gland is generally considered both safe and useful in clinical practice. The left adrenal gland is anatomically accessible via EUS as it lies in proximity to the stomach. Multiple studies have shown that EUS-FNA of the left adrenal gland has:\\n\\n1. High diagnostic accuracy (85-95%) for detecting metastases or other pathologies\\n2. Low complication rates (typically <1% for serious complications)\\n3. Clinical utility in cancer staging, particularly for lung cancer patients\\n4. Value in evaluating adrenal incidentalomas and masses\\n\\nThe procedure has become a standard approach for tissue acquisition from the left adrenal when indicated, with a favorable safety profile compared to percutaneous approaches in many cases. Complications are rare when performed by experienced endosonographers.\\n\\nBased on the medical literature, I can confidently say that eUS-FNA of the left adrenal gland is both safe and useful.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27771826",
    "question": "Is the mycobiome of root canal infections correlated to the bacteriome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the mycobiome (fungal community) of root canal infections is correlated to the bacteriome (bacterial community). To answer this, I need to consider whether scientific evidence shows a relationship between fungal and bacterial communities in root canal infections.\\n\\nBased on current research in endodontic microbiology, studies have indeed shown correlations between fungal and bacterial communities in root canal infections. Several investigations have demonstrated that specific bacterial species often co-occur with certain fungal species in infected root canals, suggesting ecological relationships between these microorganisms. For example, Candida species (fungi) have been found to have associations with certain bacterial taxa in root canal infections. These correlations may involve synergistic relationships, antagonistic interactions, or shared environmental preferences.\\n\\nResearch using modern sequencing techniques has revealed network connections between members of the mycobiome and bacteriome in endodontic infections, supporting the existence of a correlation between these microbial communities.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24881129",
    "question": "Does methamphetamine enhance the development of schizophrenia in first-degree relatives of patients with schizophrenia?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question asks about whether methamphetamine enhances the development of schizophrenia specifically in first-degree relatives of schizophrenia patients. First-degree relatives (parents, siblings, children) of schizophrenia patients already have a higher genetic risk for developing schizophrenia. The question is asking if methamphetamine use further increases this risk in this specific population.\\n\\nResearch has shown that methamphetamine use can trigger psychosis and psychotic symptoms in general, and it's known that substance use (including methamphetamine) can be a risk factor for developing schizophrenia or worsening its course. However, for a definitive 'yes' answer, I would need specific evidence showing that methamphetamine has a particular or enhanced effect specifically in first-degree relatives compared to the general population.\\n\\nWhile there is evidence that both genetic risk and methamphetamine use are independent risk factors for psychosis, I don't recall specific studies demonstrating a synergistic effect specifically in first-degree relatives. Without that specific evidence, I should answer 'no' to this precise question.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9539510",
    "question": "Does lipopolysaccharide enhance the transcription of prostaglandin H synthase-2 gene in primary human trophoblasts?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question. It's asking about the effect of lipopolysaccharide (LPS) on the transcription of prostaglandin H synthase-2 gene specifically in primary human trophoblasts. Trophoblasts are cells that form the outer layer of a blastocyst and develop into a large part of the placenta. To answer this, I need to know if LPS increases the transcription of this specific gene in this specific cell type. Based on scientific literature, LPS is known to be an endotoxin that can induce inflammatory responses and can upregulate prostaglandin synthesis in many cell types through activation of cyclooxygenase-2 (COX-2, which is encoded by the prostaglandin H synthase-2 gene). However, without specific knowledge about this effect in primary human trophoblasts, I cannot definitively say yes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11927726",
    "question": "Is an early ( sixth-hour ) serum bilirubin measurement useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if an early (sixth-hour) serum bilirubin measurement is useful in predicting two things in newborns with ABO incompatibility: 1) the development of significant hyperbilirubinemia, and 2) severe ABO hemolytic disease. This is asking about the predictive value of an early lab test in a specific high-risk population. Without specific medical research data, I cannot definitively answer this clinical question. However, based on general medical knowledge, early bilirubin measurements are often used to predict hyperbilirubinemia risk in various contexts, including ABO incompatibility situations. The question appears to be asking about established medical evidence regarding this specific predictive relationship.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25064447",
    "question": "Is lung fibrotic tenascin-C upregulation associated with other extracellular matrix proteins and induced by TGFβ1?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question about lung fibrotic tenascin-C upregulation. The question asks about two associations: 1) whether lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins, and 2) whether this upregulation is induced by TGFβ1. \\n\\nTenascin-C is an extracellular matrix glycoprotein that is known to be upregulated in fibrotic conditions. In lung fibrosis, research has shown that tenascin-C is indeed upregulated alongside other ECM proteins like collagens, fibronectin, and proteoglycans. Additionally, transforming growth factor-beta 1 (TGFβ1) is a well-established pro-fibrotic cytokine that has been shown to induce the expression of various ECM proteins, including tenascin-C, in fibrotic conditions. Multiple studies have demonstrated that TGFβ1 can directly stimulate tenascin-C expression in lung fibroblasts and other cell types involved in pulmonary fibrosis. Therefore, both parts of the question can be answered affirmatively.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23914264",
    "question": "Does early scrotal approximation after hemiscrotectomy in patients with Fournier 's gangrene prevent scrotal reconstruction with skin graft?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if early scrotal approximation after hemiscrotectomy in patients with Fournier's gangrene prevents the need for scrotal reconstruction with skin graft. To answer this, I need to consider whether early scrotal approximation is a technique that can eliminate the need for skin grafting in these cases.\\n\\nFournier's gangrene is a necrotizing fasciitis of the perineal, genital, or perianal regions that often requires aggressive surgical debridement, which may include hemiscrotectomy (removal of part of the scrotum). After such debridement, the patient is left with a significant tissue defect.\\n\\nEarly scrotal approximation refers to bringing together the remaining scrotal tissue soon after debridement. The question is whether this technique prevents the need for skin grafting for reconstruction.\\n\\nBased on medical literature, early scrotal approximation can indeed help in the healing process and may reduce the need for complex reconstructive procedures including skin grafts. The scrotal skin has remarkable elasticity and blood supply, which allows for primary closure in many cases, even after extensive debridement. By approximating the remaining scrotal tissue early, the natural healing process can be facilitated, potentially eliminating the need for skin grafts.\\n\\nSo yes, early scrotal approximation after hemiscrotectomy in patients with Fournier's gangrene can prevent the need for scrotal reconstruction with skin graft in many cases.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27593220",
    "question": "Does cinacalcet ameliorate aortic calcification in uremic rats via suppression of endothelial-to-mesenchymal transition?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether cinacalcet (a calcimimetic agent) reduces aortic calcification in uremic rats specifically through a mechanism of suppressing endothelial-to-mesenchymal transition (EndMT). To answer this, I would need to know if research has demonstrated this specific mechanism of action. Cinacalcet is known to treat secondary hyperparathyroidism in chronic kidney disease by activating calcium-sensing receptors, but the question asks about a specific molecular pathway (EndMT suppression) in the context of vascular calcification in uremic rats. Without specific research evidence showing this mechanism, I cannot confirm this claim.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20506636",
    "question": "Is [ Protein kinase C activation required for free fatty acid-induced impairment of endothelial nitric oxide synthase ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether protein kinase C activation is required for free fatty acid-induced impairment of endothelial nitric oxide synthase. This appears to be a scientific question about a biochemical pathway or mechanism. To answer this accurately, I would need specific scientific evidence from research studies. The question is phrased as a title of a research paper, which suggests it might be investigating this exact relationship. Without access to the paper's content or other scientific literature on this topic, I cannot determine whether protein kinase C activation is indeed required for this specific biochemical process. The question requires specialized knowledge in biochemistry and cellular signaling pathways.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25520081",
    "question": "Does hepatitis B virus DNA negativity act as a favorable prognostic factor in hepatocellular carcinoma patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether hepatitis B virus (HBV) DNA negativity is a favorable prognostic factor in hepatocellular carcinoma (HCC) patients. To answer this, I need to consider what research shows about the relationship between HBV DNA status and HCC outcomes.\\n\\nHepatitis B virus is a known risk factor for developing HCC. When patients have HCC and are also infected with HBV, their viral load (measured by HBV DNA levels) can potentially impact their prognosis.\\n\\nBased on medical literature, patients who are HBV DNA negative (meaning they have undetectable viral loads or have cleared the virus) generally have better liver function, less ongoing inflammation and damage, and potentially better responses to treatment compared to those with active viral replication (HBV DNA positive).\\n\\nStudies have shown that high HBV DNA levels are associated with higher rates of HCC recurrence after treatment and poorer overall survival. Conversely, patients who achieve HBV DNA negativity through antiviral therapy or naturally tend to have better outcomes.\\n\\nTherefore, HBV DNA negativity is generally considered a favorable prognostic factor in HCC patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19207009",
    "question": "Is prohibitin overexpressed in papillary thyroid carcinomas bearing the BRAF ( V600E ) mutation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To answer this question, I need to determine if there's evidence that prohibitin is overexpressed specifically in papillary thyroid carcinomas (PTCs) that have the BRAF(V600E) mutation.\\n\\nProhibitin is a protein that can function as a tumor suppressor or oncogene depending on context. The BRAF(V600E) mutation is common in papillary thyroid carcinomas.\\n\\nBased on my knowledge, there have been studies examining protein expression profiles in thyroid cancers with different genetic backgrounds, including BRAF mutations. However, I don't have specific information about prohibitin expression being higher in BRAF(V600E)-positive PTCs compared to BRAF wild-type PTCs.\\n\\nWithout specific evidence showing prohibitin overexpression in BRAF(V600E) mutant PTCs, I cannot confirm this relationship.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16401308",
    "question": "Is clinically apparent atherosclerotic disease in diabetes associated with an increase in platelet microparticle levels?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels. To answer this, I need to consider what is known about the relationship between atherosclerotic disease in diabetic patients and platelet microparticle levels. Platelet microparticles are small vesicles released from platelets that can serve as biomarkers for various cardiovascular conditions. In diabetes, there is often increased platelet activation and dysfunction. Studies have shown that patients with diabetes have higher levels of circulating platelet microparticles compared to non-diabetic individuals. When atherosclerotic disease becomes clinically apparent in diabetic patients (manifesting as conditions like coronary artery disease, peripheral artery disease, etc.), there is typically further elevation in platelet activation markers. Research has demonstrated that platelet microparticle levels are indeed elevated in diabetic patients with manifest atherosclerotic complications compared to diabetic patients without such complications. Therefore, the evidence supports that clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18090039",
    "question": "Are difficulties in eliciting broadly neutralizing anti-HIV antibodies explained by cardiolipin autoreactivity?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether the challenges in generating broadly neutralizing antibodies (bNAbs) against HIV are explained by cardiolipin autoreactivity. Broadly neutralizing antibodies are antibodies that can neutralize many different strains of HIV, which would be ideal for a vaccine. However, they have been difficult to elicit through vaccination. The question specifically asks if this difficulty is explained by cardiolipin autoreactivity - meaning that these antibodies might cross-react with cardiolipin, a self-antigen, making them autoreactive (reacting against self). \\n\\nThere is research suggesting that some HIV bNAbs do show cardiolipin autoreactivity, which could explain why they're difficult to elicit (since the immune system typically eliminates autoreactive antibodies). However, this is just one of several factors that make HIV bNAb generation challenging. Other factors include the high mutation rate of HIV, glycan shielding of conserved epitopes, and the complex maturation pathway needed for bNAb development. While cardiolipin autoreactivity is a contributing factor for some bNAbs, it doesn't fully explain all the difficulties in eliciting these antibodies.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "26659720",
    "question": "Is increased expression of ERCC2 gene in head and neck cancer associated with aggressive tumors : a systematic review and case-control study?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking if increased expression of the ERCC2 gene in head and neck cancer is associated with aggressive tumors, specifically referring to a systematic review and case-control study. The question is asking about a specific finding from a particular study or review. Without having access to the specific systematic review and case-control study mentioned, I cannot determine whether that study found an association between increased ERCC2 expression and aggressive head and neck tumors. The question is not asking for my general knowledge about ERCC2 and cancer, but rather about the findings of a specific study.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19552631",
    "question": "Is irritable bowel syndrome strongly associated with generalized anxiety disorder : a community study?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether irritable bowel syndrome (IBS) is strongly associated with generalized anxiety disorder (GAD) according to a community study. To answer this accurately, I would need to know the specific findings of the community study being referenced. However, based on general medical knowledge, there is indeed a recognized association between IBS and anxiety disorders, including GAD. Multiple studies have shown comorbidity between these conditions, with anxiety being more prevalent in IBS patients than in the general population. The gut-brain axis is thought to play a role in this relationship. Without knowing the specific community study referenced, I can say that in general, research does support an association between IBS and GAD, though the strength of this association can vary across studies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25798535",
    "question": "Does coadministration of HMG-CoA reductase inhibitors , atorvastatin and rosuvastatin , affect contraceptive efficacy of centchroman?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if coadministration of HMG-CoA reductase inhibitors (specifically atorvastatin and rosuvastatin) affects the contraceptive efficacy of centchroman. To answer this, I need to consider if there are known drug interactions between statins and centchroman (also known as ormeloxifene) that would reduce its contraceptive effectiveness. Based on available pharmacological data, there are no well-established or significant interactions between statins (atorvastatin/rosuvastatin) and centchroman that would reduce its contraceptive efficacy. While both drug classes are metabolized by liver enzymes, there is no strong evidence indicating that statins substantially alter the metabolism of centchroman to a degree that would compromise its contraceptive effects. Without specific clinical evidence demonstrating reduced efficacy, I cannot conclude that such an interaction exists.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "11048835",
    "question": "Does two-hour urine collection for evaluating renal function correlate with 24-hour urine collection in pregnant patients?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a two-hour urine collection correlates with a 24-hour urine collection for evaluating renal function specifically in pregnant patients. To answer this, I need to consider whether there's established evidence that shorter collection periods (2 hours) can reliably substitute for the standard 24-hour collection in the pregnant population. In general medicine, 24-hour collections are considered the gold standard for many renal function tests, but there has been research examining whether shorter collection periods could be valid. For pregnant patients specifically, physiological changes during pregnancy affect renal function and urine production patterns. Based on the medical literature, while some studies have explored shorter collection periods, there isn't strong consensus that a 2-hour collection specifically correlates well enough with 24-hour collections to be considered reliable in pregnant patients. Most clinical guidelines still recommend 24-hour collections for accurate assessment of renal function in pregnancy, especially for conditions like preeclampsia.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17581335",
    "question": "Does axillary lymph node visualization on F-18 FDG PET body scan in patients with rheumatoid arthritis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether axillary lymph nodes are visualized on F-18 FDG PET body scans in patients with rheumatoid arthritis. Rheumatoid arthritis (RA) is an inflammatory autoimmune disease that primarily affects joints but can have systemic manifestations. F-18 FDG PET scans detect areas of increased glucose metabolism, which occurs in inflammatory processes.\\n\\nIn patients with RA, there can be increased FDG uptake in inflamed joints and potentially in lymph nodes due to the systemic inflammatory nature of the disease. Axillary lymph nodes (located in the armpit area) can show increased metabolic activity on PET scans in patients with RA due to the inflammatory process.\\n\\nMultiple studies have demonstrated that patients with RA can show increased FDG uptake in axillary lymph nodes on PET scans, reflecting the systemic inflammatory nature of the disease. This lymph node visualization is part of the extra-articular manifestations that can be detected on imaging in RA patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11744478",
    "question": "Are plasma levels of interleukin-6 and its soluble receptor associated with prostate cancer progression and metastasis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the association between plasma levels of interleukin-6 (IL-6) and its soluble receptor with prostate cancer progression and metastasis. IL-6 is a cytokine involved in inflammation and immune responses, and elevated levels have been implicated in various cancers. \\n\\nBased on medical literature, there is evidence supporting that elevated IL-6 and soluble IL-6 receptor levels in plasma are associated with prostate cancer progression, metastasis, and poorer outcomes. Multiple studies have shown that IL-6 levels correlate with advanced disease stage, bone metastasis, and treatment resistance in prostate cancer. The soluble IL-6 receptor has also been implicated in facilitating IL-6 signaling in prostate cancer cells, promoting tumor growth and metastasis.\\n\\nTherefore, the answer is yes - plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15887118",
    "question": "Is human homologue of maid a useful marker protein in hepatocarcinogenesis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the human homologue of maid is a useful marker protein in hepatocarcinogenesis (liver cancer development). To answer this, I need to consider whether there is scientific evidence supporting the use of the human homologue of maid as a biomarker in liver cancer. \\n\\nMaid (Maternal Id-like molecule) was originally identified in Xenopus, and its human homologue is sometimes referred to as GCIP (Grap2 cyclin D interacting protein) or HHM (Human homologue of Maid). \\n\\nBased on scientific literature, GCIP/HHM has been studied in relation to hepatocarcinogenesis, and there is evidence suggesting it functions as a tumor suppressor in liver cancer. Some studies have shown that its expression is reduced in hepatocellular carcinoma compared to normal liver tissue, suggesting it could potentially serve as a marker for hepatocarcinogenesis.\\n\\nHowever, to be considered a 'useful marker protein,' it should have demonstrated clinical utility in diagnosing, staging, or monitoring liver cancer. While there is research interest in this protein's role in liver cancer, it has not been widely established or adopted as a standard clinical biomarker for hepatocarcinogenesis compared to more established markers like AFP (alpha-fetoprotein).\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20113487",
    "question": "Does transcriptome analysis of the Cryptocaryon irritans tomont stage identify potential genes for the detection and control of cryptocaryonosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if transcriptome analysis of the Cryptocaryon irritans tomont stage identifies potential genes for detection and control of cryptocaryonosis. To answer this, I need to know if there's evidence that such analysis has identified genes that could be used for detection methods or control strategies for this parasitic disease. Without specific information about research findings on C. irritans tomont transcriptome analysis, I cannot definitively answer this question. However, transcriptome analyses typically aim to identify gene expression patterns that could reveal potential targets for diagnostics or treatments, so it's plausible but not certain without specific evidence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20079161",
    "question": "Does antithrombin-III without concomitant heparin improve endotoxin-induced acute lung injury rats by inhibiting the activation of mitogen-activated protein kinase?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if antithrombin-III (AT-III) without heparin improves endotoxin-induced acute lung injury in rats specifically by inhibiting MAPK activation. This is a very specific scientific claim about a mechanism of action. To answer this accurately, I would need to know if studies have demonstrated that: 1) AT-III alone (without heparin) improves outcomes in endotoxin-induced lung injury in rats, and 2) this improvement is mechanistically linked to MAPK inhibition. Without specific research evidence supporting this exact mechanism, I cannot confirm this claim.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22608317",
    "question": "Are frozen-thawed spermatozoa from oligozoospermic ejaculates susceptible to in situ DNA fragmentation in polyvinylpyrrolidone-based sperm-immobilization medium?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether frozen-thawed sperm from men with oligozoospermia (low sperm count) are susceptible to DNA fragmentation when placed in a polyvinylpyrrolidone (PVP)-based sperm-immobilization medium. This is a specific scientific question about sperm DNA damage in a particular laboratory context.\\n\\nTo answer this accurately, I would need to know research findings on this specific topic. Research has shown that PVP, which is commonly used in ICSI procedures to slow sperm movement, can potentially affect sperm DNA integrity. Additionally, sperm from oligozoospermic men may already have higher baseline DNA fragmentation rates, and freeze-thawing processes are known to potentially increase DNA damage.\\n\\nBased on scientific literature, frozen-thawed spermatozoa from oligozoospermic samples do show increased susceptibility to DNA fragmentation when exposed to PVP-based media compared to fresh samples or samples from normozoospermic men.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27271201",
    "question": "Do prolonged esophageal acid exposures induce synaptic downscaling of cortical membrane AMPA receptor subunits in rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific physiological mechanism: whether prolonged esophageal acid exposures cause synaptic downscaling of cortical membrane AMPA receptor subunits in rats. This is a very specific neuroscience question about acid reflux effects on brain receptors. To answer this accurately, I would need to know if research has demonstrated this specific relationship between esophageal acid exposure and changes in AMPA receptor expression in the cortex of rats. This appears to be a specialized research question that would require knowledge of specific studies in this area. Based on my knowledge, there have been studies showing that acid exposure in the esophagus can trigger various neural responses, and separately, that AMPA receptor downscaling can occur in various conditions, but I don't have definitive information about this specific relationship being established in rats.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25848837",
    "question": "Do proteomic and metabolomic analyses provide insight into production of volatile and non-volatile flavor components in mandarin hybrid fruit?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question asks if proteomic and metabolomic analyses provide insight into the production of flavor components in mandarin hybrid fruit. To answer this, I need to consider whether these analytical approaches (proteomics and metabolomics) can reveal information about the biochemical pathways and compounds involved in flavor production in this specific fruit type.\\n\\nProteomics involves the study of proteins in biological systems, which would include enzymes involved in biosynthetic pathways for flavor compounds. Metabolomics involves the comprehensive analysis of small molecule metabolites, which would include volatile and non-volatile flavor compounds themselves.\\n\\nBoth of these approaches can provide significant insights into flavor component production by:\\n1. Identifying enzymes involved in flavor biosynthesis (proteomics)\\n2. Detecting and quantifying the flavor compounds themselves (metabolomics)\\n3. Elucidating the biochemical pathways connecting primary metabolism to flavor compound production\\n4. Tracking changes in flavor-related proteins and metabolites during fruit development\\n\\nFor mandarin hybrid fruits specifically, these techniques would be applicable and valuable for understanding the complex biochemistry of flavor production. Therefore, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24773571",
    "question": "Does patient-prosthesis mismatch in patients undergoing bioprosthetic aortic valve implantation increase risk of reoperation for structural valve deterioration?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether patient-prosthesis mismatch (PPM) in patients who receive bioprosthetic aortic valve implantation increases the risk of reoperation for structural valve deterioration (SVD). To answer this, I need to consider whether there's established evidence that PPM leads to higher rates of SVD requiring reoperation.\\n\\nPatient-prosthesis mismatch occurs when the effective orifice area of a prosthetic valve is too small relative to the patient's body size, resulting in higher transvalvular gradients. While PPM has been associated with various adverse outcomes like decreased regression of left ventricular hypertrophy and increased mortality in some studies, the specific link to structural valve deterioration requiring reoperation is what I need to focus on.\\n\\nBased on the medical literature, there is evidence suggesting that PPM can accelerate bioprosthetic valve degeneration through increased mechanical stress on valve leaflets due to higher transvalvular gradients. Several studies have shown that patients with significant PPM have higher rates of SVD and subsequent need for reoperation compared to those without PPM. The increased hemodynamic stress appears to accelerate calcification and tissue degeneration in bioprosthetic valves.\\n\\nTherefore, the evidence supports that PPM does increase the risk of reoperation for SVD in patients with bioprosthetic aortic valves.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18719881",
    "question": "Is beta cell glucose sensitivity decreased by 39 % in non-diabetic individuals carrying multiple diabetes-risk alleles compared with those with no risk alleles?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if beta cell glucose sensitivity is decreased by 39% in non-diabetic individuals carrying multiple diabetes-risk alleles compared with those with no risk alleles. To answer this, I would need specific research data about the relationship between diabetes-risk alleles and beta cell glucose sensitivity in non-diabetic individuals. Without being provided with specific research studies or data in the question, I cannot confirm whether this specific percentage (39%) is accurate. This would be a specific scientific finding that would need to be supported by research evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17257994",
    "question": "Are endothelial progenitor cells mobilized after cardiac surgery?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, I need to consider what happens to endothelial progenitor cells (EPCs) during and after cardiac surgery. EPCs are stem cells that can differentiate into endothelial cells which line blood vessels. Research has shown that various types of tissue injury, including surgical trauma, can trigger the mobilization of EPCs from the bone marrow into the peripheral circulation as part of the body's repair mechanism. Multiple studies have specifically demonstrated that cardiac surgery leads to increased levels of circulating EPCs, which are thought to contribute to vascular repair and angiogenesis following the surgical trauma. This mobilization appears to be mediated by various factors released during surgery, including inflammatory cytokines and hypoxia-inducible factors. So based on the scientific literature, endothelial progenitor cells are indeed mobilized after cardiac surgery.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16302179",
    "question": "Is local recurrence after curative resection for rectal cancer associated with anterior position of the tumour?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if local recurrence after curative resection for rectal cancer is associated with anterior position of the tumor. To answer this, I need to consider the medical literature on rectal cancer recurrence patterns. Based on my knowledge, tumor location within the rectum (anterior, posterior, lateral) has been studied as a potential risk factor for recurrence. Some studies have examined whether anterior tumors specifically have different recurrence rates compared to tumors in other positions. The evidence is somewhat mixed, but most larger studies and meta-analyses do not consistently identify anterior tumor position as an independent risk factor for local recurrence after proper curative resection. Other factors like surgical technique, tumor stage, circumferential resection margin status, and neoadjuvant therapy tend to be more significant predictors of recurrence. Therefore, there isn't strong evidence supporting a specific association between anterior tumor position and increased local recurrence rates.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22093622",
    "question": "Does [ Cisplatin enhance TRAIL-induced apoptosis in gastric cancer cells through clustering death receptor 4 into lipid rafts ]?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if Cisplatin enhances TRAIL-induced apoptosis in gastric cancer cells through clustering death receptor 4 into lipid rafts. This appears to be a specific scientific claim about a mechanism of action for cancer treatment. To answer this accurately, I would need to know if this specific mechanism has been established in scientific literature. The question is phrased as a scientific finding, suggesting that Cisplatin does indeed enhance TRAIL-induced apoptosis through this specific mechanism (clustering death receptor 4 into lipid rafts) in gastric cancer cells. Without specific knowledge of this research finding, I cannot confirm or deny this claim with certainty.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27789473",
    "question": "Does kv7 Channel Activation underpin EPAC-Dependent Relaxations of Rat Arteries?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific molecular mechanism in rat arteries. Specifically, it's asking whether kv7 channel activation is the underlying mechanism for EPAC-dependent relaxations in rat arteries. To answer this accurately, I would need to know the scientific literature on this topic. EPAC (Exchange Protein directly Activated by cAMP) is a signaling molecule, and Kv7 channels are voltage-gated potassium channels. The question is asking if activation of these Kv7 channels is responsible for the relaxation effects that EPAC causes in rat arteries. Without specific scientific knowledge about this mechanism, I cannot provide a definitive answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26303568",
    "question": "Does the daily incidence of out-of-hospital cardiac arrest unexpectedly increase around New Year 's Day in Japan?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about whether there is an unexpected increase in the daily incidence of out-of-hospital cardiac arrest around New Year's Day specifically in Japan. To answer this, I would need to know if there are studies or data showing a statistically significant spike in cardiac arrests during this holiday period in Japan compared to other times of the year. Some countries do show holiday-related increases in cardiac events due to factors like stress, alcohol consumption, dietary changes, and cold weather. For Japan specifically, I recall there have been studies showing such a pattern, with New Year's Day having higher rates of cardiac arrests compared to regular days. This phenomenon has been documented in Japanese medical literature, showing a holiday effect on cardiovascular emergencies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19864636",
    "question": "Does intensive coordinative training improve motor performance in degenerative cerebellar disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether intensive coordinative training improves motor performance in people with degenerative cerebellar disease. Degenerative cerebellar diseases are conditions that cause progressive deterioration of the cerebellum, which is responsible for coordination and motor control. \\n\\nResearch has shown that intensive coordinative training can lead to improvements in motor performance in patients with degenerative cerebellar disease. Multiple studies have demonstrated that specific exercises targeting coordination, balance, and motor skills can help patients with cerebellar ataxia (a common symptom of cerebellar degeneration) improve their functional abilities. While these interventions cannot stop the progression of the underlying disease, they can help improve or maintain motor function.\\n\\nFor example, studies by Ilg et al. (2009, 2010) and Miyai et al. (2012) have shown that intensive coordinative training programs can lead to improvements in ataxia rating scales, gait parameters, and activities of daily living in patients with degenerative cerebellar disease. These improvements can persist for months after the training period ends.\\n\\nBased on the available evidence, intensive coordinative training does improve motor performance in degenerative cerebellar disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15746997",
    "question": "Does initial years of recreational artistic gymnastics training improve lumbar spine bone mineral accrual in 4- to 8-year-old females?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether initial years of recreational artistic gymnastics training improves lumbar spine bone mineral accrual in 4- to 8-year-old females. To answer this, I would need specific research evidence about the effects of gymnastics training on bone mineral density in the lumbar spine specifically for this age group. Without being provided specific studies or data in the prompt, I cannot make a definitive claim about this relationship. While gymnastics is generally associated with higher bone mineral density due to its weight-bearing nature, I cannot confirm whether this specifically applies to lumbar spine bone mineral accrual in 4-8 year old females during initial training years without research evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26746989",
    "question": "Is statin therapy associated with improved outcomes after heart transplantation in children and adolescents?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the association between statin therapy and improved outcomes after heart transplantation specifically in children and adolescents. To answer this, I need to consider whether there is established evidence that statins improve outcomes in pediatric heart transplant recipients.\\n\\nStatins (HMG-CoA reductase inhibitors) are commonly used in adult heart transplant recipients to reduce the risk of cardiac allograft vasculopathy and improve long-term outcomes. However, the evidence for their use in pediatric heart transplant recipients is more limited.\\n\\nWhile some transplant centers do use statins in pediatric heart transplant recipients based on extrapolation from adult data, there are fewer large-scale studies specifically examining outcomes in children and adolescents. The pediatric population has different pharmacokinetics, risk profiles, and developmental considerations compared to adults.\\n\\nBased on my knowledge, there is not robust, conclusive evidence from large randomized controlled trials specifically showing that statin therapy is associated with improved outcomes after heart transplantation in children and adolescents, though some centers do include statins in their protocols based on limited data and extrapolation from adult studies.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "16846533",
    "question": "Is central nervous system relapse in patients with breast cancer associated with advanced stages , with the presence of circulating occult tumor cells and with the HER2/neu status?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if central nervous system relapse in breast cancer patients is associated with three specific factors: (1) advanced stages of breast cancer, (2) presence of circulating occult tumor cells, and (3) HER2/neu status. Based on medical literature, central nervous system (CNS) metastases in breast cancer are indeed associated with advanced disease stage. There is also evidence that circulating tumor cells can predict brain metastases. Additionally, HER2-positive breast cancers have a higher propensity for CNS metastases compared to other subtypes. All three factors mentioned in the question have been associated with increased risk of CNS relapse in breast cancer patients according to clinical research.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17545020",
    "question": "Does [ Nitroglycerine promote myocardial oxygen metabolism and regional cardiac function in vivo ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if nitroglycerine promotes myocardial oxygen metabolism and regional cardiac function in vivo. Nitroglycerine (also known as nitroglycerin) is a medication used primarily for treating angina (chest pain due to coronary heart disease). It works as a vasodilator, relaxing blood vessels and increasing blood flow to the heart. However, it doesn't actually promote myocardial oxygen metabolism. In fact, it works by decreasing the heart's workload and oxygen demand by dilating blood vessels. While it improves blood flow to the heart and can improve cardiac function in patients with coronary artery disease, it doesn't directly promote oxygen metabolism. It actually reduces the heart's need for oxygen by decreasing preload and afterload.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19516176",
    "question": "Does black tea consumption dose-dependently improve flow-mediated dilation in healthy males?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if black tea consumption dose-dependently improves flow-mediated dilation (FMD) in healthy males. To answer this, I need to consider whether there is evidence showing that higher doses of black tea lead to greater improvements in FMD in healthy males compared to lower doses (i.e., a dose-response relationship). \\n\\nWhile there is research suggesting black tea consumption may have beneficial effects on endothelial function and FMD, I don't have specific evidence showing a clear dose-dependent relationship between black tea consumption and FMD improvement specifically in healthy males. Without clear evidence of this dose-dependent relationship in the specific population mentioned, I cannot confidently answer 'yes'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27441059",
    "question": "Does curcumin inhibit The Adverse Effects of Sodium Arsenite in Mouse Epididymal Sperm?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if curcumin inhibits the adverse effects of sodium arsenite in mouse epididymal sperm. To answer this, I need to consider what scientific research shows about curcumin's protective effects against sodium arsenite toxicity specifically in mouse sperm cells.\\n\\nCurcumin is a polyphenol derived from turmeric with known antioxidant and anti-inflammatory properties. Sodium arsenite is an arsenic compound that has been shown to cause oxidative stress and damage to reproductive cells.\\n\\nResearch has demonstrated that curcumin can protect against arsenic-induced toxicity in various tissues. Specifically for mouse epididymal sperm, studies have shown that curcumin can counteract the oxidative damage, DNA fragmentation, and reduced motility caused by sodium arsenite exposure. Curcumin appears to work by scavenging free radicals, enhancing antioxidant defense systems, and reducing lipid peroxidation in sperm cells exposed to sodium arsenite.\\n\\nBased on the scientific literature, curcumin does demonstrate protective effects against sodium arsenite-induced damage in mouse epididymal sperm.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24418330",
    "question": "Are frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits associated with inferior survival in diffuse large B cell lymphoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between certain genetic and protein abnormalities and survival outcomes in diffuse large B cell lymphoma (DLBCL). Specifically, it's asking whether two factors are associated with worse survival: 1) frequent copy number variations (CNVs) in the PI3K/AKT pathway, and 2) aberrant protein expressions of PI3K subunits.\\n\\nTo answer this accurately, I would need to know if research has established such a connection. Based on my knowledge of cancer biology, the PI3K/AKT pathway is indeed important in many cancers including lymphomas, and alterations in this pathway can affect cancer progression and treatment response. Multiple studies have shown that genetic alterations and abnormal expression of components in the PI3K/AKT pathway are associated with poorer outcomes in various cancers including DLBCL. Research has demonstrated that copy number variations and aberrant expression of PI3K subunits can lead to constitutive activation of this pathway, promoting cell survival, proliferation, and resistance to therapy in DLBCL, which ultimately results in inferior survival outcomes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19738619",
    "question": "Does gross genomic damage measured by DNA image cytometry independently predict gastric cancer patient survival?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival. To answer this, I would need to know if there are scientific studies showing that this specific measurement technique has been demonstrated to be an independent predictor of survival outcomes in gastric cancer patients. An independent predictor would mean that this measurement provides prognostic value even after accounting for other known prognostic factors. Without specific information about research studies on this topic, I cannot definitively answer whether DNA image cytometry measurements of genomic damage independently predict gastric cancer survival.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19214839",
    "question": "Do selective auditory attention and silence elicit auditory hallucination in a nonclinical sample?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether selective auditory attention and silence can cause auditory hallucinations in people who don't have clinical conditions that are typically associated with hallucinations (like schizophrenia). \\n\\nTo answer this, I need to consider research on auditory hallucinations in the general population. There is evidence that under certain conditions, such as sensory deprivation, prolonged silence, or directed attention to auditory stimuli, people without clinical diagnoses can experience auditory hallucinations or misperceptions. For example, studies have shown that when people are placed in anechoic chambers (extremely quiet environments) or instructed to listen intently for sounds in silence, they may report hearing things that aren't actually present. This phenomenon is sometimes called 'conditioned hallucination' and represents the brain's tendency to find patterns even when none exist.\\n\\nSo based on the scientific literature, selective auditory attention and silence can indeed elicit auditory hallucination-like experiences in nonclinical populations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26010264",
    "question": "Does intraneural GJB1 gene delivery improve nerve pathology in a model of X-linked Charcot-Marie-Tooth disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if intraneural GJB1 gene delivery improves nerve pathology in a model of X-linked Charcot-Marie-Tooth disease. To answer this, I need to know if there's evidence that delivering the GJB1 gene directly into nerves has shown therapeutic benefits in animal models or clinical studies of this specific disease. X-linked Charcot-Marie-Tooth disease is caused by mutations in the GJB1 gene which encodes the gap junction protein connexin-32. Without specific information about studies showing that intraneural delivery of this gene improves nerve pathology in this disease model, I cannot confidently answer yes. However, based on general principles of gene therapy for genetic diseases, it's plausible that replacing the defective gene could help, but I need specific evidence to confirm this.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21671364",
    "question": "Is antibiotic resistance associated with longer bacteremic episodes and worse outcome in febrile neutropenic children with cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between antibiotic resistance and clinical outcomes in a specific patient population: children with cancer who have febrile neutropenia and bacteremia. Specifically, it asks whether antibiotic resistance is associated with: 1) longer duration of bacteremic episodes, and 2) worse clinical outcomes.\\n\\nTo answer this accurately, I would need to rely on medical research findings. Based on medical literature, antibiotic-resistant infections generally are more difficult to treat, often requiring alternative antibiotics or higher doses, which can lead to prolonged infection duration. In immunocompromised patients like neutropenic cancer patients, antibiotic resistance is particularly problematic.\\n\\nMultiple studies have shown that antibiotic-resistant infections in neutropenic cancer patients (both adults and children) are associated with longer duration of bacteremia, increased mortality, longer hospital stays, and worse clinical outcomes. This is because effective early antibiotic therapy is crucial in these highly vulnerable patients, and resistance compromises this approach.\\n\\nSo yes, antibiotic resistance is generally associated with both longer bacteremic episodes and worse outcomes in febrile neutropenic children with cancer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24467254",
    "question": "Is greater physical activity associated with better cognitive function in heart failure?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question asks about the relationship between physical activity and cognitive function specifically in patients with heart failure. To answer this, I need to consider the research evidence on this topic. \\n\\nThere is research suggesting that physical activity and exercise can have beneficial effects on cognitive function in various populations, including those with cardiovascular conditions. For heart failure specifically, studies have shown that physical activity and cardiac rehabilitation programs can improve not only physical functioning but also cognitive outcomes. Reduced physical activity in heart failure patients is associated with cognitive impairment, while increased physical activity has been linked to better cognitive performance, including improvements in executive function, memory, and processing speed.\\n\\nSeveral mechanisms might explain this relationship, including improved cerebral perfusion, reduced inflammation, and better overall cardiovascular health, which can benefit brain function.\\n\\nBased on the current scientific evidence, there does appear to be an association between greater physical activity and better cognitive function in heart failure patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24335892",
    "question": "Do an experience with paediatric burn wounds treated with a plant-derived wound therapeutic?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if I have personal experience with treating pediatric burn wounds using a plant-derived therapeutic. This is asking about my personal medical experience or if I've conducted such medical treatments. As an AI assistant, I don't have personal experiences, haven't treated patients, and don't have a medical background or qualifications to perform medical procedures on children or anyone else.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11745280",
    "question": "Is weekly vinorelbine an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if weekly vinorelbine is an effective palliative regimen for metastatic breast carcinoma patients who have failed treatment with anthracyclines and taxanes. To answer this, I need to consider the clinical evidence for vinorelbine in this specific context.\\n\\nVinorelbine is a vinca alkaloid chemotherapy agent that has been studied as a treatment option for metastatic breast cancer. Multiple clinical studies have shown that vinorelbine does demonstrate activity in patients with metastatic breast cancer who have previously been treated with and failed anthracycline and taxane regimens. Response rates typically range from 15-30% in this heavily pretreated population, with disease control and palliation of symptoms in a significant portion of patients.\\n\\nThe drug is generally well-tolerated with manageable toxicity profile, making it suitable for palliative settings. Weekly administration schedules have been shown to provide a good balance of efficacy and tolerability.\\n\\nBased on the clinical evidence and its inclusion in various treatment guidelines for this specific scenario, weekly vinorelbine is considered an effective palliative option after failure with anthracyclines and taxanes in metastatic breast cancer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18596942",
    "question": "Do cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about a correlation between cerebrospinal fluid B cells and early brain inflammation in multiple sclerosis (MS). To answer this, I need to consider what scientific research has established about this relationship. Multiple sclerosis is an autoimmune disease where the immune system attacks the myelin sheath of neurons in the central nervous system. B cells are a type of immune cell that can be found in cerebrospinal fluid (CSF). Research has shown that B cells play a significant role in MS pathogenesis, and increased B cell presence in CSF is associated with inflammatory activity in MS. Studies have demonstrated that B cells in the CSF correlate with MRI markers of inflammation and disease activity in early MS. The success of B-cell depleting therapies in MS further supports this connection. Therefore, there is evidence supporting a correlation between CSF B cells and early brain inflammation in MS.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26902407",
    "question": "Does α-Hederin inhibit G protein-coupled receptor kinase 2-mediated phosphorylation of β2-adrenergic receptors?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if α-Hederin inhibits G protein-coupled receptor kinase 2 (GRK2)-mediated phosphorylation of β2-adrenergic receptors. To answer this, I need to know if there is established scientific evidence showing that α-Hederin specifically interferes with this phosphorylation pathway. α-Hederin is a saponin found in plants like ivy (Hedera helix) with some known pharmacological properties, but I don't recall specific evidence that it inhibits GRK2-mediated phosphorylation of β2-adrenergic receptors. Without specific scientific literature supporting this claim, I cannot confirm this interaction.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18206409",
    "question": "Does canalicular magnetic stimulation lack specificity to differentiate idiopathic facial palsy from borreliosis in children?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether canalicular magnetic stimulation is unable to specifically differentiate between two causes of facial palsy in children: idiopathic facial palsy (Bell's palsy) versus facial palsy caused by Borrelia infection (Lyme disease). \\n\\nTo answer this question accurately, I would need to know whether canalicular magnetic stimulation has been shown to have diagnostic specificity in distinguishing between these two conditions. Based on my knowledge, canalicular magnetic stimulation is not a well-established diagnostic tool that can reliably differentiate between idiopathic facial palsy and borreliosis-related facial palsy in children. The diagnostic approaches for these conditions typically involve clinical presentation, serological tests for Borrelia, and sometimes electrophysiological studies, but canalicular magnetic stimulation is not a standard differential diagnostic method for these specific conditions.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "8939841",
    "question": "Does routine cholangiography reduce sequelae of common bile duct injuries?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether routine cholangiography reduces sequelae (consequences) of common bile duct injuries. To answer this, I need to consider what the evidence shows about routine cholangiography (a procedure where the bile ducts are imaged during surgery) and its impact on outcomes after bile duct injuries occur.\\n\\nRoutine cholangiography is sometimes performed during cholecystectomy (gallbladder removal) to identify the biliary anatomy and potentially detect bile duct injuries early. However, the question specifically asks about reducing the sequelae (consequences) of injuries that have already occurred.\\n\\nBased on medical literature, routine cholangiography may help in early detection of bile duct injuries, which could lead to earlier intervention. Earlier intervention for bile duct injuries is generally associated with better outcomes and fewer long-term complications. However, once an injury has occurred, the cholangiography itself doesn't directly reduce the sequelae - it's the earlier detection and subsequent appropriate management that potentially improves outcomes.\\n\\nSo while routine cholangiography may help in early detection, which indirectly could improve outcomes, it doesn't directly reduce sequelae of injuries that have already happened.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23107612",
    "question": "Does eeyarestatin cause cervical cancer cell sensitization to bortezomib treatment by augmenting ER stress and CHOP expression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether eeyarestatin causes cervical cancer cell sensitization to bortezomib treatment by augmenting ER stress and CHOP expression. To answer this, I need to consider if there's established scientific evidence for this specific mechanism. Eeyarestatin is known to be an inhibitor of ER-associated degradation (ERAD) that can induce ER stress. Bortezomib is a proteasome inhibitor used in cancer treatment. The question specifically asks about a mechanism where eeyarestatin sensitizes cervical cancer cells to bortezomib through ER stress and CHOP (a protein involved in ER stress-induced apoptosis) upregulation. Based on scientific literature, eeyarestatin has been shown to enhance the cytotoxicity of bortezomib in some cancer cells by increasing ER stress, and CHOP is often involved in this pathway. There are studies demonstrating this mechanism in various cancer types, including cervical cancer cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26366790",
    "question": "Is embryo quality the main factor affecting cumulative live birth rate after elective single embryo transfer in fresh stimulation cycles?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether embryo quality is the main factor affecting cumulative live birth rate after elective single embryo transfer in fresh stimulation cycles. To answer this, I need to consider what research shows about factors affecting cumulative live birth rates in this specific context. While embryo quality is certainly an important factor in IVF success, determining if it's the 'main' factor requires examining comparative research. Multiple studies have shown that while embryo quality is significant, other factors like maternal age, ovarian reserve, endometrial receptivity, and underlying fertility diagnoses also strongly impact cumulative live birth rates. Research generally indicates that a combination of factors, rather than embryo quality alone, determines cumulative success rates. Therefore, while embryo quality is important, it would be an oversimplification to call it the 'main' factor.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23177897",
    "question": "Does language of publication have a small influence on the quality of reports of controlled trials of physiotherapy interventions?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether the language of publication has a small influence on the quality of reports of controlled trials of physiotherapy interventions. To answer this, I would need to know about research that specifically examines the relationship between publication language and the methodological quality or reporting standards of physiotherapy trials. Without specific evidence about this relationship, I cannot make a definitive claim. Some research in other medical fields has found that non-English language publications sometimes have different reporting quality, but I don't have specific information about physiotherapy trials and whether any influence of language would be characterized as 'small' rather than substantial or non-existent.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25061008",
    "question": "Is dietary supplementation of Gracilariopsis persica associated with some quality related sera and egg yolk parameters in laying quails?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if dietary supplementation of Gracilariopsis persica (a type of seaweed/algae) is associated with quality-related parameters in sera and egg yolk of laying quails. To answer this, I would need to know if there are studies showing that supplementing quail diets with G. persica affects blood serum parameters or egg yolk quality metrics. Without specific research to reference, I need to consider if there's evidence in the scientific literature for such associations. Based on existing research on seaweed supplementation in poultry, many algae species have been shown to affect egg quality parameters and blood biochemistry in laying birds. While I don't have specific data on G. persica in quails, the general trend in the literature suggests this is likely the case.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16332534",
    "question": "Does centrin deficiency in Paramecium affect the geometry of basal-body duplication?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the effect of centrin deficiency in Paramecium on the geometry of basal-body duplication. To answer this, I need to recall what is known about centrin's role in Paramecium and basal body formation.\\n\\nCentrin is a calcium-binding protein found in the basal bodies of cilia and flagella in many eukaryotes, including Paramecium. It plays important roles in basal body duplication and positioning.\\n\\nResearch has shown that when centrin is depleted or deficient in Paramecium, there are indeed defects in the geometric arrangement and orientation of newly duplicated basal bodies. Specifically, centrin deficiency affects the proper positioning and angular orientation of daughter basal bodies relative to mother basal bodies during duplication.\\n\\nThe evidence indicates that centrin is required for the correct geometric pattern of basal body duplication in Paramecium.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20438408",
    "question": "Is y chromosome loss a frequent early event in urothelial bladder cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, I need to consider what is known about chromosomal abnormalities in urothelial bladder cancer. Y chromosome loss is indeed one of the common genetic alterations observed in bladder cancer, particularly in male patients. Multiple cytogenetic and molecular studies have documented that loss of the Y chromosome occurs frequently and is often detected in early-stage bladder tumors. It is considered one of the earliest genetic events in bladder carcinogenesis, along with deletions in chromosome 9. This chromosomal abnormality has been observed in both non-invasive and invasive urothelial carcinomas, supporting its role as an early event in the development of bladder cancer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23452981",
    "question": "Does additional annotation enhance potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if additional annotation enhances the potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array. The Illumina 450K array is a widely used platform for DNA methylation profiling. The standard annotation provided by Illumina contains basic information about the CpG sites measured by the array. However, researchers have developed additional annotation resources that provide more comprehensive information about the genomic and functional context of these CpG sites, including their relationship to genes, regulatory elements, and other genomic features. These enhanced annotations have been shown to improve the interpretation of methylation data in biological contexts, allowing researchers to better understand the functional implications of methylation changes. Papers like those by Price et al. and Zhou et al. have demonstrated that additional annotation resources significantly improve the biological interpretation of 450K array data. So yes, additional annotation does enhance the potential for biologically-relevant analysis of this platform.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25930191",
    "question": "Are polymorphisms related to ORMDL3 associated with asthma susceptibility , alterations in transcriptional regulation of ORMDL3 , and changes in TH2 cytokine levels?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question. It's asking about polymorphisms related to ORMDL3 and whether they are associated with three specific things:\\n1. Asthma susceptibility\\n2. Alterations in transcriptional regulation of ORMDL3\\n3. Changes in TH2 cytokine levels\\n\\nORMDL3 (ORM1-like protein 3) is a gene that has been studied in relation to asthma. Based on scientific literature, polymorphisms in the ORMDL3 gene region have indeed been associated with asthma susceptibility in multiple populations. These polymorphisms have also been shown to affect the transcriptional regulation of ORMDL3, altering its expression levels. Additionally, research has demonstrated that these ORMDL3-related polymorphisms can influence TH2 cytokine levels, which are important in allergic responses and asthma pathogenesis.\\n\\nSo all three associations mentioned in the question appear to be supported by scientific evidence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11919122",
    "question": "Does a low-sodium diet potentiate the effects of losartan in type 2 diabetes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether a low-sodium diet enhances (potentiates) the effects of losartan in patients with type 2 diabetes. Losartan is an angiotensin II receptor blocker (ARB) used to treat hypertension and protect kidney function in diabetic patients. \\n\\nResearch has shown that sodium restriction can enhance the blood pressure-lowering and antiproteinuric effects of ARBs like losartan, particularly in patients with conditions like diabetic nephropathy. The renin-angiotensin-aldosterone system (RAAS), which losartan targets, is influenced by sodium intake. When sodium intake is restricted, the RAAS becomes more activated, and drugs that block this system (like losartan) can have enhanced effects.\\n\\nThere are clinical studies demonstrating that combining a low-sodium diet with losartan treatment provides greater reduction in blood pressure and proteinuria in diabetic patients than losartan alone. This synergistic effect is well-documented in the medical literature.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26196401",
    "question": "Does topical anti-inflammatory activity of semisolid containing standardized Aleurites moluccana L. Willd ( Euphorbiaceae ) leave extract?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether a semisolid containing standardized Aleurites moluccana L. Willd (Euphorbiaceae) leaf extract has topical anti-inflammatory activity. To answer this, I would need specific scientific evidence about this particular formulation. Based on the information provided in the question alone, I don't have sufficient data to determine whether this specific semisolid preparation has demonstrated anti-inflammatory properties in scientific studies. While Aleurites moluccana (also known as candlenut tree) may have traditional uses related to inflammation, I cannot confirm whether a standardized extract in a semisolid form specifically shows topical anti-inflammatory activity without relevant research evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15591500",
    "question": "Do human peripheral and gastric lymphocyte responses to Helicobacter pylori NapA and AphC differ in infected and uninfected individuals?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if human peripheral and gastric lymphocyte responses to Helicobacter pylori NapA and AphC differ in infected and uninfected individuals. To answer this, I would need specific research data comparing these immune responses between the two groups. Without being provided specific studies or data in the prompt, I cannot make a definitive determination. However, based on general immunological principles, it would be expected that infected individuals would show different lymphocyte responses to H. pylori antigens compared to uninfected individuals, as exposure to the pathogen would typically trigger specific immune responses. The question is specifically about NapA (neutrophil-activating protein) and AphC (alkyl hydroperoxide reductase), which are H. pylori proteins that can elicit immune responses. In infected individuals, there would likely be memory T cells and other adaptive immune responses that would differ from uninfected individuals. So the answer would likely be yes, but I should be cautious without specific research data.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16095006",
    "question": "Does extended haplotype analysis reveal an association of TNF polymorphisms with susceptibility to systemic lupus erythematosus beyond HLA-DR3?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if extended haplotype analysis shows that TNF (tumor necrosis factor) polymorphisms are associated with susceptibility to systemic lupus erythematosus (SLE) independently of HLA-DR3. To answer this, I need to determine if research has demonstrated that TNF genetic variations contribute to SLE risk beyond what can be explained by linkage disequilibrium with HLA-DR3.\\n\\nWhile TNF polymorphisms have been studied in relation to SLE, the key question is whether these associations remain significant after controlling for HLA-DR3, which is known to be in linkage disequilibrium with certain TNF variants. Based on the literature, extended haplotype analyses have generally shown that TNF associations with SLE are primarily due to linkage disequilibrium with HLA-DR3 rather than independent effects. Most studies that perform proper conditional analysis find that TNF polymorphisms do not confer additional risk beyond what is explained by HLA-DR3.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22884315",
    "question": "Are balance confidence and functional balance associated with physical disability after hip fracture?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the association between balance confidence and functional balance with physical disability after hip fracture. To answer this, I need to consider what research shows about these relationships.\\n\\nBalance confidence refers to a person's self-efficacy or belief in their ability to maintain balance during activities. Functional balance refers to actual balance performance during daily activities.\\n\\nResearch generally indicates that after hip fracture, patients often experience decreased balance confidence and impaired functional balance. These factors are typically associated with poorer physical functioning and increased disability. Studies have shown that individuals with lower balance confidence tend to limit their activities, which can lead to further deconditioning and disability. Similarly, impaired functional balance is associated with mobility limitations and increased risk of falls, contributing to physical disability.\\n\\nMultiple studies have demonstrated significant correlations between measures of balance (both perceived and actual) and physical function outcomes after hip fracture. These associations are often independent of other factors like age or comorbidities.\\n\\nBased on the established literature, there is a clear association between balance confidence, functional balance, and physical disability following hip fracture.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27604637",
    "question": "Is early primary biliary cholangitis characterised by brain abnormalities on cerebral magnetic resonance imaging?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Primary biliary cholangitis (PBC) is an autoimmune liver disease that primarily affects the small bile ducts in the liver. It leads to progressive destruction of these ducts, causing cholestasis (impaired bile flow) and eventually liver damage and cirrhosis. The question asks whether early PBC is characterized by brain abnormalities on cerebral MRI. \\n\\nPBC can cause various symptoms including fatigue, pruritus (itching), and cognitive impairment in some patients, which are collectively referred to as 'brain fog.' However, these symptoms are generally thought to be related to the systemic effects of liver dysfunction and inflammation rather than direct structural brain abnormalities that would be visible on MRI.\\n\\nWhile advanced liver disease (including end-stage PBC) can lead to hepatic encephalopathy which may show brain changes on imaging, early PBC is not typically characterized by specific brain abnormalities on cerebral MRI. The primary pathology in early PBC is confined to the liver, specifically the bile ducts.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21559350",
    "question": "Does diclofenac epolamine topical patch relieve pain associated with ankle sprain?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Diclofenac epolamine topical patch (commonly known by the brand name Flector) is a nonsteroidal anti-inflammatory drug (NSAID) in a patch form that delivers the medication through the skin. It is FDA-approved for the treatment of acute pain due to minor strains, sprains, and contusions. Specifically for ankle sprains, clinical studies have shown that diclofenac epolamine topical patches can effectively reduce pain and inflammation associated with this type of injury. The patch delivers the medication directly to the affected area while minimizing systemic absorption, which helps reduce side effects compared to oral NSAIDs. So yes, diclofenac epolamine topical patch is indicated for and can relieve pain associated with ankle sprains.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23461607",
    "question": "Does resting-state connectivity of pre-motor cortex reflect disability in multiple sclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether resting-state connectivity of pre-motor cortex reflects disability in multiple sclerosis (MS). To answer this, I need to consider whether there is established evidence in neuroscience literature that shows a relationship between resting-state functional connectivity of the pre-motor cortex and disability levels in MS patients. Multiple sclerosis is a demyelinating disease that affects the central nervous system and can lead to various levels of disability. Research has shown that functional connectivity changes in various brain regions, including motor networks, can correlate with clinical disability in MS. Several studies have specifically examined pre-motor cortex connectivity in MS and found correlations with disability measures such as the Expanded Disability Status Scale (EDSS). Therefore, there is evidence supporting that resting-state connectivity of the pre-motor cortex does reflect disability in MS patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26687820",
    "question": "Do human articular chondrocytes with higher aldehyde dehydrogenase activity have stronger expression of COL2A1 and SOX9?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific relationship between aldehyde dehydrogenase (ALDH) activity in human articular chondrocytes and the expression of two specific genes: COL2A1 and SOX9. Let me analyze what we know about this relationship:\\n\\nCOL2A1 is the gene that encodes for type II collagen, which is a major component of articular cartilage.\\nSOX9 is a transcription factor that plays a key role in chondrogenesis and cartilage formation.\\nAldehyde dehydrogenase (ALDH) is an enzyme family, and its activity has been used as a marker for certain cell populations.\\n\\nResearch has indeed shown that human articular chondrocytes with higher ALDH activity (often called ALDH-bright or ALDHbr cells) do express higher levels of chondrogenic markers including COL2A1 and SOX9. Several studies have demonstrated that ALDH-bright chondrocytes maintain a more chondrogenic phenotype and express higher levels of these cartilage-specific genes compared to ALDH-low cells.\\n\\nFor example, studies have shown that sorting chondrocytes based on ALDH activity can identify subpopulations with enhanced chondrogenic potential, and these ALDH-high cells typically show stronger expression of COL2A1 and SOX9, which are key markers of the chondrocyte phenotype.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27208205",
    "question": "Does complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrate that XRCC2 is a Fanconi anaemia gene?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether complementation of hypersensitivity to DNA interstrand crosslinking agents proves that XRCC2 is a Fanconi anaemia gene. Fanconi anaemia (FA) is a genetic disorder characterized by bone marrow failure, congenital abnormalities, and cancer predisposition. FA genes are involved in the repair of DNA interstrand crosslinks. XRCC2 is a gene involved in homologous recombination repair of DNA damage. While complementation of hypersensitivity to DNA interstrand crosslinking agents is a characteristic of FA genes, this alone is not sufficient to classify a gene as an FA gene. For a gene to be officially designated as an FA gene, it must be shown to cause Fanconi anaemia when mutated in patients. Without evidence that XRCC2 mutations cause the clinical syndrome of Fanconi anaemia in patients, complementation of crosslink sensitivity alone would not definitively establish it as an FA gene.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17996240",
    "question": "Are nT-proBNP and the anti-inflammatory cytokines correlated with endothelial progenitor cells ' response to cardiac surgery?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if nT-proBNP (N-terminal pro-brain natriuretic peptide, a cardiac biomarker) and anti-inflammatory cytokines are correlated with endothelial progenitor cells' (EPCs) response to cardiac surgery. To answer this, I would need to know if there are established correlations between these specific biomarkers and EPC mobilization, proliferation, or function following cardiac surgery. Based on cardiovascular research literature, there is evidence that cardiac surgery induces changes in both nT-proBNP levels and inflammatory markers, and separately, evidence that EPCs respond to cardiac surgery with increased mobilization. However, whether there's a direct correlation between nT-proBNP, anti-inflammatory cytokines and the EPC response specifically would require studies that have examined these relationships together. Without citing specific studies that have demonstrated this correlation, I cannot definitively say yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27533962",
    "question": "Is eSC guidelines adherence associated with improved survival in patients from the Norwegian Heart Failure Registry?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if adherence to eSC (European Society of Cardiology) guidelines is associated with improved survival in patients from the Norwegian Heart Failure Registry. To answer this, I would need specific information about studies or data from this registry that examined the relationship between guideline adherence and survival outcomes. Without specific information provided in the question, I cannot determine if such an association exists in this specific population.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12160963",
    "question": "Is pharmacological preconditioning in rabbit myocardium blocked by chloride channel inhibition?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if pharmacological preconditioning in rabbit myocardium is blocked by chloride channel inhibition. To answer this, I would need specific research evidence about the relationship between chloride channel inhibition and pharmacological preconditioning specifically in rabbit heart tissue. Without having access to specific studies on this topic, I cannot make a definitive determination. There are studies on preconditioning in various animal models, and some research on ion channels including chloride channels in cardiac protection, but I don't have specific evidence that chloride channel inhibitors block pharmacological preconditioning specifically in rabbit myocardium.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9183335",
    "question": "Do intra-arterial nitrovasodilators increase cerebral blood flow in angiographically normal territories of arteriovenous malformation patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether intra-arterial nitrovasodilators increase cerebral blood flow in angiographically normal territories of arteriovenous malformation (AVM) patients. To answer this, I need to consider what is known about nitrovasodilators and their effects on cerebral blood flow, particularly in the context of AVM patients.\\n\\nNitrovasodilators are medications that cause vasodilation (widening of blood vessels) by releasing nitric oxide. Common examples include nitroglycerin and sodium nitroprusside.\\n\\nIn the context of AVMs (abnormal connections between arteries and veins), there's a phenomenon called 'vascular steal,' where blood is diverted from normal brain tissue to the AVM. The question specifically asks about 'angiographically normal territories' - areas that appear normal on angiography despite being in a patient with an AVM elsewhere in their brain.\\n\\nBased on general principles of cerebrovascular physiology, nitrovasodilators would typically increase blood flow by dilating vessels. However, in AVM patients, the situation is complex because of altered hemodynamics.\\n\\nI don't have specific studies on this exact scenario in my knowledge base. Without specific evidence about the effect of intra-arterial nitrovasodilators in this particular context, I cannot provide a definitive yes or no answer based on my current knowledge.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "20856796",
    "question": "Does neutralisation of uPA with a monoclonal antibody reduce plasmin formation and delays skin wound healing in tPA-deficient mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if neutralizing uPA (urokinase-type plasminogen activator) with a monoclonal antibody reduces plasmin formation and delays wound healing in mice that are deficient in tPA (tissue-type plasminogen activator). To answer this, I need to consider what research shows about the relationship between uPA neutralization and wound healing specifically in tPA-deficient mice. \\n\\nPlasmin is a proteolytic enzyme involved in fibrinolysis and tissue remodeling during wound healing. Both uPA and tPA are activators of plasminogen to plasmin. In tPA-deficient mice, uPA would be the primary activator of plasminogen. \\n\\nIf uPA is neutralized in these mice, it would logically reduce plasmin formation since both major activators would be compromised. This would likely impact wound healing processes that depend on plasmin. Research has shown that plasmin is important for proper wound healing, so reducing its formation would likely delay the healing process.\\n\\nBased on the physiological mechanisms and published research in this area, neutralizing uPA with a monoclonal antibody in tPA-deficient mice would reduce plasmin formation and delay skin wound healing.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12845265",
    "question": "Do serum inhibin B levels reflect contralateral testicular damage following unilateral testicular trauma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether serum inhibin B levels can serve as an indicator of damage to the contralateral (opposite) testicle following trauma to one testicle. Inhibin B is a hormone produced by Sertoli cells in the testes and is considered a marker of testicular function and spermatogenesis. To answer this question accurately, I need to consider whether scientific evidence shows that inhibin B levels in blood serum reliably reflect damage to the non-injured testicle when the other testicle experiences trauma. Based on the medical literature, while inhibin B is a marker of testicular function, there isn't strong evidence that it specifically reflects contralateral testicular damage following unilateral trauma. Most studies show that the contralateral testicle is generally protected following unilateral trauma unless there are specific immunological responses or other complications. Serum inhibin B would typically reflect overall testicular function rather than specifically indicating contralateral damage.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24751531",
    "question": "Are perioperative complications after hemiarthroplasty and total shoulder arthroplasty equivalent?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if perioperative complications after hemiarthroplasty and total shoulder arthroplasty are equivalent. To answer this, I need to consider the medical evidence comparing complication rates between these two shoulder replacement procedures.\\n\\nHemiarthroplasty involves replacing only the humeral head (ball) of the shoulder joint, while total shoulder arthroplasty (TSA) replaces both the humeral head and the glenoid (socket).\\n\\nBased on medical literature, these procedures have different complication profiles. TSA is generally a more complex procedure with longer operative times and potentially different risks. Studies have shown differences in complication rates, types of complications, and risk factors between the two procedures. For example, TSA has higher risks of glenoid component loosening (since hemiarthroplasty doesn't have a glenoid component), while hemiarthroplasty has higher rates of glenoid erosion over time.\\n\\nThe perioperative complication profiles (complications occurring during or shortly after surgery) are not equivalent between these procedures.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24521487",
    "question": "Is residential respite care associated with family carers experiencing financial strain?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if residential respite care is associated with family carers experiencing financial strain. To answer this, I need to consider whether there's evidence that family carers who use residential respite care services tend to experience financial difficulties or strain as a result. Residential respite care refers to temporary care provided in a residential facility to give family carers a break from their caregiving responsibilities. While respite care services often have costs associated with them, the relationship between using these services and experiencing financial strain isn't inherently established. Without specific research evidence showing a clear association between residential respite care use and financial strain for family carers, I cannot confidently say there is an established association.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22111793",
    "question": "Does absence of cerebral microbleeds predict reversion of vascular 'cognitive impairment no dementia ' in stroke?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the absence of cerebral microbleeds predicts reversion of vascular 'cognitive impairment no dementia' (VCIND) in stroke patients. To answer this, I would need specific research evidence showing that patients without cerebral microbleeds are more likely to experience a reversion (improvement) of their cognitive impairment after stroke. Without being provided specific studies or data on this relationship, I cannot make a definitive claim about this predictive relationship. The question assumes a specific medical correlation that requires empirical evidence to confirm.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25827752",
    "question": "Is rho involved in periodontal tissue remodelling with experimental tooth movement in rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if rho is involved in periodontal tissue remodelling during experimental tooth movement in rats. To answer this, I need to consider what 'rho' refers to in this context. Rho likely refers to the Rho family of GTPases, which are signaling proteins involved in cytoskeletal organization and cell migration. In periodontal tissue remodelling during orthodontic tooth movement, there are complex cellular processes including osteoclast and osteoblast activity. Based on scientific literature, Rho GTPases (particularly RhoA) have been shown to be involved in bone remodelling processes, including those in periodontal tissues during experimental tooth movement in animal models including rats. Studies have demonstrated that Rho signaling pathways play roles in mechanotransduction and subsequent tissue remodelling in response to orthodontic forces.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23480620",
    "question": "Are the times they a-changin ' : prognostic markers in the new era of BCR-targeting therapies for CLL?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question appears to be asking whether prognostic markers are changing in the context of BCR (B-cell receptor) targeting therapies for CLL (Chronic Lymphocytic Leukemia). It seems to be referencing a title or heading of a medical/scientific article, using a play on words from Bob Dylan's song 'The Times They Are a-Changin''. The question is asking for a yes/no answer about whether prognostic markers are changing in this new therapeutic era. However, this is actually a complex scientific question that requires evaluation of medical evidence rather than a simple yes/no answer. Without specific context about which prognostic markers are being referred to and what specific changes are being questioned, I cannot provide a definitive yes/no answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17470063",
    "question": "Does feeding sorghum ergot ( Claviceps africana ) to sow before farrowing inhibits milk production?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if feeding sorghum ergot (Claviceps africana) to sows before farrowing inhibits milk production. Sorghum ergot is a fungal disease that affects sorghum plants. Ergot fungi produce alkaloids that can have various physiological effects on animals. In mammals, ergot alkaloids can affect hormonal systems, including those related to lactation. Specifically, ergot alkaloids can inhibit prolactin, which is a hormone essential for milk production. So scientifically, there is a basis for ergot to potentially inhibit milk production in sows. Research has shown that sorghum ergot can indeed reduce milk production in lactating animals, including sows, when consumed before farrowing. This is because the ergot alkaloids interfere with the normal hormonal processes necessary for milk let-down and production.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22832328",
    "question": "Are metabolism-related proteins differentially expressed according to the molecular subtype of invasive breast cancer defined by surrogate immunohistochemistry?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether metabolism-related proteins show different expression patterns across the molecular subtypes of invasive breast cancer, specifically when these subtypes are defined using surrogate immunohistochemistry markers (like ER, PR, HER2, Ki-67) rather than genomic profiling. To answer this, I need to consider whether there is evidence in the scientific literature showing that proteins involved in cellular metabolism (e.g., glycolysis enzymes, mitochondrial proteins, lipid metabolism proteins) are expressed at different levels across luminal A, luminal B, HER2-enriched, and triple-negative breast cancer subtypes when these are classified by immunohistochemistry. Based on published research, there is substantial evidence that metabolic reprogramming differs between breast cancer subtypes, with different expression patterns of metabolism-related proteins observed across the immunohistochemically-defined molecular subtypes. For example, triple-negative breast cancers often show higher expression of glycolytic enzymes compared to luminal subtypes, reflecting their more aggressive nature and different metabolic dependencies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18726938",
    "question": "Does three-dimensional ultrasound of the urethral sphincter predict continence surgery outcome?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if three-dimensional ultrasound of the urethral sphincter can predict the outcome of continence surgery. To answer this accurately, I would need to know if there is scientific evidence showing that 3D ultrasound imaging of the urethral sphincter has predictive value for surgical outcomes in urinary incontinence procedures. Without specific research studies or medical literature to reference, I cannot make a definitive claim about whether this imaging technique has been validated as a predictive tool for continence surgery outcomes. Based on my knowledge limitations, I cannot provide a confident yes or no answer to this specific medical question.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26472817",
    "question": "Does tissue-Specific Cell Cycle Indicator reveal Unexpected Findings for Cardiac Myocyte Proliferation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if tissue-specific cell cycle indicators have revealed unexpected findings for cardiac myocyte proliferation. To answer this, I need to know if there are documented cases where tissue-specific cell cycle indicators showed surprising or contradictory results regarding cardiac myocyte proliferation compared to previous understanding.\\n\\nWithout specific research papers or studies mentioned in the question, I cannot determine if unexpected findings have been revealed. The question appears to be asking about a specific scientific discovery or research outcome related to cardiac myocyte proliferation using tissue-specific cell cycle indicators.\\n\\nSince I don't have access to specific scientific literature that would confirm or deny unexpected findings in this specific area, I cannot provide a definitive answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25027344",
    "question": "Does cluster of differentiation 24 monoclonal antibody induce apoptosis in the osteosarcoma cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"I need to determine if cluster of differentiation 24 (CD24) monoclonal antibody induces apoptosis in osteosarcoma cells. Let me analyze what we know about CD24 antibodies and their effects on osteosarcoma cells.\\n\\nCD24 is a cell surface protein that can be targeted by monoclonal antibodies. The question asks specifically about the effect of anti-CD24 monoclonal antibodies on osteosarcoma cells, particularly whether they induce apoptosis (programmed cell death).\\n\\nBased on scientific literature, there is evidence that CD24 monoclonal antibodies can induce apoptosis in various cancer cells. For osteosarcoma specifically, studies have shown that CD24 is expressed in osteosarcoma cells, and targeting CD24 with monoclonal antibodies has been demonstrated to induce apoptosis in these cells. Research has indicated that anti-CD24 antibodies can trigger apoptotic pathways in osteosarcoma cell lines.\\n\\nTherefore, the answer appears to be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24358205",
    "question": "Is mIR376A a regulator of starvation-induced autophagy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if miR376A is a regulator of starvation-induced autophagy. To answer this, I need to recall if there's established scientific evidence linking miR376A specifically to the regulation of autophagy that occurs during starvation conditions.\\n\\nBased on scientific literature, miR376A (microRNA 376A) has been identified as a regulator of autophagy, particularly starvation-induced autophagy. Research has shown that miR376A targets ATG4C and BECN1 (beclin 1), which are key components of the autophagy machinery. The expression of miR376A decreases during starvation, which allows for increased expression of these autophagy-related genes and subsequent induction of autophagy.\\n\\nSo yes, miR376A is indeed a regulator of starvation-induced autophagy according to published research.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27034707",
    "question": "Does pathogenic Network Analysis predict Candidate Genes for Cervical Cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if pathogenic network analysis predicts candidate genes for cervical cancer. To answer this, I need to consider whether pathogenic network analysis is a methodology that has been successfully applied to identify candidate genes specifically for cervical cancer. Pathogenic network analysis is a computational approach that examines the interactions between genes and proteins to identify potential disease-associated genes. While this approach has been used for various cancers and diseases to identify candidate genes, I need to determine if there's evidence of its specific application to cervical cancer. Based on my knowledge, pathogenic network analysis has indeed been applied to cervical cancer research to identify potential candidate genes involved in its development and progression. Various studies have used network-based approaches to analyze gene expression data, protein-protein interactions, and other molecular data to predict genes that might play important roles in cervical carcinogenesis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24528777",
    "question": "Are mammalian target of Rapamycin inhibition and mycobacterial survival uncoupled in murine macrophages?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between mammalian target of Rapamycin (mTOR) inhibition and mycobacterial survival in murine macrophages. Specifically, it's asking if these two processes are uncoupled, meaning that inhibiting mTOR does not affect mycobacterial survival in mouse macrophages.\\n\\nTo answer this, I need to consider what is known about mTOR inhibition and its effects on mycobacterial infections. mTOR is a key regulator of cellular metabolism and immune responses. Inhibition of mTOR (such as by rapamycin) typically affects autophagy and other cellular processes that can impact bacterial clearance.\\n\\nResearch has shown that mTOR inhibition generally enhances autophagy, which can promote mycobacterial clearance in macrophages. However, some studies have found that certain mycobacteria (like M. tuberculosis) can evade or manipulate these host defense mechanisms.\\n\\nBased on the scientific literature, mTOR inhibition and mycobacterial survival are generally not uncoupled in murine macrophages - they are typically linked, with mTOR inhibition affecting mycobacterial survival through various mechanisms including autophagy. The relationship may be complex and depend on specific conditions, but they are not completely independent processes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24884667",
    "question": "Is bipolar radiofrequency ablation useful for treating atrial fibrillation combined with heart valve diseases?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the usefulness of bipolar radiofrequency ablation for treating atrial fibrillation (AF) when it occurs together with heart valve diseases. Bipolar radiofrequency ablation is a technique used in cardiac surgery where energy is delivered between two electrodes to create lesions that block abnormal electrical pathways causing arrhythmias like AF. When patients have both AF and valve disease, they often undergo concomitant procedures - valve repair/replacement plus an ablation procedure for the AF. The literature and clinical practice support that bipolar radiofrequency ablation is indeed effective and commonly used in this combined scenario. It's particularly useful during open heart surgery for valve disease as surgeons can directly access the heart to perform the ablation. Multiple studies have shown good outcomes for patients receiving bipolar RF ablation during valve surgery, with success rates for maintaining normal rhythm generally better than for patients who receive only valve surgery without addressing the AF.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10628607",
    "question": "Does oxygenation in status asthmaticus improve during ventilation with helium-oxygen?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether using a helium-oxygen mixture (heliox) during mechanical ventilation improves oxygenation specifically in patients with status asthmaticus (a severe, potentially life-threatening asthma attack that doesn't respond to standard treatments). \\n\\nBased on medical literature, helium-oxygen mixtures can improve gas flow through narrowed airways due to helium's lower density compared to nitrogen in normal air. This can potentially reduce the work of breathing and improve ventilation in obstructive conditions like severe asthma. However, the specific effect on oxygenation (as opposed to ventilation) in status asthmaticus is what's being asked.\\n\\nStudies have shown that heliox can improve ventilation parameters and reduce airway resistance in status asthmaticus, but the direct effect on oxygenation (oxygen levels in the blood) is more variable. Some studies show modest improvements in oxygenation, while others show the primary benefit is in ventilation rather than oxygenation specifically.\\n\\nThe evidence suggests that while heliox may improve overall respiratory mechanics in status asthmaticus, its specific effect on oxygenation is positive but may be modest or variable depending on the individual case.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26912427",
    "question": "Does a 99mTc-Labeled Ligand of Carbonic Anhydrase IX Selectively target Renal Cell Carcinoma In Vivo?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether a specific ligand, labeled with technetium-99m (99mTc), selectively targets Renal Cell Carcinoma (RCC) in vivo (in living organisms). To answer this, I would need specific research evidence about this particular ligand and its targeting properties. Carbonic Anhydrase IX (CAIX) is known to be overexpressed in many RCC tumors, making it a potential target for imaging and therapy. Several studies have investigated 99mTc-labeled compounds that bind to CAIX for RCC imaging. Without specific details about which particular ligand is being referenced, I cannot make a definitive statement. However, there is published research showing that some 99mTc-labeled CAIX inhibitors do selectively accumulate in RCC tumors in animal models, suggesting selective targeting. Based on the general scientific literature, the answer would likely be 'yes' for at least some 99mTc-labeled CAIX ligands that have been developed specifically for this purpose.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24506419",
    "question": "Does comparison of skin elasticity test result from the Ballistometer ( ® ) and Cutometer ( ® )?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if there is a comparison of skin elasticity test results between two specific devices: the Ballistometer (®) and Cutometer (®). To answer this, I need to determine if the question itself contains a comparison between these two devices. Looking at the question, it's phrased as 'Does comparison of skin elasticity test result from the Ballistometer (®) and Cutometer (®)?' This appears to be an incomplete question - it's asking 'Does comparison...' but doesn't complete the thought (e.g., 'Does comparison...exist?' or 'Does comparison...show differences?'). The question as stated doesn't actually make a comparison or ask a complete question about comparison. Since the question is incomplete and doesn't actually contain a comparison between the test results from these two devices, the answer would be no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16551694",
    "question": "Are commensal isolates of methicillin-resistant Staphylococcus epidermidis also well equipped to produce biofilm on polystyrene surfaces?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether commensal isolates of methicillin-resistant Staphylococcus epidermidis (MRSE) are well equipped to produce biofilm on polystyrene surfaces. To answer this, I need to consider what's known about biofilm formation capabilities in commensal MRSE strains specifically on polystyrene.\\n\\nS. epidermidis is known for its ability to form biofilms, and this is a key virulence factor, especially in clinical isolates. Methicillin-resistant strains often carry additional genetic elements that can enhance biofilm formation. However, the question specifically asks about commensal isolates (those that are part of the normal microbiota) rather than clinical/pathogenic isolates.\\n\\nResearch has shown that while clinical isolates of S. epidermidis typically have enhanced biofilm formation capabilities, commensal isolates can also form biofilms, though often to a lesser extent. The specific surface (polystyrene) mentioned is a common material used in biofilm assays and many S. epidermidis strains, including commensal ones, can form biofilms on this surface.\\n\\nHowever, without specific studies directly comparing the biofilm formation capabilities of commensal MRSE isolates on polystyrene surfaces to a benchmark that would qualify as 'well equipped,' I cannot definitively say they are 'well equipped' for this specific function. The literature suggests variability in biofilm formation among commensal strains, with some forming robust biofilms and others forming minimal biofilms.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26707994",
    "question": "Are methylation patterns of Vegfb promoter associated with gene and protein expression levels : the effects of dietary fatty acids?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if methylation patterns of the Vegfb promoter are associated with gene and protein expression levels, specifically in the context of dietary fatty acids effects. To answer this, I would need specific scientific evidence about this relationship. Without specific studies or data provided in the question, I cannot make a definitive claim about whether such an association exists. The question appears to be asking about a specific scientific relationship that would require evidence from research studies to confirm.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27493866",
    "question": "Are sarcopenic obesity and myosteatosis associated with higher mortality in patients with cirrhosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between sarcopenic obesity/myosteatosis and mortality rates in cirrhosis patients. Sarcopenic obesity refers to the combination of low muscle mass (sarcopenia) with obesity. Myosteatosis refers to fat infiltration into muscle tissue. The question is whether these conditions are linked to higher death rates in people with cirrhosis (advanced liver disease).\\n\\nBased on medical literature, both sarcopenic obesity and myosteatosis have been associated with worse outcomes in cirrhosis patients. Multiple studies have shown that these conditions are independent risk factors for higher mortality in patients with cirrhosis. The mechanisms involve altered metabolism, increased inflammation, and reduced functional capacity that compound the already compromised health status of cirrhosis patients.\\n\\nSo yes, research supports that both sarcopenic obesity and myosteatosis are associated with higher mortality in cirrhosis patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20837905",
    "question": "Does resveratrol improve myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia. To answer this, I need to consider whether there is scientific evidence showing that resveratrol (a compound found in red wine and some plants) has beneficial effects on blood flow to the heart (myocardial perfusion) specifically in pigs (swine) that have both high cholesterol (hypercholesterolemia) and ongoing reduced blood flow to the heart muscle (chronic myocardial ischemia). \\n\\nThere have been studies showing that resveratrol has cardioprotective effects in various animal models. Specifically for swine models with these exact conditions, research has shown that resveratrol can improve collateral vessel formation and myocardial perfusion in the setting of chronic ischemia and hypercholesterolemia. A study by Chu et al. demonstrated that resveratrol supplementation improved myocardial perfusion in Yucatan miniswine with diet-induced hypercholesterolemia and chronic myocardial ischemia. The mechanism appeared to involve increased nitric oxide production and upregulation of angiogenic factors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25989972",
    "question": "Does next generation sequencing in women affected by nonsyndromic premature ovarian failure display new potential causative genes and mutations?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if next generation sequencing in women with nonsyndromic premature ovarian failure has revealed new potential causative genes and mutations. To answer this, I need to consider whether research using next generation sequencing techniques has identified previously unknown genetic factors associated with premature ovarian failure. Based on the scientific literature, next generation sequencing approaches like whole exome sequencing and targeted gene panels have indeed identified novel candidate genes and mutations in women with premature ovarian failure (also called primary ovarian insufficiency) that were not previously associated with this condition. These discoveries have expanded our understanding of the genetic basis of this disorder beyond the previously known genes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22235314",
    "question": "Do vitamins A & D inhibit the growth of mycobacteria in radiometric culture?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if vitamins A & D inhibit the growth of mycobacteria in radiometric culture. To answer this, I need to consider whether there is scientific evidence showing that vitamins A and D have inhibitory effects on mycobacterial growth specifically in radiometric culture systems.\\n\\nVitamin D has been shown to have antimycobacterial properties through various mechanisms including enhancing macrophage function and inducing antimicrobial peptides. Vitamin A also has some immunomodulatory effects.\\n\\nHowever, the question specifically asks about inhibition in radiometric culture systems (like BACTEC), which are in vitro growth detection systems that measure metabolic activity of mycobacteria.\\n\\nThere is research showing that vitamin D can inhibit mycobacterial growth in various culture systems, and some studies have demonstrated that both vitamins A and D can have inhibitory effects on mycobacteria. In radiometric culture systems specifically, these vitamins can potentially interfere with the growth detection by inhibiting mycobacterial metabolism.\\n\\nBased on the scientific literature, there is evidence supporting that vitamins A and D can inhibit mycobacterial growth in culture systems including radiometric methods.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11269453",
    "question": "Does single aortic cross-clamp technique reduce S-100 release after coronary artery surgery?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether the single aortic cross-clamp technique reduces S-100 release after coronary artery surgery. S-100 is a protein marker that is often used to detect neurological injury or brain damage. To answer this question accurately, I would need to know if there is scientific evidence showing that this specific surgical technique (single aortic cross-clamp) results in lower levels of S-100 protein release compared to other techniques in coronary artery surgery. Without specific studies or data referenced in the question, I cannot make a definitive determination. This would require knowledge of specific medical research comparing this technique with others and measuring S-100 levels as an outcome.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21152431",
    "question": "Is nuclear and cytoplasmic accumulation of Ep-ICD frequently detected in human epithelial cancers?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether nuclear and cytoplasmic accumulation of Ep-ICD (EpCAM Intracellular Domain) is frequently detected in human epithelial cancers. To answer this, I need to recall what is known about Ep-ICD in cancer biology. EpCAM (Epithelial Cell Adhesion Molecule) is a transmembrane glycoprotein that can undergo proteolytic cleavage, releasing its intracellular domain (Ep-ICD) which can translocate to the nucleus and cytoplasm. Based on scientific literature, Ep-ICD accumulation in the nucleus and cytoplasm has indeed been reported as a common feature in various epithelial cancers, including thyroid, breast, colon, and other carcinomas. This altered localization is often associated with tumor progression and poor prognosis. So yes, nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancers.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17290084",
    "question": "Is hemodynamic steroid responsiveness predictive of neurological outcome after traumatic brain injury?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if hemodynamic steroid responsiveness is predictive of neurological outcome after traumatic brain injury. To answer this, I need to consider whether there is established evidence that how a patient's hemodynamic parameters (blood pressure, cardiac output, etc.) respond to steroid administration can predict their neurological recovery after TBI. Based on current medical literature, while steroids have been studied in TBI, there isn't strong evidence that specifically hemodynamic responses to steroids are validated predictors of neurological outcomes. The use of steroids themselves in TBI has been controversial, with some large trials (like CRASH) showing no benefit or even harm. There isn't established evidence that hemodynamic responsiveness to steroids specifically serves as a reliable predictor of neurological outcomes after TBI.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21707690",
    "question": "Does a concerted decline in insulin secretion and action occur across the spectrum of fasting and postchallenge glucose concentrations?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between insulin secretion/action and glucose concentrations. Specifically, it's asking whether there is a 'concerted decline' in both insulin secretion and insulin action that occurs across the full spectrum of glucose concentrations (both fasting and after a glucose challenge).\\n\\nBased on established physiological understanding, as glucose tolerance worsens from normal to impaired glucose tolerance to type 2 diabetes, there is indeed a progressive decline in both insulin secretion (beta cell function) and insulin action (insulin sensitivity). This dual defect occurs across the continuum of glucose levels, not just at the diagnostic thresholds for diabetes.\\n\\nNumerous studies have shown that both insulin resistance and beta cell dysfunction are present early in the natural history of type 2 diabetes and worsen gradually as glucose levels rise, even within the normal range. This represents a concerted (coordinated) decline in both aspects of insulin physiology across the spectrum of glucose concentrations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10424641",
    "question": "Does the utility of Medicare claim data for measuring cancer stage?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether Medicare claim data is useful for measuring cancer stage. Medicare claim data primarily contains billing information, procedure codes, diagnosis codes, and other administrative data. While it can provide information about cancer diagnoses and treatments, it typically lacks detailed clinical information such as cancer staging, which requires specific pathological and clinical assessments. Cancer staging information is usually found in medical records, pathology reports, and cancer registries rather than in claims data. Medicare claims data may contain some procedure codes that hint at stage (like certain treatments typically used for advanced stages), but it's generally considered insufficient for accurately determining cancer stage without linkage to other data sources.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23335199",
    "question": "Is long-term antiretroviral therapy initiated during primary HIV-1 infection key to achieving both low HIV reservoirs and normal T cell counts?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if long-term antiretroviral therapy (ART) that is started during primary HIV-1 infection is essential for achieving both: 1) low HIV reservoirs, and 2) normal T cell counts.\\n\\nBased on research in HIV treatment, early initiation of ART during primary HIV infection has been shown to limit the size of viral reservoirs and help preserve immune function. Studies have demonstrated that individuals who start ART during primary infection (the early phase right after infection) tend to have smaller viral reservoirs compared to those who start treatment during chronic infection.\\n\\nAdditionally, early ART initiation helps prevent the depletion of CD4+ T cells and allows for better immune reconstitution. This can lead to more normal T cell counts compared to delayed treatment.\\n\\nHowever, while early ART is beneficial, the question asks if it's 'key' to achieving BOTH outcomes. The evidence suggests that early ART is indeed associated with both better outcomes for HIV reservoirs and T cell recovery, making it a critical factor in achieving these dual goals.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23329812",
    "question": "Does genetic profiling identify two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if genetic profiling can identify two distinct classes of soft-tissue leiomyosarcomas that have different clinical characteristics. To answer this, I need to consider what is known about genetic profiling of leiomyosarcomas (LMS), which are malignant smooth muscle tumors. Research in cancer genomics has indeed shown that genetic profiling can identify molecular subtypes of various cancers, including sarcomas. For leiomyosarcomas specifically, studies have demonstrated that genetic profiling can distinguish different molecular subtypes with distinct genomic alterations, chromosomal aberrations, and gene expression patterns. These molecular differences have been associated with different clinical behaviors, prognoses, and treatment responses. Several publications have identified at least two major genetic subgroups of soft-tissue leiomyosarcomas with different clinical features, including differences in metastatic potential, survival outcomes, and response to therapy. Therefore, the evidence supports that genetic profiling can identify distinct classes of soft-tissue leiomyosarcomas with different clinical characteristics.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23041457",
    "question": "Is lymphopenia an independent predictor of inferior outcome in clear cell renal carcinoma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether lymphopenia (low lymphocyte count) is an independent predictor of worse outcomes in clear cell renal carcinoma. To answer this, I would need to know if there are scientific studies that have specifically examined this relationship and controlled for other variables to establish independence. Without specific research data, I cannot definitively answer this medical question. However, there are studies that have examined the relationship between lymphopenia and outcomes in various cancers, including renal cell carcinoma. Some research suggests that systemic inflammatory markers, including lymphocyte counts, may have prognostic value in renal cell carcinoma. But whether lymphopenia specifically is an independent predictor would require evidence from multivariate analyses in peer-reviewed studies.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23929742",
    "question": "Do kinetics of sulforaphane in mice after consumption of sulforaphane-enriched broccoli sprout preparation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking if I know about the kinetics (how the body processes and metabolizes) of sulforaphane in mice after they consume sulforaphane-enriched broccoli sprout preparation. This is asking for factual information about a specific scientific topic. The question is phrased as a question but is missing a verb - it should be something like 'Do you know about the kinetics...' or 'What are the kinetics...'. I'm being asked to answer with only 'yes' or 'no', but this isn't a yes/no question as phrased. However, I think the intent is to ask if such kinetics exist or have been studied, in which case the answer would be 'yes' - there are studies on how sulforaphane is processed in mice after consuming broccoli sprout preparations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19234815",
    "question": "Does premedication with dexmedetomidine and midazolam attenuate agitation after electroconvulsive therapy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether premedication with dexmedetomidine and midazolam reduces agitation after electroconvulsive therapy (ECT). To answer this, I need to consider what is known about these medications in the context of ECT. Dexmedetomidine is an alpha-2 adrenergic agonist with sedative properties, and midazolam is a benzodiazepine with anxiolytic and amnestic effects. Both medications are used for sedation and anxiolysis. Research has shown that dexmedetomidine can reduce emergence agitation after general anesthesia, and midazolam is commonly used for its anxiolytic effects. When used as premedication before ECT, these medications have been studied for their effects on post-ECT agitation. Based on clinical studies, the combination of dexmedetomidine and midazolam has been found to attenuate agitation following ECT procedures.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23297503",
    "question": "Do [ Sperm DNA damage and sperm-nucleoprotein transition correlate to acrosin activity and seminal parameters ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if there is a correlation between sperm DNA damage and sperm-nucleoprotein transition with acrosin activity and seminal parameters. This is a scientific question about reproductive biology. To answer this, I would need to know if research has established such correlations. Without specific scientific evidence or studies presented in the question, I cannot definitively state whether these factors correlate. The question is phrased as a factual query about biological relationships that would require empirical evidence to answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17916255",
    "question": "Does androgen-induced masculinization in rainbow trout result in a marked dysregulation of early gonadal gene expression profiles?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the effects of androgen-induced masculinization in rainbow trout, specifically whether it causes a marked dysregulation of early gonadal gene expression profiles. To answer this, I need to consider what scientific research has shown about gene expression changes during masculinization in this species. Based on research in fish developmental biology, androgen treatment (like 17α-methyltestosterone) is often used to induce masculinization in fish including rainbow trout. Studies have shown that while this process does alter gene expression in the developing gonads, these changes tend to follow normal male developmental pathways rather than representing a dysregulation. The gene expression changes are generally consistent with normal male gonadal development, just induced in genetic females. The term 'dysregulation' implies abnormal or pathological changes, which isn't accurate for what happens during androgen-induced masculinization.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16128682",
    "question": "Does allopurinol safely and effectively optimize tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease (IBD) patients who are not responding to azathioprine and mercaptopurine. \\n\\nAllopurinol is known to inhibit xanthine oxidase, an enzyme that metabolizes mercaptopurine to inactive metabolites. When used in combination with thiopurines (azathioprine or mercaptopurine), allopurinol can shift the metabolism toward the active tioguanine metabolites. \\n\\nThere is evidence in the medical literature that adding allopurinol to reduced doses of thiopurines can optimize the metabolite profile in patients with preferential metabolism toward methylated metabolites rather than tioguanine nucleotides. This combination therapy has been shown to be effective in some IBD patients who previously failed to respond to standard thiopurine therapy.\\n\\nMultiple studies have demonstrated that allopurinol co-therapy can effectively increase tioguanine metabolite levels and improve clinical outcomes in IBD patients with suboptimal response to thiopurines alone. The safety profile is acceptable when thiopurine doses are appropriately reduced (typically by 25-33% of standard dose) to prevent myelotoxicity.\\n\\nBased on the available evidence, I can answer yes to this question.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25013418",
    "question": "Do classic papillary thyroid carcinoma with tall cell features and tall cell variant have similar clinicopathologic features?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to analyze whether classic papillary thyroid carcinoma with tall cell features and tall cell variant have similar clinicopathologic features. \\n\\nPapillary thyroid carcinoma (PTC) has several variants, including the tall cell variant (TCV), which is known to be more aggressive. Classic PTC with tall cell features refers to tumors that have some tall cell features but don't meet the full criteria for TCV (which typically requires that at least 30-50% of the tumor cells are tall cells).\\n\\nThe question is whether these two entities have similar clinicopathologic features. From the medical literature, TCV is generally associated with more aggressive behavior, higher rates of extrathyroidal extension, lymph node metastasis, distant metastasis, and poorer prognosis compared to classic PTC. Classic PTC with tall cell features falls somewhere in between classic PTC and TCV in terms of aggressiveness and outcomes, but doesn't fully match the clinicopathologic profile of TCV.\\n\\nSo while there may be some overlapping features, they don't have similar clinicopathologic features overall.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27267804",
    "question": "Is wISP1 a novel adipokine linked to metabolic parameters in gestational diabetes mellitus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"I need to determine if wISP1 (Wnt1-inducible signaling pathway protein 1) is a novel adipokine that has been linked to metabolic parameters in gestational diabetes mellitus (GDM). To answer this, I would need to know if there is scientific evidence establishing wISP1 as an adipokine (a cytokine secreted by adipose tissue) and if studies have shown a connection between wISP1 and metabolic parameters specifically in gestational diabetes mellitus. Without specific knowledge of the scientific literature on this topic, I cannot confidently answer. However, based on my training data, I believe wISP1 (also known as CCN4) has been identified as an adipokine that may have connections to insulin resistance and metabolic parameters, and some research has investigated its role in gestational diabetes mellitus.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "9322191",
    "question": "Does olive oil increase the magnitude of postprandial chylomicron remnants compared to milk fat and safflower oil?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if olive oil increases the magnitude of postprandial chylomicron remnants compared to milk fat and safflower oil. To answer this, I need to consider what research shows about how different dietary fats affect chylomicron remnant levels after meals. Chylomicron remnants are particles that remain after chylomicrons (which transport dietary fats) are partially metabolized. \\n\\nBased on scientific literature, olive oil (which is rich in monounsaturated fats) typically produces a lower postprandial lipemic response compared to saturated fats like milk fat. Safflower oil, which is high in polyunsaturated fats, also tends to produce lower postprandial lipemia than saturated fats. \\n\\nThe specific question about chylomicron remnant magnitude requires precise knowledge of comparative studies. From what I understand, olive oil generally does not increase chylomicron remnants compared to milk fat (olive oil usually produces fewer remnants than saturated fats). When comparing olive oil to safflower oil, the differences are less pronounced, but olive oil does not typically increase chylomicron remnants compared to safflower oil either.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17290189",
    "question": "Are the in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme mediated in part by Toll-like receptor 4?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the mechanism of action of lipopolysaccharide (LPS) against glioblastoma multiforme (GBM), specifically whether Toll-like receptor 4 (TLR4) is involved in mediating its anti-tumor effects in vivo. LPS is a component of the outer membrane of Gram-negative bacteria and is known to be a potent activator of TLR4. TLR4 is a pattern recognition receptor involved in innate immunity. The question specifically asks about 'in vivo' effects, meaning effects observed in living organisms rather than cell cultures. To answer this question accurately, I need to consider whether scientific evidence supports that LPS's anti-glioblastoma effects in animal models or clinical studies involve TLR4 signaling pathways. Based on the scientific literature, LPS does indeed exert some of its anti-glioblastoma effects through TLR4 activation, which can trigger immune responses against the tumor and potentially direct cytotoxic effects on TLR4-expressing glioblastoma cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18094704",
    "question": "Does nICU lactation consultant increase percentage of outborn versus inborn babies receiving human milk?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a neonatal intensive care unit (NICU) lactation consultant increases the percentage of outborn versus inborn babies receiving human milk. 'Outborn' refers to babies born at another hospital and transferred to the NICU, while 'inborn' refers to babies born at the same hospital as the NICU. \\n\\nTo answer this question, I would need specific research or data comparing human milk feeding rates between outborn and inborn babies when a lactation consultant is present versus absent. Without such specific evidence, I cannot make a definitive claim about whether lactation consultants specifically increase the percentage of outborn babies receiving human milk compared to inborn babies. The question is asking about a comparative effect (outborn versus inborn), not just whether lactation consultants help overall.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23684750",
    "question": "Do thromboxane A2 synthase inhibitors prevent production of infectious hepatitis C virus in mice with humanized livers?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if thromboxane A2 synthase inhibitors prevent production of infectious hepatitis C virus (HCV) in mice with humanized livers. To answer this, I need to consider whether there is established scientific evidence showing that these specific inhibitors have this anti-HCV effect in this particular model system.\\n\\nThromboxane A2 synthase inhibitors are compounds that block the enzyme that produces thromboxane A2, which is involved in platelet aggregation and vasoconstriction. While there are studies examining various antiviral approaches for HCV, including in humanized liver mouse models, I don't recall specific evidence demonstrating that thromboxane A2 synthase inhibitors specifically prevent HCV production in humanized liver mice models.\\n\\nWithout specific scientific literature supporting this claim, I cannot confirm that these inhibitors have this particular effect.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "1282009",
    "question": "Are antilactoferrin antibodies in patients with rheumatoid arthritis associated with vasculitis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. To answer this, I need to consider whether there is an established connection between these specific antibodies and vasculitis in RA patients. Rheumatoid arthritis (RA) is an autoimmune disease that can have various extra-articular manifestations, including vasculitis. Different autoantibodies have been associated with different manifestations of RA. While anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF) are well-known in RA, the specific association between antilactoferrin antibodies and vasculitis in RA patients is not as widely established in the medical literature. Without specific evidence supporting this association, I cannot confirm that antilactoferrin antibodies are associated with vasculitis in RA patients.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12042644",
    "question": "Does local delivery of basic fibroblast growth factor increase both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if local delivery of basic fibroblast growth factor (bFGF) increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices. To answer this, I need to consider what is known about bFGF's effects in this specific context. bFGF is known to be a potent angiogenic factor that stimulates blood vessel formation. In tissue engineering applications, it has been studied for its ability to promote vascularization. For hepatocyte engraftment specifically in polymer devices, I would need to know if studies have demonstrated that bFGF delivery increases both the vascular network formation AND the successful integration/survival of transplanted hepatocytes. Without specific research information, I cannot definitively answer this question.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17893452",
    "question": "Do novices ventilate and intubate quicker and safer via intubating laryngeal mask than by conventional bag-mask ventilation and laryngoscopy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether novices perform ventilation and intubation more quickly and safely using an intubating laryngeal mask airway (ILMA) compared to conventional bag-mask ventilation and direct laryngoscopy. To answer this, I need to consider the evidence about these two techniques when performed by inexperienced providers.\\n\\nIntubating laryngeal mask airways (like the Fastrach LMA) were designed to facilitate both ventilation and subsequent intubation through the device. They typically require less technical skill than direct laryngoscopy, which involves visualizing the vocal cords directly and can be challenging for novices.\\n\\nResearch has generally shown that:\\n1. Novices can often place supraglottic airways (including ILMAs) more quickly than they can achieve successful intubation via direct laryngoscopy\\n2. Ventilation can be established faster with supraglottic devices than with bag-mask ventilation for inexperienced providers\\n3. Success rates for first-attempt intubation are typically higher with ILMA-guided intubation for novices compared to direct laryngoscopy\\n4. Complication rates (such as dental trauma, soft tissue injury) tend to be lower with ILMA techniques\\n\\nBased on the available evidence, novices do generally ventilate and intubate quicker and with fewer complications using an ILMA compared to conventional bag-mask ventilation followed by direct laryngoscopy.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16831247",
    "question": "Does [ Dipyridamole preconditioning protect against ischemia/reperfusion injury of rat liver ]?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if dipyridamole preconditioning protects against ischemia/reperfusion injury of rat liver. This is a specific scientific claim about a pharmacological agent (dipyridamole) having a protective effect against a specific type of injury (ischemia/reperfusion) in a specific organ (liver) of a specific animal model (rat). To answer this accurately, I would need to know if there is scientific evidence supporting this claim. Based on my knowledge, dipyridamole is an antiplatelet agent that inhibits phosphodiesterase enzymes and has been studied for various protective effects in different organs. There are indeed studies showing that dipyridamole can have protective effects against ischemia/reperfusion injury in various organs including the liver in rat models, through mechanisms like inhibition of adenosine uptake, antioxidant effects, and anti-inflammatory properties. So the scientific literature does support this claim.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19735878",
    "question": "Does curcumin modulate the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity. This is a specific scientific claim about curcumin's mechanism of action in cancer treatment. To answer this accurately, I would need to be familiar with research studies on curcumin's effects on colorectal cancer cells, specifically regarding its impact on NF-kappaB activity and how that relates to radiosensitivity. There is research suggesting curcumin has anti-cancer properties and can affect NF-kappaB signaling pathways, but I need to be precise about this specific mechanism. Based on scientific literature, curcumin has been shown to inhibit NF-kappaB activation in various cancer cells including colorectal cancer, and this inhibition has been linked to enhanced sensitivity to radiation therapy. So the answer appears to be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23928408",
    "question": "Is aBO-incompatible living donor liver transplantation suitable in patients without ABO-matched donor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if ABO-incompatible living donor liver transplantation is suitable for patients who don't have an ABO-matched donor available. ABO-incompatible transplantation refers to transplanting an organ from a donor with a blood type that would normally be incompatible with the recipient's blood type. This approach has been developed specifically to address situations where ABO-matched donors are unavailable. While it carries additional immunological challenges requiring special protocols (like plasmapheresis, immunoadsorption, and enhanced immunosuppression), it has become an established alternative when ABO-compatible donors aren't available. The development of this procedure was specifically to help patients who would otherwise have no donor options, so it is indeed suitable for patients without ABO-matched donors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17314207",
    "question": "Does fasting insulin modify the relation between age and renal function?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether fasting insulin levels affect the relationship between a person's age and their kidney (renal) function. To answer this, I would need to know if there is scientific evidence showing that insulin levels influence how age impacts kidney function. This would typically be demonstrated through research studies showing that the age-related decline in renal function differs between people with different fasting insulin levels. Without specific research data, I cannot make a definitive claim. However, there is some biological plausibility - insulin resistance and hyperinsulinemia are known to affect kidney function, and both insulin sensitivity and kidney function change with age. Several studies have examined the relationships between insulin, aging, and kidney function, suggesting there may be interactions between these factors. Based on existing medical literature, there appears to be evidence supporting that insulin levels can modify the relationship between age and renal function.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10930209",
    "question": "Does propofol inhibit renal cytochrome P450 activity and enflurane defluorination in vitro in hamsters?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if propofol inhibits renal cytochrome P450 activity and enflurane defluorination in vitro in hamsters. To answer this, I need to determine if there's evidence that propofol has this specific inhibitory effect on renal cytochrome P450 and enflurane defluorination specifically in hamsters in vitro. This is a very specific biochemical question about drug interactions in a particular animal model. Without specific research data on this exact interaction in hamsters, I cannot confirm this. While propofol is known to interact with cytochrome P450 enzymes in humans and some animal models, the specific claim about inhibition of renal cytochrome P450 and enflurane defluorination in hamsters requires specific evidence from research studies. I don't have sufficient information to confirm this specific biochemical interaction in hamsters.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25573181",
    "question": "Do cardiac and inflammatory biomarkers correlate with volume of heart or lung receiving radiation?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if cardiac and inflammatory biomarkers correlate with the volume of heart or lung receiving radiation. This is asking about a relationship between biological markers (cardiac and inflammatory biomarkers) and radiation dosimetry parameters (volume of heart/lung receiving radiation). Based on medical literature, there is evidence that radiation dose to cardiac structures can correlate with changes in cardiac biomarkers like troponin, BNP, and inflammatory markers like CRP. Studies have shown that higher heart/lung volumes receiving radiation can be associated with elevated biomarker levels, suggesting radiation-induced cardiac or pulmonary toxicity. This relationship has been documented in patients receiving radiotherapy for thoracic malignancies like breast cancer, lung cancer, and lymphoma. So there is a correlation between these biomarkers and the volume of heart/lung receiving radiation.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "22483594",
    "question": "Does imidazolium salt attenuate thioacetamide-induced liver fibrosis in mice by modulating inflammation and oxidative stress?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether imidazolium salt has a therapeutic effect on liver fibrosis in mice, specifically by reducing inflammation and oxidative stress in a thioacetamide-induced model of liver fibrosis. To answer this question accurately, I would need to know about specific research studies that have investigated this relationship. Without specific knowledge of research demonstrating that imidazolium salt attenuates thioacetamide-induced liver fibrosis through these mechanisms, I cannot confidently answer 'yes'. However, there are studies showing that various imidazolium-based compounds have anti-inflammatory and antioxidant properties, and some research has explored their potential in liver protection. Without specific evidence for this exact relationship, I should answer 'no'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18606000",
    "question": "Do genetic tests of ancient asexuality in root knot nematodes reveal recent hybrid origins?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether genetic tests of ancient asexuality in root knot nematodes reveal recent hybrid origins. To answer this, I need to consider what scientific research has shown about root knot nematodes (Meloidogyne species). Root knot nematodes include some species that were thought to be ancient asexual organisms, reproducing without sex for millions of years. However, genetic studies have indeed revealed that many of these supposedly ancient asexual species actually have recent hybrid origins. Research has shown evidence of hybridization events in their evolutionary history, contradicting the hypothesis of ancient asexuality. Studies examining their genome structure, heterozygosity patterns, and phylogenetic relationships have demonstrated that many of these nematodes are actually the result of relatively recent hybridization events between sexual ancestors, followed by a transition to asexual reproduction. So the genetic tests do reveal recent hybrid origins rather than confirming ancient asexuality.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21176111",
    "question": "Does exposure to phosphodiesterase type 5 inhibitors stimulate aromatase expression in human adipocytes in vitro?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether phosphodiesterase type 5 (PDE5) inhibitors stimulate aromatase expression in human adipocytes in laboratory conditions (in vitro). To answer this, I would need specific scientific evidence from research studies that have investigated this relationship. Without access to specific studies examining the effect of PDE5 inhibitors (like sildenafil, tadalafil, etc.) on aromatase expression in human fat cells, I cannot provide a definitive answer based on established scientific evidence. I don't have information about this specific biochemical interaction in my knowledge base.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26159934",
    "question": "Do biotic context and soil properties modulate native plant responses to enhanced rainfall?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether biotic context (which refers to the living components of an ecosystem, like other plants, microbes, etc.) and soil properties (physical, chemical, and biological characteristics of soil) affect how native plants respond to increased rainfall. To answer this, I need to consider ecological research on plant-soil-water interactions. Research has shown that soil properties like texture, organic matter content, and microbial communities can significantly influence water availability and uptake by plants. Similarly, biotic interactions (competition, facilitation, etc.) can modify how plants respond to changes in water availability. Multiple studies have demonstrated that native plant responses to precipitation changes are indeed context-dependent, varying based on soil conditions and the surrounding biological community. So yes, there is substantial evidence that both biotic context and soil properties do modulate (or modify/influence) how native plants respond to enhanced rainfall.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21610013",
    "question": "Does b-type natriuretic peptide predict long-term survival after major non-cardiac surgery?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if b-type natriuretic peptide (BNP) predicts long-term survival after major non-cardiac surgery. BNP is a cardiac biomarker that is released in response to cardiac wall stress and is often used to diagnose heart failure. There is research showing that elevated pre-operative and post-operative BNP levels are associated with increased risk of adverse cardiac events and mortality after non-cardiac surgery. Studies have shown that BNP can predict short-term complications and mortality (within 30 days), but the question specifically asks about long-term survival. There is evidence from multiple studies that pre-operative BNP levels can independently predict long-term mortality (1-5 years) after non-cardiac surgery, with higher BNP levels associated with worse long-term survival outcomes. Based on the available medical literature, BNP does appear to have predictive value for long-term survival after major non-cardiac surgery.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15928720",
    "question": "Does a decrease of enlarged left atrium following cardioversion of atrial fibrillation predict the long-term maintenance of sinus rhythm?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether a decrease in the size of an enlarged left atrium after cardioversion of atrial fibrillation is predictive of long-term maintenance of sinus rhythm. To answer this, I would need to know if there's evidence showing that patients whose left atrial size decreases after cardioversion are more likely to maintain normal sinus rhythm over the long term compared to those whose left atrial size remains enlarged. Based on cardiovascular literature, left atrial remodeling (including size reduction) following successful cardioversion can be associated with better outcomes, but I need to be careful about making a definitive statement about prediction of long-term maintenance without specific studies. From my knowledge, there is some evidence suggesting that left atrial reverse remodeling (decrease in size) after cardioversion is associated with better maintenance of sinus rhythm, but the relationship is complex and involves multiple factors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20661026",
    "question": "Is labile anger during interferon alfa treatment associated with a polymorphism in tumor necrosis factor alpha?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if labile anger (mood swings with anger) during interferon alfa treatment is associated with a polymorphism (genetic variation) in tumor necrosis factor alpha (TNF-alpha). To answer this, I would need specific research evidence showing a connection between these factors. Without being provided specific studies or data in the question, I cannot determine if such an association has been scientifically established. This would require research examining both the psychological side effects of interferon treatment and genetic factors that might predispose patients to these effects. Since I don't have access to specific research establishing this link, I cannot confirm this association.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20981412",
    "question": "Does the antidepressant-like effect of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane involve a regulation of β-type estrogen receptors?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether the antidepressant-like effect of trilostane (which is a 3β-hydroxysteroid dehydrogenase inhibitor) involves regulation of β-type estrogen receptors. To answer this, I would need specific scientific evidence about the mechanism of action of trilostane and whether it has been shown to interact with or regulate β-type estrogen receptors as part of its antidepressant effects. Without specific research studies or evidence provided in the question, I cannot make a definitive determination. However, trilostane is primarily known to inhibit steroid synthesis, particularly cortisol and aldosterone, by blocking 3β-hydroxysteroid dehydrogenase. While this could theoretically affect steroid hormone pathways that might indirectly influence estrogen receptors, a direct regulation of β-type estrogen receptors is not widely established as its primary mechanism for antidepressant effects based on general pharmacological knowledge. Without specific evidence provided, I cannot confirm this relationship.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26285024",
    "question": "Does endurance Training attenuate Catabolic Signals Induced by TNF-α in Muscle of Mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if endurance training reduces (attenuates) catabolic signals that are induced by TNF-α in mouse muscle. To answer this, I need to consider what is known about endurance training effects on TNF-α signaling pathways. TNF-α is a pro-inflammatory cytokine that can promote muscle catabolism (breakdown). Endurance training has been shown in various studies to have anti-inflammatory effects and can modulate cytokine signaling. Research has demonstrated that regular endurance exercise can reduce TNF-α-induced muscle protein degradation pathways and attenuate the catabolic effects of inflammatory cytokines. Studies in mice have specifically shown that endurance training can counteract TNF-α-induced muscle wasting by activating anabolic pathways and reducing catabolic signaling. Based on the scientific literature, endurance training does appear to attenuate catabolic signals induced by TNF-α in muscle of mice.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25722366",
    "question": "Are cardiovascular risk factors associated with increased lesion burden and brain atrophy in multiple sclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question asks about the relationship between cardiovascular risk factors and multiple sclerosis (MS) disease progression, specifically whether these risk factors are associated with increased lesion burden and brain atrophy in MS patients.\\n\\nTo answer this accurately, I need to consider the current scientific evidence. Research has indeed shown that cardiovascular risk factors such as hypertension, hyperlipidemia, diabetes, smoking, and obesity can negatively impact MS disease progression. Several studies have demonstrated that these risk factors are associated with increased lesion burden (more MS plaques/lesions visible on MRI) and accelerated brain atrophy (brain volume loss) in MS patients.\\n\\nFor example, studies have shown that MS patients with comorbid cardiovascular risk factors tend to have:\\n- Higher T2 lesion volumes\\n- More rapid progression of brain atrophy\\n- Faster disability progression\\n- Poorer response to disease-modifying therapies\\n\\nThe mechanisms likely involve increased systemic inflammation, vascular damage, and oxidative stress, which can exacerbate the neuroinflammatory and neurodegenerative processes in MS.\\n\\nBased on the current scientific consensus, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27514759",
    "question": "Does weight loss induced by bariatric surgery restore adipose tissue PNPLA3 expression?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether weight loss induced by bariatric surgery restores adipose tissue PNPLA3 expression. PNPLA3 (patatin-like phospholipase domain-containing protein 3) is a gene that encodes a protein involved in lipid metabolism. To answer this question, I need to consider whether there is evidence that bariatric surgery-induced weight loss specifically affects PNPLA3 expression in adipose tissue.\\n\\nBariatric surgery is known to cause significant weight loss and improve metabolic parameters, but the specific effect on PNPLA3 expression in adipose tissue is not something I can definitively state without specific research evidence. While bariatric surgery affects many metabolic pathways and gene expressions in adipose tissue, I don't have conclusive information about its specific effect on PNPLA3 expression restoration.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24620925",
    "question": "Does plaque reduction neutralization antibody test accurately predict protection against dengue infection in Ratchaburi cohort , Thailand?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if plaque reduction neutralization antibody test accurately predicts protection against dengue infection in the Ratchaburi cohort in Thailand. To answer this, I would need specific information about studies conducted on this cohort that evaluated the correlation between plaque reduction neutralization test (PRNT) antibody levels and actual protection against dengue infection. Without specific data from studies on the Ratchaburi cohort showing that PRNT accurately predicted protection, I cannot confirm this claim. In fact, the relationship between neutralizing antibodies and protection against dengue is complex due to the four serotypes and phenomena like antibody-dependent enhancement. Many studies have shown that PRNT titers don't consistently correlate with protection across all dengue serotypes or populations.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "24836747",
    "question": "Are eRCP-directed radiofrequency ablation and photodynamic therapy associated with comparable survival in the treatment of unresectable cholangiocarcinoma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if eRCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in treating unresectable cholangiocarcinoma. To answer this, I would need to know if studies have compared these two treatment modalities and found similar survival outcomes. Without specific data comparing these two treatments directly, I cannot make a definitive statement about their comparative efficacy. The question assumes there is established evidence about the comparative survival rates between these two specific treatments for cholangiocarcinoma. Since I don't have access to comprehensive medical literature databases to verify if such comparative studies exist or what their findings are, I cannot confidently answer yes or no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16294031",
    "question": "Does cisplatin-induced GADD34 upregulation potentiate oncolytic viral therapy in the treatment of malignant pleural mesothelioma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question step by step:\\n\\n1. Cisplatin is a chemotherapy drug\\n2. GADD34 (Growth Arrest and DNA Damage-inducible protein 34) is a protein involved in cellular stress responses\\n3. The question asks if cisplatin-induced GADD34 upregulation potentiates (enhances) oncolytic viral therapy\\n4. Specifically for treating malignant pleural mesothelioma (a type of cancer)\\n\\nTo answer this, I need to determine if there is established evidence that cisplatin causes GADD34 upregulation and if this specifically enhances oncolytic viral therapy in mesothelioma.\\n\\nWhile cisplatin can induce stress responses and GADD34 is involved in stress pathways, and while oncolytic viruses are being studied for mesothelioma, I don't have specific evidence that cisplatin-induced GADD34 upregulation has been proven to potentiate oncolytic viral therapy specifically in malignant pleural mesothelioma. This appears to be a very specific mechanistic relationship that would require specialized research to establish.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12443729",
    "question": "Do neurokinin-1 receptor and substance P messenger RNA levels increase during intraabdominal adhesion formation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether neurokinin-1 receptor and substance P messenger RNA levels increase during intraabdominal adhesion formation. To answer this, I need to consider what is known about the molecular mechanisms of adhesion formation.\\n\\nIntraabdominal adhesions are fibrous bands that form between tissues and organs, often after surgery. The formation involves inflammatory processes and wound healing mechanisms.\\n\\nNeurokinin-1 receptor (NK1R) is a receptor for substance P, which is a neuropeptide involved in pain transmission and inflammation. Substance P is encoded by the TAC1 gene, and its levels can be measured by detecting its messenger RNA.\\n\\nBased on scientific literature, there is evidence that substance P and its receptor NK1R are upregulated during inflammatory processes. Studies have shown that substance P levels increase during tissue injury and inflammation, which are key components of adhesion formation.\\n\\nSpecifically regarding intraabdominal adhesion formation, research has demonstrated that both NK1R and substance P mRNA levels do increase during this process. This upregulation is part of the neurogenic inflammatory response that contributes to adhesion development.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26802181",
    "question": "Do ultrasound findings predict progression to inflammatory arthritis in anti-CCP antibody-positive patients without clinical synovitis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if ultrasound findings can predict progression to inflammatory arthritis in patients who are anti-CCP antibody-positive but don't have clinical synovitis. To answer this, I need to consider whether there's established evidence that ultrasound findings have predictive value for disease progression in this specific patient population.\\n\\nBased on medical literature, there is evidence that ultrasound can detect subclinical synovitis and other joint abnormalities in anti-CCP positive patients before they develop clinical arthritis. Several studies have shown that ultrasound findings (particularly power Doppler signals and synovial thickening) in anti-CCP positive individuals without clinical synovitis are associated with an increased risk of progression to inflammatory arthritis like rheumatoid arthritis. These findings can predict which patients are more likely to develop clinical arthritis and in what timeframe.\\n\\nSo yes, ultrasound findings do have predictive value for progression to inflammatory arthritis in this specific patient population.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27663696",
    "question": "Is the association between follicle stimulating hormone and glutathione peroxidase activity dependent on abdominal obesity in postmenopausal women?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the association between follicle stimulating hormone (FSH) and glutathione peroxidase activity depends on abdominal obesity in postmenopausal women. To answer this, I would need specific research data that examines this particular relationship. Without being provided specific studies or data that demonstrate this relationship, I cannot make a definitive claim about whether abdominal obesity mediates or moderates the relationship between FSH and glutathione peroxidase activity in postmenopausal women. This appears to be a specific scientific question that would require empirical evidence from medical research to answer accurately.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17545066",
    "question": "Does [ Hepatocyte growth factor enhance protein synthesis in cardiomyocytes exposed to gamma-ray irradiation ]?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether hepatocyte growth factor (HGF) enhances protein synthesis in cardiomyocytes (heart muscle cells) that have been exposed to gamma-ray irradiation. To answer this, I would need to know if HGF has been shown to increase protein synthesis specifically in cardiomyocytes after gamma radiation exposure. Without specific scientific evidence about this particular interaction, I cannot definitively answer. The title appears to be from a research paper that likely investigated this specific relationship, and the phrasing suggests the paper found that HGF does enhance protein synthesis in irradiated cardiomyocytes, but I would need to verify the actual findings of the study to confirm.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26298789",
    "question": "Does obstructive sleep apnea exacerbate airway inflammation in patients with chronic obstructive pulmonary disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question asks about the relationship between obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), specifically whether OSA worsens airway inflammation in COPD patients. Based on medical literature, there is evidence that OSA can indeed exacerbate airway inflammation in COPD patients. The intermittent hypoxia and sleep fragmentation associated with OSA can trigger inflammatory pathways, increase oxidative stress, and promote systemic inflammation. In patients who have both conditions (sometimes called 'overlap syndrome'), these inflammatory processes can compound each other, leading to increased airway inflammation compared to patients with COPD alone. Multiple studies have shown elevated inflammatory markers in patients with both conditions compared to those with just COPD.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21963786",
    "question": "Do spinal microglia initiate and maintain hyperalgesia in a rat model of chronic pancreatitis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the role of spinal microglia in hyperalgesia (increased sensitivity to pain) in a rat model of chronic pancreatitis. To answer this, I need to determine if there is evidence that spinal microglia are responsible for both initiating and maintaining the pain hypersensitivity in this specific disease model.\\n\\nWithout specific research papers or evidence provided in the question, I cannot make a definitive determination about whether spinal microglia have been proven to both initiate and maintain hyperalgesia specifically in a rat model of chronic pancreatitis. This would require specific experimental evidence from studies that have investigated this particular relationship.\\n\\nWhile microglia are known to play important roles in various pain conditions and neuroinflammation, confirming their specific role in both initiating AND maintaining hyperalgesia in this particular model would require specific scientific evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21720278",
    "question": "Do prognostic value of Achilles tendon Doppler sonography in asymptomatic runners?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether Achilles tendon Doppler sonography has prognostic value in asymptomatic runners. To answer this, I need to consider if there's evidence that Doppler ultrasound findings in runners without symptoms can predict future tendon problems or injuries. This is a specific medical question about the predictive capability of a particular imaging technique in a specific population. Based on my knowledge, while Doppler sonography is used to assess Achilles tendon pathology, there isn't strong established evidence that it has clear prognostic value in completely asymptomatic runners. Some studies have shown increased vascularity in asymptomatic tendons of runners, but the predictive value for future symptoms remains uncertain.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20006334",
    "question": "Are high lipoprotein ( a ) levels associated with an increased risk of retinal vein occlusion?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the association between high lipoprotein(a) levels and increased risk of retinal vein occlusion (RVO). Lipoprotein(a) is a type of lipoprotein that has been associated with cardiovascular diseases due to its prothrombotic and proatherogenic properties. Retinal vein occlusion is a condition where there is blockage of the veins carrying blood from the retina. \\n\\nResearch has shown that elevated lipoprotein(a) levels are indeed associated with an increased risk of retinal vein occlusion. Several studies have demonstrated that patients with RVO have significantly higher lipoprotein(a) levels compared to control subjects. The prothrombotic properties of lipoprotein(a) may contribute to venous thrombosis in the retina. Additionally, lipoprotein(a) has been identified as an independent risk factor for RVO in multiple studies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24369238",
    "question": "Does [ Curcumin inhibit HeLa cell invasion and migration by decreasing inducible nitric oxide synthase ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether curcumin inhibits HeLa cell invasion and migration by decreasing inducible nitric oxide synthase. To answer this, I need to analyze what the statement is claiming:\\n\\n1. Curcumin has an inhibitory effect on HeLa cell invasion and migration\\n2. This inhibition works through a specific mechanism: decreasing inducible nitric oxide synthase\\n\\nThis appears to be a scientific claim about the mechanism of action of curcumin on cancer cells (HeLa cells are a cervical cancer cell line). The statement is presented as a research finding, and based on the way it's phrased, it seems to be stating a conclusion from a research paper.\\n\\nWithout specific scientific evidence or references, I cannot verify if this specific mechanism has been established in the scientific literature. However, there are published studies showing that curcumin can inhibit cancer cell migration and invasion through various pathways, and modulation of nitric oxide synthase could be one of them.\\n\\nSince the question is asking if this specific statement is true, and I don't have definitive evidence to confirm this particular mechanism, I should answer conservatively.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15337212",
    "question": "Do african Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the prevalence of coronary calcium in African Americans compared to Caucasians in the Dallas Heart Study. To answer this accurately, I would need to know the specific findings of the Dallas Heart Study regarding coronary calcium distribution across racial groups. The Dallas Heart Study is a well-known population-based study that examined cardiovascular health across different demographics. Without having the exact data from this study, I cannot definitively state whether the prevalence is similar or different between these racial groups. Research generally shows racial disparities in coronary calcium and cardiovascular disease, but I need the specific findings from this particular study to answer correctly.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15105230",
    "question": "Does electrocerebral silence by intracarotid anesthetics affect early hyperemia after transient cerebral ischemia in rabbits?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific scientific finding related to the effect of electrocerebral silence (induced by intracarotid anesthetics) on early hyperemia following transient cerebral ischemia, specifically in rabbits. To answer this, I would need to know if studies have shown that when rabbits are given intracarotid anesthetics that cause electrocerebral silence (flat EEG), this affects the early hyperemic response (increased blood flow) that typically occurs after temporary cerebral ischemia (reduced blood flow to the brain). This is a very specific scientific question that would require knowledge of particular research studies in cerebrovascular physiology and anesthesiology. Without specific knowledge of the relevant literature, I cannot provide a definitive answer.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "23847148",
    "question": "Do serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis. To answer this, I need to consider what research has shown about metabolomic profiles in CF patients.\\n\\nCystic fibrosis (CF) is a genetic disorder that affects multiple organ systems, primarily the lungs and digestive system. Research has indeed shown that CF patients exhibit altered metabolic profiles. Several studies have demonstrated that children with CF show differences in metabolites related to energy metabolism compared to healthy controls. These include alterations in amino acid metabolism, fatty acid oxidation, and TCA cycle intermediates. The metabolomic changes observed in serum samples from CF patients reflect the underlying pathophysiology, including mitochondrial dysfunction and altered cellular energy production.\\n\\nSpecific findings from metabolomic studies have shown decreased levels of certain amino acids, altered lipid metabolism, and changes in metabolites involved in cellular energy production pathways. These metabolic signatures detected in serum samples do indicate that cellular energy metabolism is altered in children with CF.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26450422",
    "question": "Do polymorphisms in HLA Class II Genes Are Associated With Susceptibility to Staphylococcus aureus Infection in a White Population?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether polymorphisms in HLA Class II genes are associated with susceptibility to Staphylococcus aureus infection specifically in a White population. This is a scientific question about genetic factors that may influence infection susceptibility in a specific ethnic group. To answer this accurately, I would need to know if research has established such an association. Based on existing research, there is evidence that HLA Class II gene polymorphisms are indeed associated with susceptibility to S. aureus infection in White populations. Several studies have shown that certain HLA-DR and HLA-DQ alleles can influence the risk of S. aureus colonization and infection, with particular variants being more common in White individuals with recurrent or severe S. aureus infections compared to controls.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20847302",
    "question": "Is coronary artery disease-related genetic variant on chromosome 10q11 associated with carotid intima-media thickness and atherosclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the association between a coronary artery disease-related genetic variant on chromosome 10q11 and two specific outcomes: carotid intima-media thickness and atherosclerosis. To answer this, I would need to know if scientific studies have established such an association. Based on my knowledge, there have been studies showing that genetic variants on chromosome 10q11 (particularly rs1746048 and others in the CXCL12 gene region) are associated with coronary artery disease. Some research has also investigated whether these same variants are associated with carotid intima-media thickness (a marker of subclinical atherosclerosis) and atherosclerosis in other vascular beds. Several studies have indeed found associations between 10q11 variants and measures of atherosclerosis including carotid intima-media thickness, suggesting there is evidence for this association.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23058682",
    "question": "Does cancer patients ' information need the first nine months after diagnosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question seems to be asking whether cancer patients need information during the first nine months after diagnosis. This is likely referring to whether cancer patients have a need for medical information, support resources, treatment options, etc. during the initial period after being diagnosed with cancer. Based on research and common understanding of cancer patient experiences, patients typically have significant information needs throughout their cancer journey, especially in the early months after diagnosis when they are making treatment decisions and adjusting to their diagnosis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "8835556",
    "question": "Is the presence of anti-Fc gamma receptor autoantibodies related to the clinical presentation of primary Sjögren 's syndrome?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if anti-Fc gamma receptor autoantibodies are related to the clinical presentation of primary Sjögren's syndrome. To answer this, I need to consider whether there is established evidence in medical literature showing a relationship between these specific autoantibodies and how primary Sjögren's syndrome manifests clinically.\\n\\nPrimary Sjögren's syndrome is an autoimmune disorder characterized by lymphocytic infiltration of exocrine glands, particularly the salivary and lacrimal glands, leading to symptoms like dry eyes and dry mouth. Various autoantibodies have been associated with Sjögren's syndrome, including anti-Ro/SSA, anti-La/SSB, rheumatoid factor, and others.\\n\\nWhile Fc gamma receptors are important in immune function and autoimmunity, and autoantibodies against various targets are common in Sjögren's syndrome, I don't recall specific established evidence that anti-Fc gamma receptor autoantibodies in particular have been definitively linked to the clinical presentation or severity of primary Sjögren's syndrome. Without specific knowledge of research establishing this connection, I should answer 'no'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23383046",
    "question": "Does fHL2 silencing reduce Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the effects of fHL2 silencing on Wnt signaling and osteosarcoma tumorigenesis, both in laboratory cell cultures (in vitro) and in living organisms (in vivo). To answer this, I would need to know if scientific research has demonstrated that when the fHL2 gene is silenced (its expression is reduced or eliminated), there is a corresponding reduction in Wnt signaling pathways and a decrease in osteosarcoma tumor formation or growth. Without specific scientific literature to reference, I cannot make a definitive determination. However, there are studies suggesting that fHL2 can act as a modulator of Wnt signaling in certain contexts, and it has been implicated in various cancers. The specific relationship with osteosarcoma would require evidence from research directly examining this relationship.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24559856",
    "question": "Is adherence to the Mediterranean diet inversely related to binge eating disorder in patients seeking a weight loss program?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if adherence to the Mediterranean diet is inversely related to binge eating disorder in patients seeking weight loss programs. To answer this, I need to consider whether there's established scientific evidence showing that higher adherence to the Mediterranean diet is associated with lower rates of binge eating disorder specifically in weight loss program patients. Without specific studies or data provided in the question, I cannot make a definitive claim about this relationship. While the Mediterranean diet has been associated with various positive health outcomes and better psychological well-being in general, a specific inverse relationship with binge eating disorder in weight loss patients would require specific research evidence. I don't have enough information to confirm this specific relationship.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25676844",
    "question": "Is negative Sentinel Lymph Node Biopsy in Merkel Cell Carcinoma Associated with a Low Risk of Same-Nodal-Basin Recurrences?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if a negative Sentinel Lymph Node Biopsy (SLNB) in Merkel Cell Carcinoma is associated with a low risk of recurrences in the same nodal basin. Merkel Cell Carcinoma is a rare but aggressive type of skin cancer. SLNB is a procedure to determine if cancer has spread to the lymph nodes. \\n\\nTo answer this question accurately, I would need to rely on medical research findings. Based on medical literature, a negative SLNB in Merkel Cell Carcinoma generally indicates that the cancer has not spread to the lymph nodes, which is typically associated with a lower risk of recurrence in the same nodal basin compared to patients with positive SLNB results. However, Merkel Cell Carcinoma is known for its aggressive nature, and even with negative SLNB, there is still some risk of recurrence. The risk is considered relatively low but not negligible.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26209395",
    "question": "Are low serum levels of CCL5 associated with longer duration of viral shedding in norovirus infection?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the relationship between low serum levels of CCL5 (a chemokine) and the duration of viral shedding in norovirus infection. To answer this, I would need specific scientific evidence showing whether low CCL5 levels are associated with prolonged viral shedding in norovirus cases. Without having access to specific studies on this relationship, I cannot make a definitive claim. There are many chemokines and cytokines involved in viral infections, and while CCL5 (also known as RANTES) is important in immune responses to various viruses, I don't have evidence of a specific established relationship between CCL5 levels and norovirus shedding duration.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9543081",
    "question": "Do post-translational modifications influence IgE reactivity to the major allergen Phl p 1 of timothy grass pollen?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether post-translational modifications (PTMs) influence IgE reactivity to Phl p 1, which is the major allergen in timothy grass pollen. To answer this, I need to consider what's known about Phl p 1 and how PTMs might affect allergenicity.\\n\\nPhl p 1 is indeed a major allergen from timothy grass (Phleum pratense) pollen. Post-translational modifications can include glycosylation, phosphorylation, hydroxylation, etc., which can alter protein structure and potentially affect antibody binding, including IgE binding in allergic responses.\\n\\nResearch has shown that post-translational modifications, particularly glycosylation, can influence the allergenicity of many proteins. For Phl p 1 specifically, studies have demonstrated that this allergen can undergo various PTMs, and these modifications can affect IgE binding and recognition by the immune system. Some research has shown that natural Phl p 1 (with its PTMs) can have different IgE reactivity compared to recombinant versions produced without the same modifications.\\n\\nBased on the scientific literature, post-translational modifications do influence IgE reactivity to Phl p 1.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21115956",
    "question": "Does neuroanatomic basis of amnestic MCI differ in patients with and without Parkinson disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the neuroanatomic basis (brain structures and pathology) of amnestic Mild Cognitive Impairment (aMCI) differs between patients who have Parkinson's disease and those who don't. To answer this, I need to consider whether there are documented differences in brain structures, pathways, or pathological changes that underlie memory impairment in these two populations.\\n\\nParkinson's disease has distinct neuroanatomical features (primarily degeneration of dopaminergic neurons in the substantia nigra) that are not present in non-Parkinson's aMCI. Additionally, when MCI occurs in Parkinson's disease, it often involves different patterns of neurodegeneration and neurotransmitter deficiencies compared to typical amnestic MCI seen in pre-Alzheimer's conditions. Parkinson's-related MCI tends to have more subcortical and dopaminergic involvement, while non-Parkinson's aMCI typically shows more hippocampal and medial temporal lobe changes.\\n\\nSo yes, there are documented differences in the neuroanatomic basis of aMCI between patients with and without Parkinson's disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25758771",
    "question": "Is serum mannose-binding lectin a strong biomarker of diabetic retinopathy in chinese patients with diabetes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether serum mannose-binding lectin is a strong biomarker of diabetic retinopathy specifically in Chinese patients with diabetes. To answer this accurately, I would need to know if there is scientific evidence from studies conducted on Chinese populations that demonstrates serum mannose-binding lectin has high sensitivity and specificity for detecting or predicting diabetic retinopathy. Without specific information about research findings in Chinese patients, I cannot confirm that it is a strong biomarker in this specific population. While mannose-binding lectin has been studied in relation to diabetic complications in various populations, I don't have definitive evidence that it is specifically a strong biomarker in Chinese patients with diabetes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24222667",
    "question": "Does response to cold pressor test predict long-term changes in pulse wave velocity in men?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the response to a cold pressor test can predict long-term changes in pulse wave velocity specifically in men. The cold pressor test is a cardiovascular reactivity test where a person immerses their hand in cold water, and their cardiovascular responses (like blood pressure changes) are measured. Pulse wave velocity (PWV) is a measure of arterial stiffness and is considered a marker of cardiovascular health. \\n\\nTo answer this question accurately, I would need to know if there are scientific studies that have specifically examined the relationship between cold pressor test responses and subsequent changes in PWV in male subjects over a long-term period. Without specific research evidence on this relationship, I cannot provide a definitive answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22403613",
    "question": "Are common genetic variations in the NALP3 inflammasome associated with delayed apoptosis of human neutrophils?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the association between common genetic variations in the NALP3 inflammasome and delayed apoptosis of human neutrophils. To answer this, I need to consider whether there is established scientific evidence for such an association.\\n\\nThe NALP3 (also known as NLRP3) inflammasome is a multiprotein complex involved in innate immune responses and inflammation. Neutrophils are white blood cells important in the immune system, and apoptosis refers to programmed cell death.\\n\\nWhile NALP3/NLRP3 is known to play roles in inflammation and some aspects of cell death pathways, I'm not aware of specific evidence establishing that common genetic variations in NALP3 are associated with delayed apoptosis specifically in human neutrophils. This would require specific genetic association studies examining this relationship.\\n\\nWithout clear evidence from the scientific literature supporting this specific association, I should answer 'no'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9876225",
    "question": "Are two common polymorphisms in the coding part of the CD43 gene associated with atopy?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the association between two common polymorphisms in the coding part of the CD43 gene and atopy (a genetic tendency to develop allergic diseases). To answer this, I would need to know if research has established such an association. Without specific research evidence showing that these particular CD43 gene polymorphisms are linked to atopy, I cannot confirm this association. While CD43 (also known as leukosialin or sialophorin) is involved in immune function, and atopy involves immune dysregulation, I don't have evidence of a specific established link between CD43 coding polymorphisms and atopic conditions.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "24141373",
    "question": "Does peptide-based inhibition of the HOXA9/PBX interaction retard the growth of human meningioma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether peptide-based inhibition of the HOXA9/PBX interaction slows down the growth of human meningioma (a type of tumor that forms on membranes covering the brain and spinal cord). To answer this, I would need specific scientific evidence from research studies that have investigated this particular molecular interaction in the context of meningioma. Without having access to specific research papers on this topic, I cannot definitively state whether peptide-based inhibition of HOXA9/PBX interaction has been shown to retard meningioma growth. This would be a very specific finding in cancer research that would require evidence from published literature.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26407582",
    "question": "Do clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if clinically localized type 1 and 2 papillary renal cell carcinomas (pRCC) have similar survival outcomes after surgery. Type 1 and type 2 pRCC are distinct histological subtypes of papillary renal cell carcinoma. Type 2 pRCC is generally considered more aggressive with worse prognosis compared to type 1. Multiple studies have shown that patients with type 2 pRCC have worse survival outcomes compared to those with type 1, even when the disease is clinically localized and surgically treated. The difference in survival is attributed to the more aggressive biological behavior of type 2 pRCC, with higher rates of progression and metastasis. Therefore, they do not have similar survival outcomes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15298350",
    "question": "Is diabetic background retinopathy associated with impaired coronary vasoreactivity in people with Type 1 diabetes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the association between diabetic background retinopathy and impaired coronary vasoreactivity specifically in people with Type 1 diabetes. To answer this accurately, I would need to know if research has established such a connection. Diabetic retinopathy is a microvascular complication of diabetes that affects the eyes, while coronary vasoreactivity refers to the ability of coronary blood vessels to respond to stimuli. There is research suggesting that microvascular complications in diabetes can be systemic, affecting multiple organ systems. Some studies have shown associations between diabetic retinopathy and coronary artery disease or cardiovascular outcomes. However, without specific knowledge of studies examining this particular relationship in Type 1 diabetes patients, I cannot provide a definitive answer based on the information available to me.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21358599",
    "question": "Does excitatory repetitive transcranial magnetic stimulation induce improvements in chronic post-stroke aphasia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether excitatory repetitive transcranial magnetic stimulation (rTMS) induces improvements in chronic post-stroke aphasia. To answer this, I need to consider the current scientific evidence on this topic. \\n\\nRepetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique that has been studied for various neurological conditions. For post-stroke aphasia specifically, there have been multiple clinical studies and meta-analyses examining whether excitatory rTMS protocols can improve language function in chronic aphasia patients.\\n\\nThe research literature generally shows positive effects. Multiple systematic reviews and meta-analyses have found that high-frequency (excitatory) rTMS applied to language-related areas in the left hemisphere or inhibitory stimulation to right hemisphere homologous areas can produce significant improvements in naming ability, comprehension, and other language functions in chronic post-stroke aphasia. These improvements have been documented in randomized controlled trials.\\n\\nStudies by Naeser et al., Barwood et al., Thiel et al., and others have demonstrated beneficial effects of rTMS on language recovery in chronic aphasia patients. The improvements are typically modest but statistically significant compared to sham stimulation.\\n\\nBased on the preponderance of evidence in the scientific literature, I can conclude that excitatory rTMS does induce improvements in chronic post-stroke aphasia.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21590477",
    "question": "Is patch repair an independent predictor of morbidity and mortality in congenital diaphragmatic hernia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if patch repair is an independent predictor of morbidity and mortality in congenital diaphragmatic hernia (CDH). To answer this, I need to consider whether research has established that using a patch for CDH repair independently predicts worse outcomes (higher morbidity and mortality), controlling for other factors like disease severity. \\n\\nFrom medical literature, patch repair in CDH is often associated with worse outcomes, but this association is complicated because patch repairs are typically used in more severe cases with larger defects. Several studies have examined whether patch repair remains an independent predictor after controlling for disease severity and other factors. The consensus from multiple studies is that patch repair does appear to be an independent predictor of increased morbidity (including longer ventilation times, higher rates of recurrence) and in some studies, mortality - even after adjusting for severity of the defect and other clinical variables.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19819436",
    "question": "Do soy protein isolates of varying isoflavone content adversely affect semen quality in healthy young men?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether soy protein isolates with different levels of isoflavones have negative effects on semen quality in healthy young men. To answer this, I need to consider the scientific evidence on this topic. There have been some concerns about phytoestrogens in soy potentially affecting male reproductive health, but I need to consider what the research actually shows. Several clinical studies have examined this question specifically, including a study by Messina et al. (2010) that found no significant effects of soy protein or isoflavone intake on semen parameters in healthy men. Another study by Mitchell et al. (2001) specifically tested soy protein isolates with different isoflavone contents and found no adverse effects on semen quality measures. The scientific consensus based on controlled studies indicates that soy protein isolates, regardless of their isoflavone content, do not adversely affect semen quality in healthy young men.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "21171841",
    "question": "Does group aquatic training improve gait efficiency in adolescents with cerebral palsy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether group aquatic training improves gait efficiency in adolescents with cerebral palsy. To answer this, I would need evidence from research studies that specifically examined the effects of group aquatic training on gait efficiency metrics in this population. Without specific research citations in the question, I need to consider what is generally known about aquatic therapy for cerebral palsy. Aquatic therapy is often used for individuals with cerebral palsy because the buoyancy of water reduces the impact on joints and provides resistance that can help strengthen muscles. Some studies have shown improvements in gross motor function and walking ability after aquatic interventions. However, to specifically claim it improves 'gait efficiency' (which typically refers to energy expenditure during walking), I would need studies that measured this specific outcome. Since I don't have access to comprehensive research on this specific question, I should be cautious in my answer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "1545724",
    "question": "Is why alcoholism a disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether alcoholism is a disease. The phrasing 'Is why alcoholism a disease?' is grammatically awkward, but I understand the intent is to ask if alcoholism is classified as a disease. The medical consensus from organizations like the American Medical Association, the American Society of Addiction Medicine, and the National Institute on Alcohol Abuse and Alcoholism is that alcoholism (alcohol use disorder) is indeed a chronic brain disease characterized by compulsive alcohol use, loss of control over alcohol intake, and a negative emotional state when not using. It involves both genetic and environmental factors and causes measurable changes in brain function.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19797557",
    "question": "Does oral health need among adults in the United States with chronic diseases?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether oral health needs exist among adults in the United States with chronic diseases. This is asking about whether there is a relationship between chronic diseases and oral health needs in the US adult population. Research has shown that adults with chronic diseases often have greater oral health needs due to various factors: medications that cause dry mouth, compromised immune systems, limited ability to perform oral hygiene, and bidirectional relationships between oral health and conditions like diabetes and cardiovascular disease. Studies have consistently demonstrated that adults with chronic conditions in the US have higher rates of untreated dental disease, more missing teeth, and greater need for dental care than the general population.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12733595",
    "question": "Do glomerular immunoglobulin deposits induce glomerular inflammation in pregnant but not in non-pregnant rats?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether glomerular immunoglobulin deposits cause glomerular inflammation specifically in pregnant rats but not in non-pregnant rats. To answer this, I would need specific scientific evidence about the differential inflammatory response to immunoglobulin deposits based on pregnancy status in rats. Without being provided specific research findings on this topic, I cannot make a definitive determination. The question appears to be asking about a specific scientific finding that would require evidence from controlled studies comparing pregnant and non-pregnant rats' inflammatory responses to the same immunoglobulin deposits. Since I don't have access to such specific research data in the question, I cannot confirm this differential effect.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "10668704",
    "question": "Does aPOE epsilon4 predict mortality , cognitive decline , or dementia in the oldest old?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether aPOE epsilon4 (apolipoprotein E epsilon4 allele) predicts mortality, cognitive decline, or dementia specifically in the 'oldest old' population (typically referring to people 85 years or older). This is a scientific/medical question about genetic risk factors in a specific age group.\\n\\nBased on research literature, while APOE epsilon4 is a well-established risk factor for Alzheimer's disease and cognitive decline in younger elderly populations, its predictive value appears to diminish in the oldest old. Multiple studies have shown that the association between APOE epsilon4 and dementia, cognitive decline, or mortality becomes weaker or non-significant in the oldest old compared to younger elderly groups. This phenomenon is sometimes referred to as the 'APOE paradox' in very old age.\\n\\nSo the answer would be 'no' - APOE epsilon4 does not reliably predict mortality, cognitive decline, or dementia specifically in the oldest old population, even though it does in younger elderly groups.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "19488546",
    "question": "Does the attitude of anesthesiologists and anesthesiology residents of the CET/SBA regarding upper and lower limb nerve block?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if anesthesiologists and anesthesiology residents of the CET/SBA have an attitude regarding upper and lower limb nerve blocks. However, the question is incomplete or unclear. It seems to be asking if they 'have' an attitude or what their attitude 'is', but doesn't complete the thought. The question should be rephrased as 'What is the attitude of...' or 'Do anesthesiologists and anesthesiology residents of the CET/SBA have a particular attitude regarding upper and lower limb nerve blocks?'. As stated, the question doesn't form a complete inquiry that can be answered with yes or no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23064602",
    "question": "Do characterization of acute coagulopathy and sexual dimorphism after injury : females and coagulopathy just mix?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether there is a simple relationship between females and coagulopathy after injury, or if the characterization of acute coagulopathy and sexual dimorphism after injury is more complex. The phrasing 'just mix' suggests a simplistic relationship. Based on medical literature, there are actually complex sex-based differences in coagulation responses after trauma. Sexual dimorphism (biological differences between males and females) does affect coagulation pathways, and females and males can have different coagulation responses after injury due to hormonal and genetic factors. So the relationship is not simple - they don't 'just mix.'\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "19661459",
    "question": "Does heat shock protein 70 enhance vascular bone morphogenetic protein-4 signaling by binding matrix Gla protein?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific molecular interaction between heat shock protein 70 (HSP70), bone morphogenetic protein-4 (BMP-4), and matrix Gla protein (MGP). Specifically, it's asking if HSP70 enhances vascular BMP-4 signaling through a mechanism of binding to MGP.\\n\\nTo answer this accurately, I would need to know if there is established scientific evidence showing that HSP70 binds to MGP and that this binding enhances BMP-4 signaling in vascular tissues.\\n\\nBased on my knowledge, HSP70 is a chaperone protein involved in protein folding and cellular stress responses. BMP-4 is a growth factor involved in bone and blood vessel formation. MGP is a protein that can inhibit vascular calcification and can antagonize BMP signaling.\\n\\nWhile there are interactions between MGP and BMP-4 (MGP can inhibit BMP-4), and HSP70 can interact with various proteins as part of its chaperone function, I don't recall specific evidence establishing that HSP70 enhances BMP-4 signaling by binding to MGP in vascular tissues.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "10685793",
    "question": "Does rheumatoid synovial fluid contain bioactive leukemia inhibitory factor with cartilage degrading activity -- another target for chondroprotective intervention?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether rheumatoid synovial fluid contains bioactive leukemia inhibitory factor (LIF) that has cartilage degrading activity, and whether this could be a target for chondroprotective intervention. To answer this, I need to determine if scientific evidence supports that rheumatoid synovial fluid contains LIF with cartilage degrading properties.\\n\\nRheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the synovium and destruction of cartilage. Synovial fluid in RA patients contains various inflammatory cytokines and factors. Leukemia inhibitory factor (LIF) is a pleiotropic cytokine that has been studied in the context of inflammatory joint diseases.\\n\\nBased on scientific literature, LIF has been detected in synovial fluid from patients with rheumatoid arthritis, and some studies have shown that it can contribute to cartilage degradation by promoting proteoglycan breakdown and inhibiting proteoglycan synthesis. This suggests that LIF in rheumatoid synovial fluid does have cartilage degrading activity and could potentially be a target for chondroprotective intervention.\\n\\nTherefore, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16805873",
    "question": "Does vagus nerve stimulation inhibit activation of coagulation and fibrinolysis during endotoxemia in rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the effects of vagus nerve stimulation on coagulation and fibrinolysis during endotoxemia in rats. Specifically, it's asking whether vagus nerve stimulation inhibits these processes.\\n\\nVagus nerve stimulation (VNS) is known to have anti-inflammatory effects through the cholinergic anti-inflammatory pathway. Endotoxemia is a condition where endotoxins (components of bacterial cell walls) are present in the blood, which can trigger inflammatory responses and coagulation cascades.\\n\\nBased on scientific literature, VNS has been shown to inhibit the inflammatory response during endotoxemia. There are studies indicating that VNS can indeed inhibit activation of coagulation during endotoxemia in rats. For example, research has demonstrated that VNS reduces pro-inflammatory cytokines which are known to activate coagulation pathways. Additionally, some studies have specifically examined the effects of VNS on coagulation markers during endotoxemia and found inhibitory effects.\\n\\nRegarding fibrinolysis (the process that prevents blood clots from growing and becoming problematic), there is evidence that VNS can also modulate this process during endotoxemia, generally in an inhibitory direction.\\n\\nSo based on the available scientific evidence, the answer appears to be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25979041",
    "question": "Does dynamic contrast-enhanced MR microscopy identify regions of therapeutic response in a preclinical model of colorectal adenocarcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if dynamic contrast-enhanced MR microscopy identifies regions of therapeutic response in a preclinical model of colorectal adenocarcinoma. To answer this, I need to determine if there is evidence that this specific imaging technique (dynamic contrast-enhanced MR microscopy) has been used to identify therapeutic responses in colorectal adenocarcinoma models. Without specific research papers or evidence provided in the question, I cannot definitively state whether this technique has been validated for this specific purpose. However, dynamic contrast-enhanced MRI is generally used to assess tumor vascularity and perfusion, which can be indicators of therapeutic response in various cancer models. Since the question is asking about a specific application that would require evidence from research studies, and no such evidence is provided in the question, I should be cautious in my answer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22717670",
    "question": "Is use of colour duplex ultrasound as a first line surveillance tool following EVAR associated with a reduction in cost without compromising accuracy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether using color duplex ultrasound (CDUS) as the first-line surveillance method after endovascular aneurysm repair (EVAR) reduces costs without compromising diagnostic accuracy. To answer this, I need to consider the evidence comparing CDUS to the standard surveillance method (typically CT angiography). Research has shown that CDUS is significantly less expensive than CT scans for EVAR follow-up. Multiple studies have demonstrated that CDUS has good sensitivity and specificity for detecting endoleaks and other complications after EVAR, comparable to CT in many cases. While CT remains superior for certain specific findings, a surveillance protocol that uses CDUS as first-line with selective CT for abnormal findings or unclear cases has been shown to be cost-effective without missing clinically significant complications. Therefore, the evidence supports that CDUS as first-line surveillance after EVAR does reduce costs while maintaining adequate diagnostic accuracy for patient safety.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "14571236",
    "question": "Does palivizumab prophylaxis reduce hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the effectiveness of palivizumab prophylaxis in reducing hospitalization due to respiratory syncytial virus (RSV) specifically in young children with hemodynamically significant congenital heart disease (CHD). Palivizumab is a monoclonal antibody used to prevent serious lower respiratory tract infections caused by RSV. \\n\\nBased on medical literature, palivizumab has been shown to be effective in reducing RSV-related hospitalizations in high-risk infants, including those with hemodynamically significant congenital heart disease. A randomized, double-blind, placebo-controlled trial (the cardiac trial) demonstrated that palivizumab reduced RSV hospitalizations by approximately 45% in children with hemodynamically significant CHD. This evidence led to recommendations by various pediatric and cardiology organizations to use palivizumab prophylaxis in this specific high-risk population.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15136085",
    "question": "Is a poor response in the first in vitro fertilization cycle necessarily related to a poor prognosis in subsequent cycles?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether a poor response in the first IVF cycle necessarily indicates a poor prognosis for subsequent IVF cycles. To answer this, I need to consider whether there's a definitive relationship between first cycle outcomes and future cycles.\\n\\nWhile a poor response in the first IVF cycle can be concerning and may suggest potential challenges, research has shown that outcomes can vary significantly between cycles. Some patients who respond poorly in their first cycle may respond better in subsequent cycles due to protocol adjustments, different medication dosages, or other modifications to their treatment plan. Additionally, the first cycle is often considered diagnostic, helping clinicians understand how a patient responds to stimulation protocols.\\n\\nTherefore, a poor response in the first cycle does not necessarily mean all future cycles will have poor outcomes. The relationship is not absolute or deterministic.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "15939817",
    "question": "Does conditional mineralocorticoid receptor expression in the heart lead to life-threatening arrhythmias?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias. To answer this, I need to consider what is known about mineralocorticoid receptors in cardiac tissue and their relationship to arrhythmias.\\n\\nMineralocorticoid receptors (MRs) are known to play a role in cardiac pathophysiology. When activated by aldosterone or cortisol, they can influence cardiac electrophysiology, fibrosis, and remodeling. Research has shown that MR activation can contribute to cardiac fibrosis, which can create a substrate for arrhythmias.\\n\\nHowever, the question specifically asks about 'conditional MR expression' - which typically refers to genetically engineered models where MR expression can be turned on or off in specific tissues at specific times. The effects would depend on whether this conditional expression involves overexpression, underexpression, or normal expression in abnormal locations.\\n\\nBased on research literature, MR overactivation has been associated with increased risk of arrhythmias, and MR antagonists are used clinically to reduce arrhythmic risk in heart failure. However, the mere conditional expression of MRs doesn't necessarily lead to life-threatening arrhythmias - it depends on the level of expression, activation state, and other factors.\\n\\nWithout more specific details about the nature of the conditional expression, I cannot definitively say that conditional MR expression in the heart always leads to life-threatening arrhythmias.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16194336",
    "question": "Does [ Arthroscopic assisted Bankart repair with bio-absorbable fixation tack ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is incomplete. It asks 'Does [ Arthroscopic assisted Bankart repair with bio-absorbable fixation tack ]?' but doesn't complete the question. It's asking if this procedure does... something, but that something is missing. Without knowing what the question is asking about this medical procedure, I cannot provide a yes or no answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23557952",
    "question": "Are perivascular spaces associated with atherosclerosis : an insight from the Northern Manhattan Study?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if perivascular spaces are associated with atherosclerosis, specifically referencing findings from the Northern Manhattan Study. Perivascular spaces (also known as Virchow-Robin spaces) are fluid-filled spaces that surround small blood vessels as they enter the brain parenchyma. Atherosclerosis is a condition where arteries narrow and harden due to plaque buildup. The Northern Manhattan Study (NOMAS) is a population-based study of stroke risk factors. Without specific knowledge of the findings from this particular study regarding the relationship between perivascular spaces and atherosclerosis, I cannot definitively answer whether they found an association or not.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22236482",
    "question": "Is interleukin-1 receptor type-1 in non-hematopoietic cells the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the specific cellular target of interleukin-1 (IL-1) that mediates its pro-atherogenic (promoting atherosclerosis) effects in a specific mouse model (apoE-deficient mice). Specifically, it's asking whether the IL-1 receptor type-1 (IL-1R1) located on non-hematopoietic cells (cells not derived from bone marrow) is the target through which IL-1 exerts its atherosclerosis-promoting effects in these mice.\\n\\nTo answer this accurately, I would need specific research findings that have investigated this question using techniques like cell-specific receptor knockouts or bone marrow transplantation studies in apoE-deficient mice. Without citing specific studies, I cannot definitively answer whether IL-1R1 on non-hematopoietic cells is indeed the specific target for IL-1's pro-atherogenic effects in this model. This is a very specific scientific question that would require evidence from targeted research.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22774846",
    "question": "Do higher glycosylated hemoglobin levels increase the risk of overactive bladder syndrome in patients with type 2 diabetes mellitus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between glycosylated hemoglobin levels (HbA1c, a marker of long-term blood glucose control) and overactive bladder syndrome (OAB) specifically in patients with type 2 diabetes mellitus (T2DM).\\n\\nTo answer this accurately, I need to consider the medical evidence:\\n\\n1. Higher HbA1c levels indicate poorer glycemic control in diabetic patients.\\n2. Diabetes is known to cause various urological complications through mechanisms like neuropathy.\\n3. Research has shown associations between poor glycemic control and diabetic complications.\\n4. Several studies have specifically examined the relationship between HbA1c levels and overactive bladder in diabetic patients.\\n\\nBased on medical literature, there is evidence supporting that poor glycemic control (higher HbA1c) is associated with increased risk of overactive bladder syndrome in patients with diabetes. Studies have shown that diabetic patients with higher HbA1c levels have higher prevalence and severity of OAB symptoms compared to those with better glycemic control. The pathophysiological mechanism likely involves diabetic neuropathy affecting bladder innervation and function.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "7897146",
    "question": "Is sensitization to mite allergens a risk factor for early and late onset of asthma and for persistence of asthmatic signs in children?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if sensitization to mite allergens is a risk factor for: 1) early onset of asthma, 2) late onset of asthma, and 3) persistence of asthmatic signs in children. Based on medical research, sensitization to house dust mites is indeed considered a significant risk factor for the development of asthma in children. Multiple studies have shown that children sensitized to dust mite allergens have higher rates of asthma development, both in early childhood and later. Additionally, continued exposure to mite allergens in sensitized individuals is associated with persistence of asthma symptoms and poorer asthma control. The evidence supports that mite allergen sensitization is a risk factor for all three aspects mentioned in the question.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18983268",
    "question": "Are user fee exemptions enough : out-of-pocket payments for 'free ' delivery services in rural Tanzania?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether user fee exemptions are sufficient to eliminate out-of-pocket payments for delivery services that are supposed to be free in rural Tanzania. The phrasing 'Are user fee exemptions enough' suggests that there might be other costs beyond the official fees that patients still have to pay, even when the formal fees are waived. The question implies that despite services being officially 'free' (in quotes, suggesting they may not be truly free in practice), rural Tanzanian women might still face out-of-pocket expenses for delivery services. To answer this properly, I would need to know if user fee exemptions in Tanzania successfully eliminate all costs for patients or if patients still face other expenses. Based on the framing of the question with 'free' in quotation marks, it suggests that the answer is likely 'no' - user fee exemptions are not enough to eliminate all out-of-pocket payments.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "12034383",
    "question": "Does survival in human colorectal cancer correlate with expression of the T-cell costimulatory molecule OX-40 ( CD134 )?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if survival in human colorectal cancer correlates with expression of the T-cell costimulatory molecule OX-40 (CD134). To answer this, I would need specific scientific evidence from clinical studies or research papers that have investigated this relationship. Without being provided specific research findings on this topic, I cannot make a definitive statement about whether there is a correlation between OX-40 expression and colorectal cancer survival outcomes. This is a specific scientific question that requires evidence-based information from medical literature.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22739766",
    "question": "Is antiinflammation effect of human placental multipotent mesenchymal stromal cells mediated by prostaglandin E2 via a myeloid differentiation primary response gene 88-dependent pathway?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether the anti-inflammatory effect of human placental multipotent mesenchymal stromal cells is mediated by prostaglandin E2 via a specific pathway that involves myeloid differentiation primary response gene 88 (MyD88). To answer this, I would need to know if scientific research has established this specific mechanism. Without specific scientific literature to reference, I cannot definitively answer whether this particular pathway is the mediator of the anti-inflammatory effects of these cells. The question is very specific about the molecular pathway (PGE2 via MyD88-dependent pathway) for a particular cell type (human placental multipotent mesenchymal stromal cells).\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26585912",
    "question": "Does latent class analysis suggest four distinct classes of complementary medicine users among women with breast cancer?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if latent class analysis suggests four distinct classes of complementary medicine users among women with breast cancer. To answer this, I would need specific research findings about latent class analysis applied to complementary medicine use in breast cancer patients. Without being provided specific research or data on this topic, I cannot determine if latent class analysis has identified exactly four distinct classes in this population. There are studies that have used latent class analysis to categorize complementary medicine users in various populations, but whether it specifically identified four classes among breast cancer patients is a specific empirical finding that I don't have definitive information about.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17548907",
    "question": "Does clinicopathological correlate in a cohort of Hong Kong breast cancer patients presenting with screen-detected or symptomatic disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether clinicopathological factors correlate with presentation mode (screen-detected vs. symptomatic) in Hong Kong breast cancer patients. This is asking about a specific research finding or statistical correlation in a specific population. Without specific study data or research findings about Hong Kong breast cancer patients and whether there are correlations between clinicopathological features and how the cancer was detected (screening vs. symptoms), I cannot definitively answer this question. The question is phrased as if referring to a specific study or known finding, but doesn't provide enough context to determine if such a correlation exists.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18285424",
    "question": "Are interferon regulatory factor 5 ( IRF5 ) gene variants associated with multiple sclerosis in three distinct populations?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. To answer this, I would need specific research evidence showing that IRF5 gene variants have been studied and found to be associated with multiple sclerosis across three different populations. Without specific studies or data mentioned in the question, I cannot confirm this association. The question is very specific about both the gene (IRF5) and the requirement for evidence in three distinct populations. Since I don't have access to specific research studies showing this association across three populations, I cannot answer affirmatively.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "10728418",
    "question": "Are biphasic redistribution of muscarinic receptor and the altered receptor phosphorylation and gene transcription underlying mechanisms in the rat heart during sepsis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether biphasic redistribution of muscarinic receptor, altered receptor phosphorylation, and gene transcription are underlying mechanisms in the rat heart during sepsis. To answer this, I need to determine if scientific evidence supports these specific mechanisms in sepsis-related cardiac changes in rats.\\n\\nBiphasic redistribution of muscarinic receptors refers to changes in receptor location/density occurring in two distinct phases. Muscarinic receptors are important in cardiac function. Altered receptor phosphorylation would affect signaling pathways. Gene transcription changes would involve altered expression of relevant genes.\\n\\nWhile sepsis does affect cardiac function and likely involves receptor changes and signaling alterations, I don't have specific evidence that these exact mechanisms (particularly the biphasic redistribution of muscarinic receptors) are established as underlying mechanisms in rat hearts during sepsis. Without specific scientific evidence confirming these particular mechanisms, I cannot say yes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27644632",
    "question": "Does the Offer of Advanced Imaging Techniques lead to Higher Acceptance Rates for Screening Colonoscopy - a Prospective Study?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question appears to be asking whether offering advanced imaging techniques increases patient acceptance rates for screening colonoscopy. The question is phrased like a research paper title, and it's asking if there's a causal relationship between offering advanced imaging techniques and higher acceptance rates for colonoscopy screening. Without seeing the actual study results or data, I cannot definitively answer whether this relationship exists. The question itself is posing a hypothesis that would need to be tested through research.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23222801",
    "question": "Do n-3 fatty acids modulate adipose tissue inflammation and oxidative stress?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if n-3 fatty acids modulate (affect or regulate) adipose tissue inflammation and oxidative stress. To answer this, I need to consider the scientific evidence about n-3 fatty acids (like those found in fish oil) and their effects on fat tissue inflammation and oxidative stress processes.\\n\\nBased on scientific literature, n-3 fatty acids (omega-3 fatty acids) have been shown to have anti-inflammatory properties and can reduce inflammation in various tissues, including adipose tissue. They can inhibit pro-inflammatory cytokine production and modulate inflammatory signaling pathways in adipose tissue. Additionally, n-3 fatty acids have been demonstrated to affect oxidative stress parameters in adipose tissue, often showing antioxidant properties.\\n\\nNumerous studies have documented that n-3 fatty acids can reduce adipose tissue inflammation markers and improve oxidative stress parameters in both animal models and human studies. The mechanisms include altering gene expression, affecting membrane composition, producing anti-inflammatory mediators, and modulating immune cell function in adipose tissue.\\n\\nTherefore, the scientific evidence supports that n-3 fatty acids do modulate both adipose tissue inflammation and oxidative stress.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "14738099",
    "question": "Is terbinafine more effective than itraconazole in treating toenail onychomycosis : results from a meta-analysis of randomized controlled trials?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether terbinafine is more effective than itraconazole in treating toenail onychomycosis, based on results from a meta-analysis of randomized controlled trials. I don't have access to the specific meta-analysis mentioned, nor do I have comprehensive knowledge of all meta-analyses comparing these two antifungal medications for toenail fungus. However, based on my general medical knowledge, terbinafine is often considered more effective than itraconazole for dermatophyte infections like toenail onychomycosis in many clinical guidelines and studies. Multiple meta-analyses have shown terbinafine to have higher mycological and clinical cure rates compared to itraconazole for toenail fungal infections. Without seeing the specific meta-analysis referenced, I cannot confirm with absolute certainty, but the general medical consensus would suggest the answer is likely yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15229208",
    "question": "Does pharmacological manipulation of nitric oxide levels in mouse follicle cultures demonstrate key role of extrafollicular control of ovulation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether pharmacological manipulation of nitric oxide levels in mouse follicle cultures demonstrates a key role of extrafollicular control of ovulation. To answer this, I need to consider what follicle cultures represent. Follicle cultures are isolated follicles grown in vitro, separated from the rest of the ovarian tissue and systemic factors. If manipulating nitric oxide in these isolated cultures affects ovulation, it would demonstrate an intrafollicular mechanism rather than extrafollicular control, since the extrafollicular environment is absent in these cultures. Therefore, such experiments would actually demonstrate the opposite of extrafollicular control - they would show that follicle-autonomous mechanisms involving nitric oxide can regulate ovulation independent of external factors.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17888408",
    "question": "Is imbalance between left and right dorsolateral prefrontal cortex in major depression linked to negative emotional judgment : an fMRI study in severe major depressive disorder?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether there is a link between an imbalance in the left and right dorsolateral prefrontal cortex (DLPFC) in major depression and negative emotional judgment, specifically referencing an fMRI study in severe major depressive disorder. To answer this, I need to consider whether the question is stating a finding from a specific study or asking if such a link exists. The phrasing suggests it's referring to a specific fMRI study that investigated this relationship in severe major depressive disorder. Without having access to the specific study mentioned, I cannot definitively confirm its findings. However, the question appears to be asking if this specific link was established in an fMRI study, rather than asking for my opinion on whether such a link exists in general.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18257092",
    "question": "Are genetic variation and response to morphine in cancer patients : catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms associated with central side effects?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether genetic variations, specifically polymorphisms in the catechol-O-methyltransferase (COMT) gene and the multidrug resistance-1 (MDR1) gene, are associated with central side effects in cancer patients who are receiving morphine treatment. This appears to be a specific scientific question about a potential genetic association with drug side effects. Based on the phrasing, it seems to be asking if there is an established association between these specific genetic variations and central nervous system side effects from morphine in cancer patients. Without access to specific scientific literature on this topic, I cannot definitively answer whether such an association exists or has been proven in research.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20944115",
    "question": "Does jun amino-terminal kinase 1 activation promote cell survival in ErbB2-positive breast cancer?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether JNK1 (jun amino-terminal kinase 1) activation promotes cell survival in ErbB2-positive breast cancer. Let me analyze what research shows about this relationship.\\n\\nJNK1 is a stress-activated protein kinase that can have both pro-apoptotic and pro-survival functions depending on context. ErbB2 (also known as HER2) is a receptor tyrosine kinase that is overexpressed in approximately 20-30% of breast cancers.\\n\\nResearch has shown that in ErbB2-positive breast cancer, JNK1 activation actually promotes apoptosis (programmed cell death) rather than cell survival. JNK1 has been found to mediate cell death in response to various anti-cancer therapies in ErbB2-positive breast cancer cells. Inhibition of JNK1 in these cells can lead to resistance to apoptosis.\\n\\nSo the evidence suggests that JNK1 activation does not promote cell survival in ErbB2-positive breast cancer, but rather promotes cell death.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16709934",
    "question": "Does clusterin decrease oxidative stress in lung fibroblasts exposed to cigarette smoke?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether clusterin decreases oxidative stress in lung fibroblasts that have been exposed to cigarette smoke. To answer this, I need to consider what is known about clusterin's role in oxidative stress responses, particularly in lung cells exposed to cigarette smoke.\\n\\nClusterin (also known as apolipoprotein J) is a chaperone protein that has been shown to have cytoprotective effects in various tissues. It can protect cells from stress-induced apoptosis and has been implicated in various cellular processes including lipid transport, membrane recycling, and complement regulation.\\n\\nRegarding its specific role in lung fibroblasts exposed to cigarette smoke, research has shown that clusterin can indeed have protective effects against oxidative stress. Studies have demonstrated that clusterin expression increases in response to cigarette smoke exposure in lung cells, and this upregulation appears to be a protective mechanism. Clusterin has been shown to reduce reactive oxygen species (ROS) levels, decrease lipid peroxidation, and enhance antioxidant defenses in lung cells exposed to cigarette smoke.\\n\\nBased on the scientific literature, clusterin does appear to decrease oxidative stress in lung fibroblasts exposed to cigarette smoke.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "9731839",
    "question": "Does expression of gamma-glutamyl transpeptidase in stage III and IV ovarian surface epithelial carcinomas alter response to primary cisplatin-based chemotherapy?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether the expression of gamma-glutamyl transpeptidase (GGT) in advanced ovarian cancer (stages III and IV) affects how patients respond to cisplatin-based chemotherapy as their initial treatment. To answer this, I would need to know if there's evidence showing that GGT expression levels correlate with either improved or diminished response to cisplatin in ovarian cancer patients. Without specific research data cited in the question, I need to consider what's known about GGT and cisplatin resistance. GGT is an enzyme involved in glutathione metabolism, and glutathione has been implicated in cisplatin resistance mechanisms. Some studies have suggested that GGT expression may contribute to cisplatin resistance in certain cancers by affecting glutathione metabolism. However, to definitively answer whether it alters response in the specific context of stage III and IV ovarian surface epithelial carcinomas, I would need to reference specific clinical studies that have examined this relationship. Based on the general literature, there is some evidence suggesting GGT may play a role in chemotherapy resistance, but without specific studies on this exact question, I cannot give a definitive 'yes' answer.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "15011964",
    "question": "Does diet rich in saturated fat decrease the ratio of thromboxane/prostacyclin in healthy men?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a diet rich in saturated fat decreases the ratio of thromboxane/prostacyclin in healthy men. To answer this, I need to consider what scientific evidence shows about the relationship between saturated fat intake and this specific biochemical ratio.\\n\\nThromboxane and prostacyclin are eicosanoids that have opposing effects on platelet aggregation and vasoconstriction. Thromboxane promotes platelet aggregation and vasoconstriction, while prostacyclin inhibits platelet aggregation and promotes vasodilation. The ratio between these compounds is important for cardiovascular health.\\n\\nScientific evidence generally indicates that diets high in saturated fat tend to increase thromboxane production relative to prostacyclin, which would increase the thromboxane/prostacyclin ratio, not decrease it. Saturated fats are typically associated with pro-inflammatory and pro-thrombotic effects, which would favor thromboxane production.\\n\\nTherefore, a diet rich in saturated fat would not be expected to decrease the thromboxane/prostacyclin ratio in healthy men.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20683935",
    "question": "Does cX3CL1-CX3CR1 interaction prevent carbon tetrachloride-induced liver inflammation and fibrosis in mice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether the interaction between cX3CL1 and CX3CR1 prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice. To answer this, I need to consider what research shows about this specific interaction in this specific model of liver injury.\\n\\nCX3CL1 (fractalkine) is a chemokine that binds to the CX3CR1 receptor. This signaling pathway is involved in various inflammatory processes. Carbon tetrachloride (CCl4) is commonly used to induce experimental liver injury, inflammation and fibrosis in mice.\\n\\nBased on my knowledge of the literature, the CX3CL1-CX3CR1 axis actually promotes inflammation in many contexts. In liver fibrosis models, CX3CR1 deficiency or blocking this pathway has been shown to reduce liver inflammation and fibrosis in CCl4-treated mice, suggesting that the normal interaction actually contributes to pathology rather than preventing it.\\n\\nSeveral studies have shown that disrupting this interaction (through genetic knockout of CX3CR1 or antibody blockade of CX3CL1) leads to reduced liver inflammation and fibrosis in CCl4 models, indicating that the normal interaction promotes rather than prevents the pathology.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12218380",
    "question": "Is pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma associated with increased leptin levels in women with type-2 diabetes mellitus?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the association between pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma (PPAR-γ) and increased leptin levels specifically in women with type-2 diabetes mellitus. To answer this, I would need to know if research has established a positive correlation between this specific genetic variant and leptin levels in this particular population. Without specific research evidence on this association, I cannot make a definitive claim. Based on my knowledge, while PPAR-γ polymorphisms have been studied in relation to diabetes and metabolic parameters, I don't have conclusive evidence that the pro12Ala substitution specifically increases leptin levels in women with T2DM.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18818413",
    "question": "Is athsq1 an atherosclerosis modifier locus with dramatic effects on lesion area and prominent accumulation of versican?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question. It's asking about athsq1, specifically whether it is an atherosclerosis modifier locus that has two specific properties: (1) dramatic effects on lesion area and (2) prominent accumulation of versican. To answer this accurately, I would need to know about the genetic locus athsq1 and its characterized effects on atherosclerosis. Based on the naming convention ('ath' likely referring to atherosclerosis and 'sq1' suggesting it's a quantitative trait locus), this appears to be a specific genetic region that has been studied in relation to atherosclerosis. However, without specific knowledge of the research literature on this locus, I cannot confirm whether it has the specific properties mentioned regarding lesion area effects and versican accumulation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24222114",
    "question": "Does mCP-1 promote invasion and adhesion of human ovarian cancer cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"I need to determine if mCP-1 (monocyte chemoattractant protein-1) promotes invasion and adhesion of human ovarian cancer cells. Let me analyze what is known about mCP-1 in relation to ovarian cancer.\\n\\nMCP-1 (also known as CCL2) is a chemokine that has been studied in various cancer types. In some cancers, it has been shown to promote tumor progression, metastasis, and invasion. However, I need to specifically determine if there is evidence that it promotes invasion and adhesion in human ovarian cancer cells specifically.\\n\\nBased on scientific literature, MCP-1/CCL2 has been shown to promote tumor progression in ovarian cancer. Studies have demonstrated that MCP-1 can enhance the invasive capacity of ovarian cancer cells and increase their adhesion properties. It has been found to be overexpressed in ovarian cancer and correlates with poor prognosis. MCP-1 can activate various signaling pathways that lead to increased migration, invasion, and adhesion of ovarian cancer cells to the peritoneal mesothelium, which is important in ovarian cancer metastasis.\\n\\nTherefore, the evidence supports that MCP-1 does promote invasion and adhesion of human ovarian cancer cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21377210",
    "question": "Are the delivery mode and seasonal variation associated with the development of postpartum depression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question asks about the association between delivery mode (e.g., vaginal delivery vs. cesarean section) and seasonal variation (time of year) with the development of postpartum depression (PPD). To answer this, I need to consider the scientific evidence.\\n\\nRegarding delivery mode: There is some research suggesting that emergency cesarean sections may be associated with a slightly higher risk of PPD compared to planned vaginal deliveries, possibly due to factors like traumatic birth experiences, longer recovery times, and complications. However, the evidence is mixed and many studies show that after controlling for other factors, delivery mode itself may not be independently associated with PPD.\\n\\nRegarding seasonal variation: Some studies have found associations between seasonal patterns and PPD, with higher rates sometimes reported in months with less sunlight (similar to seasonal affective disorder patterns). This may relate to vitamin D levels, circadian rhythm disruptions, or seasonal stressors.\\n\\nBased on the current scientific literature, there does appear to be some evidence supporting associations between both delivery mode and seasonal variation with PPD, though neither factor is considered a primary determinant, and the relationships are complex and influenced by many other factors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24801569",
    "question": "Does storage of apheresis platelet concentrate after manual replacement of > 95 % of plasma with PAS 5?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether apheresis platelet concentrate is stored after manually replacing more than 95% of plasma with PAS 5 (platelet additive solution). This appears to be an incomplete question as it doesn't actually ask a complete question - it starts with 'Does' but doesn't complete the thought. It seems to be asking if something happens after this plasma replacement procedure, but doesn't specify what that something is. Without a complete question, I cannot provide a yes or no answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12003247",
    "question": "Does the 5-HTTPR polymorphism confer liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether the 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer's disease. To answer this, I would need to know if there is scientific evidence establishing a causal relationship between this specific genetic polymorphism and the co-occurrence of psychosis and aggression in Alzheimer's patients. Without specific research studies or data provided in the question, I cannot make a definitive claim about this relationship. The 5-HTTPR (serotonin transporter promoter region) polymorphism has been studied in relation to various psychiatric conditions, but I would need specific evidence about its role in this particular combined phenotype in Alzheimer's disease to answer 'yes'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19124438",
    "question": "Do elevated infection parameters and infection symptoms predict an acute coronary event?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether elevated infection parameters (such as markers of inflammation like C-reactive protein, white blood cell count, etc.) and infection symptoms (like fever, cough, etc.) can predict an acute coronary event (such as a heart attack or unstable angina). \\n\\nThere is scientific evidence suggesting that infections and inflammation can contribute to acute coronary events. Infections can trigger inflammatory responses that may destabilize atherosclerotic plaques and promote thrombosis. Several studies have shown associations between respiratory infections and increased risk of myocardial infarction. Elevated inflammatory markers have been associated with increased cardiovascular risk.\\n\\nHowever, while these factors may increase risk, they are not specific or sensitive enough to be considered reliable predictors of acute coronary events on their own. Many people with infections do not have coronary events, and many coronary events occur without preceding infection.\\n\\nSo while there is an association, these parameters alone cannot definitively predict an acute coronary event.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26064180",
    "question": "Do inflamed macrophage microvesicles induce insulin resistance in human adipocytes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether inflamed macrophage microvesicles induce insulin resistance in human adipocytes. To answer this, I need to determine if there is established scientific evidence showing that microvesicles released from inflamed macrophages can cause insulin resistance in human fat cells (adipocytes). This would be a specific cellular mechanism potentially linking inflammation to insulin resistance. Without specific scientific literature or data provided in the question, I need to consider whether this is an established biological mechanism. Based on my knowledge, macrophage-derived microvesicles have been shown to transfer inflammatory signals and can affect insulin signaling pathways in target cells, including adipocytes. There are studies demonstrating that pro-inflammatory factors from macrophages can indeed induce insulin resistance in adipocytes, and microvesicles are one potential mechanism for this effect.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27616138",
    "question": "Do higher Charlson Comorbidity Index scores influence Functional Independence Measure score gains in older rehabilitation patients?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether higher Charlson Comorbidity Index (CCI) scores influence Functional Independence Measure (FIM) score gains in older rehabilitation patients. The CCI is a method of categorizing comorbidities based on the ICD diagnosis codes, with higher scores indicating more comorbid conditions. The FIM is an assessment tool that measures the level of a patient's disability and indicates how much assistance they require to carry out activities of daily living. \\n\\nTo answer this question accurately, I would need to refer to research studies that have examined the relationship between CCI scores and FIM gains specifically in older rehabilitation patients. Based on existing literature, there is evidence suggesting that higher comorbidity burden (as measured by higher CCI scores) is associated with lower functional gains during rehabilitation. Several studies have shown that patients with higher CCI scores tend to have smaller FIM improvements during rehabilitation stays compared to those with lower comorbidity burdens. This is logical since multiple comorbidities can complicate recovery and limit rehabilitation potential.\\n\\nTherefore, the answer would be 'yes' - higher CCI scores do influence (specifically, they tend to negatively impact) FIM score gains in older rehabilitation patients.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "23266049",
    "question": "Does serum lactic dehydrogenase strongly predict survival in metastatic nasopharyngeal carcinoma treated with palliative chemotherapy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if serum lactic dehydrogenase (LDH) is a strong predictor of survival in patients with metastatic nasopharyngeal carcinoma who are receiving palliative chemotherapy. To answer this, I would need to know if there is established evidence in medical literature showing a strong correlation between LDH levels and survival outcomes specifically in this patient population. While LDH is often used as a prognostic marker in various cancers, including some head and neck cancers, I don't have specific information about whether it is a 'strong' predictor specifically for metastatic nasopharyngeal carcinoma patients on palliative chemotherapy. Without being able to cite specific studies showing this strong predictive relationship, I cannot confidently say 'yes'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22354318",
    "question": "Does intravenous immunoglobulin prevent release of proinflammatory cytokines in human monocytic cells stimulated with procalcitonin?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if intravenous immunoglobulin (IVIG) prevents the release of proinflammatory cytokines in human monocytic cells when these cells are stimulated with procalcitonin. To answer this, I would need specific research evidence about the interaction between IVIG, procalcitonin, and cytokine release in monocytic cells. Without specific studies on this particular interaction, I cannot provide a definitive answer. While IVIG is known to have immunomodulatory effects and can affect cytokine production in various contexts, and procalcitonin can stimulate inflammatory responses, the specific interaction asked about requires evidence from research directly testing this relationship.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20331553",
    "question": "Does methadone maintenance therapy promote initiation of antiretroviral therapy among injection drug users?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether methadone maintenance therapy (MMT) promotes the initiation of antiretroviral therapy (ART) among injection drug users (IDUs). To answer this, I need to consider the relationship between MMT and ART initiation specifically for this population.\\n\\nMethadone maintenance therapy is an evidence-based treatment for opioid use disorder that provides a stable, controlled dose of opioid medication to reduce withdrawal symptoms and cravings. It helps stabilize patients' lives and reduce illicit drug use.\\n\\nResearch has shown that MMT can improve healthcare engagement among injection drug users. When IDUs are enrolled in MMT programs, they have regular contact with healthcare providers, which creates opportunities for HIV testing, counseling, and referral to HIV care if needed. Studies have demonstrated that IDUs on MMT are more likely to initiate ART when HIV-positive compared to those not in treatment programs.\\n\\nMMT addresses many barriers that typically prevent IDUs from accessing HIV care, including chaotic lifestyles, ongoing drug use, and unstable housing. By providing structure and reducing illicit drug use, MMT helps create conditions where ART initiation becomes more feasible.\\n\\nMultiple studies, including research from various countries with different healthcare systems, have consistently shown positive associations between MMT participation and higher rates of ART initiation and adherence among HIV-positive IDUs.\\n\\nBased on the substantial body of evidence, I can conclude that methadone maintenance therapy does promote initiation of antiretroviral therapy among injection drug users.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15701498",
    "question": "Does objective assessment of videoconferenced lecture in a surgical clerkship?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is incomplete and unclear. It seems to be asking whether objective assessment of videoconferenced lectures exists or is effective in a surgical clerkship, but the question doesn't have a complete predicate - it doesn't specify what about the objective assessment we're being asked to confirm or deny. Without a complete question, I cannot provide a yes or no answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12234944",
    "question": "Does demonstration that C-reactive protein decrease eNOS expression and bioactivity in human aortic endothelial cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether C-reactive protein (CRP) has been demonstrated to decrease endothelial nitric oxide synthase (eNOS) expression and bioactivity in human aortic endothelial cells. To answer this, I need to consider whether there is scientific evidence showing that CRP reduces eNOS expression and function specifically in human aortic endothelial cells.\\n\\nBased on scientific literature, C-reactive protein has indeed been shown to decrease eNOS expression and bioactivity in human aortic endothelial cells. Multiple studies have demonstrated that CRP downregulates eNOS expression at both mRNA and protein levels, and reduces eNOS enzymatic activity in human aortic endothelial cells. This is one of the mechanisms by which CRP is thought to contribute to endothelial dysfunction and atherosclerosis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11927339",
    "question": "Do estrogen levels influence beta-3-adrenoceptor-mediated relaxation of the female rat detrusor muscle?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether estrogen levels influence beta-3-adrenoceptor-mediated relaxation of the female rat detrusor muscle. This is a specific physiological question about the relationship between estrogen (a hormone) and a particular receptor-mediated process in the urinary bladder muscle of female rats. To answer this accurately, I would need to know if scientific studies have demonstrated such a relationship. Based on scientific literature, there is evidence that estrogen levels can affect beta-adrenergic receptor function in various tissues, including the urinary bladder. Several studies have shown that estrogen status can modulate beta-3-adrenoceptor expression and function in the detrusor muscle of female rats, with changes observed during different hormonal states (e.g., estrous cycle phases, ovariectomy, and estrogen replacement). Therefore, there is a documented relationship between estrogen levels and beta-3-adrenoceptor-mediated relaxation in female rat detrusor muscle.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15128119",
    "question": "Does inhibition of enteral enzymes by enteroclysis with nafamostat mesilate reduce neutrophil activation and transfusion requirements after hemorrhagic shock?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific medical intervention and its effects. Let me analyze what it's asking:\n\n1. The intervention is 'inhibition of enteral enzymes by enteroclysis with nafamostat mesilate'\n2. The question asks if this intervention has two specific effects:\n   - Reducing neutrophil activation\n   - Reducing transfusion requirements\n3. The context is 'after hemorrhagic shock'\n\nTo answer this accurately, I would need to know if there is scientific evidence showing that nafamostat mesilate administered via enteroclysis (intestinal lavage) after hemorrhagic shock has these specific effects.\n\nWithout specific studies to reference, I cannot definitively answer this medical question. The question appears to be asking about a specific research finding or clinical application that would require evidence from medical literature.\", \n\"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22497538",
    "question": "Does two-dimensional speckle-tracking echocardiography reveal systolic abnormalities in granulomatosis with polyangiitis ( Wegener 's )?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if two-dimensional speckle-tracking echocardiography reveals systolic abnormalities in granulomatosis with polyangiitis (Wegener's disease). To answer this, I need to know if studies have shown that this specific imaging technique can detect systolic (heart contraction) abnormalities in patients with this particular autoimmune disease. Without specific research data or medical literature references in the question, I cannot determine if this imaging technique has been proven to reveal such abnormalities in this specific condition. The question is asking for a factual relationship between a diagnostic technique and disease findings that requires medical evidence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21902836",
    "question": "Does chikungunya trigger an autophagic process which promotes viral replication?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Chikungunya virus (CHIKV) is an alphavirus that causes fever and joint pain. The question asks about its relationship with autophagy, which is a cellular process that breaks down and recycles cellular components. I need to determine if CHIKV triggers autophagy and if this autophagy promotes viral replication.\\n\\nBased on scientific literature, CHIKV has been shown to induce autophagy in infected cells. Studies have demonstrated that CHIKV infection leads to an increase in autophagic markers and the formation of autophagosomes. More importantly, research has indicated that this virus-induced autophagy actually benefits viral replication. When autophagy is inhibited (either pharmacologically or genetically), CHIKV replication decreases, suggesting that the autophagic process is utilized by the virus to enhance its replication.\\n\\nSpecifically, CHIKV appears to use components of the autophagy machinery to facilitate the formation of replication complexes, which are essential for viral genome replication. The virus doesn't use the complete autophagic process but rather subverts parts of it for its own benefit.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19583703",
    "question": "Does cardioprotection of bradykinin at reperfusion involve transactivation of the epidermal growth factor receptor via matrix metalloproteinase-8?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the specific mechanism of cardioprotection by bradykinin during reperfusion. Specifically, it asks whether this protection involves the transactivation of the epidermal growth factor receptor (EGFR) through matrix metalloproteinase-8 (MMP-8). To answer this accurately, I would need to know the current scientific consensus on this specific pathway. Based on my knowledge, bradykinin has been shown to have cardioprotective effects during reperfusion injury, and some studies have demonstrated that bradykinin can transactivate EGFR through various mechanisms including matrix metalloproteinases. However, the specific involvement of MMP-8 in this pathway is not something I can confirm with certainty. Some studies have shown that bradykinin's cardioprotection involves EGFR transactivation via other MMPs like MMP-2 or MMP-9, but I don't have definitive information about MMP-8's specific role in this process.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25576438",
    "question": "Are high cumulative oxygen levels associated with improved survival of children treated with mild therapeutic hypothermia after cardiac arrest?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the relationship between high cumulative oxygen levels and improved survival in children treated with mild therapeutic hypothermia after cardiac arrest. To answer this, I need to consider what the scientific evidence shows about oxygen management during therapeutic hypothermia in pediatric cardiac arrest patients. Without specific studies cited in the question, I need to consider what is generally known in medical literature. In critical care medicine, there's been debate about optimal oxygen targets during post-resuscitation care. While oxygen is necessary for cellular metabolism and brain recovery, hyperoxia (excessive oxygen) has been associated with oxidative stress and potential harm in some studies. For therapeutic hypothermia specifically, the relationship between oxygen levels and outcomes remains an area of active research. Without specific evidence showing that high cumulative oxygen levels improve survival in this specific population, I cannot confidently answer 'yes'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22843340",
    "question": "Does a rapid decrease in temperature induce latewood formation in artificially reactivated cambium of conifer stems?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the effect of a rapid decrease in temperature on latewood formation in artificially reactivated cambium of conifer stems. To answer this, I need to consider what is known about cambial activity and wood formation in conifers. \\n\\nIn normal seasonal growth, latewood formation typically occurs in response to environmental signals including decreasing day length and temperature as the growing season ends. However, the question specifically asks about artificially reactivated cambium, which implies cambium that has been stimulated to resume activity outside its normal seasonal cycle.\\n\\nBased on plant physiology research, when cambium is artificially reactivated (such as through hormonal treatments or controlled environmental conditions), its response to environmental signals may differ from natural seasonal responses. A rapid temperature decrease is generally known to slow or stop cambial activity rather than specifically induce latewood formation. Latewood formation involves changes in cell wall thickness and cell size, which is a complex developmental process typically regulated by multiple factors including hormones, water availability, and gradual seasonal changes.\\n\\nWhile temperature is a factor in wood formation, a rapid decrease specifically would more likely cause growth cessation rather than a transition to latewood formation in artificially reactivated cambium. The research indicates that latewood formation requires a programmed developmental sequence rather than just a temperature shock.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17301041",
    "question": "Is an interleukin-18 polymorphism associated with reduced serum concentrations and better physical functioning in older people?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about a specific relationship between an interleukin-18 polymorphism, serum concentrations, and physical functioning in older people. To answer this, I would need to know if research has established that a particular IL-18 genetic variant is associated with both: 1) reduced serum concentrations of IL-18, and 2) better physical functioning specifically in older populations. Without specific research evidence on this relationship, I cannot confirm this association. I don't have information about a proven link between an IL-18 polymorphism, reduced serum levels, and improved physical functioning in older adults.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26402880",
    "question": "Does treatment of Peri-Implant Defects in the Rabbit 's Tibia with Adipose or Bone Marrow-Derived Mesenchymal stem Cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether treatment of peri-implant defects in rabbit tibias involves using adipose or bone marrow-derived mesenchymal stem cells. This appears to be asking about a scientific fact related to treatment methods for peri-implant defects in animal models. However, the question is incomplete or malformed - it's phrased as a yes/no question but doesn't actually complete the question (it's missing a verb after 'Does'). It seems to be asking if this treatment occurs or exists, but doesn't specify what exactly it wants to confirm about the treatment. Based on the structure, I think the question is trying to ask if these stem cell types are used in treating peri-implant defects in rabbit tibias.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27836485",
    "question": "Is thalidomide a therapeutic agent that is effective in inducing and maintaining endoscopic remission in adult CD patients?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if thalidomide is effective for inducing and maintaining endoscopic remission in adult Crohn's Disease (CD) patients. Let me analyze the evidence about thalidomide in CD treatment.\\n\\nThalidomide has been studied for its anti-inflammatory and immunomodulatory properties in Crohn's Disease. While some studies have shown that thalidomide may have efficacy in refractory Crohn's Disease, particularly in pediatric populations, the evidence for its effectiveness specifically for inducing and maintaining endoscopic remission in adult CD patients is limited. Most studies have focused on clinical remission rather than specifically endoscopic remission.\\n\\nThe drug has significant side effects including peripheral neuropathy and teratogenicity, which has limited its widespread use. It is generally considered a third-line or experimental therapy in CD, not a standard treatment for inducing or maintaining remission.\\n\\nBased on current evidence, thalidomide is not established as an effective agent specifically for inducing and maintaining endoscopic remission in adult CD patients.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12947327",
    "question": "Is increased PDX-1 expression associated with outcome in patients with pancreatic cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if increased PDX-1 expression is associated with outcome in patients with pancreatic cancer. PDX-1 (Pancreatic and Duodenal Homeobox 1) is a transcription factor involved in pancreatic development and function. To answer this question, I need to consider whether scientific evidence shows a correlation between higher PDX-1 expression levels and clinical outcomes (such as survival, disease progression, or treatment response) in pancreatic cancer patients. Based on research literature, PDX-1 overexpression has been associated with pancreatic cancer development and progression. Several studies have shown that increased PDX-1 expression correlates with worse prognosis, reduced survival, and more aggressive disease in pancreatic cancer patients. Therefore, there is evidence supporting an association between PDX-1 expression and patient outcomes in pancreatic cancer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10652574",
    "question": "Do viscotoxin-free aqueous extracts from European mistletoe ( Viscum album L. ) stimulate activity of human granulocytes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if viscotoxin-free aqueous extracts from European mistletoe (Viscum album L.) stimulate activity of human granulocytes. To answer this, I would need specific scientific evidence about the effects of these particular extracts on human granulocytes. Without having access to specific research studies on this topic, I cannot make a definitive determination. However, there is research suggesting that mistletoe extracts can have immunomodulatory effects, including effects on granulocytes, but the specific question about viscotoxin-free extracts requires particular evidence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20079140",
    "question": "Does apelin protect against cardiomyocyte apoptosis induced by glucose deprivation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if apelin protects against cardiomyocyte apoptosis (cell death of heart muscle cells) that is induced by glucose deprivation. To answer this, I need to consider what is known about apelin's role in cardiac protection.\\n\\nApelin is a peptide that acts as an endogenous ligand for the APJ receptor. Research has shown that apelin has cardioprotective effects in various conditions including ischemia-reperfusion injury. Specifically regarding glucose deprivation-induced apoptosis in cardiomyocytes, studies have demonstrated that apelin can activate survival pathways (like PI3K/Akt and ERK1/2) that protect cardiomyocytes from apoptosis under stress conditions including glucose deprivation.\\n\\nMultiple studies have shown that apelin treatment reduces apoptosis in cardiomyocytes subjected to glucose deprivation by inhibiting mitochondrial-dependent apoptotic pathways and promoting cell survival signals.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27026631",
    "question": "Does tRAF3 Epigenetic Regulation be Associated With Vascular Recurrence in Patients With Ischemic Stroke?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if tRAF3 epigenetic regulation is associated with vascular recurrence in patients with ischemic stroke. To answer this, I would need to know if there is scientific evidence establishing a relationship between tRAF3 epigenetic regulation and the recurrence of vascular events specifically in ischemic stroke patients. Without specific research studies or medical literature to reference, I cannot definitively confirm this association. The question appears to be asking about a specific molecular pathway (tRAF3) and its epigenetic regulation in relation to a clinical outcome (vascular recurrence) in a specific patient population (those with ischemic stroke). This would require evidence from medical research to answer accurately.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21569456",
    "question": "Is the 1287 G/A polymorphism of the norepinephrine transporter gene ( NET ) involved in commission errors in Korean children with attention deficit hyperactivity disorder?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the 1287 G/A polymorphism of the norepinephrine transporter gene (NET) is involved in commission errors in Korean children with ADHD. To answer this, I would need specific research findings about this particular genetic polymorphism, its relationship to commission errors (a type of error in cognitive/attention tasks), and specifically in Korean children with ADHD. Without having access to specific studies on this topic, I cannot make a definitive determination. The question is asking about a very specific genetic association in a specific population with a specific outcome measure, which requires evidence from relevant research studies.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27192948",
    "question": "Does choroidal thickness predict visual acuity in young high myopes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether choroidal thickness predicts visual acuity in young high myopes. To answer this, I need to consider what the research evidence shows about the relationship between choroidal thickness and visual acuity specifically in young people with high myopia. \\n\\nHigh myopia is characterized by excessive axial elongation of the eye and is often associated with pathological changes in the choroid (the vascular layer between the retina and sclera). The choroid typically becomes thinner in high myopia.\\n\\nSome studies have found correlations between choroidal thinning and reduced visual acuity in high myopes, particularly when there are pathological changes like choroidal neovascularization or macular atrophy. However, the relationship is complex and not always direct or predictive, especially in young high myopes who may not yet have developed pathological changes.\\n\\nThe current scientific consensus appears to be that while choroidal thickness is often reduced in high myopia and may be associated with visual function, it is not consistently predictive of visual acuity in young high myopes. Other factors such as retinal integrity, presence of staphyloma, and other structural changes may be more directly related to visual outcomes.\\n\\nBased on the available evidence, choroidal thickness alone is not considered a reliable predictor of visual acuity specifically in young high myopes.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "25093483",
    "question": "Does long-term , low-dose lithium treatment impair renal function in the elderly : a 2-year randomized , placebo-controlled trial followed by single-blind extension?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether a specific study found that long-term, low-dose lithium treatment impairs renal function in elderly patients. The study described is a 2-year randomized, placebo-controlled trial that was followed by a single-blind extension. The question is asking about the findings or conclusions of this study regarding lithium's effects on kidney function in elderly patients. However, the question itself doesn't contain the actual findings of the study - it's just describing the study design and asking if this study found renal impairment. Without knowing the actual results of the study, I cannot answer yes or no to whether the study found that lithium impaired renal function.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "23850909",
    "question": "Is coarctation of the aorta : lifelong surveillance mandatory following surgical repair?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Coarctation of the aorta is a congenital heart defect where there is a narrowing of the aorta. After surgical repair, patients are at risk for several long-term complications including:\n\n1. Recoarctation (recurrence of the narrowing)\n2. Aneurysm formation at the repair site\n3. Persistent hypertension\n4. Premature coronary artery disease\n5. Associated cardiac defects (like bicuspid aortic valve)\n\nDue to these potential complications, clinical guidelines from major cardiology associations (AHA/ACC, ESC) recommend lifelong surveillance for these patients. This typically includes regular blood pressure monitoring, imaging studies (echocardiography, CT, or MRI), and cardiology follow-up.\n\nSo yes, lifelong surveillance is considered mandatory following surgical repair of coarctation of the aorta to monitor for these potential complications and intervene if necessary.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15211371",
    "question": "Do elderly obese women display the greatest improvement in stair climbing performance after a 3-week body mass reduction program?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether elderly obese women show the greatest improvement in stair climbing performance after a 3-week body mass reduction program. To answer this, I would need specific research data comparing the improvements in stair climbing performance across different demographic groups (e.g., elderly obese women vs. younger obese women, elderly obese men, non-obese elderly, etc.) after the same program. Without being provided such comparative data in the question, I cannot determine if elderly obese women specifically show the 'greatest' improvement compared to other groups. The question presupposes a comparative finding that I don't have evidence for.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23311470",
    "question": "Does propofol protect against high glucose-induced endothelial adhesion molecules expression in human umbilical vein endothelial cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific biological effect of propofol (an anesthetic agent) on endothelial cells that are exposed to high glucose conditions. Specifically, it's asking whether propofol protects against the expression of adhesion molecules that would be induced by high glucose in human umbilical vein endothelial cells (HUVECs).\\n\\nTo answer this accurately, I would need to know about specific research studies that have investigated this question. Based on my knowledge, there have been studies showing that propofol does have anti-inflammatory properties and can reduce expression of adhesion molecules like ICAM-1, VCAM-1, and E-selectin in endothelial cells under various stress conditions. Some research has specifically examined propofol's effects on high glucose-induced inflammation in HUVECs and found protective effects.\\n\\nFor example, research has shown that propofol can attenuate high glucose-induced oxidative stress and inflammation in HUVECs, which would include reducing adhesion molecule expression. Propofol appears to work through multiple mechanisms including antioxidant effects and inhibition of inflammatory signaling pathways that would otherwise lead to adhesion molecule expression.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15602653",
    "question": "Does local methacholine but not bradykinin potentiate insulin-mediated glucose uptake in muscle in vivo by augmenting capillary recruitment?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether local methacholine (but not bradykinin) potentiates insulin-mediated glucose uptake in muscle in vivo by augmenting capillary recruitment. This is a specific scientific claim about the differential effects of two vasodilators (methacholine and bradykinin) on insulin-mediated glucose uptake and the mechanism involved (capillary recruitment). To answer this accurately, I would need to know the research findings on this specific comparison. Without specific knowledge of the research literature on this topic, I cannot confidently answer yes or no. However, based on my understanding, methacholine is known to be a vasodilator that can increase blood flow and potentially capillary recruitment, which could enhance insulin-mediated glucose uptake. The question suggests a differential effect where methacholine has this effect but bradykinin does not. Since this is a very specific scientific claim that I don't have definitive knowledge about, I should not speculate.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15652954",
    "question": "Does prolonged exposure of canine coronary arteries to a nitric oxide donor desensitize soluble guanylate cyclase?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether prolonged exposure of canine coronary arteries to a nitric oxide donor desensitizes soluble guanylate cyclase (sGC). To answer this, I need to consider what happens to sGC when it's exposed to nitric oxide donors for extended periods. Soluble guanylate cyclase is an enzyme that is activated by nitric oxide and catalyzes the conversion of GTP to cGMP, which is important in vasodilation. Desensitization would mean that after prolonged exposure, sGC becomes less responsive to nitric oxide stimulation. Without specific research data on this particular experimental setup with canine coronary arteries, I cannot make a definitive claim. However, in general, many receptor systems do exhibit desensitization after prolonged agonist exposure, and there is literature suggesting that prolonged exposure to nitric oxide donors can lead to tolerance or desensitization of the nitric oxide-sGC-cGMP pathway in various tissues. Given the general biological principle of receptor desensitization and the specific context of nitric oxide signaling, I would lean toward answering 'yes', but without specific experimental evidence for canine coronary arteries, I cannot be completely certain.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24606172",
    "question": "Is cystatin C differentially involved in multiple system atrophy phenotypes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether cystatin C is differentially involved in multiple system atrophy (MSA) phenotypes. MSA is a rare neurodegenerative disorder with different clinical phenotypes, typically classified as MSA with predominant parkinsonism (MSA-P) or MSA with predominant cerebellar ataxia (MSA-C). To answer this question, I need to determine if there is evidence that cystatin C (a protein encoded by the CST3 gene that functions as a cysteine protease inhibitor) shows different involvement patterns, levels, or functions across these different MSA phenotypes. Based on the current scientific literature, there is some evidence suggesting that cystatin C levels may differ between MSA phenotypes, with studies showing variations in CSF or plasma levels between MSA-P and MSA-C patients. Therefore, the answer would be 'yes.'\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20922881",
    "question": "Is probability of spacesuit-induced fingernail trauma associated with hand circumference?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about a specific correlation between hand circumference and the probability of experiencing fingernail trauma when wearing a spacesuit. This is a very specific scientific/medical question related to astronaut health and spacesuit design. To answer this accurately, I would need to be familiar with aerospace medicine research or NASA studies on spacesuit-related injuries. There have indeed been studies on spacesuit-induced fingernail trauma among astronauts, and some research has examined anthropometric factors (including hand measurements) as potential risk factors. Based on NASA research, hand circumference has been identified as a factor associated with the risk of fingernail delamination during EVA (spacewalk) activities in pressurized gloves. Specifically, astronauts with larger hand circumferences relative to their spacesuit glove size have shown higher incidence of fingernail trauma.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25952148",
    "question": "Are current controlled vocabularies insufficient to uniquely map molecular entities to mass spectrometry signal?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if current controlled vocabularies are insufficient to uniquely map molecular entities to mass spectrometry signal. This is asking about a technical limitation in the field of mass spectrometry and molecular identification. \\n\\nIn mass spectrometry, controlled vocabularies are standardized terminologies used to annotate and describe data. The question is whether these existing vocabularies are inadequate for creating unique mappings between detected signals and the actual molecular entities they represent.\\n\\nBased on current literature in the field, there are indeed challenges in uniquely mapping MS signals to specific molecules. Mass spectrometry signals can be ambiguous - multiple molecules can produce similar spectral patterns, isomers can be difficult to distinguish, and complex biological samples create overlapping signals. Current controlled vocabularies often lack the specificity needed to address these ambiguities completely.\\n\\nAdditionally, the field continues to develop new ontologies and standards specifically because existing ones have limitations in uniquely identifying molecular entities from MS data.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18971777",
    "question": "Is tumor budding a strong and reproducible prognostic marker in T3N0 colorectal cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether tumor budding is a strong and reproducible prognostic marker specifically in T3N0 colorectal cancer. To answer this, I need to consider what the scientific consensus is regarding tumor budding as a prognostic marker in this specific subset of colorectal cancer patients (those with T3 tumors but no lymph node involvement).\n\nTumor budding refers to the presence of single cells or small clusters of cancer cells at the invasive front of a tumor. While tumor budding has been studied as a prognostic marker in colorectal cancer generally, the question specifically asks about its value in T3N0 cases.\n\nBased on my knowledge, tumor budding has been shown in multiple studies to be a prognostic factor in colorectal cancer, including in some studies focusing on T3N0 patients. Several studies have demonstrated that high-grade tumor budding is associated with worse outcomes in T3N0 colorectal cancer patients. However, there have been some issues with reproducibility due to variations in assessment methods and cutoff values.\n\nThe International Tumor Budding Consensus Conference (ITBCC) in 2016 worked to standardize the assessment of tumor budding, which has improved reproducibility. Studies following these standardized criteria have generally confirmed tumor budding as a prognostic marker in T3N0 colorectal cancer.\n\nSo yes, tumor budding is generally considered a strong and reproducible prognostic marker in T3N0 colorectal cancer, especially with standardized assessment methods.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17651469",
    "question": "Is ethanol preference inversely correlated with ethanol-induced dopamine release in 2 substrains of C57BL/6 mice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the relationship between ethanol preference and ethanol-induced dopamine release in two substrains of C57BL/6 mice. Specifically, it asks if these two factors are inversely correlated (meaning as one increases, the other decreases).\\n\\nTo answer this question accurately, I would need specific research data about these two substrains of C57BL/6 mice and their ethanol preference and dopamine release patterns. Without specific studies to reference, I cannot make a definitive claim about this correlation.\\n\\nHowever, there is research showing that different substrains of C57BL/6 mice (commonly C57BL/6J and C57BL/6N) do show differences in ethanol preference and neurochemical responses to ethanol. Some studies have found that these differences can include inverse relationships between preference and certain neurochemical responses, but I would need to verify if dopamine release specifically shows this inverse correlation.\\n\\nWithout being able to cite specific research confirming this inverse correlation between ethanol preference and ethanol-induced dopamine release in these substrains, I should answer 'no' to be conservative.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20104191",
    "question": "Is second-line therapy for elderly patients with non-small cell lung cancer who failed previous chemotherapy as effective as for younger patients?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the comparative effectiveness of second-line therapy for elderly versus younger patients with non-small cell lung cancer (NSCLC) who have failed previous chemotherapy. To answer this, I need to consider what the research shows about treatment outcomes in these two age groups.\\n\\nIn general, elderly patients often have more comorbidities, reduced organ function, and potentially different pharmacokinetics compared to younger patients. These factors can affect treatment tolerance and efficacy. Studies have shown that elderly patients with NSCLC may experience more toxicity and sometimes have poorer outcomes with certain chemotherapy regimens compared to younger patients.\\n\\nSpecifically for second-line therapy after chemotherapy failure, some studies suggest that while selected elderly patients can benefit from second-line treatments, the overall efficacy (measured by response rates, progression-free survival, and overall survival) tends to be somewhat lower in elderly populations compared to younger patients. Factors like performance status often become more important than chronological age alone in determining outcomes.\\n\\nBased on the available evidence, second-line therapy for elderly NSCLC patients who failed previous chemotherapy is generally not as effective as it is for younger patients, though individual factors play an important role.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "10946069",
    "question": "Does hMG CoA reductase inhibition reduce sarcolemmal Na ( + ) -K ( + ) pump density?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if inhibiting HMG-CoA reductase (the enzyme targeted by statin medications) reduces the density of Na+/K+ pumps in the sarcolemma (the cell membrane of muscle cells). To answer this, I need to consider the relationship between statins and Na+/K+ pump expression.\\n\\nThere is research suggesting that statins can affect membrane properties and ion transport mechanisms. Some studies have shown that statins can reduce cholesterol content in cell membranes, which could potentially affect membrane-bound proteins like the Na+/K+ pump. However, the specific effect on Na+/K+ pump density in the sarcolemma is what's being asked.\\n\\nBased on the available scientific literature, statins (HMG-CoA reductase inhibitors) have been found to reduce Na+/K+ pump activity and expression in some contexts. For example, some research has shown that statins can decrease the number of functional Na+/K+ pumps in cardiac and skeletal muscle cells, which would constitute a reduction in sarcolemmal Na+/K+ pump density.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24656290",
    "question": "Does single-dose carbohydrate treatment in the immediate preoperative phase diminish development of postoperative peripheral insulin resistance?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether a single dose of carbohydrates given right before surgery can reduce the development of peripheral insulin resistance after surgery. To answer this, I need to consider what the research evidence shows about preoperative carbohydrate loading and its effects on postoperative insulin sensitivity.\\n\\nResearch has shown that preoperative carbohydrate loading (often called 'carbohydrate drinks' or 'preoperative carbohydrate treatment') can help reduce postoperative insulin resistance. When patients receive carbohydrates 2-3 hours before surgery, studies have demonstrated improved insulin sensitivity compared to fasting patients. This is part of the rationale behind Enhanced Recovery After Surgery (ERAS) protocols that have moved away from traditional preoperative fasting.\\n\\nThe mechanism appears to be that carbohydrate loading before surgery helps maintain a more anabolic state, reducing the catabolic stress response to surgery that contributes to insulin resistance. Multiple randomized controlled trials have shown that preoperative carbohydrate treatment can reduce postoperative insulin resistance by approximately 50%.\\n\\nSo based on the available evidence, the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27055439",
    "question": "Does mechanosensory organ regeneration in zebrafish depend on a population of multipotent progenitor cells kept latent by Schwann cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the mechanism of mechanosensory organ regeneration in zebrafish, specifically whether it depends on multipotent progenitor cells that are kept latent by Schwann cells. To answer this, I need to consider what's known about zebrafish lateral line regeneration.\\n\\nZebrafish can regenerate their lateral line mechanosensory organs (neuromasts) after damage. Research has shown that this regeneration process involves mantle cells that act as progenitor cells. These mantle cells can give rise to multiple cell types in the neuromast, making them multipotent.\\n\\nCritically, there is evidence that Schwann cells play a role in regulating this regeneration process. Studies have shown that Schwann cells inhibit the proliferation of progenitor cells in the lateral line, effectively keeping them in a latent state until regeneration is needed. When injury occurs, the inhibitory effect of Schwann cells is temporarily relieved, allowing progenitor cells to proliferate and regenerate the damaged structures.\\n\\nSo based on current scientific understanding, yes, mechanosensory organ regeneration in zebrafish does depend on multipotent progenitor cells that are kept latent by Schwann cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22590618",
    "question": "Do nK cells promote Th-17 mediated corneal barrier disruption in dry eye?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the role of natural killer (NK) cells in promoting T helper 17 (Th-17) mediated disruption of the corneal barrier in dry eye disease. To answer this, I need to consider what's known about NK cells, Th-17 cells, and their interaction in dry eye pathophysiology.\\n\\nIn dry eye disease, there is evidence that Th-17 cells contribute to corneal barrier disruption through the production of inflammatory cytokines like IL-17. The question specifically asks if NK cells promote this Th-17 mediated process.\\n\\nBased on scientific literature, NK cells have been shown to interact with the adaptive immune system and can influence T cell responses. There is research indicating that NK cells can promote Th-17 cell differentiation and function in certain inflammatory conditions. Specifically in dry eye disease, studies have demonstrated that NK cells can produce cytokines that support Th-17 cell development and enhance their pathogenic effects on the corneal epithelial barrier.\\n\\nResearch by Chen et al. and others has shown that NK cells are increased in dry eye and can contribute to Th-17 mediated inflammation through cytokine production. These NK-derived cytokines help maintain the Th-17 response that leads to corneal barrier disruption.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10902760",
    "question": "Does autocrine stimulation by insulin-like growth factor 1 and insulin-like growth factor 2 mediate chondrocyte survival in vitro?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether autocrine stimulation by insulin-like growth factor 1 (IGF-1) and insulin-like growth factor 2 (IGF-2) mediates chondrocyte survival in vitro. To answer this, I need to determine if there is scientific evidence showing that chondrocytes produce IGF-1 and IGF-2 themselves (autocrine) and if these factors help keep the chondrocytes alive in laboratory conditions (in vitro survival). Without specific research papers or evidence provided in the question, I cannot make a definitive determination. However, based on general knowledge of growth factor biology, IGFs are known to be important survival factors for many cell types, and autocrine signaling is a common mechanism. But I should not speculate without specific evidence about chondrocytes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26176067",
    "question": "Does host Immunity influence the Efficacy of Combined Intra-Arterial Chemotherapy for Advanced Hepatocellular Carcinoma in Liver Cirrhosis Patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether host immunity influences the efficacy of combined intra-arterial chemotherapy for advanced hepatocellular carcinoma (HCC) in patients with liver cirrhosis. To answer this, I need to consider what is known about the relationship between immune function and cancer treatment outcomes, particularly in the context of liver disease.\\n\\nIn general, immune function is known to play a role in cancer treatment outcomes across many therapies. For hepatocellular carcinoma specifically, the immune system's status can affect both disease progression and treatment response. Patients with cirrhosis often have compromised immune function due to their underlying liver disease. This immune dysfunction could potentially impact how well chemotherapy works.\\n\\nIntra-arterial chemotherapy delivers drugs directly to the tumor through the hepatic artery, which can improve efficacy while reducing systemic side effects. However, the ultimate tumor response likely still depends on multiple factors, including the patient's immune status.\\n\\nBased on general principles of cancer immunology and treatment response, it's reasonable to conclude that host immunity would influence treatment efficacy in this specific scenario, though the exact mechanisms and magnitude of effect might vary.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19453426",
    "question": "Is chloroquine effective against influenza A virus in vitro but not in vivo?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"I need to analyze whether chloroquine is effective against influenza A virus in vitro (in laboratory settings outside a living organism) but not in vivo (within a living organism).\\n\\nBased on scientific literature:\\n- Chloroquine has shown antiviral activity against influenza A virus in vitro in some studies. It can inhibit viral replication in cell cultures by interfering with endosomal acidification and other cellular processes.\\n- However, in vivo studies (in animal models and human clinical trials) have generally not shown significant efficacy of chloroquine against influenza A infection. Several studies have demonstrated that despite promising in vitro results, chloroquine fails to show protective effects in animal models or humans infected with influenza A.\\n\\nThis pattern of chloroquine showing effectiveness in laboratory settings but failing to translate this efficacy to living organisms is documented in the scientific literature regarding influenza A virus.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18501606",
    "question": "Does endogenous RNA interference provide a somatic defense against Drosophila transposons?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether endogenous RNA interference (RNAi) serves as a defense mechanism in somatic cells (non-germline cells) against transposons in Drosophila (fruit flies). Transposons are mobile genetic elements that can move within a genome, potentially causing mutations and genomic instability. RNA interference is a biological process in which RNA molecules inhibit gene expression or translation by neutralizing targeted mRNA molecules.\\n\\nTo answer this question accurately, I need to consider what's known about RNAi pathways in Drosophila. In Drosophila, the primary defense against transposons in germline cells is the piRNA pathway. However, in somatic cells, endogenous siRNAs (endo-siRNAs), which are part of the RNAi machinery, have been shown to target and silence transposons. Studies have demonstrated that components of the RNAi pathway, such as Dicer-2 and Argonaute-2, are involved in suppressing transposon activity in somatic tissues of Drosophila.\\n\\nSo yes, endogenous RNA interference does provide a somatic defense against Drosophila transposons.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22224253",
    "question": "Do [ Influence of rhubarb on gastrointestinal motility and intestinal mucosal barrier in patients with severe burn ]?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking if a research paper or study titled 'Influence of rhubarb on gastrointestinal motility and intestinal mucosal barrier in patients with severe burn' exists. The title is in square brackets, suggesting it might be a published article. However, the question is incomplete - it's asking 'Do [title]?' without specifying what action is being questioned. Since the most likely interpretation is whether this paper exists, I'll answer based on that. While I don't have complete information about all medical literature, this appears to be a legitimate research topic examining how rhubarb affects gut function in burn patients. Such studies do exist in medical literature, particularly in Chinese medicine research where rhubarb has been studied for gastrointestinal effects.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26633560",
    "question": "Is novel CAD-ALK gene rearrangement drugable by entrectinib in colorectal cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if a novel CAD-ALK gene rearrangement in colorectal cancer can be treated with entrectinib. Let me analyze this:\\n\\nEntrectinib is a TRK/ROS1/ALK inhibitor that has shown efficacy against tumors with ALK gene rearrangements. Since this question mentions an ALK gene rearrangement (specifically CAD-ALK), it's relevant to consider if entrectinib would be effective.\\n\\nALK gene rearrangements are known to be targetable by ALK inhibitors like entrectinib in some cancer types. Entrectinib has FDA approval for solid tumors with NTRK gene fusions and for ROS1-positive non-small cell lung cancer.\\n\\nFor colorectal cancer specifically with CAD-ALK rearrangement, there is some evidence in the literature suggesting ALK inhibitors may be effective against ALK fusion-positive colorectal cancers. While CAD-ALK may be a novel fusion partner, the presence of the ALK kinase domain would theoretically make it susceptible to ALK inhibitors like entrectinib.\\n\\nBased on the mechanism of action of entrectinib as an ALK inhibitor, it would likely have activity against CAD-ALK fusion in colorectal cancer, though clinical evidence for this specific fusion may be limited due to its novelty.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21493736",
    "question": "Does the oxidized low-density lipoprotein receptor mediate vascular effects of inhaled vehicle emissions?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the oxidized low-density lipoprotein (oxLDL) receptor mediates vascular effects of inhaled vehicle emissions. To answer this, I need to consider what is known about the relationship between vehicle emissions, oxLDL receptors, and vascular effects.\\n\\nOxLDL receptors, particularly LOX-1 (lectin-like oxidized LDL receptor-1), are known to be involved in atherosclerosis and vascular inflammation. They recognize oxidized LDL particles and trigger inflammatory responses in vascular cells.\\n\\nVehicle emissions contain particulate matter and gases that can induce oxidative stress and inflammation when inhaled. Some research has shown that exposure to air pollution, including vehicle emissions, can promote atherosclerosis and vascular dysfunction.\\n\\nHowever, to definitively state that oxLDL receptors specifically mediate the vascular effects of inhaled vehicle emissions, there would need to be research demonstrating this mechanistic link. While it's plausible given what we know about oxidative stress pathways, I need to be careful not to overstate the evidence.\\n\\nBased on my knowledge, there is some research suggesting that air pollution exposure can increase oxLDL levels and potentially activate oxLDL receptors, but I don't have definitive evidence that these receptors are the primary mediators of vascular effects from vehicle emissions.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20031594",
    "question": "Is a common variant of the FTO gene associated with not only increased adiposity but also elevated blood pressure in French Canadians?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about a specific genetic association in French Canadians - whether a common variant of the FTO gene is associated with both increased adiposity (fat accumulation/obesity) and elevated blood pressure in this specific population. To answer this accurately, I would need to know about specific genetic studies conducted on French Canadian populations that examined both the FTO gene variants and their relationship to both adiposity and blood pressure. Without specific knowledge of such studies in French Canadians, I cannot confidently answer yes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17407575",
    "question": "Does matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue block?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question seems incomplete or unclear. It asks if 'matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue block' does something, but doesn't complete the predicate - it doesn't specify what the technique does or doesn't do. Matrix-comparative genomic hybridization (matrix-CGH) is a technique that can be applied to formalin-fixed paraffin-embedded (FFPE) tissue samples, including colorectal cancer samples, to analyze genomic alterations. But without knowing what specific action or outcome is being asked about, I cannot provide a yes or no answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18398019",
    "question": "Is pTH and 1.25 vitamin D response to a low-calcium diet associated with bone mineral density in renal stone formers?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between parathyroid hormone (pTH) and 1,25 vitamin D response to a low-calcium diet, and whether this response is associated with bone mineral density specifically in people who form kidney stones (renal stone formers). To answer this question accurately, I would need specific research evidence that examines this particular relationship in this specific population. Without citing specific studies that have investigated this association, I cannot definitively answer yes or no. The question is asking about a specific physiological relationship in a specific patient population that would require evidence from medical research.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24963013",
    "question": "Is radial versus femoral access associated with reduced complications and mortality in patients with non-ST-segment-elevation myocardial infarction : an observational cohort study of 10,095 patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether radial access (through the wrist) compared to femoral access (through the groin) is associated with reduced complications and mortality in patients with non-ST-segment-elevation myocardial infarction (NSTEMI), based on an observational cohort study of 10,095 patients. The question is phrased as a title of a research paper or study, and is asking if this specific study found such an association. Without having access to the specific study mentioned or its results, I cannot definitively answer whether this particular study found such an association.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23545714",
    "question": "Is the Western dietary pattern prospectively associated with nonalcoholic fatty liver disease in adolescence?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the association between the Western dietary pattern and nonalcoholic fatty liver disease (NAFLD) in adolescents, specifically whether there is a prospective (forward-looking, longitudinal) association. \\n\\nThe Western dietary pattern typically refers to a diet high in red meat, processed foods, refined grains, sugar, and unhealthy fats. NAFLD is a condition where excess fat builds up in the liver not due to alcohol consumption.\\n\\nBased on medical research, there is evidence supporting that Western dietary patterns characterized by high intake of processed foods, refined carbohydrates, and saturated fats are indeed prospectively associated with increased risk of NAFLD development in adolescents. Multiple longitudinal studies have shown that adolescents who adhere to Western dietary patterns have higher rates of NAFLD development over time compared to those following healthier dietary patterns.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16186284",
    "question": "Is serum ferritin associated with visceral fat area and subcutaneous fat area?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"I need to determine if there is a scientific association between serum ferritin levels and both visceral fat area and subcutaneous fat area. Serum ferritin is a blood protein that contains iron and is a marker for iron stores in the body. Visceral fat is fat that surrounds the internal organs in the abdominal cavity, while subcutaneous fat is the fat layer directly under the skin. \\n\\nBased on medical literature, there are studies that have shown associations between serum ferritin levels and visceral fat accumulation. For example, some research has demonstrated that elevated serum ferritin levels are positively correlated with increased visceral fat area, particularly in conditions like metabolic syndrome. Similarly, there are studies showing relationships between ferritin and subcutaneous fat area, though the association with visceral fat is often stronger. \\n\\nThe relationship is thought to be related to the inflammatory nature of visceral fat and iron metabolism. Visceral adiposity is associated with chronic low-grade inflammation, which can affect iron homeostasis and ferritin levels.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26247669",
    "question": "Is non-alcoholic steatohepatitis-related liver cirrhosis increasing in China : a ten-year retrospective study?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether non-alcoholic steatohepatitis (NASH)-related liver cirrhosis is increasing in China, specifically referencing a ten-year retrospective study. To answer this, I would need to know the results of this specific study. Without having access to the study mentioned or its findings, I cannot determine whether NASH-related cirrhosis is increasing in China according to this particular research. The question is phrased as if it's the title of a research paper, asking about the conclusion of that specific study.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22257140",
    "question": "Are positive surgical margins a risk factor for significant biochemical recurrence only in intermediate-risk disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if positive surgical margins are a risk factor for significant biochemical recurrence only in intermediate-risk disease. To answer this, I need to consider whether positive surgical margins affect biochemical recurrence in other risk categories as well.\\n\\nPositive surgical margins (PSM) are generally considered a risk factor for biochemical recurrence (BCR) across different risk categories of prostate cancer, not just in intermediate-risk disease. Multiple studies have shown that PSMs are associated with increased risk of BCR in low-risk, intermediate-risk, and high-risk prostate cancer patients. \\n\\nWhile the impact might vary by risk category, with possibly stronger effects in certain risk groups, the evidence does not support that PSMs are a risk factor exclusively in intermediate-risk disease. They represent a risk factor across the spectrum of disease risk classifications.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17533046",
    "question": "Is cD23 recognized as tumor-associated antigen ( TAA ) in B-CLL by CD8+ autologous T lymphocytes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if CD23 is recognized as a tumor-associated antigen (TAA) in B-cell chronic lymphocytic leukemia (B-CLL) by CD8+ autologous T lymphocytes. To answer this, I need to consider whether there is scientific evidence showing that CD23 serves as a TAA in B-CLL that can be recognized by the patient's own CD8+ T cells. CD23 (also known as FcεRII) is a low-affinity receptor for IgE and is indeed overexpressed in B-CLL cells. However, for it to be considered a TAA recognized by CD8+ T cells, there would need to be evidence that CD23-derived peptides are presented on MHC class I molecules and recognized by autologous CD8+ T cells in B-CLL patients. Based on my knowledge of the scientific literature, while CD23 is a marker of B-CLL, there isn't strong evidence establishing it as a TAA specifically recognized by CD8+ autologous T lymphocytes in B-CLL.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21646792",
    "question": "Do peripheral blood mononuclear cells from patients with bronchial asthma show impaired innate immune responses to rhinovirus in vitro?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if peripheral blood mononuclear cells (PBMCs) from asthma patients show impaired innate immune responses to rhinovirus in laboratory settings. To answer this, I would need to know about specific research findings on this topic. Based on scientific literature, there is evidence that asthmatic patients' immune cells do show deficient antiviral responses to rhinovirus. Multiple studies have demonstrated that PBMCs and other respiratory cells from asthmatic patients produce reduced amounts of type I and III interferons (key antiviral immune mediators) when exposed to rhinovirus in vitro. This impairment in innate antiviral immunity is considered one mechanism explaining why asthmatic patients experience more severe and prolonged rhinovirus infections. So the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15486744",
    "question": "Has anorectal pathology in HIV/AIDS-infected patients been impacted by highly active antiretroviral therapy?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether highly active antiretroviral therapy (HAART) has impacted anorectal pathology in HIV/AIDS-infected patients. To answer this, I need to consider whether there's evidence that HAART has changed the incidence, severity, or management of anorectal diseases in HIV/AIDS patients.\\n\\nHAART, introduced in the mid-1990s, dramatically changed the course of HIV infection by suppressing viral replication and allowing immune reconstitution. This has had widespread effects on HIV-associated conditions.\\n\\nFor anorectal pathology specifically, there is evidence that HAART has:\\n1. Reduced the incidence of certain opportunistic infections that affect the anorectal region\\n2. Changed the natural history of some HIV-associated anorectal conditions\\n3. Impacted the prevalence and management of human papillomavirus (HPV)-related anal dysplasia and cancer\\n4. Affected the presentation and treatment outcomes of anorectal conditions\\n\\nStudies have shown that HAART has decreased the incidence of some opportunistic infections that can cause anorectal pathology, though certain conditions like anal cancer have actually increased in the HAART era due to longer survival. The management approach to anorectal conditions in HIV patients has also evolved in response to HAART availability.\\n\\nBased on the medical literature, HAART has definitely had an impact on anorectal pathology in HIV/AIDS patients, though the nature of this impact varies by specific condition.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "25871338",
    "question": "Does traditional Chinese medicine baicalin suppress mESCs proliferation through inhibition of miR-294 expression?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether baicalin, a compound used in traditional Chinese medicine, suppresses mESCs (mouse embryonic stem cells) proliferation by inhibiting miR-294 expression. To answer this, I would need specific scientific evidence about baicalin's mechanism of action on mESCs and whether it specifically targets miR-294. Without having access to specific research studies demonstrating this particular mechanism, I cannot confirm this specific molecular pathway. While baicalin has been studied for various biological effects, this specific mechanism involving miR-294 in mESCs is not something I can verify without relevant scientific literature.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20934711",
    "question": "Does prolonged cold ischemic time result in increased acute rejection in a rat allotransplantation model?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between prolonged cold ischemic time and acute rejection in a rat allotransplantation model. Cold ischemic time refers to the period during which an organ is preserved at cold temperatures after removal from the donor and before transplantation into the recipient. The question specifically asks whether prolonging this cold preservation time increases the rate or severity of acute rejection in rats that receive organ transplants from other rats (allotransplantation).\\n\\nTo answer this accurately, I would need specific research data about rat transplantation models. Based on general transplantation principles, prolonged cold ischemia typically causes ischemia-reperfusion injury which can increase immunogenicity of the graft. This can potentially lead to increased recognition by the recipient's immune system and potentially more acute rejection. However, I don't have specific data about this effect in rat models to make a definitive statement.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "8384938",
    "question": "Does endothelium-dependent relaxation compete with alpha 1- and alpha 2-adrenergic constriction in the canine epicardial coronary microcirculation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if endothelium-dependent relaxation competes with alpha 1- and alpha 2-adrenergic constriction in the canine epicardial coronary microcirculation. To answer this, I need to analyze what is known about these physiological mechanisms.\\n\\nEndothelium-dependent relaxation refers to the process where the endothelium (inner lining of blood vessels) releases vasodilatory substances like nitric oxide that cause vessel relaxation. Alpha-adrenergic constriction involves alpha-1 and alpha-2 adrenergic receptors mediating vasoconstriction when stimulated by catecholamines.\\n\\nIn the coronary microcirculation, these opposing mechanisms (vasodilation vs. vasoconstriction) can indeed compete with each other physiologically. Research has shown that in canine coronary vessels, endothelium-derived relaxing factors can counteract or modulate the constrictive effects of alpha-adrenergic stimulation. This represents a physiological balance between vasodilatory and vasoconstrictive influences in the regulation of coronary blood flow.\\n\\nBased on the physiological understanding of these mechanisms and research in coronary circulation, endothelium-dependent relaxation does compete with alpha-adrenergic constriction in the canine epicardial coronary microcirculation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16697401",
    "question": "Is recording lead V ( 4 ) R associated to enhanced use of fibrinolytic therapy in acute myocardial infarction?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if recording lead V4R (right-sided precordial lead) is associated with increased use of fibrinolytic therapy in acute myocardial infarction. Lead V4R is primarily used to detect right ventricular involvement in inferior myocardial infarctions. While it's valuable for diagnosis and risk stratification, I'm not aware of evidence specifically linking V4R recording to enhanced or increased use of fibrinolytic therapy. V4R helps identify right ventricular infarction, which might actually be a relative contraindication for aggressive fibrinolysis in some cases due to hemodynamic concerns. The decision to use fibrinolytic therapy is typically based on multiple factors including time from symptom onset, contraindications, and overall clinical presentation rather than specifically on V4R findings.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26553007",
    "question": "Does g-8 indicate overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to analyze whether g-8 is used to indicate overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy. G-8 is actually a geriatric screening tool used to assess the vulnerability of elderly cancer patients. It's a questionnaire that evaluates various aspects of geriatric health like nutrition, mobility, neuropsychological problems, etc. It helps in determining which elderly patients might need comprehensive geriatric assessment. G-8 is not a measure or indicator of survival outcomes (either overall survival or quality-adjusted survival). Rather, it's a screening tool used before treatment to assess patient fitness. Therefore, g-8 does not indicate survival outcomes in this patient population.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22030047",
    "question": "Is comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death : condensation - misoprostol and mifepristone combination more effective than misoprostol alone in the management of intrauterine death?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether a combination of mifepristone and misoprostol is more effective than misoprostol alone in managing intrauterine death. The question itself contains the answer in the condensation part, which states 'misoprostol and mifepristone combination more effective than misoprostol alone in the management of intrauterine death'. This appears to be a statement rather than a question, and it's indicating that the combination therapy is indeed more effective.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10826425",
    "question": "Does schistosomal pelvic floor myopathy contribute to the pathogenesis of rectal prolapse in young males?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"I need to determine if schistosomal pelvic floor myopathy contributes to the pathogenesis of rectal prolapse in young males. Schistosomiasis is a parasitic disease that can affect the pelvic region, and in endemic areas, it can cause various complications. Pelvic floor myopathy refers to damage or weakness of the pelvic floor muscles. Rectal prolapse is a condition where the rectum protrudes through the anus. The question asks about a specific causal relationship between schistosomal pelvic floor myopathy and rectal prolapse specifically in young males. Based on medical literature, schistosomiasis can cause pelvic floor damage, and this damage can contribute to rectal prolapse. In endemic areas, young males with rectal prolapse often have a history of schistosomiasis, and studies have shown a correlation between schistosomal infection, pelvic floor muscle damage, and rectal prolapse in this demographic group.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15358029",
    "question": "Do age and gender affect ventricular-vascular coupling during aerobic exercise?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether age and gender have an impact on ventricular-vascular coupling during aerobic exercise. Ventricular-vascular coupling refers to the interaction between the heart (ventricles) and the arterial system (blood vessels). It's a measure of cardiovascular efficiency. \\n\\nBased on physiological research, both age and gender do affect cardiovascular function. Aging typically leads to arterial stiffening and changes in cardiac function, which would affect ventricular-vascular coupling. Gender differences in cardiovascular structure and function are well-documented, with women typically having smaller hearts and different vascular properties than men.\\n\\nDuring aerobic exercise, the cardiovascular system needs to adapt to increased demands, and these adaptations can be influenced by both age and gender. Research has shown that older individuals have different cardiovascular responses to exercise compared to younger individuals, and men and women show different patterns of cardiac adaptation to exercise.\\n\\nTherefore, the scientific evidence supports that both age and gender do affect ventricular-vascular coupling during aerobic exercise.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25086943",
    "question": "Does the prognosis of pulmonary metastasectomy depend on the location of the primary colorectal cancer?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether the prognosis (outcome) after pulmonary metastasectomy (surgical removal of lung metastases) is influenced by the location of the primary colorectal cancer. To answer this, I need to consider whether there's evidence that patients with rectal cancer vs. colon cancer, or right-sided vs. left-sided colorectal tumors, have different survival outcomes after lung metastasis resection.\\n\\nBased on medical literature, there is some evidence suggesting that the location of the primary colorectal tumor can influence overall prognosis and patterns of metastasis. For example, right-sided colon cancers often have different molecular characteristics and sometimes worse overall prognosis than left-sided tumors. \\n\\nHowever, specifically regarding pulmonary metastasectomy outcomes, most studies have found that the location of the primary colorectal tumor (whether rectal vs. colon, or right vs. left) is not an independent prognostic factor for survival after lung metastasectomy. Factors like disease-free interval, number of metastases, completeness of resection, and presence of KRAS mutations tend to be more significant predictors of outcome after pulmonary metastasectomy than the primary tumor location.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26486507",
    "question": "Are pepsinogen-II 100 bp ins/del gene polymorphism and its elevated circulating levels associated with gastric cancer , particularly with Helicobacter pylori infection and intestinal metaplasia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the association between pepsinogen-II 100 bp ins/del gene polymorphism and elevated circulating levels with gastric cancer, particularly in relation to Helicobacter pylori infection and intestinal metaplasia. To answer this, I need to determine if there is scientific evidence supporting such an association.\\n\\nPepsinogen-II is a precursor of the digestive enzyme pepsin. Gene polymorphisms and serum levels of pepsinogens have been studied as potential biomarkers for gastric conditions.\\n\\nBased on the scientific literature, there is evidence suggesting that pepsinogen-II levels can be elevated in gastric cancer patients, especially those with H. pylori infection. Some studies have also found associations between certain pepsinogen-II gene polymorphisms and increased risk of gastric cancer or precancerous lesions like intestinal metaplasia.\\n\\nSpecifically regarding the 100 bp ins/del polymorphism mentioned in the question, there are studies that have investigated this particular genetic variation in relation to gastric cancer risk, with some showing positive associations, particularly in the context of H. pylori infection.\\n\\nTherefore, the answer appears to be yes - there is evidence supporting an association between pepsinogen-II 100 bp ins/del polymorphism and elevated circulating levels with gastric cancer, particularly in relation to H. pylori infection and intestinal metaplasia.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21623747",
    "question": "Does sun exposure rapidly reduce plasmacytoid dendritic cells and inflammatory dermal dendritic cells in psoriatic skin?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if sun exposure rapidly reduces plasmacytoid dendritic cells and inflammatory dermal dendritic cells in psoriatic skin. To answer this, I would need to know about the effects of sun exposure (or phototherapy) on specific immune cell populations in psoriasis. Psoriasis is an inflammatory skin condition, and dendritic cells play a role in its pathogenesis. UV radiation from sunlight is known to have immunomodulatory effects and is used therapeutically for psoriasis (as phototherapy). However, without specific knowledge about whether sun exposure rapidly reduces these particular dendritic cell populations in psoriatic skin, I cannot confidently answer yes or no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25248370",
    "question": "Do miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the synergistic regulation of ERBB3 by miR-143 and miR-145 in breast cancer, specifically whether they work together to suppress cell proliferation and invasion. Let me analyze what research shows about this relationship.\\n\\nBased on scientific literature, miR-143 and miR-145 are microRNAs that are often co-expressed and downregulated in various cancers including breast cancer. ERBB3 (HER3) is a member of the epidermal growth factor receptor family that can promote cancer cell proliferation and invasion.\\n\\nThere is evidence that miR-143 and miR-145 do synergistically regulate ERBB3 in breast cancer. Studies have shown that these microRNAs target ERBB3, leading to its downregulation, which in turn suppresses cell proliferation and invasion in breast cancer cells. The synergistic effect occurs because they target different sites on ERBB3 mRNA or different components of the same pathway, enhancing the overall inhibitory effect.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26164182",
    "question": "Does the Deauville 5-Point Scale improve the Prognostic Value of Interim FDG PET/CT in Extranodal Natural Killer/T-Cell Lymphoma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the Deauville 5-Point Scale improves the prognostic value of interim FDG PET/CT specifically in Extranodal Natural Killer/T-Cell Lymphoma (ENKTL). To answer this, I would need specific research evidence about the application of the Deauville 5-Point Scale in this particular lymphoma subtype. The Deauville scale is commonly used to interpret PET/CT findings in lymphomas, particularly in Hodgkin lymphoma and some B-cell non-Hodgkin lymphomas, but without specific information about its validated use in ENKTL, I cannot definitively say it improves prognostic value in this specific context.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16135898",
    "question": "Does hIV-1 p24 vaccine protect cats against feline immunodeficiency virus infection?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if HIV-1 p24 vaccine protects cats against feline immunodeficiency virus (FIV) infection. HIV-1 p24 is a capsid protein of human immunodeficiency virus type 1, which affects humans. FIV is a lentivirus that affects cats and is similar to HIV in humans, but they are distinct viruses. While both are retroviruses in the same family, a vaccine designed specifically against HIV-1 components would not typically provide protection against FIV due to significant differences in viral proteins and structure. Cross-protection between these viruses is not established in scientific literature. FIV has its own specific vaccines that have been developed for cats.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21524662",
    "question": "Does temporal trends and correlate of passive commuting to and from school in children from 9 provinces in China?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if there are temporal trends and correlations of passive commuting to and from school in children from 9 provinces in China. This is not a yes/no question as phrased - it's asking if something 'does' exist, but it's grammatically incomplete. The question should be something like 'Does passive commuting to and from school in children from 9 provinces in China show temporal trends and correlations?' I can't answer yes or no to the question as stated because it's not properly formed. The question is missing a verb after 'correlate' - it should be something like 'correlate with' something else.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11581618",
    "question": "Is malignant transformation of the esophageal mucosa enhanced in p27 knockout mice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether malignant transformation of the esophageal mucosa is enhanced in p27 knockout mice. To answer this, I need to consider whether there is scientific evidence showing that mice with p27 gene knocked out have increased rates of malignant transformation in their esophageal mucosa compared to normal mice. P27 (also known as p27Kip1) is a cell cycle inhibitor protein that regulates cell proliferation. Without specific research data on this particular relationship between p27 knockout and esophageal malignancy, I cannot make a definitive claim. While p27 knockout mice do show increased susceptibility to certain tumors due to loss of this tumor suppressor, I don't have specific information about enhanced esophageal mucosa malignant transformation in these mice.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11522536",
    "question": "Do additional cytogenetic changes influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol . A report of the Spanish group PETHEMA?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether additional cytogenetic changes (beyond the characteristic PML-RARA fusion) affect outcomes in newly diagnosed acute promyelocytic leukemia (APL) patients who are treated with ATRA (all-trans retinoic acid) plus anthracycline-based protocols, specifically according to a report from the Spanish PETHEMA group. To answer this, I would need to know the findings of this specific PETHEMA group report. Without having the specific report referenced, I cannot definitively answer whether their research showed that additional cytogenetic changes influenced outcomes in this patient population. The question is asking for a factual finding from a specific research report.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "25441581",
    "question": "Does pregestational maternal obesity impair endocrine pancreas in male F1 and F2 progeny?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if pregestational maternal obesity impairs the endocrine pancreas in both male F1 and F2 progeny. To answer this, I need to consider whether there's scientific evidence showing that obesity in mothers before pregnancy affects the pancreatic function across two generations of male offspring. The endocrine pancreas refers to the insulin-producing parts of the pancreas (islets of Langerhans). Research has shown that maternal obesity can program metabolic dysfunction in offspring, but I need to determine if this specifically affects the endocrine pancreas in both F1 (children) and F2 (grandchildren) males. Based on existing research, maternal obesity has been shown to impair pancreatic beta-cell function and insulin secretion in F1 offspring, and some transgenerational effects have been observed extending to F2 generation. However, without specific studies cited in the question, I should be cautious about making a definitive claim about both generations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "14613990",
    "question": "Does reverse transcription-PCR analysis of laser-captured cells point to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question. Reverse transcription-PCR (RT-PCR) is a technique used to detect RNA expression in cells. Laser capture microdissection allows for isolation of specific cell types from tissue samples. The question asks whether RT-PCR analysis of laser-captured cells has provided evidence for potential paracrine and autocrine actions of neurotrophins in pancreatic cancer.\\n\\nParacrine signaling refers to cell signaling where the target cell is near the signal-releasing cell, while autocrine signaling is when cells release signals that bind to receptors on the same cell. Neurotrophins are growth factors that regulate neural development and function.\\n\\nBased on scientific literature, RT-PCR analysis of laser-captured pancreatic cancer cells has indeed shown expression patterns of neurotrophins and their receptors that suggest both paracrine and autocrine signaling mechanisms in pancreatic cancer. Studies have demonstrated that pancreatic cancer cells can both produce neurotrophins and express their receptors, supporting potential autocrine loops, while also showing patterns consistent with paracrine interactions between different cell types in the tumor microenvironment.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27133058",
    "question": "Does long noncoding RNA BDNF-AS protect local anesthetic induced neurotoxicity in dorsal root ganglion neurons?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if long noncoding RNA BDNF-AS protects against local anesthetic induced neurotoxicity in dorsal root ganglion neurons. To answer this, I would need specific scientific evidence about BDNF-AS (Brain-derived neurotrophic factor antisense RNA) and its protective effects against local anesthetic toxicity in dorsal root ganglion neurons. Without specific research studies demonstrating this protective effect, I cannot confirm this relationship. The question is asking about a very specific molecular mechanism and cellular protection that would require evidence from neuroscience research. Based on the information provided in the question alone, I don't have sufficient evidence to confirm that BDNF-AS has this protective function.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23814624",
    "question": "Is spondylolysis frequently missed by MRI in adolescents with back pain?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if spondylolysis (a defect or stress fracture in the pars interarticularis of the vertebral arch) is frequently missed by MRI when diagnosing adolescents with back pain. To answer this, I need to consider what the medical literature indicates about MRI's sensitivity for detecting spondylolysis specifically in adolescent patients.\\n\\nSpondylolysis is indeed known to be sometimes missed on MRI. While MRI is excellent for many spinal conditions, for spondylolysis specifically, CT scans are generally considered more sensitive and the gold standard for detection. MRI can miss early or subtle cases of spondylolysis, particularly in adolescents where the fracture may be acute or developing. Studies have shown that conventional MRI has limitations in detecting spondylolysis compared to CT or specialized MRI protocols.\\n\\nSo yes, there is evidence in the medical literature that spondylolysis is frequently missed by standard MRI in adolescents with back pain, which is why specific imaging protocols or alternative imaging modalities like CT may be recommended when this condition is suspected.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16885746",
    "question": "Does early endoscopic treatment of acute inflammatory airway lesions improve the outcome of postintubation airway stenosis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether early endoscopic treatment of acute inflammatory airway lesions improves the outcome of postintubation airway stenosis. To answer this, I would need specific clinical evidence from controlled studies that compare early endoscopic intervention versus standard care or delayed intervention for patients with acute inflammatory airway lesions following intubation. Without being provided specific studies or medical literature that demonstrates this causal relationship, I cannot make a definitive claim about whether early endoscopic treatment improves outcomes for postintubation airway stenosis. This would be a specific medical claim requiring evidence-based support.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27228567",
    "question": "Does hypoxia induce myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine ( C-C motif ) ligand 26?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific mechanism of myeloid-derived suppressor cell (MDSC) recruitment to hepatocellular carcinoma (HCC). Specifically, it's asking whether hypoxia (low oxygen conditions) induces this recruitment through a specific chemokine called CCL26 (C-C motif ligand 26).\\n\\nTo answer this accurately, I would need to know if there is established scientific evidence showing that hypoxic conditions in HCC lead to increased CCL26 expression, which then acts as a chemoattractant for MDSCs. This is a very specific molecular pathway in cancer biology.\\n\\nBased on my knowledge, while hypoxia is known to promote MDSC recruitment to tumors through various mechanisms, and CCL26 is a chemokine that can attract certain immune cells, I don't have specific evidence confirming that CCL26 specifically mediates hypoxia-induced MDSC recruitment to HCC. The most well-established chemokines for MDSC recruitment include CCL2, CXCL12, and CXCL5, among others. CCL26 is more commonly associated with eosinophil and basophil recruitment.\\n\\nWithout specific scientific literature confirming this exact pathway, I cannot confidently say yes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19058791",
    "question": "Is a neuregulin 1 variant associated with increased lateral ventricle volume in patients with first-episode schizophrenia?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about a specific association between a neuregulin 1 variant and increased lateral ventricle volume in patients with first-episode schizophrenia. To answer this accurately, I would need to know if research has established such a connection. Neuregulin 1 (NRG1) is a gene that has been implicated in schizophrenia risk in some studies. Enlarged lateral ventricles are a common neuroanatomical finding in schizophrenia. However, without specific research evidence linking a particular NRG1 variant to increased lateral ventricle volume specifically in first-episode schizophrenia patients, I cannot confidently answer yes. Based on my knowledge, while both NRG1 and ventricular enlargement have been separately studied in schizophrenia, I don't recall definitive evidence establishing this specific association.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25131361",
    "question": "Do primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if primary cutaneous anaplastic large cell lymphomas (PC-ALCL) with a specific genetic abnormality (6p25.3 rearrangement) have distinctive histological features that set them apart from other PC-ALCLs. To answer this, I need to recall if there are documented specific histological patterns associated with this genetic subtype. Based on medical literature, PC-ALCLs with 6p25.3 rearrangement (which typically involves the DUSP22-IRF4 locus) do indeed show particular histological features. They often display a more monomorphic cytomorphology with smaller cells, less pleomorphism, and fewer hallmark cells compared to other PC-ALCL subtypes. They also tend to have a sheet-like growth pattern and may show certain immunophenotypic characteristics. So there are documented particular histological features associated with this genetic subtype.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19769665",
    "question": "Do a retrospective study of the MRI findings in 18 dogs with stifle injuries?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking if I, as an AI, will conduct a retrospective study of MRI findings in 18 dogs with stifle injuries. This would involve collecting and analyzing past MRI data from these dogs, interpreting the images, and drawing conclusions about patterns in their injuries. As an AI language model, I don't have the ability to access medical records, view or analyze MRI images, or conduct original research. I can discuss existing studies on this topic, but I cannot perform a new retrospective study myself.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22826618",
    "question": "Does zinc finger protein A20 protect rats against chronic liver allograft dysfunction?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if zinc finger protein A20 protects rats against chronic liver allograft dysfunction. To answer this, I need to consider whether there is scientific evidence showing that A20 (a zinc finger protein with anti-inflammatory properties) has a protective effect specifically in rat models of liver transplantation and chronic rejection/dysfunction. \\n\\nBased on my knowledge, A20 (also known as TNFAIP3) is indeed an important regulator of inflammation and has been studied in various transplant models. There is research showing that A20 can protect against liver injury in various contexts by inhibiting NF-κB activation and reducing inflammation. \\n\\nSpecifically regarding rat liver allografts and chronic dysfunction, there are studies demonstrating that A20 expression or upregulation can protect against chronic rejection and improve long-term outcomes in liver transplantation models in rats. The research shows that A20 helps maintain liver allograft function by reducing inflammatory responses and preventing chronic damage.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15917709",
    "question": "Do ex vivo expanded murine bone marrow cells with a multiple cytokine cocktail retain long-term hematopoietic reconstitution potentials?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether ex vivo expanded murine bone marrow cells that have been treated with a multiple cytokine cocktail retain their long-term hematopoietic reconstitution potentials. To answer this, I need to determine if such expanded cells maintain their ability to repopulate the blood system over the long term after transplantation.\\n\\nBased on hematopoietic stem cell biology research, while ex vivo expansion with cytokine cocktails can increase cell numbers, there is significant evidence that such expansion often leads to differentiation and loss of long-term repopulating ability. Most studies show that extensive ex vivo expansion with cytokines results in maintenance of short-term reconstitution potential but compromises long-term reconstitution capacity. The long-term hematopoietic stem cells (LT-HSCs) tend to differentiate during cytokine-driven expansion, reducing their self-renewal capacity.\\n\\nTherefore, the answer would be no - ex vivo expanded murine bone marrow cells with multiple cytokine cocktails generally do not retain their long-term hematopoietic reconstitution potentials at levels comparable to fresh cells, though they may retain short-term reconstitution ability.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23376651",
    "question": "Is impaired coronary flow reserve evaluated by echocardiography associated with increased aortic stiffness in patients with metabolic syndrome : an observational study?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking if there is an association between impaired coronary flow reserve (as evaluated by echocardiography) and increased aortic stiffness in patients with metabolic syndrome, and whether this is an observational study. The question appears to be asking about the findings or design of a specific research study. Based on the phrasing, it seems to be the title of an observational study that investigated this association. Since the question is asking if this is an observational study, and the phrase 'an observational study' is included in what appears to be a study title, the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17965488",
    "question": "Is hypoadiponectinemia associated with impaired glucose tolerance and coronary artery disease in non-diabetic men?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the association between hypoadiponectinemia (low levels of adiponectin) and both impaired glucose tolerance and coronary artery disease specifically in non-diabetic men. To answer this, I need to consider what is known about adiponectin's role in metabolism and cardiovascular health. Adiponectin is an adipokine (a protein secreted by adipose tissue) that has insulin-sensitizing, anti-inflammatory, and anti-atherogenic properties. Research has shown that low adiponectin levels (hypoadiponectinemia) are associated with insulin resistance, metabolic syndrome, and increased risk of cardiovascular disease. Studies have demonstrated that hypoadiponectinemia is linked to impaired glucose tolerance even in individuals without diabetes, and it's also been associated with coronary artery disease independent of traditional risk factors. These associations have been observed in non-diabetic populations, including men specifically.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "7638738",
    "question": "Do y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the effects of y2 receptors on human pancreatic cancer growth and intracellular cyclic adenosine monophosphate (cAMP) levels. Let me analyze what I know about this topic.\\n\\nY2 receptors are a type of neuropeptide Y receptor. In the context of cancer biology, some research has investigated whether these receptors can affect cancer growth and signaling pathways.\\n\\nBased on scientific literature, Y2 receptors have been shown to inhibit pancreatic cancer growth in some studies. Additionally, activation of Y2 receptors has been associated with decreased intracellular cAMP levels in various cell types, including pancreatic cancer cells.\\n\\nThere are studies demonstrating that Y2 receptor agonists can inhibit pancreatic cancer cell proliferation and that this effect is partly mediated through reduction of intracellular cAMP levels. This is consistent with the general understanding that Y2 receptors are coupled to Gi proteins, which inhibit adenylyl cyclase and thereby reduce cAMP production.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25809080",
    "question": "Are socio-contextual factors linked to differences in the course of problem drinking in midlife : A discordant-twin study?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether socio-contextual factors (like social environment, economic status, etc.) are linked to differences in how problem drinking progresses in middle-aged individuals, specifically using a discordant-twin study methodology. Discordant-twin studies compare twins who differ on a particular trait or exposure to control for genetic factors. The question is phrased like a research paper title, and is asking if this specific study found such a link. Without knowing the specific study results, I cannot definitively answer. However, based on general knowledge of alcohol research, socio-contextual factors are typically found to influence drinking patterns. The question is specifically asking if this particular study found such a link.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27492911",
    "question": "Is prophylactic Plasma Transfusion Before Interventional Radiology Procedures Associated With Reduced Bleeding Complications?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether prophylactic plasma transfusion before interventional radiology procedures is associated with reduced bleeding complications. To answer this, I need to consider the evidence from clinical studies on this topic.\\n\\nBased on medical literature, prophylactic plasma transfusion before interventional procedures has been studied, and the evidence generally does not support that it reduces bleeding complications in most patients. Multiple studies and guidelines have shown that prophylactic plasma transfusion before procedures does not significantly reduce bleeding risk compared to no transfusion, especially in patients with mild to moderate coagulopathy.\\n\\nThe American Association of Blood Banks (AABB) and other organizations have recommended against routine prophylactic plasma transfusion before procedures in the absence of active bleeding. Studies have shown that the correction of laboratory values (like INR) with plasma transfusion often doesn't translate to clinical reduction in bleeding events.\\n\\nTherefore, the evidence does not support that prophylactic plasma transfusion before interventional radiology procedures is associated with reduced bleeding complications in most clinical scenarios.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "20621628",
    "question": "Are conscious awakenings commonly associated with Acid reflux events in patients with gastroesophageal reflux disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the relationship between conscious awakenings and acid reflux events in patients with gastroesophageal reflux disease (GERD). Based on medical literature, acid reflux events in GERD patients can indeed cause sleep disruptions, including conscious awakenings. Studies have shown that nocturnal reflux events can trigger arousals and awakenings from sleep. This is one of the mechanisms by which GERD can cause sleep disturbances and poor sleep quality. Research has demonstrated that when acid reflux occurs during sleep, it can lead to conscious awakenings as the body responds to the discomfort or irritation caused by the reflux. Therefore, conscious awakenings are commonly associated with acid reflux events in GERD patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12513703",
    "question": "Do host-specific cues cause differential attractiveness of Kenyan men to the African malaria vector Anopheles gambiae?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether host-specific cues (like body odor, heat, CO2, etc.) cause Kenyan men to be differentially attractive to the malaria mosquito Anopheles gambiae. This is asking about a specific scientific finding related to malaria vector biology.\\n\\nResearch has indeed shown that Anopheles gambiae mosquitoes show preferences between different human hosts, and that these preferences are based on host-specific cues. Studies have demonstrated that some individuals are more attractive to malaria mosquitoes than others based on their specific body odors and other chemical cues. There have been specific studies conducted in Kenya showing differential attractiveness of men to An. gambiae based on these host-specific factors.\\n\\nSo the answer would be yes - host-specific cues do cause differential attractiveness of Kenyan men to Anopheles gambiae.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24026297",
    "question": "Is de-escalation of empirical therapy associated with lower mortality in patients with severe sepsis and septic shock?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether de-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. De-escalation typically refers to narrowing the spectrum of antimicrobial therapy based on culture results and clinical improvement. I need to consider the evidence on this topic.\\n\\nBased on medical literature, several observational studies have shown that de-escalation of empirical antimicrobial therapy in patients with sepsis and septic shock is associated with lower mortality rates. A systematic review and meta-analysis by Tabah et al. (2016) found that de-escalation was associated with lower mortality compared to maintaining broad-spectrum therapy. Similarly, Leone et al. (2014) and Garnacho-Montero et al. (2014) found that de-escalation was associated with improved survival in septic patients.\\n\\nThe proposed mechanisms include reduced antimicrobial resistance, fewer drug-related adverse events, and potentially indicating a less severe disease course in patients who can have their therapy de-escalated.\\n\\nTherefore, the evidence suggests that de-escalation of empirical therapy is indeed associated with lower mortality in patients with severe sepsis and septic shock.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22581717",
    "question": "Do succinobucol-eluting stents increase neointimal thickening and peri-strut inflammation in a porcine coronary model?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether succinobucol-eluting stents increase neointimal thickening and peri-strut inflammation in a porcine coronary model. To answer this, I would need to know about studies that have investigated the effects of succinobucol-eluting stents in porcine coronary models. Succinobucol is an antioxidant compound, and drug-eluting stents are designed to reduce restenosis. Without specific information about studies on succinobucol-eluting stents in porcine models, I cannot definitively answer whether they increase neointimal thickening and inflammation. However, if succinobucol-eluting stents did increase these negative outcomes, it would be contrary to the general purpose of drug-eluting stents, which is to reduce such complications. Without specific research evidence, I cannot provide a definitive answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26970858",
    "question": "Does parents ' experiences and need regarding physical and occupational therapy for their young children with cerebral palsy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether parents have experiences and needs regarding physical and occupational therapy for their young children with cerebral palsy. This is not a yes/no question as phrased. It seems to be an incomplete question that's asking about what parents' experiences and needs are, rather than whether they exist. The question should be rephrased as 'Do parents have experiences and needs regarding physical and occupational therapy for their young children with cerebral palsy?' to be answerable with yes/no. Since parents of children with cerebral palsy would naturally have experiences with therapy and associated needs, the answer would be yes, but the question itself is grammatically malformed.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26423796",
    "question": "Does the IL-15-Based ALT-803 Complex enhance FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the IL-15-Based ALT-803 Complex enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas. To answer this, I need to determine if there's evidence that ALT-803 (an IL-15 complex) improves natural killer (NK) cell responses specifically through the FcγRIIIa receptor pathway and if it improves clearance of B cell lymphomas in vivo (in living organisms).\\n\\nALT-803 is a known IL-15 superagonist complex that can stimulate NK cells and enhance their cytotoxicity. FcγRIIIa (CD16a) is an important receptor on NK cells that mediates antibody-dependent cellular cytotoxicity (ADCC). \\n\\nBased on scientific literature, ALT-803 has been shown to enhance NK cell proliferation, activation, and cytotoxicity. Studies have demonstrated that ALT-803 can potentiate NK cell-mediated killing of tumor cells, including B cell lymphomas. Furthermore, research has shown that ALT-803 can enhance FcγRIIIa-triggered responses in NK cells, thereby improving antibody-dependent cellular cytotoxicity against cancer cells. In vivo studies have confirmed improved clearance of B cell lymphomas when ALT-803 is combined with therapeutic antibodies that engage FcγRIIIa on NK cells.\\n\\nTherefore, the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19352439",
    "question": "Do novel ABCA4 compound heterozygous mutations cause severe progressive autosomal recessive cone-rod dystrophy presenting as Stargardt disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if novel ABCA4 compound heterozygous mutations cause severe progressive autosomal recessive cone-rod dystrophy presenting as Stargardt disease. Let me analyze this:\n\n1. ABCA4 mutations are known to be associated with Stargardt disease, which is an autosomal recessive macular dystrophy.\n2. Compound heterozygous mutations refer to different mutations in both copies of a gene.\n3. Cone-rod dystrophy is a progressive retinal disorder that can have overlapping features with Stargardt disease.\n4. The literature does support that certain ABCA4 mutations can cause phenotypes that span both Stargardt disease and cone-rod dystrophy.\n5. Novel mutations in ABCA4 have been reported to cause severe progressive forms of retinal dystrophy that can initially present as Stargardt disease but progress to cone-rod dystrophy.\n\nBased on the scientific literature, ABCA4 compound heterozygous mutations can indeed cause severe progressive autosomal recessive cone-rod dystrophy that may initially present with features of Stargardt disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25378634",
    "question": "Does disulfiram modulate stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors. To answer this, I need to consider whether there is established scientific evidence for this specific effect of disulfiram on this particular type of brain tumor.\\n\\nDisulfiram (Antabuse) is primarily known as a medication for alcohol dependence treatment. However, it has been studied for potential anti-cancer properties in various cancers. \\n\\nFor the specific claim about disulfiram modulating stemness and metabolism in brain tumor initiating cells in atypical teratoid/rhabdoid tumors (AT/RT), I would need to know if research has demonstrated this effect. This is a very specific claim about a particular drug effect on a rare pediatric brain tumor type.\\n\\nWithout specific knowledge of research demonstrating this effect, I cannot confidently say yes. However, there have been studies examining disulfiram's effects on various cancer stem cells, so it's plausible that such research exists.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21071938",
    "question": "Is cCN2 ( CTGF ) gene polymorphism a novel prognostic risk factor for cardiovascular outcomes in hemodialysis patients?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether cCN2 (CTGF) gene polymorphism is a novel prognostic risk factor for cardiovascular outcomes in hemodialysis patients. To answer this accurately, I would need to know if there is established scientific evidence showing that polymorphisms in the cCN2 (CTGF) gene have been demonstrated to predict cardiovascular outcomes specifically in hemodialysis patients. CTGF (Connective Tissue Growth Factor) is involved in fibrosis and has been studied in various cardiovascular contexts, but I need to determine if there's specific evidence for it being a prognostic factor in the hemodialysis population. Without specific studies showing this relationship, I cannot confirm this as an established prognostic risk factor.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17941864",
    "question": "Is subclinical hypothyroidism a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases specifically in Type 2 diabetic patients. To answer this, I need to consider the medical evidence on this relationship.\\n\\nSubclinical hypothyroidism is a condition where thyroid hormone levels are within normal range but TSH is elevated. There is research suggesting that subclinical hypothyroidism may be associated with increased cardiovascular risk in the general population.\\n\\nFor diabetic patients specifically, some studies have shown that subclinical hypothyroidism is associated with an increased risk of diabetic nephropathy and cardiovascular complications in Type 2 diabetes. The thyroid dysfunction may exacerbate insulin resistance, dyslipidemia, and endothelial dysfunction, which are all risk factors for both nephropathy and cardiovascular disease.\\n\\nMultiple studies have demonstrated this association, showing that Type 2 diabetic patients with subclinical hypothyroidism have higher rates of nephropathy and cardiovascular events compared to euthyroid diabetic patients.\\n\\nBased on the medical literature, the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18492020",
    "question": "Does curcumin reduce the toxic effects of iron loading in rat liver epithelial cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if curcumin reduces the toxic effects of iron loading in rat liver epithelial cells. To answer this, I need to consider if there is scientific evidence showing that curcumin has a protective effect against iron toxicity specifically in rat liver epithelial cells. \\n\\nCurcumin is known to have antioxidant properties and has been studied for potential protective effects against various toxicities. Iron overload can cause oxidative stress and damage to liver cells. \\n\\nWhile curcumin has been shown to have hepatoprotective effects in some studies, I need to determine if there is specific evidence for protection against iron loading toxicity in rat liver epithelial cells specifically.\\n\\nBased on my knowledge, there are studies showing that curcumin can chelate iron and reduce oxidative stress in various experimental models, including some studies in liver cells. However, I don't have definitive evidence specifically about curcumin reducing toxic effects of iron loading in rat liver epithelial cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20628261",
    "question": "Do prehypertensive African-American women have preserved nitric oxide and renal function but high cardiovascular risk?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether prehypertensive African-American women have three specific characteristics: (1) preserved nitric oxide, (2) preserved renal function, and (3) high cardiovascular risk. This is a specific medical claim that would require evidence from medical research studies. Without specific medical literature or studies to reference, I cannot definitively confirm that all three of these conditions simultaneously apply specifically to prehypertensive African-American women. While there is research showing African-Americans have higher rates of hypertension and cardiovascular disease risk factors, making a specific claim about preserved nitric oxide levels, preserved renal function, AND high cardiovascular risk specifically in prehypertensive African-American women would require specific medical evidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9088380",
    "question": "Does sequential serum creatine kinase determination differentiate vaso-vagal syncope from generalized tonic-clonic seizures?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether sequential serum creatine kinase (CK) determination can differentiate between vaso-vagal syncope and generalized tonic-clonic seizures. Let me analyze this:\n\nGeneralized tonic-clonic seizures typically cause significant muscle activity that can lead to muscle breakdown, resulting in elevated CK levels in the blood. These elevations can be substantial and often peak 24-48 hours after the seizure event.\n\nVaso-vagal syncope, on the other hand, is a brief loss of consciousness due to a sudden drop in blood pressure and heart rate. It typically doesn't involve the intense muscle activity seen in seizures, so CK elevations are minimal or absent.\n\nSequential CK measurements (taking multiple measurements over time) can show the characteristic rise and fall pattern after seizures, which would be absent or minimal in vaso-vagal syncope.\n\nBased on medical literature, sequential serum CK determinations can indeed help differentiate between these two conditions, with significant elevations strongly suggesting seizure activity rather than simple syncope.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15459589",
    "question": "Do short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if short alleles of P-selectin glycoprotein ligand-1 (PSGL-1) protect against premature myocardial infarction (heart attack). To answer this, I need to consider the scientific evidence about PSGL-1 genetic variants and their relationship to heart disease risk.\\n\\nPSGL-1 is a cell adhesion molecule involved in inflammatory processes. Some research has investigated whether variations in the PSGL-1 gene affect cardiovascular disease risk. \\n\\nBased on my knowledge, there have been studies suggesting that certain PSGL-1 polymorphisms may be associated with cardiovascular disease risk, but I don't have specific evidence that short alleles of PSGL-1 have a protective effect against premature myocardial infarction. Without clear evidence supporting this specific protective relationship, I cannot confirm that short alleles of PSGL-1 protect against premature myocardial infarction.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17915219",
    "question": "Do nOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about nOD2 transgenic mice and whether they exhibit two specific characteristics: 1) enhanced MDP-mediated down-regulation of TLR2 responses, and 2) resistance to colitis induction.\\n\\nTo answer this accurately, I would need to know about the properties of nOD2 transgenic mice from scientific literature. NOD2 (nucleotide-binding oligomerization domain-containing protein 2) is a pattern recognition receptor involved in immune responses, and MDP (muramyl dipeptide) is a bacterial cell wall component that activates NOD2. TLR2 is Toll-like receptor 2, another pattern recognition receptor.\\n\\nBased on my knowledge of immunology literature, NOD2 transgenic mice (mice engineered to overexpress NOD2) have been shown to exhibit enhanced MDP-mediated down-regulation of TLR2 responses. This cross-regulation between NOD2 and TLR2 pathways is a documented phenomenon. Additionally, these mice typically show increased resistance to experimental colitis induction compared to wild-type mice.\\n\\nHowever, I need to be careful about the specific notation 'nOD2' in the question, which might refer to a specific variant or mutation of NOD2 rather than standard NOD2. If 'nOD2' refers to standard NOD2 transgenic mice, then the answer would be 'yes'. If it refers to a specific variant with different properties, I would need more information.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10507622",
    "question": "Does lung recruitment during small tidal volume ventilation allow minimal positive end-expiratory pressure without augmenting lung injury?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether lung recruitment during small tidal volume ventilation allows for minimal positive end-expiratory pressure (PEEP) without increasing lung injury. To answer this, I need to consider the current understanding in respiratory medicine and critical care.\\n\\nLung recruitment refers to the process of opening collapsed alveoli through the application of pressure. Small tidal volume ventilation is a lung-protective strategy used to minimize ventilator-induced lung injury. PEEP is used to prevent alveolar collapse at the end of expiration.\\n\\nThe question essentially asks if combining lung recruitment maneuvers with small tidal volume ventilation allows clinicians to use lower PEEP settings without causing additional lung injury.\\n\\nBased on current medical literature, lung recruitment maneuvers can open collapsed lung units, but using minimal PEEP afterward may not be sufficient to keep these units open, leading to repeated opening and closing of alveoli (atelectrauma). This cyclic collapse and reopening is known to contribute to lung injury.\\n\\nMost evidence suggests that after recruitment, an adequate level of PEEP (not necessarily minimal) is needed to maintain the recruited lung units open and prevent derecruitment. Using minimal PEEP after recruitment would likely lead to derecruitment and potentially increase lung injury through atelectrauma.\\n\\nTherefore, the answer would be no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22361981",
    "question": "Is arm length associated with type 2 diabetes mellitus in Japanese-Americans?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to determine if there's an established association between arm length and type 2 diabetes mellitus specifically in Japanese-Americans. This is a very specific medical correlation question.\\n\\nTo my knowledge, there isn't robust scientific evidence establishing arm length as a risk factor or correlate for type 2 diabetes specifically in Japanese-Americans. While there have been some studies examining body proportions and diabetes risk in various populations, arm length specifically as a predictor in Japanese-Americans is not a well-established or widely reported association in medical literature.\\n\\nSome studies have looked at height, leg length, or other anthropometric measurements in relation to diabetes risk across different populations, but I'm not aware of conclusive evidence specifically linking arm length to diabetes in Japanese-Americans.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27283324",
    "question": "Is increased visfatin expression associated with nuclear factor-kappa B and phosphatidylinositol 3-kinase in periodontal inflammation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the association between increased visfatin expression and two specific signaling pathways (nuclear factor-kappa B and phosphatidylinositol 3-kinase) in the context of periodontal inflammation. To answer this, I need to consider what is known about visfatin's relationship with these pathways in periodontal disease.\\n\\nVisfatin (also known as PBEF or Nampt) is an adipokine that has been implicated in inflammatory processes. In periodontal inflammation, several studies have shown that visfatin levels are elevated and that it can promote inflammatory responses.\\n\\nRegarding the specific pathways mentioned:\\n1. Nuclear factor-kappa B (NF-κB): Research has demonstrated that visfatin can activate the NF-κB signaling pathway in various cell types, including periodontal cells. This activation contributes to the production of pro-inflammatory cytokines in periodontal disease.\\n\\n2. Phosphatidylinositol 3-kinase (PI3K): Studies have shown that visfatin can signal through the PI3K pathway in inflammatory conditions, including periodontal inflammation.\\n\\nBased on the scientific literature, increased visfatin expression has been associated with both NF-κB and PI3K signaling pathways in the context of periodontal inflammation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16186286",
    "question": "Is elevated C-reactive protein a predictor of the development of diabetes in a general Japanese population : the Hisayama Study?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether elevated C-reactive protein (CRP) is a predictor of diabetes development in the Japanese population, specifically referencing the Hisayama Study. To answer this, I would need to know the findings of the Hisayama Study regarding the relationship between CRP levels and diabetes incidence. Without specific information about the results of this study, I cannot definitively answer whether elevated CRP was found to be a predictor of diabetes in this particular Japanese population study. The question appears to be asking about a specific scientific finding from a specific epidemiological study.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10743818",
    "question": "Does bone mineral density vary as a function of the rate of joint space narrowing in the hip?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between bone mineral density (BMD) and the rate of joint space narrowing in the hip joint. Joint space narrowing is a radiographic measure of cartilage loss and is commonly used to assess the progression of osteoarthritis. The question specifically asks if BMD varies as a function of (i.e., is related to or changes with) the rate of joint space narrowing.\\n\\nBased on medical research, there is evidence that bone mineral density can be related to joint space narrowing in osteoarthritis. Studies have shown that subchondral bone changes, including alterations in BMD, often occur alongside cartilage degradation in osteoarthritis. Some research indicates that higher BMD may be associated with a lower rate of joint space narrowing in some cases, while other studies suggest more complex relationships depending on the stage of disease and location of measurement.\\n\\nSo yes, bone mineral density does appear to vary as a function of the rate of joint space narrowing in the hip, though the exact relationship is complex and may depend on multiple factors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25298006",
    "question": "Do probiotic Lactobacillus rhamnosus GG ( LGG ) and prebiotic prevent neonatal inflammation-induced visceral hypersensitivity in adult rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if probiotic Lactobacillus rhamnosus GG (LGG) and prebiotic prevent neonatal inflammation-induced visceral hypersensitivity in adult rats. This is asking about a specific scientific finding regarding whether these supplements can prevent a particular condition in rats when administered during the neonatal period. To answer this accurately, I would need to know specific research findings on this topic. Without access to specific studies on this exact question, I cannot provide a definitive yes or no answer based on scientific evidence. However, there is research suggesting that both probiotics (including LGG strains) and prebiotics can have protective effects against visceral hypersensitivity in various models, including those involving early-life inflammation. Some studies have shown that certain probiotics can reduce visceral pain responses in animal models of irritable bowel syndrome and other conditions involving visceral hypersensitivity. Since I don't have access to specific studies addressing this exact question with the specific probiotic strain (LGG) and unspecified prebiotic in the neonatal rat model described, I should be cautious in my answer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "10199230",
    "question": "Do reductions in risk behaviour provide the most consistent explanation for declining HIV-1 prevalence in Uganda?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if reductions in risk behavior provide the most consistent explanation for declining HIV-1 prevalence in Uganda. To answer this, I need to consider whether there is scientific consensus that behavioral changes (like reduced sexual partners, increased condom use, delayed sexual debut) were the primary driver of Uganda's HIV decline in the 1990s and early 2000s. While Uganda's HIV decline has been attributed to various factors including the 'ABC' approach (Abstinence, Be faithful, Condoms), there have been debates about the relative importance of these behavioral changes versus other factors like increased mortality, migration patterns, or improved treatment. However, most epidemiological studies have concluded that behavioral changes, particularly partner reduction, were indeed the most consistent explanation for Uganda's HIV decline. This is supported by data showing changes in sexual behavior preceding and coinciding with HIV prevalence declines.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19414429",
    "question": "Are aRTS1 polymorphisms associated with ankylosing spondylitis in Koreans?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the association between aRTS1 polymorphisms and ankylosing spondylitis specifically in the Korean population. To answer this, I would need to know if there are studies showing a statistically significant association between genetic variations in the aRTS1 gene and the development or severity of ankylosing spondylitis in Korean individuals. Without specific research data on this particular gene in this specific population, I cannot provide a definitive answer. I should note that ARTS-1 (also known as ERAP1) polymorphisms have been associated with ankylosing spondylitis in some populations, but whether this association has been specifically demonstrated in Koreans requires population-specific research.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24627869",
    "question": "Does inhibition of microRNA miR-92a induce apoptosis and necrosis in human acute promyelocytic leukemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question about the effects of inhibiting microRNA miR-92a in acute promyelocytic leukemia (APL).\\n\\nThe question asks if inhibiting miR-92a induces apoptosis (programmed cell death) and necrosis (unprogrammed cell death) in human APL cells.\\n\\nBased on research literature, miR-92a is part of the miR-17-92 cluster that is often overexpressed in various cancers including leukemias. Studies have shown that inhibition of miR-92a can induce apoptosis in some cancer cells by affecting various cellular pathways involved in cell survival and proliferation.\\n\\nSpecifically for acute promyelocytic leukemia, research has demonstrated that inhibition of miR-92a does induce apoptosis in APL cells. For example, studies have shown that miR-92a targets pro-apoptotic proteins, and when miR-92a is inhibited, these proteins are upregulated, leading to increased apoptosis in APL cells.\\n\\nRegarding necrosis, there is also evidence that miR-92a inhibition can lead to necrotic cell death in APL cells, though apoptosis is the more predominant mechanism of cell death observed.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20110724",
    "question": "Does distal and proximal resource influence on economic dependency among the oldest old?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether distal and proximal resources influence economic dependency among the oldest old population. This appears to be a research question about factors affecting economic dependency in very elderly populations. 'Distal' resources likely refer to resources from earlier in life (like education, career history, etc.), while 'proximal' resources refer to current resources (like current income, assets, social support). The question is asking if these types of resources have an influence on economic dependency for the oldest old population (typically those 85+ years). However, the question is phrased as a yes/no question without providing any specific research findings or data. Without specific evidence or context, I cannot definitively answer whether these resources do influence economic dependency.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18786263",
    "question": "Does pressure support ventilation attenuate ventilator-induced protein modifications in the diaphragm?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether pressure support ventilation (PSV) reduces or lessens (attenuates) protein modifications in the diaphragm that are caused by mechanical ventilation (ventilator-induced). To answer this, I need to consider what research shows about PSV's effects on diaphragm protein structure compared to other ventilation modes.\\n\\nPressure support ventilation is a mode where the patient initiates breaths but receives pressure assistance from the ventilator. It allows for some diaphragmatic activity, unlike fully controlled modes. Research has shown that maintaining some diaphragmatic activity during mechanical ventilation can help prevent diaphragm atrophy and dysfunction.\\n\\nStudies have demonstrated that controlled mechanical ventilation can lead to oxidative stress, proteolysis, and other protein modifications in the diaphragm, collectively termed ventilator-induced diaphragmatic dysfunction (VIDD). PSV, by allowing partial diaphragm contraction, has been shown to reduce these negative effects compared to fully controlled ventilation.\\n\\nMultiple studies have specifically examined protein modifications in the diaphragm and found that PSV does attenuate various protein alterations including reduced proteolysis, less oxidative damage, and preservation of contractile proteins compared to controlled modes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26816546",
    "question": "Does notch1 control cell chemoresistance in small cell lung carcinoma cells?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether Notch1 controls cell chemoresistance in small cell lung carcinoma (SCLC) cells. To answer this, I need to consider whether there is established scientific evidence linking Notch1 signaling to chemoresistance mechanisms specifically in SCLC cells. \\n\\nNotch1 is a transmembrane receptor that plays important roles in cell fate decisions and has been implicated in chemoresistance in various cancer types. However, in small cell lung carcinoma specifically, the literature shows that Notch signaling typically functions as a tumor suppressor rather than a promoter of chemoresistance. In fact, SCLC is characterized by loss of Notch signaling rather than activation. The chemoresistance mechanisms in SCLC are more commonly attributed to other pathways.\\n\\nWhile Notch1 has been linked to chemoresistance in non-small cell lung cancer (NSCLC), the evidence does not support this role in SCLC specifically.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "10805885",
    "question": "Does phosphorus 31 nuclear magnetic resonance spectroscopy suggest a mitochondrial defect in claudicating skeletal muscle?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about whether phosphorus 31 (31P) nuclear magnetic resonance (NMR) spectroscopy provides evidence for mitochondrial dysfunction in skeletal muscle of patients with claudication (pain caused by insufficient blood flow during exercise, often associated with peripheral artery disease). To answer this, I need to consider what 31P NMR spectroscopy typically shows in claudicating muscle.\\n\\n31P NMR spectroscopy can measure metabolites like ATP, phosphocreatine, and inorganic phosphate, as well as intracellular pH in muscle tissue. In claudicating muscle, studies have shown abnormal energy metabolism during exercise and recovery, including:\\n- Faster depletion of phosphocreatine\\n- Slower recovery of phosphocreatine after exercise\\n- Greater acidification during exercise\\n- Abnormal ATP metabolism\\n\\nThese findings are consistent with impaired oxidative metabolism, which could suggest mitochondrial dysfunction. However, the primary pathology in claudication is reduced blood flow (ischemia) rather than an intrinsic mitochondrial defect. The metabolic abnormalities seen on 31P NMR are primarily consequences of the reduced oxygen delivery rather than evidence of a primary mitochondrial disorder.\\n\\nSo while 31P NMR does show metabolic abnormalities in claudicating muscle, these are generally attributed to reduced perfusion rather than indicating a primary mitochondrial defect.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24918346",
    "question": "Does genistein prevent cadmium-induced neurotoxic effects through its antioxidant mechanisms?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether genistein prevents cadmium-induced neurotoxic effects through its antioxidant mechanisms. To answer this, I would need specific scientific evidence about genistein's effects on cadmium neurotoxicity and whether its antioxidant properties are the mechanism of action. Without specific studies or evidence provided in the question, I cannot make a definitive determination. While genistein is known to have antioxidant properties, and cadmium toxicity often involves oxidative stress mechanisms, I don't have enough information to confirm that genistein specifically prevents cadmium-induced neurotoxicity through antioxidant mechanisms.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27105157",
    "question": "Does a loss-of-function variant in OSBPL1A predispose to low plasma HDL cholesterol levels and impaired cholesterol efflux capacity?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a loss-of-function variant in the OSBPL1A gene predisposes to low plasma HDL cholesterol levels and impaired cholesterol efflux capacity. To answer this, I need to consider what is known about OSBPL1A's role in cholesterol metabolism and transport.\\n\\nOSBPL1A (Oxysterol Binding Protein Like 1A) is a member of the OSBP family involved in lipid transport and metabolism. However, without specific research evidence linking loss-of-function variants in this gene to low HDL cholesterol levels and impaired cholesterol efflux capacity, I cannot definitively answer yes.\\n\\nWhile some OSBP family members have been implicated in lipid disorders, I don't have specific evidence that OSBPL1A loss-of-function variants cause the specific phenotypes mentioned. Some genes like ABCA1, APOA1, and LCAT are well-established causes of low HDL, but OSBPL1A is not among the commonly cited genes for this condition.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26678064",
    "question": "Does a novel analysis strategy for integrating methylation and expression data reveal core pathways for thyroid cancer aetiology?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a novel analysis strategy for integrating methylation and expression data reveals core pathways for thyroid cancer aetiology. To answer this, I need to determine if there's evidence of such a strategy being developed and successfully identifying core pathways specific to thyroid cancer development. Without specific research papers or studies mentioned in the question, I cannot confirm that such a novel analysis strategy exists or has successfully revealed core pathways for thyroid cancer aetiology. The question appears to be asking about a specific research finding that I don't have information about.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26439325",
    "question": "Does patient-reported physical functioning predict the success of hematopoietic cell transplantation ( BMT CTN 0902 )?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if patient-reported physical functioning predicts the success of hematopoietic cell transplantation, specifically referencing a study called BMT CTN 0902. To answer this, I would need to know the findings of this specific study. BMT CTN refers to Blood and Marrow Transplant Clinical Trials Network, and 0902 appears to be a specific trial number. Without having access to the results of this specific clinical trial, I cannot definitively say whether patient-reported physical functioning was found to predict transplantation success in this study.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11399697",
    "question": "Does bAL induce an increase in peripheral blood neutrophils and cytokine levels in healthy volunteers and patients with pneumonia?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if bAL (which I assume refers to bronchoalveolar lavage) induces an increase in peripheral blood neutrophils and cytokine levels in both healthy volunteers and pneumonia patients. \\n\\nBronchoalveolar lavage (BAL) is a diagnostic procedure where a bronchoscope is used to instill fluid into a small segment of the lung and then recollect the fluid for analysis. It's primarily a sampling technique rather than a treatment that would be expected to systematically alter blood neutrophil counts or cytokine levels.\\n\\nWhile BAL can cause some local inflammation at the site of the procedure, there's no strong evidence in the medical literature suggesting that BAL itself causes significant systemic increases in peripheral blood neutrophils or cytokine levels in either healthy individuals or pneumonia patients. Any changes in these parameters in pneumonia patients would more likely be attributed to the underlying infection rather than the BAL procedure.\\n\\nTherefore, the answer is no.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9731620",
    "question": "Do endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to determine if endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm. Endothelin is a potent vasoconstrictor, and its receptors (particularly endothelin A receptors) have been implicated in cerebral vasospasm following subarachnoid hemorrhage. While endothelin A receptor antagonists have shown efficacy in reducing vasospasm, the role of endothelin B receptor antagonists is less clear. Endothelin B receptors can actually mediate vasodilation in some contexts through nitric oxide release. Selective endothelin B receptor antagonists might potentially worsen vasospasm by blocking this vasodilatory pathway. The research literature generally suggests that combined endothelin A/B receptor antagonists or selective endothelin A receptor antagonists are more effective for treating subarachnoid hemorrhage-induced vasospasm than selective endothelin B receptor antagonists. In fact, selective endothelin B receptor blockade might be counterproductive.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16796214",
    "question": "Does new approach to the study of periodic leg movements during sleep in restless legs syndrome?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether there is a new approach to the study of periodic leg movements during sleep in restless legs syndrome. However, the question is incomplete or grammatically incorrect. It starts with 'Does' but doesn't complete the thought - it should be something like 'Does [something] exist/work/help' etc. Without a complete predicate, I cannot determine what is being asked about the new approach. Based on the incomplete information, I cannot provide a definitive yes or no answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26167081",
    "question": "Does miR-122 negatively correlate with liver fibrosis as detected by histology and FibroScan?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"I need to analyze whether miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan. A negative correlation would mean that as liver fibrosis increases (worsens), miR-122 levels decrease, or vice versa.\\n\\nBased on scientific literature, miR-122 is a liver-specific microRNA that is typically abundant in healthy liver tissue. In various liver diseases including fibrosis, miR-122 levels in liver tissue tend to decrease as fibrosis progresses. Studies have shown that serum/circulating miR-122 levels often decrease with advancing fibrosis stages as measured by histology (liver biopsy) and non-invasive methods like FibroScan (transient elastography).\\n\\nMultiple studies have demonstrated this inverse relationship between miR-122 expression and the severity of liver fibrosis, supporting a negative correlation between miR-122 and liver fibrosis as detected by both histological examination and FibroScan measurements.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19936712",
    "question": "Does repeated cocaine administration increase nitric oxide efflux in the rat dorsal striatum?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if repeated cocaine administration increases nitric oxide efflux in the rat dorsal striatum. To answer this, I need to consider what is known about cocaine's effects on nitric oxide signaling in the brain, particularly in the dorsal striatum. Research has shown that cocaine can affect nitric oxide systems in the brain. Some studies have demonstrated that cocaine administration can lead to increased nitric oxide production in certain brain regions. Specifically for the dorsal striatum, there is evidence that repeated cocaine exposure does increase nitric oxide efflux in this region. Studies have shown that cocaine administration can stimulate nitric oxide synthase activity in striatal neurons, leading to enhanced nitric oxide release. This effect appears to be part of the neuroadaptive changes that occur with repeated cocaine exposure.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25406294",
    "question": "Are mutations in the ABCA3 gene associated with cataract-microcornea syndrome?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to determine if mutations in the ABCA3 gene are associated with cataract-microcornea syndrome. ABCA3 (ATP Binding Cassette Subfamily A Member 3) is a gene that encodes a protein involved in pulmonary surfactant metabolism. It's primarily associated with respiratory disorders, particularly surfactant metabolism dysfunction and neonatal respiratory distress syndrome. Cataract-microcornea syndrome is an eye disorder characterized by cataracts and abnormally small corneas. This syndrome is typically associated with mutations in genes involved in eye development and lens formation, such as CRYAA, CRYBB1, GJA8, and MAF. Based on my knowledge, ABCA3 mutations are not known to be associated with cataract-microcornea syndrome.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27461236",
    "question": "Does a family-based genome-wide association study reveal an association of spondyloarthritis with MAPK14?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if a family-based genome-wide association study has revealed an association between spondyloarthritis and MAPK14 (Mitogen-Activated Protein Kinase 14). To answer this accurately, I would need to know about specific research findings from family-based GWAS studies on spondyloarthritis. While MAPK14 is involved in inflammatory pathways that could theoretically be relevant to spondyloarthritis pathogenesis, I don't have information about a confirmed association specifically from a family-based GWAS. Major genes associated with spondyloarthritis in GWAS studies include HLA-B27 and several non-MHC genes, but without specific evidence about MAPK14 from family-based GWAS, I cannot confirm this association.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21314296",
    "question": "Is anatomic thoracoscopic lung resection for non-small cell lung cancer in stage I associated with less morbidity and shorter hospitalization than thoracotomy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the comparative outcomes of two surgical approaches for non-small cell lung cancer (NSCLC) in stage I: anatomic thoracoscopic lung resection versus thoracotomy. Specifically, it asks whether the thoracoscopic approach is associated with less morbidity and shorter hospitalization compared to thoracotomy.\\n\\nAnatomic thoracoscopic lung resection, often referred to as video-assisted thoracoscopic surgery (VATS), is a minimally invasive surgical technique. Thoracotomy, on the other hand, is a more traditional open surgical approach that involves a larger incision in the chest.\\n\\nBased on the medical literature, VATS/thoracoscopic approaches for early-stage lung cancer are generally associated with less postoperative pain, reduced complications (lower morbidity), shorter chest tube duration, and shorter length of hospital stay compared to thoracotomy. Multiple studies and meta-analyses have consistently shown these benefits of the minimally invasive approach for stage I NSCLC.\\n\\nTherefore, the answer to whether anatomic thoracoscopic lung resection for non-small cell lung cancer in stage I is associated with less morbidity and shorter hospitalization than thoracotomy would be 'yes'.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21956456",
    "question": "Is an intensive 5-year-long influenza vaccination campaign effective among doctors but not nurses?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether an intensive 5-year-long influenza vaccination campaign is effective among doctors but not nurses. This is asking me to make a specific factual claim about the differential effectiveness of a vaccination campaign between two healthcare professional groups. The question doesn't provide any data, studies, or evidence about such a campaign or its outcomes. Without specific information about a particular campaign and its measured outcomes across these professional groups, I cannot make a definitive claim that such a campaign would be effective for one group but not the other. There could be various factors affecting vaccination effectiveness in different healthcare worker populations, but I don't have evidence to support the specific claim in the question.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23948847",
    "question": "Does chronic ankle instability alter eccentric eversion/inversion and dorsiflexion/plantarflexion ratio?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if chronic ankle instability alters the eccentric eversion/inversion and dorsiflexion/plantarflexion ratio. To answer this, I would need to know if research has shown that people with chronic ankle instability demonstrate different muscle strength ratios in these ankle movements compared to those without ankle instability. Based on research in sports medicine and biomechanics, chronic ankle instability is often associated with altered neuromuscular control and strength imbalances around the ankle joint. Studies have shown that individuals with chronic ankle instability often demonstrate altered strength ratios, particularly in the eversion/inversion movements, which are critical for lateral stability. There is evidence that eccentric strength deficits and altered ratios between antagonist muscle groups are present in those with chronic ankle instability. Therefore, the answer would be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12045074",
    "question": "Are parents and practitioners poor judges of young children 's pain severity?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if parents and practitioners are poor judges of young children's pain severity. This is a question about the accuracy of pain assessment by adults who care for children. To answer this, I would need to consider research on pain assessment in pediatrics. Studies have shown that there can be discrepancies between children's self-reported pain and adult assessments, with adults sometimes underestimating children's pain. However, the question uses the strong term 'poor judges' which implies a significant and consistent inability to assess pain accurately. While there are challenges in assessing pre-verbal or young children's pain, many parents and practitioners can become quite skilled at recognizing pain cues with proper training and experience. The research doesn't support a blanket statement that parents and practitioners are categorically poor judges of children's pain.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27817102",
    "question": "Does curcumin inhibit placental inflammation to ameliorate LPS-induced adverse pregnancy outcomes in mice via upregulation of phosphorylated Akt?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific mechanism of action for curcumin in preventing adverse pregnancy outcomes in mice exposed to LPS (lipopolysaccharide, an endotoxin that can induce inflammation). Specifically, it's asking if curcumin inhibits placental inflammation through upregulation of phosphorylated Akt (a protein kinase involved in cellular signaling pathways).\n\nTo answer this question accurately, I would need to know if research has demonstrated that curcumin works through this specific mechanism (upregulation of phosphorylated Akt) to reduce placental inflammation and improve pregnancy outcomes in LPS-exposed mice.\n\nWithout specific research papers showing this exact mechanism, I cannot definitively say 'yes'. The question contains a very specific claim about a molecular mechanism that would require experimental evidence to confirm.\", \n\"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26355117",
    "question": "Are plasma Levels of the Cerebral Biomarker , Neuron-Specific Enolase , Elevated During Pregnancy in Women Developing Preeclampsia?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether plasma levels of neuron-specific enolase (NSE), a cerebral biomarker, are elevated during pregnancy in women who develop preeclampsia compared to normal pregnancies. To answer this accurately, I would need to know if research studies have demonstrated such an elevation. Without specific research data provided in the question, I cannot make a definitive determination. Preeclampsia is known to involve various biomarker changes and potential neurological complications, but whether NSE specifically is elevated requires evidence from medical literature.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25981118",
    "question": "Does intravitreal inhibition of complement C5a reduce choroidal neovascularization in mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if intravitreal inhibition of complement C5a reduces choroidal neovascularization (CNV) in mice. To answer this, I need to consider whether there is scientific evidence showing that blocking C5a (a component of the complement system) through intravitreal injection has an inhibitory effect on CNV in mouse models.\\n\\nThe complement system is known to be involved in the pathogenesis of age-related macular degeneration (AMD), of which CNV is a feature. C5a is a potent anaphylatoxin that can promote inflammation and angiogenesis. There are studies showing that inhibition of various complement components can reduce CNV in experimental models.\\n\\nSpecifically for C5a inhibition, research has demonstrated that blocking C5a signaling through intravitreal administration of C5a receptor antagonists or anti-C5a antibodies can indeed reduce CNV in mouse models. These studies have shown that targeting C5a can decrease the size and leakage of CNV lesions, supporting the role of C5a in promoting choroidal neovascularization.\\n\\nBased on the scientific literature, intravitreal inhibition of complement C5a does reduce choroidal neovascularization in mice.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25065861",
    "question": "Is longitudinal epigenetic variation of DNA methyltransferase genes associated with vulnerability to post-traumatic stress disorder?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific scientific relationship: whether longitudinal epigenetic variation (changes over time) in DNA methyltransferase genes is associated with vulnerability to PTSD. To answer this accurately, I would need to know if research has established such a connection. DNA methyltransferases are enzymes that add methyl groups to DNA, affecting gene expression without changing the DNA sequence itself. Some research has examined epigenetic factors in PTSD, including methylation patterns, but I need to determine if studies specifically show that variations in the genes encoding these enzymes (the methyltransferase genes themselves) over time (longitudinal variation) are linked to PTSD vulnerability. Based on current research, while epigenetic modifications including DNA methylation have been implicated in PTSD, I don't have sufficient evidence to confirm that longitudinal variations specifically in the DNA methyltransferase genes (DNMT1, DNMT3A, DNMT3B, etc.) are established as associated with PTSD vulnerability.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12028404",
    "question": "Are thrombopoietin serum levels elevated in patients with hepatitis B/C infection compared to other causes of chronic liver disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about thrombopoietin (TPO) serum levels in patients with hepatitis B/C infection compared to patients with other causes of chronic liver disease. TPO is a glycoprotein hormone that regulates platelet production. I need to consider whether there is evidence that TPO levels are specifically elevated in hep B/C compared to other chronic liver diseases.\\n\\nBased on medical literature, thrombopoietin is primarily produced in the liver, and liver diseases can affect its production. In hepatitis B and C infections, there is evidence that TPO levels can be elevated compared to healthy controls. However, the question specifically asks about comparison to OTHER causes of chronic liver disease (like alcoholic liver disease, NAFLD, autoimmune hepatitis, etc.).\\n\\nFrom my knowledge of the medical literature, TPO levels are generally elevated in various forms of liver disease, and there isn't strong evidence that hepatitis B/C specifically causes higher TPO levels than other chronic liver diseases. In fact, TPO levels tend to correlate more with the severity of liver dysfunction rather than the specific etiology. Some studies have shown that TPO levels may actually be lower in advanced cirrhosis regardless of cause.\\n\\nTherefore, there isn't clear evidence that TPO levels are specifically elevated in hep B/C compared to other chronic liver diseases.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "16183767",
    "question": "Are adult women with mitral valve prolapse more flexible?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if adult women with mitral valve prolapse (MVP) are more flexible than those without this condition. MVP is a heart valve condition where the valve between the left atrium and left ventricle doesn't close properly. There is some research suggesting a connection between MVP and connective tissue disorders like Marfan syndrome or Ehlers-Danlos syndrome, which do cause increased flexibility or hypermobility. Some studies have found that people with MVP, particularly women, may have a higher prevalence of joint hypermobility compared to the general population. This association has been documented in medical literature, suggesting that women with MVP may indeed tend to be more flexible on average.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26088203",
    "question": "Does systemic Escherichia coli infection influence clinical symptoms and neurodegeneration in experimental autoimmune encephalomyelitis?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether systemic Escherichia coli (E. coli) infection has an influence on clinical symptoms and neurodegeneration in experimental autoimmune encephalomyelitis (EAE), which is an animal model of multiple sclerosis. To answer this, I would need to know if there is scientific evidence showing that E. coli infections affect the severity, progression, or pathology of EAE. Research has shown that infections, including bacterial infections, can influence autoimmune diseases through various mechanisms like molecular mimicry, bystander activation, or altered immune responses. Some studies have specifically investigated how infections, including bacterial ones, might affect EAE models. While I don't have access to the complete scientific literature, there is evidence suggesting that systemic infections, including bacterial ones, can influence autoimmune conditions including EAE. Therefore, it is plausible that systemic E. coli infection could influence EAE symptoms and neurodegeneration, but I should be careful not to overstate the evidence if I'm not aware of specific studies on E. coli and EAE.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "id": "25034499",
    "question": "Do serum suPAR levels help differentiate steroid resistance from steroid-sensitive nephrotic syndrome in children?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether serum suPAR (soluble urokinase plasminogen activator receptor) levels can be used to distinguish between steroid-resistant nephrotic syndrome and steroid-sensitive nephrotic syndrome in pediatric patients. To answer this, I need to consider whether there is evidence that suPAR levels differ significantly between these two conditions in a way that would make it a useful biomarker for clinical differentiation. Based on research literature, elevated suPAR levels have been associated with steroid-resistant nephrotic syndrome compared to steroid-sensitive cases in children. Multiple studies have shown that children with steroid-resistant nephrotic syndrome tend to have higher serum suPAR levels than those with steroid-sensitive disease, suggesting that suPAR can indeed help differentiate between these two conditions.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12744789",
    "question": "Does [ External evaluation of serology result in blood banks in Colombia ]?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if there is external evaluation of serology results in blood banks in Colombia. This is asking about a specific healthcare practice in a specific country. To answer this accurately, I would need specific information about Colombia's blood bank regulations and quality control systems. I don't have specific information about whether Colombia has a system for external evaluation of serology results in their blood banks. Without this specific information, I cannot provide a definitive yes or no answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26247568",
    "question": "Is liquid nitrogen vapor comparable to liquid nitrogen for storage of cryopreserved human sperm : evidence from the characteristics of post-thaw human sperm?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if liquid nitrogen vapor is comparable to liquid nitrogen for storing cryopreserved human sperm, based on evidence from post-thaw sperm characteristics. This is asking about a scientific comparison between two storage methods for preserved sperm. To answer this accurately, I would need to know if research has shown that sperm stored in liquid nitrogen vapor has similar post-thaw characteristics (like motility, viability, DNA integrity) compared to sperm stored in liquid nitrogen. Without specific scientific evidence, I cannot definitively answer this question.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26968694",
    "question": "Do severe Hand Osteoarthritis Strongly Correlates With Major Joint Involvement and Surgical Intervention?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if severe hand osteoarthritis strongly correlates with major joint involvement and surgical intervention. To answer this, I need to consider what the medical literature shows about the relationship between hand osteoarthritis severity and 1) involvement of other major joints, and 2) the likelihood of requiring surgical intervention.\\n\\nBased on medical research, hand osteoarthritis does have some correlation with osteoarthritis in other joints (like knees and hips), as there can be a systemic component to osteoarthritis development. However, the correlation is not necessarily strong enough to be characterized as a \\\"strong correlation.\\\" Many patients have isolated hand osteoarthritis without significant involvement of other major joints.\\n\\nRegarding surgical intervention, while severe hand osteoarthritis may eventually require surgical options in some cases (like joint fusion or arthroplasty), the majority of hand osteoarthritis cases are managed non-surgically with medications, splinting, and therapy. Surgery is typically reserved for cases that fail conservative management, not as a strongly correlated outcome of the disease progression.\\n\\nThe phrasing \\\"strongly correlates\\\" implies a high degree of association that isn't fully supported by the medical evidence. The relationship exists but is more moderate than strong.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23814634",
    "question": "Do amnion-derived multipotent progenitor cells improve achilles tendon repair in rats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether amnion-derived multipotent progenitor cells improve Achilles tendon repair in rats. To answer this, I need to consider if there is scientific evidence showing that these specific cells (amnion-derived multipotent progenitor cells) have a positive effect on Achilles tendon healing in rat models.\\n\\nBased on scientific literature, there are studies showing that amnion-derived multipotent progenitor cells (AMPCs) have been used in rat models of Achilles tendon injury and have demonstrated improved healing outcomes. Research has shown these cells can enhance tendon repair by promoting collagen organization, reducing inflammation, and improving biomechanical properties of the healing tendon in rat models. Several studies have documented positive effects including better structural organization, increased tensile strength, and accelerated healing when compared to control groups.\\n\\nTherefore, there is scientific evidence supporting that amnion-derived multipotent progenitor cells do improve Achilles tendon repair in rats.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21562077",
    "question": "Does diabetes adversely affect macrophages during atherosclerotic plaque regression in mice?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between diabetes and macrophage function specifically during atherosclerotic plaque regression in mice. To answer this, I need to consider whether there is established scientific evidence showing that diabetes has negative effects on macrophages during the process of plaque regression in mouse models.\\n\\nResearch has shown that diabetes impairs macrophage function in several ways, including reducing their ability to efferocytose (clear dead cells), increasing inflammatory responses, and impairing cholesterol efflux. In the context of atherosclerosis, studies in diabetic mouse models have demonstrated that diabetes does indeed impair macrophage emigration from plaques and reduces their capacity to resolve inflammation, which are critical processes for plaque regression. Several papers have shown that hyperglycemia and insulin resistance associated with diabetes negatively affect macrophage polarization toward an anti-inflammatory phenotype that would normally facilitate plaque regression.\\n\\nSo based on the scientific literature, diabetes does adversely affect macrophage function during atherosclerotic plaque regression in mice.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22797193",
    "question": "Does pulmonary artery dilatation correlate with the risk of unexpected death in chronic arterial or thromboembolic pulmonary hypertension?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about a correlation between pulmonary artery dilatation and the risk of unexpected death in patients with chronic arterial or thromboembolic pulmonary hypertension. To answer this, I need to consider whether medical research has established such a correlation.\\n\\nPulmonary artery dilatation is a common finding in pulmonary hypertension as the increased pressure causes the vessel to enlarge over time. Research has shown that pulmonary artery diameter can be a marker of disease severity in pulmonary hypertension.\\n\\nStudies have demonstrated that pulmonary artery dilatation (particularly when measured as pulmonary artery to aorta ratio) is associated with increased mortality in pulmonary hypertension. For example, research has shown that a dilated pulmonary artery is an independent predictor of mortality in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.\\n\\nSpecifically regarding 'unexpected death', there is evidence that severe pulmonary artery dilatation increases the risk of sudden cardiac death in patients with pulmonary hypertension, which would qualify as unexpected death.\\n\\nBased on the medical literature, there does appear to be a correlation between pulmonary artery dilatation and increased risk of unexpected/sudden death in the conditions mentioned.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "14720427",
    "question": "Do [ Endobronchial eosinophils preferentially stimulate T helper cell type 2 responses ]?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if endobronchial eosinophils preferentially stimulate T helper cell type 2 (Th2) responses. Eosinophils are a type of white blood cell that are involved in allergic and inflammatory responses. They are known to be associated with Th2-mediated immune responses, particularly in allergic conditions and asthma. Eosinophils can release various cytokines and mediators that promote Th2 responses, including IL-4, IL-5, and IL-13. When present in the bronchial tissue (endobronchial), eosinophils are indeed known to contribute to Th2 polarization of the immune response. This is a well-established aspect of their role in allergic airway inflammation and asthma pathogenesis. So yes, endobronchial eosinophils do preferentially stimulate Th2 responses.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "18761738",
    "question": "Are s-ICAM-1 and s-VCAM-1 in healthy men strongly associated with traits of the metabolic syndrome , becoming evident in the postprandial response to a lipid-rich meal?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if s-ICAM-1 and s-VCAM-1 in healthy men are strongly associated with traits of the metabolic syndrome, particularly in the postprandial response to a lipid-rich meal. To answer this, I would need specific research evidence about these soluble adhesion molecules (s-ICAM-1 and s-VCAM-1) and their relationship with metabolic syndrome traits in healthy men, specifically in the context of postprandial responses. Without specific research data provided in the question, I cannot make a definitive determination about whether there is a strong association.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20843364",
    "question": "Does respiratory syncytial virus ( RSV ) RNA loads in peripheral blood correlate with disease severity in mice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if RSV RNA loads in peripheral blood correlate with disease severity in mice. To answer this, I need to consider whether there is established evidence that higher RSV viral RNA levels in the blood of mice are associated with more severe disease manifestations. RSV primarily infects the respiratory tract, and while viral load in the respiratory tract often correlates with disease severity, the question specifically asks about peripheral blood RNA loads. Based on my knowledge of RSV pathogenesis in mouse models, RSV is primarily a respiratory pathogen with limited viremia (presence in blood). While RSV RNA may be detectable in blood in some cases, there isn't strong established evidence that blood RNA loads consistently correlate with disease severity in mouse models. Most studies measuring disease severity in mice focus on respiratory parameters, viral loads in lung tissue/lavage, and immune responses rather than blood viral RNA.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21123447",
    "question": "Does preconception folic acid use modulate estradiol and follicular responses to ovarian stimulation?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if preconception folic acid use affects estradiol levels and follicular responses when a woman undergoes ovarian stimulation (typically for fertility treatments like IVF). To answer this, I need to consider the scientific evidence on this specific relationship. While folic acid is commonly recommended before conception to prevent neural tube defects, its effects on ovarian stimulation outcomes are less clear. Some studies have investigated whether micronutrients like folic acid might influence ovarian response parameters, but there isn't strong consensus in the literature that folic acid specifically modulates estradiol levels or follicular development during stimulation protocols. The evidence for this specific effect is limited and not well-established in reproductive medicine.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20952763",
    "question": "Does ondansetron block paracetamol-induced analgesia in a mouse model of fracture pain?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if ondansetron blocks paracetamol-induced analgesia in a mouse model of fracture pain. To answer this, I need to consider what is known about the pharmacological interactions between ondansetron (a 5-HT3 receptor antagonist commonly used as an antiemetic) and paracetamol (acetaminophen, an analgesic). \\n\\nThere is research suggesting that ondansetron can antagonize the analgesic effects of paracetamol in certain pain models. This is because paracetamol's analgesic action is partially mediated through serotonergic mechanisms, particularly 5-HT3 receptors. By blocking these receptors, ondansetron could potentially reduce paracetamol's pain-relieving effects.\\n\\nHowever, the question specifically asks about a mouse model of fracture pain. Without specific research data on this particular model, I cannot definitively state whether ondansetron blocks paracetamol analgesia in this specific context. Different pain models may show different interactions between these drugs.\\n\\nBased on general pharmacological principles, it's plausible that ondansetron could interfere with paracetamol analgesia in a fracture pain model, but I don't have specific evidence for this exact scenario.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "26572230",
    "question": "Is activation of MEK2 sufficient to induce skin papilloma formation in transgenic zebrafish?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if activation of MEK2 is sufficient to induce skin papilloma formation in transgenic zebrafish. To answer this, I need to consider whether MEK2 activation alone can cause skin papillomas in zebrafish models.\\n\\nBased on my knowledge of cancer biology and zebrafish models, MEK2 is part of the MAPK/ERK signaling pathway which is involved in cell proliferation and differentiation. While constitutive activation of this pathway can contribute to tumor formation, I don't have specific evidence that MEK2 activation alone is sufficient to induce skin papillomas specifically in zebrafish models. Some oncogenic pathways require multiple mutations or co-factors to induce tumor formation.\\n\\nWithout specific studies demonstrating that MEK2 activation alone induces skin papillomas in transgenic zebrafish, I cannot confirm this is sufficient.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20016211",
    "question": "Does angiotensin receptor blocker reduce proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether angiotensin receptor blockers (ARBs) can reduce proteinuria (protein in urine) in children who are already being treated with angiotensin-converting enzyme inhibitors (ACEIs), and specifically whether this reduction is independent of blood pressure effects. \\n\\nTo answer this, I would need to know if there is evidence showing that ARBs have an anti-proteinuric effect beyond their blood pressure lowering effect when added to ACEI therapy in pediatric patients. \\n\\nBased on medical literature, there is some evidence that dual blockade of the renin-angiotensin system with both ACEIs and ARBs can provide additional reduction in proteinuria beyond what is achieved with either agent alone in adults. This effect appears to be partly independent of blood pressure reduction. However, the specific evidence in children who are already on ACEIs is more limited. \\n\\nSome studies have shown that adding an ARB to ACEI therapy in children with proteinuric kidney diseases can further reduce protein excretion, and this effect may be partially independent of blood pressure changes. However, the evidence is not as robust as in adults, and there are concerns about increased adverse effects with dual therapy.\\n\\nBased on available evidence, I would say yes, ARBs can reduce proteinuria somewhat independently of blood pressure effects in children already on ACEIs, though the magnitude of this effect and risk-benefit ratio remains an area of ongoing research.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26645604",
    "question": "Does atorvastatin restrict HIV replication in CD4+ T cells by upregulation of p21?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific mechanism of action for atorvastatin (a statin medication commonly used to lower cholesterol) in relation to HIV. Specifically, it's asking if atorvastatin restricts HIV replication in CD4+ T cells through a specific mechanism - upregulation of p21 (a cell cycle regulator protein). To answer this accurately, I would need to know if research has established this specific mechanism. While some studies have investigated statins' effects on HIV replication, I need to determine if this specific pathway (atorvastatin → p21 upregulation → HIV restriction in CD4+ T cells) has been established in the scientific literature. Based on my knowledge, while statins have been studied in the context of HIV, this specific mechanism involving p21 upregulation by atorvastatin has not been definitively established as the way atorvastatin affects HIV replication in CD4+ T cells.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9207276",
    "question": "Does bromelain prevent secretion caused by Vibrio cholerae and Escherichia coli enterotoxins in rabbit ileum in vitro?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether bromelain prevents secretion caused by Vibrio cholerae and Escherichia coli enterotoxins in rabbit ileum in vitro. To answer this, I would need specific scientific evidence from studies that tested bromelain's effect on these specific bacterial enterotoxins in rabbit ileum tissue under laboratory conditions. Without having access to such specific research data, I cannot make a definitive claim about bromelain's effect in this particular experimental setup. This is a very specific scientific question that requires evidence from controlled laboratory studies.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "18922616",
    "question": "Does triptolide cooperate with chemotherapy to induce apoptosis in acute myeloid leukemia cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells. To answer this, I need to consider whether there is evidence that triptolide works together with chemotherapeutic agents to enhance apoptosis (programmed cell death) specifically in acute myeloid leukemia (AML) cells.\\n\\nTriptolide is a diterpenoid compound isolated from the Chinese herb Tripterygium wilfordii that has shown anti-cancer properties. There is research indicating that triptolide can enhance the effects of various chemotherapeutic agents in different cancer types by promoting apoptosis.\\n\\nSpecifically for AML, studies have shown that triptolide can sensitize AML cells to chemotherapeutic agents like daunorubicin and cytarabine by enhancing apoptotic pathways. Research has demonstrated that triptolide can downregulate anti-apoptotic proteins and activate pro-apoptotic pathways in AML cells, making them more susceptible to chemotherapy-induced cell death.\\n\\nBased on the scientific literature, triptolide does cooperate with chemotherapy to induce apoptosis in AML cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22809894",
    "question": "Are symptoms of depression and PTSD associated with elevated alcohol demand?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between symptoms of depression and PTSD (Post-Traumatic Stress Disorder) and alcohol demand. 'Alcohol demand' typically refers to the reinforcing value of alcohol or motivation to consume alcohol. Research has shown that there is indeed an association between depression/PTSD symptoms and increased alcohol consumption or problematic drinking. Many studies have found that individuals with depression or PTSD symptoms often show higher alcohol demand, which can be measured through various behavioral economic tasks. This relationship is often explained through self-medication theory, where individuals may use alcohol to cope with negative emotions or symptoms. So based on the scientific literature, there is evidence supporting an association between depression/PTSD symptoms and elevated alcohol demand.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "26894433",
    "question": "Do coenzyme Q10 Levels Are Decreased in the Cerebellum of Multiple-System Atrophy Patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether coenzyme Q10 levels are decreased in the cerebellum of patients with multiple-system atrophy (MSA). To answer this accurately, I would need to know if scientific research has established this specific biochemical finding in MSA patients. Multiple-system atrophy is a rare neurodegenerative disorder that affects the autonomic nervous system and movement. Some research has indeed found reduced coenzyme Q10 levels in MSA patients, particularly in the cerebellum, which is a region commonly affected in this disease. Studies have shown decreased coenzyme Q10 levels in cerebellar tissue samples from MSA patients compared to controls, suggesting a potential role of coenzyme Q10 deficiency in the pathogenesis of MSA.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17313307",
    "question": "Is slow change in body mass index during early triplet pregnancy associated with decreased birth weight?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the relationship between slow change in body mass index (BMI) during early triplet pregnancy and decreased birth weight. To answer this, I need to consider whether there is evidence that slower BMI increases in mothers carrying triplets during early pregnancy correlates with lower birth weights of the babies. This is a specific medical question about triplet pregnancies, which are high-risk and have different growth patterns than singleton pregnancies. Without specific medical studies on this particular relationship in triplet pregnancies, I cannot make a definitive claim. However, in general, inadequate maternal weight gain in multiple pregnancies is associated with lower birth weights. The question specifically asks about 'slow change' in BMI, which suggests insufficient weight gain during early pregnancy, which would typically be concerning for fetal growth in multiple gestations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20151299",
    "question": "Is protein kinase C-delta involved in the inflammatory effect of IL-6 in mouse adipose cells?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if protein kinase C-delta (PKC-delta) is involved in the inflammatory effect of interleukin-6 (IL-6) specifically in mouse adipose cells. To answer this accurately, I would need specific research evidence showing a direct relationship between PKC-delta and IL-6 signaling in mouse adipose tissue inflammation. While PKC-delta is known to be involved in various inflammatory pathways, and IL-6 is a pro-inflammatory cytokine that affects adipose tissue, I don't have specific evidence establishing that PKC-delta is directly involved in mediating IL-6's inflammatory effects specifically in mouse adipose cells. Without specific research demonstrating this relationship, I cannot confirm this connection.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "26236396",
    "question": "Do closely related fungi employ diverse enzymatic strategies to degrade plant biomass?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether closely related fungi use diverse enzymatic strategies to break down plant biomass. Based on mycological research, even fungi that are taxonomically related often develop different enzymatic toolkits for plant biomass degradation. This is due to ecological specialization, where different fungi adapt to specific plant substrates or environmental niches. For example, within the same fungal family, some species might specialize in breaking down lignin while others focus on cellulose or hemicellulose components. This enzymatic diversity has been documented in studies of wood-decay fungi, where closely related species can employ significantly different arrays of carbohydrate-active enzymes (CAZymes) and oxidative enzymes. So yes, closely related fungi do often employ diverse enzymatic strategies for plant biomass degradation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27859294",
    "question": "Does tGF-β antagonist attenuate fibrosis but not luminal narrowing in experimental tracheal stenosis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether tGF-β antagonist attenuates fibrosis but not luminal narrowing in experimental tracheal stenosis. I need to analyze whether this statement is accurate based on research about tGF-β antagonists in tracheal stenosis treatment. TGF-β is a cytokine involved in fibrosis, and antagonists would block its action. In tracheal stenosis, both fibrosis and luminal narrowing are concerns. The question specifically asks if the antagonist reduces fibrosis while NOT affecting luminal narrowing. Without specific research papers cited in the question, I cannot verify this specific claim with certainty. However, generally, reducing fibrosis would typically be expected to also reduce luminal narrowing, as fibrosis contributes to the stenosis. Since I don't have definitive evidence that tGF-β antagonists selectively affect fibrosis without impacting luminal narrowing, I cannot confirm this statement.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17266134",
    "question": "Is tRPV1 involved in stretch-evoked contractile changes in the rat autonomous bladder model : a study with piperine , a new TRPV1 agonist?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if tRPV1 (transient receptor potential vanilloid 1) is involved in stretch-evoked contractile changes in the rat autonomous bladder model, specifically in a study that used piperine as a TRPV1 agonist. To answer this, I would need to know the specific findings of this study. Without having access to the specific study mentioned, I cannot definitively say whether tRPV1 was found to be involved in stretch-evoked contractile changes in this particular rat bladder model using piperine. The question appears to be asking about the findings or conclusions of a specific scientific study, which I don't have information about.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15041998",
    "question": "Is aberrant p16 methylation a biomarker for tobacco exposure in cervical squamous cell carcinogenesis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if aberrant p16 methylation is a biomarker for tobacco exposure specifically in the context of cervical squamous cell carcinogenesis. To answer this, I would need to know if research has established a clear connection between tobacco exposure and p16 methylation patterns in cervical cancer development. Without specific scientific evidence from studies showing that p16 methylation patterns reliably indicate tobacco exposure in cervical cancer patients, I cannot confirm this relationship. While both p16 alterations and tobacco exposure may be relevant to cervical cancer, the specific biomarker relationship being asked about requires evidence from medical literature.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21519151",
    "question": "Does β-blockade restore muscle sympathetic rhythmicity in human heart failure?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether β-blockade restores muscle sympathetic rhythmicity in human heart failure. To answer this, I need to consider what is known about sympathetic nervous system activity in heart failure and the effects of β-blockers on this system.\\n\\nIn heart failure, there is typically increased sympathetic nervous system activity, which can be dysregulated and show abnormal rhythmicity. β-blockers are medications that block the effects of epinephrine and norepinephrine on β-adrenergic receptors, and they are commonly used in heart failure treatment.\\n\\nHowever, to specifically answer whether β-blockade restores muscle sympathetic rhythmicity in human heart failure, I would need to know about specific research studies that have examined this question. Without specific knowledge of such studies, I cannot provide a definitive answer based on general knowledge of β-blockers and heart failure pathophysiology.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22532837",
    "question": "Does lestaurtinib inhibit histone phosphorylation and androgen-dependent gene expression in prostate cancer cells?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to determine if lestaurtinib inhibits both histone phosphorylation and androgen-dependent gene expression in prostate cancer cells. Let me analyze what I know about lestaurtinib:\\n\\nLestaurtinib (CEP-701) is a tyrosine kinase inhibitor that was initially developed as a TrkA inhibitor and has been studied for various cancers. It's known to inhibit FLT3, JAK2, and other kinases.\\n\\nHowever, I don't have specific information indicating that lestaurtinib inhibits histone phosphorylation in prostate cancer cells. Similarly, I don't have information showing it inhibits androgen-dependent gene expression in prostate cancer cells.\\n\\nWithout specific evidence that lestaurtinib has both of these effects in prostate cancer cells, I cannot confirm this claim.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "24717767",
    "question": "Does alogliptin improve steroid-induced hyperglycemia in treatment-naïve Japanese patients with chronic kidney disease by decrease of plasma glucagon levels?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about a specific effect of alogliptin (a DPP-4 inhibitor used for diabetes) on steroid-induced hyperglycemia in a very specific population: treatment-naïve Japanese patients with chronic kidney disease. More specifically, it's asking if this improvement occurs through a specific mechanism: decrease of plasma glucagon levels.\\n\\nTo answer this accurately, I would need specific clinical study data about alogliptin in this exact population, with measurements of plasma glucagon levels before and after treatment. Without citing specific research that demonstrates this exact relationship, I cannot confidently say 'yes'. The question contains a very specific claim about a medication's mechanism of action in a specific population that requires evidence-based confirmation.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "25793991",
    "question": "Are elevated endogenous erythropoietin concentrations associated with increased risk of brain damage in extremely preterm neonates?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between elevated endogenous erythropoietin concentrations and brain damage risk in extremely preterm neonates. Erythropoietin (EPO) is a hormone that stimulates red blood cell production. The question specifically asks if higher natural (endogenous) levels of EPO are associated with increased risk of brain damage in extremely premature babies.\\n\\nTo answer this accurately, I need to consider the scientific evidence. Research has actually shown the opposite relationship - elevated endogenous erythropoietin is generally considered neuroprotective in preterm infants. Higher EPO levels are typically a physiological response to hypoxia (low oxygen) and appear to be a protective mechanism. Studies have found that higher endogenous EPO levels are associated with reduced brain injury and better neurodevelopmental outcomes in preterm infants.\\n\\nIn fact, this protective relationship is why exogenous (administered) EPO has been studied as a potential neuroprotective treatment for preterm infants.\\n\\nTherefore, elevated endogenous erythropoietin concentrations are not associated with increased risk of brain damage in extremely preterm neonates, but rather with decreased risk.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "27733120",
    "question": "Does comparative proteomics reveal that central metabolism changes are associated with resistance against Sporisorium scitamineum in sugarcane?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if comparative proteomics reveals that central metabolism changes are associated with resistance against Sporisorium scitamineum in sugarcane. To answer this, I would need to know if there are proteomics studies that have specifically examined protein expression differences between resistant and susceptible sugarcane varieties when challenged with S. scitamineum (the causal agent of sugarcane smut disease). Furthermore, I would need to know if these studies found differences in proteins involved in central metabolic pathways (like glycolysis, TCA cycle, etc.) that correlate with resistance. Without specific information from the literature on this topic, I cannot definitively answer. However, many plant pathogen resistance mechanisms do involve metabolic reprogramming, so it's plausible but not certain without evidence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17575490",
    "question": "Do changes in pain perception and descending inhibitory controls start at middle age in healthy adults?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether changes in pain perception and descending inhibitory controls begin at middle age in healthy adults. To answer this, I need to consider what research shows about age-related changes in pain processing systems.\\n\\nResearch indicates that age-related changes in pain perception and descending pain inhibitory systems do occur, but the timing varies. Some studies suggest that these changes may begin gradually, with noticeable differences emerging in middle age (typically 40-60 years). Other research indicates that significant changes in pain modulation systems may not be prominent until later in life (60+ years).\\n\\nThe evidence suggests that while some subtle changes may begin in middle age, major alterations in descending pain inhibitory controls are more characteristic of older age rather than middle age specifically. Most research points to a gradual decline that becomes more pronounced in later life rather than a distinct onset at middle age.\\n\\nBased on current scientific understanding, it would be an oversimplification to state that these changes definitively 'start' at middle age, as the process appears more gradual and variable across individuals.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17867402",
    "question": "Do the effectiveness of a novel infant tooth wipe in high caries-risk babies 8 to15 months old?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether tooth wipes are effective for high caries-risk babies between 8 to 15 months old. However, the question is phrased incorrectly. It starts with 'Do the effectiveness...' which is not grammatically correct. It should be asking 'What is the effectiveness...' or 'Are tooth wipes effective...'. Since this is a yes/no question format, I need to determine if there's a clear question being asked despite the grammatical error. The intent seems to be asking if tooth wipes are effective, but the phrasing makes it unclear what exactly is being asked. Since I can only answer yes or no, and the question as stated is not properly formed to elicit such a response, I cannot provide a definitive answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22935634",
    "question": "Is effect of 9p21 genetic variation on coronary heart disease modified by other risk markers . The Atherosclerosis Risk in Communities ( ARIC ) Study?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether the effect of 9p21 genetic variation on coronary heart disease is modified by other risk markers, specifically in the context of the Atherosclerosis Risk in Communities (ARIC) Study. This appears to be a title or research question from a scientific paper, not a yes/no question directed at me. I cannot answer definitively whether the 9p21 genetic variation's effect is modified by other risk markers based solely on this title. To answer this properly, I would need to read the actual study results. Since I don't have access to the specific findings of this ARIC Study, I cannot provide a yes or no answer to this research question.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "12427649",
    "question": "Is low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects : no further effect of vitamin E?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether the reduction of low-density lipoprotein (LDL) levels by simvastatin (a statin drug) is accompanied by a reduction in F2-isoprostane formation in people with high cholesterol, and whether vitamin E has any additional effect. The question is phrased as a research question, asking about a specific scientific relationship. It's not asking for a yes/no confirmation of a fact, but rather posing a complex research question that would require data analysis to answer. The question itself contains a hypothesis (that simvastatin reduces F2-isoprostane formation) and asks if vitamin E provides additional benefits. This is not a simple factual question that can be answered with just 'yes' or 'no' without supporting evidence or research data.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22424887",
    "question": "Does unilateral maxillary molar extraction influence AQP5 expression and distribution in the rat submandibular salivary gland?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether unilateral maxillary molar extraction (removing upper molars from one side) affects the expression and distribution of AQP5 (Aquaporin-5, a water channel protein) in the submandibular salivary gland of rats. To answer this, I would need to know if there's research showing a relationship between molar extraction and changes in AQP5 in salivary glands. Without specific research knowledge on this topic, I cannot definitively say whether such a relationship exists. However, based on general knowledge of oral physiology, tooth extraction can affect various aspects of oral function, potentially including salivary gland function. But whether it specifically affects AQP5 expression is a detailed scientific question requiring specific research evidence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23927486",
    "question": "Does quorum sensing influence growth and photosynthetic membrane production in high-cell-density cultivations of Rhodospirillum rubrum?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Let me analyze this question. It's asking about whether quorum sensing (a bacterial communication mechanism) affects two specific processes in Rhodospirillum rubrum when grown at high cell densities: 1) growth and 2) photosynthetic membrane production. To answer this accurately, I would need to know if scientific studies have demonstrated this relationship specifically for R. rubrum. Based on my knowledge, quorum sensing has been shown to regulate various physiological processes in many bacteria, including some photosynthetic bacteria. For R. rubrum specifically, research has indicated that quorum sensing does influence both growth patterns and the production of photosynthetic membranes when these bacteria are grown at high cell densities. The bacteria use quorum sensing to coordinate their metabolic activities based on population density, which affects both their growth rate and the production of photosynthetic apparatus.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23117161",
    "question": "Are qRS duration and QRS fractionation on surface electrocardiogram markers of right ventricular dysfunction and atrialization in patients with Ebstein anomaly?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if qRS duration and QRS fractionation on surface electrocardiogram are markers of right ventricular dysfunction and atrialization in patients with Ebstein anomaly. Ebstein anomaly is a congenital heart defect where the tricuspid valve is abnormally formed and positioned, often leading to right ventricular dysfunction and atrialization (where part of the right ventricle becomes functionally part of the right atrium). \\n\\nBased on medical literature, prolonged QRS duration and QRS fractionation on ECG are indeed associated with right ventricular dysfunction in Ebstein anomaly. These ECG findings reflect the abnormal ventricular conduction and myocardial activation that occurs with the anatomical and functional changes in the right ventricle in this condition. Multiple studies have shown correlations between these ECG parameters and the severity of right ventricular dysfunction and atrialization in Ebstein anomaly patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19270731",
    "question": "Is the cellular distribution of serotonin transporter impeded on serotonin-altered vimentin network?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the relationship between the cellular distribution of serotonin transporter (SERT) and the vimentin network that has been altered by serotonin. Specifically, it's asking if the distribution of SERT is impeded (hindered or blocked) when the vimentin network is altered by serotonin. To answer this, I would need to know if there's evidence showing that alterations in the vimentin network caused by serotonin affect the distribution of SERT in cells. This is a specific biochemical/cellular question that requires knowledge of research in this area. Based on my knowledge, there is research suggesting that the vimentin cytoskeleton can interact with and affect the distribution of various transporters, including potentially SERT, and that serotonin can modify vimentin. However, without specific evidence directly linking serotonin-altered vimentin to impeded SERT distribution, I cannot confidently answer yes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "9439403",
    "question": "Is post-operative blood loss after transurethral prostatectomy dependent on in situ fibrinolysis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if post-operative blood loss after transurethral prostatectomy is dependent on in situ fibrinolysis. This is a specific medical question about the mechanism of bleeding after prostate surgery. Fibrinolysis is the process that prevents blood clots from growing and becoming problematic, and 'in situ fibrinolysis' refers to this process occurring locally at the surgical site. The question is asking whether this local clot-dissolving activity is responsible for blood loss after this specific type of prostate surgery. This is a specialized medical research question that would require specific studies examining the relationship between measured fibrinolytic activity and blood loss in this surgical context. Without citing specific medical literature on this topic, I cannot definitively answer this question.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23799977",
    "question": "Do non-radiological method for three-dimensional implant position evaluation using an intraoral scan method?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether non-radiological methods exist for three-dimensional implant position evaluation using an intraoral scan method. Intraoral scanning is indeed a non-radiological method that can be used for evaluating implant positions in three dimensions. These scanners use optical technology (typically light or laser) to capture the 3D geometry of dental structures without using radiation. They can be used to evaluate implant positions by scanning special scan bodies attached to implants or by directly scanning implant platforms. The digital data from these scans can then be used to assess the 3D position of implants. So yes, non-radiological methods do exist for 3D implant position evaluation using intraoral scanning.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19936373",
    "question": "Does hepatitis C virus induce nasal epithelial erosion and sub-epithelial rhinitis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"I need to determine if hepatitis C virus (HCV) causes nasal epithelial erosion and sub-epithelial rhinitis. HCV primarily affects the liver, causing hepatitis and potentially leading to cirrhosis and liver cancer. It's a bloodborne virus that targets hepatocytes (liver cells). While HCV can have extrahepatic manifestations affecting other organ systems (like cryoglobulinemia affecting blood vessels, or associations with certain skin conditions), I'm not aware of any established connection between HCV and nasal pathology specifically. HCV is not known to directly infect or damage nasal epithelial tissue or cause rhinitis. These would be unusual and non-characteristic manifestations for hepatitis C virus.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15569889",
    "question": "Do hippocampal volume in adult burn patients with and without posttraumatic stress disorder?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question seems incomplete. It's asking about hippocampal volume in adult burn patients with and without PTSD, but it doesn't specify what about the hippocampal volume - whether it differs, decreases, increases, etc. The question as stated doesn't form a complete yes/no question. I need to interpret what's being asked. I believe the question is trying to ask whether hippocampal volume differs between adult burn patients with PTSD and those without PTSD. Research has shown that PTSD is often associated with reduced hippocampal volume, but I can't answer definitively about this specific population without more context. Since the question is incomplete and doesn't form a proper yes/no question, I should indicate this.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19095788",
    "question": "Does proton MR spectroscopy improve discrimination between tumor and pseudotumoral lesion in solid brain masses?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses. To answer this, I need to consider the diagnostic capabilities of proton MR spectroscopy in differentiating true brain tumors from lesions that mimic tumors (pseudotumoral lesions) on conventional imaging.\\n\\nProton MR spectroscopy (MRS) is an advanced MRI technique that provides biochemical information about tissues by measuring metabolite concentrations. It can detect changes in metabolites like N-acetylaspartate (NAA), choline, creatine, lactate, and lipids. \\n\\nResearch has shown that proton MRS can help differentiate various brain pathologies based on their metabolic profiles. Tumors typically show elevated choline (marker of cell membrane turnover) and reduced NAA (neuronal marker), while different patterns may be seen in inflammatory lesions, demyelinating diseases, and other pseudotumoral conditions.\\n\\nNumerous studies have demonstrated that adding MR spectroscopy to conventional MRI improves diagnostic accuracy in distinguishing neoplastic from non-neoplastic lesions. It provides additional metabolic information that complements the anatomical data from standard MRI.\\n\\nBased on the established literature, proton MR spectroscopy does improve discrimination between tumor and pseudotumoral lesions in solid brain masses.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12552214",
    "question": "Does activation of peripheral excitatory amino acid receptors decrease the duration of local anesthesia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether activation of peripheral excitatory amino acid receptors decreases the duration of local anesthesia. To answer this, I need to consider the relationship between excitatory amino acid receptors (like NMDA and AMPA receptors) and local anesthetics.\\n\\nExcitatory amino acid receptors, when activated, typically increase neuronal excitability and promote signal transmission. Local anesthetics work by blocking sodium channels, preventing nerve impulse generation and transmission, thus causing numbness and loss of sensation.\\n\\nResearch has shown that activation of peripheral excitatory amino acid receptors (particularly NMDA receptors) can actually enhance nociception (pain perception) and potentially counteract the effects of local anesthetics. This suggests that activating these receptors could indeed decrease the duration or effectiveness of local anesthesia by opposing its inhibitory effects.\\n\\nBased on the neurophysiological mechanisms, the answer appears to be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27219231",
    "question": "Does concomitant Liposuction reduce Complications of Vertical Medial Thigh Lift in Massive Weight Loss Patients?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether concomitant liposuction (performing liposuction at the same time) reduces complications when doing vertical medial thigh lifts in patients who have experienced massive weight loss. To answer this, I would need specific medical research or studies that have compared complication rates between thigh lift procedures with and without simultaneous liposuction in this specific patient population. Without being provided such evidence in the question, and not having access to medical databases to check for such studies, I cannot make a definitive claim about whether concomitant liposuction reduces complications in this specific procedure for this specific patient group. There are theoretical arguments both ways - liposuction might reduce tension on closure but might also increase risks of seroma or other complications. Without specific evidence, I cannot provide a yes or no answer with confidence.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "10583306",
    "question": "Does acute dexamethasone administration enhance GH responsiveness to GH releasing peptide-6 ( GHRP-6 ) in man?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question. It's asking whether acute (short-term) administration of dexamethasone (a synthetic glucocorticoid) enhances the growth hormone (GH) response to GHRP-6 (a growth hormone releasing peptide) in humans. To answer this, I would need to know about studies that specifically examined this interaction. Based on the endocrinology literature, glucocorticoids like dexamethasone typically suppress GH secretion rather than enhance it. However, the specific interaction with GHRP-6 might be different. Without specific studies showing that acute dexamethasone enhances GH responsiveness to GHRP-6, I cannot confirm this effect.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "11136942",
    "question": "Does prolonged mild hypothermia therapy protect the brain against permanent focal ischemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if prolonged mild hypothermia therapy protects the brain against permanent focal ischemia. Focal ischemia refers to a reduction in blood flow to a specific area of the brain, which can lead to tissue damage. Hypothermia therapy involves lowering body temperature to reduce metabolic demands and potentially protect tissues during periods of reduced blood flow.\\n\\nBased on scientific literature, mild hypothermia has been shown to have neuroprotective effects in various models of brain injury, including focal ischemia. Clinical and experimental studies have demonstrated that mild hypothermia can reduce infarct size, decrease inflammatory responses, and improve neurological outcomes after focal ischemic events. The protective mechanisms include reduction of metabolic rate, decreased excitotoxicity, reduced free radical production, and preservation of the blood-brain barrier.\\n\\nSo, does prolonged mild hypothermia therapy protect the brain against permanent focal ischemia? The evidence from both animal models and clinical studies suggests that it does provide protection, though the degree of protection may vary depending on timing, duration, and depth of hypothermia.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23312561",
    "question": "Does elevated reward region responsivity predict future substance use onset but not overweight/obesity onset?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking whether increased responsivity in brain reward regions predicts the onset of substance use but does not predict the onset of overweight/obesity. To answer this, I need to consider whether there's scientific evidence showing that heightened activity in reward regions of the brain (like the nucleus accumbens, ventral tegmental area, etc.) specifically predicts future substance use initiation while simultaneously not predicting weight gain or obesity development. This is a specific neuroscience claim about differential predictive relationships between reward processing and two different health outcomes. Without specific research studies that have directly tested this differential relationship, I cannot confidently answer yes.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22521381",
    "question": "Do fragmented QRS complexes predict right ventricular dysfunction and outflow tract aneurysms in patients with repaired tetralogy of Fallot?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the predictive value of fragmented QRS complexes for specific cardiac complications in patients with repaired tetralogy of Fallot (TOF). Specifically, it asks whether these fragmented QRS complexes can predict: 1) right ventricular dysfunction, and 2) outflow tract aneurysms in this specific patient population.\\n\\nTo answer this accurately, I would need to know if there is established evidence in cardiology literature showing that fragmented QRS complexes are reliable predictors of these specific complications in repaired TOF patients. \\n\\nBased on my knowledge, fragmented QRS complexes (fQRS) have been associated with myocardial scarring and fibrosis in various cardiac conditions. In patients with repaired tetralogy of Fallot, studies have indeed shown that fQRS can be markers of right ventricular dysfunction and may correlate with adverse outcomes. Some research has demonstrated that the presence and extent of fQRS on ECG correlate with right ventricular enlargement, dysfunction, and fibrosis as detected by cardiac MRI in these patients.\\n\\nRegarding outflow tract aneurysms specifically, there is evidence suggesting that fQRS can be associated with right ventricular outflow tract issues in repaired TOF, though the direct predictive relationship with aneurysms may be less extensively documented than the relationship with general RV dysfunction.\\n\\nBased on the available evidence, I believe the answer is yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27316323",
    "question": "Is pI3K pathway involved in ERK signaling cascade activation by histamine H2R agonist in HEK293T cells?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To answer this question, I need to analyze whether there's evidence that PI3K (phosphoinositide 3-kinase) pathway is involved in ERK signaling cascade activation specifically when histamine H2 receptors (H2R) are activated by an agonist in HEK293T cells.\\n\\nWhat I know about these pathways:\\n- PI3K pathway typically activates AKT and can cross-talk with MAPK/ERK pathway\\n- ERK (Extracellular signal-Regulated Kinase) is part of the MAPK signaling cascade\\n- Histamine H2 receptors are G-protein coupled receptors that typically signal through Gs proteins and cAMP\\n- HEK293T cells are a specific human embryonic kidney cell line\\n\\nThe question is very specific about this particular signaling relationship in this specific cell type. Based on general signaling knowledge, H2R activation could potentially activate ERK through various mechanisms, and PI3K could be one of them. However, without specific evidence from studies showing PI3K involvement in H2R-mediated ERK activation in HEK293T cells, I cannot definitively say yes.\\n\\nFrom my knowledge base, I don't have specific evidence demonstrating that PI3K is involved in ERK activation by H2R agonists specifically in HEK293T cells. While it's possible, I don't have the specific experimental evidence to confirm this pathway interaction in this cell type.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "8203977",
    "question": "Is insulin regulation of hepatic glucose transporter protein impaired in chronic pancreatitis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if insulin regulation of hepatic glucose transporter protein is impaired in chronic pancreatitis. To answer this, I need to consider what happens in chronic pancreatitis and how it affects insulin production and function.\\n\\nChronic pancreatitis involves progressive inflammation and fibrosis of the pancreas, which damages both exocrine and endocrine functions. The endocrine portion includes the islets of Langerhans, which contain beta cells that produce insulin.\\n\\nIn chronic pancreatitis, there is often damage to these beta cells, leading to reduced insulin production and secretion. This can result in diabetes mellitus secondary to pancreatic disease (Type 3c diabetes).\\n\\nWhen insulin levels are reduced or insulin signaling is impaired, this affects various insulin-dependent processes throughout the body, including in the liver. Insulin normally regulates glucose transport proteins (particularly GLUT2 in the liver) and their translocation to cell membranes.\\n\\nSince chronic pancreatitis can lead to insulin deficiency or resistance, it is reasonable to conclude that insulin regulation of hepatic glucose transporter proteins would be impaired in this condition.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "20460558",
    "question": "Does inappropriate prescribing predict adverse drug events in older adults?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if inappropriate prescribing predicts adverse drug events in older adults. Based on research in geriatric pharmacology and medication safety, there is substantial evidence that inappropriate prescribing (such as prescribing medications that are contraindicated in older adults, prescribing excessive doses, or medications with significant drug-drug interactions) is associated with higher rates of adverse drug events in older populations. Multiple studies using criteria like the Beers Criteria or STOPP/START criteria have demonstrated that potentially inappropriate medications increase the risk of adverse outcomes including falls, hospitalizations, and other medication-related problems in elderly patients. So there is a predictive relationship between inappropriate prescribing and adverse drug events in older adults.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "19476603",
    "question": "Is electrical impedance tomography able to track changes in respiratory function in endotoxin-challenged rodents?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if electrical impedance tomography (EIT) can track changes in respiratory function in rodents that have been challenged with endotoxin. To answer this, I need to consider what is known about EIT technology and its applications in respiratory monitoring, particularly in animal models with endotoxin challenges.\\n\\nElectrical impedance tomography is a non-invasive imaging technique that measures electrical conductivity distribution within a body section. In respiratory applications, it can detect changes in air volume in the lungs because air has different electrical properties than tissue.\\n\\nResearch has shown that EIT can indeed be used to monitor regional lung ventilation and detect changes in respiratory function. There are published studies demonstrating the use of EIT to track respiratory changes in various animal models, including rodents, after different challenges including endotoxin administration (which simulates sepsis or acute lung injury).\\n\\nSpecifically, researchers have used EIT to monitor the progression of lung injury, changes in regional ventilation, and response to treatments in endotoxin-challenged rodent models. The technology has been validated against other respiratory monitoring techniques in these settings.\\n\\nBased on the scientific literature, EIT has been successfully used to track respiratory function changes in endotoxin-challenged rodents.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "9808608",
    "question": "Does direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augment revascularization in the rabbit ischemic hindlimb?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether direct intramuscular injection of plasmid DNA encoding angiopoietin-1 augments revascularization in the rabbit ischemic hindlimb, while plasmid DNA encoding angiopoietin-2 does not have this effect. Let me analyze this carefully.\\n\\nThe statement contains a contrast between angiopoietin-1 and angiopoietin-2. It's claiming that:\\n1. Plasmid DNA encoding angiopoietin-1 DOES augment revascularization in the rabbit ischemic hindlimb when directly injected intramuscularly.\\n2. Plasmid DNA encoding angiopoietin-2 does NOT augment revascularization in the same model.\\n\\nThe question is asking if this contrast is true. Without specific scientific knowledge about these experiments, I need to take the question at face value and determine if the statement as presented is accurate.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23433781",
    "question": "Is leukoaraiosis associated with short- and long-term mortality in patients with intracerebral hemorrhage?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if leukoaraiosis (a type of white matter disease seen on brain imaging) is associated with both short-term and long-term mortality in patients who have intracerebral hemorrhage (bleeding in the brain tissue).\\n\\nLeukoaraiosis is characterized by white matter changes/damage that appears as hypodensities on CT scans or hyperintensities on T2-weighted MRI. It's often associated with small vessel disease and vascular risk factors.\\n\\nResearch has shown that leukoaraiosis is indeed associated with worse outcomes in patients with intracerebral hemorrhage. Multiple studies have demonstrated that the presence and severity of leukoaraiosis correlate with both short-term mortality (in-hospital or 30-day) and long-term mortality (months to years) in ICH patients. The association is often independent of other prognostic factors like age, hematoma volume, and Glasgow Coma Scale.\\n\\nThis relationship likely exists because leukoaraiosis represents underlying cerebrovascular disease that compromises the brain's ability to recover from the acute injury of hemorrhage.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15139917",
    "question": "Does the Neurospora crassa cfp promoter drive a carbon source-dependent expression of transgenes in filamentous fungi?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if the Neurospora crassa cfp promoter drives carbon source-dependent expression of transgenes in filamentous fungi. Let me analyze what I know about this promoter:\\n\\nThe cfp (copper-fist protein) promoter in Neurospora crassa is indeed known to be regulated by carbon sources. It shows different expression levels depending on the available carbon source in the growth medium. This promoter has been characterized and used in molecular biology applications with filamentous fungi, where its expression is modulated depending on whether glucose, sucrose, or alternative carbon sources are present. This carbon source-dependent regulation makes it useful for controlled expression of transgenes in filamentous fungi systems.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "17869063",
    "question": "Is myocardial radial strain in early diastole useful for assessing left ventricular early diastolic function : comparison with invasive parameters?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether myocardial radial strain in early diastole is useful for assessing left ventricular early diastolic function, specifically when compared with invasive parameters. This appears to be asking about a specific medical diagnostic technique and its clinical utility. To answer this accurately, I would need to know if studies have validated radial strain measurements in early diastole against invasive hemodynamic parameters (the gold standard for diastolic function assessment). Research has shown that various strain parameters (including radial strain) can provide insights into diastolic function, and some studies have compared these non-invasive measurements with invasive parameters. Based on current literature, myocardial strain imaging, including radial strain, has demonstrated utility in assessing diastolic function when compared with invasive measurements.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25577303",
    "question": "Does depression attribute Among White Non-Hispanic and Mexican-Origin Older Men?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether depression is attributed to or associated with White Non-Hispanic and Mexican-Origin older men. This is asking if depression is a characteristic or attribute found among these specific demographic groups. The question is somewhat unclear, but it seems to be asking if depression is present or observed in these populations. Based on research, depression can affect people of all racial, ethnic, and age groups, including White Non-Hispanic and Mexican-Origin older men. So depression would be an attribute that can be found among these populations, though rates and manifestations might vary.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25891929",
    "question": "Is a functional polymorphism of the microRNA-146a gene associated with susceptibility to drug-resistant epilepsy and seizures frequency?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about a specific relationship between a functional polymorphism of the microRNA-146a gene and two outcomes: (1) susceptibility to drug-resistant epilepsy and (2) seizure frequency. To answer this, I would need to know if there are scientific studies that have established such associations. Based on my knowledge, there have indeed been studies suggesting that microRNA-146a gene polymorphisms are associated with susceptibility to drug-resistant epilepsy. For example, some research has found that certain variants of this gene may influence inflammatory processes in the brain that affect drug response in epilepsy patients. There is also evidence suggesting correlations between these polymorphisms and seizure frequency in some patient populations. The research in this area supports a positive association.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "24335168",
    "question": "Does metformin inhibit esophagus cancer proliferation through upregulation of USP7?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To answer this question, I need to analyze whether there's established scientific evidence that metformin inhibits esophageal cancer proliferation specifically through upregulation of USP7 (Ubiquitin Specific Peptidase 7).\\n\\nMetformin is a widely used anti-diabetic drug that has shown anti-cancer properties in various cancer types. Its anti-cancer mechanisms include AMPK activation, mTOR inhibition, and various other pathways.\\n\\nUSP7 is a deubiquitinating enzyme that plays roles in multiple cellular processes including DNA damage response and tumor suppression or promotion depending on context.\\n\\nWhile metformin has been studied in esophageal cancer, and there are studies on USP7 in cancer biology, I'm not aware of established evidence specifically linking metformin's anti-esophageal cancer effects to USP7 upregulation. This would require specific studies demonstrating: 1) metformin inhibits esophageal cancer proliferation, 2) metformin upregulates USP7, and 3) this upregulation is causally linked to the anti-proliferative effect.\\n\\nTo my knowledge, this specific mechanism (metformin inhibiting esophageal cancer through USP7 upregulation) has not been conclusively established in the scientific literature.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21715037",
    "question": "Does aMPK regulate metabolism and survival in response to ionizing radiation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if aMPK (AMP-activated protein kinase) regulates metabolism and survival in response to ionizing radiation. Based on scientific literature, AMPK is indeed known to be activated in response to various stressors including ionizing radiation. When cells are exposed to ionizing radiation, there is often metabolic stress and DNA damage, which can lead to AMPK activation. Once activated, AMPK helps regulate cellular metabolism by promoting catabolic pathways to generate ATP while inhibiting anabolic processes. It also plays a role in cell survival pathways, autophagy, and DNA damage responses. Multiple studies have demonstrated that AMPK activation following radiation exposure can influence cellular survival outcomes, either promoting survival through metabolic adaptation or contributing to cell death depending on the context and severity of damage. Therefore, there is substantial evidence that AMPK regulates both metabolism and survival in response to ionizing radiation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "27207270",
    "question": "Does lATE ELONGATED HYPOCOTYL regulate photoperiodic flowering via the circadian clock in Arabidopsis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether LATE ELONGATED HYPOCOTYL (LHY) regulates photoperiodic flowering via the circadian clock in Arabidopsis. LHY is indeed a key component of the circadian clock in Arabidopsis thaliana. It is a MYB-related transcription factor that, together with CIRCADIAN CLOCK ASSOCIATED 1 (CCA1), forms part of the central oscillator of the plant circadian clock. Research has shown that LHY does play a role in regulating photoperiodic flowering through its function in the circadian clock. It affects the expression of genes involved in photoperiodic flowering pathways, particularly CONSTANS (CO), which is a key regulator of flowering time in response to day length. Mutations in LHY alter flowering time in Arabidopsis, supporting its role in this process.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "12932169",
    "question": "Is leucine 7 to proline 7 polymorphism of the preproneuropeptide Y gene associated with restenosis after coronary stenting?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about a specific genetic polymorphism (leucine 7 to proline 7 polymorphism of the preproneuropeptide Y gene) and whether it's associated with restenosis (re-narrowing of a blood vessel) after coronary stenting (a procedure to open blocked coronary arteries). To answer this, I would need to know if there are scientific studies showing a statistically significant association between this specific genetic variant and the clinical outcome of restenosis after stenting. Without specific knowledge of the research literature on this topic, I cannot provide a definitive answer.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "24618767",
    "question": "Is epistasis between polymorphisms in PCSK1 and DBH associated with premature ovarian failure?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if there is an association between epistasis (gene-gene interaction) involving polymorphisms in two specific genes (PCSK1 and DBH) and premature ovarian failure (POF). To answer this, I would need to know if there are scientific studies that have demonstrated such an association. Based on my knowledge, while both PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1) and DBH (Dopamine Beta-Hydroxylase) are important genes with various functions, I'm not aware of specific research establishing epistatic interactions between these two genes in relation to premature ovarian failure. POF (now often called primary ovarian insufficiency) has been associated with various genetic factors, but I don't recall evidence specifically linking epistasis between PCSK1 and DBH polymorphisms to this condition.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "19202305",
    "question": "Does chronic smoking prevent amelioration of endothelial function in the course of the menstrual cycle?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking whether chronic smoking prevents the improvement (amelioration) of endothelial function (the function of cells lining blood vessels) that normally occurs during the menstrual cycle. \\n\\nTo answer this, I need to consider what research shows about:\\n1. Normal endothelial function changes during the menstrual cycle\\n2. How smoking affects endothelial function\\n3. Whether smoking specifically interferes with menstrual cycle-related improvements in endothelial function\\n\\nResearch has shown that endothelial function typically improves during certain phases of the menstrual cycle, particularly during the follicular phase when estrogen levels rise. Estrogen has vasodilatory and anti-inflammatory effects that benefit endothelial function.\\n\\nChronic smoking is well-documented to cause endothelial dysfunction through oxidative stress, inflammation, and reduced nitric oxide bioavailability.\\n\\nStudies have indeed found that women who smoke chronically do not experience the same improvements in endothelial function during the menstrual cycle as non-smoking women. The toxic effects of smoking appear to override or block the beneficial effects of cyclical hormonal changes on the endothelium.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15774218",
    "question": "Are [ ERK1/2 and p38 kinases important regulators in P2Y receptor-mediated prostate cancer invasion ]?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks if ERK1/2 and p38 kinases are important regulators in P2Y receptor-mediated prostate cancer invasion. This is a specific scientific question about molecular signaling pathways in cancer biology. To answer this accurately, I would need to know if research has established these kinases as key regulators in this specific pathway. Based on my knowledge of cancer biology, ERK1/2 and p38 are indeed important MAP kinases involved in various cancer progression pathways, including invasion and metastasis. P2Y receptors are purinergic receptors that can activate various signaling cascades. There is scientific literature supporting that P2Y receptor activation can signal through ERK1/2 and p38 MAPK pathways in various cancer types, including prostate cancer, and these pathways can contribute to cancer cell invasion. Therefore, the answer appears to be yes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "16210933",
    "question": "Do glucose abnormalities and heart failure predict poor prognosis in the population-based Reykjavík Study?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether glucose abnormalities and heart failure are predictors of poor prognosis in a specific study called the Reykjavík Study, which appears to be a population-based study conducted in Reykjavík, Iceland. To answer this question accurately, I would need to know the findings of this specific study. Without having access to the results of the Reykjavík Study, I cannot definitively say whether these factors were found to predict poor prognosis in that particular research. This appears to be asking about the findings of a specific scientific study rather than a general medical fact.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "11500531",
    "question": "Do changes of adiposity in response to vitamin A status correlate with changes of PPAR gamma 2 expression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the correlation between changes in adiposity (fat accumulation in the body) in response to vitamin A status and changes in PPAR gamma 2 expression. PPAR gamma 2 (Peroxisome Proliferator-Activated Receptor gamma 2) is a nuclear receptor that regulates adipocyte differentiation and glucose metabolism.\\n\\nTo answer this question, I need to consider whether there is evidence in the scientific literature showing a correlation between these two factors. Based on research, vitamin A and its metabolites (particularly retinoic acid) can influence adipocyte differentiation and function. There are studies suggesting that vitamin A status can affect PPAR gamma expression, including the PPAR gamma 2 isoform which is predominantly expressed in adipose tissue. Some research indicates that retinoic acid (a vitamin A metabolite) can inhibit adipogenesis by suppressing PPAR gamma 2 expression.\\n\\nSo yes, there appears to be evidence supporting a correlation between changes in adiposity in response to vitamin A status and changes in PPAR gamma 2 expression.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "23351133",
    "question": "Do surface-stabilized lopinavir nanoparticles enhance oral bioavailability without coadministration of ritonavir?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether surface-stabilized lopinavir nanoparticles can enhance oral bioavailability without needing to coadminister ritonavir. Lopinavir is an HIV protease inhibitor that typically has poor oral bioavailability due to extensive first-pass metabolism and P-glycoprotein efflux. In clinical practice, lopinavir is almost always coadministered with ritonavir (a CYP3A4 inhibitor) to boost its bioavailability - this combination is known as Kaletra. The question is specifically asking if nanoparticle formulation technology can overcome the need for this ritonavir boosting effect. Based on pharmaceutical research literature, surface-stabilized nanoparticle formulations of lopinavir have indeed been shown to enhance oral bioavailability without requiring ritonavir coadministration. The nanoparticle formulation helps protect lopinavir from first-pass metabolism and enhances its absorption through the intestinal epithelium.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "22008878",
    "question": "Do acalypha wilkesiana extracts induce apoptosis by causing single strand and double strand DNA breaks?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if acalypha wilkesiana extracts induce apoptosis by causing single strand and double strand DNA breaks. To answer this, I need to consider what is known about the mechanism of action of acalypha wilkesiana extracts on cells. Based on scientific literature, acalypha wilkesiana (commonly known as copper leaf or fire dragon) extracts have been studied for potential anticancer properties. Some studies have shown that these extracts can induce apoptosis (programmed cell death) in cancer cells. However, the specific mechanism involving DNA strand breaks needs verification. While some plant extracts with cytotoxic properties do cause DNA damage leading to apoptosis, I need to be careful not to assume this specific mechanism for acalypha wilkesiana without evidence. From my knowledge, while acalypha wilkesiana extracts have been shown to induce apoptosis in some studies, the specific mechanism involving single and double strand DNA breaks has not been definitively established as the primary pathway.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "15335813",
    "question": "Does association of pRas and pRaf-1 in a complex correlate with activation of a signal transduction pathway?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"This question is asking about the correlation between the association of pRas and pRaf-1 in a complex and the activation of a signal transduction pathway. In cellular signaling, Ras is a small GTPase that, when activated (phosphorylated, becoming pRas), can bind to and activate Raf-1 (becoming pRaf-1). This interaction is a key step in the MAPK/ERK pathway, which is a major signal transduction pathway involved in cell growth, differentiation, and survival. The binding of pRas to pRaf-1 is indeed a critical event that leads to downstream signaling events in this pathway. So yes, the association of pRas and pRaf-1 in a complex does correlate with the activation of a signal transduction pathway, specifically the MAPK/ERK pathway.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "25981324",
    "question": "Is polymorphisms of rs174616 in the FADS1-FADS2 gene cluster associated with a reduced risk of type 2 diabetes mellitus in northern Han Chinese people?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about a specific genetic association: whether polymorphisms of rs174616 in the FADS1-FADS2 gene cluster are associated with a reduced risk of type 2 diabetes mellitus specifically in northern Han Chinese people. To answer this accurately, I would need to know about studies that have specifically examined this genetic variant in this particular population with respect to type 2 diabetes risk. Without specific knowledge of research demonstrating this association in northern Han Chinese populations, I cannot confirm this relationship. The question is very specific about the genetic variant (rs174616), the gene cluster (FADS1-FADS2), the direction of association (reduced risk), the condition (type 2 diabetes mellitus), and the population (northern Han Chinese). Without specific evidence for this precise association, I should answer 'no'.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "20690561",
    "question": "Is hepatitis C genotype 4 response rate to pegylated interferon and ribavirin treatment in Belgium similar to genotype 1?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if the response rate to pegylated interferon and ribavirin treatment for hepatitis C genotype 4 is similar to genotype 1 in Belgium specifically. To answer this accurately, I would need specific clinical data from Belgian studies comparing these two genotypes' treatment responses. Genotypes 1 and 4 are generally considered more difficult to treat with pegylated interferon and ribavirin compared to genotypes 2 and 3, but there can be regional variations in response rates. Without specific Belgian data, I cannot make a definitive comparison between genotype 4 and genotype 1 response rates in that country.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "22327086",
    "question": "Do influence of a new bicycle crank design on aerobic parameters of non-cyclists?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether a new bicycle crank design has an influence on aerobic parameters of non-cyclists. This is asking about a causal relationship between a bicycle component design and physiological measurements in people who don't regularly cycle. The question is phrased in a somewhat grammatically incorrect way - it should be 'Does the influence...' or 'Is there an influence...' rather than 'Do influence...'. However, I understand it's asking if a bicycle crank design affects aerobic parameters in non-cyclists. Without specific research or data provided in the question, I cannot make a definitive claim about whether such an influence exists.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23455443",
    "question": "Is enteral nutrition associated with improved outcome in patients with severe sepsis . A secondary analysis of the VISEP trial?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking if enteral nutrition is associated with improved outcomes in patients with severe sepsis, specifically referring to a secondary analysis of the VISEP trial. To answer this, I would need to know the specific findings of this secondary analysis of the VISEP trial. The VISEP trial was a randomized controlled trial that primarily studied intensive insulin therapy and pentastarch resuscitation in patients with severe sepsis. Without knowing the specific results of the secondary analysis regarding enteral nutrition, I cannot provide a definitive yes or no answer based on the information given.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "17488769",
    "question": "Is n-terminal pro-B-type natriuretic peptide better than TIMI risk score at predicting death after acute myocardial infarction?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking me to compare the predictive value of n-terminal pro-B-type natriuretic peptide (NT-proBNP) versus the TIMI risk score specifically for predicting mortality after acute myocardial infarction (heart attack).\\n\\nTo answer this accurately, I would need to review clinical studies that directly compare these two prognostic tools. NT-proBNP is a biomarker that reflects cardiac wall stress and has been shown to have prognostic value in heart failure and acute coronary syndromes. The TIMI risk score is a well-established clinical risk stratification tool specifically developed for patients with acute coronary syndromes.\\n\\nSome studies have suggested that NT-proBNP provides independent and potentially complementary prognostic information to clinical risk scores like TIMI. However, to definitively state that one is 'better' than the other would require consistent evidence from multiple comparative studies showing superior predictive value.\\n\\nWithout citing specific comparative studies that consistently demonstrate superiority of NT-proBNP over TIMI for post-MI mortality prediction, I cannot make a definitive claim that one is better than the other. The current consensus in cardiology generally views biomarkers like NT-proBNP as complementary to, rather than replacements for, clinical risk scores.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23800645",
    "question": "Does diacylglycerol promote GLUT4 translocation to the cell surface in a PKCε-dependent and PKCλ/ι and -ζ-independent manner?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"This question is asking about the specific mechanism by which diacylglycerol (DAG) promotes GLUT4 translocation to the cell surface. Specifically, it's asking whether this process depends on PKCε but is independent of PKCλ/ι and PKCζ.\\n\\nTo answer this, I need to consider what's known about DAG signaling and GLUT4 translocation:\\n\\n1. DAG is a second messenger that activates several PKC isoforms\\n2. GLUT4 translocation is important for glucose uptake, especially in muscle and fat cells\\n3. The question specifically asks about dependency on PKCε and independence from PKCλ/ι and PKCζ\\n\\nBased on the scientific literature, DAG does activate conventional and novel PKCs (including PKCε), but the atypical PKCs (PKCλ/ι and PKCζ) are generally not directly activated by DAG. However, whether GLUT4 translocation specifically occurs through PKCε and not through PKCλ/ι and PKCζ is a specific mechanistic detail.\\n\\nThe consensus in the field is that insulin-stimulated GLUT4 translocation primarily involves atypical PKCs (PKCλ/ι and PKCζ) downstream of PI3K, while DAG-activated novel PKCs like PKCε may be involved in alternative pathways of GLUT4 translocation. However, DAG-stimulated GLUT4 translocation is not exclusively dependent on PKCε while being completely independent of atypical PKCs.\\n\\nSo the answer would be no, as this statement oversimplifies the complex signaling involved in GLUT4 translocation.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "12511150",
    "question": "Is axillary dissection required for all patients with breast cancer and positive sentinel nodes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if axillary lymph node dissection (ALND) is required for all breast cancer patients who have positive sentinel lymph nodes. This is an important clinical question about surgical management of breast cancer.\\n\\nBased on current medical evidence and guidelines, axillary dissection is NOT required for all patients with positive sentinel nodes. Several major clinical trials (including the ACOSOG Z0011 trial) have shown that certain patients with limited sentinel node involvement (1-2 positive nodes) who are undergoing breast conservation therapy with whole breast radiation and systemic therapy can safely avoid complete axillary dissection without compromising survival outcomes.\\n\\nThe current approach is more selective, with factors like the extent of nodal involvement, tumor characteristics, planned treatments, and patient factors all influencing the decision. Many patients with limited sentinel node involvement can now avoid the additional morbidity of complete axillary dissection.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "id": "27055012",
    "question": "Does a CpG-SNP Located within the ARPC3 Gene Promoter be Associated with Hypertriglyceridemia in Severely Obese Patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking if a specific type of genetic variant (a CpG-SNP) that is located in the promoter region of the ARPC3 gene is associated with hypertriglyceridemia (high triglyceride levels in the blood) specifically in patients who are severely obese. This is a very specific scientific question about a genetic association. Without specific research data or studies that have investigated this particular relationship, I cannot definitively answer whether such an association exists. The question appears to be asking about a specific research finding that would require evidence from genetic association studies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "21912714",
    "question": "Does early peritoneal immune response during Echinococcus granulosus establishment display a biphasic behavior?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the peritoneal immune response during the establishment of Echinococcus granulosus infection, specifically whether it displays a biphasic behavior in its early stages. To answer this, I need to recall what is known about the immune response to E. granulosus, which causes hydatid disease. Based on immunological studies, the early peritoneal immune response to E. granulosus does indeed show a biphasic pattern. Initially, there is an inflammatory response with neutrophil infiltration, followed by a shift toward a Th2-dominated response that is associated with parasite survival. This biphasic nature has been documented in experimental models where the initial pro-inflammatory response is followed by an anti-inflammatory/regulatory phase that allows parasite establishment.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "id": "15951286",
    "question": "Are numerous erythroblasts in maternal blood impervious to fluorescent in situ hybridization analysis , a feature related to a dense compact nucleus with apoptotic character?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if numerous erythroblasts in maternal blood are impervious (resistant) to fluorescent in situ hybridization (FISH) analysis, and if this imperviousness is related to a dense compact nucleus with apoptotic character.\\n\\nErythroblasts are nucleated red blood cell precursors. In maternal blood, fetal nucleated red blood cells can sometimes be found, and these can be analyzed using FISH to determine fetal genetic characteristics. \\n\\nThe key claim here is whether these cells are 'impervious' to FISH analysis due to their nuclear characteristics. In fact, erythroblasts can be successfully analyzed using FISH techniques. While some erythroblasts, particularly those undergoing apoptosis (programmed cell death), might have condensed chromatin that makes FISH analysis more challenging, they are not generally impervious to this technique. FISH has been successfully used to analyze erythroblasts in maternal blood for prenatal diagnosis.\\n\\nTherefore, the answer is no - erythroblasts in maternal blood are not generally impervious to FISH analysis.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "21559523",
    "question": "Is tMEFF2 a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including glioma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Let me analyze this question. It's asking if tMEFF2 is a protein that binds to PDGF-AA and has methylation-associated gene silencing in multiple cancer types, including glioma. I need to determine if this is an accurate characterization of tMEFF2.\\n\\nMEFF2 (mesoderm induction early response 1, family member 2) is known to be a transmembrane protein with EGF-like domains. It can undergo methylation-associated silencing in various cancers. However, I don't have specific information indicating that MEFF2 is a PDGF-AA binding protein. PDGF-AA (Platelet-derived growth factor subunit A) has its own specific receptors, primarily PDGFR-α, and I don't recall evidence that MEFF2 is among its binding partners.\\n\\nWhile MEFF2 methylation has been observed in cancers including gliomas, the specific claim about it being a PDGF-AA binding protein appears incorrect based on my knowledge.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23877744",
    "question": "Does etanercept induce low QRS voltage and autonomic dysfunction in mice with experimental Chagas disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks whether etanercept induces low QRS voltage and autonomic dysfunction in mice with experimental Chagas disease. To answer this, I would need specific research evidence about etanercept's effects in this particular disease model. Etanercept is a TNF-alpha inhibitor used for autoimmune conditions, but without specific studies showing it causes these cardiac effects in Chagas disease mouse models, I cannot confirm this claim. I don't have evidence that etanercept specifically induces low QRS voltage and autonomic dysfunction in mice with Chagas disease.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "id": "23217055",
    "question": "Does adenosine A2A receptor activation reduce recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks if adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment. To answer this, I would need specific research evidence about this particular receptor's effects in this specific context. Without having access to specific studies on adenosine A2A receptor activation in C. difficile infection models in mice post-vancomycin treatment, I cannot provide a definitive answer based on established scientific evidence.\", \"answer\": \"no\"}",
    "correct": false
  }
]